<SEC-DOCUMENT>0001558370-21-015974.txt : 20211115
<SEC-HEADER>0001558370-21-015974.hdr.sgml : 20211115
<ACCEPTANCE-DATETIME>20211115161126
ACCESSION NUMBER:		0001558370-21-015974
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		77
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211115
DATE AS OF CHANGE:		20211115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Miromatrix Medical Inc.
		CENTRAL INDEX KEY:			0001527096
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				271285782
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40518
		FILM NUMBER:		211410646

	BUSINESS ADDRESS:	
		STREET 1:		10399 WEST 70TH STREET
		CITY:			EDEN PRAIRIE
		STATE:			MN
		ZIP:			55344
		BUSINESS PHONE:		(612)202-7026

	MAIL ADDRESS:	
		STREET 1:		10399 WEST 70TH STREET
		CITY:			EDEN PRAIRIE
		STATE:			MN
		ZIP:			55344
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>tmb-20210930x10q.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 9.6.7908.23199 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 11/15/2021 8:22:38 PM -->
      <!-- iXBRL Library version: 1.0.7908.23207 -->
      <!-- iXBRL Service Job ID: 1e22e3fe-291e-4275-a391-8ea152b3a883 -->

  <html xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:miro="http://miromatrix.com/20210930" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="text/html" http-equiv="content-type" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" xs:nil="true" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" name="us-gaap:CommitmentsAndContingencies" id="Hidden_a3dZYnuF80uCmmcOGnAHdg"></ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" xs:nil="true" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" name="us-gaap:CommitmentsAndContingencies" id="Hidden_8IARyE5qLU6M9kDYiwZ6Nw"></ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="Hidden_Aa8SLdhSCEmHjN0NIXjQTg">http://fasb.org/us-gaap/2021-01-31#LicenseMember</ix:nonNumeric><ix:nonNumeric contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="Hidden_Jg-kJ7EoyEe8QiseRbAy9g">http://fasb.org/us-gaap/2021-01-31#LicenseMember</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="Hidden_NtwjgHBUbE6ggkKaDV2M7w">http://fasb.org/us-gaap/2021-01-31#LicenseMember</ix:nonNumeric><ix:nonNumeric contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="Hidden_FVobFD_ldkmQEKAnaRHG_w">http://fasb.org/us-gaap/2021-01-31#LicenseMember</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="Hidden_3Z1TCFvbYESFeSplnZ2XZQ">http://fasb.org/us-gaap/2021-01-31#LicenseMember</ix:nonNumeric><ix:nonNumeric contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="Hidden_m9qCGqblck2nOBvfto9KFA">http://fasb.org/us-gaap/2021-01-31#LicenseMember</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="Hidden_rWrUtBmjtk-Ptlvu5g_p0Q">http://fasb.org/us-gaap/2021-01-31#LicenseMember</ix:nonNumeric><ix:nonNumeric contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="Hidden_yd-2sSkQ2E62uxjYMXKFvA">http://fasb.org/us-gaap/2021-01-31#LicenseMember</ix:nonNumeric><ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" sign="-" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_I4VPS8bWE0WnUenLiYZkQw">0.25</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" sign="-" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_8yC7k7zXREiHVz3catFFWA">1.37</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" sign="-" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_qMPm0a8gzUeNb9ssrLV5OA">1.08</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" sign="-" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="Hidden_66drd2pNjES43DZ-at97TQ">4.27</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_fvJrsBFr1E2lunLbPO2EXw">20145321</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_iP19vIz9-USU7gCXl-FY3Q">2183322</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_nzRDPD1O80mQadrXfO_6qA">8503743</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Hidden_CcWn9M-hb0yP9KhyA0Paww">2158632</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_XRcRC9vzqUmNSRJaT8OgEQ" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" id="Hidden_A19XiktScUSoIq3tNHnEPg">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_XRcRC9vzqUmNSRJaT8OgEQ" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" id="Hidden_U4StnGehukefsbxQPJkgtA">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_giB21kpH7UCySM-3NM5GMA" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" id="Hidden_e9vz8cVU5kOiNrHdxSP9lA">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_giB21kpH7UCySM-3NM5GMA" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" id="Hidden_ITvLAd6LUU6dorEH8hxqzQ">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_b56DfHPV7k2k1IdW58ycBg" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" id="Hidden_qLigljAiDEeLWxvU7929eQ">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_95DdDuScoU63qH12JU9kvw">20254645</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_okO5EGoGLke5FxP0c_-aoA">2185822</ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityCentralIndexKey" id="Tc_4apVpxyyf0KAUm-lEdwxlA_2_1">0001527096</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:CurrentFiscalYearEndDate" id="Tc_y1WOUxeSPEKd7O_fZQYHGQ_3_1">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:DocumentFiscalYearFocus" id="Tc_6rF0RqVjrESmovi7QBmGcg_4_1">2021</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:DocumentFiscalPeriodFocus" id="Tc_Z7LPQf0gFE25EeYZ6HlVPQ_5_1">Q3</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:AmendmentFlag" id="Tc_V6jF4MnDBECTb5NrYH-Uaw_6_1">false</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" id="Hidden_vz2qWyZfgEqnJs_vv-BXMg">2095874</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" id="Hidden_AXJ02AwWXEOrPkGjAArO4A">3218282</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_b56DfHPV7k2k1IdW58ycBg" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" id="Hidden_9PlECnxOG0GNJW38iWPKbQ">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" id="Hidden_9o88EG-w5E-Zb117OIqlQA">3000380</ix:nonFraction><ix:nonNumeric contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="Hidden_Hm1nq61nbUCGgQMTKFG8ew">P12M</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_GdaMreGh4UWpAbI1JPGEhQ">2185822</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_WX4Ga6iaZ02G6yjt970rOA">20254645</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" id="Hidden_DNi9Vf20okCb087fMwdOZw">0</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_gQqNjbZf3kitvnDKHNvcqQ" decimals="0" name="miro:AllowanceForDoubtfulAccountsRelatedParties" id="Hidden_2po9q6YWxEaI543p-8A5uQ">803404</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_saJtd_zSdkCdwSY-MhYn9A" decimals="0" name="miro:AllowanceForDoubtfulAccountsRelatedParties" id="Hidden_Q7GTX4o5nEWWyrC9lnCvQw">343672</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_cRCCz2S2j0Sk68z8xyXCTg" decimals="0" name="miro:AllowanceForDoubtfulAccountsRelatedParties" id="Hidden_V19YDa0XdUuAk6nk7v2a7g">453470</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="tmb-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="As_Of_3_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_fmQDXKgxeEiyIStEpmlASQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsCompanyShareholderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_ze4CSI6Mzk-ZR5OI8HnD8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_b56DfHPV7k2k1IdW58ycBg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_giB21kpH7UCySM-3NM5GMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_XRcRC9vzqUmNSRJaT8OgEQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesB2ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_Ho_LSq9GrEC0Bq3haRfarQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_iKt7zxYygUezKqnAXBiqsQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_P0FovK3_vEmt4Nbg26vc9g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_hOJYsLwUhE-2VMUraYrYJA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesB2ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2021_J4lgZ-q5v02aj1SQxigv9w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesB2ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_jgndyTBo4kmjINCHYzZc9Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_g67rL0VSYUuJLtgWVN02og"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_JwkSx9yECEqsu5y6ZmvOwA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_6_1_2021_To_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_s5dfWC6rwUCezVcVwV3Tlg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2015_To_1_1_2015_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_us-gaap_TypeOfArrangementAxis_miro_ResearchAndDevelopmentContractMember_6E_wdZQoSUqyfCptlYZBkg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">miro:ResearchAndDevelopmentContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Q9R7jNA_kk6E26TVZk6K5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_BAFNsPfZ306w0rPJrdHROA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_hJm_H_CmaUKQYQsG7Q0bOA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_8YSV2HeTl0O8xWN1mRaSSw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_ReKi1zH93kOF4ZIWEaTZLQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2021_SPtw5tHT3k6JDysLGb0wNw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_UkafvMeDh02ELaaw-wUr5A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_QPA5yoiM3U6iLWS98GAGHw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2021_svAh3vgTQEO6ofy12nzIaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_skQC9Tm4L068d2CO6DNYuA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_CSxBNgaEF0Os5-o-5D0nNg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_7YsfFYJ7r02IKnkspoVFDQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_IeptdhXZvES-2yRyQFy8qw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_X24d21muVUiqauo73XMZ6Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_USH1GwFq-EuR2zkUYP0bfw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2020_NdUbxN7H60abPZxL_rdgcg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_YGScN6RDoUitB_OqPuCA3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_bCstooZB5EijeOk-sHr8Sw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2020_UOLsCPKKbEmhyF78HT5_XQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_Fqh6xEaMFkaS8jG4_GyGRQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_jD--vlyzLkiWS0X8coG22g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_qsMCAn9EN0mSGkuoU6XYuQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_D8qKF6W_5EqZAfHpIf6RUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_MJo6GylBG0KwIG9o-vIDAA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Ej34jWijlUGaHWWuYVa4Yg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Ujd_JULeH0eOzL9jR9r4VQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Zp8WC33yq0ebMiPW4NZNIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ttLecL7oRkWwB-XxzLao0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_wKqlw5fr5EWLskUxmEQ3gw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_yAsbjp9bDUazwowV3IQPOg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2019_dei_LegalEntityAxis_miro_RepriseBiomedicalInc.Member_R2d8cn9CGUK8VjOUJnYEwQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_1_2015_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_us-gaap_TypeOfArrangementAxis_miro_ResearchAndDevelopmentContractMember_Y_meruMSPEO7A3bUcsxnaA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">miro:ResearchAndDevelopmentContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_miro_ExercisePriceOf1.25Member_oooEOJ4y2kee2kSZatqRNg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">miro:ExercisePriceOf1.25Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_miro_ExercisePriceOf0.10Member_xehDfIZz-EWtTdFbk8j1fQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">miro:ExercisePriceOf0.10Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_tNkW5JyZSEem2SQQAsVb6w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_20_2021_To_5_20_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_t8AKALY0zUWWcDB5cdE9FQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-20</xbrli:startDate><xbrli:endDate>2021-05-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_9z94lpGqiUK-UGTQzRUXmg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_lHsE8nx05E6MJohdoQuOHw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_2DJ3l3afI0CleWh6XWHWoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:EquityIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_o6eAWaymy0yRcfbd6hpu6g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_McJXXc_Kf0uPYR-o6Dcyzw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_7_31_2019_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_C6HVYrURKkyIQjOgOtfdLA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_13_2017_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_6aqbm-JWHUKb0XhszArtdQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_8_12_2016_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_bHSdVDHwNkir9pwGVxJShw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_7_31_2015_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_IOV5CcCN1kafEI0aNGuk7A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_1_2014_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_B1MdDsK4eU6ABBhy1iHGqQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2013_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_jitbOwlHxEatY3c8sdyT8Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_20_2011_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_p8iI4CpuukSW-_z9m6tgFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2011-06-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_28_2010_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_KR1v8aGoW06UTHLbKbrWzg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2010-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_gR2zVN5q-0a1swvGNHwoWw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_9_30_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_2DY7Kr23UEejqlQcdXp2IQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_YBwL7RLuskyd3vBZWh7WQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_BOZzIx3NHUyi4rOJ8vvwWg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_GGnger605kSAQV-cbnUI1Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_vmM7oFOzwUe43nHIwqu2bA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_cVjMYLi1J0iHUg_2B18WtQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_qnWtgiTGikOSXP25mjvZYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:ConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:CorporationOwnedByDirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_9WxjyLUpOUiRks_Oq_p5vw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:ConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:CorporationOwnedByDirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_XueQO35tzkidWpI2arMRfw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:ConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:CorporationOwnedByDirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_6W4hac0WQU-mcQ8HdTtbAQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:ConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:CorporationOwnedByDirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_fRxvAQCNO0uRd-IxLvwfDg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_meG4-bg4kUO8x0E1C04Kqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember_lwr3FLyMikqQkZtq70jcoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FurnitureFixturesAndComputersMember_S_oUYLkJy06xhe5H4RKyJw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:FurnitureFixturesAndComputersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_eOuiFcUJCEOgeU3oV-a2mw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_jFveJ8RoEEKFIHidVPDl4w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FurnitureFixturesAndComputersMember__gu0MdxH50m20YVzxIH-Pg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:FurnitureFixturesAndComputersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_3_1_2021_To_3_31_2021_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_5uz6xTTzoUS7vZbEYgcwoA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_6_1_2021_To_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_5Odx1hNFgE-EjIs5X0GrZQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_6_1_2021_To_6_30_2021_v1CMQoC_MEO53dW7J_nzAA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_YIeLLI8Zuka4IuRCQnSL5A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_oBuuB5uPg0C8wAZV2nRBKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_ogBGhyb8QkWldjubXwC2ug"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_QSVhaJp0c0qau5mbNttKZw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2020_To_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_pw-r84ndYkSP68XRrV0yTw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_nMl7KbsZzkqXzxdBQILxoA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_EZhNVV5fvEixIfenKVx60Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_lP4_QEOZzE2bhzXyZUrCrQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PaycheckProtectionProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_qjeQidbY9E2QpOxvv_Bvsg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_on7-uRHX1EqyH81rkRruuw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_7Seab1iWakasudo2xAp8XA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_La1M4nHdNUqTqG0rxpNa8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_m4hqd27BVkSFna6qz43sIQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PaycheckProtectionProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_hmQR2sxXt0-QPIS6GgjMrQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_-vxPZ28Xykq2zceJbECjfg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_CthJKcprL0eLenTLOw8F7g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_DTVpyL5NAkWKW7wh4gUxRg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_2TuG7gXboUazxii0VRpqgg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_8sleYqexjESt21JPVmSmbw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_6_30_2019_To_6_30_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_W19jgtfrJ0q1_pcaKF15Lg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-30</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_11_30_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_2ePGV84R7kOqVJlCe8VRFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_11_15_2020_srt_RangeAxis_srt_MaximumMember_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_GHS7IyK-b0atc14LN7N6WA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_11_14_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_Aj4TjkpEqk2FBavVoeElPg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_1WHSkAXpykyT6aLBtPKDLQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_XGJvV0_cDkeQhRzARKjL8g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_xQEMjYvAV02ThX-j5BQaAQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_27cslPMf0kKYRf5e8pUZUg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2016_To_1_1_2016_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_U8JeOxzzD0Gx5vKq-ysy3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_1_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_MVZBEzT7O0S0Q0T1zli4Gw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_1_2016_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_tqLAJsmEVECzNI54zhIGFA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_1_2014_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_6QJUbguDpkyAkL3RR7QOTA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_6_1_2020_To_6_1_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_0lnUqVT07kOlXfiqqRCW9Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_6_1_2020_To_6_1_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_NAJB56TxHEmziVpHGC_jWw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_4_16_2020_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_K_b8S5kNXUi8BLFNMA8rKw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PaycheckProtectionProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_ez_THl-rSUu9GNrnq2nCuA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_31_2019_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithUniversityOfMinnesotaMember_cdcye0WMqEqRbPNdnP1VxQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PromissoryNoteWithUniversityOfMinnesotaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_31_2012_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_QQnUDFDrzk2Vm5Fpppjj3g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2010_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_pkNNDT8Wak6IONNfMjjxqg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2010-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_23_2021_1kBpKsAjAkafdUqrpHlz-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_22_2021_jAIYqLNp8kqUDCDCdGqUMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_HGDc3Os7mEWTu-CAaq3ruA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:SeriesPreferredWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_qZGOmr_ea0Ows1t9YaOzcw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsUniversityOfMinnesotaMember_2n5C9faFyUubXOXkidk78w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsUniversityOfMinnesotaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_31_2012_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsRegentsOfUniversityOfMinnesotaMember_ZXk4sItmP06Wo1dejovXIg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2020_LW-AR2B-IUCYjTsTG_L0Gg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_gbPT0CGmrE-mrppNChpn0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_bva1e1NEu0CDDbO2hz_bYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseOctober2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_We8kS0mQrU-z2lQGO0T3dw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseJuly2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_Atsn9P5ITkm9fny6aynNaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseOctober2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_QDAsoSke6UmzGRrYBpT5Ug"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseSeptember2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_7_31_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_ny50Pi8_jEyfyuCfKjRFVA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseJuly2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_10_31_2018_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_gG5hkjufDEyK2-0RVsaTHg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseOctober2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_1Bh3g4CG70OKdz3TgSxqQg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_hUvKTTEpGkeeRuM5ul5Jjg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">miro:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_nC9T8Rfgokqilo8qcuIGWw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_YiQ5qq1-cUeG-3Hyz5MNuw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">miro:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_GmTrWD189EWwo_du3vbdCQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertiblePreferredStockMember_G2AenK_gbk-ZZfv0d9YO_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_ByAiKa5lkUuPyzg8VR9VHQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">miro:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_idwa40aKQUC_0HjRs6iVKQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertiblePreferredStockMember_Gh_jQ_Q0W02MUqDL5oQyCw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_ConvertiblePreferredStockWarrantsMember_nZXuGpmc3kOiTFiqFvQENQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">miro:ConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_Jdt9LOisJEWDjroNeaE7OA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">miro:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_vdIpyWd9LEaTHDagY0ShUQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_XIKPHQwclUmF18L2ad03-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_A4MlM41kpUeFYHhM3kDtsg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_SBOFqQEpQEyPvYOkIlK1HA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_JGIso0rEp0yd4KJDkgW6xQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_3_31_2021_foKQtmn6f0it35GNZ-xuwQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gkWjeTErEEKrQ1vY2z-omg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2020_To_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_Qm42BmYK-UOKhFqGE3GLXA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2020_To_6_30_2020_NDTiF3J6pE6DAJHe0861mA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_iRO3LslO3kas_t0T5hUdPQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:SeriesPreferredWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_qaXZChAjbUKzlsfIAO2k2w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_ECMqdRae7ESrv1pIfHDKnQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_NJLzPJiJr0KqVC9ODnYXMg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:SeriesPreferredWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_PzoHbCzBmE6ej-n_Qpwy4w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_2H40H7i-ukaCvdguWaUOFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsCompanyShareholderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_6_1_2021_To_6_30_2021_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_VeZ4VJDJtkmpGyjtYu7oNw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_1_QI08EAgkeFGMJvDi62nw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DZF78Qgsdk-UpOA4nYZypg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DhADGZrh1EmAAzxwiQhJGw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_3_31_2020_5jHwYW7aQkqXNV2KSw6vaQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6V1pKA0LTEOpb09NqY9M3g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_6_1_2021_To_6_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_eJwJJs9VSkeObpA8PJb8LQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsCompanyShareholderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_B2zSRfZBIkue8c0XT4p-dw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_20_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_GpP9eDFV_U6tUH14QDYSzA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_gq9MkhmKcki_IgIkqiLqdA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_w0E9NO5A40-QYiUe_4grhw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_20_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_tlUM_j86VUem4H1Fs0WXtA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:EquityIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_5_20_2021_To_5_20_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_bH9uVGXInE2mfvC2nlVwVA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:EquityIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-20</xbrli:startDate><xbrli:endDate>2021-05-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_EyrEwEwwC0iERsWsXg8aaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_20_2021_To_5_20_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_iDuQ8yFyEEqVI8V78JY8tg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-20</xbrli:startDate><xbrli:endDate>2021-05-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_1_2021_To_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_2kXm4JqYrUGIQ5XQlQ4tBQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_1_2020_To_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_Bn7cHTalvk6YlTP7ftzPRg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_q7UZpcFoxEOYivXSsLQKIA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">miro:OneCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_tRMEi9tWY0-0d3TnCQQhlg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">miro:OneCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_9_30_2020_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_1uLdZHYzVEqRW879bg0kPQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">miro:OneCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_9_30_2020_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_vwuQIzABmEWaeqLv7nnUlg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">miro:OneCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_6_23_2021_To_6_23_2021_nAJYhIVR5k6XfLRbSV0y5A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-23</xbrli:startDate><xbrli:endDate>2021-06-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_srt_StatementScenarioAxis_miro_Period3Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_SecondFacilityEdenPrairieMember_xF6oO6QCv0CweJW-fgnyeA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">miro:Period3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:SecondFacilityEdenPrairieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_srt_StatementScenarioAxis_miro_Period3Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_rhWhUWLpAkCFncruQK6Agg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">miro:Period3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:FirstFacilityEdenPrairieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_1_2020_To_5_31_2020_srt_StatementScenarioAxis_miro_Period2Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_SecondFacilityEdenPrairieMember_XQsUNAY8E0CKMy7vg7p45g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">miro:Period2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:SecondFacilityEdenPrairieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_1_2019_To_11_30_2019_srt_StatementScenarioAxis_miro_Period2Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_A300O00RHU28LyFbFXEpQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">miro:Period2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:FirstFacilityEdenPrairieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_1_2015_To_2_28_2015_srt_StatementScenarioAxis_miro_Period1Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_P0y2up9X2E6mBHwqP3Cl8A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">miro:Period1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:FirstFacilityEdenPrairieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-02-01</xbrli:startDate><xbrli:endDate>2015-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_srt_CounterpartyNameAxis_miro_UniversityOfMinnesotaMember_us-gaap_TypeOfArrangementAxis_miro_PatentLicenseAgreementMember_jedF-oqTMEuu3qGVMv8CqQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">miro:UniversityOfMinnesotaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">miro:PatentLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_8_2_2021_To_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_FAYf9bRq1UeMVt01TiNLBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:BuildingResearchAndDevelopmentAndOfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-02</xbrli:startDate><xbrli:endDate>2021-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:BuildingResearchAndDevelopmentAndOfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_28_2015_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_Cl7f8VTFAUeR61K3rR-tWg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:FirstFacilityEdenPrairieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_30_2020_To_11_30_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_npnVQruhDkGjzL1UROIouw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-30</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_11_15_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_2Sa5NjL2Kk-ibyq3uXUDjQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_CSoklVBQa02SoJByMzWnzQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_m7wWrzDt8kKqdsrFFqI6Aw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_1_2021_To_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_XoFDCEt86EOimiVOhB2Tgw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseSeptember2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2021_To_7_31_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_Jz0WwUyS-E6Z18dHVsppFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseJuly2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_10_1_2018_To_10_31_2018_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_OZdwLy5NM0Go4Ki1KftRlw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseOctober2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_1_2015_To_12_1_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_jA_SRrDvgkqJaPnK7QABEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-12-01</xbrli:startDate><xbrli:endDate>2015-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_8_6_2021_To_8_6_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_FHW-5iosOkaC1XBwtIzjrw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PaycheckProtectionProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-06</xbrli:startDate><xbrli:endDate>2021-08-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_4_2021_To_3_4_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_YFZmZWhoU0m7w2SwZnEVSQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PaycheckProtectionProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-04</xbrli:startDate><xbrli:endDate>2021-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_KFeJzTMvrEGq3LDu1xCU5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_A9qxS9oZnkya-NmJw5L2zg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_1dorSEZUh0ybHPBVgUSX4A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:SeriesPreferredWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_1_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsUniversityOfMinnesotaMember_MJIM8ECHsEqx2RTxL_0tQg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsUniversityOfMinnesotaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2012_To_1_31_2012_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsRegentsOfUniversityOfMinnesotaMember_sZ5sdIuCHkukaGha2I_3MQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-01</xbrli:startDate><xbrli:endDate>2012-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_6_1_2021_To_6_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_Umm_MfnOZUaOKyWI9XnCRg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_3gjNoRIV2UGDPT9hi71nlw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_YDeFWSbjDkOyTwmafCkiqQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_N-QYK6IT_0K6cQJR8rQQUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_gQqNjbZf3kitvnDKHNvcqQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_cRCCz2S2j0Sk68z8xyXCTg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_saJtd_zSdkCdwSY-MhYn9A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_10_31_2021_srt_CounterpartyNameAxis_miro_UniversityOfMinnesotaMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_us-gaap_NoncollaborativeArrangementTransactionsMember_3MpIEZ7k8UW2x-fwsNXB8Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">miro:UniversityOfMinnesotaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:NoncollaborativeArrangementTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_11_11_2021_bEdaa5RP50iWhTuUho5FFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001527096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="Unit_Standard_item_dMkQsh8WpkaQAEVQgwXZFA"><xbrli:measure>miro:item</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_sqft_TVbtuT9o3UCYFiZW5wDD2w"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_payment_r6kmSj8FdkWHfPCK9l_Ahg"><xbrli:measure>miro:payment</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_class_iV0uheBxPk-h-k5jyvqyzg"><xbrli:measure>miro:class</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_customer_oBpQWOLWXkK3Il-nSeGoKQ"><xbrli:measure>miro:customer</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_shareholder_EnWQEbPDAka0m--RoRqebg"><xbrli:measure>miro:shareholder</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_agreement_od-gDHq4Z0WVrTpltuYtzw"><xbrli:measure>miro:agreement</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_Vote_5PNXDYCebUiYVCiCDg0ocw"><xbrli:measure>miro:Vote</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div style="max-width:100%;padding-left:4.47%;padding-right:4.47%;position:relative;"><div style="margin-top:21.6pt;min-height:5.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:12.65pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_44530756_1ce2_4098_80be_89122ab7b6a7"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Washington, D.C. 20549</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:11.0pt;margin-bottom:2pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:17pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:DocumentType" id="Narr_E2ZN_yMlAkCjwB3d6nlYBQ"><b style="font-weight:bold;">10-Q</b></ix:nonNumeric></p><div style="font-family:'Times New Roman','Times','serif';font-size:11.0pt;margin-bottom:2pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">(Mark&#160;One)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="display:inline-block;text-align:left;width:36pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:DocumentQuarterlyReport" id="Narr_9rOUUdR-wEy2tyo3fLyRiA"><b style="font-family:'Segoe UI Symbol';font-size:11pt;font-style:normal;font-weight:bold;text-align:center;">&#9746;</b></ix:nonNumeric></span><b style="font-weight:bold;">QUARTERLY&#160;REPORT&#160;PURSUANT&#160;TO&#160;SECTION&#160;13&#160;OR&#160;15(d)&#160;OF&#160;THE&#160;SECURITIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:11pt;font-weight:bold;">EXCHANGE&#160;ACT OF 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:9pt;font-weight:bold;">For the quarterly period ended </b><ix:nonNumeric format="ixt:datemonthdayyearen" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:DocumentPeriodEndDate" id="Narr_DE5tMjd1IEil80jzy7tZvw"><b style="font-size:9pt;font-weight:bold;">September 30, 2021</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;">or</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><span style="display:inline-block;text-align:left;width:36pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:DocumentTransitionReport" id="Narr_2JE5kTFxrEyeLDnXOCEEDA"><b style="font-family:'Segoe UI Symbol';font-size:11pt;font-style:normal;font-weight:bold;text-align:center;">&#9744;</b></ix:nonNumeric></span><b style="font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:11pt;font-weight:bold;">EXCHANGE&#160;ACT OF 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;">For the transition period from </b><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><b style="font-weight:bold;">&#160; to </b><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><b style="font-weight:bold;">&#160;</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:9pt;font-weight:bold;">Commission File Number: </b><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityFileNumber" id="Narr_jDLr5yNPska5SvVhKp2T-w"><b style="font-size:9pt;font-weight:bold;">001-40518</b></ix:nonNumeric></p><div style="font-family:'Times New Roman','Times','serif';font-size:11.0pt;margin-bottom:3pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:23pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityRegistrantName" id="Narr_HjwAbCbGY02IpW3tMcS5xA"><b style="font-weight:bold;">Miromatrix Medical&#160;Inc.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;">(Exact name of registrant as specified in its charter)</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:11.0pt;margin-bottom:3pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"><a id="_3ae27f8f_014e_4702_bb0b_ae8b778282a7"></a><a id="Tc_Y7qbyl4eDUm6_Y65wk8OHg_2_0"></a><a id="Tc_yS-qk3vrNEmRt68H6oF9jA_2_1"></a></div></div><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:stateprovnameen" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityIncorporationStateCountryCode" id="Tc_N1wjOkKIME21zeOwiKsXYg_1_0"><b style="font-size:9pt;font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityTaxIdentificationNumber" id="Tc_WDLn0VdO7EqPUQPNMODBrg_1_1"><b style="font-size:9pt;font-weight:bold;">27-1285782</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">(State or other jurisdiction of</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">incorporation)</b></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">(I.R.S. Employer</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Identification Number)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:4pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityAddressAddressLine1" id="Narr_27gtKxmlIUqVuRnLeyf_bg"><b style="font-size:9pt;font-weight:bold;">10399 West 70th Street</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityAddressCityOrTown" id="Narr_KU2zp-F8IE-4YdOh_PzSlw"><b style="font-size:9pt;font-weight:bold;">Eden Prairie</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityAddressStateOrProvince" id="Narr_a9DEEijDmEWYXlez-N2GdA"><b style="font-size:9pt;font-weight:bold;">MN</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityAddressPostalZipCode" id="Narr_fTpLC27JLU6iV4oBHGOuKg"><b style="font-size:9pt;font-weight:bold;">55344</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;">(Address of principal executive offices, including zip code)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-size:9pt;font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:CityAreaCode" id="Narr_BNuuacAn902ljKP8qDEaKQ"><b style="font-size:9pt;font-weight:bold;">952</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:LocalPhoneNumber" id="Narr_0u7q7v1F3ESE-gNZCnKLgQ"><b style="font-size:9pt;font-weight:bold;">942-6000</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;">(Registrant&#8217;s telephone number, including area code)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">Not Applicable</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-weight:bold;">(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:3pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:0pt;margin:0pt;">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:3pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_c10b6844_992f_4a21_b6f2_d2e2cdf321ec"></a><a id="Tc_IB3EOSOMekO8GHCqhqzN_w_1_0"></a><a id="Tc_MKZsDRmjqUqIsdi1q09leA_1_1"></a><a id="Tc_Kf5z3EHTP0-Qq2rtzohSYQ_1_2"></a><a id="Tc_W7FZzNbGN0GrPkY4whigOA_2_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:99.9%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">Title of each class</b></p></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">Trading symbol</b></p></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">Name of exchange on which registered</b></p></td></tr><tr><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:Security12bTitle" id="Narr_IKJtwMvbvEyaHIHgPAC0ZQ"><b style="font-size:9pt;font-weight:bold;">Common Stock</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, par value $0.00001 per share</b></p></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:TradingSymbol" id="Tc_ToIVqIlsD0iuSZc0vIsY3Q_2_1"><b style="font-size:9pt;font-weight:bold;">MIRO</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:exchnameen" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:SecurityExchangeName" id="Tc_oYjbL10xj0GCfxcY-xd9MA_2_2"><b style="font-size:9pt;font-weight:bold;">The Nasdaq Stock Market LLC</b></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:3pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><span style="font-size:9pt;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. &#160;&#160;</span><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityCurrentReportingStatus" id="Narr_dCzXX4frC06BOiVxCX82xQ"><span style="font-size:9pt;">Yes</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;</span><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9746;</span><span style="font-size:9pt;">&#160;&#160;&#160;&#160;No&#160;&#160;&#160;</span><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><span style="font-size:9pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files). &#160;&#160;</span><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityInteractiveDataCurrent" id="Narr_2CQN6J004kywi3KxV-WB8w"><span style="font-size:9pt;">Yes</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;</span><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9746;</span><span style="font-size:9pt;">&#160;&#160;&#160;&#160;No&#160;&#160; </span><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:0pt;margin:0pt 0pt 3pt 0pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</p><a id="_49971800_b02e_4e5b_a603_af6d94d529f6"></a><a id="Tc_m0Ob5ZcZo0qe4KNy9-o0Zg_1_0"></a><a id="Tc_Gr1I4oBM7028TmikdhjSxA_1_1"></a><a id="Tc_hZtyfZ3d-EOrVt6z0Em2Rg_1_2"></a><a id="Tc_L-eXD60N3ECSrskiu0LfXw_1_3"></a><a id="Tc_J-qjY9D6H0mJ7TT8BaK5iA_3_1"></a><a id="Tc_4S40L45_R02Vfi_OUOGiyQ_3_2"></a><a id="Tc_iRtjBBa8GkeJWPpkYBZQ_Q_3_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:16.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:23.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:20.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:15.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:3.65pt;"><td style="vertical-align:bottom;width:16.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:0pt;margin:0pt;">Large&#160;accelerated&#160;filer</p></td><td style="vertical-align:bottom;width:23.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:bottom;width:20.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:0pt;margin:0pt;">Accelerated&#160;filer</p></td><td style="vertical-align:top;width:15.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:top;width:20.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:6.3pt;"><td style="vertical-align:middle;width:16.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:23.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:20.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:15.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:4.05pt;"><td style="vertical-align:bottom;width:16.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:entityfilercategoryen" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityFilerCategory" id="Tc_Q2br1jl2Pku895aEoTuu1A_3_0"><span style="font-size:9pt;">Non-accelerated filer</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:23.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9746;</span>&#160;</p></td><td style="vertical-align:bottom;width:20.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:0pt;margin:0pt;">Smaller&#160;reporting&#160;company</p></td><td style="vertical-align:top;width:15.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntitySmallBusiness" id="Tc_mR_ar6dFqk6dR-f6TqCbAg_3_3"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9746;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:20.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:0pt;margin:0pt;">Emerging&#160;growth&#160;company</p></td><td style="vertical-align:bottom;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityEmergingGrowthCompany" id="Tc_fpau0F9jqUabB1Kx0C_l8Q_3_5"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9746;</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><span style="font-size:9pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. </span><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityExTransitionPeriod" id="Narr_5BVUbaHTGkatfT5JF3dAEw"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><span style="font-size:9pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). &#160;&#160;Yes&#160;&#160;</span><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="dei:EntityShellCompany" id="Narr_LghKAs_pwUeMoMbsvSwhpw"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9746;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:18pt;margin:0pt 0pt 3pt 0pt;">As of November 11, 2021, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" format="ixt:numdotdecimal" scale="0" contextRef="As_Of_11_11_2021_bEdaa5RP50iWhTuUho5FFw" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" id="Narr_J5ejU1HJ4U-XVYMgRtt16g">20,254,645</ix:nonFraction> shares of the registrant&#8217;s common stock outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-indent:0pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:91.06%;border:0;margin:30pt 4.47% 30pt 4.47%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_9c480411_a6ea_45b6_ad6c_b7b1211afd45"></a><a id="TOC"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">TABLE OF CONTENTS</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:-7.2pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:80.44%;margin:0pt;padding:0pt 0pt 0pt 7.19pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:5.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Page</b></p></th></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#PARTIFINANCIALINFORMATION_636104"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Part&#160;I</b></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#PARTIFINANCIALINFORMATION_636104"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Financial Information</b></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#Item1FinancialStatements_860480"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item&#160;1.</span></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item1FinancialStatements_860480"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Financial Statements</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">3</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#CondensedConsolidatedBalanceSheets_74335"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Condensed Balance Sheets as of September&#160;30, 2021 (Unaudited) and December&#160;31, 2020 (Audited)</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">3</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#CondensedConsolidatedStatementsofOperati"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Condensed Statements of Operations for the three and nine&#160;months ended September&#160;30, 2021 and 2020 (Unaudited)</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">4</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ShareholdersEquity_946117"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Condensed Statements of Changes in Shareholders&#8217; Equity (Deficit) for the three and nine&#160;months ended September&#160;30, 2021 and 2020 (Unaudited)</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">5</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#CondensedConsolidatedStatementsofCashFlo"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Condensed Statements of Cash Flows for the nine&#160;months ended September&#160;30, 2021 and 2020 (Unaudited)</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">6</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#NotestoCondensedConsolidatedFinancialSta"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Notes&#160;to Condensed Financial Statements (Unaudited)</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">7</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#Item2ManagementsDiscussionandAnalysisofF"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item&#160;2.</span></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item2ManagementsDiscussionandAnalysisofF"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">21</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#Item3QuantitativeandQualitativeDisclosur"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item&#160;3.</span></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item3QuantitativeandQualitativeDisclosur"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Quantitative and Qualitative Disclosures about Market Risk</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">29</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#Item4ControlsandProcedures_206943"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item&#160;4.</span></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item4ControlsandProcedures_206943"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Controls and Procedures</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">29</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#PARTIIOTHERINFORMATION_825165"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Part&#160;II</b></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#PARTIIOTHERINFORMATION_825165"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Other Information</b></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#Item1LegalProceedings_657175"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item&#160;1.</span></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item1LegalProceedings_657175"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Legal Proceedings</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">30</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#Item1ARiskFactors_343626"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item&#160;1A.</span></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item1ARiskFactors_343626"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Risk Factors</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">30</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#Item2UnregisteredSalesofEquitySecurities"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item&#160;2.</span></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item2UnregisteredSalesofEquitySecurities"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">30</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#Item3DefaultsUponSeniorSecurities_709038"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item&#160;3.</span></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item3DefaultsUponSeniorSecurities_709038"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Defaults Upon Senior Securities</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">31</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#Item4MineSafetyDisclosures_481827"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item&#160;4.</span></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item4MineSafetyDisclosures_481827"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Mine Safety Disclosures</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">31</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#Item5OtherInformation_231484"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item&#160;5.</span></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item5OtherInformation_231484"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Other Information</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">31</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#Item6Exhibits_639467"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item&#160;6.</span></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item6Exhibits_639467"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Exhibits</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">32</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:-12pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#EXHIBITINDEX_83501"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Exhibit&#160;Index</span></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:-12pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:14.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><a href="#SIGNATURES_10952"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Signatures</span></a></p></td><td style="vertical-align:top;width:80.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_e0b1cf70_0b32_4561_8ba9_031107ecfb60"></a><a id="PARTIFINANCIALINFORMATION_636104"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PART&#160;I&#160;&#8212;FINANCIAL INFORMATION</p><a id="Item1FinancialStatements_860480"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 6pt 0pt;">Item&#160;1. Financial Statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">MIROMATRIX MEDICAL&#160;INC.</p><a id="CondensedConsolidatedBalanceSheets_74335"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Condensed Balance Sheets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_622f1528_ec2d_4009_bb07_938ba4df20c7"></a><a id="_ecfa1180_ec9d_4d9c_895e_bc7c896b3b47"></a><a id="_757879db_7377_4073_b96b_7a89dc366a61"></a><a id="_6994e16a_d720_4932_9838_9a852ebf7dce"></a><a id="_bae8481e_42ee_456f_84c7_0ccda64580a4"></a><a id="_e73cc55a_91c4_4ac7_be7e_2677be1f54ea"></a><a id="_c176560a_79c0_4de2_854e_ae6720447a4d"></a><a id="_66e9467e_88b8_4a5c_8263_4ea0e3301de1"></a><a id="_9f4f75af_9d6e_4224_aef5_2bc120e5b496"></a><a id="Tc_8J3opg5luEKOhgKGSq5brA_1_2"></a><a id="Tc_DRItg3bVXEyajOOvjAbG5w_1_5"></a><a id="_8f99020c_2b82_4971_9f45_d1c205b487ec"></a><a id="Tc_YM7BLI8ZvUu9H-wwdEUy-A_2_2"></a><a id="Tc_y4TG3ZqjyEiseJGsTZWolw_2_5"></a><a id="_d1a81f26_78ed_40b1_8f28_b7f77c9ae976"></a><a id="_c0cc202e_e924_4ca6_9455_8554b60066b1"></a><a id="Tc_2crjfKur5UW2zIbg97kXJA_4_2"></a><a id="_07490ec7_6896_408f_ab2e_b1fce6a010e9"></a><a id="Tc_LkRYcjlalkuo_4dHeqEnsw_5_0"></a><a id="_a4b03877_ffbf_4580_b378_7b54d7516825"></a><a id="Tc_G9jEg-4NqUOlRuVDqIBQxA_6_0"></a><a id="_9193a1c3_64e6_4487_989f_7fc3e89c9dea"></a><a id="Tc_eD9essfqVken3mDbIDiTeQ_7_0"></a><a id="Tc_QsZ-M8F6mUawV62qHQi1yg_7_2"></a><a id="Tc_gLmEQ7Bzj0e7k3UE9hCxfQ_7_5"></a><a id="_ca10d1ce_1642_4157_a705_2c3375206f25"></a><a id="Tc_jTUBk0rPxE29OAQWyDbtMQ_8_0"></a><a id="_8e0585d6_8d45_4765_b4b6_5d65c33301c6"></a><a id="Tc_XoiPcmfGlEWKpryVBESfBA_9_0"></a><a id="_4e83bd72_ea35_433e_9a85_cb617193c12c"></a><a id="Tc_iOp2aGb-HUuIcFdvtCbavg_10_0"></a><a id="_4eb74d40_ef95_4180_9778_60bfe9abd794"></a><a id="Tc_Xc-EqnUFHUabzQOyIvJMmQ_11_0"></a><a id="_3474c61e_5cee_4dc5_9191_ce711577d6d6"></a><a id="Tc_sIoM1ZRq10qb7fW3kQdYZg_12_0"></a><a id="_9296e382_1994_4a02_8f6f_45a6a530208e"></a><a id="Tc_0N5-Zgtb0UObp3-EAJtqNw_13_0"></a><a id="Tc_4lW2cWI4-k6mGTPEqiVz5g_13_3"></a><a id="_840633fc_0aee_4236_8fdb_8e5923a4c8c8"></a><a id="Tc_Ha637QeGFECryHvkeosTNA_14_0"></a><a id="Tc_uw4aeaUWDEWpFIjYEqILHw_14_2"></a><a id="Tc_hbTrF31y9kqn3NUL4q5aMg_14_5"></a><a id="_98531216_8386_4954_a44a_99f376a903f8"></a><a id="Tc_8sQWAhJ0j0G786SX-1fdsA_15_0"></a><a id="_aef795d5_d1a7_4106_87f0_b9f465e0a689"></a><a id="Tc_qetL1T-ezEWZq0Kzjd1W-g_16_0"></a><a id="_eba4fdfe_0218_44ff_9aad_7f586ea65445"></a><a id="Tc_x67OviklMUe4_854ifmKBw_17_0"></a><a id="Tc_rogHI_Ryuk-xSB3wYw0bGA_17_2"></a><a id="Tc_ZRSNOfNom0Od1FCkqmwnxA_17_5"></a><a id="_e7852d06_cd15_4f9d_8093_bcd7e58af569"></a><a id="Tc_PytMd0QL20G-arm29GyaQw_18_0"></a><a id="_17b4f4b0_5f53_47a2_b34f_1e541f12c83c"></a><a id="Tc_UG8VRFnTukWka5SNpERkHg_19_0"></a><a id="Tc_93PtoPP1F0aNdHwdbwcclg_19_3"></a><a id="_6b17d0e1_a9eb_4dd8_a67a_b05e31e0d3fa"></a><a id="Tc_JbjuyXZLFUmjDkBjPKWKGg_20_0"></a><a id="Tc_Brd3FCW_mUSpvhepM7ScTQ_20_3"></a><a id="_bcd8083e_4134_453a_bc97_c1a72e20c638"></a><a id="Tc_EP90XPE-p0qhW64BOCB6Xw_21_0"></a><a id="_f6908fcc_6a5a_495b_b250_42908980e957"></a><a id="Tc_CCYlh-wC1UyxY2WWQTga5g_22_0"></a><a id="_ebc26820_430b_4ecb_91e2_04c032c22769"></a><a id="Tc_Xs5IsJaZeE2ZyZdpUG3Tvw_23_0"></a><a id="_fb7e83cc_8cd7_4672_9e8e_b16ef013ba65"></a><a id="Tc_zh-xDEbXjUO8iyh9Q23cVg_24_0"></a><a id="_2065fb3f_5699_4521_a330_6adce86b32e5"></a><a id="Tc_pQiw8QkydkuJutZRsRQOfA_25_0"></a><a id="_f183fdc3_ce6b_423b_a39f_8a368ef6e156"></a><a id="Tc_yCnzmeKsZkWazFHfbb50ig_26_0"></a><a id="_276cb8a1_3028_4e37_ab91_40d6295611ab"></a><a id="Tc_Gph3X2-yikWo9O40DYu0Vg_27_0"></a><a id="_6f0a28d3_1e6c_49ed_9715_649f1a884820"></a><a id="Tc_H7P-synHFE2I4EFXdInIKg_28_0"></a><a id="_2756330d_66ba_4015_b338_8fe5f0697a21"></a><a id="Tc_gp-Sb3CVo0-TK2fEl5nc6g_29_0"></a><a id="Tc_C1IGgXbVTU-MO4vExIr1JA_29_3"></a><a id="_c6391275_ff31_4288_abbb_e5df3ed08d0c"></a><a id="Tc_rcpLyE-130OJft2jscPSuQ_30_0"></a><a id="Tc_Bcna0jHxCkOOTDoUQdmpiA_30_3"></a><a id="_07698dbc_87f3_49a3_8ade_106c470a6c53"></a><a id="Tc_owKCKEctgUq23cMVkQwaWg_31_0"></a><a id="Tc_iJ3RCi554keoyixZzm9hXg_31_3"></a><a id="_ad4e3322_35c4_4dbf_a8fd_32820e1bc150"></a><a id="Tc_hA5EQQRILU6MWZ-R8FYQnQ_32_0"></a><a id="_4e153005_e8e5_4783_9daa_e51b966273ba"></a><a id="Tc_6jUEgbITzkWDq5kmR-QS6g_33_0"></a><a id="_400b5401_9ff1_4abe_8d4a_946c990d070f"></a><a id="Tc_a5axkdjxAEaArbXqdCmMKw_34_0"></a><a id="_df4a4baf_cde1_47e1_89cc_569ea9be289d"></a><a id="Tc_8IC3BIplT0iuIHkgoKgR1w_35_0"></a><a id="_f1dbb584_515e_4aba_b7da_dceca62b31e7"></a><a id="Tc_VFjFsHWF_UqJe_uBDXkJNQ_36_0"></a><a id="_5e024cab_c558_4f3c_abf6_a4ee737a489c"></a><a id="Tc_hNXTrbJ_00avrTXphCZMkQ_37_0"></a><a id="Tc_2mz5DaHcdEq2PNVrl3Kqew_37_2"></a><a id="Tc_AJvSN8jfW0-uudyZ3j4rZw_37_5"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">ASSETS</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Current assets:</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Cash and cash equivalents</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="Tc_JdC2Bm4cOkSOZtcMQ9sJsA_7_3">62,087,678</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"><ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="Tc_ThZFrjbGr0Gk4wXoz5MVSA_7_6">4,444,395</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Receivable from Reprise Biomedical, Inc.</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueFromRelatedPartiesCurrent" scale="0" id="Tc_lCGY4R5q7Uu7qNHZ8iVpNA_8_3">9,819</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueFromRelatedPartiesCurrent" scale="0" id="Tc_n-7gAxOM9kmK-_f4Ttkazw_8_6">15,202</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Grant receivable</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GrantsReceivableCurrent" scale="0" id="Tc_z6xmWFSCJUGB8dHqCRjFkg_9_3">115,530</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GrantsReceivableCurrent" scale="0" id="Tc_8fvYpwGMR0eVbw3JdVTpRQ_9_6">100,000</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Prepaid expenses and other current assets</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" id="Tc_DuWbATjm_Eu16fPjOOM2VA_10_3">334,310</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" id="Tc_sOxWj4fxeEinIDjqMZe3IQ_10_6">130,576</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 18pt;"><span style="color:#231f20;">Total current assets</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="0" id="Tc_6tvybIUy0EO2bpn59cTQzw_11_3">62,547,337</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="0" id="Tc_exicNHfsP0atF_LXeiB9TQ_11_6">4,690,173</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Lab equipment, furniture, leasehold improvements and construction in progress, net</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" id="Tc_pwAxuehDeEi-lJ42aREgog_12_3">1,678,648</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" id="Tc_wvzftnQB30SkyJ4pdq8qeg_12_6">324,534</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Investment in Reprise Biomedical, Inc</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="0" id="Tc_PL4KoK9zckygIxzVYGxdoQ_13_6">239,721</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 18pt;"><span style="color:#231f20;">Total assets</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="0" id="Tc_CAjukAOZTE6KbMOopnBv-A_14_3">64,225,985</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="0" id="Tc_ntwOiMhMzkmFTmEr4LDlNw_14_6">5,254,428</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY (DEFICIT)</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Current liabilities:</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Current portion of long-term debt</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="0" id="Tc_XF2YLgX2gUCN3I4M8qxK4Q_17_3">386,161</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="0" id="Tc_hqZMq2QJzkmnX5eQvV_lXQ_17_6">6,413,733</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Accounts payable</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="0" id="Tc_7_ci4tnWYU-BnaU4VqRQuA_18_3">1,249,259</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="0" id="Tc_-BhswkUqlU6r-Fataf_ktw_18_6">130,160</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Accrued interest expense</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestPayableCurrent" scale="0" id="Tc_F4dteZ9PfE6MVcSkQabOPA_19_6">612,705</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Embedded derivative liability</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="0" id="Tc_mBaeS1lCfE6RiTwZTwjC1g_20_6">246,962</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Accrued expenses</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" id="Tc_5Hyqed0Q_UW_hhjXXwB6qw_21_3">1,922,617</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" id="Tc_M2RpYVz1uEylMunl8SzjLw_21_6">760,889</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;"><span style="color:#231f20;">Total current liabilities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="0" id="Tc_as-qnpGpME-foHV_2mLmAw_22_3">3,558,037</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="0" id="Tc_vMKj-KQ5EEadO7KUGjwGLQ_22_6">8,164,449</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Accrued royalties</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:AccruedRoyaltiesNoncurrent" scale="0" id="Tc_DkqvHKwae02QY45mYsHSzw_23_3">857,101</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:AccruedRoyaltiesNoncurrent" scale="0" id="Tc_y50ajNj5VEGhcaa_txCkXw_23_6">488,368</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Long-term debt, less current portion</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="0" id="Tc_O8lt4WPYfUSa_qkgkHnqGw_24_3">478,766</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="0" id="Tc_EKKTShjh2Ui5un6myfn4vQ_24_6">928,623</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Accrued interest</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:InterestPayableNoncurrent" scale="0" id="Tc_w5k9wEtU-0yplgiInM6k8g_25_3">65,032</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:InterestPayableNoncurrent" scale="0" id="Tc_HYC59kvd1EiFN8aVdEDo5w_25_6">45,691</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;"><span style="color:#231f20;">Total liabilities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="0" id="Tc_SELLcu1znUGeztI0MSLeew_26_3">4,958,936</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="0" id="Tc_9eco0mj2dEajPJIW3XsGng_26_6">9,627,131</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Commitments and contingencies</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Mezzanine equity:</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;font-size:8pt;">Convertible preferred stock &#8211; Series B-2, par value </span><span style="color:#231f20;font-size:8pt;">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="Narr_0SKrW4469k69jRFZY_JRrA">0.00001</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;">; </span><span style="color:#231f20;font-size:8pt;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_XRcRC9vzqUmNSRJaT8OgEQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="Narr_EFeAtuIil0-xQoHBuvtyzw">0</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> shares authorized, </span><span style="-sec-ix-hidden:Hidden_A19XiktScUSoIq3tNHnEPg;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">issued</span></span><span style="color:#231f20;font-size:8pt;"> and </span><span style="-sec-ix-hidden:Hidden_U4StnGehukefsbxQPJkgtA;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span><span style="color:#231f20;font-size:8pt;"> as of September&#160;30,&#160;2021 and </span><span style="color:#231f20;font-size:8pt;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="Narr_MR5rhiy1oUOUsgBJQlu4Hg">2,500,000</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> shares authorized; </span><span style="color:#231f20;font-size:8pt;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="Narr_N5BKvma4I0ilxH8Dcr1wsg">2,095,874</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> issued and </span><span style="-sec-ix-hidden:Hidden_vz2qWyZfgEqnJs_vv-BXMg;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span><span style="color:#231f20;font-size:8pt;"> as of December&#160;31,&#160;2020 (Liquidation preference </span><span style="color:#231f20;font-size:8pt;">$<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_XRcRC9vzqUmNSRJaT8OgEQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="0" id="Narr_fdtzR9odi0Kz_rB2uSBldA">0</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> and </span><span style="color:#231f20;font-size:8pt;">$<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="0" id="Narr_XIMAlcxBg0CwW3LK6ckacw">15,719,055</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;">, respectively)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_V327DxGIck2E55tDucNfIw_29_6">15,670,097</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;font-size:8pt;">Convertible preferred stock &#8211; Series B, par value </span><span style="color:#231f20;font-size:8pt;">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="Narr_I_YIztCeWEuSzS3DXImn8g">0.00001</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;">; </span><span style="color:#231f20;font-size:8pt;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_giB21kpH7UCySM-3NM5GMA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="Narr_m6aXntvrT0u4PiE9rZR7Ug">0</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> shares authorized, </span><span style="-sec-ix-hidden:Hidden_e9vz8cVU5kOiNrHdxSP9lA;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">issued</span></span><span style="color:#231f20;font-size:8pt;"> and </span><span style="-sec-ix-hidden:Hidden_ITvLAd6LUU6dorEH8hxqzQ;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span><span style="color:#231f20;font-size:8pt;"> as of September&#160;30,&#160;2021 and </span><span style="color:#231f20;font-size:8pt;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="Narr_Y61d4q46KEWVKGqCVHlfwQ">4,000,000</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> shares authorized; </span><span style="color:#231f20;font-size:8pt;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="Narr_m6UFXLO0E0G8Y6e8w_9EpA">3,218,282</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> issued and </span><span style="-sec-ix-hidden:Hidden_AXJ02AwWXEOrPkGjAArO4A;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span><span style="color:#231f20;font-size:8pt;"> as of December&#160;31,&#160;2020 (Liquidation preference </span><span style="color:#231f20;font-size:8pt;">$<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_giB21kpH7UCySM-3NM5GMA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="0" id="Narr_ZIQsIJTwskurg_VFqwePbg">0</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> and </span><span style="color:#231f20;font-size:8pt;">$<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="0" id="Narr_3pCBc4242UufuZD0ee4Abw">24,137,115</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;">, respectively)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_qwjBlbmhAkieuCM6JxTh6A_30_6">23,865,732</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;font-size:8pt;">Convertible preferred stock &#8211; Series A, par value </span><span style="color:#231f20;font-size:8pt;">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="Narr_dtxJ23urp0eOlbSqu0xgnQ">0.00001</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;">; </span><span style="color:#231f20;font-size:8pt;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_b56DfHPV7k2k1IdW58ycBg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="Narr_O8Fgnl6ZdUKanj3rnsrY_Q">0</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> shares authorized, </span><span style="-sec-ix-hidden:Hidden_qLigljAiDEeLWxvU7929eQ;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">issued</span></span><span style="color:#231f20;font-size:8pt;"> and </span><span style="-sec-ix-hidden:Hidden_9PlECnxOG0GNJW38iWPKbQ;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span><span style="color:#231f20;font-size:8pt;"> as of September&#160;30,&#160;2021 and </span><span style="color:#231f20;font-size:8pt;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="Narr_QuU1Tx5_iUmSEZK4eXbi7w">3,300,000</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> shares authorized; </span><span style="color:#231f20;font-size:8pt;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="Narr_86LTHXJM60OhcMGGQI-H0A">3,000,380</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> issued and </span><span style="-sec-ix-hidden:Hidden_9o88EG-w5E-Zb117OIqlQA;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span><span style="color:#231f20;font-size:8pt;"> as of December&#160;31,&#160;2020 (Liquidation preference </span><span style="color:#231f20;font-size:8pt;">$<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_b56DfHPV7k2k1IdW58ycBg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="0" id="Narr_GvC7vWtGx0qX3SF0jlFQKg">0</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> and </span><span style="color:#231f20;font-size:8pt;">$<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="0" id="Narr_cRJHB6212kWlpQt_up5duw">7,500,950</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;">, respectively)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" id="Tc_1gSgEppYRki3DUfQYBSWmA_31_6">7,125,661</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Shareholders&#8217; equity (deficit):</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;font-size:8pt;">Common stock, par value </span><span style="color:#231f20;font-size:8pt;">$<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_S7NuntstEESB_pv6Z74wfQ"><ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_lzprEsdEB0yMRw5Wg6dOhg">0.00001</ix:nonFraction></ix:nonFraction></span><span style="color:#231f20;font-size:8pt;">; </span><span style="color:#231f20;font-size:8pt;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_Xo1bmdb-2E-wQg83LSzbWw">190,000,000</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> shares authorized; </span><span style="color:#231f20;font-size:8pt;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_pBXkRR0fUUiefjIWDk4YFw">20,254,645</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> issued and </span><span style="-sec-ix-hidden:Hidden_95DdDuScoU63qH12JU9kvw;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span><span style="color:#231f20;font-size:8pt;"> as of September&#160;30,&#160;2021 and </span><span style="color:#231f20;font-size:8pt;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_WD_uqxXlsU-zAL0z1OwVAQ">30,000,000</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> shares authorized; </span><span style="color:#231f20;font-size:8pt;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_iCeaex4B9ECjimXj4GFPfA">2,185,822</ix:nonFraction></span><span style="color:#231f20;font-size:8pt;"> issued and </span><span style="-sec-ix-hidden:Hidden_okO5EGoGLke5FxP0c_-aoA;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span><span style="color:#231f20;font-size:8pt;"> as of December&#160;31,&#160;2020</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="Tc_6csO5B6Xj0Sl7ZVvLGVoBQ_33_3">202</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="Tc_CrTn3k02CkO0VxZDwgvh3g_33_6">22</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Additional paid-in capital</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="0" id="Tc_wqPpn_8XjE2uUmaeFCvGHQ_34_3">127,842,762</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="0" id="Tc_zdBcJS5oV06zaFKXHDpJOQ_34_6">8,346,943</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Accumulated deficit</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" sign="-" scale="0" id="Tc_vp8Ox2iS9kSb5AuC_sMNkQ_35_3">68,575,915</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" sign="-" scale="0" id="Tc_2kgYWSEAd0albqcxuDaJbg_35_6">59,381,158</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;"><span style="color:#231f20;">Total shareholders&#8217; equity (deficit)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_j4awgVUuuEOH4zOiFLDg1Q_36_3">59,267,049</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_qF-xZ7ECJ06ctpwdCqy4qQ_36_6">51,034,193</ix:nonFraction>)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 12pt;"><span style="color:#231f20;">Total Liabilities, Mezzanine Equity and Shareholders&#8217; Equity (Deficit)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" id="Tc_CoPRdbbXvkmB28JMrNc3wQ_37_3">64,225,985</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" id="Tc_CavV-gY9pkuERrKq9tbiuA_37_6">5,254,428</ix:nonFraction></span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_44e57d55_0e35_4831_94ed_4e397b937668"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these condensed financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_5ee5a436_a531_4964_843d_9ab02aecc694"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">MIROMATRIX MEDICAL&#160;INC.</p><a id="CondensedConsolidatedStatementsofOperati"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Condensed Statements of Operations</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p><a id="_d12298a7_6f15_4fb0_9301_c5849ee71ab3"></a><a id="Tc_JyWcF-Q9t0qLddndFszpqQ_1_2"></a><a id="Tc_BximbcdwgkiWLIRFjlwLAA_1_8"></a><a id="Tc_sd2k0I-fa0iv_0Nwkij8-Q_2_2"></a><a id="Tc_k4ZKR3UFMUKXvu5KVXkRNA_2_8"></a><a id="Tc_MkCJb5CYsUi9GeoLQSxeCg_3_2"></a><a id="Tc_BLPcfoZCKk2VxaPW47sPBQ_3_5"></a><a id="Tc_a8oDen7b5UK-IIx_OL1LVg_3_8"></a><a id="Tc_E8UkJzyRGEKlcU-rbMwalg_3_11"></a><a id="Tc_RdCEXe8WFEmeqwlFVWesLw_5_2"></a><a id="Tc_LRq3J4S4xE6RNc5SGeL0Ig_5_5"></a><a id="Tc_Bn2PIgONvEarNEg4kB4KZQ_5_8"></a><a id="Tc_fLve5ugkME6zv2rEcd2Ayg_5_11"></a><a id="Tc_bCC27SPHAEWiQ3Z1R4O52g_7_0"></a><a id="Tc_sIAdvHTV1EqNp21IrsNUCQ_8_0"></a><a id="Tc_vzYAqVgjCU68BosZ2Jx20w_9_0"></a><a id="Tc_qAqkT1FFmU6Ub02V3HLArw_10_0"></a><a id="Tc_9cpQ6Y96wEOdnmKR5UCqxw_11_0"></a><a id="Tc_t-vwFkkOU0WsP0-Pv0SGbQ_12_0"></a><a id="Tc_iWJGAB1Gf0KcgezBG_2eJA_13_0"></a><a id="Tc_P-BVsMu7wkCZ4IrH_XnB5A_14_0"></a><a id="Tc_voXka8uRvE6Pdl_a9tSVfA_15_0"></a><a id="Tc_xQ5phKtbwUusw8v0fFBfcw_16_0"></a><a id="Tc_ijOldxojiE6yG888I5b4Lw_17_0"></a><a id="Tc_iFh8_auN_kqM7evrmg-whA_17_3"></a><a id="Tc_gW8-8-Vt40qyfDaHCStoMw_18_0"></a><a id="Tc_zgp5u3Oepkq2zzEAr14SZQ_18_3"></a><a id="Tc_EXM2sttNeEi3hahLsCpNBw_18_6"></a><a id="Tc_TEzgiMLXsUWLIlq1EKRyhw_18_12"></a><a id="Tc_F0iyTGCUL0uhKPG67ZKdfQ_19_0"></a><a id="Tc_SgXvPXMjREyPz-P0wi-dog_20_0"></a><a id="Tc_o2VeFKvizU-EUZs0OJdbKg_20_3"></a><a id="Tc_h3NlZo8LT06yN8KwCUaXYA_21_0"></a><a id="Tc_e7Zgc8RzMEeb-p5A8_t9VQ_21_3"></a><a id="Tc_JZ4H13yHWkOyDrwsags58A_21_6"></a><a id="Tc_hB-IIrP850Swx-cEf0OFKQ_21_12"></a><a id="Tc_vVqteeFNs0uod08YiLwI6g_22_0"></a><a id="Tc_VwaBxP7CpUqo8G-pzhOeOg_22_6"></a><a id="Tc_R2i-hibvdEGvSX__6O-pog_22_12"></a><a id="Tc_xZTgKp9YaEyH_SGN5e3BYg_23_0"></a><a id="Tc_08MI6MooxUCsCEg7S4ljRA_23_2"></a><a id="Tc_sfblhe9_MUG5bg8aC6BCxA_23_5"></a><a id="Tc_MLBy5deeR0u4PKuhlns90A_23_8"></a><a id="Tc_CE8he_LgLkSjI8-9t4yTMg_23_11"></a><a id="Tc_bJc08ZVYhkm_jyRC7bhlcA_24_0"></a><a id="Tc_Mz4tkX6av0SCYwMILWyimg_24_2"></a><a id="Tc_8UDzdikEfUqp1UVv81Ls3w_24_5"></a><a id="Tc_V-vohUL6KEW_Nl4YxSx71Q_24_8"></a><a id="Tc_LvSUQgLSyE6tv59FeXvRRg_24_11"></a><a id="Tc_XN1hldWhGkOkYc7H-w6fdQ_25_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:24.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Nine Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:24.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_Aa8SLdhSCEmHjN0NIXjQTg;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Licensing revenue</span></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="Tc_9y3u4CTlS0iWutnfWAq6Aw_5_3">9,819</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="Tc_DDZPfiAjXkOSQDbzBSBRnw_5_6">10,846</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="Tc_VvGZXhHxY0ytbunZ_6jR3g_5_9">25,066</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="Tc_uGxJIzqZDEmMIB-HXUOHGQ_5_12">31,328</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_3Z1TCFvbYESFeSplnZ2XZQ;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Cost of goods sold</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" id="Tc_R6diytMZt0Ocl1m5OTaNiw_6_3">125,000</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" id="Tc_sAVq3PMy9U-8nW-b5D2M2g_6_6">125,000</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" id="Tc_xwa6-nr1GU-p0I1cp-6Uyg_6_9">375,000</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" id="Tc_tBQiydMvBUqDsp6nvPgq4w_6_12">375,000</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Gross margin</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" sign="-" scale="0" id="Tc_ttqZaR_6gkquy8EP1pbDEw_7_3">115,181</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" sign="-" scale="0" id="Tc_NuTJXjoyCkaTN05YLtrAeQ_7_6">114,154</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" sign="-" scale="0" id="Tc_AchSD9KF6UqGwAAPKrAICg_7_9">349,934</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" sign="-" scale="0" id="Tc_1UWncQ5xnUO8OwZsmzlY9g_7_12">343,672</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Operating expenses:</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Research &amp; development</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" id="Tc_TDxKBQi41k-Dfs_QKLrjPA_9_3">3,349,898</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" id="Tc_GDYDLKHoOUq9JmkF7891UA_9_6">1,870,039</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" id="Tc_nm7O5RzqQUOA91tfu1jUqg_9_9">7,698,786</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" id="Tc_XXpEbrXCLE6kIqmbbf3QQQ_9_12">5,750,320</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Regulatory and clinical</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="miro:RegulatoryAndClinicalExpense" scale="0" id="Tc_X_9gJ2q5N0u1Hon2yneOBg_10_3">105,208</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="miro:RegulatoryAndClinicalExpense" scale="0" id="Tc_mNglrMfkSkqVpoXuJiVClg_10_6">64,083</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="miro:RegulatoryAndClinicalExpense" scale="0" id="Tc_eKyvPvnnb0mz77OA7pL07Q_10_9">292,169</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="miro:RegulatoryAndClinicalExpense" scale="0" id="Tc_tbRjxgMJP0uDybQnXsGq8w_10_12">208,276</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Quality</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="miro:QualityExpense" scale="0" id="Tc_zcPwh5DErE6WwMVrgQs72A_11_3">150,675</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="miro:QualityExpense" scale="0" id="Tc_StHsCqPuAkapX6M1eZGctg_11_6">75,850</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="miro:QualityExpense" scale="0" id="Tc_LPDcP5EzAEO6xPms7OhaAQ_11_9">322,719</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="miro:QualityExpense" scale="0" id="Tc_BTQImFOZt06yXETPvOZ0RQ_11_12">75,850</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">General &amp; administration</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" id="Tc_QM_-YeKc8Ee10U9cq4-FCA_12_3">1,487,654</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" id="Tc_9oFvbCK0xEanA2K8oQxCfg_12_6">460,105</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" id="Tc_TlMuAmYovkW7obMKmuT3Aw_12_9">2,836,850</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" id="Tc_4Z99Tkoj3EasGglZzOz_aA_12_12">1,530,915</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><span style="color:#231f20;">Total operating expenses</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="0" id="Tc_yKpKTWHVGk2_RZjjOPjOrA_13_3">5,093,435</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="0" id="Tc_zGI174JTmE6IQfCi5A2gwg_13_6">2,470,077</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="0" id="Tc_xWuDJxYCpk-TScV9hMk_AA_13_9">11,150,524</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="0" id="Tc_0W0_PFaXiUeOF80KQ-l2Hw_13_12">7,565,361</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><span style="color:#231f20;">Operating loss</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" sign="-" scale="0" id="Tc_cfsaa4mLgUy5lHuuYwi2nQ_14_3">5,208,616</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" sign="-" scale="0" id="Tc_g7Egj-pQj0qGcBFT8cG2eg_14_6">2,584,231</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" sign="-" scale="0" id="Tc_DOugF10Ll060zP3oE5CJcg_14_9">11,500,458</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" sign="-" scale="0" id="Tc_wWQFanZC7EGiDtxbUgy9qw_14_12">7,909,033</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Interest income</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="0" id="Tc_zdsjsFQd30ScgSvAiqA3kA_15_3">766</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="0" id="Tc__u6FZoTPHkmEaKtZgDzJWg_15_6">94</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="0" id="Tc_8MXObQh4QEi5XlIPaUZ4ng_15_9">851</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="0" id="Tc_MInOyD9QxU6AvlYSsMw9gw_15_12">8,683</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Interest expense </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="0" id="Tc_I8r0hSOoNk-aUJ5r0Hhexg_16_3">15,255</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="0" id="Tc_IIbH9ZMNDUKTdajFfk-KvQ_16_6">208,926</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="0" id="Tc_R99D81Q4wUSbtoVLWbmRrg_16_9">601,292</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="0" id="Tc_nCp1x_qcCEuav1NVJly9JQ_16_12">363,444</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Amortization of discount on note </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="0" id="Tc_CfTd-G6qY0OrmXE1LqdayA_17_6">32,586</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="0" id="Tc_cfMxTJ4_rESEtNnQT85Z8g_17_9">62,638</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="0" id="Tc_7ItGDp_x902ZPQuAZ8BUjA_17_12">76,034</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Change in fair value of derivative </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeGainOnEmbeddedDerivative" scale="0" id="Tc_kYQDwGoNR0-WJoiFt_EUjg_18_9">246,962</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Research grants</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="miro:ResearchGrants" scale="0" id="Tc_svuz1j8Y9ESZOh8gLKayGA_19_3">115,069</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="miro:ResearchGrants" scale="0" id="Tc_rS_8_2K-tE-zHRGVSCjXQg_19_6">328,424</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="miro:ResearchGrants" scale="0" id="Tc_A2LvEOCqDE-_0Xyl0qycdg_19_9">393,034</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="miro:ResearchGrants" scale="0" id="Tc_A155qoRaaEyrX3r-KuymRg_19_12">794,291</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Equity loss in affiliate</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" sign="-" scale="0" id="Tc_jN0vIg6BNkejw6ZOMHQ_kA_20_6">495,000</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" sign="-" scale="0" id="Tc_TmKyrm5rgUSIZx_oZ6nInA_20_9">223,633</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" sign="-" scale="0" id="Tc_5sL98mJzc0W9mwC3k4iO1A_20_12">1,676,000</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Gain on sale of equity investment</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="0" id="Tc_Rpt_qyp7hEC4jkCazlxNcw_21_9">1,983,912</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Gain on debt extinguishment</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="0" id="Tc_sBI0VIS78kqMe4EsvDknbw_22_3">50,455</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="0" id="Tc_1m2ssYZmMkWa_BO-eZ0BcQ_22_9">568,505</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><span style="color:#231f20;">Net loss</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_khnr9XOkEEKJEcV1M_NCVw_23_3">5,057,581</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_F2SuwBuUakiqLBDqDjBjVQ_23_6">2,992,225</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_NPzIdUuK-0OTyZoqMfG3jA_23_9">9,194,757</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_8sQX3vM6ek68TxLYxFqD6g_23_12">9,221,537</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><span style="color:#231f20;">Net loss per share, basic and diluted</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" scale="0" id="Tc_GXVLYXXyX0m59KGcGJL6Bw_24_3">0.25</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" scale="0" id="Tc_Os4-omp0wEqe5X99GSWM_Q_24_6">1.37</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" scale="0" id="Tc_ZIFKNJIsNkqCankCYipKug_24_9">1.08</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" scale="0" id="Tc_1gB946Tds02abPO1hzlLbA_24_12">4.27</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"><span style="color:#231f20;">Weighted average shares used in computing net loss per share, basic and diluted</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_NUv_r9LsTECKFtQWfagf4A_25_3">20,145,321</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_NRczvRsB1E6frI8WteySOA_25_6">2,183,322</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_yEQ01RfS6EuyhP5pGXiHbA_25_9">8,503,743</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="Tc_fkwLLyaxT0W7a1t-4YPulA_25_12">2,158,632</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these condensed financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_854945b6_7c17_4b32_a36e_25e0307d4f6b"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">MIROMATRIX MEDICAL&#160;INC.</p><a id="ShareholdersEquity_946117"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Condensed Statements of Shareholders&#8217; Equity (Deficit)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p><a id="_6edd727c_bdac_49fa_951c_b52a2396dc48"></a><a id="Tc_baGPhoBGFUCymQcAcc-0pg_1_7"></a><a id="Tc_biuNpf0ET0OPEGImjlQACw_1_13"></a><a id="Tc_UvbklCN7SEa9JBL7HkjhCQ_2_2"></a><a id="Tc_B5k-tl0fY0-eE2AIO7ubvg_2_7"></a><a id="Tc_F5oAP4QKyUqrkOoFrWJySA_2_10"></a><a id="Tc_yC_5Q9rdiEaA6mClAWCehg_2_13"></a><a id="Tc_aerQILmu1UqgeL71WsZwdA_3_2"></a><a id="Tc_Bag0yJ_O1UeFs2AjTUMAYA_3_4"></a><a id="Tc_TCTAupGjq02T8M6mN6NqzQ_3_7"></a><a id="Tc_HMnWMUiJNEibxflK50Zj-g_3_10"></a><a id="Tc_LOxdAc4OiEyuce1X6RscVg_3_13"></a><a id="Tc_Bqe-w5cbKUWBEYIyBfxq1g_4_0"></a><a id="Tc_I7ilWs5gOEeRf7noIuPB8Q_4_4"></a><a id="Tc_vCNpfsjerEy2g7a4Ae_khg_4_7"></a><a id="Tc_yTO8TOuhHkGml_VlHaXgDQ_4_10"></a><a id="Tc_vZzJgeXjkE-A1eSfJt3cjw_4_13"></a><a id="Tc_-SU0Dcltt0-g84wEsdiRqg_5_0"></a><a id="Tc_zRuQbrptEEupqiJ3bIfaXw_5_2"></a><a id="Tc_SkwHre7Kz06I1zKRTp_Xgg_5_5"></a><a id="Tc_5HN_rdsrZEeshmUNvvNNew_5_11"></a><a id="Tc_s_RBBOQ56kqyMDUtpwUtHw_6_0"></a><a id="Tc_bBK5Wx-ifUCFY8TEtd_Shw_6_11"></a><a id="Tc_rstoBG_FEEGC9vy-FJM_Eg_7_0"></a><a id="Tc_XJT6uIzB0EGcfZmKCnKl5A_7_2"></a><a id="Tc_T-HXt7Bup0yUkgPNbK6tMQ_7_5"></a><a id="Tc_9h7Uy3IR2k2TuLfQaxa98A_7_8"></a><a id="Tc_dzFmAeg9UE-39H-wO7FGUQ_8_0"></a><a id="Tc_6ztmkn16PkugIsFEX_h7rQ_8_4"></a><a id="Tc_CSrDRvGUFESCayiBXtd3Hw_8_7"></a><a id="Tc_S3cBCdPDdkW1P-q5YwUB1g_8_10"></a><a id="Tc_coCMqEFPlkemaTombJWL_g_8_13"></a><a id="Tc_hld3LTSpjUukJJ0rNhcYwA_9_0"></a><a id="Tc_vzo6c3a-vEi1cDJgJ6xJCg_9_2"></a><a id="Tc_XQQxYQwFJUmkSy8fVnKaWw_9_5"></a><a id="Tc_HufSPp7n1kSWGvUyCv2L5A_9_11"></a><a id="Tc_hMuEt_95YEqm-gUtJVzzTA_10_0"></a><a id="Tc_PyHEnLU0rUS9-JxY0ouQ-w_10_11"></a><a id="Tc_4tL72a_gGEWwEwlODj_jzw_11_0"></a><a id="Tc_mOn9nh4hxkq5amgjrK_jKg_11_5"></a><a id="Tc_uPNkHYQXNEujWMS6axixgQ_11_11"></a><a id="Tc_PCkfnnqkrUCP2yZc6TfaFw_12_0"></a><a id="Tc_bAwWG5u260W9FEqwGSsD6Q_12_11"></a><a id="Tc_A3ObGm-K2kGkdKvHVchU0A_13_0"></a><a id="Tc_Onr9QrSfgEaVRvGN-CAZXA_13_11"></a><a id="Tc_X2liC0viFEOFdhckuZgdbw_14_0"></a><a id="Tc_2NW-yEcHNUyjiY2FfmEj1A_14_11"></a><a id="Tc_UfDW1Sws1U2fq8DqQr38kg_15_0"></a><a id="Tc_Cs0pyMS3mkK0rHqpI9jw9Q_15_2"></a><a id="Tc_5RcCN4J_KU-FBwgKTHRyeg_15_5"></a><a id="Tc_zHeNlKvTC0eI6Z4it1XaIg_15_8"></a><a id="Tc_e0cgy0Xb0USlkBJSGEK1Qw_16_0"></a><a id="Tc_gXnTLShVUke_1e7GRDFH4Q_16_4"></a><a id="Tc_H2Pz1fp9dUS2u-1UTxQdEw_16_7"></a><a id="Tc_RciAeOOKF02oSwT_X7uyCg_16_10"></a><a id="Tc_B4ih-TzynESuqVKiOZ4WPw_16_13"></a><a id="Tc_ijnOw8g2WEap9bfRjzVJ4g_17_0"></a><a id="Tc_DlQb_MtoO0mxSaJzzCW7_A_17_2"></a><a id="Tc_ep1iWOSq7U-oLcHKFX2CPg_17_5"></a><a id="Tc_2S33hWTY1EOmC2jL1U7RMg_17_11"></a><a id="Tc_Du1M9xClLUOYJlan4cyNYg_18_0"></a><a id="Tc_cKZyhiix0UWCoLA31qtq2Q_18_5"></a><a id="Tc_ubabmuilW0mKn7nMvGvn4Q_18_11"></a><a id="Tc_89Tpd6__1ESFoZHehkVD8Q_19_0"></a><a id="Tc_XU4wTbqy1kq9TUWZwDCKWQ_19_11"></a><a id="Tc_x6Vx8wcA-EGnzNXnsXcujA_20_0"></a><a id="Tc_CtWLZgJ3ukGEVknkUuNeLA_20_2"></a><a id="Tc_ERaQlABNdECvZQJz0HTMDA_20_5"></a><a id="Tc_BcynfMbaP06NWegT0IKkUA_20_8"></a><a id="Tc_6hCuDFpXr0a4UkrRaNWoAg_21_0"></a><a id="Tc_5hy8o0psvU2RM0i7oQOQDg_21_4"></a><a id="Tc_REhw6LQvsUWHs8NKLowDXw_21_7"></a><a id="Tc_6Iq3LyLwQE6nGgly2tlaog_21_10"></a><a id="Tc_w_cu1MLxw0ickdQ-CJkkDQ_21_13"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Additional</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Pain-&#160;In</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Shareholders&#8217;</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Equity (Deficit)</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Balance at December&#160;31,&#160;2020</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Ej34jWijlUGaHWWuYVa4Yg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="Tc_1dJ9YEtwq0GKUHPBhvKvrA_4_2">2,185,822</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Ej34jWijlUGaHWWuYVa4Yg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_e5J9wQEbwk2CwRyqDRF3-A_4_5">22</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_CSxBNgaEF0Os5-o-5D0nNg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_8At6nacWREqHFoxRclerBw_4_8">8,346,943</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_skQC9Tm4L068d2CO6DNYuA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_GMMOAPugFkG5tjVAyWj9zw_4_11">59,381,158</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_xu-kmwc11U6rBG2uQyoAFg_4_14">51,034,193</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Stock-based compensation expense </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_JGIso0rEp0yd4KJDkgW6xQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" id="Tc_pAc7JCu2eki_KaDj4CQYvw_5_8">133,451</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_3_31_2021_foKQtmn6f0it35GNZ-xuwQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" id="Tc_4mekugnTTU23N0G5rFwIzQ_5_14">133,451</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Exercise of stock options</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_g67rL0VSYUuJLtgWVN02og" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Tc_CqpYDSjQFk6sx7Ej_WC2-w_6_2">105,000</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_g67rL0VSYUuJLtgWVN02og" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="Tc_8F0gTUeNSkG-z1RwtDPUvw_6_5">1</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_JGIso0rEp0yd4KJDkgW6xQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="Tc_y9pgV0HGJECele8ufSMWvA_6_8">28,749</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_3_31_2021_foKQtmn6f0it35GNZ-xuwQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="Tc_rlWBBwLcxk-PHhoDkoZfPw_6_14">28,750</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Net loss</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_ogBGhyb8QkWldjubXwC2ug" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_mhbn-3XD00Snfafjvy0Xyg_7_11">434,342</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_3_31_2021_foKQtmn6f0it35GNZ-xuwQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_LTLW3leDxk-kMysQ3Gm2Fw_7_14">434,342</ix:nonFraction>)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Balance at March&#160;31,&#160;2021</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_MJo6GylBG0KwIG9o-vIDAA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="Tc_lskt-gZVGE--Yg-hdngqXA_8_2">2,290,822</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_MJo6GylBG0KwIG9o-vIDAA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_o-zyS9eHkESjg3oXiEY7jA_8_5">23</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_QPA5yoiM3U6iLWS98GAGHw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_1r8kfDbMCk20zDOUqfq_CQ_8_8">8,509,143</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_UkafvMeDh02ELaaw-wUr5A" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_NdOl53KgxEuakaACLDWtaw_8_11">59,815,500</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_3_31_2021_svAh3vgTQEO6ofy12nzIaw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_WX7RhkXZ20y4CnhkLRLRcw_8_14">51,306,334</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Stock-based compensation expense </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" id="Tc_7iO8l67XP02l74Sx_B1_Kw_9_8">105,879</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" id="Tc_XOTEoURsIU66iYHV00Tm2A_9_14">105,879</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Exercise of stock options</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Tc_OZl602-k9EOtgzye9p2fKQ_10_2">58,750</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="Tc_1U3bxAwJg0izfOHap695gA_10_5">1</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="Tc_ZQ-ogcnPuEe4AvYCUVK5gg_10_8">5,874</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="Tc_TeMFj0h9H0qCqBzWQUhHsQ_10_14">5,875</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Exercise of stock warrants</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q" decimals="INF" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodSharesWarrantsExercised" scale="0" id="Tc_kZBfqtT_60uS2PEA8L0QBQ_11_2">65,909</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w" decimals="0" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodValueWarrantsExercised" scale="0" id="Tc_Z_WlMx3MukG2odLaI4DT-w_11_8">6,250</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg" decimals="0" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodValueWarrantsExercised" scale="0" id="Tc_L7k7sv-WcUmPcnvtOzPxNQ_11_14">6,250</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Conversion of preferred stock to common stock</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q" decimals="INF" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodSharesConversionOfPreferredStock" scale="0" id="Tc_n_bBQB2v702QYhpc0QQ0jg_12_2">11,092,314</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q" decimals="0" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodValueConversionOfPreferredStock" scale="0" id="Tc_lvbtvemcyEeR5y4LVrMaHQ_12_5">111</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w" decimals="0" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodValueConversionOfPreferredStock" scale="0" id="Tc_xreZnSIFiUmK1jf4s4KbCg_12_8">66,553,049</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg" decimals="0" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodValueConversionOfPreferredStock" scale="0" id="Tc_W4elq_10q0my0JWvBfucvQ_12_14">66,553,160</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Note payable and accrued interest converted to common stock</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q" decimals="INF" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest" scale="0" id="Tc_xN0asDbjq0O5aOysijZbXA_13_2">996,757</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q" decimals="0" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest" scale="0" id="Tc_NKzskZ_PdEumn5DNfRd5mA_13_5">10</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w" decimals="0" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest" scale="0" id="Tc_yYauVxQY6kWnqP8kMWFuOw_13_8">7,152,389</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg" decimals="0" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest" scale="0" id="Tc_g6hSF_eXFkW78Sa91j_Zgw_13_14">7,152,399</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Sales of common stock, net of expenses</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="Tc_byLA0Ng5tEOMdAaXM31bIw_14_2">5,520,000</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Tc_NYn-v-JCLkWJAYowBOdd0Q_14_5">55</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Tc_PTIoWte65kWaSqgln2FoDA_14_8">44,593,631</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="Tc_GJFktKcSCkaJ7UR4XkHC-g_14_14">44,593,686</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Net loss</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_oBuuB5uPg0C8wAZV2nRBKg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_z0GMWus_j0msrQ9LZr-Wsg_15_11">3,702,834</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_i5Mc8dZyZUWe4QI1um9IpA_15_14">3,702,834</ix:nonFraction>)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Balance at June&#160;30,&#160;2021</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_D8qKF6W_5EqZAfHpIf6RUw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="Tc_NKl9OLLqa0uNntBXmrPZzg_16_2">20,024,552</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_D8qKF6W_5EqZAfHpIf6RUw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_fERF5PMqeUq2qV_iuri5wg_16_5">200</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_ReKi1zH93kOF4ZIWEaTZLQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_Suoj_JbTC0GzWF0yRbIBww_16_8">126,926,215</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_8YSV2HeTl0O8xWN1mRaSSw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_W-PkikEA-kydJH3LKdk4cw_16_11">63,518,334</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_6_30_2021_SPtw5tHT3k6JDysLGb0wNw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_Kg59qmWuVUW9X67bB_ULdQ_16_14">63,408,081</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Stock-based compensation expense </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DZF78Qgsdk-UpOA4nYZypg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" id="Tc_NfI23UTiUkWLMfCeBknD0A_17_8">144,969</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" id="Tc_STKRDcEyCUyborZvQ-x-qA_17_14">144,969</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Exercise of stock warrants</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6V1pKA0LTEOpb09NqY9M3g" decimals="INF" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodSharesWarrantsExercised" scale="0" id="Tc_FNrc_1uwyU6IHftAN4peMA_18_2">11,977</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DZF78Qgsdk-UpOA4nYZypg" decimals="0" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodValueWarrantsExercised" scale="0" id="Tc_TisWagc6vE6bC8KDJL_NHQ_18_8">2,725</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodValueWarrantsExercised" scale="0" id="Tc_g3EWDwojhkuxwNMZ5HTGyg_18_14">2,725</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Exercise of stock options</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6V1pKA0LTEOpb09NqY9M3g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Tc_UUUQZf4GFUWB7WGCZ5QrcA_19_2">218,116</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6V1pKA0LTEOpb09NqY9M3g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="Tc_kNDjjYjixEWtxMpUgeb3gw_19_5">2</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DZF78Qgsdk-UpOA4nYZypg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="Tc_uPSFI8iyhk6iA8X9TOzaow_19_8">768,853</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="Tc_8cjIwKIrk0eMykN5VWAPlg_19_14">768,855</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Net loss</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_YIeLLI8Zuka4IuRCQnSL5A" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_whMPaAOI90uaSsFXLUGgng_20_11">5,057,581</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_1KIcqhuP8k2rApK1-DGAZA_20_14">5,057,581</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:37.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Balance at September&#160;30,&#160;2021</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_qsMCAn9EN0mSGkuoU6XYuQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="Tc_Slfjg2D_AUCwi1pS4QUv_A_21_2">20,254,645</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_qsMCAn9EN0mSGkuoU6XYuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_my52tBAf7Uyuxq2gFt4VIA_21_5">202</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_hJm_H_CmaUKQYQsG7Q0bOA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc__4v5tkUC80W9P8Kq2qUf6A_21_8">127,842,762</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_BAFNsPfZ306w0rPJrdHROA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_WAK7RNn7iE-ETWfifPm2tw_21_11">68,575,915</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_H2H46lZltEeGO0jkbFTJfg_21_14">59,267,049</ix:nonFraction></span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_c8d2e738_e608_4c27_960d_c95641fa8061"></a><a id="Tc_HO7YL5q1vk2Q5nrFzI2gBg_1_7"></a><a id="Tc_PewuCCRPU0-dTtbUfQDiWA_1_13"></a><a id="Tc_h4_EnKHYREGSeUHs4dZ-Sg_2_2"></a><a id="Tc_zQh45JIw8EOxBp0c9kGSBg_2_7"></a><a id="Tc_J-glKq5bo0WIoh9JhWHt9A_2_10"></a><a id="Tc_OJtBlC-BtUiEh-oEfevKXQ_2_13"></a><a id="Tc_PI5HryT9fU6y6hgYGGeyqQ_3_2"></a><a id="Tc_U5FZx9PPE0CyBt4anuGfKA_3_4"></a><a id="Tc_mxsFmNFpM0i3I5bt7QLM4g_3_7"></a><a id="Tc_ONWBIR9aoEKI3Pf8-br0vg_3_10"></a><a id="Tc_Byiw6Vk2_kWvDNIE6qMgEA_3_13"></a><a id="Tc_XGttLiTm9EKyLYuFJ4pE2g_4_0"></a><a id="Tc_LfwtVoexM0GV3FE3_4CIvg_4_4"></a><a id="Tc_SbDrWjQGrkyR2Z1sBpkEng_4_7"></a><a id="Tc_kHz2esRxA0OCcCWn7O6UsA_4_10"></a><a id="Tc_yXGNP7I3kked3C2rcGmnoQ_4_13"></a><a id="Tc_-exZIqOUZ0irwvYtUOLCvA_5_0"></a><a id="Tc_GuPQCOE0fUCIXppslZpETA_5_2"></a><a id="Tc_osaEfWvdT0iSG5Q6F6-73g_5_5"></a><a id="Tc_SMteDkGRvUug3KfaaQvL7g_5_11"></a><a id="Tc_0_VOCVi-40KTpIyNEnCsCw_6_0"></a><a id="Tc_gA0IQrcdmkKeApscvLRdNw_6_2"></a><a id="Tc_yM4y5DxVmUaNIr4dihcATw_6_5"></a><a id="Tc_jNWO0lPm6UareSR0o63SKg_6_11"></a><a id="Tc_S-FLfRpzukCYEMqS5w4upQ_7_0"></a><a id="Tc_NDf-_V5G1kOWOTJpOMs8jg_7_11"></a><a id="Tc_nu5ImTfI0UOod6V8pSzotQ_8_0"></a><a id="Tc__dMBRa7iKEmc2ZRMnsOGfw_8_2"></a><a id="Tc_56A20CJVYEuunuw_scil0w_8_5"></a><a id="Tc_2aBKOQn7G0CcXN5VLo4rAg_8_8"></a><a id="Tc_JEWiuq-VnUi3luQXEQAJlQ_9_0"></a><a id="Tc_zL0ZtlDvkkGpCJXTQ_BK-g_9_4"></a><a id="Tc_e1Rq2pyFhUue_TPW-9EKRw_9_7"></a><a id="Tc_AopitYOLZ0qcnmwYVm75nA_9_10"></a><a id="Tc_4UrlfIlt2kWtgDZ2u6EkQw_9_13"></a><a id="Tc_7Xlu2-6hZUma55HuLFQ_pA_10_0"></a><a id="Tc_00G07-LjHkWcCdItr-a_lg_10_2"></a><a id="Tc_orAAaVwi4kirfTAFEcEk3g_10_5"></a><a id="Tc_LBfHA824qk2ohDvswurv4g_10_11"></a><a id="Tc_W2L5z8YL1Ua-MKoHTh57NQ_11_0"></a><a id="Tc_cBMpmrLf1EaJnkBT-LwMMg_11_2"></a><a id="Tc_CNW3FtHYC0GPWUSaBOfo5Q_11_5"></a><a id="Tc_SgULIEJqmEeGpyKyHfxKiw_11_8"></a><a id="Tc_RHusEdabrkinU3R8nFkysQ_12_0"></a><a id="Tc_Hc7Uj9SL9E-QiZuI-VP-pw_12_4"></a><a id="Tc_vjSNVh2knEmD123E1IcpBA_12_7"></a><a id="Tc_WuD0RD2w_0ijMPPTA3tNIQ_12_10"></a><a id="Tc_Cxu25v6yTU6GhlepbHVWHA_12_13"></a><a id="Tc_F2oc1DnXtE2FopMEk7EPmQ_13_0"></a><a id="Tc_uuYva4upSkOEfZNkThqmOg_13_2"></a><a id="Tc_agiqBAI9f0CHYx5oOI1b7Q_13_5"></a><a id="Tc__k7yHnZ6oU6--XQO2hd69A_13_11"></a><a id="Tc_uN-5TfplckaRmm6RBdlriA_14_0"></a><a id="Tc_aBYm31zLA0qdaarvrPKplg_14_2"></a><a id="Tc_AzwiPWh3Ikiw3rh8dPwTxQ_14_5"></a><a id="Tc_1Rglc8bVMUiwHS7M2znR1A_14_8"></a><a id="Tc_xLT_Rx0sKUaqDXFHXHvzfg_15_0"></a><a id="Tc_7upSNehPi0KdhhpEtRZxcg_15_4"></a><a id="Tc_vyHf-SztXEKPckNYY7TXkw_15_7"></a><a id="Tc_J3FqEOBjnUOMCTO4R9rEqA_15_10"></a><a id="Tc_PKvNdpgK1kGlQPz4hdOllw_15_13"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Additional</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:17.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Pain-&#160;In</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Shareholders&#8217;</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Amounts</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Deficit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Equity (Deficit)</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Balance at December&#160;31,&#160;2019</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_wKqlw5fr5EWLskUxmEQ3gw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="Tc_IHUKu1p3yEafeVOJ6PfjVA_4_2">2,075,822</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_wKqlw5fr5EWLskUxmEQ3gw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_6attWkLkMEmWm7gTW-XsXA_4_5">21</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_jD--vlyzLkiWS0X8coG22g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_8jqglSJCukOQBuNeVlgaSA_4_8">7,638,190</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_Fqh6xEaMFkaS8jG4_GyGRQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_pnkY7obhWEa9TDeaX7PZ7w_4_11">49,071,590</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2019_gbPT0CGmrE-mrppNChpn0g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_cIDyA4OpH0ilTLFich6GaQ_4_14">41,433,379</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Stock-based compensation expense </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DhADGZrh1EmAAzxwiQhJGw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" id="Tc_CY3EaMnD40W3NkG1s7Pcrw_5_8">157,398</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_3_31_2020_5jHwYW7aQkqXNV2KSw6vaQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" id="Tc_v34nimvZb0KAw6cr7b8QZA_5_14">157,398</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Exercise of stock warrants</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DhADGZrh1EmAAzxwiQhJGw" decimals="0" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodValueWarrantsExercised" scale="0" id="Tc_jDk_UCaRLEy2OmWh3mzXnQ_6_8">56,250</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_3_31_2020_5jHwYW7aQkqXNV2KSw6vaQ" decimals="0" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodValueWarrantsExercised" scale="0" id="Tc_m_4ef5m7xEu2jT0vXRMhdw_6_14">56,250</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Exercise of stock options</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_JwkSx9yECEqsu5y6ZmvOwA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Tc_AyZ5PNMD8U2TBmp1ZsauHw_7_2">62,500</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_JwkSx9yECEqsu5y6ZmvOwA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="Tc_lKMgCrQXAUaZjk9zOPBc1w_7_5">1</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DhADGZrh1EmAAzxwiQhJGw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="Tc_XcCkDlo5LkyLtEBioV9OWA_7_8">6,249</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_3_31_2020_5jHwYW7aQkqXNV2KSw6vaQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="Tc_C_J9eFYV_kGCtR-BFahDaA_7_14">6,250</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Net loss</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_nMl7KbsZzkqXzxdBQILxoA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_nY5qQNQ0DEapmrn7PU0J_Q_8_11">2,956,233</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_3_31_2020_5jHwYW7aQkqXNV2KSw6vaQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_dsKzSIZ1MUWmsndskl_ClQ_8_14">2,956,233</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Balance at March&#160;31,&#160;2020</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ttLecL7oRkWwB-XxzLao0g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="Tc_0IKNz0NOYUG5sXxg_vKbVw_9_2">2,138,322</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ttLecL7oRkWwB-XxzLao0g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_CDHPdWLB_E2GFmsJo-by2g_9_5">22</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_bCstooZB5EijeOk-sHr8Sw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_rCbzJw3_0U63JyrwYZTrBw_9_8">7,858,087</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_YGScN6RDoUitB_OqPuCA3A" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_YhVIjZHyd06-Nb_b9pt7gA_9_11">52,027,823</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_3_31_2020_UOLsCPKKbEmhyF78HT5_XQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_ANLsIy6yRU2Hy_unNT_b6A_9_14">44,169,714</ix:nonFraction>)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Stock-based compensation expense </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2020_To_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_Qm42BmYK-UOKhFqGE3GLXA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" id="Tc_CB4GVJV9Rki3sFt8CjjPMg_10_8">157,398</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2020_To_6_30_2020_NDTiF3J6pE6DAJHe0861mA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" id="Tc_BAYwFmKr802RS1zQjfx52A_10_14">157,398</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Net loss</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2020_To_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_pw-r84ndYkSP68XRrV0yTw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_wEAfMA32KUGQISOt9-k7lg_11_11">3,273,079</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_4_1_2020_To_6_30_2020_NDTiF3J6pE6DAJHe0861mA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_2x6ws_S1aUeHl1QXGp0sVg_11_14">3,273,079</ix:nonFraction>)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Balance at June&#160;30,&#160;2020</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Zp8WC33yq0ebMiPW4NZNIw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="Tc_H-zVW8zQUE23qdjCe5Vanw_12_2">2,138,322</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Zp8WC33yq0ebMiPW4NZNIw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_9Sr_uBHtEU2Pq5LqozgmqA_12_5">22</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_USH1GwFq-EuR2zkUYP0bfw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_Ly2DfZNatky8BVeoaTKYSg_12_8">8,015,485</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_X24d21muVUiqauo73XMZ6Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_mPlvfO2bx0G7YkeaGbR59Q_12_11">55,300,902</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_6_30_2020_NdUbxN7H60abPZxL_rdgcg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_Wbmq0RXEKk66LaUNi30adw_12_14">47,285,395</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Stock-based compensation expense </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gkWjeTErEEKrQ1vY2z-omg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" id="Tc_JjbGlhPPKUG0JEVC9_fD3A_13_8">157,398</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" id="Tc_Hl0TqnxSnUmsIkNjuCYLWg_13_14">157,398</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Net loss</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_QSVhaJp0c0qau5mbNttKZw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_fgUhi93J20a_U1w7woxOVw_14_11">2,992,225</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_IZoFBfKoF0GOzVWbuFZmaw_14_14">2,992,225</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Balance at September&#160;30,&#160;2020</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Ujd_JULeH0eOzL9jR9r4VQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="Tc_CARebtryOU-HYzYwW6ft3w_15_2">2,138,322</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Ujd_JULeH0eOzL9jR9r4VQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_ejS1h8yZW0yWTZOHPLhKQA_15_5">22</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_IeptdhXZvES-2yRyQFy8qw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_D5CL3rIkb0K1qDnNo0bwhg_15_8">8,172,883</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_7YsfFYJ7r02IKnkspoVFDQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_3xIi6eISNkikg9UdhZyNIQ_15_11">58,293,127</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2020_LW-AR2B-IUCYjTsTG_L0Gg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="0" id="Tc_I5r0fXAc9EawtxKvGqLWPw_15_14">50,120,222</ix:nonFraction>)</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these condensed financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_2ee33e2d_9d1d_441c_804e_5408fc5d3199"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">MIROMATRIX MEDICAL&#160;INC.</p><a id="CondensedConsolidatedStatementsofCashFlo"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Condensed Statements of Cash Flow</b><b style="font-weight:bold;">s</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p><a id="_85612c56_7c40_459f_ade2_5c0744fda604"></a><a id="Tc_FkIb2IK-wkC4klzjx7bRjQ_1_2"></a><a id="Tc_EUQjc9hvn0GDZt1NVr2Z3A_2_2"></a><a id="Tc_6T1eozM9E0SIXFFnGyFOFQ_3_2"></a><a id="Tc_0dt2_swTaEylCXc9nr9bGA_3_5"></a><a id="Tc_QAuNPeWKy0qXipAH7aWvKQ_5_0"></a><a id="Tc_m5njlDTrA0ObM8HNTg2_gQ_6_0"></a><a id="Tc_gEXEK15GWkWp-g5FLuNdqg_6_2"></a><a id="Tc_CXT1NXmet0ae9RJbGNsc8w_6_5"></a><a id="Tc_oAZR56qad0KJ2uQJWi3rBA_7_0"></a><a id="Tc_EnBFUR188Ua92kjKI9aY4A_8_0"></a><a id="Tc_CLttQJr7oU26duqsXZ5pLg_9_0"></a><a id="Tc_B23sBS5t9EWZeZZAfvb34A_10_0"></a><a id="Tc_zudws_bDHEmIEKgMaE79VA_10_3"></a><a id="Tc_C0UTYbYzcU64Vz4MzBtqHQ_11_0"></a><a id="Tc_i3myvTxiwkyvFu6OlTm0Mg_12_0"></a><a id="Tc_WGEMoj_VCUOh4bJEtv_9oA_12_6"></a><a id="Tc_Jfo7fivmEkyJaPh-XioZww_13_0"></a><a id="Tc_3P0-bwF4s0GlI6KVSBVDLg_13_6"></a><a id="Tc_8fl44OVa-ESyFCHnH_ZMEw_14_0"></a><a id="Tc_L-sC_e4qoUepawZrwTd5Kw_15_0"></a><a id="Tc_IFbIFnrl_UegSfTSq6Pogg_15_6"></a><a id="Tc_wcA6EKb5v06ao-Y6UBWE5Q_16_0"></a><a id="Tc_fSE3bwu3EUSRZL6JNnA9sA_17_0"></a><a id="Tc_B5m0GkI19k2dqa7dbOmEpQ_17_3"></a><a id="Tc_Bbyy9FJmb0GrcWaa1N9wfg_18_0"></a><a id="Tc_DT9DhcgZckSpjvm9HKswkQ_19_0"></a><a id="Tc_slM3PyqG5k-2CaWPBPWUbw_20_0"></a><a id="Tc_yMriO1j8FkClClo-gVkpMQ_21_0"></a><a id="Tc_S7Rgc9hdokufVtCpZVj3tQ_22_0"></a><a id="Tc_TnyboDfGUUKjt6ICc0_XdQ_23_0"></a><a id="Tc_cjzThjqIrkiA4oZ15jAPWg_24_0"></a><a id="Tc_QC9jBzYl4ka0FBpDhW6HRA_25_0"></a><a id="Tc_fnTbTExLXUupABAQPqBthQ_25_6"></a><a id="Tc_zjwB23qMEkG06QegrecQJA_26_0"></a><a id="Tc_8MlsilARoUS4gpuP3YwCAw_26_6"></a><a id="Tc_TzQErH6GZ06KvMDnJNsWSg_27_0"></a><a id="Tc_v2wglg-jpEmrdEmhvjXLRA_28_0"></a><a id="Tc_arI8XOklrEWqFC86g-zFjw_29_0"></a><a id="Tc_mMNf_elox0iQmtVo7A-w6A_30_0"></a><a id="Tc_McamUYQhtE6TWRqwoMr64Q_31_0"></a><a id="Tc_Lz7OvlZNf0Svr24COSKGwA_32_0"></a><a id="Tc_CQOkpek3d0GpqoaZ6CmyeQ_32_6"></a><a id="Tc_lmQiw_Cl3k6xQprI8MzA2w_33_0"></a><a id="Tc_ZtgjC92ZfkiDUwZShM5hBQ_33_6"></a><a id="Tc_axZ4Pf1JLEKbuGqMLi5igQ_34_0"></a><a id="Tc_DOC6i31vWkab2VriO-jq8Q_35_0"></a><a id="Tc_UntNUdmAH0C-KVF2X8zMmA_36_0"></a><a id="Tc_j9Urg9T9iUuqZmBvseoWww_37_0"></a><a id="Tc_WFNQdO0d_UWmuuFkywjfBQ_38_0"></a><a id="Tc_W5x3hRuc50yLCd4Hxyzz0g_39_0"></a><a id="Tc_hML6RHlf-kOdxaSdI4zSxg_39_2"></a><a id="Tc_q4kHMnBmQUqmIOuplEyBAA_39_5"></a><a id="Tc_Px-374lTkUqcRhsdiDr39Q_41_0"></a><a id="Tc_UUG_pW8ty0CIx8R2subrLg_42_0"></a><a id="Tc_OUGcW_rOQ0KJR2HEiRqY1w_42_2"></a><a id="Tc_wJPGfCY_z0idn7rsiqX9Hw_42_5"></a><a id="Tc_2tgjpeXBGUOlNW0Ca7wCcw_44_0"></a><a id="Tc_xvdTsUOGfUiG4xw8EBmbvA_45_0"></a><a id="Tc__0jOxkxAtUiQqc62uwOqMg_45_2"></a><a id="Tc_tnljp1u_-UePpcvXuI5FeQ_45_5"></a><a id="Tc_A8x-PNQSEEawtHSjrbWVDg_45_6"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine months ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">Cash flows from operating activities:</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">Net loss</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" scale="0" id="Tc_ZuGI_UfDFkWpfHv0wAnVvQ_6_3">9,194,757</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" scale="0" id="Tc_EMGRRXlyTUKIVThAdcRtzg_6_6">9,221,537</ix:nonFraction>)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Adjustments to reconcile net loss to net cash from operating activities:</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Depreciation and amortization</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" id="Tc_jQJNE3Qdc0OwYSJLujF7FQ_8_3">93,575</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" id="Tc_mHdT6-CJmUyIqSWwUmvQEw_8_6">139,921</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Stock-based compensation</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="0" id="Tc_c2SSxnCEC0e8CjMqK8bkzw_9_3">384,299</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="0" id="Tc_BZUEMuXEGUWnFpsJaHRcDA_9_6">472,194</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Reserve for bad debt</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProvisionForDoubtfulAccounts" sign="-" scale="0" id="Tc_5n5sxi3UjEG9wLuXQfAAaw_10_6">7,501</ix:nonFraction>)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Amortization of discount on note </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="0" id="Tc_kDGc00davEm7eYIyaEocFQ_11_3">62,638</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="0" id="Tc_AqWxVWK5uk2GZhBOzEIBCw_11_6">76,034</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Change in fair value of derivative</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeGainOnEmbeddedDerivative" scale="0" id="Tc_jV7ysQ_Jx0uJL2A2FjyW-A_12_3">246,962</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Forgiveness of paycheck protection program loan</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="miro:GainOnForgivenessOfDebt" scale="0" id="Tc_N-f9F-nLBEy-uk-yIXNLbw_13_3">568,505</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Equity loss in affiliate</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" sign="-" scale="0" id="Tc_XyXwzIPVWUSL6oDXvsaMTg_14_3">223,633</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" sign="-" scale="0" id="Tc_1tKvUXX_vkKN7cEwvGDxhw_14_6">1,676,000</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Gain on sale of equity investment</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="0" id="Tc_L7XJ68zq40C7-pqwWTKG4g_15_3">1,983,912</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Changes in operating assets and liabilities:</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;">&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;">&#160;&#160;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Accounts receivable</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" sign="-" scale="0" id="Tc_o5KF4HYjqEuuDp8SznBJ-w_17_6">49,676</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Receivable from Reprise Biomedical, Inc</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent" sign="-" scale="0" id="Tc_bi3Ub0RFTE277Bsc414DTQ_18_3">5,383</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent" sign="-" scale="0" id="Tc_RPpk06hHUkeKpUJIL7VQbQ_18_6">217,405</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Grant receivable </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="miro:IncreaseDecreaseInGrantsReceivable" sign="-" scale="0" id="Tc_Y5rXrNQjs0y8FVC991cqCw_19_3">15,530</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="miro:IncreaseDecreaseInGrantsReceivable" scale="0" id="Tc_aJleuRMf80qOg8PLXidogA_19_6">257,380</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Prepaid expenses</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="0" id="Tc_5haYDEXIgUqDFhlSqDv9ng_20_3">203,734</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="0" id="Tc_g_vZO0EPr0iUzfBQlWtd-A_20_6">17,535</ix:nonFraction>)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Accounts payable and accrued expenses</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="0" id="Tc_hlvhOq1I30mHI9empLIpJA_21_3">2,649,560</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" sign="-" scale="0" id="Tc_GLQi1mKiQk6jzcfDVh7L6Q_21_6">83,702</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;">Accrued interest</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="miro:IncreaseDecreaseInInterestPayableNoncurrent" scale="0" id="Tc_KALY6XgJME6QfQZpL8O4AQ_22_3">583,293</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="miro:IncreaseDecreaseInInterestPayableNoncurrent" scale="0" id="Tc_tb5r-eh0l0S3OAyWmD_B-A_22_6">347,349</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;"><span style="color:#231f20;">Net cash used in operating activities</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" sign="-" scale="0" id="Tc_TAzJcJ0UskO8sESGRSAsKQ_23_3">8,211,019</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" sign="-" scale="0" id="Tc_3DqyROC2G0Ohuh3X7mz8EQ_23_6">6,094,316</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">Cash flows from investing activities:</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Proceeds from sale of equity-method investment</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="0" id="Tc_T1zoHvDflkyOPS7RDOp1_g_25_3">2,000,000</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Purchases of construction in process</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsForConstructionInProcess" scale="0" id="Tc_879WbaWoAkORumoUJ_rt3g_26_3">1,166,129</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Purchases of lab equipment, furniture and leasehold improvements</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="miro:PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements" scale="0" id="Tc_aSKPakiot0Ce6o6PHDYEAA_27_3">281,560</ix:nonFraction>)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="miro:PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements" scale="0" id="Tc_CdBlOh_600qRPpxwFx60Ug_27_6">123,167</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;"><span style="color:#231f20;">Net cash provided by (used in) investing activities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" id="Tc_PUrKlkp94kC22LOQjogCFA_28_3">552,311</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" sign="-" scale="0" id="Tc_lXRQYoolNUGLKr0HocJpjg_28_6">123,167</ix:nonFraction>)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">Cash flows from financing activities:</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Payments on long-term debt</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="0" id="Tc_HVG0XgIQwE-GoKE-GmTZyQ_30_3">83,387</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="0" id="Tc_vpDsLwqqIEWb_HM10QREWg_30_6">97,311</ix:nonFraction>)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Proceeds from long-term debt</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="0" id="Tc_DxsQx8hEAkSMCWSLDHLedA_31_3">87,567</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="0" id="Tc_PxXtyRKwwESB_wj5ZqmB3A_31_6">6,563,397</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Proceeds from sale of common stock, net</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="miro:ProceedsFromIssuanceOfCommonStockNet" scale="0" id="Tc_xqySPdDjJkqDT9QAbrHZ0g_32_3">44,593,686</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Proceeds from sale of preferred stock, net</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="miro:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet" scale="0" id="Tc_IL2UxXSsLU6NleeV8vNP6g_33_3">19,891,670</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Proceeds from stock warrants exercise</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromWarrantExercises" scale="0" id="Tc_p3Mypcd1LEq5w0f_Q7qahQ_34_3">8,975</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromWarrantExercises" scale="0" id="Tc_Zk9puF8U4EesK9lpDZ0P9w_34_6">6,250</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Proceeds from stock options exercise</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="0" id="Tc_C-iEW0BIW0m0rcfeYE0gwg_35_3">803,480</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="0" id="Tc_B9hS54Y1skqyVtKA1Q-LSQ_35_6">56,250</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 18pt;"><span style="color:#231f20;">Net cash provided by financing activities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" id="Tc_cx9kZ6xx4U6pC_kiuYaefQ_36_3">65,301,991</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" id="Tc_Hqw-ktFQrE-IT5t9NuQuTQ_36_6">6,528,586</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">Increase (decrease) in cash and cash equivalents</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" id="Tc_8DRgJduQyE2rDaRKALqsWQ_37_3">57,643,283</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" id="Tc_ldoh1O5-w0uEfgNcWGpZQQ_37_6">311,103</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">Cash and cash equivalents at beginning of period</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_HjvzSw96mEananLUpF98Tg_38_3">4,444,395</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2019_gbPT0CGmrE-mrppNChpn0g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_fMkzQ5AuSEeMPhdhEaltYA_38_6">3,250,014</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">Cash and cash equivalents at end of period</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_EUYOqkU_nEuWMpC_HlMt3w_39_3">62,087,678</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2020_LW-AR2B-IUCYjTsTG_L0Gg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="Tc_8TDm1mSVc0K1yyTOVxIu5A_39_6">3,561,117</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">Supplemental disclosure of cash flow information:</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Interest paid</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="0" id="Tc_7sY0HnbbQk-aQNbydxnBcw_42_3">17,999</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="0" id="Tc_4uzhqneCO0uI2TVGMd2CfQ_42_6">16,095</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">Supplemental disclosure of non-cash activities:</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Accrued expenses related to financing</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="miro:NoncashInvestingAndFinancingFinancingExpenses" scale="0" id="Tc_9BP8mj4ik0i4gHJMEPTj5Q_45_3">936,652</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these condensed financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_1f201f03_2d70_4fdd_9655_3a589c963f6c"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">MIROMATRIX MEDICAL&#160;INC.</p><a id="NotestoCondensedConsolidatedFinancialSta"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Notes&#160;to Condensed Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="Tb_VHlajgWLfEG7fOZ-XmoQyw" continuedAt="Tb_VHlajgWLfEG7fOZ-XmoQyw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;1&#160;&#8212; DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Description of Business</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Miromatrix Medical&#160;Inc. (the &#8220;Company&#8221;) is a life science company that has a proprietary technology to remove cells from, or decellularize, and also to recellularize organs and tissues from animal and human sources, facilitating the creation of numerous products.</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="Tb_CFka2W-5ckC4FvFklKU7Ug" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Basis of Preparation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.3pt;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and the rules of the Securities and Exchange Commission (&#8220;SEC&#8221;) applicable to interim reports of companies filing as a smaller reporting company.&#160; These financial statements should be read in conjunction with the audited financial statements and notes thereto contained in the Company&#8217;s Registration Statement on Form S-1 (File No. 333-256649), as amended, (the &#8220;Form S-1&#8221;) for the fiscal year ended December 31, 2020 filed with the SEC on June 22, 2021.&#160; In the opinion of management, the accompanying condensed interim financial statements include all adjustments necessary in order to make the financial statements not misleading.&#160; The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year or any other future period.&#160; Certain notes to the financial statements that would substantially duplicate disclosures contained in the audited financial statements for the most recent fiscal year as reported in the Company&#8217;s Form S-1 have been omitted.&#160; The accompanying condensed balance sheet at December 31, 2020 has been derived from the audited balance sheet at December 31, 2020 contained in the Form S-1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">In the opinion of management, the accompanying condensed financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, stockholders&#39; equity and cash flows for the interim periods but are not necessarily indicative of the results of operations or cash flows to be anticipated for the full year 2021 or any future period. The Company has evaluated subsequent events occurring after the date of the condensed financial statements for events requiring recording or disclosure in the condensed financial statements.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Amended and Restated Charter</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">On May 20, 2021, the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) and stockholders approved an amendment and restatement of the Company&#8217;s then-existing certificate of incorporation (the &#8220;Pre-IPO Certificate&#8221;) to create, among other changes, a Series C Convertible Preferred Stock (&#8220;Series C Stock&#8221;). The Series C Stock would convert into shares of the Company&#8217;s common stock upon the Company&#8217;s initial public offering at <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_5_20_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_GpP9eDFV_U6tUH14QDYSzA" decimals="INF" format="ixt:numdotdecimal" name="miro:StockConversionPercentage" scale="-2" id="Narr_aDGcF9l3VkiDJCQWpPOeyA">80</ix:nonFraction>% of the price at which the common stock is being sold in the initial public offering (see Note 8).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">June 2021 Amended and Restated Charter</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Prior to the completion of the initial public offering of the Company&#8217;s common stock (the &#8220;IPO&#8221;), the Company&#39;s Board and stockholders approved an amendment (the &#8220;Charter Amendment&#8221;) to the Pre-IPO Certificate and an amended and restated certificate of incorporation (&#8220;Post-IPO Certificate&#8221;) that became effective on June 23, 2021. The Charter Amendment increased the number of authorized shares of the Company&#8217;s common stock from <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_6_22_2021_jAIYqLNp8kqUDCDCdGqUMQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_A7qSELFEf0i2rq-vBj41NA">30,000,000</ix:nonFraction> to <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_6_23_2021_1kBpKsAjAkafdUqrpHlz-w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_EfHuuS05ckmpEWdvK72WZA">190,000,000</ix:nonFraction> and authorized <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_6_23_2021_1kBpKsAjAkafdUqrpHlz-w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="Narr_Kc0sclJ1n0eXOgxwxmAtIw">10,000,000</ix:nonFraction> shares of undesignated preferred stock. Under the Post-IPO Certificate, the Company is authorized to issue <ix:nonFraction unitRef="Unit_Standard_class_iV0uheBxPk-h-k5jyvqyzg" contextRef="Duration_6_23_2021_To_6_23_2021_nAJYhIVR5k6XfLRbSV0y5A" decimals="INF" format="ixt-sec:numwordsen" name="miro:NumberOfClassesOfStock" scale="0" id="Narr_UM6hSoIC9EWoCU2cpC4GhQ">two</ix:nonFraction> classes of stock, Common Stock and Preferred Stock.</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:EquityMethodInvestmentsPolicy" id="Tb_flYd0p0Y0kKFyrP_CyBYpg" continuedAt="Tb_flYd0p0Y0kKFyrP_CyBYpg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Equity Method Investments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;">Investments in 20% to 50%-owned companies are accounted for under the equity method as the Company can exercise significant influence, but not control, over such investments. The equity method requires that gains (losses) are </p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_VHlajgWLfEG7fOZ-XmoQyw_cont1" continuedAt="Tb_VHlajgWLfEG7fOZ-XmoQyw_cont2"><ix:continuation id="Tb_flYd0p0Y0kKFyrP_CyBYpg_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">recognized in other income (expense), net in the statements of operations. The gain on equity investment in Reprise Biomedical,&#160;Inc. (&#8220;Reprise&#8221;) resulted from recording the fair value of the Company&#8217;s investment in Reprise upon losing a controlling interest in the Company on June&#160;30, 2019. The Company recorded its equity method share of losses in Reprise from July&#160;1, 2019 through December&#160;31, 2019, from January&#160;1, 2020 to December&#160;31, 2020 and from January&#160;1, 2021 to March&#160;15, 2021 in the statements of operations. Even though the Company&#8217;s ownership dropped below <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_11_15_2020_srt_RangeAxis_srt_MaximumMember_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_GHS7IyK-b0atc14LN7N6WA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="Narr_gh-GeyDNpUeZUf74gooBBQ">20</ix:nonFraction>% on November&#160;15, 2020, the Company still had significant influence over the activities of Reprise due to common board members (See Note&#160;4).</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="Tb_iujWOVpViEmUwfcG-7Z_Xg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Research and Development Costs</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Research and development expenses consist primarily of engineering, product development, consulting services, materials, depreciation and other costs associated with products and technologies in development. These expenses include employee and non-employee compensation, including stock-based compensation, supplies, materials, consulting expenses, related travel expenses, and facility costs. Expenditures for research and development activities are charged to operations as incurred.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="Tb_ZwZNNXFe3UmeHN7j3WPcQA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Stock-Based Compensation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company is required to determine the fair value of equity incentive awards and recognize compensation expense for all equity incentive awards made to employees and directors, including employee stock options. The Company also determines the fair value of non-statutory stock options issued to consultants based on the fair value of the consultant&#8217;s commitment at the date of grant. Such expense is recognized over the requisite service period. In addition, stock-based compensation expense recognized in the statements of operations is based on awards expected to vest and therefore the amount of expense has been reduced for estimated forfeitures. The Company uses the straight-line method for expense attribution, except for awards issued with performance-based conditions which require an accelerated attribution method over the requisite performance and service periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Under the applicable accounting guidance for equity incentive awards issued to non-employees, the date at which the fair value of such awards is measured is equal to the earlier of: 1) the date at which a commitment for performance by the counterparty to earn the equity instrument is reached; or <span style="color:#231f20;">2) the date at which the counterparty</span><span style="color:#231f20;font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="color:#231f20;">s performance is complete. The Company recognizes stock-based compensation expense for the fair value of the vested portion of the non-employee awards in the statements of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The valuation model used for calculating the fair value of awards for stock-based compensation expense is the Black-Scholes option-pricing model (the &#8220;Black-Scholes model&#8221;). The Black-Scholes model requires the Company to make assumptions and judgments about the variables used in the calculation, including the expected term (weighted average period of time that the options granted are expected to be outstanding), the volatility of common stock, and an assumed risk-free interest rate. The Company uses the &#8220;simplified method&#8221; to determine the expected term of the stock option. Volatility is based on an average of the historical volatilities of the common stock of publicly-traded companies with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected term of the option. The expected dividend assumption is based on the Company&#8217;s history of not paying dividends and its expectation that it will not declare dividends for the foreseeable future. Potential forfeitures of awards are estimated based on the Company&#8217;s historical forfeiture experience. The estimate of forfeitures will be adjusted over the service period to the extent that actual forfeitures differ, or are expected to differ, from prior estimates.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:ConcentrationRiskCreditRisk" id="Tb_RtFOfRz_6Uup6G6oK9KaTw" continuedAt="Tb_RtFOfRz_6Uup6G6oK9KaTw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, accounts receivable, and accounts payable. </p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_VHlajgWLfEG7fOZ-XmoQyw_cont2"><ix:continuation id="Tb_RtFOfRz_6Uup6G6oK9KaTw_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:UseOfEstimates" id="Tb_5IP9-_ggAEmrXpmSmVwdMQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Use of Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="miro:EmergingGrowthCompanyStatusPolicyPolicyTextBlock" id="Tb_ARHOnVaBrUiBLo_W3IFMKQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Emerging Growth Company Status</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (&#8220;JOBS Act&#8221;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as to those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i)&#160;is no longer an emerging growth company or (ii)&#160;affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:EarningsPerSharePolicyTextBlock" id="Tb_MgDqvZarjU6BqH7sMRKQtA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Net Loss Per Share</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Basic net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock and dilutive potential shares of common stock outstanding during the period. Because we have reported a net loss for all periods presented, diluted net loss per share is the same as basic net loss per share for those periods as all potentially dilutive shares consisting of stock options and warrants were antidilutive in those periods (See Note 13).</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Tb_Nb8XS8ZFxU2IT72vR9tWMA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Recent Accounting Pronouncements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;">During February&#160;2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No.&#160;2016-02, &#8220;Leases (Topic 842).&#8221; ASU No. 2016-02 requires lessees to recognize the assets and liabilities that arise from leases on the balance sheet. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. During 2018, the FASB also issued ASU No.&#160;2018-10, &#8220;Codification Improvements to Topic 842, Leases&#8221;, which addresses narrow aspects of the guidance originally issued in ASU No.&#160;2016-02; ASU 2018-11, &#8220;Targeted Improvements&#8221;, which provides entities with an additional (and optional) transition method whereby an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption and also provides lessors with a practical expedient, by class of underlying asset, to not separate non-lease components from the associated lease component and, instead, to account for those components as a single component. During 2019, the FASB also issued ASU No.&#160;2019-01, which clarified Topic 842&#8217;s interim disclosure requirements and amend certain industry-specific guidance related to determining the fair value of leased assets and the cash flow presentation of principal payments received under sales-type and direct finance leases. Topic 842 (as amended) is effective for annual periods beginning after December&#160;15, 2021, and interim periods within fiscal&#160;years beginning after December&#160;15, 2022. Early adoption is permitted. The Company is currently assessing the effect that Topic 842 (as amended) will have on its results of operations, financial position and cash flows.</p></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="miro:StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock" id="Tb_xg9Rit5yeUSRrDOFj8-nbw" continuedAt="Tb_xg9Rit5yeUSRrDOFj8-nbw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 2 &#8212; INITIAL PUBLIC OFFERING</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 10pt 0pt;">In June 2021, the Company completed the IPO in which the Company sold <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_5Odx1hNFgE-EjIs5X0GrZQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr_3BeVnzqb1kuxcnhaQs2Vgg">5,520,000</ix:nonFraction> shares of its common stock at a price to the public of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_yAsbjp9bDUazwowV3IQPOg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="Narr_A3YUCY33KEKMJ3pu9yikCg">9.00</ix:nonFraction> per share, which included the sale of <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_s5dfWC6rwUCezVcVwV3Tlg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr_BKlr8jDWOEOV7zONFt8_0A">720,000</ix:nonFraction> shares of common stock as a result of the full exercise of the underwriter&#8217;s overallotment option. The Company received proceeds of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_5Odx1hNFgE-EjIs5X0GrZQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="Narr_qXUvYuyQMEGE8Lm2UwIT5A">49.7</ix:nonFraction> million, excluding underwriting discounts and commissions, which was recorded to additional paid-in capital. The Company&#8217;s common stock commenced trading on the Nasdaq Capital Market on June 24, 2021 under the trading symbol &#8220;MIRO.&#8221;</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_xg9Rit5yeUSRrDOFj8-nbw_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">Upon the closing of the IPO, all shares of the then-outstanding convertible preferred stock were converted on their respective terms into a total of </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Q9R7jNA_kk6E26TVZk6K5Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="Narr_K7v8_D2hk0We9eMF5nYLNA">12,139,071</ix:nonFraction></span><span style="font-weight:normal;"> shares of common stock. This resulted in a reclassification of </span><span style="font-weight:normal;">$<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_jgndyTBo4kmjINCHYzZc9Q" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="Narr_q0F-wSsYM0u47k82GhyNkg">73.7</ix:nonFraction></span><span style="font-weight:normal;"> million to additional paid-in capital.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Offering costs incurred by the Company were approximately $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_6_1_2021_To_6_30_2021_v1CMQoC_MEO53dW7J_nzAA" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="Narr_kq6pFgvNmkynVzEjnXTDEQ">1.6</ix:nonFraction> million, excluding underwriting commissions and discounts, which were recorded to additional paid-in capital. The Company issued the underwriter in the IPO a warrant to purchase up to <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_Umm_MfnOZUaOKyWI9XnCRg" decimals="INF" format="ixt:numdotdecimal" name="miro:ClassOfWarrantOrRightGranted" scale="0" id="Narr_EL9TeyvEFEOh2TeKDjY0mg">276,000</ix:nonFraction> shares of its common stock.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="Tc_RrN_efOlGkK8xsyFWyO2xw_1_2"></a><a id="Tc_o_ZtiQsE70-kbQCjahBbUg_1_5"></a><a id="Tc_xH_lg57t6069-opBo5iJYg_2_2"></a><a id="Tc_AePELfT4TEaEOfYWdiNhTQ_3_0"></a><a id="Tc_hGVVchD61k2XTffA12CO_g_3_2"></a><a id="Tc_XNUF_kzj00eD_KWk4ueQSQ_3_5"></a><a id="Tc_TN0bDezPVU-NDdNxuWztRg_4_0"></a><a id="Tc_jKHkPUJ2akunUe1EmH_jug_4_6"></a><a id="Tc_8KZVHzgZeEGEzzidFDyrag_5_0"></a><a id="Tc_mIPOTh7Y2kux7XNydnYPlA_6_0"></a><a id="Tc_E8iGwAU6i0WZtPwuhIXMkQ_8_0"></a><a id="Tc_TDIDhr9X6EKe7w7OXR5OuA_9_2"></a><a id="Tc_kqOdqsLor06P6tn3JF6nGQ_9_5"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="Tb_0RzrDhjoIUiSj4JF1sSSvQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:49.5pt;text-indent:-49.5pt;margin:0pt 0pt 12pt 0pt;">NOTE&#160;3&#160;&#8212; LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Lab equipment, furniture, leasehold improvements and construction in progress consisted of the following as of:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="Tb_76NnM7h-8UyXRWcfhx8wig" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&#160;30,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lab equipment</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_meG4-bg4kUO8x0E1C04Kqw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" id="Tc_Mx66UWRG6UqSBL0MBuGv-w_3_3">1,762,512</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_jFveJ8RoEEKFIHidVPDl4w" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" id="Tc_v5DUugQss0uVDhUY9Gaxhg_3_6">1,480,952</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Construction in progress</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember_lwr3FLyMikqQkZtq70jcoQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" id="Tc_HL9SImqmvkinEkcF8sM5Ag_4_3">1,166,129</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Leasehold improvements</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_fRxvAQCNO0uRd-IxLvwfDg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" id="Tc_Sl8RrCxmSUCNVlUSTlxXEg_5_3">310,225</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_eOuiFcUJCEOgeU3oV-a2mw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" id="Tc_sMYbBUqr-U6WdHEKvHn9Aw_5_6">310,225</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Furniture and fixtures &amp; computers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FurnitureFixturesAndComputersMember_S_oUYLkJy06xhe5H4RKyJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" id="Tc_SVu1ZQmKvUO4j3FV3ziPgw_6_3">112,302</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FurnitureFixturesAndComputersMember__gu0MdxH50m20YVzxIH-Pg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" id="Tc_01KrcCosJUGli7xvq9LU6A_6_6">112,302</ix:nonFraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" id="Tc_kDFnka3nzU2TZMG_RDexig_7_3">3,351,168</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" id="Tc_960Nvup9p0ucD8XC1kFcRQ_7_6">1,903,479</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less accumulated depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" id="Tc_n6JL4JC2fk6jwgQywUmCbA_8_3">1,672,520</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" id="Tc_psQioS1PlEKUaYek9oP2Tw_8_6">1,578,945</ix:nonFraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" id="Tc_gJ121esKrU-rJJG2YqOC4g_9_3">1,678,648</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" id="Tc_oX1watLw_kCh-hmaHMu2Gg_9_6">324,534</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;">Depreciation and amortization expense was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" id="Narr_6DXHuxTFRkSN5KoBgMekHg">34,401</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" id="Narr_XIYRopEof02dxu1BrGFwUg">34,901</ix:nonFraction> for the three&#160;months ended September 30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" id="Narr_QLJROIeJd0OzLJAmVLholw">93,575</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" id="Narr_k2dF54pcpkGIcuBS7mYR0w">139,921</ix:nonFraction> for the nine&#160;months ended September 30, 2021 and 2020, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;">The Company is moving into a new facility in December 2021 and has paid $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsForConstructionInProcess" scale="0" id="Narr_Hg1px2gUGEyd5cWidY9TgA">1,166,129</ix:nonFraction> toward leasehold improvements and other costs and recorded these as construction in progress.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="Tb_pMfdQHkAoki_Pe9EEJpF1g" continuedAt="Tb_pMfdQHkAoki_Pe9EEJpF1g_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 4 &#8212; EQUITY METHOD INVESTMENT</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company previously manufactured and sold acellular medical devices in the hernia mesh and wound care markets through a separately identifiable business unit (the &#8220;Acellular Business&#8221;). On June&#160;30, 2019, the Acellular Business was spun-out to Reprise. At the time of the spin-out the common stock of Reprise was valued at $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_6_30_2019_dei_LegalEntityAxis_miro_RepriseBiomedicalInc.Member_R2d8cn9CGUK8VjOUJnYEwQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharePrice" scale="0" id="Narr_oHH5QS-ReEi3Ciw1wUMK6A">1.00</ix:nonFraction> per share and therefore the Company recognized a gain of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_6_30_2019_To_6_30_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_W19jgtfrJ0q1_pcaKF15Lg" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="0" id="Narr_iyveAqEhakODMHNw4QjHfw">4,495,500</ix:nonFraction> on its Reprise common stock holdings. At the time of the spin-out and until November&#160;15, 2020, the Company owned <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_6_30_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_CSoklVBQa02SoJByMzWnzQ" decimals="-5" format="ixt:numdotdecimal" name="miro:EquityMethodInvestmentSharesOwned" scale="0" id="Narr_fBVzGqIkykSDt0jTK17JJw"><ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_11_15_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_2Sa5NjL2Kk-ibyq3uXUDjQ" decimals="-5" format="ixt:numdotdecimal" name="miro:EquityMethodInvestmentSharesOwned" scale="0" id="Narr_IdmOLkjBYk-0j5r_RY79aA">4,500,000</ix:nonFraction></ix:nonFraction> shares of common stock of Reprise, which represented <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_6_30_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_CSoklVBQa02SoJByMzWnzQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="Narr_pKWljZ6kJEK5Uc03QUgTmw"><ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_11_14_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_Aj4TjkpEqk2FBavVoeElPg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="Narr_M8mu1S-cqU2UbH3lNPP22A">45</ix:nonFraction></ix:nonFraction>% ownership in Reprise. In November&#160;2020, the Company sold <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_11_30_2020_To_11_30_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_npnVQruhDkGjzL1UROIouw" decimals="-5" format="ixt:numdotdecimal" name="miro:EquityMethodInvestmentSharesSold" scale="0" id="Narr_UZH8p4QKdkmyqH44NbVMCg">2,700,000</ix:nonFraction> shares of common stock of Reprise and retained an <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_11_30_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_2ePGV84R7kOqVJlCe8VRFw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="Narr_YmbirHa6-E6oiZt8NJmf3w">18</ix:nonFraction>% ownership interest in Reprise. The Company sold its remaining shares of Reprise in March&#160;2021 for $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_3_1_2021_To_3_31_2021_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_5uz6xTTzoUS7vZbEYgcwoA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="0" id="Narr_utyhq5ik4E2OuMx_8aHDDQ">2,000,000</ix:nonFraction>.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_4322a3a5_74a9_4035_8a2e_534c947f1757"></a><a id="Tc_H6zJbYVCq061Aa8qr0xgPQ_1_2"></a><a id="Tc_5DfE7e1BWES4OGy7iBiG-A_1_5"></a><a id="Tc_6Y23AFoqrESxNPAi2A9FRA_2_2"></a><a id="Tc_KVPQHDqzO02-_k6o_lgTzw_3_0"></a><a id="Tc_4s-ebxo0AEGzpoZgHydrAA_3_2"></a><a id="Tc_IhUcwhvYbEmctf5M3l78Tg_3_3"></a><a id="Tc_ni2Q927OdEe6Bpe2uILICA_3_5"></a><a id="Tc_BW0a2TLEPEqHyzvBY3SEng_4_0"></a><a id="Tc_oO76l5OpiUagdzv78_A7VQ_4_3"></a><a id="Tc_3vfiKjKc3UmmU7ipQ42vYA_5_0"></a><a id="Tc_EbPiFjK6r0mF02qQgCBmJA_5_3"></a><a id="Tc_CRIiC5bEMU2DiempHXY05w_6_0"></a><a id="Tc_MzVwviy4CkeEZ9rMx_7nuw_6_3"></a><a id="Tc_h2JpGcjOcUasoGQpt1QL5A_7_0"></a><a id="Tc__9oQY62XEE-xM_YoQHg4-g_7_3"></a><a id="Tc_qbnUuQM4JEiC-ehRBIOyDQ_8_0"></a><a id="Tc_uH_1k8oCZUijZWn64hDZSg_8_3"></a><a id="_4fafd0ea_6a37_4130_9e0b_fa2ba4e43b9e"></a><a id="Tc_a7rHpI5ayUmJPjqyOaXIaw_2_2"></a><a id="Tc_lm6XBqv3GkGUAth1hzHovg_2_8"></a><a id="Tc_GuGJPF1F9kmkdIPk9trLYQ_3_2"></a><a id="Tc_3eExwHo0r0usyUElU5zw5Q_3_5"></a><a id="Tc_eJwT7cyf0Ea4GWpAvJAOYg_3_8"></a><a id="Tc_11x5E5e4HUusATM2n5YsJw_3_11"></a><a id="Tc_DCW-_RD22UC-OHHLzPDl8A_4_2"></a><a id="Tc_i4RzfZAtzUmliYbuBXpQHQ_4_5"></a><a id="Tc_RqIjp3sVrE-QmvxOq_4-CA_4_8"></a><a id="Tc_IesabZqRKUqyIHewcfeRJg_4_11"></a><a id="Tc_jtRgK_JGekWm16h4p5d01Q_5_0"></a><a id="Tc__wTtuapGZU6WAYzI5eOTaw_5_2"></a><a id="Tc_FTbsk8I7wUG2b3frAmwtBA_5_3"></a><a id="Tc_RwMVuTDXIUiMizr6tVu2LQ_5_5"></a><a id="Tc__apvg69sFkOaN_XVYtYzTg_5_8"></a><a id="Tc_t7txE-X-ykeRfcccIToHgg_5_11"></a><a id="Tc_cDCA_PuykUa6epVSpeKieg_6_0"></a><a id="Tc_RRUMDC5FwESHCwpbDn64Mg_6_3"></a><a id="Tc__FLRlNYw4UCKCJaZ9J_aEg_7_0"></a><a id="Tc_h2-nod_VW0WSySyDwZB5bw_7_3"></a><a id="Tc_YkIjRTT2jkmaWO8gA7pzyA_8_0"></a><a id="Tc_KNuq5VihFUOvi9CiEb6D7Q_8_3"></a><ix:continuation id="Tb_pMfdQHkAoki_Pe9EEJpF1g_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2020, the Company had an investment in Reprise that it accounts for under the equity method (See Note&#160;1). The Company considers its investment in Reprise to be significant to its income as of December&#160;31, 2020. Financial information from the financial statements of Reprise are summarized as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:EquityMethodInvestmentsTextBlock" id="Tb_30AJEDGYmEqSMlW8yIm9aQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Current assets</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="0" id="Tc_pd80biH1mU25f3Ph9aNEcQ_3_6">4,309,045</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Total assets</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="0" id="Tc_aVgLnrBD_kSeJk__JzNUmw_4_6">5,312,350</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Current liabilities</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="0" id="Tc_YbJ1f3mEEU27UtyuJCy-rw_5_6">2,534,673</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Non-current liabilities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesNoncurrent" scale="0" id="Tc_jjmf_RoK0kC2_TjFksuX4Q_6_6">489,785</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Shareholders&#8217; equity</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="0" id="Tc_3lOYjtjLvkOWMngg3yz0SQ_7_6">2,287,892</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Miromatrix Medical Inc. share of shareholders&#8217; equity</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="Tc_NcDC5vdndUixIC3VVe8zfg_8_6">411,821</ix:nonFraction></span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;width:22.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">For the Three Months Ended September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;width:24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">For the Nine Months Ended September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net sales</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_2TuG7gXboUazxii0VRpqgg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="Tc_7A76f1qqRk60X7ib9WvtcQ_5_6">169,277</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_DTVpyL5NAkWKW7wh4gUxRg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="Tc_6sT3yBwwOkm6JgKCKGHv1w_5_9">93,985</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_8sleYqexjESt21JPVmSmbw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="Tc_IrUTzRJIk0ilzoGjdPfwUQ_5_12">484,067</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross margin</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_2TuG7gXboUazxii0VRpqgg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="0" id="Tc_QR3hCU6xA06FOeUTBgzYVA_6_6">109,497</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_DTVpyL5NAkWKW7wh4gUxRg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="0" id="Tc_oPFBzwHOJU-cj8ZYamk5GQ_6_9">47,708</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_8sleYqexjESt21JPVmSmbw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="0" id="Tc_zCNe2_OydU2FM1sOvfW4Lw_6_12">307,573</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_2TuG7gXboUazxii0VRpqgg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" sign="-" scale="0" id="Tc_g-ABKIYxjEa6QRAhJmGITg_7_6">1,188,678</ix:nonFraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_DTVpyL5NAkWKW7wh4gUxRg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" sign="-" scale="0" id="Tc_QOVmfQlUAESJza1vlpL3NA_7_9">1,376,522</ix:nonFraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_8sleYqexjESt21JPVmSmbw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" sign="-" scale="0" id="Tc_vs3Chqcq_kmy8MwBTCDdVw_7_12">3,723,533</ix:nonFraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Miromatrix Medical Inc. share of net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_2TuG7gXboUazxii0VRpqgg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_MMa3VYBQWUOmUrGdmmgwzQ_8_6">495,000</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_DTVpyL5NAkWKW7wh4gUxRg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_1OBfCT6BikWZBQrSxgz-lg_8_9">223,633</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_8sleYqexjESt21JPVmSmbw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_HgBGjUt6502hPrvCu9r43g_8_12">1,676,000</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="Tc_YvGJOaBqcEm7yeLBeSrz0w_1_2"></a><a id="Tc_J1-loXxaF0ODYhfs8CTa9g_1_5"></a><a id="Tc_BsM1im3aGk6rjFl-bAPBiQ_2_2"></a><a id="Tc_YogUJVp-60-5Dfl0Bf8vEw_2_5"></a><a id="Tc_H5mk7TfJ10SyQE2M9cf7MQ_3_2"></a><a id="Tc_b-oyRHfp_UmJxcnHtnXItA_4_0"></a><a id="Tc_NxB_Vsk_b0Ow1mNQFKaSdg_4_2"></a><a id="Tc_rJbFjWa2JU21hEnE3CxnaQ_4_5"></a><a id="Tc_3VPKHJGkAkuYM8E33E9yxQ_5_0"></a><a id="Tc_RsPuzu-asEmbByY_9E1e9A_6_0"></a><a id="Tc_aKah5jvpOEKoFMipzQNJZg_7_0"></a><a id="Tc_4vBzhhrUwUWhH4UpnNDzMg_7_6"></a><a id="Tc_OIpV2lin1EOcKYKEo3IRpw_8_0"></a><a id="Tc_jPfRtXvhtkOQpWxJJiG4Wg_8_6"></a><a id="Tc_LvecVLYQE0Wn__MQGn2oFw_9_0"></a><a id="Tc_UHCPLU7Q1UiSJ6rEgCUASw_10_0"></a><a id="Tc_6GovtQXLC0yuwM0GfQ-qWw_10_6"></a><a id="Tc_kyNdyPtZ00aft0P8tUtV3Q_11_0"></a><a id="Tc_KZZ0VF54IEqjgKLmUl9Nrw_12_0"></a><a id="Tc_4U9YhFwP10GJ5ddQFJn35w_12_2"></a><a id="Tc_0ohQXbtIR0WkgmiL8GG1rg_12_5"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="Tb_n7SwvtQjS0-375fioqlYVQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 5 &#8212; ACCRUED EXPENSES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Accrued expenses consisted of the following as of:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="Tb_6EDWKe6sn0ignSqyDkxAtA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Wages</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedSalariesCurrent" scale="0" id="Tc_5xEWFV8P_UO_YHxNfDXD3Q_4_3">549,685</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedSalariesCurrent" scale="0" id="Tc_bIR-s4PYJUaIEDvSi4Pe8A_4_6">217,825</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Legal</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="0" id="Tc_pyD65p5QTEmXiv5HrCc5FA_5_3">120,000</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="0" id="Tc_QeDG8LXxwEaT4YE_j7L-og_5_6">452,778</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Royalties</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedRoyaltiesCurrent" scale="0" id="Tc_N2x3fa8_R0ee2y1TCJbzjQ_6_3">2,455</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedRoyaltiesCurrent" scale="0" id="Tc_qcirMwROwUyWxuoimbW9FA_6_6">3,800</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Supplies</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:AccruedSuppliesCurrent" scale="0" id="Tc_I3fuQgv_0UqTJ6_GZxdNbA_7_3">80,700</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">IPO expenses</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:AccruedLiabilitiesPublicOfferingExpensesCurrent" scale="0" id="Tc__0J1cxDcYE2jPSFI-mYXZg_8_3">936,652</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Key opinion leader compensation</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:AccruedKeyOpinionLeadedCompensationCurrent" scale="0" id="Tc_SPw6XLk3m0C4YQ2eQsQ3ww_9_3">100,000</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:AccruedKeyOpinionLeadedCompensationCurrent" scale="0" id="Tc_kXwhrb7ygUWgDrQ4ZACMNg_9_6">34,000</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Board compensation</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:AccruedBoardCompensationCurrent" scale="0" id="Tc_XDg6UllOik2L_vUD3jTe8A_10_3">58,125</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Other</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="0" id="Tc_gUH37bBDbE2YP43TTzsBpA_11_3">75,000</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="0" id="Tc_26_0amDqDEW-SY83UKFAug_11_6">52,486</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Accrued expenses</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" id="Tc_nCPNsrPQCEmkzlaDKqBwtg_12_3">1,922,617</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" id="Tc_HzxH_-yla0Ca-Y10_orbEg_12_6">760,889</ix:nonFraction></span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:FairValueDisclosuresTextBlock" id="Tb_EewxaU0xTEOhLejtb1Y5VQ" continuedAt="Tb_EewxaU0xTEOhLejtb1Y5VQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 6 &#8212; FAIR VALUE MEASUREMENT</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">The fair value of the Company&#8217;s financial instruments reflect the amount that the Company estimates that it would receive in connection with the sale of an asset or paid in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). </p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_M85PbGl7wEKl9S3OiVUMOg_1_0"></a><a id="Tc_qr7OF9K9bkiCyng3bN5Alw_1_2"></a><a id="Tc_niJD0v72uE-U4KmBq-kBeg_1_3"></a><a id="Tc_5lPm2NmRHkmGa4G469ZzAw_2_0"></a><a id="Tc_BsfUckNExE-gVyDgPkNSMQ_3_0"></a><a id="Tc_i7CqmOAxZUaOxdsKyE7VJQ_4_0"></a><a id="Tc_lwA66nFP8kedEvCjSKP7vQ_5_0"></a><a id="Tc_YiEyAeG8Dkup9fH6Pxx_bQ_6_0"></a><a id="Tc_ybOClBVs0UK3u2r_EswakA_6_2"></a><a id="Tc_HS-HyyDsGU2e0lNrEovRKg_6_3"></a><ix:continuation id="Tb_EewxaU0xTEOhLejtb1Y5VQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes a fair value hierarchy that distinguishes between (1)&#160;market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2)&#160;an entity&#8217;s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC 820 are described below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Level 2: Directly or indirectly observable inputs as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data from actively quoted markets for substantially the full term of the financial instrument.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Level 3: Unobservable inputs that are supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management&#8217;s estimates of market participant assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company classified its equity method investments as Level 3 securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company determined that a promissory note issued in March&#160;2020 (&#8220;March&#160;2020 Note&#8221;) contained a change in control provision which is a level 3 embedded derivative and is required to be bifurcated. In accordance with ASC 815, <i style="font-style:italic;">Derivatives and Hedging</i>, the Company determined the fair value of the derivative liability and recorded it on the balance sheet. At inception, the fair value of the derivative liability was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_3_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_27cslPMf0kKYRf5e8pUZUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="0" id="Narr_uCzOPTmDiUST31BsBEmEiQ">195,516</ix:nonFraction>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The table below discloses changes in value of the Company&#8217;s embedded derivative liabilities discussed above.</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="Tb_D_QZrd4KBkWCHRK1TQakPA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative liability balance at December&#160;31,&#160;2019</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative instrument related to March 2020 Note</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_m7wWrzDt8kKqdsrFFqI6Aw" decimals="0" format="ixt:numdotdecimal" name="miro:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions" scale="0" id="Tc__qVgnYHqDUqA2Ye3u77AFQ_2_3">195,516</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Gain/Loss recognized to revalue derivative instrument at fair value</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_m7wWrzDt8kKqdsrFFqI6Aw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" sign="-" scale="0" id="Tc_oKIUBq8BL0qjhd9O8DySlQ_3_3">51,446</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative liability balance at December&#160;31,&#160;2020</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_xQEMjYvAV02ThX-j5BQaAQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="0" id="Tc_ajtcm4d9EU-ArWZINwn_mw_4_3">246,962</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Gain/Loss recognized to revalue derivative instrument at fair value (unaudited)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_XGJvV0_cDkeQhRzARKjL8g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" scale="0" id="Tc_ms315N9G_ESp24S5pYUhAw_5_3">246,962</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative liability balance at September&#160;30,&#160;2021 (unaudited)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock" id="Tb_pqeIgJrR_USXjgxkNFZc8w" continuedAt="Tb_pqeIgJrR_USXjgxkNFZc8w_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;7&#160;&#8212; DEBT AND CAPITAL LEASE OBLIGATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2010, the Company entered into a loan and security agreement with the Minnesota Agricultural and Economic Development Board under which the Company borrowed $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2010_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_pkNNDT8Wak6IONNfMjjxqg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="Narr_2ZE8UmtsAUabYzGnadB0bw">250,000</ix:nonFraction>. The loan had a maturity date of November&#160;1, 2020. Commencing on December&#160;1, 2014, the loan started to bear interest at a rate of <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_12_1_2014_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_6QJUbguDpkyAkL3RR7QOTA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="Narr_yzEm_rscCU6aw3VKnn6QOg">6</ix:nonFraction>% per annum. Per the loan agreement, the Company began making&#160;monthly principal and interest payments on December&#160;1, 2015 in the amount of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_12_1_2015_To_12_1_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_jA_SRrDvgkqJaPnK7QABEg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPayment" scale="0" id="Narr_UT0b3GGpTUm9UP5Y5LC-7w">3,000</ix:nonFraction>. The Company made <ix:nonFraction unitRef="Unit_Standard_payment_r6kmSj8FdkWHfPCK9l_Ahg" contextRef="Duration_12_1_2015_To_12_1_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_jA_SRrDvgkqJaPnK7QABEg" decimals="INF" format="ixt:numdotdecimal" name="miro:DebtInstrumentPeriodicMonthlyPaymentNumber" scale="0" id="Narr_gmOWOsdw00a0Zf8KJZrg0Q">59</ix:nonFraction>&#160;monthly payments, plus <ix:nonFraction unitRef="Unit_Standard_payment_r6kmSj8FdkWHfPCK9l_Ahg" contextRef="Duration_12_1_2015_To_12_1_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_jA_SRrDvgkqJaPnK7QABEg" decimals="INF" format="ixt-sec:numwordsen" name="miro:DebtInstrumentNumberOfFinalPayment" scale="0" id="Narr_dt84fjJUmEy0S5KpMY725Q">one</ix:nonFraction> final payment equal to the then unpaid principal and interest. The loan was secured by the Company&#8217;s accounts receivable. As of September 30, 2021 and December&#160;31, 2020, the principal outstanding on this loan was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_7Seab1iWakasudo2xAp8XA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="Narr_tybDeAs7RUmeec_jcqab-Q">0</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_CthJKcprL0eLenTLOw8F7g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="Narr__V6BSnL5KECL0VA-6_apQg">168,193</ix:nonFraction>, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In January&#160;2012, the Company signed a promissory note with the Regents of the University of Minnesota (the &#8220;University&#8221;) for $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_1_31_2012_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_QQnUDFDrzk2Vm5Fpppjj3g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="Narr_0_KRXiUZlk62kJ3gSYM0Wg">405,559</ix:nonFraction>. Commencing on January&#160;1, 2016 the promissory note bears interest at <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_1_1_2016_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_tqLAJsmEVECzNI54zhIGFA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="Narr_y_k4dgbsEES67eJiCi8qNQ">3</ix:nonFraction>% per annum, compounded&#160;monthly. On or before January&#160;31, 2018, the Company is required to make&#160;monthly principal and interest payments of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2016_To_1_1_2016_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_U8JeOxzzD0Gx5vKq-ysy3A" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPayment" scale="0" id="Narr_vSy3NRyt40OOtEocy-Pk9w">7,737</ix:nonFraction> until the note is paid in full. The note has a maturity date of December&#160;31, 2022 and is unsecured. In association with the promissory note, the Company issued the University warrants to purchase <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2012_To_1_31_2012_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsRegentsOfUniversityOfMinnesotaMember_sZ5sdIuCHkukaGha2I_3MQ" decimals="INF" format="ixt:numdotdecimal" name="miro:ClassOfWarrantOrRightNumberOfWarrantsIssued" scale="0" id="Narr_Q_hA2LK5sk--YzxMgw4sWA">80,000</ix:nonFraction> shares of the Company&#8217;s common stock at an exercise price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_1_31_2012_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsRegentsOfUniversityOfMinnesotaMember_ZXk4sItmP06Wo1dejovXIg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="Narr_IBM9SqRg_0GBisAwAlDfQA">1.69</ix:nonFraction>. As of September 30, 2021 and December&#160;31, 2020, the principal outstanding on this loan was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_EZhNVV5fvEixIfenKVx60Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="Narr_atB1rl_UTUeU3TfKdzqArw">106,320</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_La1M4nHdNUqTqG0rxpNa8w" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="Narr_Z9FZg809kE-pIIEuaGmA2Q">172,731</ix:nonFraction>, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2015, the Company entered into a loan agreement with the Minnesota Department of Employment&#160;&amp; Economic Development under which the Company borrowed $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_5_31_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_A9qxS9oZnkya-NmJw5L2zg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="Narr_QZFDqaa1AUi_KTp_eo647w">250,000</ix:nonFraction>. The loan does not bear interest, is due in a lump sum payment on April&#160;1, 2022 and is uncollateralized. If there is a substantial ownership change in the Company (greater than <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_5_31_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_A9qxS9oZnkya-NmJw5L2zg" decimals="INF" format="ixt:numdotdecimal" name="miro:SubstantialOwnershipChangePercentage" scale="-2" id="Narr_mOOeUJwaFU6-keecoIncWg">50</ix:nonFraction>% to one entity), the Company will pay the Minnesota Department of Employment&#160;&amp; Economic Development additional compensation of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_5_31_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_A9qxS9oZnkya-NmJw5L2zg" decimals="0" format="ixt:numdotdecimal" name="miro:DebtInstrumentAdditionalCompensation" scale="0" id="Narr_qKwPnkk_UEeGhCm597IHTg">75,000</ix:nonFraction>. As of both September 30, 2021 and December&#160;31, 2020, the balance outstanding on this loan was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_on7-uRHX1EqyH81rkRruuw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="Narr_q_xH_W21c0K44U85HV3rMA"><ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_-vxPZ28Xykq2zceJbECjfg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="Narr_OwYFbFDP_kujcU0LBE0vCw">250,000</ix:nonFraction></ix:nonFraction>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In October&#160;2018, the Company signed a lease agreement for a piece of equipment that is being accounted for as a capitalized lease. The total cost of the equipment was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_10_31_2018_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_gG5hkjufDEyK2-0RVsaTHg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CapitalLeasedAssetsGross" scale="0" id="Narr_gUGBBTIr80qbUj678P-fQQ">102,026</ix:nonFraction>. The lease bears interest at <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_10_31_2018_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_gG5hkjufDEyK2-0RVsaTHg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="Narr_lGmM1RtIG0-NKd_0jtUxbg">7.2</ix:nonFraction>% and the Company will make <ix:nonFraction unitRef="Unit_Standard_payment_r6kmSj8FdkWHfPCK9l_Ahg" contextRef="Duration_10_1_2018_To_10_31_2018_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_OZdwLy5NM0Go4Ki1KftRlw" decimals="INF" format="ixt:numdotdecimal" name="miro:DebtInstrumentPeriodicMonthlyPaymentNumber" scale="0" id="Narr_RY5Py3pnq0S3zc_M7kk9lw">60</ix:nonFraction> monthly payments of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_10_1_2018_To_10_31_2018_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_OZdwLy5NM0Go4Ki1KftRlw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPayment" scale="0" id="Narr_x8LT8AXlnkmI8lR2RjFMrg">2,003</ix:nonFraction> until the lease is paid in full. As of September 30, 2021 and December&#160;31, 2020, the amount outstanding on the lease was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_bva1e1NEu0CDDbO2hz_bYA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CapitalLeaseObligations" scale="0" id="Narr_UKpMb7rOPUmfHfds9yQBwg">43,113</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_Atsn9P5ITkm9fny6aynNaw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CapitalLeaseObligations" scale="0" id="Narr_QNm-TMwZKEa2bN3iZFVg3g">57,127</ix:nonFraction>, respectively. The lease is secured by the piece of equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In January&#160;2019, Company issued the University a promissory note in the amount of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_1_31_2019_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithUniversityOfMinnesotaMember_cdcye0WMqEqRbPNdnP1VxQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="Narr_ArF7cy8d2EWgSt8se8cfbg">385,997</ix:nonFraction> in satisfaction of the Company&#8217;s minimum royalty obligation for the&#160;year ended December&#160;31, 2018. The note bears interest at <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_1_31_2019_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithUniversityOfMinnesotaMember_cdcye0WMqEqRbPNdnP1VxQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="Narr_SvkOJsIQUkORQH4JcM-7PQ">6</ix:nonFraction>% per annum and is due on January&#160;31, 2025. In addition, the Company issued the University a <ix:nonNumeric contextRef="As_Of_1_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsUniversityOfMinnesotaMember_2n5C9faFyUubXOXkidk78w" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Narr_CxHDOO8GDEm4IA40J_6GEQ">10-year</ix:nonNumeric> warrant to purchase <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2019_To_1_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsUniversityOfMinnesotaMember_MJIM8ECHsEqx2RTxL_0tQg" decimals="INF" format="ixt:numdotdecimal" name="miro:ClassOfWarrantOrRightNumberOfWarrantsIssued" scale="0" id="Narr_serHxm36rkquLiF2MIe-bQ">20,587</ix:nonFraction> shares of the Company&#8217;s common stock at an exercise price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_1_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsUniversityOfMinnesotaMember_2n5C9faFyUubXOXkidk78w" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="Narr_qQxrOqAJ5EmanHqWzB4ODQ">3.75</ix:nonFraction> per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In March&#160;2020, the Company entered into a note and warrant purchase agreement (the &#8220;Purchase Agreement&#8221;) with <ix:nonFraction unitRef="Unit_Standard_shareholder_EnWQEbPDAka0m--RoRqebg" contextRef="Duration_3_1_2020_To_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_Bn7cHTalvk6YlTP7ftzPRg" decimals="INF" format="ixt-sec:numwordsen" name="miro:NumberOfShareholders" scale="0" id="Narr_ZwYMQgFA8k-tHLSxoEB0-g">one</ix:nonFraction> of the Company&#8217;s shareholders under which the Company borrowed $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_KFeJzTMvrEGq3LDu1xCU5Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="Narr_5aCgZsPr9UuxgadS-gYTjA">6,000,000</ix:nonFraction>. As part of the Purchase Agreement, the Company signed a convertible promissory note (the &#8220;Note&#8221;) and issued the shareholder a warrant (the &#8220;Warrant&#8221;). The Note&#160;was unsecured and had a maturity date of September&#160;6, 2021. If the Company completed a preferred stock offering of at least $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_KFeJzTMvrEGq3LDu1xCU5Q" decimals="0" format="ixt:numdotdecimal" name="miro:DebtInstrumentConvertibleMinimumPreferredStockOffering" scale="0" id="Narr_JfS0zyLTbU2AcezNa4k2jw">34,000,000</ix:nonFraction> prior to the maturity date, the Note&#160;and all accrued interest would have automatically converted into preferred shares of such offering at the offering price. The Note&#160;initially bore interest at <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_KFeJzTMvrEGq3LDu1xCU5Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="Narr_UwDmMrGD00G43AYbE-5LRw">5</ix:nonFraction>% per annum. If the Note&#160;was not converted prior to May&#160;1, 2020, the interest rate increased to <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_5_1_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_MVZBEzT7O0S0Q0T1zli4Gw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="Narr_urUm-oNNP0SYfERg4PCXvw">7</ix:nonFraction>% on May&#160;1, 2020 and by an additional <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="Duration_6_1_2020_To_6_1_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_0lnUqVT07kOlXfiqqRCW9Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateIncreaseDecrease" scale="-2" id="Narr_0FJZoJGgYEqyLIVvvG1wkQ">2</ix:nonFraction>% on the first day of each subsequent&#160;month prior to the maturity date starting on June&#160;1, 2020, provided that the interest rate shall not exceed <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="Duration_6_1_2020_To_6_1_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_NAJB56TxHEmziVpHGC_jWw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="Narr_BYc4x6SXaEWm-KYLUF1qQQ">20</ix:nonFraction>%. The <ix:nonNumeric contextRef="As_Of_3_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_fmQDXKgxeEiyIStEpmlASQ" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Narr_EoWnt-np1E6XckgZVME4kA">5-year</ix:nonNumeric> Warrant has a warrant coverage amount of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_3_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_fmQDXKgxeEiyIStEpmlASQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" id="Narr_bZ_V9uz2y0aO4vXRGAwvwQ">750,000</ix:nonFraction> with an exercise price equal to the conversion price of the Note. If the Note&#160;had not been converted or repaid in accordance with its terms prior to May&#160;1, 2020, the Company will issue an additional warrant on May&#160;1, 2020, and the first day of each additional&#160;month the Note&#160;remains outstanding, for $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_5_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_2H40H7i-ukaCvdguWaUOFw" decimals="0" format="ixt:numdotdecimal" name="miro:WarrantsAndRightsAdditionalCoverage" scale="0" id="Narr_4kDHvGaEKE6XmVERFFkZeg">75,000</ix:nonFraction> of warrant coverage. In June 2021, the Note and all accrued interest was converted into <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_VeZ4VJDJtkmpGyjtYu7oNw" decimals="INF" format="ixt:numdotdecimal" name="miro:TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" scale="0" id="Narr_0pF6KWEyQEWPGEmpD0-S1g">956,887</ix:nonFraction> shares of the Company&#8217;s Series C Convertible Preferred Stock. As of September 30, 2021 and December&#160;31, 2020, the balance outstanding on the Note was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_qjeQidbY9E2QpOxvv_Bvsg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="Narr_8GY6AcqA_k2d0pKyv4PDNg">0</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_hmQR2sxXt0-QPIS6GgjMrQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="Narr_MrfqItHmakOiLuk-f7h10w">6,000,000</ix:nonFraction>, respectively.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_cabe5e77_69e6_4398_948c_073a24841ee7"></a><a id="Tc_DwTTSIcsSUCNoA5ZFu2S5g_1_0"></a><a id="Tc_vRGVIfLOyUifOiSeV-o8hQ_1_2"></a><a id="Tc_nCn2O2Uz8kqXhGwe0b2g_w_1_5"></a><a id="Tc_KTCp60tc7EizQUU4Ly_D0Q_1_8"></a><a id="Tc_sZXx4ofAgkSP7rnBxZl9fg_2_0"></a><a id="Tc_saE1Q7iQPkKzPB0uR5nikg_2_2"></a><a id="Tc_TdXpAmAZCkiq2v2xCnGdXg_2_5"></a><a id="Tc_7bs8ICeXJUybbCjsvz2cnw_2_8"></a><a id="Tc_be_Lwio9fU-frPY59cPQWA_3_0"></a><a id="Tc_NPtU_nJsZ0GaEdCdmrMjhw_4_0"></a><a id="Tc_U9OvPNEz80q58KrVlbaxdg_4_3"></a><a id="Tc_KBEzkTEuikCihr7Kkf4ZFA_5_0"></a><a id="Tc_oUgowrN1vEeznhyCTxRWMw_5_3"></a><a id="Tc_s_BjC_2i0EO9iUA1UBAV_g_5_6"></a><a id="Tc_MIWukspeEkWfWqQaidaprQ_5_9"></a><a id="Tc_-pHYrTd57EmmEh37pz3I4A_6_0"></a><a id="Tc_efUH5ln75kaH_VmAgZ42QA_6_6"></a><a id="Tc_qqCkTALfFUiI8JJrnTKtqw_7_0"></a><a id="Tc_ROcZUCb2qk-mN1Fpe3xLJg_8_0"></a><a id="Tc_RC57fb8Tg0GYf-ZZbuYULw_9_0"></a><a id="Tc_pNs1GTjV1USXqAPqNZHBpw_9_2"></a><a id="Tc_usGkiM9Gvk69mkkrmMzd8w_9_5"></a><a id="Tc_Rh56vjeDR0SjVoC0wl7wQQ_9_8"></a><a id="_d7f1a8e7_ad5e_4346_a625_eec6fc153b3c"></a><a id="Tc_-uwvTuJOeUW42nClpuVRig_1_0"></a><a id="Tc_ATIYa9KIR0evhc64bRWs3A_1_2"></a><a id="Tc__ZD2xiQvjEaIoxa2r2GdCA_1_5"></a><a id="Tc__M-tRBqYb0eDL6mA6yFtTg_1_8"></a><a id="Tc_6gHkqY7Mz0OecneIA0IKaQ_2_0"></a><a id="Tc_JE--mxL7HUSkugaeEeZa-A_3_0"></a><a id="Tc_rTJciDC9lkGdCeZL4xMqHg_3_2"></a><a id="Tc_SPupl-GgP0mSgeyAwaKrdg_3_5"></a><a id="Tc_4Vx7pPWnh0KLX7FPZV1TvA_3_8"></a><a id="Tc_zMO4wX_2PU-c83v92E7wtQ_4_0"></a><a id="Tc_BtAhsOOWw0m_6gg8-BNHjw_5_0"></a><a id="Tc_Nbu3Hr9aiEqzU0B5Vp4AWQ_5_3"></a><a id="Tc_o2o6UgoUv0COLHbTsfII2Q_6_0"></a><a id="Tc_Lx3NUkBebkSUK8zysTZmCw_6_6"></a><a id="Tc_Bn23YczV5USDCZNWYe_cLA_7_0"></a><a id="Tc_XdNIWToFPESERFd7_tR2HA_8_0"></a><a id="Tc_zpW7_TqfLkStttw8XLqMYw_9_0"></a><a id="Tc_S8eyyI7_vEefiMlCWd_zcw_9_2"></a><a id="Tc_u1M4JO_Y10iYXiB7GMoTQA_9_5"></a><a id="Tc_nucw7pfB4U-X1WLzWjTejg_9_8"></a><ix:continuation id="Tb_pqeIgJrR_USXjgxkNFZc8w_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">On April&#160;16, 2020, the Company issued a promissory note for $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_4_16_2020_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_K_b8S5kNXUi8BLFNMA8rKw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="Narr_jZIVhtrJVE6sao3ECCpARg">563,397</ix:nonFraction> under the Paycheck Protection Program (&#8220;PPP&#8221;) through the U.S. Small Business Administration (SBA). The PPP was authorized in the Coronavirus Aid, Relief and Economic Security (CARES) Act. The promissory note is uncollateralized and is fully guaranteed by the Federal government. The outstanding balance of the promissory note bears interest at <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_4_16_2020_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_K_b8S5kNXUi8BLFNMA8rKw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="Narr_fdeNmSQWZU6kdMR12-AK3w">1</ix:nonFraction>% per annum and is due on April&#160;16, 2022. Per the PPP&#8217;s terms, some or all of the debt may be forgiven based upon the Company&#8217;s use of the funds. On March&#160;4, 2021, $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_3_4_2021_To_3_4_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_YFZmZWhoU0m7w2SwZnEVSQ" decimals="0" format="ixt:numdotdecimal" name="miro:DebtInstrumentPrincipalForgiveness" scale="0" id="Narr_xVpTvMviyEubWe-TZH655w">513,520</ix:nonFraction> of the principal balance under the promissory note and associated interest of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_3_4_2021_To_3_4_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_YFZmZWhoU0m7w2SwZnEVSQ" decimals="0" format="ixt:numdotdecimal" name="miro:DebtInstrumentInterestForgiveness" scale="0" id="Narr_6bqe08ccw0iBeVvzIM_wSA">4,530</ix:nonFraction> were forgiven by the SBA. On August 6, 2021, the remaining principal balance of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_8_6_2021_To_8_6_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_FHW-5iosOkaC1XBwtIzjrw" decimals="0" format="ixt:numdotdecimal" name="miro:DebtInstrumentPrincipalForgiveness" scale="0" id="Narr_0pkCWnG_wEuQONSTtMPN-g">49,877</ix:nonFraction> along with associated interest of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_8_6_2021_To_8_6_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_FHW-5iosOkaC1XBwtIzjrw" decimals="0" format="ixt:numdotdecimal" name="miro:DebtInstrumentInterestForgiveness" scale="0" id="Narr_aBfz9T5JlEm2CC5xlh7j5A">440</ix:nonFraction> were forgiven by the SBA. As of September 30, 2021 and December&#160;31, 2020, the balance outstanding on the promissory note was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_lP4_QEOZzE2bhzXyZUrCrQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="Narr_xS1HIU5XhESrKmHwwOZtvw">0</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_m4hqd27BVkSFna6qz43sIQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="Narr_Dj0tSd86GEOncsHOAQutmw">563,397</ix:nonFraction> respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In July&#160;2021, the Company signed a lease agreement for a piece of equipment that is being accounted for as a capitalized lease. The total cost of the equipment was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_7_31_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_ny50Pi8_jEyfyuCfKjRFVA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CapitalLeasedAssetsGross" scale="0" id="Narr_9TbRz4YM60ihHsbYpSBEbw">44,251</ix:nonFraction>. The lease bears interest at <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_7_31_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_ny50Pi8_jEyfyuCfKjRFVA" decimals="3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="Narr_x6uTwDtz6kmT8A3BF2t-Iw">5.0</ix:nonFraction>% and the Company will make <ix:nonFraction unitRef="Unit_Standard_payment_r6kmSj8FdkWHfPCK9l_Ahg" contextRef="Duration_7_1_2021_To_7_31_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_Jz0WwUyS-E6Z18dHVsppFw" decimals="INF" format="ixt:numdotdecimal" name="miro:DebtInstrumentPeriodicMonthlyPaymentNumber" scale="0" id="Narr_KyTDPa-Hu0ir6iiLa49mlg">24</ix:nonFraction> monthly payments of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_7_31_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_Jz0WwUyS-E6Z18dHVsppFw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPayment" scale="0" id="Narr_62VDSXz-mUastop9Vky-XQ">1,941</ix:nonFraction> until the lease is paid in full. As of September 30, 2021, the amount outstanding on the lease was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_We8kS0mQrU-z2lQGO0T3dw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CapitalLeaseObligations" scale="0" id="Narr_JRHoflfd7kipvLJHuAB6JA">37,178</ix:nonFraction>. The lease is secured by the piece of equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In September&#160;2021, the Company signed a lease agreement for a piece of equipment that is being accounted for as a capitalized lease. The total cost of the equipment was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_QDAsoSke6UmzGRrYBpT5Ug" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CapitalLeasedAssetsGross" scale="0" id="Narr_YyCUVBFqm0KFHBkgP-CWPA">43,317</ix:nonFraction>. The lease bears interest at <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_QDAsoSke6UmzGRrYBpT5Ug" decimals="3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="Narr_2Mmxoq1ppUW_CZUdg4Ambg">6.8</ix:nonFraction>% and the Company will make <ix:nonFraction unitRef="Unit_Standard_payment_r6kmSj8FdkWHfPCK9l_Ahg" contextRef="Duration_9_1_2021_To_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_XoFDCEt86EOimiVOhB2Tgw" decimals="INF" format="ixt:numdotdecimal" name="miro:DebtInstrumentPeriodicMonthlyPaymentNumber" scale="0" id="Narr_5E6i5b23006GRojeUTNq_w">36</ix:nonFraction> monthly payments of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_9_1_2021_To_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_XoFDCEt86EOimiVOhB2Tgw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPayment" scale="0" id="Narr_micB3tCqBkakpqIN_AiIvQ">1,448</ix:nonFraction> until the lease is paid in full. As of September 30, 2021, the amount outstanding on the lease was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_QDAsoSke6UmzGRrYBpT5Ug" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CapitalLeaseObligations" scale="0" id="Narr_lw93ITQ_WUCO83hU257lOA">42,319</ix:nonFraction>. The lease is secured by the piece of equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Principal maturities were as follows as of the periods indicated:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="Tb_lH1KONhxIUmykJDX1GhD1Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Debt</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Capital Lease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Total</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" scale="0" id="Tc_kLPigzBzeUSVqi2axgt8xw_2_3">6,481,774</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" scale="0" id="Tc_RorQ5tXcmUCjyE5uDQdLzg_2_6">18,855</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" scale="0" id="Tc_iIMpnh-8EUOui5nPob0D7Q_2_9">6,500,629</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" scale="0" id="Tc_WuGrn22vx0GO-_5ICsABQg_3_3">504,354</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" scale="0" id="Tc_8Fm-moaemEGv7tv_8V7IKA_3_6">20,261</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" scale="0" id="Tc_aUrwQKAotkWteLCOkPSN2g_3_9">524,615</ix:nonFraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" scale="0" id="Tc_-OhDZR4pckmf8s2XNCsltg_4_6">18,011</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" scale="0" id="Tc_1wadrcFH5EuXpsNRHo3Xmw_4_9">18,011</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive" scale="0" id="Tc_xeqhKwBnmEC4A-Bgr41bGQ_6_3">385,997</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive" scale="0" id="Tc_K55nA1A7vEKE3dkIyQLURw_6_9">385,997</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Totals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA" decimals="0" format="ixt:numdotdecimal" name="miro:DebtAndCapitalLeaseObligationsGross" scale="0" id="Tc_bp4QypgLPUS3L2P8g_ckVw_7_3">7,372,125</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w" decimals="0" format="ixt:numdotdecimal" name="miro:DebtAndCapitalLeaseObligationsGross" scale="0" id="Tc_fScKERAMIUSTSYNHTSTYxQ_7_6">57,127</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:DebtAndCapitalLeaseObligationsGross" scale="0" id="Tc_b-w35YVIREqXdpGvJ6EwOA_7_9">7,429,252</ix:nonFraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less current portion </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA" decimals="0" format="ixt:numdotdecimal" name="miro:DebtAndCapitalLeaseObligationsGrossCurrent" scale="0" id="Tc_SrIOE4vVE0SHVMd8JWCb4g_8_3">6,481,774</ix:nonFraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w" decimals="0" format="ixt:numdotdecimal" name="miro:DebtAndCapitalLeaseObligationsGrossCurrent" scale="0" id="Tc_O9QEC9TZi0G1_wGZQ46wcA_8_6">18,855</ix:nonFraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:DebtAndCapitalLeaseObligationsGrossCurrent" scale="0" id="Tc_P-QN6-Nik0urEudb7WEjPA_8_9">6,500,629</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term portion </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA" decimals="0" format="ixt:numdotdecimal" name="miro:DebtAndCapitalLeaseObligationsGrossNoncurrent" scale="0" id="Tc_Cg5ezGm6G0K0fpcUSxSe7g_9_3">890,351</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w" decimals="0" format="ixt:numdotdecimal" name="miro:DebtAndCapitalLeaseObligationsGrossNoncurrent" scale="0" id="Tc_ZEi_nNIV3UWMiYQSw8fhKA_9_6">38,272</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:DebtAndCapitalLeaseObligationsGrossNoncurrent" scale="0" id="Tc_RkYbCXV3_UWujvtPDSEYUg_9_9">928,623</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Debt</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Capital Lease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" scale="0" id="Tc_vKXthKnSuESY5UySPNpKcQ_3_3">333,223</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" scale="0" id="Tc_GbHDbMw-e0Sx8PWnWI3Gzg_3_6">52,938</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" scale="0" id="Tc_xOlUP5YGnkaWTHiMZZ0awg_3_9">386,161</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" scale="0" id="Tc_4wiUMLaHg0ulPu4A3Xd_Aw_4_3">23,097</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" scale="0" id="Tc_VI4TkBdxukGsNi1b_WsRKg_4_6">51,008</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" scale="0" id="Tc_ErPd5p41pUOkVp4Mnh4R2g_4_9">74,105</ix:nonFraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" scale="0" id="Tc_APEimxsyJkCFcxLBD24QwQ_5_6">18,664</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" scale="0" id="Tc_lfsVii5HrkiNeKQKq29rbQ_5_9">18,664</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour" scale="0" id="Tc_AGNFevvUrkqzWqBUeyowjA_6_3">385,997</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour" scale="0" id="Tc_KGo_EoHel0SvtKLJvHiYRg_6_9">385,997</ix:nonFraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Totals </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="0" id="Tc_LiO2ABPxAEOFEqEk7a8nag_7_3">742,317</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="0" id="Tc_OmtkIvdvqUOPcWm8a804zA_7_6">122,610</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="0" id="Tc_gt3GmokWhUWRHkXjIyL_UQ_7_9">864,927</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less current portion </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="0" id="Tc_w6Z1M1TDP02ahuMaChijvg_8_3">333,223</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="0" id="Tc_fqyp4siVNk-9uJ-ghqPguA_8_6">52,938</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="0" id="Tc_dt1QAkp5I0CC79oNRvSxMg_8_9">386,161</ix:nonFraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term portion </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="0" id="Tc_jwHT6pFp10a80jeFJ5Tuqw_9_3">409,094</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="0" id="Tc_leIYNuWtmUWkYqNKKCtLhQ_9_6">69,672</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="0" id="Tc_Z2lPURKNMEmjthtLrRz41Q_9_9">478,766</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_6CqlD8yqfEWfxU4cZucC5w_1_6"></a><a id="Tc_kGu0BR_lfkS0miAL1ZZOfQ_2_2"></a><a id="Tc_uKI4yDVIK0G4Fgt0_zrfcQ_2_4"></a><a id="Tc_wm1Qy1fYSUycQbC--kT85Q_2_6"></a><a id="Tc_HUK1ZxwqfUWXng0U_vL7hg_3_2"></a><a id="Tc_B9vcN9g0XUezswLM0Rr7NA_3_4"></a><a id="Tc_Z-WJ35EudEeRcT_mF6ym1g_3_6"></a><a id="Tc_eLagQ2eQIEeh1qD0E550GQ_5_0"></a><a id="Tc_hBrfGNeRqUaMb-28Wq8IWw_6_0"></a><a id="Tc_y74MTZD-cE23cMCd2OtJhQ_7_0"></a><a id="Tc_vJICDULtzECNIycHFXOgWA_8_0"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="miro:ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock" id="Tb_ISwHjizDiE2PmA_hIt3kkw" continuedAt="Tb_ISwHjizDiE2PmA_hIt3kkw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;8&#160;&#8212; CAPITAL STOCK</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Convertible Preferred Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Immediately prior to the IPO, the Company had the following outstanding convertible preferred stock:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:TemporaryEquityTableTextBlock" id="Tb_Y0GXwhtmaki1bZn1FFX0_w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Liquidation</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Authorized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Preference</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible Preferred Stock - Series C</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_iKt7zxYygUezKqnAXBiqsQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="Tc_jTXc0hhc9EyxAgn3Ie3mog_5_2">6,100,000</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_iKt7zxYygUezKqnAXBiqsQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Tc_NCDVIJ0YKEeCAoC-Am4qEw_5_4">3,671,554</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">$ <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_iKt7zxYygUezKqnAXBiqsQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="0" id="Tc_1ikDtRPKPEqbAHjJS1RpWA_5_6">27,536,655</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible Preferred Stock - Series B-2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_hOJYsLwUhE-2VMUraYrYJA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="Tc_gEna43-BOkaveouMtFay2A_6_2">2,500,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_hOJYsLwUhE-2VMUraYrYJA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Tc_lS7s_X93_EC7yDttOASMbg_6_4">2,095,874</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_hOJYsLwUhE-2VMUraYrYJA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="0" id="Tc_-ZkEh4EZ40qNg78q-5hv6Q_6_6">15,719,055</ix:nonFraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible Preferred Stock - Series B</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_P0FovK3_vEmt4Nbg26vc9g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="Tc_ZNJGHi2F0UekpqhQDAjJnA_7_2">4,000,000</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_P0FovK3_vEmt4Nbg26vc9g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Tc_sJz_NaIKTkeIcp_UAf1RiQ_7_4">3,218,282</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_P0FovK3_vEmt4Nbg26vc9g" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="0" id="Tc_R2ZZsoyVMkqIfJ5kf8Q1yQ_7_6">24,137,115</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible Preferred Stock - Series A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_Ho_LSq9GrEC0Bq3haRfarQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="Tc_lYsT4qBEl0evNpotk0xPFg_8_2">3,300,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_Ho_LSq9GrEC0Bq3haRfarQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Tc_Zw9KhN4d2k-shPvbJH9Rkg_8_4">3,000,380</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_Ho_LSq9GrEC0Bq3haRfarQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="0" id="Tc_G3HLBtaDhEmUlzmsjOwD_Q_8_6">7,500,950</ix:nonFraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_5_31_2021_J4lgZ-q5v02aj1SQxigv9w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="Tc_IYZEIY-KH02gjym4yB5Chg_9_2">15,900,000</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_5_31_2021_J4lgZ-q5v02aj1SQxigv9w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Tc_P9wfWMewuEim2iABFTgbHQ_9_4">11,986,090</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">$ <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_5_31_2021_J4lgZ-q5v02aj1SQxigv9w" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="0" id="Tc_m01bZvx5o02RYNwhdMj_vQ_9_6">74,893,775</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Upon the closing of the IPO, all shares of convertible preferred stock then outstanding were automatically converted into an aggregate of <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Q9R7jNA_kk6E26TVZk6K5Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="Narr_P94CvedodEGuJ-kAVXzXGA">12,139,071</ix:nonFraction> shares of common stock, resulting in the reclassification of the related convertible preferred stock into $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Q9R7jNA_kk6E26TVZk6K5Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" id="Narr_syfrGjwmJEWG9YDSBKyN7Q">121</ix:nonFraction> of common stock and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_jgndyTBo4kmjINCHYzZc9Q" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="Narr_VyPdbj7ZSESwutEd0At3kA">73.7</ix:nonFraction> million into additional paid-in capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2021, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_Zktvjk_gy0ClXB0E2ZYcYA">no</ix:nonFraction> shares of convertible preferred stock outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Common Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">All of the shares sold by the Company in the IPO were common stock. The Company is authorized to issue <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_MhAz_dLoG0u29RtLT7-_tA">190,000,000</ix:nonFraction> shares of common stock, with a par value of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_3i_mb0NP70SjMb23DH3KPg">0.00001</ix:nonFraction>. Holders of common stock are entitled to <ix:nonFraction unitRef="Unit_Standard_Vote_5PNXDYCebUiYVCiCDg0ocw" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt-sec:numwordsen" name="miro:NumberOfVotesForCommonStockHolders" scale="0" id="Narr_Riyw1bxpg0e7yckFpNqumA">one</ix:nonFraction> vote for each share held on all matters submitted to a vote of common shareholders, as provided in the Post-IPO Certificate. Subject to preferences that may be applicable to any outstanding preferred shares, each share of common stock is entitled to share pro rata in any distributions. In any distribution of capital assets, holders of common stock are entitled to receive pro rata the assets remaining after payment of liabilities and liquidation preferences on any outstanding preferred stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In 2020, the Company issued <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_miro_ExercisePriceOf0.10Member_xehDfIZz-EWtTdFbk8j1fQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Narr_qjkcCU-3SkWOe1LGSY0NJA">64,000</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_miro_ExercisePriceOf1.25Member_oooEOJ4y2kee2kSZatqRNg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Narr_HRRPw21RQkWZxzudufQh7A">1,000</ix:nonFraction> shares of common stock in connection with the exercise of stock option agreements at exercise prices of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_miro_ExercisePriceOf0.10Member_xehDfIZz-EWtTdFbk8j1fQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="Narr_7FkLTCFidU-9rPHhlwoeyA">0.10</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_miro_ExercisePriceOf1.25Member_oooEOJ4y2kee2kSZatqRNg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="Narr_lp5s4mibAEyYOKEoxw3fow">1.25</ix:nonFraction> per share, respectively. The Company also issued <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2020_To_12_31_2020_B2zSRfZBIkue8c0XT4p-dw" decimals="INF" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodSharesWarrantsExercised" scale="0" id="Narr_BOqQEA-OS0CGpRrwf2NNUA">45,000</ix:nonFraction> shares of common stock in connection with the exercise of stock warrant agreements at an exercise price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="Narr_uxovBIRCNEe5xRDOn3W1NA">1.25</ix:nonFraction> per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In 2019, the Company issued <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2019_To_12_31_2019_tNkW5JyZSEem2SQQAsVb6w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Narr_btpZyAPHOEinrfyalOh23A">50,000</ix:nonFraction> shares of common stock in connection with the exercise of stock option agreements at exercise price of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="Duration_1_1_2019_To_12_31_2019_tNkW5JyZSEem2SQQAsVb6w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="Narr_vtq2CzupH0yl8JWkLxh0Fg">1.25</ix:nonFraction> per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">At December 31, 2020, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_cnTwmCHxFUGCWKfjdv4hTw">2,185,822</ix:nonFraction> shares of common stock issued and <span style="-sec-ix-hidden:Hidden_GdaMreGh4UWpAbI1JPGEhQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span>. At September 30, 2021, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_N5f3ajCHH0y1L8Q4bZDkdA">20,254,645</ix:nonFraction> shares of common stock issued and <span style="-sec-ix-hidden:Hidden_WX4Ga6iaZ02G6yjt970rOA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Preferred Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company is authorized to issue <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="Narr_l5-YomqlgEupX6d7wfrS3g">10,000,000</ix:nonFraction> shares of preferred stock, with a par value of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="Narr_5pAeh-tTO0i0d-qgBkuUNw">0.00001</ix:nonFraction>, as provided in the Post-IPO Certificate. As of September 30, 2021, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="Narr_8iMpC9C3m0y18z7Bhi4U5g">no</ix:nonFraction> shares of preferred stock issued and <span style="-sec-ix-hidden:Hidden_DNi9Vf20okCb087fMwdOZw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">The Company previously classified its Series&#160;A Convertible Preferred Stock, Series&#160;B Convertible Preferred Stock, Series&#160;B-2 Convertible Preferred Stock, and Series C Convertible Preferred Stock as mezzanine equity due to their liquidation provisions under a change in control.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_ISwHjizDiE2PmA_hIt3kkw_cont1" continuedAt="Tb_ISwHjizDiE2PmA_hIt3kkw_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Series&#160;C Convertible Preferred Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In May 2021, the Company entered into <ix:nonFraction unitRef="Unit_Standard_agreement_od-gDHq4Z0WVrTpltuYtzw" contextRef="Duration_5_1_2021_To_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_2kXm4JqYrUGIQ5XQlQ4tBQ" decimals="INF" format="ixt-sec:numwordsen" name="miro:NumberOfStockPurchaseAgreements" scale="0" id="Narr_xGR2Fm9tRESWhnalkooNAQ">two</ix:nonFraction> stock purchase agreements under which it sold an aggregate of <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_5_1_2021_To_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_2kXm4JqYrUGIQ5XQlQ4tBQ" decimals="INF" format="ixt:numdotdecimal" name="miro:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" scale="0" id="Narr_gaeo2lIye0ugEtIWkWOh3g">2,666,667</ix:nonFraction> shares of Series C Preferred Stock at $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_iKt7zxYygUezKqnAXBiqsQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="Narr_DGioDeDkFEaFJNC0OUQaMQ">7.50</ix:nonFraction> per share for gross proceeds of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_5_1_2021_To_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_2kXm4JqYrUGIQ5XQlQ4tBQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="0" id="Narr_Eh9LVK3pi0mtrcTEODYDvg">20,000,003</ix:nonFraction>. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In June 2021, the $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_ez_THl-rSUu9GNrnq2nCuA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="Narr_Dl97VncYQEaODS0dSy5SMg">6,000,000</ix:nonFraction> Note issue by the Company in March 2020 (See Note 7) and all accrued interest was converted into <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_VeZ4VJDJtkmpGyjtYu7oNw" decimals="INF" format="ixt:numdotdecimal" name="miro:TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" scale="0" id="Narr_w_Hr0JtnvEaaweafmICzeg">956,887</ix:nonFraction> shares of Series C Preferred Stock. On the same date, the Warrant issued in connection with the Note was converted into <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_eJwJJs9VSkeObpA8PJb8LQ" decimals="INF" format="ixt:numdotdecimal" name="miro:StockIssuedDuringPeriodSharesWarrantsExercised" scale="0" id="Narr_OTIYwFrfGEyxbownLoP_dg">48,000</ix:nonFraction> shares of Series C Preferred Stock via a cashless exercise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Series C Preferred Stock converted into common stock at a <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_6_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_gq9MkhmKcki_IgIkqiLqdA" decimals="INF" format="ixt:numdotdecimal" name="miro:StockConversionDiscount" scale="-2" id="Narr_1JPArNbRp0q7lRXOe7gU7g">20</ix:nonFraction>% discount to the price to the public in the IPO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2021, all <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_1_QI08EAgkeFGMJvDi62nw" decimals="INF" format="ixt:numdotdecimal" name="miro:TemporaryEquitySharesConvertedInPeriod" scale="0" id="Narr_JfSRQc6cUEOTGUXDOwtJXg">3,671,554</ix:nonFraction> shares of the Series C Preferred Stock had been converted into common stock and <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_ze4CSI6Mzk-ZR5OI8HnD8w" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="Narr_4Ulp8_ctjUOMRY5o6JYIbA">none</ix:nonFraction> remained outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Stock Options</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In February 2010, the Company adopted a stock option plan (the &#8220;2010 Plan&#8221;) which authorized options to acquire <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_2_28_2010_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_KR1v8aGoW06UTHLbKbrWzg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="Narr_rI_y9AFj0UacEufpuZ5BIw">375,000</ix:nonFraction> shares of the Company&#8217;s common stock. On June&#160;20, 2011, the number of shares authorized to be issued as options under the 2010 Plan was increased to <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_6_20_2011_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_p8iI4CpuukSW-_z9m6tgFw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="Narr_UTgNczwVrEe_u7my7--zmA">600,000</ix:nonFraction>. On September&#160;30, 2013, the number of shares authorized to be issued as options under the 2010 Plan was increased to <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2013_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_jitbOwlHxEatY3c8sdyT8Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="Narr_KPIG5oX4NES7WFyhi3oFtg">1,300,000</ix:nonFraction>. On March&#160;1, 2014, the number of shares authorized to be issued as options under the 2010 Plan was increased to <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_3_1_2014_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_B1MdDsK4eU6ABBhy1iHGqQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="Narr_Bhp67QDycE23asbAmwLsLQ">1,700,000</ix:nonFraction>. On July&#160;31, 2015, the number of shares authorized to be issued as options under the 2010 Plan was increased to <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_7_31_2015_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_IOV5CcCN1kafEI0aNGuk7A" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="Narr_qnCgBGj6Q0SKBI-eXLvhuQ">2,500,000</ix:nonFraction> shares. On August&#160;12, 2016, the number of shares authorized to be issued as options under the 2010 Plan was increased to <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_8_12_2016_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_bHSdVDHwNkir9pwGVxJShw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="Narr_DR5mawXaB0qheKMJdAsGyg">3,250,000</ix:nonFraction> shares. On December&#160;13, 2017, the number of shares authorized to be issued as options under the 2010 Plan was increased to <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_13_2017_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_6aqbm-JWHUKb0XhszArtdQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="Narr_DFPSH3o4DEaj-TlAH7VVZg">3,850,000</ix:nonFraction> shares. At September 30, 2021, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_lHsE8nx05E6MJohdoQuOHw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="Narr_QanRAKDEo0-6WzvAipaVJw">2,876,305</ix:nonFraction> options outstanding under the 2010 Plan and <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_lHsE8nx05E6MJohdoQuOHw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="Narr_PCx4J6va4UOGB1HRqCpknQ">0</ix:nonFraction> options available for grant. At December&#160;31, 2020, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_McJXXc_Kf0uPYR-o6Dcyzw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="Narr_yVYs5NLTCEuRBoDJocQqzA">3,287,230</ix:nonFraction> options outstanding under the 2010 Plan and <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_McJXXc_Kf0uPYR-o6Dcyzw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="Narr_rVdH3aUphEumpbj-ScmzxA">0</ix:nonFraction> options available for grant. The Company ceased making awards under the 2010 Plan upon approval of the 2019 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In July 2019, the Company adopted a stock option plan (the &#8220;2019 Plan&#8221;) which authorized options to acquire <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_7_31_2019_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_C6HVYrURKkyIQjOgOtfdLA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="Narr_C2zFa5mWGUSFLZxXpNkEkg">1,000,000</ix:nonFraction> shares of the Company&#8217;s common stock. At September 30, 2021, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_9z94lpGqiUK-UGTQzRUXmg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="Narr_Bc_ftQrQt0CBZ0yIUyeA1A">377,000</ix:nonFraction> options outstanding under the 2019 Plan and <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_9z94lpGqiUK-UGTQzRUXmg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="Narr_bXdepU4-ZkmobTEF2XMXfQ">0</ix:nonFraction> options available for grant. At December&#160;31, 2020, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_o6eAWaymy0yRcfbd6hpu6g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="Narr_hD6qa_a3rEymOxpCstsovg">481,500</ix:nonFraction> options outstanding under the 2019 Plan and <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_o6eAWaymy0yRcfbd6hpu6g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="Narr_se0imehZFUyzbQar-vyC0Q">518,500</ix:nonFraction> options available for grant. The Company ceased making awards under the 2019 Plan upon stockholder approval of the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">On May 20, 2021, the Company&#8217;s stockholders approved the 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;). The 2021 Plan provides for the issuance of stock options, restricted stock units and other awards to employees, directors and consultants of the Company. The number of shares of common stock that may be the subject of awards issued under the 2021 plan is <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_5_20_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_tlUM_j86VUem4H1Fs0WXtA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="Narr_T77-C5-BMka3eLlEof8WQg">1,000,000</ix:nonFraction>. In addition, shares of common stock that would have otherwise been available under our 2019 Plan will increase the number of shares of common stock available for issuance under our 2021 plan. Shares of common stock subject to outstanding awards under the 2019 Plan that would otherwise return to the share reserve of the 2019 plan upon expiration, forfeiture, retention by the Company to satisfy any exercise price or any tax withholding, repurchase by the Company at their original purchase price, or settlement in cash of awards outstanding under the 2019 Plan may be added to the number of shares of common stock available for issuance under the 2021 Plan. The number of shares of common stock reserved for issuance under our 2021 Plan will automatically increase on the first day of each year, beginning on January 1, 2022, in amount equal to the lesser of (a) <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_5_20_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_tlUM_j86VUem4H1Fs0WXtA" decimals="INF" format="ixt:numdotdecimal" name="miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" scale="-2" id="Narr_Z07uYBmAUkaJhqtK4xZuXw">4.5</ix:nonFraction>% of the total number of shares of common stock outstanding on December 31 of the immediately preceding calendar year, (b) <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_5_20_2021_To_5_20_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_bH9uVGXInE2mfvC2nlVwVA" decimals="INF" format="ixt:numdotdecimal" name="miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" scale="0" id="Narr_7phMnGVZFEiSIKEXJghsnQ">600,000</ix:nonFraction> shares of common stock, or (c) such lesser number of shares as determined by the Board. At September 30, 2021, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_2DJ3l3afI0CleWh6XWHWoQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="Narr_dmYruulgDUG5Zr9D8bDRaw">244,831</ix:nonFraction> awards outstanding and <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_2DJ3l3afI0CleWh6XWHWoQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="Narr_Yq_fszHw_E2HPAj4MY7PZw">1,323,169</ix:nonFraction> awards available for grant under our 2021 Plan.</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_qB4UUtn42UOsX_eMHQFCEg_1_2"></a><a id="Tc_J0Cx-pN0d0S_g6HYsxEjjA_2_2"></a><a id="Tc_Y1PdNDg_lUi27DXMyqbHMg_3_4"></a><a id="Tc_6ogK2PfA_k-bO3Wa0U7Eow_4_4"></a><a id="Tc_rmObPwwYnkiw--GaewzpFg_5_4"></a><a id="Tc_mvyLkiqqtU6Eci0yD3wSbw_6_2"></a><a id="Tc_CQ11El7aUUqwargmlgxJwg_6_4"></a><a id="Tc_Kp4z7aK-sky6YTzCZnW6Ng_7_0"></a><a id="Tc_04kUtrk1aU2pbsSLGiUNbA_7_4"></a><a id="Tc_PO3QdbIPi0y124f_cRY65g_8_0"></a><a id="Tc_5NkwlguUBkSznfgypYaSmQ_8_4"></a><a id="Tc_-OSWBc_GXEa2C54r6SdmVg_9_0"></a><a id="Tc_B-lWJjSjQEGBuYin8vaWyA_9_4"></a><a id="Tc_Kg-zAzhKd0eFNLCjDCeKAg_10_0"></a><a id="Tc_m-LwVEEQ3kiZ9x9KAX6EXQ_10_4"></a><a id="Tc_hOcBIpq3YEiOo1CcMK2PxQ_11_0"></a><a id="Tc_aD-nN4rAbEWtib5FBwCHhQ_11_4"></a><a id="Tc_Nk9F_X6760CEAP4sePVk_w_12_0"></a><a id="Tc_AqOM3gN1Fky6FZ2eM4hMCA_12_4"></a><ix:continuation id="Tb_ISwHjizDiE2PmA_hIt3kkw_cont2" continuedAt="Tb_ISwHjizDiE2PmA_hIt3kkw_cont3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following is a summary of options to purchase common stock during the nine&#160;months ended September 30 (unaudited):</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="Tb_TK-jJtqhc0KRauu5KLgmFg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:25.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine months ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:25.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Weighted </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Average </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Exercise</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Price</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options outstanding at beginning of the period </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="Tc_D-1_62cQSkek4jzhLvBAAA_7_2">3,768,730</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="Tc_xsXoM9mqJE-_cZlmBhJV9g_7_5">3.15</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="Tc_KV8QlzSUPE-Hx6AlTZtjsQ_8_2">215,500</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="Tc_5bG6QxTxh0Oi2EXPkl0HOA_8_5">9.99</ix:nonFraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Tc_Vfffim2CpUisQlb-hqqT4g_9_2">381,866</ix:nonFraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="Tc_gwK4JZSADkiMblSpXn_KEA_9_5">2.10</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled or expired </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="Tc_FaV3HMcmYEirWqSF4y9z1w_10_2">137,559</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="Tc_sUXSFytCGUaMl8LU93IQdA_10_5">3.01</ix:nonFraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options outstanding at end of the period </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="Tc_sgftyc4_DkK53FUDL0QiuA_11_2">3,464,805</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="Tc_LLcggoI70UewZEhlaxSdVQ_11_5">3.70</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options Exercisable </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="Tc_aRV6OSBbAUeeS9shy4yrYQ_12_2">3,075,006</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="Tc_vKLUJqVW1U6uJMUNZnI70A_12_5">3.29</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The weighted average fair value of options granted for the nine months ended September 30, 2021 and 2020 was $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Narr_4cbX7nrs1ketw1ECYPRBOw">4.33</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="Duration_1_1_2020_To_12_31_2020_B2zSRfZBIkue8c0XT4p-dw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Narr_RNBc7AG8OEC6c0mLZXf7rQ">0.94</ix:nonFraction> per share, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2021, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="Narr_Q5M87DNOp0iOy2S0yYrJ7w">3,464,805</ix:nonFraction> common stock options outstanding with a weighted average remaining contractual life of <ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Narr_2_cW6N2MWU-STnfpkgEgAw"><span style="color:#231f20;">4.73</span></ix:nonNumeric><span style="color:#231f20;font-family:'Arial','Helvetica','sans-serif';">&#160;</span><span style="color:#231f20;">years.</span> As of December&#160;31, 2020, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="Narr_yJuYmD_3YE-meOMUSDTUjw">3,768,730</ix:nonFraction> common stock options outstanding with a weighted average remaining contractual life of <ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_B2zSRfZBIkue8c0XT4p-dw" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Narr__UTWE05RDE-rMzTDie-iBg">5.08</ix:nonNumeric>&#160;years<span style="color:#231f20;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2021, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="Narr_4oweQCCC_0Cb0xMI_iJJlQ">3,075,006</ix:nonFraction> common stock options exercisable with a weighted average remaining contractual life of <ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="Narr_yT8hmaO4s06F-CLDBwKehw"><span style="color:#231f20;">4.19</span></ix:nonNumeric><span style="color:#231f20;font-family:'Arial','Helvetica','sans-serif';">&#160;</span><span style="color:#231f20;">years. </span>As of December&#160;31, 2020, there were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="Narr__X2Q0AzBp0SCZEMLF8Uqpw">3,426,440</ix:nonFraction> common stock options exercisable with a weighted average remaining contractual life of <ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_B2zSRfZBIkue8c0XT4p-dw" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="Narr_omOsMkTc0ECfTKl-IYuz2A">4.74</ix:nonNumeric>&#160;years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The intrinsic value of the outstanding options as of September 30, 2021 and December&#160;31, 2020 was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="Narr_7A0VTXhjB06xe7npummalw">11,962,604</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="Narr_b2jqn5kw8kS6YM3ivtnMAQ">1,906,200</ix:nonFraction>, respectively. The intrinsic value of the exercisable options as of September 30, 2021 and December 31, 2020 was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="0" id="Narr_9zA6PL0BpUeMXiiZtQi8_A">11,342,114</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="0" id="Narr_rQpRkNHES0i5jA8tdr_2jg">1,906,200</ix:nonFraction>, respectively. The intrinsic value of options exercised was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="0" id="Narr_DtQuYfxX4kSj8_qCkcg22w">1,418,173</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="0" id="Narr_AKk8EzNV406IXo6DexeZeg">1,915,060</ix:nonFraction> for the three and nine months ended September 30, 2021, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company recognized $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="Narr_4cgjA9_wjkir2NkVvZ-1tg">167,469</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="Narr_apEVF0XleUWzbxK2Qc6HYQ">157,398</ix:nonFraction> of stock-based compensation related to option grants during the three&#160;months ended September 30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="Narr_JXMv-YrWqUyJVtiLZmGRCg">450,300</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="Narr_wL0HH5RE4kO8SYZu30xUGQ">472,194</ix:nonFraction> of stock-based compensation related to option grants during the nine&#160;months ended September 30, 2021 and 2020, respectively. As of December&#160;31, 2020, there was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="0" id="Narr_SayZ2mAvJEGXiAfuA4QyPg">562,456</ix:nonFraction> of unrecognized compensation costs related to stock option grants of which $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne" scale="0" id="Narr_UQ_XwJTsb06x8yW2XwGcWQ">280,269</ix:nonFraction>, $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo" scale="0" id="Narr_aAUMuNDgfkahdP_nz7Mv3A">182,465</ix:nonFraction>, $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree" scale="0" id="Narr_DlQT7TEGJ0iTzUaJXab38g">61,890</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw" decimals="0" format="ixt:numdotdecimal" name="miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour" scale="0" id="Narr_UA9hSV9J1E2k5jWwkeFO8w">37,832</ix:nonFraction> is expected to be recognized during the years ending December 31, 2021, 2022, 2023 and 2024, respectively. As of September 30, 2021, there was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="0" id="Narr_DpjLdiR5BUqToFBKMFBFzQ">1,106,705</ix:nonFraction> of unrecognized compensation costs related to stock option grants of which $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear" scale="0" id="Narr_exqgou1kqkmHUbk716HGSg">98,154</ix:nonFraction>, $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne" scale="0" id="Narr_tUvLDbH8WkCXNhw9seACxg">391,038</ix:nonFraction>, $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo" scale="0" id="Narr_mhi0k4WIKkSarNXSAgfC0w">274,705</ix:nonFraction>, $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree" scale="0" id="Narr_AtaTOIa-10SDIpW_4-XsGQ">255,880</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour" scale="0" id="Narr_JCUfJC37k0-xCDKXMjrz9g">86,929</ix:nonFraction> is expected to be recognized during the years ending December 31, 2021, 2022, 2023, 2024, and 2025 respectively. The Company issues new common shares for options exercised.</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_QYuQFJdfTkyKUlnlV-MuWA_1_2"></a><a id="Tc_aOKpj8V20E6KrdIBH3QAcw_2_2"></a><a id="Tc_WRtQmuWCzUGpdNaKvg9tZQ_3_2"></a><a id="Tc_lAR4KAcPa0u9rPSM8WrlGQ_3_4"></a><a id="Tc_oB9u3oX7GUi3OtfSPaT7Vg_4_2"></a><a id="Tc_rB6jw7r4PU-m0KyLyMa-iA_4_4"></a><a id="Tc_AZC8t0EKVUmWlQNG2I6PcA_5_0"></a><a id="Tc_hXnXBle5ckKo2pTgOym7fQ_6_0"></a><a id="Tc_KbSJEcZVaEi1y0jqT5YDAw_6_3"></a><a id="Tc_GgryxCmjukK5dAY0nq5hgw_6_5"></a><a id="Tc_eOnXOGMjH0-wEeCksRSccQ_7_0"></a><a id="Tc_76JjK9LedUq98WFLITpQPA_7_2"></a><a id="Tc_bSyb0JWh7ESk34MvIbEwMQ_7_4"></a><a id="Tc_Vjg7P6md5ES4-2nlr4IoHg_8_0"></a><a id="Tc_9GDjB_xrl0GC8oEl70comw_8_3"></a><a id="Tc_SgzF4GjbQUC96_JvLMcT5Q_8_5"></a><ix:continuation id="Tb_ISwHjizDiE2PmA_hIt3kkw_cont3" continuedAt="Tb_ISwHjizDiE2PmA_hIt3kkw_cont4"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Black-Scholes Assumptions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option grants with the following weighted average assumptions:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="Tb_nDvFMzDqa0K_wllxGh4WBw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100.14%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Nine months ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Expected life in years </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_gR2zVN5q-0a1swvGNHwoWw" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Tc_miN_DSAdcE2J8ZafNYPSFQ_5_2"><span style="color:#231f20;"> 5.99</span></ix:nonNumeric></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_2DY7Kr23UEejqlQcdXp2IQ" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Tc_ib3BvCOnckewr4gQpPKEaQ_5_4"><span style="color:#231f20;"> 5.95</span></ix:nonNumeric></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Risk-free interest rate </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_gR2zVN5q-0a1swvGNHwoWw" decimals="4" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="Tc_VP1Vuozbz0OQiJvcXQ62Nw_6_2">1.16</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">%</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_2DY7Kr23UEejqlQcdXp2IQ" decimals="4" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="Tc_AJD4OVtKMUqI1np_7VqHGA_6_4">0.67</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">%</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Expected dividend yield </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Expected volatility </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_gR2zVN5q-0a1swvGNHwoWw" decimals="4" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="Tc_HAk6rdyQU06RxmyDzwmjmg_8_2">44.30</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">%</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_2DY7Kr23UEejqlQcdXp2IQ" decimals="4" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="Tc_FH6L4lufLUeGJV6dctkDjA_8_4">35.00</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">%</span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Restricted Stock Units</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">During the nine months ended September 30, 2021, the Company granted directors restricted stock unit (&#8220;RSU&#8221;) awards totaling <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_YBwL7RLuskyd3vBZWh7WQw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="Narr_CgrrQSpZBEu_G74rZqXe7w">33,331</ix:nonFraction> shares of common stock under the 2021 Plan in accordance with the Company&#8217;s non-employee director compensation policy. Each RSU is eligible to vest over time and settle into one newly issued share of Company common stock. The weighted average fair value of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_YBwL7RLuskyd3vBZWh7WQw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Narr_ZaETHvSs4EmEHk4KFhGARA">9.00</ix:nonFraction> per unit was calculated based upon the IPO stock price.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">As of September 30, 2021, there was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_1WHSkAXpykyT6aLBtPKDLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="0" id="Narr_7zqAUzg6N0umU8eIdQG2Zw">250,000</ix:nonFraction> of unrecognized compensation costs related to restricted stock units of which $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_SBOFqQEpQEyPvYOkIlK1HA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="Narr_JDXdgimkIUeaDPKT8h6lpw">50,000</ix:nonFraction>, $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_A4MlM41kpUeFYHhM3kDtsg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="Narr_JEyX-V3wp0ml1TGdsfxweQ">125,000</ix:nonFraction>, $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2023_To_12_31_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_XIKPHQwclUmF18L2ad03-g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="Narr_p54O2hfBA02xpcZjnLOHyA">50,000</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2024_To_12_31_2024_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_vdIpyWd9LEaTHDagY0ShUQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="Narr_Z99Xdg0LbUyyQHyukzG-Lg">25,000</ix:nonFraction> is expected to be recognized during the years ending December 31, 2021, 2022, 2023 and 2024 respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">2021 Employee Stock Purchase Plan</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">On May 20, 2021, the Company&#8217;s stockholders adopted the 2021 Employee Stock Purchase Plan (&#8220;2021 ESPP&#8221;), which became effective in connection with the Company&#8217;s IPO. The 2021 ESPP allows eligible employees to purchase shares of the Company&#8217;s common stock in an offering on each purchase date no less than <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="Duration_5_20_2021_To_5_20_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_t8AKALY0zUWWcDB5cdE9FQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="Narr_52wQSxbOx0GoMJLve5oz0A">85</ix:nonFraction>% of the lower of (i) the closing market price per share of common stock on the first day of the applicable purchase period or (ii) the closing market price per share of common stock on the purchase date at the end of the applicable <ix:nonNumeric contextRef="Duration_5_20_2021_To_5_20_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_iDuQ8yFyEEqVI8V78JY8tg" format="ixt-sec:durwordsen" name="miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" id="Narr_o-h_MwGFDEqVqN-i5IwHmw">six-month</ix:nonNumeric> purchase period. No participant will have the right to purchase shares in an amount that has a fair value of more than $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_5_20_2021_To_5_20_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_iDuQ8yFyEEqVI8V78JY8tg" decimals="0" format="ixt:numdotdecimal" name="miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee" scale="0" id="Narr_WT4GoDyL0UqvWwojcLspUg">25,000</ix:nonFraction> determined as of the first day of the applicable purchase period, for each calendar year, nor purchase more than <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_5_20_2021_To_5_20_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_iDuQ8yFyEEqVI8V78JY8tg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" scale="0" id="Narr_rs37CJwkDUumby_WtGVOzA">5,000</ix:nonFraction> shares of common stock on any one purchase date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">There were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_w0E9NO5A40-QYiUe_4grhw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="Narr_9BrEn7s3sUm9zOEYimd8dQ">300,000</ix:nonFraction> shares of common stock initially reserved for issuance under the 2021 ESPP. In addition the 2021 ESPP contains a provision which provides for an automatic annual share increase on January 1 of each year, in an amount equal to the lesser of (i) <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_w0E9NO5A40-QYiUe_4grhw" decimals="INF" format="ixt:numdotdecimal" name="miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" scale="-2" id="Narr_EA40RaUCqkO-gkN5seK2fg">1</ix:nonFraction>% of the total number of shares outstanding as of December 31 of the immediately preceding calendar year, (ii) <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_EyrEwEwwC0iERsWsXg8aaw" decimals="INF" format="ixt:numdotdecimal" name="miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" scale="0" id="Narr_CJ4Ao22YS0-hoknEZiVozw">200,000</ix:nonFraction> shares or (iii) such number of shares as determined by the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">The Company accounts for employee stock purchases made under its 2021 ESPP using the estimated grant date fair value of accounting in accordance with ASC 718, <i style="font-style:italic;">Stock Compensation</i>. The Company values ESPP shares using the Black-Scholes model.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">There were <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="Narr_TcWfUk8NQ0CbVkslRAQXOg">no</ix:nonFraction> shares issued under the 2021 ESPP during the three and nine months ended September 30, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_UJAYsGG0r0OnWC9TYS05mA_1_2"></a><a id="Tc_lTpqxcp_Xku6y4mhV_VAng_2_2"></a><a id="Tc_BqknNfv0HEKD97kkDImZpw_2_5"></a><a id="Tc_2XT6PZxjX0q-fE6da39Kyw_3_0"></a><a id="Tc_JUBeLNd7dUKTY2rdhT1itQ_4_0"></a><a id="Tc_O8VpfLqb1kyk8bX2VVGXcQ_4_3"></a><a id="Tc_rCe9xHWxCEuCtrrfLN2ozA_5_0"></a><a id="Tc_ay2222ubcUKFUM3f62D1hw_5_3"></a><a id="Tc_V9FZFMXwD0WDlyb30EWPbw_5_6"></a><a id="Tc_FaZdCwtRpE617vJKwyGAww_6_0"></a><a id="Tc_hsEVRiNOa0enxu92jNmUig_6_3"></a><a id="Tc_Rd70Ra1CpUGV_z-1TYxoig_6_6"></a><a id="Tc_t7fbpbkDZEinHKsQ3kAGUQ_7_0"></a><a id="Tc_mgTMfhLAG0mIUleO8e24Pw_8_0"></a><a id="Tc_t8sJ23GX8UOfHtuF94RALw_8_3"></a><a id="Tc_1cSof4vaDEyZdqyAy7TN1w_8_6"></a><a id="Tc_fbmc6A_ZXEeUbQMPtp9x9A_9_0"></a><a id="Tc_DYMd6YOCaEKahDz3uX80BA_9_3"></a><a id="Tc_tTjf85YZ7kuiFiWslJNfaQ_10_0"></a><a id="Tc_bQhSOI0GXkivfOC9eDpJKQ_10_6"></a><a id="Tc_r0jeUJVPYkS2X0g76DRrHQ_11_0"></a><a id="Tc_rLehgMdz-UewCB1kkh_Vbw_11_3"></a><a id="Tc_DEmLLppJvUK6nyFaxK_RcQ_12_0"></a><a id="Tc_8Z-zFGsvd0y6EvNIuUXldQ_12_3"></a><a id="Tc_GCgAslJaJka-SrlfdZNxRw_13_0"></a><a id="Tc_xtBZ3g7Dnk-clPbZNC4a9Q_13_3"></a><a id="Tc_TToou8OmWUe1ZF77c98LOg_14_0"></a><a id="Tc_uM9B2jO5skSHp9lGwP93uQ_14_3"></a><a id="Tc_JVmrdR6s20a3ggNd23DfPA_14_6"></a><a id="Tc_6fnNRUqxYE2VIMUJoy8XTA_15_0"></a><a id="Tc_ZjGJhpKpT0aD31VF0GrWeg_15_3"></a><a id="Tc_nUf270nW5U-YbJiPmpL-yQ_17_0"></a><a id="Tc_ce562nwzyUSGQmE51sdCMw_18_0"></a><a id="Tc_L9M0sE8pwEed9Frrci6N2w_18_2"></a><a id="Tc__-q8ahczf0e7OBqwZ9qNog_18_3"></a><a id="Tc_nNKdmU3W9Uyc6m9moW3GXg_18_5"></a><a id="Tc_A2Li8dGXB0itV_gyMJ40TQ_19_0"></a><a id="Tc_tvZXFD6C_kmFMv7Ag1WYCg_19_3"></a><a id="Tc_xRuyDNqewkqk640T-YXKnw_20_0"></a><a id="Tc_zb947NV-ok6EpAaAA9DNAw_22_0"></a><a id="Tc_RAw25oiIz0K6mAZaLIQNGg_23_0"></a><a id="Tc_0_WGevxYjUeRQ9UvzzMUpg_23_3"></a><a id="Tc_i0c7FMatUUqmwOs2WAIC-g_24_0"></a><a id="Tc_yhkFbbrGh06IDdEskHMU8g_24_3"></a><a id="Tc_0xVW4cvDQE-6gg2xnyzS4Q_25_0"></a><ix:continuation id="Tb_ISwHjizDiE2PmA_hIt3kkw_cont4"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Stock Warrants</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Information with respect to warrants is summarized as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="Tb_GdrFGXZwU0yhdX5QgOMfkA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:middle;white-space:nowrap;width:13.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Series A Preferred</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:middle;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Common warrants</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding December&#160;31,&#160;2018</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2018_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_HGDc3Os7mEWTu-CAaq3ruA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="Tc_gH0uXh-Mp0OA3O7opZtGyQ_3_3">40,000</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2018_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_qZGOmr_ea0Ows1t9YaOzcw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="Tc_qUg6DZf1LUivsQt_GKXiLA_3_6">732,082</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted</p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2019_To_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_3gjNoRIV2UGDPT9hi71nlw" decimals="INF" format="ixt:numdotdecimal" name="miro:ClassOfWarrantOrRightGranted" scale="0" id="Tc_k1_leAtMnkulV8Q6ACdKpQ_4_6">20,587</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Terminated</p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding December&#160;31,&#160;2019</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_NJLzPJiJr0KqVC9ODnYXMg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="Tc_meJ51i-7XkOcMzKM4qF7Ag_7_3">40,000</ix:nonFraction></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_PzoHbCzBmE6ej-n_Qpwy4w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="Tc_ShKcJnv9Z0eSF7NOGTHpvA_7_6">752,669</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted</p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_N-QYK6IT_0K6cQJR8rQQUw" decimals="INF" format="ixt:numdotdecimal" name="miro:ClassOfWarrantOrRightExercised" sign="-" scale="0" id="Tc_9OiZmiJZLUu_I_VhEUPk3A_9_6">45,000</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Terminated</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_1dorSEZUh0ybHPBVgUSX4A" decimals="INF" format="ixt:numdotdecimal" name="miro:ClassOfWarrantOrRightTerminated" scale="0" id="Tc_YWzfV3GywUSqLponMoCBoQ_10_3">40,000</ix:nonFraction>)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding December&#160;31,&#160;2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_ECMqdRae7ESrv1pIfHDKnQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="Tc_3P9zRV5KKUWS4vt-PPRXyw_11_6">707,669</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted</p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_YDeFWSbjDkOyTwmafCkiqQ" decimals="INF" format="ixt:numdotdecimal" name="miro:ClassOfWarrantOrRightGranted" scale="0" id="Tc_YE8UGeupZ0yRBNelqJ_pWw_12_6">276,000</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (<ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_YDeFWSbjDkOyTwmafCkiqQ" decimals="INF" format="ixt:numdotdecimal" name="miro:ClassOfWarrantOrRightExercised" sign="-" scale="0" id="Tc_XQQONUgvMkOpZkBs2HdiIw_13_6">32,790</ix:nonFraction>)</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Terminated</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding September&#160;30,&#160;2021 (unaudited)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="As_Of_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_qaXZChAjbUKzlsfIAO2k2w" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="Tc_S_9kYMLnkUqyf6t9tdSHrg_15_6">950,879</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average exercise price:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">September&#160;30,&#160;2021 (unaudited)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_qaXZChAjbUKzlsfIAO2k2w" decimals="2" format="ixt:numdotdecimal" name="miro:WarrantsOutstandingWeightedAverageExercisePrice" scale="0" id="Tc_VaTkcsCLCkqlQZimcUktuw_18_6">4.53</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_ECMqdRae7ESrv1pIfHDKnQ" decimals="2" format="ixt:numdotdecimal" name="miro:WarrantsOutstandingWeightedAverageExercisePrice" scale="0" id="Tc_UzqZqw-m6UWkFRH3BKsquA_19_6">2.34</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_NJLzPJiJr0KqVC9ODnYXMg" decimals="2" format="ixt:numdotdecimal" name="miro:WarrantsOutstandingWeightedAverageExercisePrice" scale="0" id="Tc_1jTpWF-UgUCZCeKGGPIerg_20_3">2.88</ix:nonFraction></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_PzoHbCzBmE6ej-n_Qpwy4w" decimals="2" format="ixt:numdotdecimal" name="miro:WarrantsOutstandingWeightedAverageExercisePrice" scale="0" id="Tc_w_imGlDyd0mQrMZkpXNdZQ_20_6">2.27</ix:nonFraction></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average remaining contractual life in years:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">September&#160;30,&#160;2021 (unaudited)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_YDeFWSbjDkOyTwmafCkiqQ" format="ixt-sec:duryear" name="miro:WarrantsOutstandingWeightedAverageRemainingContractualTerm" id="Tc_1wJY7NbgIEiAm-jRA241FA_23_6"><span style="color:#231f20;">2.56</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_N-QYK6IT_0K6cQJR8rQQUw" format="ixt-sec:duryear" name="miro:WarrantsOutstandingWeightedAverageRemainingContractualTerm" id="Tc_FvDz9JO5JUS2iD1u0YKR0A_24_6"><span style="color:#231f20;">2.32</span></ix:nonNumeric></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2019</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2019_To_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_iRO3LslO3kas_t0T5hUdPQ" format="ixt-sec:duryear" name="miro:WarrantsOutstandingWeightedAverageRemainingContractualTerm" id="Tc_zEKezr2cC0mC_IO2lX1-YQ_25_3"><span style="color:#231f20;">0.83</span></ix:nonNumeric></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2019_To_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_3gjNoRIV2UGDPT9hi71nlw" format="ixt-sec:duryear" name="miro:WarrantsOutstandingWeightedAverageRemainingContractualTerm" id="Tc_LvRweFN230Wn7DPk84pNsw_25_6"><span style="color:#231f20;">3.23</span></ix:nonNumeric></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="font-weight:normal;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:DefinedContributionPlanTextBlock" id="Tb_FogMotxGKkORufscx2Q6Fg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;9&#160;&#8212; EMPLOYEE BENEFIT PLANS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company&#8217;s employees are eligible to participate in a defined contribution benefit plan. Employees may contribute a&#160;percentage of their wages, subject to limits established by the Internal Revenue Code. The Company may elect to make discretionary contributions to the plan. There were <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="0" id="Narr_D8ZjpAtQqkyKp8u1igS81g"><ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="0" id="Narr_0cMbPXEGUUSzcIy2Z37pPg"><ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="0" id="Narr_7glaYRfAb0KCr-gbIPH_6A"><ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="0" id="Narr_e7ptxEIq7kOUNIrWmbdYRQ">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> discretionary contributions during the three and nine months ended September 30, 2021 and 2020.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="Tb_F0UYwIC3tEiLd5oeewylTw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;10&#160;&#8212; SIGNIFICANT CUSTOMERS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt;">The Company had <ix:nonFraction unitRef="Unit_Standard_customer_oBpQWOLWXkK3Il-nSeGoKQ" contextRef="Duration_1_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_tRMEi9tWY0-0d3TnCQQhlg" decimals="INF" format="ixt-sec:numwordsen" name="miro:NumberOfCustomers" scale="0" id="Narr_9YqXaowic0Sh8M8Mhxjbaw"><ix:nonFraction unitRef="Unit_Standard_customer_oBpQWOLWXkK3Il-nSeGoKQ" contextRef="Duration_7_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_q7UZpcFoxEOYivXSsLQKIA" decimals="INF" format="ixt-sec:numwordsen" name="miro:NumberOfCustomers" scale="0" id="Narr_V0a4cmuh_06Cjs9CgTlK8g"><ix:nonFraction unitRef="Unit_Standard_customer_oBpQWOLWXkK3Il-nSeGoKQ" contextRef="Duration_1_1_2020_To_9_30_2020_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_vwuQIzABmEWaeqLv7nnUlg" decimals="INF" format="ixt-sec:numwordsen" name="miro:NumberOfCustomers" scale="0" id="Narr_evJubFEka021ug_LuzSspA"><ix:nonFraction unitRef="Unit_Standard_customer_oBpQWOLWXkK3Il-nSeGoKQ" contextRef="Duration_7_1_2020_To_9_30_2020_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_1uLdZHYzVEqRW879bg0kPQ" decimals="INF" format="ixt-sec:numwordsen" name="miro:NumberOfCustomers" scale="0" id="Narr_u7I2JPprQUShQPmbkhUMlw">one</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> customer that accounted for <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="Duration_1_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_tRMEi9tWY0-0d3TnCQQhlg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_X71UYQcUDUO9URcMMbcnlw"><ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="Duration_7_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_q7UZpcFoxEOYivXSsLQKIA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_jZF9SRzBpUy1CNiosk6soQ"><ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="Duration_1_1_2020_To_9_30_2020_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_vwuQIzABmEWaeqLv7nnUlg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_cZWKQBX150q3RBJMiiOSRg"><ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="Duration_7_1_2020_To_9_30_2020_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_1uLdZHYzVEqRW879bg0kPQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_D0FoBHViV0W2TbVtj92FpA">100</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% of total revenue for the three&#160;and nine months ended September 30, 2021 and 2020. The current receivable for this customer is included in Receivable From Reprise Biomedical,&#160;Inc. The long-term receivable related to minimum royalties from this customer has been completely reserved against due to uncertainty regarding collectability.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Tb_nquln7adJkWfiddWnUp8jA" continuedAt="Tb_nquln7adJkWfiddWnUp8jA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;11&#160;&#8212; COMMITMENTS AND CONTINGENCIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Patent License Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Under an Exclusive Patent License Agreement between the Company and the University (the &#8220;Agreement&#8221;) the Company is required to make minimum royalty payments to the University of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_srt_CounterpartyNameAxis_miro_UniversityOfMinnesotaMember_us-gaap_TypeOfArrangementAxis_miro_PatentLicenseAgreementMember_jedF-oqTMEuu3qGVMv8CqQ" decimals="0" format="ixt:numdotdecimal" name="miro:MinimumRoyaltyPayable" scale="0" id="Narr_GYMPJXaydkeWftGjZVaMPw">500,000</ix:nonFraction> per&#160;year. Under the Patent and Know-How License Agreement with Reprise, Reprise has minimum royalty obligations to the Company of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_gQqNjbZf3kitvnDKHNvcqQ" decimals="0" format="ixt:numdotdecimal" name="miro:MinimumRoyaltyReceivable" scale="0" id="Narr_Y97ji8VVrUW9IL-kSc0F1g">500,000</ix:nonFraction> per&#160;year. (See Note&#160;12.)</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_qYlmm4pEA0WG0heJSNwsXw_1_3"></a><a id="Tc_mZqtKzCQOU-aNeuckzp2Jw_2_0"></a><a id="Tc_Bfz3-0daYkGpzNScnNogvg_2_2"></a><a id="Tc_pRITjYb4ykGvVy3PPa_peQ_3_0"></a><a id="Tc_Ig0a55sjek6U1TH8K75seA_3_2"></a><ix:continuation id="Tb_nquln7adJkWfiddWnUp8jA_cont1" continuedAt="Tb_nquln7adJkWfiddWnUp8jA_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Leases</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In February&#160;2015, the Company executed a lease for a facility in Eden Prairie, Minnesota. The Company had leased this facility through March&#160;31, 2020 at a rate of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_2_1_2015_To_2_28_2015_srt_StatementScenarioAxis_miro_Period1Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_P0y2up9X2E6mBHwqP3Cl8A" decimals="0" format="ixt:numdotdecimal" name="miro:MonthlyLeaseRentPayments" scale="0" id="Narr_7JrU9Qn24keTeItG83AQ6Q">13,100</ix:nonFraction> per&#160;month with&#160;yearly rent increases of approximately <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_2_28_2015_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_Cl7f8VTFAUeR61K3rR-tWg" decimals="INF" format="ixt:numdotdecimal" name="miro:IncreaseInYearlyRentPercentage" scale="0" id="Narr_VE9cNAlboU-22XFs2rOEZw">3</ix:nonFraction>% per&#160;year. In November&#160;2019, the lease for the facility was extended to December&#160;31, 2020 at a rate of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_11_1_2019_To_11_30_2019_srt_StatementScenarioAxis_miro_Period2Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_A300O00RHU28LyFbFXEpQw" decimals="0" format="ixt:numdotdecimal" name="miro:MonthlyLeaseRentPayments" scale="0" id="Narr_hNH2ywTzJ0ukYGQrn8n98A">15,100</ix:nonFraction> per&#160;month starting April&#160;1, 2020. In August&#160;2020, the lease for this facility was extended to December&#160;31, 2021 at a rate of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_srt_StatementScenarioAxis_miro_Period3Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_rhWhUWLpAkCFncruQK6Agg" decimals="0" format="ixt:numdotdecimal" name="miro:MonthlyLeaseRentPayments" scale="0" id="Narr_cf3kNIDM3UKXoDwU6BVyow">16,600</ix:nonFraction> per&#160;month starting in January&#160;2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2020, the Company executed a lease for a second facility in the same Eden Prairie, Minnesota office park as its other facility. The Company leased this space through December&#160;31, 2020 at a rate of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_5_1_2020_To_5_31_2020_srt_StatementScenarioAxis_miro_Period2Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_SecondFacilityEdenPrairieMember_XQsUNAY8E0CKMy7vg7p45g" decimals="0" format="ixt:numdotdecimal" name="miro:MonthlyLeaseRentPayments" scale="0" id="Narr_HH2QcrpNB0ylSUj7IKupfQ">2,500</ix:nonFraction> per&#160;month starting in May&#160;2020. In August&#160;2020, the lease for this facility was extended to December&#160;31, 2021 at a rate of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_srt_StatementScenarioAxis_miro_Period3Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_SecondFacilityEdenPrairieMember_xF6oO6QCv0CweJW-fgnyeA" decimals="0" format="ixt:numdotdecimal" name="miro:MonthlyLeaseRentPayments" scale="0" id="Narr_Vvs_txhNiEmD389SRsFSJw">3,400</ix:nonFraction> per&#160;month starting in January&#160;2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Total rent expense under operating leases was $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="0" id="Narr_1F2iUc26D0CIG-I6daJLHg">60,096</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="0" id="Narr_EOsBjQSEcEyHw6svBNy8mw">52,865</ix:nonFraction> for the three&#160;months ended September 30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="0" id="Narr_w_pSl8GLpUSklT6SWem88w">183,389</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="0" id="Narr_99yU7LsliU2_4v8b30L89g">148,425</ix:nonFraction> for the nine&#160;months ended September 30, 2021 and 2020, respectively. The Company has future minimum non-cancelable lease commitments as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="Tb_bKEj-TTqEUKBK7qba8PvwA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">At September&#160;30,&#160;2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">2021</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" scale="0" id="Tc_sEYATzzLKUOcdxnxBvEJtQ_2_3">60,096</ix:nonFraction></span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Total</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> <ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" scale="0" id="Tc_rFpZ8lU67U2hfLpW0SEFEQ_3_3">60,096</ix:nonFraction></span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On August 2, 2021, the Company entered into a Multi-Tenant Industrial Triple Net Lease (the &#8220;Lease&#8221;) with B9 Polar Prairie Oaks Corporate LLC, a Delaware limited liability company (the &#8220;Landlord&#8221;), for research and development and office space located at 6455 Flying Cloud Drive, Eden Prairie, Minnesota 55344 (the &#8220;Building&#8221;). Under the terms of the Lease, starting on December 31, 2021 (the &#8220;Commencement Date&#8221;) the Company will lease approximately <ix:nonFraction unitRef="Unit_Standard_sqft_TVbtuT9o3UCYFiZW5wDD2w" contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AreaOfRealEstateProperty" scale="0" id="Narr_zaFE1ywOCku17EQNMWdsgA">42,278</ix:nonFraction> square feet of the Building (the &#8220;Premises&#8221;) as the sole tenant at the Premises, which will replace the Company&#8217;s current leased premises at 10399 West 70<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street, Eden Prairie, Minnesota 55344. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The base rent under the Lease is $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_8_2_2021_To_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_FAYf9bRq1UeMVt01TiNLBA" decimals="0" format="ixt:numdotdecimal" name="miro:MonthlyLeaseRentPayments" scale="0" id="Narr_epTmZ87lukim7muN3U6h9Q">41,397</ix:nonFraction> per month for the <span style="-sec-ix-hidden:Hidden_Hm1nq61nbUCGgQMTKFG8ew;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;white-space:pre-wrap;">12-month</span></span><span style="white-space:pre-wrap;"> period beginning on the Commencement Date and ending on December 31, 2022, and thereafter is subject to scheduled annual increases of approximately <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA" decimals="2" format="ixt:numdotdecimal" name="miro:LesseeOperatingLeaseAnnualBaseRateIncreasePercentage" scale="-2" id="Narr_m1CXY_y3IU6FWfJzY5ftig">3</ix:nonFraction>% during the term of the Lease. However, under the terms of the Lease, the Company&#8217;s monthly base rent will be abated for the period beginning on the Commencement Date and ending on May 31, 2022, provided the Lease is not terminated due to default. In addition to base rent, the Company is obligated under the Lease to pay to the Landlord certain costs, operating expenses and taxes, including approximately <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA" decimals="4" format="ixt:numdotdecimal" name="miro:LesseeOperatingLeaseRealPropertyTaxesPercentage" scale="-2" id="Narr_vt_kFjgW0Eu7cwbwdMKS5A">61.08</ix:nonFraction>% of the real property taxes of the Building and the land on which it is located and approximately <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA" decimals="4" format="ixt:numdotdecimal" name="miro:LesseeOperatingLeaseManagementFeePercentage" scale="-2" id="Narr_BdqTjzjHFUeNxf84ybHIpg">61.08</ix:nonFraction>% of the Landlord&#8217;s management fee, which equals an amount of up to <ix:nonFraction unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q" contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA" decimals="2" format="ixt:numdotdecimal" name="miro:LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts" scale="-2" id="Narr_e1zdEnLhsUm2eo152TyHlQ">5</ix:nonFraction>% of the Landlord&#8217;s gross receipts from leases at the Building. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The term of the Lease begins on the Commencement Date and ends on May 31, 2029. The Company has <ix:nonFraction unitRef="Unit_Standard_item_dMkQsh8WpkaQAEVQgwXZFA" contextRef="Duration_8_2_2021_To_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_FAYf9bRq1UeMVt01TiNLBA" decimals="INF" format="ixt-sec:numwordsen" name="miro:OperatingLeaseNumberOfOptionsToExtend" scale="0" id="Narr_HU6FpcO_X0KVZB67NnT1wQ">one</ix:nonFraction> option to extend the term for a period of <ix:nonNumeric contextRef="Duration_8_2_2021_To_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_FAYf9bRq1UeMVt01TiNLBA" format="ixt-sec:durwordsen" name="miro:LesseeOperatingLeaseOptionToExtendTermOfContract" id="Narr_4VuSYZcQTE6GTv9CW_6QrQ"><span style="white-space:pre-wrap;">five years</span></ix:nonNumeric><span style="white-space:pre-wrap;"> beginning on June 1, 2029.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">The Company plans to deliver a security deposit to the Landlord through an irrevocable, standby letter of credit (&#8220;LOC&#8221;) issued by Park State Bank in the amount of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DepositAssets" scale="0" id="Narr_aczIJgSnFkui3taEZL1xTA">800,000</ix:nonFraction> (&#8220;Security Amount&#8221;), which will be retained by the Landlord as security for the Company&#8217;s performance and observance of its obligations under the Lease. To secure the LOC, the Company will be required to place the Security Amount in a restricted cash account at Park State Bank, which may be drawn from in limited circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">License Contract</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;">On December&#160;1, 2014, the Company entered into a research and development contract with an outside developer. The term of the contract was set to expire on December&#160;31, 2016, but in September&#160;2016 the expiration date was extended to December&#160;31, 2017; in January&#160;2018 the expiration date was extended to June&#160;30, 2019; in May&#160;2019 the expiration date was extended to March&#160;30, 2020; in February&#160;2020 the expiration date was extended to February&#160;28, 2021. In February&#160;2021 the contract was extended to December&#160;31, 2021. As partial consideration for the developer&#8217;s </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">20</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_nquln7adJkWfiddWnUp8jA_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">services, on January&#160;1, 2015, the Company issued <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2015_To_1_1_2015_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_us-gaap_TypeOfArrangementAxis_miro_ResearchAndDevelopmentContractMember_6E_wdZQoSUqyfCptlYZBkg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="0" id="Narr_cyZPcs0pJkipKyJ6Iv-Nvg">26,667</ix:nonFraction> shares of Series&#160;B preferred stock at a fair value of $<ix:nonFraction unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug" contextRef="As_Of_1_1_2015_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_us-gaap_TypeOfArrangementAxis_miro_ResearchAndDevelopmentContractMember_Y_meruMSPEO7A3bUcsxnaA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharePrice" scale="0" id="Narr_TthDp-mQWkuw3qouehlLnQ">7.50</ix:nonFraction> per share. The value of these shares was charged to research&#160;&amp; development expenses in the statements of operations.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="Tb_jKKVP3FFsEWVoTejXMBIEQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;12&#160;&#8212; RELATED PARTY TRANSACTIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">A corporation owned by a former director of the Company that resigned as a director in June 2021 received payments for providing a consultant to the Company of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_qnWtgiTGikOSXP25mjvZYA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="Narr_bsNstKCsskuzmjQJj2GA1g">1,141</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_XueQO35tzkidWpI2arMRfw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="Narr_bA-ka9-V_Eu72mQCWHBtVA">1,579</ix:nonFraction> for the three&#160;months ended September 30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_9WxjyLUpOUiRks_Oq_p5vw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="Narr_hp6rhxD3kUyUTAkKM7hlmA">4,992</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_6W4hac0WQU-mcQ8HdTtbAQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="Narr_S5_MyzqM5E-gxVeL_OgzRQ">4,626</ix:nonFraction> for the nine&#160;months ended September 30, 2021 and 2020, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company received $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_BOZzIx3NHUyi4rOJ8vvwWg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="0" id="Narr_7kd8JyFGzE6PwFPC6SLgtQ">9,819</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_vmM7oFOzwUe43nHIwqu2bA" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="0" id="Narr_akzDJn_KoUmPVOq3PJ9w9w">10,846</ix:nonFraction> for the three&#160;months ended September 30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_GGnger605kSAQV-cbnUI1Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="0" id="Narr_JCMOnNUXVECmgwPt5eYKJA">25,066</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_cVjMYLi1J0iHUg_2B18WtQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="0" id="Narr_ww-pIQ4lQ0SzjJ6EB1VXBQ">31,328</ix:nonFraction> for the nine&#160;months ended September 30, 2021 and 2020, respectively, as royalty related to the spin-out of the Acellular Business to Reprise. As of September 30, 2021 and 2020 the Company had long term receivables of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_gQqNjbZf3kitvnDKHNvcqQ" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableRelatedPartiesNoncurrent" scale="0" id="Narr_nWM9G7QADEi6-EmnSK8Keg">803,404</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_saJtd_zSdkCdwSY-MhYn9A" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableRelatedPartiesNoncurrent" scale="0" id="Narr_vrbt-25dF02RPrqGWePw9g">343,672</ix:nonFraction>, respectively, but due to the uncertainty regarding collectability the Company fully <span style="-sec-ix-hidden:Hidden_2po9q6YWxEaI543p-8A5uQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">reserved</span></span> against the <span style="-sec-ix-hidden:Hidden_Q7GTX4o5nEWWyrC9lnCvQw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">receivables</span></span>. The Company recorded a long-term receivable of $<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_12_31_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_cRCCz2S2j0Sk68z8xyXCTg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableRelatedPartiesNoncurrent" scale="0" id="Narr_tHmdAWXBwkiB7ubHiKRymQ">453,470</ix:nonFraction> related to the minimum royalty due from Reprise for the&#160;year ended December&#160;31, 2020, but due to the uncertainty regarding collectability the Company fully <span style="-sec-ix-hidden:Hidden_V19YDa0XdUuAk6nk7v2a7g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">reserved</span></span> against the receivable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><a id="Tc_-mZaqhsXNEWeaVBY5My0Bw_1_2"></a><a id="Tc_nBnTLOGCZkmmzBA4KT1CHw_1_6"></a><a id="Tc_OASIlNABJ0CptSOIZj_zhw_2_2"></a><a id="Tc_fC8QfBT2U0OM7NAD8RGnyA_2_4"></a><a id="Tc_3fiZ4goqEk2klkqfijBc4Q_2_6"></a><a id="Tc_Zt7qmPM0UEi596IsKOmyIw_2_8"></a><a id="Tc_kPJw9A8i9EuF47ARcW8ojQ_3_2"></a><a id="Tc_8bZ4c7kH3EWBu4Z5brxXjA_3_4"></a><a id="Tc_stSZ7pMtJEW85RuFoWq2Og_3_6"></a><a id="Tc_FwlpRKdFAEO09dyw7xrLtw_3_8"></a><a id="Tc_hVzdJumVEEmoNPE6kc_-GA_4_0"></a><a id="Tc_-I5FWAmCs0Wjdi4po6r1Dw_4_2"></a><a id="Tc_ArokCTWYxU6Fr85ME01eVA_4_6"></a><a id="Tc_FCpDsLiZXEW1typh14x-vw_5_0"></a><a id="Tc_UC6JygnQYke0O2CxNIOp2w_5_2"></a><a id="Tc_MnLfRXfqvUie2LAViW_5XQ_5_4"></a><a id="Tc_g1Mir7_yeEi0xNndjowQrg_5_6"></a><a id="Tc_2wIzU-aU5EqEplQ4vU8Pzw_6_0"></a><a id="Tc_M1kKe90AckWNLsTTVa-d9A_7_0"></a><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:EarningsPerShareTextBlock" id="Tb_bz2ELx46a0yaZTkrTnBJGg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;13&#160;&#8212; NET LOSS PER SHARE</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Under the two-class method, for periods with net income, basic net income per common share is computed by dividing the net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Net income attributable to common stockholders is computed by subtracting from net income the portion of current&#160;year earnings that participating securities would have been entitled to receive pursuant to their dividend rights had all of the&#160;year&#8217;s earnings been distributed. No such adjustment to earnings is made during periods with a net loss as the holders of the participating securities have no obligation to fund losses. Diluted net loss per common share is computed under the two-class method by using the weighted average number of shares of common stock outstanding plus, for periods with net income attributable to common stockholders, the potential dilutive effects of stock options and warrants. In addition, the Company analyzes the potential dilutive effect of the outstanding participating securities under the if-converted method when calculating diluted earnings per share in which it is assumed that the outstanding participating securities convert into common stock at the beginning of the period. The Company reports the more dilutive of the approaches (two-class or if-converted) as its diluted net income per share during the period. Due to the existence of net losses for the three and nine&#160;months ended September 30, 2021 and 2020, basic and diluted loss per share were the same, as the effect of potentially dilutive securities would have been anti-dilutive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The following potentially dilutive securities outstanding have been excluded from the computations of diluted weighted average shares outstanding because such securities have an antidilutive impact due to losses reported:</p><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="Tb_H96j84GCiUumc-W9uAXBEQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:middle;white-space:nowrap;width:25.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Three Months Ended September&#160;30,&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:middle;white-space:nowrap;width:25.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Nine Months Ended September&#160;30,&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible preferred stock outstanding </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertiblePreferredStockMember_G2AenK_gbk-ZZfv0d9YO_A" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_QJVMrchetEemth1IumZ9Pg_4_4">8,314,536</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertiblePreferredStockMember_Gh_jQ_Q0W02MUqDL5oQyCw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_F3w0OqsNwUOJah6DrlKzjQ_4_8">8,314,536</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible preferred stock warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_ConvertiblePreferredStockWarrantsMember_nZXuGpmc3kOiTFiqFvQENQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_c5SKp0P-yE2LP72aMw415Q_5_8">40,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Common stock options outstanding</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_1Bh3g4CG70OKdz3TgSxqQg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_SUGeQOvQh0aOBV0nIAB1KQ_6_2">3,464,805</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_GmTrWD189EWwo_du3vbdCQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_WPCCo_LkjUy-6YRXDCgA6A_6_4">3,907,163</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_nC9T8Rfgokqilo8qcuIGWw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_9phku3lbkEijL3Q4lPF7wg_6_6">3,464,805</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_idwa40aKQUC_0HjRs6iVKQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_IWKrvlK_ck-AEX3Yh56Axg_6_8">3,907,163</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Common stock warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_hUvKTTEpGkeeRuM5ul5Jjg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_k8EKwwf8zUGYx_e6kCw7gQ_7_2">950,879</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_ByAiKa5lkUuPyzg8VR9VHQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_E4dD1Fn0CEOynD5mjwVYTw_7_4">707,669</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_YiQ5qq1-cUeG-3Hyz5MNuw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_6-XvrEn9WE62FiJolSkl5g_7_6">950,879</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_Jdt9LOisJEWDjroNeaE7OA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_Vydo2rnz_0Si6GBL7FpKSQ_7_8">707,669</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_sbB3iGZsNkGiQf1zR-4JQA_8_2">4,415,684</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_ANVeV8b_3ka9-QzzyL0_zA_8_4">12,929,368</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_Jxls6xCYN0iwtysjQQbPXQ_8_6">4,415,684</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg" contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="Tc_YwYAsLog0EyeZKCApOSymA_8_8">12,969,368</ix:nonFraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">21</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw" name="us-gaap:SubsequentEventsTextBlock" id="Tb_VRepn3R-MUmIL0GBm7wV5Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 9pt 0pt;">NOTE&#160;14&#160;&#8212; SUBSEQUENT EVENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 9pt 0pt;"><span style="font-weight:normal;text-decoration:none;">In October 2021, the Company and Mayo Foundation for Medical Education and Research executed a ninth amendment to their agreement whereby the term was extended to March 31, 2022 and the Company agreed to provide </span><span style="font-weight:normal;text-decoration:none;">$<ix:nonFraction unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA" contextRef="As_Of_10_31_2021_srt_CounterpartyNameAxis_miro_UniversityOfMinnesotaMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_us-gaap_NoncollaborativeArrangementTransactionsMember_3MpIEZ7k8UW2x-fwsNXB8Q" decimals="0" format="ixt:numdotdecimal" name="miro:AdditionalFundingToBeProvided" scale="0" id="Narr_IdefF9yXnkWd2v0D8hEEMw">279,500</ix:nonFraction></span><span style="font-weight:normal;text-decoration:none;"> of additional funding.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">22</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_7e375748_6290_4195_a36d_9bb561c8a75b"></a><a id="Item2ManagementsDiscussionandAnalysisofF"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">References in this report (the &#8220;Quarterly Report&#8221;) to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; or the &#8220;Company&#8221; refer to Miromatrix Medical Inc. The following discussion and analysis of the Company&#8217;s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Special Note Regarding Forward-Looking Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This Quarterly Report includes &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; the Company&#8217;s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;seek&#8221; and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management&#8217;s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company&#8217;s Registration Statement on Form S-1 (File No. 333-256649), as amended, filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;). The Company&#8217;s securities filings can be accessed on the EDGAR section of the SEC&#8217;s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">We are a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients&#8217; lives. Organ disease is a major public health issue. According to the American Transplant Foundation, there are an estimated 114,000 people in the U.S. waiting for a lifesaving organ transplant, and on average 20 people die daily due to lack of available organs. We have developed a proprietary perfusion technology platform for bioengineering organs that we believe will efficiently scale to address the shortage of available human organs. Our initial development focus is on human livers and kidneys, and we have demonstrated the ability to bioengineer these organs with functional vasculature and important organ function in preclinical studies. In addition, we believe our technology platform will be able to develop other organs, including lungs, pancreases, and hearts. We have collaborations with the Mayo Clinic, Mount Sinai and the Texas Heart Institute, and our strategic investors include DaVita, Baxter and CareDx.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Substantially all of our revenue to date has been generated by royalties we received from the sale of our biologic surgical products Miromesh and Miroderm which we spun out as Reprise Biomedical, Inc. (&#8220;Reprise&#8221;) effective June&#160;30, 2019. We subsequently divested our minority ownership stake in Reprise in March&#160;2021. We continue to receive a royalty on the sales of these products by Reprise. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Our revenue for the three months ended September 30, 2021 and 2020 was $10,000 and $11,000, respectively, consisting entirely of licensing revenue. Our revenue for the nine months ended September 30, 2021 and 2020 was $25,000 and $31,000, respectively, consisting entirely of licensing revenue. Our net loss for the&#160;three months ended September 30, 2021 and 2020 was $5.1 million and $3.0 million, respectively. Our net loss for the&#160;nine months ended September 30, 2021 and 2020 was $9.2 million and $9.2 million, respectively. We have not been profitable since inception and as of September&#160;30, 2021, we had an accumulated deficit of $68.6 million.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">21</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Components of Our Results of Operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Revenue</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">For the periods presented, all of our revenue consists of licensing revenue pursuant to a license agreement with Reprise. Revenue pursuant to this agreement is recognized at the later of (i)&#160;when the related sales occur after the minimum guarantee is satisfied, or (ii)&#160;when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cost of Goods Sold</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Cost of goods sold for continuing operations relates to our license agreement with the University of Minnesota (the &#8220;University&#8221;), pursuant to which we owe the University royalties on our revenues, which are subject to annual minimum payments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Gross Margin</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our gross margin is calculated by subtracting our cost of goods sold from our revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Research and Development Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Research and development expenses consist primarily of engineering, product development, consulting services, materials, depreciation and other costs associated with products and technologies in development. These expenses include payroll and related expenses, consulting expenses, laboratory supplies, and amounts incurred under certain collaborative agreements. Expenditures for research and development activities are charged to operations as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">We expect research and development expenses in absolute dollars to increase in the future as we develop our lead product candidates and expand into other programs. We expect research and development expenses as a&#160;percentage of revenue to vary over time depending on the level and timing of new product development initiatives.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Regulatory and Clinical Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Regulatory and clinical expenses include costs for developing our regulatory and clinical study strategies for our products. These expenses include payroll and related expenses and consulting expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Over time we expect our regulatory and clinical expenses to increase in absolute dollars as we continue to expand our product offerings and move through various regulatory processes. We expect our regulatory and clinical expenses to decrease as a&#160;percentage of revenue primarily as, and to the extent, our revenue grows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Quality Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Quality expenses relate to costs of systems and procedures to develop a manufacturing facility that is compliant with Current Good Manufacturing Practices. These expenses include payroll and related expenses. We expect our quality expenses to increase in future&#160;years as we continue to develop the process and systems need to produce our products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">General and Administrative Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">General and administrative expenses include costs for our executive, accounting, and human resources functions. Costs consist primarily of payroll and related expenses, professional service fees related to accounting, legal, and other contract and administrative services and related infrastructure expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;">We expect that our general and administrative expenses will increase in absolute dollars as we expand our headcount to support our growth and incur additional expenses related to operating as a public company, including director and officer insurance coverage, legal costs, accounting costs, costs related to exchange listing and costs related </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">22</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">to SEC compliance and investor relations. We expect our general and administrative expenses to decrease as a&#160;percentage of revenue primarily as, and to the extent, we generate revenue and our revenue grows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Interest Income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Interest income consists of interest earned on our cash and cash equivalents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Interest Expense</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Interest expense consists of interest under our loan agreements. See &#8220;&#8212; Liquidity and Capital Resources.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Results of Operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Comparison of the Three&#160;and Nine Months Ended September 30, 2021 and 2020</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="5" style="vertical-align:middle;white-space:nowrap;width:14.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:middle;white-space:nowrap;width:14.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Nine Months Ended </b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:14.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Change</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:14.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Change</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Dollar</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Percentage</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Dollar</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Percentage</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">(unaudited)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">(unaudited)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">(unaudited)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">(unaudited)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">(unaudited)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">(unaudited)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">(unaudited)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">(unaudited)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in thousands) Statement of Operations:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Licensing revenue</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 10</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (9.1)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 25</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 31</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (6)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (19.4)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Cost of goods sold </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 125</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 125</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 375</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 375</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 12pt;">Gross margin </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (115)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (114)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 0.9</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (350)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (344)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (6)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.7</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Operating expenses:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 6pt;">Research and development </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,350</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,870</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,480</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 79.1</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,699</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5,750</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,949</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 33.9</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 6pt;">Regulatory and clinical </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 105</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 64</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 41</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 64.1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 292</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 208</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 84</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 40.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 6pt;">Quality </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 151</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 76</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 75</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 98.7</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 323</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 76</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 247</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 325.0</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 6pt;">General and administrative </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,488</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 460</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,028</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 223.5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,837</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,531</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,306</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 85.3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 12pt;">Total operating expenses </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5,094</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,470</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,624</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 106.2</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,151</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,565</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,586</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 47.4</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 12pt;">Operating loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (5,209)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2,584)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2,625)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 101.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (11,501)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (7,909)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3,592)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 45.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Other income (expense):</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 6pt;">Interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (8)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (88.9)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (15)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (209)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 194</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (92.8)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (601)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (364)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (237)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 65.1</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 6pt;">Amortization of discount on note </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (32)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 32</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (100.0)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (63)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (76)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 13</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (17.1)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 6pt;">Change in fair value of derivative </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 247</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 247</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 6pt;">Research grants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 115</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 328</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (213)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (64.9)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 393</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 794</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (401)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (50.5)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Equity loss in affiliate </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (495)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 495</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (100.0)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (224)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1,676)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,452</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (86.6)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Gain on sale of equity investment </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,984</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,984</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Gain on debt extinguishment</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 50</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 50</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 569</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 569</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Net loss </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (5,058)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2,992)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2,066)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 69.1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (9,195)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (9,222)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 27</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (0.3)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Revenue</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Licensing revenue was $11,000 for the three&#160;months ended September 30, 2020 and $10,000 the three&#160;months ended September 30, 2021. The licensing revenue is a result of the licensing agreement with Reprise. The minimum royalties due from Reprise for 2020 and 2021 have been deferred to 2022 and 2023, respectively. Due to the uncertainty regarding the collectability of these minimum royalties from Reprise, the Company has set up an allowance to offset the receivable amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Licensing revenue decreased by $6,000, or 19.4%, from $31,000 for the nine&#160;months ended September 30, 2020, to $25,000 for the nine&#160;months ended September 30, 2021. The decrease in licensing revenue was due to lower royalties on the licensing agreement with Reprise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cost of Goods Sold</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Cost of goods sold was $125,000 for the three months ended September 30, 2020 and 2021 and was $375,000 for the nine months ended September 30, 2020 and 2021. Cost of goods sold relates to the minimum royalty due to the University under our licensing agreement.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">23</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Gross Margin</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Gross margin was $(114,000) for the three&#160;months ended September 30, 2020 and was $(115,000) for the three&#160;months ended September 30, 2021. The gross margin was negative for the three&#160;months ended September 30, 2021 and 2020 due to the uncertainty of collecting the deferred minimum royalty from Reprise which was fully reserved against.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Gross margin decreased by $6,000 from $(344,000) for the nine&#160;months ended September 30, 2020, to $(350,000) for the nine&#160;months ended September 30, 2021. The gross margin was negative for the nine&#160;months ended September 30, 2021 and 2020 due to the uncertainty of collecting the deferred minimum royalty from Reprise which was fully reserved against.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Research and Development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Research and development expenses increased by $1,480,000, or 79.1%, from $1,870,000 for the three&#160;months ended September 30, 2020, to $3,350,000 for the three&#160;months ended September 30, 2021. The increase in research and development expenses was primarily due to increases in employee costs and lab supplies partially offset by a decrease in contract pre-clinical costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Research and development expenses increased by $1,949,000, or 33.9%, from $5,750,000 for the nine&#160;months ended September 30, 2020, to $7,699,000 for the nine&#160;months ended September 30, 2021. The increase in research and development expenses was primarily due to increases in employee costs and lab supplies partially offset by a decrease in contract pre-clinical costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Regulatory and Clinical</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Regulatory and clinical expenses increased by $41,000, or 64.1%, from $64,000 for the three&#160;months ended September 30, 2020, to $105,000 for the three&#160;months ended September 30, 2021<b style="font-weight:bold;">. </b>The increase in regulatory and clinical expenses was primarily due to increases in employee costs as well as regulatory consulting expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Regulatory and clinical expenses increased by $84,000, or 40.4%, from $208,000 for the nine&#160;months ended September 30, 2020, to $292,000 for the nine&#160;months ended September 30, 2021. The increase in regulatory and clinical expenses was primarily due to increases in employee costs and regulatory consulting costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Quality Expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Quality expenses increased by $75,000, or 98.7%, from $76,000 for the three months ended September 30, 2020, to $151,000 for the three&#160;months ended September 30, 2021. The increase in quality expenses in the current period was due to increased headcount in the quality department in 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Quality expenses increased by $247,000, or 325.0%, from $76,000 for the nine months ended September 30, 2020, to $323,000 for the nine months ended September 30, 2021. The increase was primarily due to the Company having a Vice President of Quality for the entire nine months of 2021 as well as additional headcount in the nine months ended September 30, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">General and Administrative</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">General and administrative expenses increased by $1,028,000, or 223.5%, from $460,000 for the three&#160;months ended September 30, 2020, to $1,488,000 for the three&#160;months ended September 30, 2021. The increase in general and administrative expenses was primarily due to increases in employee costs, legal and accounting expenses, consulting expenses, board compensation expense, and insurance expenses. These increases can primarily be attributed to the cost of being a public company.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">24</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">General and administrative expenses increased by $1,306,000, or 85.3%, from $1,531,000 for the nine&#160;months ended September 30, 2020, to $2,837,000 for the nine&#160;months ended September 30, 2021. The increase in general and administrative expenses was primarily due to increases in employee costs, legal and accounting expenses, consulting expenses, board compensation expense, and insurance expenses. These increases can primarily be attributed to the cost of being a public company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Interest Income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Interest income increased by $1,000, or 100.0%, from an immaterial amount of $0 for the three&#160;months ended September 30, 2020, to $1,000 for the three&#160;months ended September 30, 2021. The increase in interest income was due to larger cash balances in 2021 as compared with 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Interest income decreased by $8,000, or 88.9%, from $9,000 for the nine&#160;months ended September 30, 2020, to $1,000 for the nine&#160;months ended September 30, 2021. The decrease in interest income was due to lower interest rates on cash balances in 2021 as compared with 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Interest Expense</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Interest expense decreased by $194,000, or 92.8%, from $209,000 for the three&#160;months ended September 30, 2020, to $15,000 for the three&#160;months ended September 30, 2021. The decrease was primarily the result of interest expense on the Cheshire Note (as defined below) being lower in 2021 as compared to 2020 as the note was converted to equity in June 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Interest expense increased by $237,000, or 65.1%, from $364,000 for the nine&#160;months ended September 30, 2020, to $601,000 for the nine&#160;months ended September 30, 2021. The increase was primarily the result of interest expense on the Cheshire Note.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Amortization of Discount on Note</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Amortization expense related to the Cheshire Note decreased by $32,000, or 100.0%, from $32,000 for the three&#160;months ended September 30, 2020, to none for the three&#160;months ended September 30, 2021. The decrease in amortization expense was due to the note being converted to equity in June 2021 and therefore there was less amortization expense related to the note in 2021 as compared to 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Amortization expense related to the Cheshire Note decreased by $13,000, or 17.1%, from $76,000 for the nine&#160;months ended September 30, 2020, to $63,000 for the nine&#160;months ended September 30, 2021. The decrease in amortization expense was due to the note being converted to equity in June 2021 and therefore there was less amortization expense related to the note in 2021 as compared to 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Change in Fair Value of Derivative</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The change in fair value of the embedded derivative related to the Cheshire Note decreased by $247,000 from none for the nine&#160;months ended September 30, 2020, to $247,000 for the nine&#160;months ended September 30, 2021. The decrease in the change in fair value of the embedded derivative was due to the Cheshire Note being converted to equity in June 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Research Grants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Research grants decreased by $213,000, or 64.9%, from $328,000 for the three&#160;months ended September 30, 2020, to $115,000 for the three&#160;months ended September 30, 2021. The decrease in research grants was primarily due to a decrease in the expenditures for pre-clinical contracting, resulting in lower grant funds, during the three&#160;months ended September 30, 2021 as compared to the three&#160;months ended September 30, 2020.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">25</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Research grants decreased by $401,000, or 50.5%, from $794,000 for the nine&#160;months ended September 30, 2020, to $393,000 for the nine&#160;months ended September 30, 2021. The decrease in research grants was primarily due to a decrease in the expenditures for pre-clinical contracting, resulting in lower grant funds, during the nine&#160;months ended September 30, 2021 as compared to the nine&#160;months ended September 30, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Equity Loss in Affiliate</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Equity loss in affiliate decreased by $495,000, or 100.0%, from $495,000 for the three&#160;months ended September 30, 2020, to none for the three&#160;months ended September 30, 2021. The decrease in equity loss in affiliate was due to the Company selling all of its ownership in Reprise on March&#160;15, 2021 and therefore not recording any loss for the three months ending September 30, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Equity loss in affiliate decreased by $1,452,000, or 86.6%, from $1,676,000 for the nine&#160;months ended September 30, 2020, to $224,000 for the nine&#160;months ended September 30, 2021. The decrease in equity loss in affiliate was due to the Company owning a smaller&#160;percentage of Reprise in the nine&#160;months ended September 30, 2021 as compared to the comparable period in the prior&#160;year as well as the Company selling all of its ownership in Reprise on March&#160;15, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Gain on Debt Extinguishment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">During the three&#160;months ended September 30, 2021 the Company had a gain on the extinguishment of debt of $50,000 related to the forgiveness of our loan under the Small Business Administration&#8217;s Paycheck Protection Program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">During the nine&#160;months ended September 30, 2021 the Company had a gain on the extinguishment of debt of $569,000 related to the forgiveness of our loan under the Small Business Administration&#8217;s Paycheck Protection Program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Gain on Sale of Equity Investment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">For the nine&#160;months ended September 30, 2021, we recognized a gain of $2.0 million related to the sale of 1.8 million shares in Reprise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Liquidity and Capital Resources</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">We have incurred net losses since our inception. For the three&#160;months ended September 30, 2021 and 2020, we incurred net losses of $5,058,000 and $2,993,000, respectively. For the nine months ended September 30, 2021 and 2020, we incurred net losses of $9,195,000 and $9,222,000, respectively. As of September 30, 2021, we had an accumulated deficit of $68.6 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">We expect to incur additional losses in the near future, and we expect our expenses to increase substantially in connection with our ongoing activities, particularly as we continue to develop our bioengineered organs, as we conduct clinical trials and other studies for our bioengineered organs, seek regulatory clearances or approvals for Miroliver and Mirokidney, continue preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights, and to investing in our infrastructure to support our future manufacturing and other activities. In addition, we expect to incur additional costs associated with operating as a public company in the United States. The timing and amount of our operating expenditures will depend largely on our ability to, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#231f20;font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">advance clinical development of our product candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#231f20;font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">manufacture, or have manufactured on our behalf, our preclinical and clinical materials and develop processes for commercial manufacturing of any product candidates that may receive regulatory approval;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#231f20;font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">seek regulatory approvals for any product candidates that successfully complete clinical trials;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">26</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#231f20;font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">establish a sales, marketing, medical affairs and distribution infrastructure to commercialize any product candidates for which we may obtain marketing approval and intend to commercialize on our own;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#231f20;font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">establish collaborations to commercialize any product candidates for which we may obtain marketing approval but do not intend to commercialize on our own;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#231f20;font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">expand our operational, financial and management systems and hire additional personnel, including personnel to support our clinical development, quality control, research and development, manufacturing and commercialization efforts, our general and administrative activities and our operations as a public company; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#231f20;font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">obtain new intellectual property and maintain, expand, and protect our intellectual property portfolio.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">To date, we have primarily financed our operations through equity and debt financings as well as research grants. We believe that our existing cash and cash equivalents will enable us to fund our operating expenses and capital expenditure requirements for at least the next 12 months. As of September 30, 2021, we had cash and cash equivalents of $62.1 million, which includes the net proceeds from our initial public offering (&#8220;IPO&#8221;). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Until such time, if ever, as we can generate substantial revenue from sales of our bioengineered organs, we expect to finance our cash needs through a combination of securities offerings and debt financings. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our shareholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our shareholders. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, or declaring dividends. Additional capital may not be available when needed, on reasonable terms, or at all, and our ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and the recent disruptions to and volatility in the credit and financial markets in the United States and worldwide resulting from the ongoing COVID-19 pandemic. If we are unable to raise additional funds through equity or debt financings or other arrangements when needed, we may be required to delay, curtail or discontinue our product development or future commercialization efforts, or grant rights to develop and market products that we would otherwise prefer to develop and market ourselves.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In January&#160;2012, we signed a promissory note with the University for $405,559. The promissory note bears interest at 3% per annum, compounded&#160;monthly. The note is scheduled to mature on December&#160;31, 2022 and is unsecured. We are required to make&#160;monthly principal and interest payments of $7,737 until the note is paid in full. In connection with the promissory note, we issued the University warrants to purchase 80,000 shares of our common stock at an exercise price of $1.69. As of September 30 2021 and December&#160;31, 2020, the principal outstanding on this loan was $106,320 and $172,731, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2015, we entered into a loan agreement with the Minnesota Department of Employment&#160;&amp; Economic Development under which we borrowed $250,000. The loan is unsecured and does not bear interest. The loan is due in a lump sum payment on April&#160;1, 2022. As of both September 30, 2021 and December&#160;31, 2020, the balance outstanding on this loan was $250,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In October&#160;2018, we entered into a lease agreement for certain lab equipment, which is being accounted for as a capitalized lease. The total cost of the equipment was $102,026. The lease bears interest at 7.2% per annum and we will make 60 monthly payments in total of $2,003 until the lease is paid in full. As of September 30, 2021 and December&#160;31, 2020, the amount outstanding on the lease was $43,113 and $57,127, respectively. The lease is secured by the lab equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In July&#160;2021, the Company signed a lease agreement for a piece of equipment that is being accounted for as a capitalized lease. The total cost of the equipment was $44,251. The lease bears interest at 5.0% and the Company will make 24 monthly payments of $1,941 until the lease is paid in full. As of September 30, 2021, the amount outstanding on the lease was $37,178. The lease is secured by the piece of equipment.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">27</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In September&#160;2021, the Company signed a lease agreement for a piece of equipment that is being accounted for as a capitalized lease. The total cost of the equipment was $43,317. The lease bears interest at 6.8% and the Company will make 36 monthly payments of $1,448 until the lease is paid in full. As of September 30, 2021, the amount outstanding on the lease was $42,319. The lease is secured by the piece of equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In January&#160;2019, we issued the University a promissory note in the amount of $385,997 in satisfaction of our minimum royalty obligation under the license agreement with the University for the&#160;year ended December&#160;31, 2018. The note bears interest at 6% per annum and is due on January&#160;31, 2025. In addition, we issued the University a 10-year warrant to purchase 20,587 shares of our common stock at an exercise price of $3.75 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">On March&#160;6, 2020, we entered into a note and warrant purchase agreement (the &#8220;Cheshire Purchase Agreement&#8221;) with Cheshire MD Holdings, LLC (&#8220;Cheshire&#8221;), an affiliate of DaVita&#160;Inc., under which we received a bridge financing of $6,000,000. In connection with the Cheshire Purchase Agreement, we issued a $6,000,000 convertible promissory note (the &#8220;Cheshire Note&#8221;) to Cheshire and issued Cheshire a warrant to purchase up to $750,000 of shares of our preferred stock. The Cheshire Note&#160;is unsecured and had a maturity date of September&#160;6, 2021. The Cheshire Note&#160;bore interest at 5% per annum through and until May&#160;1, 2020, at which time the interest rate increased to 7%. The interest rate increased by an additional 2% on the first day of each subsequent&#160;month (beginning on June&#160;1, 2020) prior to the maturity date, provided that the interest rate would not exceed 20%. As of December&#160;1, 2020, the interest rate reached the maximum of 20%. Under the Cheshire Purchase Agreement, as long as the Cheshire Note&#160;remains outstanding, the Company is required to issue to Cheshire additional warrants, on the first date of each&#160;month beginning on May&#160;1, 2020, to purchase up to $75,000 of shares of our preferred stock. In June 2021, the Note and all accrued interest was converted into 956,887 shares of the Company&#8217;s Series C Convertible Preferred Stock. As of September 30, 2021 and December&#160;31, 2020, the balance outstanding on the loan was $0 and $6,000,000, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">On April&#160;16, 2020, we issued a promissory note for $563,397 under the Paycheck Protection Program (&#8220;PPP&#8221;) through the U.S. Small Business Administration (&#8220;SBA&#8221;), as part of the Coronavirus Aid, Relief and Economic Security (CARES) Act. The promissory note is unsecured and is fully guaranteed by the SBA. The promissory note bears interest at 1% per annum and is due on April&#160;16, 2022. Under the terms of the note, some or all of the debt may be forgiven based upon our use of the funds. We received notification from the bank that held the promissory note in March&#160;2021 that $513,520 had been forgiven and on August 6, 2021 we received notification that the remaining amount due on the note of $49,877 had been forgiven. As of September 30, 2021 and December&#160;31, 2020, the balance outstanding on the loan was $0 and $563,397, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash Flows</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our net cash usage during the quarter ended September 30, 2021 was approximately $4,438,000. We anticipate our quarterly net cash usage to increase in the fourth quarter as we continue to build out our infrastructure in anticipation of our first clinical trial.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following table summarizes our sources and uses of cash for each of the periods presented:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:middle;white-space:nowrap;width:23.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net cash provided by (used in):</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Operating activities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (8,211)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (6,094)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Investing activities </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 552</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (123)</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Financing activities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 65,302</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 6,528</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net increase in cash and cash equivalents </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 57,643</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 311</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Operating Activities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Net cash used in operating activities consisted of net losses adjusted for certain non-cash items and changes in operating assets and liabilities.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">28</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">During the nine&#160;months ended September 30, 2021, net cash used in operating activities was $8,211,000 and reflected (i)&#160;the net loss of $9,195,000, (ii)&#160;net non-cash usage items of $2,040,000, including a gain on sale of equity investment of $1,984,000, $573,000 related to the forgiveness of the PPP promissory note and $247,000 related to the change in fair value of embedded derivative, partially offset by $384,000 of stock-based compensation and $224,000 in equity loss in affiliate, and (iii) <span style="color:#231f20;">a net cash inflow from changes in balances of operating assets and liabilities of $3,019,000.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">During the nine&#160;months ended September 30, 2020, net cash used in operating activities was $6,094,000 and reflected (i)&#160;the net loss of $9,222,000, (ii)&#160;net non-cash items of $2,356,000, including $472,000 of stock-based compensation and $1,676,000 in equity loss in an affiliate, and (iii)&#160;net cash inflows from changes in balances of operating assets and liabilities of $771,000. The most significant items comprising the changes in the balance of operating assets and liabilities was a lower balance of receivable from Reprise of $217,000, a lower balance of grant receivable of $257,000 and an increase in accrued interest of $347,000, partially offset by a lower balance of accounts payable and accrued expenses of $84,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Investing Activities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During the nine&#160;months ended September 30, 2021, net cash provided by investing activities was $552,000 and reflected $2,000,000 from the sale of Reprise stock, $1,166,000 used for construction in process, and $282,000 used to purchase equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">During the nine&#160;months ended September 30, 2020, net cash used in investing activities was $123,000 to purchase equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Financing Activities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During the nine&#160;months ended September 30, 2021, net cash provided by financing activities was $65,302,000 and was primarily the result of net proceeds from the Company&#8217;s IPO of $44,594,000, net proceeds from sales of Series C Preferred Stock of $19,892,000, $812,000 related to proceeds from stock option and warrant exercises and $88,000 related to proceeds from long-term debt, partially offset by payments on long term-debt of $83,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During the nine&#160;months ended September 30, 2020, net cash provided by financing activities was $6,528,000 which was primarily related to proceeds from a promissory note with one of our shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_8e23ec11_28d0_4860_a41b_b1c87d4d0a37"></a><a id="Item3QuantitativeandQualitativeDisclosur"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;3. Quantitative and Qualitative Disclosures About Market Risk.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Not required for smaller reporting companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_ca655e02_3d94_4782_a464_b5d9216fb7a8"></a><a id="Item4ControlsandProcedures_206943"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;4. Controls and Procedures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Evaluation of Disclosure Controls and Procedures</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2021, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were effective as of September 30, 2021.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">29</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Changes in Internal Control over Financial Reporting</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There was no change in our internal control over financial reporting that occurred during the fiscal quarter of 2021 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_600d317d_1dee_4c7b_be90_23f91db99a87"></a><a id="PARTIIOTHERINFORMATION_825165"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PART&#160;II&#160;&#8212; OTHER INFORMATION</p><a id="Item1LegalProceedings_657175"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;1. Legal Proceedings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are not presently a party to any litigation the outcome of which, we believe, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, cash flows or financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_6373546d_81f8_4042_acd9_f873d154ce62"></a><a id="Item1ARiskFactors_343626"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;1A. Risk Factors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This Quarterly Report on Form 10-Q should be read in conjunction with the risk factors included in our final prospectus filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended, on June 23, 2021 (the &#8220;Prospectus&#8221;). There have been no material changes to the risk factors disclosed under the heading &#8220;Risk Factors&#8221; in our Prospectus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_c8a7a07f_266c_4fa2_a538_9662c769c063"></a><a id="Item2UnregisteredSalesofEquitySecurities"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Unregistered Sales of Equity Securities</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During the three months ended September 30, 2021, the Company issued 1,340 shares of its common stock related to stock warrant exercises for cash and 10,637 shares of its common stock related to cashless stock warrant exercises with a weighted average exercise price of $2.46 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of Proceeds from Initial Public Offering of Common Stock </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On June 28, 2021, we completed our IPO in which we sold 5,520,000 shares of common stock at a public offering price of $9.00 per share. The offer and sale of all of the shares in the IPO were registered under the Securities Act pursuant to the Company&#8217;s registration statement on Form S-1 (File No. 333-256649), as amended, which was declared effective by the SEC on June 23, 2021, and the Company&#8217;s registration statement on Form S-1 (File No. 333-257329) filed on June 23, 2021 pursuant to Rule 462(b) under the Securities Act. Craig-Hallum Capital Group acted as sole managing underwriter for the IPO. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We received net proceeds of approximately $44.6 million from the IPO, after paying $342,500 of fees and expenses of Craig-Hallum. We are using the net proceeds from the IPO as follows: </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">between approximately $34.8 million to $40.0 million to fund our research and development activities, including, but not limited to, our Phase I trial for External Liver Assist Product and certain pre-clinical trials for our bioengineered organs;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">between approximately $3.0 million to $4.0 million to fund the full cost of constructing a new facility; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">the remaining funds for working capital and general corporate purposes.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">30</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_cb290baa_81d0_4030_ad06_0d485970402e"></a><a id="Item3DefaultsUponSeniorSecurities_709038"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;3. Defaults Upon Senior Securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">None.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_37449d46_94e8_4b0a_a20f_f0e9a4b8626c"></a><a id="Item4MineSafetyDisclosures_481827"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;4. Mine Safety Disclosures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_35c9243c_5158_4170_840d_1b97936782f9"></a><a id="Item5OtherInformation_231484"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;5. Other Information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">None.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">31</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:10.35pt;"><a id="_7db2bb27_dbe0_43f4_8a1a_535032d03f26"></a><a id="Item6Exhibits_639467"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;6. Exhibits.</p><a id="EXHIBITINDEX_83501"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.</p><a id="_5abe62fd_dc76_4b90_bea7_1b940af655c1"></a><a id="_5423368f_686f_43eb_bd8b_a794fdde0b39"></a><a id="_db4b7ac2_54c4_4ee6_bf6a_4b89e1079802"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:90.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr style="height:22.15pt;"><td style="vertical-align:bottom;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Exhibit</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">No.</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.1</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/1527096/000110465921086261/tm2111005d27_ex3-1.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Second Amended and Restated Certificate of Incorporation of Miromatrix Medical Inc. (incorporated herein by reference to Exhibit 3.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 28, 2021)</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.2</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/1527096/000110465921086261/tm2111005d27_ex3-2.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Amended and Restated Bylaws of Miromatrix Medical Inc. (incorporated herein by reference to Exhibit 3.2 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 28, 2021).</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.1</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/1527096/000155837021010583/tmb-20210802xex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Multi-Tenant Industrial Triple Net Lease, dated August 2, 2021, by and between the Company and B9 Polar Prairie Oaks Corporate LLC. (incorporated herein by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on August 5, 2021).</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.2*</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/1527096/000155837021012223/tmb-20210831xex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Employment Agreement, dated August 31, 2021, by and between Miromatrix Medical Inc. and Jeff Ross. (incorporated herein by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on September 3, 2021).</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.3*</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/1527096/000155837021012223/tmb-20210831xex10d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Employment Agreement, dated August 31, 2021, by and between Miromatrix Medical Inc. and Brian Niebur. (incorporated herein by reference to Exhibit 10.2 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on September 3, 2021).</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.4&#8224;</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="tmb-20210930xex10d4.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Eighth amendment to the Mayo License Agreement dated October 21, 2021 between the Company and Mayo Foundation for Medical Education and Research</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.5&#8224;*</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="tmb-20210930xex10d5.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Form of Employee Confidentiality, Non-Competition and Non-Solicitation Agreement.</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">31.1&#8224;</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="tmb-20210930xex31d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Certification of Chief Executive Officer Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">31.2&#8224;</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="tmb-20210930xex31d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Certification of Chief Financial Officer Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"></td></tr><tr style="height:3.5pt;"><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">32.1&#8224;</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="tmb-20210930xex32d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">32.2&#8224;</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="tmb-20210930xex32d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</span></a></p></td></tr><tr style="height:4.6pt;"><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">101.INS&#8224;</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Inline XBRL Instance Document&#160;&#8211; the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">101.SCH&#8224;</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Inline XBRL Taxonomy Extension Schema Document</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">101.CAL&#8224;</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">101.DEF&#8224;</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Inline XBRL Taxonomy Extension Definition Linkbase Document</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">101.LAB&#8224;</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Inline XBRL Taxonomy Extension Label Linkbase Document</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">101.PRE&#8224;</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:9.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">104&#8224;</p></td><td style="vertical-align:top;width:90.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cover Page&#160;Interactive Data File (embedded within the inline XBRL document)</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#8224;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Filed herewith.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Management contract or compensatory plan or arrangement.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">32</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ace95816_1b6b_4bad_8641_4f262a9ec1bd"></a><a id="SIGNATURES_10952"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">SIGNATURES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto, duly authorized.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:43.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:middle;width:6.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:middle;width:49.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:43.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:56.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">MIROMATRIX MEDICAL&#160;INC.</b></p></td></tr><tr style="height:12pt;"><td style="vertical-align:middle;width:43.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:49.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:43.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dated: November 15, 2021</p></td><td style="vertical-align:top;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:49.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Jeff Ross</p></td></tr><tr><td style="vertical-align:top;width:43.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:49.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Jeff Ross</p></td></tr><tr><td style="vertical-align:top;width:43.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:49.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr><tr><td style="vertical-align:top;width:43.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(on behalf of Registrant)</p></td></tr><tr style="height:12pt;"><td style="vertical-align:middle;width:43.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:49.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:12pt;"><td style="vertical-align:middle;width:43.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dated: November 15, 2021</p></td><td style="vertical-align:top;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:49.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Brian Niebur</p></td></tr><tr style="height:12pt;"><td style="vertical-align:middle;width:43.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:49.57%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Brian Niebur</p></td></tr><tr style="height:12pt;"><td style="vertical-align:middle;width:43.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:49.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr><tr style="height:12pt;"><td style="vertical-align:middle;width:43.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(Principal Financial and Accounting Officer)</p></td></tr><tr style="height:12pt;"><td style="vertical-align:middle;width:43.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:6.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:49.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">33</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>2
<FILENAME>tmb-20210930xex10d4.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 11/15/2021 08:24:11 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title>________________________________________________________________________</title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;">Exhibit 10.4&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-family:'Cambria';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><b style="font-family:'Cambria';font-weight:bold;">LICENSE AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><b style="font-family:'Cambria';font-weight:bold;">AMENDMENT #8</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-family:'Cambria';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><b style="font-family:'Cambria';font-weight:bold;">WHEREAS,</b><font style="font-family:'Cambria';"> effective as of December 1, 2014, and as further amended, Miromatrix Medical Inc., a corporation organized under the laws of the State of Delaware and having an office </font><font style="font-family:'Cambria';">10399 West 70th Street, Eden Prairie, MN 55344</font><font style="font-family:'Cambria';"> (&#8220;Miromatrix&#8221;) and Mayo Foundation for Medical Education and Research, a not for profit corporation with an address at 200 First Street SW, Rochester, MN 55905 (&#8220;Mayo&#8221;) executed a License Agreement (the &#8220;Agreement&#8221;) for Services as outlined in the Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-family:'Cambria';">&#160;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><b style="font-family:'Cambria';font-weight:bold;">WHEREAS</b><font style="font-family:'Cambria';">, Miromatrix and Mayo wish to amend said Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-family:'Cambria';">&#160;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><b style="font-family:'Cambria';font-weight:bold;">NOW, THEREFORE</b><font style="font-family:'Cambria';">, Miromatrix and Mayo agree as follows:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-family:'Cambria';">&#160;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Cambria';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.</td><td style="padding:0pt;"><font style="font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;text-align:justify;">Miromatrix has agreed to provide additional funding of $75,608 for expansion to include more control animals for additional experiments. &#160;Accordingly, the attached Exhibit B-5 shall amend Section 3 of the Agreement.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 0pt 0pt 72pt;"><font style="font-family:'Cambria';margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Cambria';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">2.</td><td style="padding:0pt;"><font style="font-family:'Cambria';font-size:12pt;font-style:normal;font-weight:normal;text-align:justify;">Except as specifically provided herein, the terms and conditions of the Agreement shall remain in force.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-family:'Cambria';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-family:'Cambria';font-weight:bold;">IN WITNESS WHEREOF</b><font style="font-family:'Cambria';">, the Parties have executed this Amendment which shall be effective as of the last dated signature below.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-family:'Cambria';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><b style="font-family:'Cambria';font-weight:bold;">MIROMATRIX MEDICAL INC.</b><font style="display:inline-block;width:25.82pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><b style="font-family:'Cambria';font-weight:bold;">MAYO </b><b style="font-family:'Cambria';font-weight:bold;">FOUNDATION</b><b style="font-family:'Cambria';font-weight:bold;"> </b><b style="font-family:'Cambria';font-weight:bold;">FOR</b><b style="font-family:'Cambria';font-weight:bold;"> MEDICAL</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><b style="font-family:'Cambria';font-weight:bold;">EDUCATION</b><b style="font-family:'Cambria';font-weight:bold;"> AND RESEARCH</b><font style="display:inline-block;width:24.46pt;"></font><b style="font-family:'Cambria';font-weight:bold;white-space:pre-wrap;">       </b><font style="display:inline-block;width:17.5pt;"></font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-family:'Cambria';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-family:'Cambria';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-family:'Cambria';">By: </font><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:16.81pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;">/s/ Jeff Ross</u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:8.86pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="display:inline-block;width:36pt;"></font><font style="font-family:'Cambria';">By: </font><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:16.81pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;">/s/ Randall S. Jones</u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:7.94pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-family:'Cambria';">Name: </font><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:0.33pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;">Jeff Ross</u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:28.42pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="display:inline-block;width:36pt;"></font><font style="font-family:'Cambria';">Name: </font><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:0.33pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;">Randall S. Jones</u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:27.5pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-family:'Cambria';">Title: </font><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:6.57pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;">CEO</u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:14.51pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="display:inline-block;width:36pt;"></font><font style="font-family:'Cambria';">Title: </font><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:6.57pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;">Operations Manager</u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:3.6pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-family:'Cambria';">Date: </font><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:6.48pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;">7/5/2021</u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:20.37pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="display:inline-block;width:36pt;"></font><font style="font-family:'Cambria';">Date: </font><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:6.48pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;">6/30/2021</u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:13.72pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-family:'Cambria';text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-family:'Cambria';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-family:'Cambria';"><img src="tmb-20210930xex10d4001.jpg" alt="Graphic" style="display:inline-block;height:55.5pt;width:64.8pt;"></font><font style="font-family:'Cambria';">&#160;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-family:'Cambria';visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-family:'Cambria';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-family:'Cambria';">Budget &#8211; Exhibit B-5</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-family:'Cambria';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><img src="tmb-20210930xex10d4002.jpg" alt="Graphic" style="display:inline-block;height:586.75pt;width:468pt;"></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>3
<FILENAME>tmb-20210930xex10d5.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 11/15/2021 08:24:14 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman Bold';font-size:10pt;font-weight:bold;text-align:right;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;text-transform:none;">Exhibit 10.5</font></p><p style="font-family:'Times New Roman Bold';font-size:10pt;font-weight:bold;text-align:center;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Employee CONFIDENTIALITY, <br>NON-COMPETITION, AND NON-SOLICITATION AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;">This Employee Confidentiality, Non-Competition, and Non-Solicitation Agreement (this &#8220;Agreement&#8221;) is entered into as of the date of the execution of this Agreement and is effective as of _____________, 202___ (the &#8220;Effective Date&#8221;), by and between Miromatrix Medical Inc., (&#8220;Company&#8221;), and _______________ (&#8220;Employee&#8221;).</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New (W1)';font-size:11pt;font-weight:bold;margin-bottom:6pt;margin-top:0pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">1. &#160; </b></p></td><td style="padding:0pt;"><p style="font-family:'Times New (W1)';font-size:11pt;font-weight:bold;margin-bottom:6pt;margin-top:0pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Definitions </b></p></td></tr></table><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">1.1 &#160; </b></font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">&#8220;Confidential Information&#8221; means all nonpublic or proprietary information (in tangible or intangible form) arising from, relating to or in the possession of Company or any of its affiliates, Company&#8217;s or any of its affiliates&#8217; business, or any Customer (defined below) of Company or any of its affiliates, including, but not limited to: software (in source or object code form), databases, algorithms, processes, designs, prototypes, methodologies, specifications; reports; information regarding products sold, distributed or being developed or regarding current and developing technology; information regarding vendors, customers, prospective customers, clients, and business contacts; prospective and executed contracts and subcontracts; marketing plans, sales plans, or any other plans and proposals developed or used by Company; information relating to Company&#8217;s present or future business plans; financial and accounting information; and information concerning Company Inventions. </font></p><p style="font-family:'Times New (W1)';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">1.2 &#160; </b></font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;">&#8220;Company Inventions&#8221; means any or all of the following and all statutory and/or common law rights throughout the world in, arising out of, or associated therewith: (i) all ideas, methodologies, processes, inventions (whether patentable or not), discoveries, modifications, improvements, know how and technology; (ii) all works of authorship, copyrights, mask works, and applications and registrations therefor; (iii) all patents and applications therefor and all reissues, divisions, renewals, extensions, provisionals, substitutions, continuations and continuations-in-part thereof; (iv) all designs and any registrations and applications therefor; (v) all trade names, logos, trademarks and service marks, and applications and registrations therefor and all goodwill associated with any of the foregoing; (vi) all databases and data collections (including, but not limited to) knowledge databases; (vii) rights to uniform resource locators, web site addresses and domain names; (viii) all moral rights; (ix) Confidential Information, (x) any equivalent rights to any of the foregoing; and (xi) all rights to enforce any of the foregoing rights, including the right to sue for past damages that directly or indirectly arise from or relate to: </font><font style="display:inline-block;width:11.5pt;"></font></p><p style="font-family:'Times New (W1)';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;">(a) Company&#8217;s business, technology, products, software, or services; </font></p><p style="font-family:'Times New (W1)';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;">(b) work or research performed for Company by Employee or any other Company officer, employee, agent, contractor or subcontractor; </font></p><p style="font-family:'Times New (W1)';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;">(c) the use of Company&#8217;s products, scientific methods, technology, equipment, software, or time; or </font></p><p style="font-family:'Times New (W1)';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;">(d) access to Confidential Information</font><font style="font-size:10.5pt;">.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">1.3 &#160; </b></font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;"> &#8220;Competing Business&#8221; means a business which competes or is reasonably likely to compete with any business (i) which the Company conducts or proposes to conduct at any time during Employee&#8217;s service with the Company or (ii) any other business which the Company or any of its affiliates conducts or proposes to conduct, if Employee participated in the conduct of or planning for such business.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">1.4 &#160; </b></font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;"> &#8220;Customer&#8221; means any present or past vendor, supplier, investor, customer, or business partner of the Company or any prospective vendor, supplier, investor, customer, or business partner of the Company with whom Employee has had contact during Employee&#8217;s service with the Company.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">1.5 &#160; </b></font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;"> &#8220;Solicit&#8221; means to, directly or indirectly: (i) solicit the business or patronage of any Customer for any Competing Business; (ii) divert, entice, or otherwise take away from the Company the business or patronage of any Customer, or attempt to do so; or (iii) solicit or induce any Customer to terminate or reduce its relationship with the Company.</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New (W1)';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">1.6 &#160; </b></font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;"> &#8220;Territory&#8221; means: (i) all counties in the State of Minnesota; (ii) all other states of the United States of America; and (iii) all other countries of the world</font><font style="font-size:11pt;"> in which the Company does business at any time prior to the date of the termination of Employee&#8217;s relationship with the Company</font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;">. </font></p><p style="font-family:'Times New (W1)';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">1.7 &#160; </b></font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;">&#8220;Restricted Period&#8221; means a period of twelve (12) months immediately following the termination of Employee&#8217;s employment or engagement by the Company for any reason or no reason, whether with or without cause or for any or no reason, at the option of either Company or Employee, with or without notice.</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New (W1)';font-size:11pt;font-weight:bold;margin-bottom:6pt;margin-top:0pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">2. &#160; </b></p></td><td style="padding:0pt;"><p style="font-family:'Times New (W1)';font-size:11pt;font-weight:bold;margin-bottom:6pt;margin-top:0pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Confidential Information.</b></p></td></tr></table><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">2.1 &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Employee&#8217;s Use of Confidential Information. </b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> Employee will at all times during and after this Agreement, maintain the confidentiality of the Confidential Information. &#160;Not limiting the foregoing, Employee will not, without Company&#8217;s prior written consent, directly or indirectly: (i) copy or use any Confidential Information for any purpose not within the scope of Employee&#8217;s current work for Company; or (ii) show, give, sell, disclose or otherwise communicate any Confidential Information to any person or entity other than Company unless such person or entity is authorized by Company to have access to the Confidential Information in question. These restrictions do not apply if the Confidential Information has been made generally available to the public by Company or becomes generally available to the public through some other proper course of events. &#160;All Confidential Information prepared by or provided to Employee are and will remain Company&#8217;s property or the property of Company&#8217;s customer to which they belong.</font><b style="font-size:11pt;font-weight:bold;"> &#160;</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">Notice of Immunity under Defend Trade Secrets Act of 2016, 18 U.S.C. &#167; 1833(b): &#160;Notwithstanding any other provision of this Agreement or any policy of the Company, Employee will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney if such disclosure is made solely for the purpose of reporting or investigating a suspected violation of law or for pursuing an anti-retaliation lawsuit or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal and Employee does not disclose the trade secret except pursuant to a court order.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">2.2 &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Former Employers&#8217; Confidential Information.</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> &#160;Employee will not improperly use or disclose to Company or any Company employee, agent or contractor any confidential or proprietary information (including the substance of any unpublished patent applications or invention disclosures) belonging to any former employer of Employee or any other person or entity to which Employee owes a duty of nondisclosure</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">2.3 &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Return of Material.</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> &#160;Upon request of Company or upon termination (whether voluntary or involuntary), Employee will immediately turn over to Company all Confidential Information, including all copies, and other property belonging to Company or any of its customers, including documents, disks, or other computer media in Employee&#8217;s possession or under his/her control. &#160;Employee will also return any materials that contain or are derived from Confidential Information, or are connected with or relate to Employee&#8217;s services to Company or any of its customers.</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New (W1)';font-size:11pt;font-weight:bold;margin-bottom:6pt;margin-top:0pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">3. &#160; </b></p></td><td style="padding:0pt;"><p style="font-family:'Times New (W1)';font-size:11pt;font-weight:bold;margin-bottom:6pt;margin-top:0pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Company Inventions.</b></p></td></tr></table><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">3.1 &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Disclosure of Company Inventions. &#160;</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">Employee will promptly disclose to Employee&#8217;s supervisor and Company, or its designee, all Company Inventions that Employee has made, discovered, conceived, reduced to practice, or developed, contributed to or knows about, regardless of the nature of that knowledge, and regardless of whether such Company Invention, or any aspect of such Company Invention, has been described, committed to writing, or reduced to practice, in whole or part, by any other person. &#160; &#160;</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">3.2 &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Assignment of Inventions; Waiver of &#8220;Moral Rights&#8221;.</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> &#160;All Company Inventions created by Employee (solely or jointly with others) that are &#8220;works made for hire&#8221; (as that term is defined by applicable law) are owned by Company. &#160;To the extent that any Company Inventions are not owned by the Company by operation of law, Employee hereby assigns to Company all right, title, and interest in and to such Company Inventions. &#160;To the extent moral rights are not permitted to be assigned to Company by law, Employee hereby irrevocably waives, to the extent permitted by law, all rights under all laws (of the United States and all other countries) now existing or hereafter in effect, with respect to any and all Company Inventions, including without limitation: (i) all rights under the United States Copyright Act, or any other country&#8217;s copyright law, including </font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">but not limited to, any rights provided in 17 U.S.C. &#167;&#167; 106 and 106A; and (ii) any rights of attribution and integrity or any other &#8220;moral rights of authors&#8221; existing under statutory, common or any other law. &#160;The consideration for such assignment, waiver and the assistance required in this Section 3.3 and Section 3.4, is the normal compensation paid to Employee by virtue of his/her service to Company. &#160;</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">3.3 &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Additional Assistance.</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> At no additional cost, whether during or after Employee&#8217;s employment with Company, Employee will promptly execute and deliver to Company all additional instruments or documents and perform any acts reasonably requested by Company to assist it in evidencing, obtaining, maintaining, defending and enforcing any rights and/or assignment of a Company Invention. &#160;Employee hereby irrevocably designates and appoints Company and its duly authorized officers and agents, as Employee&#8217;s agent and attorney-in-fact to act for and on Employee&#8217;s behalf and instead of Employee, to execute and file any documents or applications or to do all other lawfully permitted acts in furtherance of the purposes set forth above in this paragraph, including, without limitation, the perfection of assignment and the prosecution and issuance of patents, patent applications, copyright applications and registrations, trademark applications and registrations, or other rights in connection with such Company Inventions and improvements thereto with the same legal force and effect as if executed by Employee. </font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">3.4 &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Pre-existing Inventions. </b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> Employee has listed on </font><u style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;text-decoration:underline;text-decoration-color:#000000;">Schedule 1</u><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> all inventions and works of authorship related to Company&#8217;s business, that Employee created prior to employment with Company. &#160;If </font><u style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;text-decoration:underline;text-decoration-color:#000000;">Schedule 1</u><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> is left blank, Employee warrants that no such pre-existing inventions exist. &#160;Except as provided herein, as between Employee and Company, Employee will retain all right, title and interest in and to such inventions and works of authorship. &#160;Employee will promptly disclose to Company any modifications or improvements to any such prior inventions or works of authorship that fall within the definition of Company Invention (and assigns rights thereto to Company pursuant to Section 3.2). &#160;In the event Employee, during the course of or resulting from employment with Company, uses, develops, or otherwise provides Confidential Information, Company Inventions or other works that incorporate or reasonable require the use any of Employee&#8217;s prior inventions or works of authorship, Employee hereby grants Company an unrestricted, royalty-free, perpetual, irrevocable, transferable license to make, have made, use, market, import, distribute, copy, modify, prepare derivative works, perform, display, disclose, sublicense and otherwise exploit any and all such inventions and works of authorship. </font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">4. &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Use of Company Equipment</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">. &#160;Employee will not use any of the Company&#8217;s equipment or facilities for any purpose other than in connection with the performance of services on behalf of the Company unless Employee receives prior written authorization from the Company.</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New (W1)';font-size:11pt;font-weight:bold;margin-bottom:6pt;margin-top:0pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">5. &#160; </b></p></td><td style="padding:0pt;"><p style="font-family:'Times New (W1)';font-size:11pt;font-weight:bold;margin-bottom:6pt;margin-top:0pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Restrictive Covenants. &#160; </b></p></td></tr></table><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">5.1 &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Non-Solicitation of Customers. &#160; </b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">During Employee&#8217;s employment with (or other affiliation with) Company and for the duration of the Restricted Period, Employee will not Solicit.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">5.2 &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;"> Non-Solicitation of Company Employees. </b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">During Employee&#8217;s employment with (or other affiliation with) Company and for the duration of the Restricted Period, Employee will not, directly or indirectly: (i) encourage or solicit any employee or consultant who worked for Company on the date of Employee&#8217;s termination to leave Company for any reason, nor will Employee solicit such person&#8217;s services; (ii) assist any other person or entity in such encouragement or solicitation; or (iii) otherwise interfere with the relationship any employee or consultant has with Company.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">5.3 &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Non-Competition. &#160;</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">In order to protect Confidential Information, which would cause irreparable harm to Company if disclosed in violation of this Agreement, while employed by (or otherwise affiliated with) Company and for the duration of the Restricted Period, Employee will not, in every part of the Territory, without the prior written consent of Company</font><font style="font-size:11pt;font-weight:normal;">: (i) serve as a </font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">partner, employee, consultant, officer, director, manager, agent, associate, investor, </font><font style="font-size:11pt;font-weight:normal;">or otherwise for; (ii) directly or indirectly, own, purchase, organize</font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> or </font><font style="font-size:11pt;font-weight:normal;">take preparatory steps for the organization of; or (iii) build, design, finance, acquire, lease, operate, manage, invest in</font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">, work </font><font style="font-size:11pt;font-weight:normal;">or consult for or otherwise affiliate</font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> with</font><font style="font-size:11pt;font-weight:normal;">: (a)</font><font style="font-size:10.5pt;font-weight:normal;"> any </font><font style="font-size:11pt;font-weight:normal;">Competing Business, (b) any business that is otherwise similar to the Company&#8217;s business, or (c)</font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> any </font><font style="font-size:11pt;font-weight:normal;">business that inevitably will result in the disclosure or use of Confidential Information.&#160;</font><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">&#160;The covenants contained in this subsection will </font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">be construed as a series of separate covenants, one for each city, county and state of any geographic area in the Territory. &#160;If, in any judicial proceeding, a court refuses to enforce any of such separate covenants (or any part thereof), then such unenforceable covenant (or such part) will be eliminated from this Agreement to the extent necessary to permit the remaining separate covenants (or portions thereof) to be enforced.&#160; </font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">5.4 &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Certain Acknowledgements by Employee. </b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> Employee acknowledges that: (i) Employee will derive significant value from the Confidential Information that Company will provide to Employee in order to enable Employee to optimize the performance of Employee&#8217;s duties to Company, and Employee will occupy a position of trust and confidence with Company; (ii) Employee&#8217;s fulfillment of the obligations contained in this Agreement are reasonable and necessary to protect the Confidential Information and the value and goodwill of the Company; (iii) Employee will not be precluded from gainful employment if obligated not to compete with the Company during the period specified in subsection 5.3 within the Territory as described above; and (iv) &#160;Company would be irreparably damaged if Employee were to provide services to any person or entity in violation of the provisions of this Agreement.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">5.5 &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Duration of Covenant. &#160;</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">If Employee violates any covenant contained in this Section 5, the duration of such covenant so violated will be automatically extended for a period of time equal to the period of such violation.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">6. &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Supplemental Agreements and Policies.</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> &#160;Without limiting Employee&#8217;s obligations set forth herein, Employee will comply with Company&#8217;s then current policies and procedures (including, but not limited to, policies and procedures relating to Confidential Information).</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">7. &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Survival.</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> &#160;Employee&#8217;s obligations under this Agreement will survive the termination of Employee&#8217;s employment with Company regardless of the reason for the termination and whether the termination was voluntary or involuntary on the part of the Employee. &#160;Company is entitled to communicate Employee&#8217;s obligations under Sections 2, 3 and 5 to Employee&#8217;s future or potential employer.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">8. &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Remedies.</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> &#160;Each of the rights and remedies enumerated herein is independent of the other, and will be severally enforceable, and such rights and remedies will be in addition to, and not in lieu of, any other rights and remedies available to the Company under law or equity. &#160;In the event of any breach of any obligation under this Agreement, including obligations of confidentiality, non-solicitation, non-competition and disclosure of inventions, Company will suffer immediate and irreparable harm and damage and will not have an adequate remedy at law. &#160;Upon any such breach or threatened breach, in addition to any and all legal remedies, Company will be entitled to obtain injunctive and all other appropriate relief from a court of competent authority in order to prevent or restrain any such breach or threatened breach by Employee or by Employee&#8217;s partners, agents, representatives, servants, employees, and/or any and all persons directly or indirectly acting for Employee, without being required to: (i) show any actual damage or irreparable harm; (ii) prove the inadequacy of its legal remedies; or (iii) post any bond or other security. &#160;This Section may not be construed as an election of any remedy or as a waiver of any right available to Company under this Agreement or the law, including the right to seek damages from Employee for a breach of any provision of this Agreement.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">9. &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Entire Agreement.</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;"> &#160;This Agreement, the Schedule attached hereto and all supplemental agreements and policies pursuant to Section 6 sets forth the entire agreement between the parties and supersedes any and all prior agreements or representations, written or oral, of the parties with respect to the subject matter of this Agreement. &#160;In the event of any conflict between any term of this Agreement and any term of any other agreement either written or oral, the terms of this Agreement will control, unless explicitly stated otherwise in the subsequent agreement. &#160;If Employee signed or signs any other agreement(s) relating to or arising from Employee&#8217;s service to or employment with Company, provisions of such agreement(s) that do not directly conflict with a provision of this Agreement will not be affected, modified or superseded by this Agreement, but rather will remain fully enforceable according to their terms.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">10. &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Modification</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">. &#160;This Agreement can only be modified by a subsequent written agreement executed by Employee and a duly authorized officer of Company.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt;"><font style="display:inline-block;text-align:left;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">11. &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Heirs and Assigns</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">. &#160;In light of the unique personal services to be performed by Employee hereunder, any purported or attempted assignment or transfer by Employee of this Agreement or any of Employee&#8217;s </font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">responsibilities or obligations hereunder will be void. The assignment and waiver of rights under this Agreement are irrevocable and binding on Employee&#8217;s heirs and assigns. Company in its sole discretion may assign this Agreement to any parent, subsidiary, affiliate or successor of Company without prior written consent of Employee.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">12. &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Governing Law and Venue</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">. &#160;The validity, enforceability, construction and interpretation of this Agreement are governed by the laws of the State of Minnesota. &#160;In the event a dispute arises regarding this Agreement, the parties will submit to the jurisdiction of the federal and state courts of the State of Minnesota. &#160;Employee expressly waives any objection as to jurisdiction or venue in the state and federal courts located in Hennepin County, Minnesota.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">13. &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Severability</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">. &#160;Subject to Section 5.3, if any court of competent jurisdiction declares any provision of this Agreement invalid or unenforceable, the remainder of this Agreement will remain fully enforceable. &#160;To the extent that any court concludes that any provision of this Agreement is void or voidable, the court will reform such provision(s) to render the provision(s) enforceable, but only to the extent absolutely necessary to render the provision(s) enforceable and only in view of the parties&#8217; express desire that Company be protected to the greatest extent allowed by law from unfair competition and/or the misuse or disclosure of Confidential Information and/or Company Inventions.</font></p><p style="font-family:'Times New (W1)';font-size:10pt;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">14. &#160; </b></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">At-Will Employment</b><font style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:normal;">. &#160;THIS AGREEMENT IS NOT A GUARANTEE OR PROMISE OF EMPLOYMENT FOR A DEFINITE PERIOD OF TIME, AND EMPLOYEE&#8217;S EMPLOYMENT WITH COMPANY IS &#8220;AT-WILL&#8221; AND MAY BE TERMINATED BY EITHER PARTY AT ANY TIME, WITH OR WITHOUT CAUSE AND WITH OR WITHOUT NOTICE.</font></p><p style="font-family:'Times New (W1)';font-size:11pt;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;width:36pt;"></font><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-weight:bold;">Employee has carefully read and considered all provisions of this Agreement and acknowledges that all of the restrictions set forth herein are fair and reasonable and reasonably required to protect Company&#8217;s interests.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;margin-bottom:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="font-size:10.5pt;">IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized representatives, on the Effective Date above.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;font-weight:bold;margin-bottom:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10.5pt;font-style:normal;font-weight:bold;text-align:justify;">Employee</b></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><b style="font-size:10.5pt;font-weight:bold;"> &#160; &#160; &#160;MIROMATRIX MEDICAL INC.</b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:99.89%;"><tr><td style="vertical-align:top;width:50.02%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;margin-bottom:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;">Signature: &#160;____</font><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:2.59pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;">Print name: &#160;</font><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:18.05pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;">Date: &#160;</font><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:8.01pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;margin-bottom:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.97%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;margin-bottom:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;">By: </font><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:18.2pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;">Print Name: &#160;</font><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:15.72pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;">Title: &#160;</font><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:8.01pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;">Date: &#160;</font><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:8.01pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="font-size:10.5pt;text-decoration:underline;text-decoration-color:#000000;"><u style="display:inline-block;overflow:hidden;position:relative;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><font style="font-size:10.5pt;"><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br></font><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font><font style="font-size:10.5pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-size:10.5pt;font-weight:bold;">SCHEDULE 1<br>Pre-Existing Inventions</b></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="height:0pt;position:relative;width:100%;"><div style="height:20.15pt;left:0%;position:absolute;top:0pt;width:201.6pt;z-index:-9223372036603117568;"><div style="height:20.15pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:201.6pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;width:100%;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>tmb-20210930xex31d1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 11/15/2021 08:24:16 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 6pt 0pt;">Exhibit 31.1</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;">I, Jeff Ross, certify that:</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">1.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">I have reviewed this quarterly report on Form 10-Q of Miromatrix Medical Inc.;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">2.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">3.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">4.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(a)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(b)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(c)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(d)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">5.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(a)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(b)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: November 15, 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:51.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:5.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:42.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:42.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;"> /s/ Jeff Ross</font></p></td></tr><tr><td style="vertical-align:top;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:42.42%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Jeff Ross </p></td></tr><tr><td style="vertical-align:top;width:51.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:42.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>tmb-20210930xex31d2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 11/15/2021 08:24:20 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 6pt 0pt;">Exhibit 31.2</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">CERTIFICATION OF CHIEF FINANCIAL OFFICER</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;">I, Brian Niebur, certify that:</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">1.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">I have reviewed this quarterly report on Form 10-Q of Miromatrix Medical Inc.;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">2.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">3.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">4.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(a)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(b)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(c)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(d)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">5.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(a)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(b)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: November 15, 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:51.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:5.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:42.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:51.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:42.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Brian Niebur</p></td></tr><tr><td style="vertical-align:top;width:51.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:42.41%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Brian Niebur</p></td></tr><tr><td style="vertical-align:top;width:51.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:42.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>tmb-20210930xex32d1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 11/15/2021 08:24:23 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 6pt 0pt;">Exhibit 32.1</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Certification of CEO Pursuant to 18 U.S.C. Section&#160;1350,</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">As Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;">In connection with the quarterly report of Miromatrix Medical Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended September 30, 2021 (the &#8220;Report&#8221;), as filed with the Securities and Exchange Commission on the date hereof, I, the undersigned, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(1)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">The Report fully complies with the requirements of Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934; and</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(2)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: November 15, 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:6.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:43.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:43.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:43.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Jeff Ross</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:43.51%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Jeff Ross</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:43.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>tmb-20210930xex32d2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 11/15/2021 08:24:25 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 6pt 0pt;">Exhibit 32.2</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Certification of CFO Pursuant to 18 U.S.C. Section&#160;1350,</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">As Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;">In connection with the quarterly report of Miromatrix Medical Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended September 30, 2021 (the &#8220;Report&#8221;), as filed with the Securities and Exchange Commission on the date hereof, I, the undersigned, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(1)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">The Report fully complies with the requirements of Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934; and</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">(2)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: November 15, 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:6.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:43.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:43.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:43.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Brian Niebur</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:43.51%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Brian Niebur</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:43.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tmb-20210930xex10d4001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210930xex10d4001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "Y -@# 2(  A$! Q$!_\0
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M/^ASUS_OS9?_ "/7044 <_\ \([JG_0YZY_WYLO_ )'H_P"$=U3_ *'/7/\
MOS9?_(]=!10!S_\ PCNJ?]#GKG_?FR_^1Z/^$=U3_H<]<_[\V7_R/7044 <_
M_P ([JG_ $.>N?\ ?FR_^1Z/^$=U3_H<]<_[\V7_ ,CUT%% '/\ _".ZI_T.
M>N?]^;+_ .1Z/^$=U3_H<]<_[\V7_P CUT&:3(% &!_PCNJ?]#GKG_?FR_\
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M%W/_ **:MN/_ %2?[HK$\;_\B#XC_P"P7<_^BFK;C_U2?[HH ?1110 4444
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M I8Q0ZA<1QAW+E5#D 9))Z4 =H@(5=_WL<XZ4^D_"EH **** "BBB@ HHHH
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MMRQ'MG-+H&B+HMB8WD\ZYFD:XN9R,;Y6Y8X[ G/%;"= 3UP* 'T444 %%%%
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M>:>X>^MX[>X,A4;E0,,_*!@G><XX] *S%\"6#)(E[?7U]&]F;)5G:-1'$2I
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<]X<_P"0SXJ_["J_^DEM11X<_P"0SXJ_["J_^DEM10 _QO\ \B#XC_[!=S_Z
M*:MN/_5)_NBL3QO_ ,B#XC_[!=S_ .BFK;C_ -4G^Z* 'T444 %%9&H:_9Z7
M<"&XAU)W(SFVTRYN%_[ZCC8?AFJO_"8Z7_SZZY_X(;W_ .,T =#17/?\)CI?
M_/KKG_@AO?\ XS1_PF.E_P#/KKG_ ((;W_XS0!T-%<]_PF.E_P#/KKG_ ((;
MW_XS1_PF.E_\^NN?^"&]_P#C- '0T5SW_"8Z7_SZZY_X(;W_ .,T?\)CI?\
MSZZY_P""&]_^,T =#17/?\)CI?\ SZZY_P""&]_^,T?\)CI?_/KKG_@AO?\
MXS0!T-%<]_PF.E_\^NN?^"&]_P#C-'_"8Z7_ ,^NN?\ @AO?_C- '0T5SW_"
M8Z7_ ,^NN?\ @AO?_C-'_"8Z7_SZZY_X(;W_ .,T =#17/?\)CI?_/KKG_@A
MO?\ XS1_PF.E_P#/KKG_ ((;W_XS0!T-%<]_PF.E_P#/KKG_ ((;W_XS1_PF
M.E_\^NN?^"&]_P#C- '0T5E:;KUIJDSQ6\.HHRKN)NM.N+=<>QD103["M6@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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BN]-NK W&I"1(KD)N*BV@7.49E(RIY#'ICJ" 5T]% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tmb-20210930xex10d4002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210930xex10d4002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 26 Z@# 2(  A$! Q$!_\0
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MK\/]#OK_ $"QN+J:T1I)9(LLQZ<FND_X5CX(_P"A8TW_ +\BD^%__),?#O\
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MK** .-N? 'A+2S:WMCX?L(+J&\MVCE2(!E/G)R**Z/6/^/*/_KZM_P#T<E%
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M0 4444 %%%% %>[Z0_\ 75:L57N^D/\ UU6K% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@"O=](?^NJU8JO=](?^NJU8H ****
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M""#\Q!YY&* .]@A2VMXX(AB.- BC.< # J2FQH8XD0L6*J 6/4^].H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"AK'_'E
M'_U]6_\ Z.2BC6/^/*/_ *^K?_T<E% &#\+_ /DF/AW_ *\TKK:Y+X7_ /),
M?#O_ %YI76T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% %>[Z0_]=5JQ5>[Z0_\
M75:L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!7N[&SOXQ'>6L%R@.0LT8< _0U-'&D4:QQHJ(HPJ
MJ, #T IU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!0UC_ (\H_P#KZM__ $<E%&L?\>4?_7U;_P#HY**
M.<^&-S GPS\/*TR!A9ID%A76?:[?_GO'_P!]"N6^&"*?AEX=)4$_8T[5UOEI
M_<7\J (_M=O_ ,]X_P#OH4?:[?\ Y[Q_]]"I/+3^XOY4>6G]Q?RH C^UV_\
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M_<7\J (_M=O_ ,]X_P#OH4?:[?\ Y[Q_]]"I/+3^XOY4>6G]Q?RH C^UV_\
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M_<7\J (_M=O_ ,]X_P#OH4?:[?\ Y[Q_]]"I/+3^XOY4>6G]Q?RH C^UV_\
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MVS(<2J3AATJ?[7;_ //>/_OH5'=(H$.%'^M7M5CRT_N+^5 $?VNW_P">\?\
MWT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X
M_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%
M_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $
M?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\
MWT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X
M_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%
M_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $
M?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\
MWT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X
M_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%
M_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $
M?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\
MWT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X
M_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%
M_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $
M?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\
MWT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X
M_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%
M_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $
M?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\
MWT*/M=O_ ,]X_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X
M_P#OH5)Y:?W%_*CRT_N+^5 $?VNW_P">\?\ WT*/M=O_ ,]X_P#OH5)Y:?W%
M_*CRT_N+^5 &;JUS ]I$JS(S&ZM\ ,/^>R44_5T4649"@'[5;]O^FR44 8?P
MO_Y)CX=_Z\TKK:XOX96Y?X:>'F\^9<V:<*W KK/LA_Y^9_\ OK_ZU %BBJ_V
M0_\ /S/_ -]?_6H^R'_GYG_[Z_\ K4 6**K_ &0_\_,__?7_ -:C[(?^?F?_
M +Z_^M0!8HJO]D/_ #\S_P#?7_UJ/LA_Y^9_^^O_ *U %BBJ_P!D/_/S/_WU
M_P#6H^R'_GYG_P"^O_K4 6**K_9#_P _,_\ WU_]:D-MM4LUU. .22XX_2@"
MS155+=9$#I=S,IZ%7!!_2G?9#_S\S_\ ?7_UJ +%%5_LA_Y^9_\ OK_ZU'V0
M_P#/S/\ ]]?_ %J +%%5_LA_Y^9_^^O_ *U'V0_\_,__ 'U_]:@"Q15?[(?^
M?F?_ +Z_^M4<T<=O"\T][)%$@RSO(%51ZDGI0!<HJI%"DT22Q7DLD;J&1TD!
M# ]"#W%/^R'_ )^9_P#OK_ZU %BBJ_V0_P#/S/\ ]]?_ %J/LA_Y^9_^^O\
MZU %BBJ_V0_\_,__ 'U_]:C[(?\ GYG_ .^O_K4 6**K_9#_ ,_,_P#WU_\
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MZ_\ K4?9#_S\S_\ ?7_UJ +%%5_LA_Y^9_\ OK_ZU'V0_P#/S/\ ]]?_ %J
M+%%5_LA_Y^9_^^O_ *U'V0_\_,__ 'U_]:@"Q15?[(?^?F?_ +Z_^M1]D/\
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MR'_GYG_[Z_\ K4?9#_S\S_\ ?7_UJ +%%5_LA_Y^9_\ OK_ZU'V0_P#/S/\
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MR'_GYG_[Z_\ K4?9#_S\S_\ ?7_UJ +%%5_LA_Y^9_\ OK_ZU'V0_P#/S/\
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MCX-U?^S(9DA2&PE@=B'"L&_>$].5 R!WZ4 =AX$N=>NO"MM)XAM;:WN<*(A
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M\9]/\4;;=M*ATYK64,_SEB)!C;CD?.* /$_BSXD;QY*FM63'^R--BM[=0?\
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M &9O^?F?\Q_A1]F;_GYG_,?X5\T_#9+(^+?!I\+ZA?2ZDZ2OKL3%A$B#&.H
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MW:#M(..I&>:;I'QC\17</A_4K[PY;0Z+J=[]@>Y28EO,+$ JN<X ]>I5NG%
M'L'V9O\ GYG_ #'^%'V9O^?F?\Q_A7E/B7XM:]IDWB.ZTO0+>YT?1KA;)[J6
M4AO/W -E1U7DCCN5/M75?%&1F^%&N2CY6:T#<=OF6@#K/LS?\_,_YC_"C[,W
M_/S/^8_PKYU\ R:9I_CWP;'X3U2\N9KVS)URW9V:-&\O)'( X;=ZX('K7?>%
M/B;K^NPW>JWF@P6_A_3UN#>7J29.8U+ (I.3QC)YY/;% 'IGV9O^?F?\Q_A1
M]F;_ )^9_P Q_A7E.F_%K7S-HNIZSX=M[3PYK5S]FM;B.<M+&2<*7'<<'L.
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M!7^S-_S\S_F/\*/LS?\ /S/^8_PJQ10!7^S-_P _,_YC_"C[,W_/S/\ F/\
M"K%% %?[,W_/S/\ F/\ "C[,W_/S/^8_PJQ10!1N;=E$7^D3',BCDCC]*F^S
M-_S\S_F/\*+OI#_UU6K% %?[,W_/S/\ F/\ "C[,W_/S/^8_PJQ10!7^S-_S
M\S_F/\*/LS?\_,_YC_"K%% %?[,W_/S/^8_PH^S-_P _,_YC_"K%% %?[,W_
M #\S_F/\*/LS?\_,_P"8_P *L44 5_LS?\_,_P"8_P */LS?\_,_YC_"K%%
M%?[,W_/S/^8_PH^S-_S\S_F/\*L44 5_LS?\_,_YC_"C[,W_ #\S_F/\*L44
M 5_LS?\ /S/^8_PH^S-_S\S_ )C_  JQ10!7^S-_S\S_ )C_  H^S-_S\S_F
M/\*L44 5_LS?\_,_YC_"C[,W_/S/^8_PJQ10!7^S-_S\S_F/\*/LS?\ /S/^
M8_PJQ10!7^S-_P _,_YC_"C[,W_/S/\ F/\ "K%% %?[,W_/S/\ F/\ "C[,
MW_/S/^8_PJQ10!7^S-_S\S_F/\*/LS?\_,_YC_"K%% %?[,W_/S/^8_PH^S-
M_P _,_YC_"K%% %?[,W_ #\S_F/\*/LS?\_,_P"8_P *L44 5_LS?\_,_P"8
M_P */LS?\_,_YC_"K%% %?[,W_/S/^8_PH^S-_S\S_F/\*L44 5_LS?\_,_Y
MC_"C[,W_ #\S_F/\*L44 5_LS?\ /S/^8_PH^S-_S\S_ )C_  JQ10!7^S-_
MS\S_ )C_  H^S-_S\S_F/\*L44 5_LS?\_,_YC_"C[,W_/S/^8_PJQ10!7^S
M-_S\S_F/\*/LS?\ /S/^8_PJQ10!7^S-_P _,_YC_"C[,W_/S/\ F/\ "K%%
M %?[,W_/S/\ F/\ "C[,W_/S/^8_PJQ10!7^S-_S\S_F/\*/LS?\_,_YC_"K
M%% %?[,W_/S/^8_PH^S-_P _,_YC_"K%% %?[,W_ #\S_F/\*/LS?\_,_P"8
M_P *L44 96JP%+2)C/*V+JWX8C!_?)[45-K'_'E'_P!?5O\ ^CDHH \O/AO4
M/%G[.NDZ1I:QM=RV\#*)'VC"N">?H*Z[3?A]I<6MZ-XCNHW_ +8L-/CM"%<>
M62$VEB,9+ $@'/3%-^&4#-\-/#S"XE4&S3@8P/TKJ_LS_P#/U-^G^% 'B^D?
M"'7%^%S:/<306FN6NJG4;&59-R!@BJ 2!QG![=0*ZFVM_B+K^@Z]8>([+2K1
M)]*GM;:.VDRTL[K@,QR0%Z^G7IZ=_P#9G_Y^IOT_PH^S/_S]3?I_A0!Y-#\-
MM:TO3/ ^HZ9;6J:[HLFR]"R!1-"Q.X;N_&0/]XUUWQ)\-:CXGTK2+?35C:2U
MU:"[D\Q]H\M V<>_(XKJ_LS_ //U-^G^%'V9_P#GZF_3_"@#E_B=X7O/%_@2
M]TK3V07A9)80[85BK XSVR,_CBN6T7PIXUO/'-WXD\10Z?$]SHKV0CMI,B-R
M1A><^A).<<XKU'[,_P#S]3?I_A1]F?\ Y^IOT_PH \F@^'/B"/X?^"=&:.W^
MV:1JXN[H>:-HC\V1N#W.&'%5]8\!>-K>]\8Z;H::=)H_B&1KHSSR8DC=LED
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M^IOT_P */LS_ //U-^G^% %BBJ_V9_\ GZF_3_"C[,__ #]3?I_A0!8HJO\
M9G_Y^IOT_P */LS_ //U-^G^% %BBJ_V9_\ GZF_3_"C[,__ #]3?I_A0!8H
MJO\ 9G_Y^IOT_P */LS_ //U-^G^% %BBJ_V9_\ GZF_3_"C[,__ #]3?I_A
M0!8HJO\ 9G_Y^IOT_P */LS_ //U-^G^% %BBJ_V9_\ GZF_3_"C[,__ #]3
M?I_A0!8HJO\ 9G_Y^IOT_P */LS_ //U-^G^% %BBJ_V9_\ GZF_3_"C[,__
M #]3?I_A0!8HJO\ 9G_Y^IOT_P */LS_ //U-^G^% %BBJ_V9_\ GZF_3_"C
M[,__ #]3?I_A0!8HJO\ 9G_Y^IOT_P */LS_ //U-^G^% %BBJ_V9_\ GZF_
M3_"C[,__ #]3?I_A0!8HJO\ 9G_Y^IOT_P */LS_ //U-^G^% %BBJ_V9_\
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MC!R5/4=/PKAO$GAG6]*^&GCS7==L;/3KK5Y[,BRM&!2)8YE&>"1D[L]?4]Z
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M[S?]\-_A1]M@_O-_WPW^%<YXU\;Q>#(K OI=YJ,M],88H;10SE@,]._X5?\
M"OB&3Q+I!OY=(O\ 2V$K1_9[Z/9(< ?-CT.?TH U/ML']YO^^&_PH^VP?WF_
M[X;_  KF)_']E%J7B*TBL+RY7084>XD@ ;>[C(C09Y;K^55/"GQ*A\1>(I=
MOM$U'1=36'[1'#>I@R1^HZ$'VQV//% '9?;8/[S?]\-_A1]M@_O-_P!\-_A7
M$W'Q.A/B6XTG2_#^JZK!9SK;WE[:Q9BAD)P1[[>_3&#]:Z;Q/XAM/"OAR]UJ
M]#-!:H&*)C<Y) "C/<D@4 :'VV#^\W_?#?X4?;8/[S?]\-_A7#^(OB9+H"V^
MWPIK%XS6,=_=&% 4M8VSP[#/S#:V>W'6M*Z^(&GQ>![3Q59V.H7]K=8\J"UA
MW2Y.<@C/&"I!//3O0!TWVV#^\W_?#?X4?;8/[S?]\-_A67X2\20>+O#%GKMM
M!)!#=;]L<I!9=KLASCCJM;= $'VV#^\W_?#?X4?;8/[S?]\-_A4]% $'VV#^
M\W_?#?X4?;8/[S?]\-_A4]% $'VV#^\W_?#?X4?;8/[S?]\-_A4]% $'VV#^
M\W_?#?X4?;8/[S?]\-_A4]% $'VV#^\W_?#?X4?;8/[S?]\-_A4]% $'VV#^
M\W_?#?X4?;8/[S?]\-_A4]% $'VV#^\W_?#?X4?;8/[S?]\-_A4]% $'VV#^
M\W_?#?X4?;8/[S?]\-_A4]% $'VV#^\W_?#?X4?;8/[S?]\-_A4]% $'VV#^
M\W_?#?X4?;8/[S?]\-_A4]% $'VV#^\W_?#?X4?;8/[S?]\-_A4]% $'VV#^
M\W_?#?X4?;8/[S?]\-_A4]% $'VV#^\W_?#?X4?;8/[S?]\-_A4]% $'VV#^
M\W_?#?X4?;8/[S?]\-_A4]% $'VV#^\W_?#?X4?;8/[S?]\-_A4]% $'VV#^
M\W_?#?X4?;8/[S?]\-_A4]% $'VV#^\W_?#?X4?;8/[S?]\-_A4]% $'VV#^
M\W_?#?X4?;8/[S?]\-_A4]% $'VV#^\W_?#?X4?;8/[S?]\-_A4]% $'VV#^
M\W_?#?X4?;8/[S?]\-_A4]% $'VV#^\W_?#?X4?;8/[S?]\-_A4]% %&YNH6
M$6&;B12?D/\ A4_VV#^\W_?#?X4EWTA_ZZK5B@"#[;!_>;_OAO\ "C[;!_>;
M_OAO\*GHH @^VP?WF_[X;_"C[;!_>;_OAO\ "IZ* (/ML']YO^^&_P */ML'
M]YO^^&_PJ>B@"#[;!_>;_OAO\*/ML']YO^^&_P *GHH @^VP?WF_[X;_  H^
MVP?WF_[X;_"IZ* (/ML']YO^^&_PH^VP?WF_[X;_  J>B@"#[;!_>;_OAO\
M"C[;!_>;_OAO\*GHH @^VP?WF_[X;_"C[;!_>;_OAO\ "IZ* (/ML']YO^^&
M_P */ML']YO^^&_PJ>B@"#[;!_>;_OAO\*/ML']YO^^&_P *GHH @^VP?WF_
M[X;_  H^VP?WF_[X;_"IZ* (/ML']YO^^&_PH^VP?WF_[X;_  J>B@"#[;!_
M>;_OAO\ "C[;!_>;_OAO\*GHH @^VP?WF_[X;_"C[;!_>;_OAO\ "IZ* (/M
ML']YO^^&_P */ML']YO^^&_PJ>B@"#[;!_>;_OAO\*/ML']YO^^&_P *GHH
M@^VP?WF_[X;_  H^VP?WF_[X;_"IZ* (/ML']YO^^&_PH^VP?WF_[X;_  J>
MB@"#[;!_>;_OAO\ "C[;!_>;_OAO\*GHH @^VP?WF_[X;_"C[;!_>;_OAO\
M"IZ* (/ML']YO^^&_P */ML']YO^^&_PJ>B@"#[;!_>;_OAO\*/ML']YO^^&
M_P *GHH @^VP?WF_[X;_  H^VP?WF_[X;_"IZ* (/ML']YO^^&_PH^VP?WF_
M[X;_  J>B@"#[;!_>;_OAO\ "C[;!_>;_OAO\*GHH @^VP?WF_[X;_"C[;!_
M>;_OAO\ "IZ* (/ML']YO^^&_P */ML']YO^^&_PJ>B@"#[;!_>;_OAO\*/M
ML']YO^^&_P *GHH RM5NHGM(E5FR;JWQ\I'_ "V3VHJ;6/\ CRC_ .OJW_\
M1R44 >)>+?\ DU_1?]RV_P#0C6EX^U+3M:\=?#RRT>Z@N]3@ODED:V<.8H@4
M)W$>RL<>@/K74^#O#NE>*/@[X?TS6;7[39M:QN8_,9.1T.5(/ZUN>'? 'A;P
MG</<:)H\5M.Z[3*7>1\>@9R2!]* / -:N[:6ZA\8:%H*::G]O[$U)M1=Y[A]
MQ9@8N@4YZ#H..<UVOP[\(Z#;?$_Q;.D!^V:1>#[ AG;(#H^[C/S?C7<M\)/
M[WMQ=OH:F6>83,1/( KYSE0&&T9[#BM;_A"/#@\6KXI&F*NM+G_25D<=4*$E
M0=I.TD9(H ^>?#>F^)M:LX/%>GZ2'U>/4S-/K<NK)&3@X:%HF( '(^HXZ'%>
M]VNEZ3'\4+_4X]4#ZM)IJ0R6'&4B# A_7DX%5Y?A3X,FUXZR^CJ+LRB<A9I%
M0R9SNV!L9S[8KH8]!TR+Q#-KR6V-3F@%M)/YC<Q@Y VYV]1UQF@#G_'?A6W\
M5SZ1"^ORZ1=6LDD\#6[!9G.T E3D$8R,D>O:N;^&_C&\@\%^);C7-1;4HM N
MIHTOF.3<1HN1SW)[=3\PKMO%/@K0/&<%O#KED;@6Y9H665D*$XS@J1UP.OI6
M9JOPWTJY\$?\(GI3G2M->9))A$I=I0"&())SDD+R2>F* ,[X90+H/P]F\1ZW
M*L-QJDDFK7LS\!5?E?PVX./<UF^!KA?&OCVY\=7,D-O$MN;'2;,R+YS1!B6E
M=<Y&26P/<^@)](O]&T_4]&ET>[M@]A+%Y+PAB@*>F5((Z=C6!H/PR\'^&=5C
MU31](^S7D:LJR?:9GP",'AG(Z>U 'A6E7GB+PQX9U3Q)9Z]/#+8^(FMI-)P-
MD['!<L.I)Z?13CV]8^(/_%2^-/"_@M/F@:;^T]07_IC'G:I]F;(^N*W[CX;>
M$KKQ./$4VD1MJ/F"4MO;8T@Z.4SM)_#WZU8TSPFECXTUCQ-->-<W5_''!&A3
M:+>)?X0<G.2 3TY% &#\3O%_]F64?AG33%)KNLHT,2R.%2")LAI7)Z #./<'
MTK3TC3-/\+_#*/2[>^AFMK>SDC%QO&V1R&+$'..6+<5-XC^'7A3Q;J*:AKFE
M?:KI(A"LGVB6/" D@81@.K'\Z?+\/_"\WA6#PQ)IF[1X)#)';?:)1M;<6SNW
M;CRQ[]Z ,+X(S1/\)]%B61&D03;T# E<SR8R.U>A5SOAGP+X;\'27+Z#IWV1
MKD*)3Y\DFX+G'WV..IZ5T5 !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% %>[Z0_P#75:L57N^D/_75:L4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P"?E?\ OW_]>K%% %?RKG_GY7_OW_\ 7H\JY_Y^5_[]_P#UZL44 5_*N?\
MGY7_ +]__7H\JY_Y^5_[]_\ UZL44 5_*N?^?E?^_?\ ]>CRKG_GY7_OW_\
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M_P#UZL44 5_*N?\ GY7_ +]__7H\JY_Y^5_[]_\ UZL44 5_*N?^?E?^_?\
M]>CRKG_GY7_OW_\ 7JQ10!7\JY_Y^5_[]_\ UZ/*N?\ GY7_ +]__7JQ10!7
M\JY_Y^5_[]__ %Z/*N?^?E?^_?\ ]>K%% %?RKG_ )^5_P"_?_UZ/*N?^?E?
M^_?_ ->K%% %?RKG_GY7_OW_ /7H\JY_Y^5_[]__ %ZL44 57MIY-NZY'RL&
M'[ON/QIWE7/_ #\K_P!^_P#Z]6** *_E7/\ S\K_ -^__KT>5<_\_*_]^_\
MZ]6** *_E7/_ #\K_P!^_P#Z]'E7/_/RO_?O_P"O5BB@"OY5S_S\K_W[_P#K
MT>5<_P#/RO\ W[_^O5BB@"OY5S_S\K_W[_\ KT>5<_\ /RO_ '[_ /KU8HH
MK^5<_P#/RO\ W[_^O1Y5S_S\K_W[_P#KU8HH K^5<_\ /RO_ '[_ /KT>5<_
M\_*_]^__ *]6** *_E7/_/RO_?O_ .O1Y5S_ ,_*_P#?O_Z]6** *_E7/_/R
MO_?O_P"O1Y5S_P _*_\ ?O\ ^O5BB@"OY5S_ ,_*_P#?O_Z]'E7/_/RO_?O_
M .O5BB@"OY5S_P _*_\ ?O\ ^O1Y5S_S\K_W[_\ KU8HH K^5<_\_*_]^_\
MZ]'E7/\ S\K_ -^__KU8HH K^5<_\_*_]^__ *]'E7/_ #\K_P!^_P#Z]6**
M *_E7/\ S\K_ -^__KT>5<_\_*_]^_\ Z]6** *_E7/_ #\K_P!^_P#Z]'E7
M/_/RO_?O_P"O5BB@"OY5S_S\K_W[_P#KT>5<_P#/RO\ W[_^O5BB@"OY5S_S
M\K_W[_\ KT>5<_\ /RO_ '[_ /KU8HH K^5<_P#/RO\ W[_^O1Y5S_S\K_W[
M_P#KU8HH K^5<_\ /RO_ '[_ /KT>5<_\_*_]^__ *]6** *_E7/_/RO_?O_
M .O1Y5S_ ,_*_P#?O_Z]6** *_E7/_/RO_?O_P"O1Y5S_P _*_\ ?O\ ^O5B
MB@"OY5S_ ,_*_P#?O_Z]'E7/_/RO_?O_ .O5BB@"OY5S_P _*_\ ?O\ ^O1Y
M5S_S\K_W[_\ KU8HH K^5<_\_*_]^_\ Z]'E7/\ S\K_ -^__KU8HH K^5<_
M\_*_]^__ *]'E7/_ #\K_P!^_P#Z]6** *_E7/\ S\K_ -^__KT>5<_\_*_]
M^_\ Z]6** *_E7/_ #\K_P!^_P#Z]'E7/_/RO_?O_P"O5BB@"OY5S_S\K_W[
M_P#KT>5<_P#/RO\ W[_^O5BB@"OY5S_S\K_W[_\ KT>5<_\ /RO_ '[_ /KU
M8HH RM5CG%I$6G#+]JM\C9C/[Y/>BIM8_P"/*/\ Z^K?_P!')10!@_"__DF/
MAW_KS2NMKDOA?_R3'P[_ ->:5UM !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/I7>7?BG2[+Q58>&YY9!J5_$TL"",E2JAB<MT'"&@#)_X69X<_ZBO_@HNO\
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M_P#@HNO_ (W6?X7^+^@^*-<@TB.SU*PN+I#):F]A"+.H!/RD,>P/MQUS7H%
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M (*+K_XW1_PLSPY_U%?_  477_QNNPHH X__ (69X<_ZBO\ X*+K_P"-T?\
M"S/#G_45_P#!1=?_ !NNPHH X_\ X69X<_ZBO_@HNO\ XW1_PLSPY_U%?_!1
M=?\ QNL_Q9\8/#G@W7GT?4K?47N417)@B1EPPR.2X_E5GP7\5-!\=ZI/I^E0
M7\<T,)G8W,2JNT,%XPQYRPH G_X69X<_ZBO_ (*+K_XW1_PLSPY_U%?_  47
M7_QNNPHH X__ (69X<_ZBO\ X*+K_P"-T?\ "S/#G_45_P#!1=?_ !NNPHH
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M='_"S/#G_45_\%%U_P#&ZZ#1-:L/$6CVVJZ9.)[.X7<C@8[X(([$$$$>U:%
M''_\+,\.?]17_P %%U_\;H_X69X<_P"HK_X*+K_XW72:O?G2M%O]1$#W!M+>
M2<0Q_>DVJ6VCW.,55\,ZV?$?AVSU9K*:R-RI;[/-]],,1SP/3/XT 8O_  LS
MPY_U%?\ P477_P ;H_X69X<_ZBO_ (*+K_XW7844 <?_ ,+,\.?]17_P477_
M ,;H_P"%F>'/^HK_ ."BZ_\ C=:V@>*=+\2R:@FFRR.VGW!MKC?&5PXZ@9Z]
M.M0^+?%,/A33[6=[9[JXO+N.SMK=&"F21SQSVX!- &?_ ,+,\.?]17_P477_
M ,;H_P"%F>'/^HK_ ."BZ_\ C=+XE^)&A>$_$>GZ)J@NEGO@K)*B*8T#.5RQ
M+ CD<\'BKM_XSTS3O&NF^%)H[DZAJ$)FA=4!C"@.?F.<@_(>Q[4 4?\ A9GA
MS_J*_P#@HNO_ (W1_P +,\.?]17_ ,%%U_\ &Z["N7OO&D-E\1-,\'M9R--?
MVK7*W <!4 #\$=_]6?SH K_\+,\.?]17_P %%U_\;H_X69X<_P"HK_X*+K_X
MW7844 <?_P +,\.?]17_ ,%%U_\ &Z/^%F>'/^HK_P""BZ_^-UV%% ''_P#"
MS/#G_45_\%%U_P#&Z/\ A9GAS_J*_P#@HNO_ (W6A-XIAMO'5MX7GMG22ZLV
MNK>XW#;(5.&3'7( S]*Z"@#C_P#A9GAS_J*_^"BZ_P#C='_"S/#G_45_\%%U
M_P#&Z["B@#C_ /A9GAS_ *BO_@HNO_C='_"S/#G_ %%?_!1=?_&Z["B@#C_^
M%F>'/^HK_P""BZ_^-T?\+,\.?]17_P %%U_\;KL** ./_P"%F>'/^HK_ ."B
MZ_\ C='_  LSPY_U%?\ P477_P ;KL** ./_ .%F>'/^HK_X*+K_ .-T?\+,
M\.?]17_P477_ ,;KL** ./\ ^%F>'/\ J*_^"BZ_^-T?\+,\.?\ 45_\%%U_
M\;KL** ./_X69X<_ZBO_ (*+K_XW1_PLSPY_U%?_  477_QNNPHH X__ (69
MX<_ZBO\ X*+K_P"-T?\ "S/#G_45_P#!1=?_ !NNPHH X_\ X69X<_ZBO_@H
MNO\ XW1_PLSPY_U%?_!1=?\ QNNPHH X_P#X69X<_P"HK_X*+K_XW1_PLSPY
M_P!17_P477_QNNPHH X__A9GAS_J*_\ @HNO_C='_"S/#G_45_\ !1=?_&Z[
M"B@#B;CQ]H6IM:V5M_:/G37ELJ>9IMQ&N?.3JS( /Q-%=/K'_'E'_P!?5O\
M^CDHH \M?PM?^+?V?-"L=+*?;H88;F%)" LA7/RY/'0GKQG&:CT;Q=K_ (K_
M +;\'^)[%M"\01Z>TL=[:@HQ0%<XY[\<AL'GIBM?0M$U;7?@KX<M]$U=M*U"
M*&*:*X )!QD;3CL<^_TJ;P9\/]>L?$M]XC\7ZU#JFI7%K]C3R%VJD9()_A7G
MCH!W/7- 'F?@C2M3T[X-:SXGM/$>IPJ+:>**QBF9(XGWK^\7#<-P>0.YKH->
MU_6(? /PUN(M7ODN+RZ@6YE6Y<-."!D.<Y8?6MSPW\*=<T?2-9\-W?B..Y\.
MWEI-%!"L&'BE<KB0\=@#QNQS6/;_  :\62V^A0ZGXGM9X-&NE:UMUC.Q(@P8
M\[02QP!ST ZT .F'B'QS\4_$T5GXCO-*@\/H$M886.QI.?OKG# D-G/8@5RG
MARYU72?@9:>(-)O+J!M+USSKB.&9D6:([ 5< X89V]<\9KTC6_AGKS^.K_6_
M#?B%-+M-7B$6HQF/<^, $ID$9.,YX()/-)IGA*S\"?"#5M"\3:I:"WN/.W7
MR%!=0% SR6R,B@"3PYK5WXI^,NKW%IJ-RVA:9I\,:0I,PADED 8,4S@G!<9Q
MG@>E6_C<B?\ "I=;?8N[-O\ -CG_ %\=9WP"T-M,^'OV^92)M2G:8%NOEK\B
MCZ<,1]:Z[X@>&KCQAX)U#0K6>*":Y\O;)*"5&V17.<<]%H \^\?:A>Z-\!-
MN]+O+BQN3#9*9K65HG(,7(W*0<5F>._#5YJ?Q^T:VA\0ZA9/J-J\D4T#D-:!
M(G!6/!& VPDXQ]\UW/B[X?WOB+X8Z9X6@O;>*YM$MU:9PVQO+3:<8YYH\>>
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M QZ$@-V/;TH \U\,/K!\>> ?^$SMDLX8M/\ +T8VZ@B8A %\T[B0<%> .I'
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MGAE:/SMH.TOMQD8*Y'0D&NOUCX5^)K;7=<N?"'B*WL-/UTDWUO/&25+9W;"
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M@O4M$MIHX)KI459) =JX=6YQ]*Y_Q%\/[W6OA/8>$(KVWCNK:&WC:=PVPF,
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MOW_.O6*\SU/2KO4_B7X*T]H)/LNAV+WEQ+M.SS" B+NZ9#*#CT->F4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!0UC_CR
MC_Z^K?\ ]')11K'_ !Y1_P#7U;_^CDHH P?A?_R3'P[_ ->:5UM<E\+_ /DF
M/AW_ *\TKK: "BBB@ JIJ6EZ?K%H;34K*WO+8L&,5Q&'4D=#@\5;HH 9##%;
MPI##&D<4:A41% 50.  !T%/HHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ JC_8NE_P!K_P!K_P!G6G]I;=GVOR5\W;C&-V,XQQ5ZB@ H
MHHH **** "BBB@ HHHH J#2].&IG4Q86HU IY9NO)7S2G]W?C./;-6Z** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *>I:3IVLVRVVJ6
M%M>P*XD$=Q$)%##.#@\9Y/YU:1%C1410J*,*JC  ]!3J* "BBB@ HHHH ***
M* *-KHNEV6H7%_:Z=:07ES_K[B.%5DD[_,P&35ZBB@ HHHH *RU\-:$NK'55
MT;3QJ).XW0MD\W/KNQG/O6I10 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!0UC_CRC_Z^K?\ ]')11K'_ !Y1_P#7
MU;_^CDHH \[\ >)]5LO .AVT'A#5[V*.T0+<0O $?CJ-T@/YBND_X3'6O^A#
MUW_OY;?_ !VG?"__ ))CX=_Z\TKK: .0_P"$QUK_ *$/7?\ OY;?_':/^$QU
MK_H0]=_[^6W_ ,=KKZ* .0_X3'6O^A#UW_OY;?\ QVC_ (3'6O\ H0]=_P"_
MEM_\=KKZ* .0_P"$QUK_ *$/7?\ OY;?_':/^$QUK_H0]=_[^6W_ ,=KKZ*
M.0_X3'6O^A#UW_OY;?\ QVC_ (3'6O\ H0]=_P"_EM_\=KKZ* .0_P"$QUK_
M *$/7?\ OY;?_':/^$QUK_H0]=_[^6W_ ,=KKZ* .0_X3'6O^A#UW_OY;?\
MQVC_ (3'6O\ H0]=_P"_EM_\=KKZ* .0_P"$QUK_ *$/7?\ OY;?_':/^$QU
MK_H0]=_[^6W_ ,=KKZ* .0_X3'6O^A#UW_OY;?\ QVC_ (3'6O\ H0]=_P"_
MEM_\=KKZ* .0_P"$QUK_ *$/7?\ OY;?_':/^$QUK_H0]=_[^6W_ ,=KKZ*
M.0_X3'6O^A#UW_OY;?\ QVC_ (3'6O\ H0]=_P"_EM_\=KKZ* .0_P"$QUK_
M *$/7?\ OY;?_':/^$QUK_H0]=_[^6W_ ,=KKZ* .0_X3'6O^A#UW_OY;?\
MQVC_ (3'6O\ H0]=_P"_EM_\=KKZ* .0_P"$QUK_ *$/7?\ OY;?_':/^$QU
MK_H0]=_[^6W_ ,=KKZ* .0_X3'6O^A#UW_OY;?\ QVC_ (3'6O\ H0]=_P"_
MEM_\=KKZ* .0_P"$QUK_ *$/7?\ OY;?_':/^$QUK_H0]=_[^6W_ ,=KKZ*
M.0_X3'6O^A#UW_OY;?\ QVC_ (3'6O\ H0]=_P"_EM_\=KKZ* .0_P"$QUK_
M *$/7?\ OY;?_':/^$QUK_H0]=_[^6W_ ,=KKZ* .0_X3'6O^A#UW_OY;?\
MQVC_ (3'6O\ H0]=_P"_EM_\=KKZ* .0_P"$QUK_ *$/7?\ OY;?_':/^$QU
MK_H0]=_[^6W_ ,=KKZ* .0_X3'6O^A#UW_OY;?\ QVC_ (3'6O\ H0]=_P"_
MEM_\=KKZ* .0_P"$QUK_ *$/7?\ OY;?_':/^$QUK_H0]=_[^6W_ ,=KKZ*
M.0_X3'6O^A#UW_OY;?\ QVC_ (3'6O\ H0]=_P"_EM_\=KKZ* .0_P"$QUK_
M *$/7?\ OY;?_':/^$QUK_H0]=_[^6W_ ,=KKZ* .0_X3'6O^A#UW_OY;?\
MQVC_ (3'6O\ H0]=_P"_EM_\=KKZ* .0_P"$QUK_ *$/7?\ OY;?_':/^$QU
MK_H0]=_[^6W_ ,=KKZ* .0_X3'6O^A#UW_OY;?\ QVC_ (3'6O\ H0]=_P"_
MEM_\=KKZ* .0_P"$QUK_ *$/7?\ OY;?_':/^$QUK_H0]=_[^6W_ ,=KKZ*
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M=BLQ#C$9 R0WH0"#SZT <O\ \)CK7_0AZ[_W\MO_ ([1_P )CK7_ $(>N_\
M?RV_^.UT5QK&EV<5O+<ZE9P1W.! \LZJ)<]-I)^;J.E9.I>++:PU_1[+S;4V
M5]%=R2W;3 +%Y.S//3JQ!R>,4 4_^$QUK_H0]=_[^6W_ ,=H_P"$QUK_ *$/
M7?\ OY;?_':Z>RO[/4K9;FPNX+JW8D++!('4_0CBL'7/&,>C:[INEKIUU<&[
MN8K>2X VQ0F3.W+'[S<$[1T'4CC(!6_X3'6O^A#UW_OY;?\ QVC_ (3'6O\
MH0]=_P"_EM_\=K3U_7KK2I[*ST_29=2O[POY<:R"*-%4 LSR$$*.1C@DD\4O
MAKQ"=?M[P364EC>V-RUK=6SN'V. &&&'#*58$'B@#+_X3'6O^A#UW_OY;?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSM;&)HK2VAMXV=I&6*,("S'+,0.Y/)/>@#R>6/2%^&/@J325MO[1-UIYMFB
M\PS%E\W..<X\S=^.:T;>^M;+1/B:ES/'$ZW]RVQF ;#VT83 _P!H\#UKN[;P
MYH=GJ;ZE;:/80W[Y+7,=LBR'/7Y@,\]Z+GPYHEYJ/]HW.CV$][MV_:)+9&DQ
MC&-Q&>G% 'GWAU=.?6]$&L"V-N/!]J8!=;=G4^=C=QT\O/M61X1LK&]F^'<;
MPB:U7^V7C28;@<3#:2#U(X//<9ZUZ#XA\.7EW+IQTRTT*:VLXRD=GJ5F&CB/
M&UXRHRI &,#C'IBKWAWPU;Z)I&G6TPBNKRS$A%VT0#!Y6+R%>ZAF/0'H!Z4
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MRH&V VH)VYZ9P.GH/2LVUT^VL_#/POO[2VB2^FN8-\X4;W,EM(S[FZG)ZYH
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M&+\P>=@NH4?.$"=<[R3PN.E>7'2K!/@7J6I"TA^W?;9Y1<% 9%9;TA2&ZC
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M ,DQ\._]>:5UM<E\+_\ DF/AW_KS2NMH **** "BBB@ HHHH **** "BBB@
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MC_A.7_Z%'Q1_X K_ /%T =;17)?\)R__ $*/BC_P!7_XNC_A.7_Z%'Q1_P"
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M?_BZ/^$Y?_H4?%'_ ( K_P#%T =;17)?\)R__0H^*/\ P!7_ .+H_P"$Y?\
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MC4DO8)EN]@\U6^VJHPW487Y<>E=GHO\ R4/X@_\ 7*Q_]$-1_;VG?V4NE?\
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M^$Y?_H4?%'_@"O\ \71_PG+_ /0H^*/_  !7_P"+H ZVBN2_X3E_^A1\4?\
M@"O_ ,71_P )R_\ T*/BC_P!7_XN@#>UC_CRC_Z^K?\ ]')17-7/B][XVMJ?
M#7B"V$EY;+YUQ:*L:?ODY8[C@44 3_"__DF/AW_KS2NMKDOA?_R3'P[_ ->:
M5UM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!R'C_\ U/AS_L/V7_H9KKZY#Q__
M *GPY_V'[+_T,UU] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_@_^,T?\(/=_]#OXI_[_ ,'_ ,9H ZZBN1_X0>[_ .AW\4_]_P"#_P",T?\
M"#W?_0[^*?\ O_!_\9H ZZBN1_X0>[_Z'?Q3_P!_X/\ XS1_P@]W_P!#OXI_
M[_P?_&: .NHKD?\ A![O_H=_%/\ W_@_^,T?\(/=_P#0[^*?^_\ !_\ &: .
MNHKD?^$'N_\ H=_%/_?^#_XS1_P@]W_T._BG_O\ P?\ QF@#KJ*Y'_A![O\
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M*?\ O_!_\9H ZZBN1_X0>[_Z'?Q3_P!_X/\ XS1_P@]W_P!#OXI_[_P?_&:
M$\?_ .I\.?\ 8?LO_0S77UY5XT\(W-K%H1;Q;XBN/-UJUB FFA/EDL?G7$0^
M8=LY'L:Z?_A![O\ Z'?Q3_W_ (/_ (S0!UU%<C_P@]W_ -#OXI_[_P '_P 9
MH_X0>[_Z'?Q3_P!_X/\ XS0!UU%<C_P@]W_T._BG_O\ P?\ QFC_ (0>[_Z'
M?Q3_ -_X/_C- '745R/_  @]W_T._BG_ +_P?_&:/^$'N_\ H=_%/_?^#_XS
M0!UU%<C_ ,(/=_\ 0[^*?^_\'_QFC_A![O\ Z'?Q3_W_ (/_ (S0!UU%<C_P
M@]W_ -#OXI_[_P '_P 9H_X0>[_Z'?Q3_P!_X/\ XS0!UU%<C_P@]W_T._BG
M_O\ P?\ QFC_ (0>[_Z'?Q3_ -_X/_C- '745R/_  @]W_T._BG_ +_P?_&:
M/^$'N_\ H=_%/_?^#_XS0!UU%<C_ ,(/=_\ 0[^*?^_\'_QFC_A![O\ Z'?Q
M3_W_ (/_ (S0!UU%<C_P@]W_ -#OXI_[_P '_P 9H_X0>[_Z'?Q3_P!_X/\
MXS0!UU%<C_P@]W_T._BG_O\ P?\ QFC_ (0>[_Z'?Q3_ -_X/_C- '745R/_
M  @]W_T._BG_ +_P?_&:/^$'N_\ H=_%/_?^#_XS0!UU%<C_ ,(/=_\ 0[^*
M?^_\'_QFC_A![O\ Z'?Q3_W_ (/_ (S0!UU%<C_P@]W_ -#OXI_[_P '_P 9
MH_X0>[_Z'?Q3_P!_X/\ XS0!UU%<C_P@]W_T._BG_O\ P?\ QFC_ (0>[_Z'
M?Q3_ -_X/_C- '745R/_  @]W_T._BG_ +_P?_&:/^$'N_\ H=_%/_?^#_XS
M0!UU%<C_ ,(/=_\ 0[^*?^_\'_QFC_A![O\ Z'?Q3_W_ (/_ (S0!UU%<C_P
M@]W_ -#OXI_[_P '_P 9H_X0>[_Z'?Q3_P!_X/\ XS0!UU%<C_P@]W_T._BG
M_O\ P?\ QFC_ (0>[_Z'?Q3_ -_X/_C- '745R/_  @]W_T._BG_ +_P?_&:
M/^$'N_\ H=_%/_?^#_XS0!UU%<C_ ,(/=_\ 0[^*?^_\'_QFC_A![O\ Z'?Q
M3_W_ (/_ (S0!UU%<C_P@]W_ -#OXI_[_P '_P 9H_X0>[_Z'?Q3_P!_X/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 4444 %%%% !7'KK>OK\1[72KN*U@TNYMKF2&-#OE;RV0!V;H-V\D*.@ZG/
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M4O\ P47?_P :KK** .3_ .%D>&O^>VI?^"B[_P#C5'_"R/#7_/;4O_!1=_\
MQJNLHH Y/_A9'AK_ )[:E_X*+O\ ^-4?\+(\-?\ /;4O_!1=_P#QJNLHH Y/
M_A9'AK_GMJ7_ (*+O_XU1_PLCPU_SVU+_P %%W_\:KK** .3_P"%D>&O^>VI
M?^"B[_\ C5'_  LCPU_SVU+_ ,%%W_\ &JZRB@#D_P#A9'AK_GMJ7_@HN_\
MXU1_PLCPU_SVU+_P47?_ ,:KK** .3_X61X:_P">VI?^"B[_ /C5'_"R/#7_
M #VU+_P47?\ \:KK** .3_X61X:_Y[:E_P""B[_^-4?\+(\-?\]M2_\ !1=_
M_&JZRB@#D_\ A9'AK_GMJ7_@HN__ (U1_P +(\-?\]M2_P#!1=__ !JNLHH
MY/\ X61X:_Y[:E_X*+O_ .-4?\+(\-?\]M2_\%%W_P#&JZRB@#D_^%D>&O\
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M/#7_ #VU+_P47?\ \:KK** .3_X61X:_Y[:E_P""B[_^-4?\+(\-?\]M2_\
M!1=__&JZRB@#D_\ A9'AK_GMJ7_@HN__ (U1_P +(\-?\]M2_P#!1=__ !JN
MLHH Y/\ X61X:_Y[:E_X*+O_ .-4?\+(\-?\]M2_\%%W_P#&JZRB@#D_^%D>
M&O\ GMJ7_@HN_P#XU1_PLCPU_P ]M2_\%%W_ /&JZRB@#D_^%D>&O^>VI?\
M@HN__C5'_"R/#7_/;4O_  47?_QJNLHH Y/_ (61X:_Y[:E_X*+O_P"-4?\
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M=910!R?_  LCPU_SVU+_ ,%%W_\ &J/^%D>&O^>VI?\ @HN__C5=910!R?\
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M4O\ P47?_P :H_X61X:_Y[:E_P""B[_^-5UE% ')_P#"R/#7_/;4O_!1=_\
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M^<G5FC 'XFBNDUC_ (\H_P#KZM__ $<E% 'G_A^2=?A)X-AM[J>V-Q+:P/)
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M:;;P:AJ%OK]Y=VEK;&2ZM+TEIH67)+8;#+P",8P3TQ5AO%5[9:=<7VK:(]M
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MH)L$;5"I*KG&!UP#^-$9)60-/4VZ***S+"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#D/'_^I\.?]A^R_P#0S77UR'C_ /U/AS_L/V7_ *&:Z^@
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M  CWC?\ Z'N'_P $L?\ \778T4 <=_PCWC?_ *'N'_P2Q_\ Q='_  CWC?\
MZ'N'_P $L?\ \778T4 <=_PCWC?_ *'N'_P2Q_\ Q='_  CWC?\ Z'N'_P $
ML?\ \778T4 <=_PCWC?_ *'N'_P2Q_\ Q='_  CWC?\ Z'N'_P $L?\ \778
MT4 <=_PCWC?_ *'N'_P2Q_\ Q='_  CWC?\ Z'N'_P $L?\ \778T4 <=_PC
MWC?_ *'N'_P2Q_\ Q='_  CWC?\ Z'N'_P $L?\ \778T4 <=_PCWC?_ *'N
M'_P2Q_\ Q='_  CWC?\ Z'N'_P $L?\ \778T4 <=_PCWC?_ *'N'_P2Q_\
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M_P (]XW_ .A[A_\ !+'_ /%T?\(]XW_Z'N'_ ,$L?_Q==C10!QW_  CWC?\
MZ'N'_P $L?\ \71_PCWC?_H>X?\ P2Q__%UV-% ''?\ "/>-_P#H>X?_  2Q
M_P#Q='_"/>-_^A[A_P#!+'_\778T4 <=_P (]XW_ .A[A_\ !+'_ /%T?\(]
MXW_Z'N'_ ,$L?_Q==C10!QW_  CWC?\ Z'N'_P $L?\ \71_PCWC?_H>X?\
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MT5RG_"S/!/\ T,^F?]_Q1_PLSP3_ -#/IG_?\4 =717*?\+,\$_]#/IG_?\
M%'_"S/!/_0SZ9_W_ !0!U=%<I_PLSP3_ -#/IG_?\4?\+,\$_P#0SZ9_W_%
M'5T5RG_"S/!/_0SZ9_W_ !1_PLSP3_T,^F?]_P 4 =717*?\+,\$_P#0SZ9_
MW_%'_"S/!/\ T,^F?]_Q0!U=%<I_PLSP3_T,^F?]_P 4?\+,\$_]#/IG_?\
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MAE9VTGPT\/.]M"S&S3)9 2:ZO[!9_P#/I!_W[%<U\+_^28^'?^O-*ZV@"O\
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MO!5SXPLOAUHD]M?>&+;31:H(FOUF#@?[1#!<YSTKJ OQ'(!%QX4(/0B&X_\
MBZ .QHKC]GQ(_P"?CPI_WXN/_BZHZ5JWC;7+0W6E:MX-O+<.8S) EPRAA@D9
M#]>1^= '?45Q^SXD?\_'A3_OQ<?_ !=48]6\:37S6,6M>"'O$.&MU\XR ^Z[
M\T =]17'[/B1_P _'A3_ +\7'_Q=&SXD?\_'A3_OQ<?_ != '845Q^SXD?\
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MS\>%/^_%Q_\ %T =A17'[/B1_P _'A3_ +\7'_Q=&SXD?\_'A3_OQ<?_ !=
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M .+HV?$C_GX\*?\ ?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C_GX\*?\
M?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C_GX\*?\ ?BX_^+H ["BN/V?$
MC_GX\*?]^+C_ .+HV?$C_GX\*?\ ?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+H
MV?$C_GX\*?\ ?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C_GX\*?\ ?BX_
M^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C_GX\*?\ ?BX_^+H ["BN/V?$C_GX
M\*?]^+C_ .+HV?$C_GX\*?\ ?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C
M_GX\*?\ ?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C_GX\*?\ ?BX_^+H
M["BN/V?$C_GX\*?]^+C_ .+HV?$C_GX\*?\ ?BX_^+H ["BN/V?$C_GX\*?]
M^+C_ .+HV?$C_GX\*?\ ?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C_GX\
M*?\ ?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C_GX\*?\ ?BX_^+H ["BN
M/V?$C_GX\*?]^+C_ .+HV?$C_GX\*?\ ?BX_^+H ["BN/V?$C_GX\*?]^+C_
M .+HV?$C_GX\*?\ ?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C_GX\*?\
M?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C_GX\*?\ ?BX_^+H ["BN/V?$
MC_GX\*?]^+C_ .+HV?$C_GX\*?\ ?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+H
MV?$C_GX\*?\ ?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C_GX\*?\ ?BX_
M^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C_GX\*?\ ?BX_^+H ["BN/V?$C_GX
M\*?]^+C_ .+HV?$C_GX\*?\ ?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C
M_GX\*?\ ?BX_^+H ["BN/V?$C_GX\*?]^+C_ .+HV?$C_GX\*?\ ?BX_^+H
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M#AY"&&%; ##+#IGA<]Q7!>&]8UZ#X<^)-"TSPW>:C%JNH2P1W5LI<1.50.'
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M^W(IXDNKQY9DMTPPS+G..G..A[&M7XKZ9!JWB&_CM? ^N'Q!NC6SU6R#&&?
M7YFXQD#*^O Y'8 ]Y,ZQ69N+DK"J1[Y"QP$ &3D^@KYK\"IX0\5_$+7K/Q%
M]Y)JMU)-I=_([Q[P';@<C!(QC/\ =(]J]YU+1[_5?AY<Z--.!J-SIAMGE)R#
M*8]I)/INKY_N-/\ $FH>$=)\(_\ "#:K#XAT>X)M-2B!1$4N6)+XQC)Z[L9
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MZLQ(QP>:]OMQ*+:(3E3,$'F%>A;'./QH DHHHH **** "BBB@ HHHH ****
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M0NQB<Y(VX)[UTVOWEC%:6F@^--)N+G36LXG-]&DLR27"\,C"-=RGN">#D^E
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M"#JW_@7:_P#QRNOHH Y#_A+/$7_0@ZM_X%VO_P <H_X2SQ%_T(.K?^!=K_\
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M"#JW_@7:_P#QRC_A+/$7_0@ZM_X%VO\ \<KKZ* .0_X2SQ%_T(.K?^!=K_\
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MO_QRNOHH Y#_ (2SQ%_T(.K?^!=K_P#'*/\ A+/$7_0@ZM_X%VO_ ,<KKZ*
M.*N?$FMW9M8+CP;J5G"]Y;![B2YMV6,><G)"N2?P%%=-K'_'E'_U]6__ *.2
MB@#!^%__ "3'P[_UYI76UY7X!^(7A?2? .AV%]J9BN8;1%D3[/*V#C/4*1WK
MH_\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,
M'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .
MQHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^
M@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B
M*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,
M'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .
MQHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^
M@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B
M*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,
M'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .
MQHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^
M@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B
M*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,
M'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .
MQHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^
M@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B
M*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,
M'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .
MQHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^
M@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B
M*/\ A:?@S_H,'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,
M'_P%F_\ B* .QHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* .
MQHKCO^%I^#/^@P?_  %F_P#B*/\ A:?@S_H,'_P%F_\ B* '>/\ _4^'/^P_
M9?\ H9KKZ\H\9_$3PK?Q:&+;5#(8-9M9Y/\ 1I1M16)8\KS].M=-_P +3\&?
M]!@_^ LW_P 10!V-%<=_PM/P9_T&#_X"S?\ Q%'_  M/P9_T&#_X"S?_ !%
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M]!@_^ LW_P 10!V-%<=_PM/P9_T&#_X"S?\ Q%'_  M/P9_T&#_X"S?_ !%
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M]!@_^ LW_P 10!V-%<=_PM/P9_T&#_X"S?\ Q%'_  M/P9_T&#_X"S?_ !%
M'8T5QW_"T_!G_08/_@+-_P#$4?\ "T_!G_08/_@+-_\ $4 =C17'?\+3\&?]
M!@_^ LW_ ,11_P +3\&?]!@_^ LW_P 10!V-%<=_PM/P9_T&#_X"S?\ Q%'_
M  M/P9_T&#_X"S?_ !% '8T5QW_"T_!G_08/_@+-_P#$4?\ "T_!G_08/_@+
M-_\ $4 =C17'?\+3\&?]!@_^ LW_ ,11_P +3\&?]!@_^ LW_P 10!V-%<=_
MPM/P9_T&#_X"S?\ Q%'_  M/P9_T&#_X"S?_ !% '8T5QW_"T_!G_08/_@+-
M_P#$4?\ "T_!G_08/_@+-_\ $4 =C17'?\+3\&?]!@_^ LW_ ,11_P +3\&?
M]!@_^ LW_P 10!V-%<=_PM/P9_T&#_X"S?\ Q%'_  M/P9_T&#_X"S?_ !%
M'1:Q_P >4?\ U]6__HY**Y>X^(GA75&M+&SU0RW,]Y;)&GV:5<GSD[E0!10!
M5\(>(-.\+_!;1=7U6;RK2"R3<0,LQ)P !W)-:'@OXF:!X[N+BWTD7:3VZ>8Z
M7$04[<XR""1U]ZXNX\,ZCXJ_9YT*STE4DO88H;F.)R )=N<KSQT/?TJ?PQ\0
MK_5YM<TC7M 71O$MEI<LJ3(A0L@'09Y7DJ1R0?PH ]>KFY_&=G;^/[;P@UM.
M;RXM#=+,,>6%&[@\YS\I[5Y%<>*]?7]G*TUD:Q>C4VOBANO./F%?,88W=<8
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M-QXA\??"O5;L@W-Q8S-*0,!G"N"<=LD9_&O=J "BBB@ HHHH **** "BBB@
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M9IC-!/"#RI<H-I([[2 15/\ L;Q]_P!#AIG_ ()O_MM']C>/O^APTS_P3?\
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MS.6*1R*-R#/15)4 =!S7?5YGI0,W[1&O2Q_<M]%BAE_WV9&'Z"O3* "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML+1_^@58_P#@.G^% ''>'+KPKH>M^(-7G\8Z+=7>L70E+"[B3RXE&(X_OG.
M3SQGTKI?^$T\*_\ 0S:-_P"!\7_Q57/["T?_ *!5C_X#I_A1_86C_P#0*L?_
M  '3_"@"G_PFGA7_ *&;1O\ P/B_^*H_X33PK_T,VC?^!\7_ ,55S^PM'_Z!
M5C_X#I_A1_86C_\ 0*L?_ =/\* *?_":>%?^AFT;_P #XO\ XJC_ (33PK_T
M,VC?^!\7_P 55S^PM'_Z!5C_ . Z?X4?V%H__0*L?_ =/\* *?\ PFGA7_H9
MM&_\#XO_ (JC_A-/"O\ T,VC?^!\7_Q57/["T?\ Z!5C_P" Z?X4?V%H_P#T
M"K'_ ,!T_P * *?_  FGA7_H9M&_\#XO_BJ/^$T\*_\ 0S:-_P"!\7_Q57/[
M"T?_ *!5C_X#I_A1_86C_P#0*L?_  '3_"@"G_PFGA7_ *&;1O\ P/B_^*H_
MX33PK_T,VC?^!\7_ ,55S^PM'_Z!5C_X#I_A1_86C_\ 0*L?_ =/\* *?_":
M>%?^AFT;_P #XO\ XJC_ (33PK_T,VC?^!\7_P 55S^PM'_Z!5C_ . Z?X4?
MV%H__0*L?_ =/\* *?\ PFGA7_H9M&_\#XO_ (JC_A-/"O\ T,VC?^!\7_Q5
M7/["T?\ Z!5C_P" Z?X4?V%H_P#T"K'_ ,!T_P * *?_  FGA7_H9M&_\#XO
M_BJ/^$T\*_\ 0S:-_P"!\7_Q57/["T?_ *!5C_X#I_A1_86C_P#0*L?_  '3
M_"@"G_PFGA7_ *&;1O\ P/B_^*H_X33PK_T,VC?^!\7_ ,55S^PM'_Z!5C_X
M#I_A1_86C_\ 0*L?_ =/\* *?_":>%?^AFT;_P #XO\ XJC_ (33PK_T,VC?
M^!\7_P 55S^PM'_Z!5C_ . Z?X4?V%H__0*L?_ =/\* *?\ PFGA7_H9M&_\
M#XO_ (JC_A-/"O\ T,VC?^!\7_Q57/["T?\ Z!5C_P" Z?X4?V%H_P#T"K'_
M ,!T_P * *?_  FGA7_H9M&_\#XO_BJ/^$T\*_\ 0S:-_P"!\7_Q57/["T?_
M *!5C_X#I_A1_86C_P#0*L?_  '3_"@"G_PFGA7_ *&;1O\ P/B_^*H_X33P
MK_T,VC?^!\7_ ,55S^PM'_Z!5C_X#I_A1_86C_\ 0*L?_ =/\* *?_":>%?^
MAFT;_P #XO\ XJC_ (33PK_T,VC?^!\7_P 55S^PM'_Z!5C_ . Z?X4?V%H_
M_0*L?_ =/\* *?\ PFGA7_H9M&_\#XO_ (JC_A-/"O\ T,VC?^!\7_Q57/["
MT?\ Z!5C_P" Z?X4?V%H_P#T"K'_ ,!T_P * *?_  FGA7_H9M&_\#XO_BJ/
M^$T\*_\ 0S:-_P"!\7_Q57/["T?_ *!5C_X#I_A1_86C_P#0*L?_  '3_"@"
MG_PFGA7_ *&;1O\ P/B_^*H_X33PK_T,VC?^!\7_ ,55S^PM'_Z!5C_X#I_A
M1_86C_\ 0*L?_ =/\* *?_":>%?^AFT;_P #XO\ XJC_ (33PK_T,VC?^!\7
M_P 55S^PM'_Z!5C_ . Z?X4?V%H__0*L?_ =/\* *?\ PFGA7_H9M&_\#XO_
M (JC_A-/"O\ T,VC?^!\7_Q57/["T?\ Z!5C_P" Z?X4?V%H_P#T"K'_ ,!T
M_P * *?_  FGA7_H9M&_\#XO_BJ/^$T\*_\ 0S:-_P"!\7_Q57/["T?_ *!5
MC_X#I_A1_86C_P#0*L?_  '3_"@#B?''BOPY=1: +?7]*E,>N6DC^7>1MM0,
M<L<'@#N:ZK_A-/"O_0S:-_X'Q?\ Q5<_X[T?3(H?#WEZ=9INUVS5ML"C*ESD
M'CI76?V%H_\ T"K'_P !T_PH XUK/X5MX@&MF\\-?:\$X^TP;"^0?,*Y^_QU
MKIO^$T\*_P#0S:-_X'Q?_%5<_L+1_P#H%6/_ (#I_A1_86C_ /0*L?\ P'3_
M  H I_\ ":>%?^AFT;_P/B_^*H_X33PK_P!#-HW_ ('Q?_%5<_L+1_\ H%6/
M_@.G^%']A:/_ - JQ_\  =/\* *?_":>%?\ H9M&_P# ^+_XJC_A-/"O_0S:
M-_X'Q?\ Q57/["T?_H%6/_@.G^%']A:/_P! JQ_\!T_PH I_\)IX5_Z&;1O_
M  /B_P#BJ/\ A-/"O_0S:-_X'Q?_ !57/["T?_H%6/\ X#I_A1_86C_] JQ_
M\!T_PH I_P#":>%?^AFT;_P/B_\ BJ/^$T\*_P#0S:-_X'Q?_%5<_L+1_P#H
M%6/_ (#I_A1_86C_ /0*L?\ P'3_  H I_\ ":>%?^AFT;_P/B_^*H_X33PK
M_P!#-HW_ ('Q?_%5<_L+1_\ H%6/_@.G^%']A:/_ - JQ_\  =/\* *?_":>
M%?\ H9M&_P# ^+_XJC_A-/"O_0S:-_X'Q?\ Q57/["T?_H%6/_@.G^%']A:/
M_P! JQ_\!T_PH I_\)IX5_Z&;1O_  /B_P#BJ/\ A-/"O_0S:-_X'Q?_ !57
M/["T?_H%6/\ X#I_A1_86C_] JQ_\!T_PH I_P#":>%?^AFT;_P/B_\ BJ/^
M$T\*_P#0S:-_X'Q?_%5<_L+1_P#H%6/_ (#I_A1_86C_ /0*L?\ P'3_  H
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M-HW_ ('Q?_%5<_L+1_\ H%6/_@.G^%']A:/_ - JQ_\  =/\* *?_":>%?\
MH9M&_P# ^+_XJC_A-/"O_0S:-_X'Q?\ Q57/["T?_H%6/_@.G^%']A:/_P!
MJQ_\!T_PH I_\)IX5_Z&;1O_  /B_P#BJ/\ A-/"O_0S:-_X'Q?_ !57/["T
M?_H%6/\ X#I_A1_86C_] JQ_\!T_PH I_P#":>%?^AFT;_P/B_\ BJ/^$T\*
M_P#0S:-_X'Q?_%5<_L+1_P#H%6/_ (#I_A1_86C_ /0*L?\ P'3_  H I_\
M":>%?^AFT;_P/B_^*H_X33PK_P!#-HW_ ('Q?_%5<_L+1_\ H%6/_@.G^%']
MA:/_ - JQ_\  =/\* *?_":>%?\ H9M&_P# ^+_XJC_A-/"O_0S:-_X'Q?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPM_X$7'_ ,17744 <CYGQ$_Y]O"W_@1<?_$4>9\1/^?;PM_X$7'_ ,17744
M<CYGQ$_Y]O"W_@1<?_$4>9\1/^?;PM_X$7'_ ,17744 <CYGQ$_Y]O"W_@1<
M?_$4>9\1/^?;PM_X$7'_ ,17744 <CYGQ$_Y]O"W_@1<?_$4>9\1/^?;PM_X
M$7'_ ,17744 <CYGQ$_Y]O"W_@1<?_$4>9\1/^?;PM_X$7'_ ,17744 <CYG
MQ$_Y]O"W_@1<?_$4>9\1/^?;PM_X$7'_ ,17744 <CYGQ$_Y]O"W_@1<?_$4
M>9\1/^?;PM_X$7'_ ,17744 <CYGQ$_Y]O"W_@1<?_$4>9\1/^?;PM_X$7'_
M ,17744 <CYGQ$_Y]O"W_@1<?_$4>9\1/^?;PM_X$7'_ ,17744 <CYGQ$_Y
M]O"W_@1<?_$4>9\1/^?;PM_X$7'_ ,17744 <CYGQ$_Y]O"W_@1<?_$4>9\1
M/^?;PM_X$7'_ ,17744 <CYGQ$_Y]O"W_@1<?_$4>9\1/^?;PM_X$7'_ ,17
M744 <CYGQ$_Y]O"W_@1<?_$4>9\1/^?;PM_X$7'_ ,17744 <CYGQ$_Y]O"W
M_@1<?_$4>9\1/^?;PM_X$7'_ ,17744 <CYGQ$_Y]O"W_@1<?_$4>9\1/^?;
MPM_X$7'_ ,17744 >5^-'\<&+0OML'AX#^VK7R?)FF.9-QV[LI]WUQS73>9\
M1/\ GV\+?^!%Q_\ $4GC_P#U/AS_ +#]E_Z&:Z^@#D?,^(G_ #[>%O\ P(N/
M_B*/,^(G_/MX6_\  BX_^(KKJ* .1\SXB?\ /MX6_P# BX_^(H\SXB?\^WA;
M_P "+C_XBNNHH Y'S/B)_P ^WA;_ ,"+C_XBCS/B)_S[>%O_  (N/_B*ZZB@
M#D?,^(G_ #[>%O\ P(N/_B*/,^(G_/MX6_\  BX_^(KKJ* .1\SXB?\ /MX6
M_P# BX_^(H\SXB?\^WA;_P "+C_XBNNHH Y'S/B)_P ^WA;_ ,"+C_XBCS/B
M)_S[>%O_  (N/_B*ZZB@#D?,^(G_ #[>%O\ P(N/_B*/,^(G_/MX6_\  BX_
M^(KKJ* .1\SXB?\ /MX6_P# BX_^(H\SXB?\^WA;_P "+C_XBNNHH Y'S/B)
M_P ^WA;_ ,"+C_XBCS/B)_S[>%O_  (N/_B*ZZB@#D?,^(G_ #[>%O\ P(N/
M_B*/,^(G_/MX6_\  BX_^(KKJ* .1\SXB?\ /MX6_P# BX_^(H\SXB?\^WA;
M_P "+C_XBNNHH Y'S/B)_P ^WA;_ ,"+C_XBCS/B)_S[>%O_  (N/_B*ZZB@
M#D?,^(G_ #[>%O\ P(N/_B*/,^(G_/MX6_\  BX_^(KKJ* .1\SXB?\ /MX6
M_P# BX_^(H\SXB?\^WA;_P "+C_XBNNHH Y'S/B)_P ^WA;_ ,"+C_XBCS/B
M)_S[>%O_  (N/_B*ZZB@#D?,^(G_ #[>%O\ P(N/_B*/,^(G_/MX6_\  BX_
M^(KKJ* .1\SXB?\ /MX6_P# BX_^(H\SXB?\^WA;_P "+C_XBNNHH Y'S/B)
M_P ^WA;_ ,"+C_XBCS/B)_S[>%O_  (N/_B*ZZB@#D?,^(G_ #[>%O\ P(N/
M_B*/,^(G_/MX6_\  BX_^(KKJ* .1\SXB?\ /MX6_P# BX_^(H\SXB?\^WA;
M_P "+C_XBNNHH Y'S/B)_P ^WA;_ ,"+C_XBCS/B)_S[>%O_  (N/_B*ZZB@
M#D?,^(G_ #[>%O\ P(N/_B*/,^(G_/MX6_\  BX_^(KKJ* .1\SXB?\ /MX6
M_P# BX_^(H\SXB?\^WA;_P "+C_XBNNHH Y'S/B)_P ^WA;_ ,"+C_XBCS/B
M)_S[>%O_  (N/_B*ZZB@#D?,^(G_ #[>%O\ P(N/_B*/,^(G_/MX6_\  BX_
M^(KKJ* .1\SXB?\ /MX6_P# BX_^(H\SXB?\^WA;_P "+C_XBNNHH Y'S/B)
M_P ^WA;_ ,"+C_XBCS/B)_S[>%O_  (N/_B*ZZB@#D?,^(G_ #[>%O\ P(N/
M_B*/,^(G_/MX6_\  BX_^(KKJ* .*N7\<$VHU&#P\MG]LMO--O-,9 OG)]T,
M@&?K173:Q_QY1_\ 7U;_ /HY** ,'X7_ /),?#O_ %YI76UR7PO_ .28^'?^
MO-*ZV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#B2&>/[T3C(!'J,$@CN#^-<)8?!6\N=3L)?%7BV[UNPT\@V]FZ$*<= 26/'
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M_".?%G_H?;;_ ,!Q_P#$4?\ ".?%G_H?;;_P''_Q%'*PNCV>BO&/^$<^+/\
MT/MM_P" X_\ B*/^$<^+/_0^VW_@./\ XBCE871[/17C'_".?%G_ *'VV_\
M <?_ !%'_".?%G_H?;;_ ,!Q_P#$4<K"Z/9Z*\8_X1SXL_\ 0^VW_@./_B*/
M^$<^+/\ T/MM_P" X_\ B*.5A='L]%>,?\(Y\6?^A]MO_ <?_$4?\(Y\6?\
MH?;;_P !Q_\ $4<K"Z/9Z*\8_P"$<^+/_0^VW_@./_B*/^$<^+/_ $/MM_X#
MC_XBCE871[/17C'_  CGQ9_Z'VV_\!Q_\11_PCGQ9_Z'VV_\!Q_\11RL+H]G
MHKQC_A'/BS_T/MM_X#C_ .(H_P"$<^+/_0^VW_@./_B*.5A='L]%>,?\(Y\6
M?^A]MO\ P''_ ,11_P (Y\6?^A]MO_ <?_$4<K"Z/9Z*\8_X1SXL_P#0^VW_
M (#C_P"(H_X1SXL_]#[;?^ X_P#B*.5A='L]%>,?\(Y\6?\ H?;;_P !Q_\
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MM+++'( P\M.&!).T'G ]*-;"TN>>>(-=\8>%-!M9]2\1(+KQ!)%MD$9*Z?&
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MHH **** "BBB@#E?''^JT#_L.6G_ *$:ZJN5\<?ZK0/^PY:?^A&NJH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** *M__ *JW_P"ONV_]')11?_ZJW_Z^[;_T<E%1
M/<N.QQ'@32O&4W@319-.U318K-K5#$D]G([@8[D2 'GVKHO[%^('_09\/?\
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M_P!!GP]_X 3?_'*/[%^('_09\/?^ $W_ ,<KNJ*.9A9'"_V+\0/^@SX>_P#
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M\/?^ $W_ ,<KNJ*.9A9'"_V+\0/^@SX>_P# ";_XY1_8OQ _Z#/A[_P F_\
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M^R?'G_0U:3_X)V_^/4?V3X\_Z&K2?_!.W_QZ@#KZ*Y#^R?'G_0U:3_X)V_\
MCU']D^//^AJTG_P3M_\ 'J .OHKD/[)\>?\ 0U:3_P""=O\ X]1_9/CS_H:M
M)_\ !.W_ ,>H Z^BN0_LGQY_T-6D_P#@G;_X]1_9/CS_ *&K2?\ P3M_\>H
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MX\_Z&K2?_!.W_P >H_LGQY_T-6D_^"=O_CU '7T5R']D^//^AJTG_P $[?\
MQZC^R?'G_0U:3_X)V_\ CU '7T5R']D^//\ H:M)_P#!.W_QZC^R?'G_ $-6
MD_\ @G;_ ./4 =?17(?V3X\_Z&K2?_!.W_QZC^R?'G_0U:3_ ."=O_CU '7T
M5R']D^//^AJTG_P3M_\ 'J/[)\>?]#5I/_@G;_X]0!U]%<A_9/CS_H:M)_\
M!.W_ ,>H_LGQY_T-6D_^"=O_ (]0!U]%<A_9/CS_ *&K2?\ P3M_\>H_LGQY
M_P!#5I/_ ()V_P#CU '7T5R']D^//^AJTG_P3M_\>H_LGQY_T-6D_P#@G;_X
M]0!U]%<A_9/CS_H:M)_\$[?_ !ZC^R?'G_0U:3_X)V_^/4 =?17(?V3X\_Z&
MK2?_  3M_P#'J/[)\>?]#5I/_@G;_P"/4 =?17(?V3X\_P"AJTG_ ,$[?_'J
M/[)\>?\ 0U:3_P""=O\ X]0!U]%<A_9/CS_H:M)_\$[?_'J/[)\>?]#5I/\
MX)V_^/4 =?17(?V3X\_Z&K2?_!.W_P >H_LGQY_T-6D_^"=O_CU '7T5R']D
M^//^AJTG_P $[?\ QZC^R?'G_0U:3_X)V_\ CU '7UQ'BW2?$6I^)+":VTZP
MU'1[2/S1:7-XT(:YW<.X"-N"C& >Y)["K']D^//^AJTG_P $[?\ QZC^R?'G
M_0U:3_X)V_\ CU %VXU77K72+.XN=,LXKV6_AMY8([AIE$3R*I96VJ20"3C&
M  :P+SP[XGM8->T328[!]-UF>:9;V6=E>S\[_6CRPIW\EBN".O-:7]D^//\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!R'C__ %/AS_L/V7_H9KKZY#Q__J?#G_8?LO\ T,UU] !17)>/
M_'FF^!M$DGN)T_M":*3[#;LC-YLBKQD#HN2,G(ZU>\)>,-)\9Z4U]I,S2+$_
ME3*\;(4? )&#]1TS0!OT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ3L%P&;UY^;!R,Y['%7K#X6:7I__  B_EWUXW_".M*UONV_O?,;<=_'8^F*
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M73_!%G=):SW%W=WDGFW5Y<MF25N<9]AD_F: -K6/^/*/_KZM_P#T<E%&L?\
M'E'_ -?5O_Z.2B@#SWP!I'BJX\ :'+8^*H+2U:T0QP-I:RE!CIN+C/Y5T?\
M87C7_H=;;_P3)_\ '*7X7_\ ),?#O_7FE=;0!R/]A>-?^AUMO_!,G_QRC^PO
M&O\ T.MM_P""9/\ XY7744 <C_87C7_H=;;_ ,$R?_'*/["\:_\ 0ZVW_@F3
M_P".5UU% '(_V%XU_P"AUMO_  3)_P#'*/["\:_]#K;?^"9/_CE==10!R/\
M87C7_H=;;_P3)_\ '*/["\:_]#K;?^"9/_CE==10!R/]A>-?^AUMO_!,G_QR
MC^PO&O\ T.MM_P""9/\ XY7744 <C_87C7_H=;;_ ,$R?_'*/["\:_\ 0ZVW
M_@F3_P".5UU% '(_V%XU_P"AUMO_  3)_P#'*/["\:_]#K;?^"9/_CE==10!
MR/\ 87C7_H=;;_P3)_\ '*/["\:_]#K;?^"9/_CE==10!R/]A>-?^AUMO_!,
MG_QRC^PO&O\ T.MM_P""9/\ XY7744 <C_87C7_H=;;_ ,$R?_'*/["\:_\
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MOYDK$/&KE,<#C.&KPO2?#VM7_P *?$6J6^O?9](M;XFXTU@0L[#RSDL#UY7
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MJFH0ZM\;_AYJ-N<PW>FRSI_NM%(1_.@#L?'_ /J?#G_8?LO_ $,UU]<AX_\
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M7_11/$'_ '\;_P"+H_X4MJ7_ $43Q!_W\;_XN@#URBO(_P#A2VI?]%$\0?\
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MQ,=JD@#C<2>*WOV?O^28K_U^S?\ LM<XGB71?"W[0_BR]UR86]N]G'$DQC+
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M\AHR6D(V#=G&/E*,3GICWK=M]1M?#6I?"WQ#K!9-)327A:;87$<A1AG !/\
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M@V]UJ=W"EHAC8^:?F.,@8'#KUQUK6^/5E(_@*#58!B?2[Z*X5_0$[/YLOY4
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M!1$><_=QCJ :Y'2/C'X+UO7(M)M-1E$\S^7"\L#(DC'H 3T)[9Q7>,P52S$
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M%Y+,@"$$,<K@DD (>H%+?>.=$M/!,OBZ&66]TF,9#VR?,_[SRS@,5Z-ZXZ4
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MD.=I)SDCJ<>HK,\$>"_$=OX\N?%7B*UT:PD-F;1+;2D*K(2P)=O?CUR>.F*
M.<^*^E:S=?%KPHMGK9M6NRR63>4&^R,NW<W^UG(_*J>KZ3XD?XU:;I-EKBQZ
MNVB+%/JC0Y( #;G"YZG&/;-=]\2/!FO>(-4T#6_#=U:0ZEI$DC*MUG:P;;Z
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M0Z/I<.H:?93WEI:0PM*T2N044#AB,XSG%86G^$M2M?C'JWBJ1H/[.N].6VC
M<^9O!CZC&,?(>] 'D.M?$+6;K6-<27QP^BOHV;>QM8[=G%[)'D,68# W%?XL
M_>''!JW\2=6U/QA\*?"'B-KP0QSW0AGME3Y6N!O7S!Z8V/Q_M>U=9=^!/&'A
MWQ9K.H>$XM#OK'6)O/>+4T):WD)))&,<98]SVXXK2\8>!O$7B/X>Z+HYGL)-
M5M;Z.ZN77]U$0!)G8 O^V.PH S]4U#Q1X8\6^ -!N_$,MZUW-,+V41A!<#>"
MH(YQ@'''I2CQ3K?_  GOQ$L?[1E^RZ;I;36<>!B%_*4Y''J>]:_Q-\&Z[K^H
M:!K?AJ:V34](G9U2X.%8,5/IV*].X)K&\/\ PY\56>K>+]0UB\LKJXUO37@2
M2)BH\UEZ8QPH/ /H!Q0!PS^*OB#8^ M#\=7'B5I;;[:;<67E@><H9\M(>AR5
M*XQP ".:[C7=4\5>*OB]<^&/#^O'1K;2+1;AY!$'$KD(V&'&1^\48/ P3S4.
MH_"[Q!=?!+2/"$;V7]IVEVTTA,I\O:7E;@[<YPZ]O6M+Q'X(\6VOQ&/BOP==
MV,4E];+:WJWF2%P%&X#'/"+[Y7N#0!R/P]NY[7X9>,)[C78] N/[7_>7XC\P
M1'*;@J]6)&0 .>:D\!>.+N7Q^=!A\577B/2;RRE<37=N8GBE56; W<XPOT^;
MVJU%\'/$'_"M=:T":\M6OYM3%];OYAVR@+MPYQP3R>_.*U]+\#^-;KXAZ5XH
M\02Z4!;V$EJT%F640@I(JJH(.>6R3GN0. * /-O"W_"8Z9\(YO$VC^(/L5CI
M=X2+%(@?/RR!F9CU^\!M(Q@'\>^@U7^W/C?X(U;8$-[X=\\H/X2RRDC\,UBV
MOPJ^(MIX,;PI%J.E#3+ZX\R[&YBT6"I^5L<@[0<>H]S7>Q> ;RQ^(_AG5K-H
M3I&D:0-/.]R)"0K@'&,'[P[^M 'D^I_$_5]2N=9UF+QJVE3VER5TW1DMF9)X
MU/\ $P&W)'][.3GH,5]"^%]9_P"$A\*Z7K!01M>6R2N@Z*Q'('MG->80^ ?&
MWA/5-4MO"T?A^\TF_N6N(VU*,F2V+=1QZ<#^+.!P.:]9T:VN;/1+&VO9(Y;N
M*W1)Y(E"J\@4;F  & 3D]!0!X#X<U6^T3X7_ !$U'3;E[:\AU8&.5,97,B ]
M?8FK]EK_ (XT7Q#X"U+5_$'VRT\2>7$]D(PJ1JPC )]6(D5LC'.1TK9MOA?K
M\7P^\8:&SV7VO5[X7%L1*=H42*WS';P<*?6M36/ &LWX^&_DM:_\4XT)O=TA
M&=GDYV<<_P"K;KCM0!C-J6O:_+\5M+35W@6Q\O[*QC!\I!YC.H_WE4KSTS7,
M^&%\2Z!\";WQ';>(7%F;=EM+(0C_ $=_M85FW'.<X?M_%7IOA_P-J%EXB\=W
M-])"+3Q 5%N8F+,JXD!W# P?G%<K8?#CQU;_  ZU?P9=7>DS6+1 6!C9@0_G
MB1MQ*YQC=Z\T 7?&.NF+PAX4N;WQW/X>-Q8+)-]GMC+-=.4C.<+@J!\V3T^:
MN$N_%VH>)/@QXLL[_46U,:=?VZP7KQ[&FB:3Y21U_A)YYYQVKO\ 7O /BF/4
M?!NMZ VFRZEHM@EG+#>%O*R$V[ACDCYF]#P"*QV^$WBJ3PSXRL;FZL)[[6KV
M&YBFWE5?;(S.6&WY<[N!S0!Z_9?\BO;?]>2_^@"O%_A[KG_".?LZZWJ:OME2
M:=(CZ2.$1?U8'\*]NMK62+18;1MOFI;B(X/&0N*\6'PE\5GX96/A(S6"$ZJU
MW=NLS8\O:  /EY.<G'L* .8\%6]OX'\6> =3CNHF&M6SP7JI(#M:1CMW#^'A
MXNO]PUVVB65MK_[1OB6;5(DN#IMJ@M8I5#*G$8W 'ZL?JV:/%7P$TO\ LE)/
M""-:ZM%.CH]Q<L5*C.1T.#T/X5H^*/ ?BK_A*+7QIX3O+2UUQ[98=0MI3^[E
M(4 X..1P!@X^Z"#F@"7XT:;8Z=\*-:-E:0V_GW$$LHA0*'?S$&X@=\ #/M7,
M_$K_ )-R\+_]<;#_ -$&NUC\(>)?$OP^UC1O&>I6TFH:A)OB:V7*6P7:4&,#
M.&7)^O6N&/PO^(NN:;I?A;7M4TY/#VGR*0\+9=E4$ #Y020I(&<?CB@"?Q1;
MQ:W\2_AOH>HJ)--%@LYB?[KOM)P1WSY:C'O7M$&D:=:WAO+>QMH;DQ^498X@
MK%,@[21U&17%?$7X?77B2'2K_P /W<=AK6CMNM)'R%*\?*3@XP0,<$=0>M6O
M!-IX_&HW%WXROK%H/)\J"UM!T;()=L#T&.IZ]!0!P7Q?OX=+^+'A.]N-.?48
MH;9V:TCC#M+RPP%/7U_"LWP/KBZ%X2^('CW3XK:!;BX5;;3U.?L[%R%W@ #&
M91@#T->D^)/!VIZM\4O#/B.V:W%CIJ,LX=R').[[HQSU'>L&?X57\OB7QA#'
M-;Q>'?$4&["L?,AN 0ZOMQ@@/N[]#0!Q7AGXC:G8>(_#<LGC1]=_M698=2T^
M2W9!:%R -I( ."W\.!\O<&NSG\;:IX9\4?$#3]4OGF2UL?[0TL2 80$8"CCD
M;Y$7G^[3_#/AGXBZ?-I6F7L?AJ/2]/DC$EY%$6N)XD(^4$CJ0,9P#[YI_P 5
M/A?J/C77M+O],G@A3ROLU_YCE2T0<.N, YP2QP?04 9-GK_B>TNOA?#?ZK/+
M+JYFFO=ZK^\5BK(#QQA6'2L'Q7\1-2U#Q=XDA7QFWAZ'1W>&PM8[=G^URH2#
MN*C@$KWX^8<<&O4/%'@V^U3QIX-U/3Q;I8Z+)(9D9R&"D(%"C'/W?:N=U'P+
MXNT#QEK&K^$XM$O;/69!--!J:$F&3))88QW9CU[X(X!H S-?^(.OS?"CPMXR
MM+I[>47HBU&.)1ME +*<@C@$IV_OT]_B5J=K\3/$327C/H$=K=Q649QL\^WA
M21\'J3U_[ZKK]<\&ZOKWPEG\.W\UE)K,B;S+"OEPB02;QC"C Q\O2N&O_@SK
M\_PUTS2H9[3^W(;^>YN9&F8(RR@JWS;<DD+'GCUH [_X27VKZI\/+'4M;O9;
MN[NWDD#R  A Q51P/]G/XUY#X8O=3MO$_BB*R\"V_B*)]9E\RXEB#^1\YXY4
M]N:^@O#>DC0O#.EZ2-I-G:QPL5Z%E4 G\3DUS?P\\):EX7NO$LFH- 5U+4GN
MH/*<MA"3C=D#!YH X;XC>.;L_$5_#/\ PE3^&-,LK99);J*!I7EE8!@OR\XP
MP]!P>O%-TWXL:NOP5U/5Y)H[C6+*[^P176SB3=@K(1CJ%)[<E1GJ:Z/Q?X'\
M11^.AXP\*+I=S<SVPM[NSU)24?&,,/P5>X(V]\D59N/ NN>)OASJ>B^)+C38
M=3NY_/@:PBVPP;0NQ>@)Y#9/)PW4XH X3P5X_O[/QSH6GMXR?Q):ZLOEW<<D
M#)]EF(XVEAR,\<<$9X'%?05>8>%=#^(4.J:;%K4/ARWTZQXEFM8LSW("D#DC
M YP21MK1\!76JZAXP\;7=S>7$VEQZ@+2SCDD++&T>X2! > ,E>GI[4 4/%?B
M74_#GQ@\.0RW\B:!J%M(DL! V^8H;YLXSWCKSNV^*?B6/X?^)I[S4)8]3>>V
MDTZ0A<I'*S$A>.@5#^=>E?%[P'J7C?3-+_L>2"._LKAF#3.4 1EYP0#SE5KF
M_$/P;U'4==\*O:26HTZPM+2VOT:0@OY3'+ 8Y)4D<XH U]/U?7;;XN>']!O=
M0EEB;P^DMTC*O[R<;PS'C.<BN&L?^2,_$G_L,/\ ^AQUZK=>$]1F^,=EXK5H
M/[.ATPVK N?,WY<\#&,?,.]<W;?#778?AYXPT)GL_MFKW[7-L1*=@0LA^8XX
M/RGUH ] \%?\B'X=_P"P9;?^BEKYY\*P>+H/AUX@UO0O$!TZSTO499S;QQ@M
M</M3?N;T"A<#!!YS7T?X<L)M*\,:3IUP5,]I9PP2;#D;E0*<'TR*\4MOA=\1
MM-\+ZGH-E?Z4MEJUTS7,;.Q,:?+\P;;WQ@C'11CK0 [Q5\4;[4D\)V"ZY_PC
MMOJ.GK>ZA?Q1&1D)++M4#G&Z-NGJ.< UU?P<\97GB*/6]*O=3&JG2YU%OJ'E
ME#<0MNVD@\Y^7OSSWQ5;7OA=J=BWAG4_"DME+J.B6@LWAOU_=W*8/)]\LYQQ
M][@C%=;X(T_Q/:K?7/B==)AEG*>1;:;'M2)1G.21DDDCN>E ')^-M6\2:Y\4
MM.\%^']:?1HDM#=W%S&FYB><#'&1PO&1]XYZ5QGAG4-9T;1_BU?-=+'K%M<H
M7N(5P/-$DH9E!Z G/YUZ!XW\%^)9?'.G>+_"%Q9I?Q0&UN(KLD(R\X;@<\,<
MCV&*S?#WPMURWT?QU8:S?6TLVOD-%<QD\OF0[F7'&68' SWH K:YXNUZV\)_
M#:ZAU.5)]4G@6]< 9F#!<@\=\GI6%XQ^(&H7WCC7K >,F\-VFD@Q6<4=NSFZ
MF7KN*C@9!Z\ 8X/-6X/AC\0;R'PO#JM]IAM="ND\FW1R#Y2LI+%@O)PH 'I6
M_K'@7Q7HWC?5->\)1:->V^K[6N+;4T)\J0=6&,=R3U[D8.!0!UGPS\47'B_P
M'I^JWH7[8=T4Y48#.K$;L=LC!_&N6T#Q/K5UXG^)5M/J$CPZ6A-DA Q#Q)TX
M]AU]*[[PK9:KI_AVV@UN6TEU++M,UHFR+)8D!1@<!2!T[5YIK'PZ\9Q^,_$=
MSX>U&Q@TKQ!$1<O-DR)E3D 8ZY+8/HWJ* ,"\\=>*T^#7AG5[?593JMWJKP2
M2L%_>+F3"GCIP*WM.UOQ3X*^*D&A^(]>;6;+5+*2ZW^4$$+JKL0J]A\A&!P0
MP.!7,^-/"NH>&/A#X4T&_EB2\36CF2!BRKO\P@@D#ID5VVA> _%6H?$1?$OC
M6ZL)UL;5K6T2T! D#!E+$8XX=CZY/H* .)BUWX@Z]X0U3XB6WB=K.&SN#Y6E
MI$#&8U*Y]N-W<$G!Y%;6N^-O%&N:SX%C\/ZB-.?7+(M,A0/&CG(9L'D[>2!W
MP,U"WPN\?:=I&H>#M)U+36\-7MQYGVB8D3(F1E<8[[1D#.?49-=7+\.+RT\7
M^";K3GA;3- MC!*9'(D<X(W 8QR3D\]Z *_PJUG7_P#A)?%/A?7M4?4WTN9#
M%<N,,02P/X<*<=N:YKQYHVO7OQ^T:&PU\V<]W:N]E,(0WV15B<.N/XMQ5S_P
M/VKOO"G@_4]%^(GBO7;IK<V>J,AMPCDN,9SN&./SJEX_\&>)-3\6Z+XI\*W=
MC%J&G1/"4O,[2&!&1@'/#,.<=J .%FTCQ+>_'+5]+TG7%L]1.C0QW6HF++%0
MD.YE&>"SA?H":+;XJ>(;/X(RW\MT)-9753I<=W(H8J-@DWGC!(&1T]#S7H.A
M>#]:M/BSJ'BN_>U-M=Z5';$1N=WF@0[N,?=RC=_2N6L?@[JLOPQU+P]?7-K#
MJ+:L=1LY8W+(#L50&XR,C<. <9!YZ4 5/A]XYNXOB+9^'AXN?Q/IVHV[,9Y(
M&C:WG568@;ADC"_3D=,5U_QC\8WWA+PQ:KIEPMK=W]R(!=,N[R$P2S 8//3L
M>I[XI?">E^/O[=M9_$-OX=M+"V1@XL(?WL[%2 2<'')SQM^E:/Q+\%3^-?#\
M$-C<1V^I65PMS:R2C*%AD;6X/!SZ'D"@#A?AOXVN9/'\GAD^*I/$NFW5H9H;
MR2%HGBE499?FYQ@'U[8QS55O$?C@>,/^%<#4YOMYU+S1JV$W_8MF[&,8SCGZ
M\5V_A/3O':ZR+SQ#:^'K6UA@=4@TZ/#RR'&&+$' Z]".O2N5/PJ\4&8^+/MM
MI_PF?]J?:P?-;R/(QCRLXSC'MTXH I>//'-W+\1+WP\?%[^&-,TV!<3QP-*]
MQ,55L':,X^;Z?+WS3X_BSK3? _\ MA71M<^W_P!E"YV#!?;O\S;C&=GX9YQV
MK?\ $?@CQ/:^.9O%WA:+2;B6_MTBO+'4@60, HW*1C/"CN._7-6]5^'^M^*?
MAK/H^N76G1:RUU]K@>SCVP1,.%7@ XQD$\GGOB@#*UC3_&O@7X=>(-3OO&$V
MHW)@A:)C'@VTGFJ&VDYR"#CM]*37?%>N6MI\*'AU&5&U=[87Y '[\,(=V>.^
MYNGK6DGAKQ]XG\'ZWHGBVZTQ//M5AM&M\DM(K;M\AQT)"]/?BN:L_AKX_N[S
MP=-K-[IK6WA^ZB$=O&Y!2%&0YR!\S$(!C_9'J: *7AK0/$L_QM\20V_B=H9[
M:2&6[E\@'[3$2I$>,\87 S[5J:9\0=8TOP#XYUFXN/M5U8ZJ]M9B11A-S*J\
M #(&[//I6_<>"_%FF_%>Y\3:#>:?_9NIM M]%/GS!&NT.%XQG"D@Y[U!I?PN
MO9/!_B_0M6F@C_MC4'NK:6%B^SD,A;@=U&1Z4 <HVM>.? \'A;Q1JWB5]5L-
M:DC^U6,D8 B5P& 4^NTDY &",<BKVI:CXW\0?$?Q?H.C^(VT^RL(1.I* E<*
MI"*1R-Q/)[8_"I+3X;>.=<G\/Z5XKO=-&@Z&ZE/LQ+27 7 4'CT&W)QP3P37
M7:/X+U2Q^(GBW79FM_L>K0+';A7)<$*!\PQQT]Z )OA%XCO_ !1\/;2^U.4S
M7D<DD#RD8,FT\$^^"!^%<)+J?C7Q_P"(O%DVB>(WT>QT!VBMK>),^>R[A\Q]
M]A.3G&0,5W_PK\*:CX-\%KI.J- ;D7$DF8'++AL8Y('I7(:E\/\ QOH7B#Q#
M-X,O-._L[Q 2TZ71(>!FW$E>.V]L$9X/3@&@#B/&.OZSXW^&7A?6[F_$;)J?
MV*XA6, /. Q6;VPO;IEC7O\ I:7_ (;\'$ZWJ+:I=V<,LL]ULV&4 LPX[87
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MICY3GG!S@\^A&.:Z'P;HGQ!\0Z-;^)+CQQ)$=2@E(M/LX*0AE81NO.,@[3@
M<=Z?9_#?Q1K'C&_UCQ7/IWE:EI,EE*ED6'D%@  @;J !G)/7/:M+P#X?^(7A
MJ[L=%U*[TN;PY8^8!+'DS2*0VQ>1P Q![=,9- ',_L^Z5K)TDZHNM$:.L\L;
M:;Y0PTFU?GW?EQ[5[I7F/PU\%^+/ ^HW.F7%YI\_AMGDFB\O/G;SM"YR!C@<
MC)YKTZ@"AK'_ !Y1_P#7U;_^CDHHUC_CRC_Z^K?_ -')10!@_"__ ))CX=_Z
M\TKK:\_\'>(-,\,?!K0M4U>Y^SV<5I&&?8S\DX PH)ZUK^'/B+X7\5K='2=2
M\U[6,RS1O$R.J#^( CD?3/;UH ZFBN&3XP^ Y);.-->C)NVVQDPR*%YQ\V5&
MT9[G'KTK2T;XA^%M?U^?1-,U5)[^'=E C!7V_>VL1AL>Q]^E '3T5QM_\5?!
M>FZ^=%NM:C2\5_+DQ&QCC?IAG VCWYX[XK5U[QCX?\,7%E!K.I):/>[O(WHQ
M5MN-Q+ $*!D=2* -VBN=\->.O#GBZ&[ET;45F6T(\_>C1E <X;# <<'GVKS+
MXE_%K3+[PHR^#_$$B:A!?1K(8@T;-&5?)7(&Y<@=/;U% 'M]%<QKGQ#\+>&]
M1ET_5M56VNXX/M#1-%(<H>F"%P2?3.:S9?C!X&ATZTOGUQ/*NF*HJQ.SKCKN
M4#*XSWZ]LT =S17/^(?&_AWPOIEOJ&JZE'%;W0S;E 9#,, Y4*"2,$<].1ZT
M[3?&?A_5_#5QXALM1673+9'>>4(V8@@W-N7&[('.,<]LT ;U%<5;?%KP1>:E
M8V%OKB23WN!#^ZD R3@!B5&TD]CCMZBN9O/C)I^E?%._TC4=1AAT&U@,;2?9
M9&<7((!7@$D?>YQCWH ];IJ(D8(154$EC@8R3U-4M9UK3O#^ERZEJMRMM9Q%
M0\K D#) ' !/4BO,/"/Q-F\4:A#I4.LV_P#:-SI4K1(T& +LN[*"=O\ !&HS
MV.>YH ]>IJHJ A5"@G)P,9/K7@VOZM\7/"^K:)8W_B72KB;5KH00Q6MNC-U4
M$G=$N!\PYKV/Q7JK:)X6U'4$.)(HB(SZ.WRK^I%*4E%-LTI4I5:D:<=VTE\S
M8HKSWQ1K.M^'/ 6BS6]\W]H2R1)--*H<L61F(Y![_P J-&U[Q/I?C:V\/>))
M[6[%Y"9(I8% VX#'L!_=(Y'I6/UB*ERM/I^)Z*RFK*BZT91:7-I=W:CNUI\]
MST*BO+?&_CG6=*\526NE2#[)8Q1O=KY:MDEAW(R.&4<5O^/_ !'>Z1X9L=1T
MBX$;7%U&N_8K;D9&;H0?04?6(>]_=!9/B/W.W[W;RZZZ::.YV=%>=^*-9\3G
MQY;Z#H-]#;^=:B4":-2N1N)Y*D]%JQX8\3:O=:U>^%_$:+#J*1%HIX>-PQ[<
M9P<@CT-"KQYN6S[>5Q/*:RH*MS1>G-:_O*/>UOR.\HKCO"OB81^"KJ_URZ(;
M2I)8KR=E+'Y.=V "3P1TKH;?7-.N] 77(+C?IK0&Y$VQA^[ R6VD;N@Z8S6L
M)*45)'#B*$J%65*6Z=C0HKQWP?\ %^'Q#;ZW87VHQ)J;/<?V6D-O(I>)8V8,
M3C .%)Y(/'2D^''Q8T>W\):5;>*/$#/J]U+("TH9RH\PA=[ 84?7Z]*HQ/8Z
M*YOQ3X\\.>#?)76]0$$LXS'$J,[L/7"@X'N:U=&UK3O$&E0ZGI5TEU9S#*2)
MD>Q!!Y!'H>: +]%<AXA^)_A'PMJ_]EZMJGE78 9T2%Y/+!Y&XJ#CCG'6K7B3
MQ_X:\)P6TNKZDL/VI=\*(C.[KZ[0"0/<XH Z6BLFP\3Z+J7A[^W[7487TL(T
MC7!.U4"]=V>01Z'FLKP[\2?"OBJZN[?2=3\Q[6(S2F2)XU$8(!;+ # R* .K
MHKBM,^+/@K6-;32;/6D:ZD?RXMT3HDC>BL0 3Z>O;-6M:^)7A+P_J-YI^IZN
ML%Y9QK)+"89"<-MQM(7#$[AP"3U]#@ ZNBN?B\;^'9O";>*$U./^R%!+3E6&
M"#C:5QG=GC&,UY[)\1(?$?Q6\(Q>'=:EDTFY29;J!<H"ZJQ =2,YZ&@#V*BL
MGQ#XFT?PII\=]K=Y]EMI)1"K^6[Y<@D#"@GHIYZ<5G:%\0O"_B76;C2=)U6.
MXO( 24", X!P2A(PP'M]>E '3T5PR_%_P.VM?V5_;.VX\WR=SP2*@?.,%BN!
MSWZ>]='8^)M'U+5=2TNUO U[IA NXFC=/+SG!RP (XZC(_.@#6HKD?\ A9_@
M[^S;+43K(6SO9VM[>9[>55=UQD<KP!D<G ]^#52/XO\ @:73[R]77$\JT<(X
M,3AF)SC8I&6S@].G?% '<T5@0^-?#L_A7_A)EU2(:0 2;A@1@YQM*XSNSQC&
M:A\+>/O#?C)YX]$U$3S0#=)$\;1N%Z;L,!D>XH Z6BN'O?B_X&L/-$^MC?%.
MUO(BV\I977[W&WH/4<5B>/OBM;^&M?\ #%O8W]N;.\9+B^<PM)BT8KM=2!SD
M!^F3QTZ4 >IT51TG6+#7=(@U73KCSK*=2T<I5DR 2"<, 1R#U%<M!\7? ]SK
M8TF+7(S<-)Y:N8W$3-G& ^-OXYQ[T =O17A?Q+^(+_\ "PK?P[;>+9M!TRV@
M)OKN"U>1EGY(3 &2,;.G'S'TKUGQ-X@M_"'A2[UJ]#S1V<:Y"\-(Q(51[98C
MZ4 ;=%>8?#WQOXEUO6+FWU3PS=PV=Q=2LEV;@2+:X0,(F&WCV/'+=*HZ3XC\
M=V?QCT_PYXBU"R:SO;:6Z6WM8EPJ 2!06*[LY3/4T >NT5XWXG\5>--=\::[
MI7A#4+>PM?#UMYT[/$KM<28SM^93CN!TZ'/7C9@^)DMU\(+?Q+%"IUB[_P!#
M@MT&0]V6*  'MD;\>G% 'I=%>>?!OQ/K/BOPC>7NNW*W%W#J$EN'6-4PH2,X
MPH ZL:?\5=1\8Z/H9U/PS=V=K:6D3RWCS('D."H4("".YSG\Z /0**\MU[X@
MZGH?P7TC7P4GUK4H8(HW9!CS74L6VCCH&XZ9Q57PYXB\:Z-XWE\&>)]1M;^]
MO=.:[L+E(U4)( WRG"C(RK=OX?>@#URBO$KK6OB/X(\8^&[?7]>LM7M=8NA;
MO;PP*NS+*I(PBGC>"#[<BO5O$/BC1_"EE#>:W>?9;>:80I(8G<%R"0/E!QP#
MR>.* ->BL@^*-&'B@>&S>C^US#YXMMC?<]=V-OX9S7$>+O&NE:YX:M+S0?%Q
MTR*+6([66Z6VGQ(VQB8>$SSP<]..M 'IU%><_P!M:E_POW^QOMLW]F_V/YWV
M;=\F_=]['K1\&M:U+7/#>L3ZI>S7<L6L30QO*V2J!(R%'MR?SH ]&IJHJ A%
M"@G)P,<UY)J'CP>&_C5K$.MZQ)!H5OI:R) Q++YI,>-JCDL<GI[UW]EXS\/7
M_A=_$D&IQ?V3&"9)WRNPC@@@C(.2.,9.1C.10!O45R_A?XA^&/&-S-;:+J0F
MN(5WM$\;1L5SC< P&1].G>MC6]<T[PYI,VJ:K=+;6<(&^1@3U.  !R23V% &
MA17C\7Q!C\2?&3PK#H&LRS:+<VD_VBW7*J9%28_.I&01A3^5=];>.O#=WI.I
MZI!J.^RTMVCO)/(D'E,.HP5R?P!H Z*BN;U'Q]X9TKPY:Z_>:FL>G7@!MG\M
M]TN?[J8W?IQWJWX:\5:+XNTXW^B7JW,*ML?Y2K(WHRD B@#9HK)O?$VCZ=KU
MAH=W>>7J-^";:'RW/F 9S\P&!T/4BJP\:^'C<:U;C4/WNBQF74%\F3]RH!)/
MW?FX!^[F@#?HKB[7XL^"+W4[+3[?7(WGO,>3^Z=5R3@!B5&TGT..WJ*N>*/B
M'X8\'3Q6^M:D(;B5=RPI&TC[?4A0<#Z]: .HHKG9?'?AF'PLOB5M5C.CLP47
M"1N^&)Q@J 6!SV(XJOI'Q'\)Z]X@;1--U9)[X*65 C!7P,D*Q&"0.P]#Z&@#
MJJ*HZQK.G>']+FU+5;M+6SA&7D?/'H !R2?0<UD>%_'OAOQC]H&B:AY\EN-T
MD31LC@>NT@$CW% &GK&@:5X@B@BU6RCNDMY1-$KD_*XZ-P?<UI5RO_"R/"0T
M%];.K@6"7/V1G,$H838SLV;=^<<]*=XF^(?ACP@]O%K.H^1-.N](5B=WV_WB
MH&5'UQT/I0!U%%9*>)M%D\-_\)"NI0'2/+\W[5G"[<X^N<\8ZYXQFL+3OBMX
M-U33M1O[;56^S:<JO<NUM*-BLVT'&W)R?2@#LZ*P+GQKX>M(-%FGU#9'K91=
M//DR'SB^W;T7Y<[E^]CK7!Z7\9-/D^)>KZ/?ZC"FD*R0:>RVLF]YOE5E) )^
M]N&2 />@#UNBN$\":JIA\37%YXG74X+74)=SR(\:V:KR8R7 X [CBK&B_%7P
M9K^LKI6GZPKW;MMB5XGC$A]%+  GV[]J .SHKD=8^)_@_0;V^LM0U=8KNR*B
M:'R9"P+ $ ?+AN#G@G'>M_1M9T_Q!I-OJFEW*W%G<+F.101G!P00>0001@T
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M%44LY4A><!2>.N.,UC?"GXIQ>+X&T_5[R'^W6FD:*"&W=0854$'."N?O=\T
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M7&"3/-S"M"MB9SAJNGHM+_,\1^&DNAV]KXVL9S8QZN+R\^S1.%$P01MG8.N
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M5"VY0P(;DGDD,1DY-1W7P[\(WNJ7>IW.A6LEY=J5FD.?FSP3C. 3W(&3D\T
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MG[..JV\$EB=9C@D-PB;?/"&X&-W\6W[OMTKWRW\/Z3:Z[=:W#91IJ5V@CGN
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M=,AO?LTL1B DN#UR>/E4?=X(.?6NLT'QMXTMOB9I.D>)FL38ZY:&ZMX+=?\
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M"\L#CG.T''O7D?PXL?$LVKM%=:CI$=C;:+%;W#(6\U(Y4DE7!Z;PS N>G3%
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M_P#]>Y_]#:O-8O'/Q+UC1O$>IZ9=Z='::%=2&1GA&^6->2BC!'"@DG@G(P:
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M]GK5KX$L6U:6Q>":"%[(6J;66$H,"3Y1EO7K]: .UN]1M;*XLH+B0K)>S&"
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M#R:II,B1W0N(XPSH'&#G/!KE['QGXWT3QYH%GXJ>P?3?$*?N(;9.;9CC"[L
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M#)!(+8 R<UC:5X:U>V^.&N^(IK3;I-UIR00W'F(=SCRLC:#N'W6Y(QQ7H-%
M'A,OA7Q_X/N?$^C^'-'@U+2M==VAN3,JFWWY!R"PY ;'IP#ZBIM:^&/B#1_
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M/$WAG3/%NCMI>K1O):EUD*HY0Y'3D5K1QK%$D:?=10H^@H ^;IOAKXUB\/\
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MYP1C-8/PU\0>)]"\<Q>$]7N[?4+*_N+XK,H_>++')(7<G .&9&/.?O#&,8H
MZ'PCX[\97_Q(/AKQ-I>GZ>#9-="*#+.HR-N6WD>M4?$OQ)\72>(?$$/A/3["
M73?#:;K^2Y!+2$9+ 8(Z;6X'/RDYZ"GI?6G_  TF\_VJ#R?[&V^9Y@VYR.,U
MA^';J#2I/C+;WTJ1S;IY0KG!=6\[&/7.Y?\ OH>M '?ZI\1X8?A=;>*K& /=
MWZ)'9VK?-NN&.W9QC."&STR%-6?A=XKU#QGX,CU?4X[=+EIY(R+=2JX4\<$G
M^=>':#K=QH>G>$_[3T;4;ZPL=.N+FUCMHBRB>::0!V)XX3!'H3FNQ^"/C32]
M'^']U;ZL7L;:RN 3=RJ?+D,I.%7'<;>?J* .N^*7BWQ=X1L?[0T+2[&;38(@
M]U=71)V,SA%4*&!/4>M/\5_$&[\/?#O1]7@M8;C6=62!+>#!">;(@8G&<X'I
MGN.:/C9/"GPHUN%I4$KK"50L S?OX^@[UQ'CV>%?"'PRU#SHVM;.XM%N&5@0
MA\M#SZ<(U '1:%X]\7IJ&N^&=;TNSE\2V=E]KL5ML^7<<#"GGU8<@COZ9JO8
M^.O'>@^.-%T;QGI^FBVUEMD+6><QOD#&<G."5!'OD&HI[^T'[1EUJ!N(UL],
MT0R7<V[Y8UQGD_\  UJ'PSJ%O\2/B+%XLU&[MK72],<P:-8R3*)9I"<>85SG
MKCCU '\)R >MZCK6F:0]LFHW]O:M<R>7 )G"^8WH,]3R*5-:TR35YM)2_MVU
M"&/S9;82#S$3CYB.H'S#\Q7GOQZL'N/AV-1AXFTR\BN58=0"=G\W!_"O+;OQ
M)-!KFH_$1&=8-6>_TV/VVVR"$_BP'_?- 'L_B#Q6UXFA7/A?Q)HZ6LVI+;W+
MRRJ1,O&8T.#E\'H,=:CL/%&JS_&77?#DDZG3+33%N(8_+7(<^7D[L9/WCQ7E
M[Z5_9/P\^%R,N)+C68[ISZ[WW+_X[MKM]*_Y.,\4_P#8%3_VC0!N_"/Q+JGB
MSP,FIZO,LUV;F2,LL80;1C' XK-MOB#)8_%/Q3I>N:I;6NAZ=;Q-!YH5-KLL
M9QNZL3N/%1_L_P#_ "3"/_K\F_I7-V^CZ!K7[0_BV#7X;:>%+)'CCN" N?+B
M!;GN%)^G)[4 >S+K>EOHPUA=1M?[-*>9]K\T>7M]=W3VJ#1/$VB>)(Y7T;5+
M:]$1 D$+Y*9Z9'45\NFYO#\'([*)R^E_\),8T,C%49?*#!2>RYR?KS7IW@WP
MOXDTOXI6>KW>CZ+HEG/9O!+:Z=.H64 $A@F22<[,D>F: /7]3U2PT:PDOM2N
MX;2UC^_+*VU1GI^-<!;>.[C4_C!I^CZ9J-O<Z!<Z8;D>4JL&<%QG=U_AZ>U9
M7QUV3/X/L[UBNDSZJHO"3A<?*.3_ +K/6?I>EZ-I'[2D=IHD,$%N--9I(8,!
M$D*G( '3C:?QH ]8B\5:!-H\^KQ:Q9OIT#^7+=+*#&C<<%N@/S+^8I=0\3:'
MI6E0:I?ZK:6]C.%:&9Y %D##(V^N1SQVKYXT:^M;?]F_Q3:RSQI</JH18BPW
M$EH#T^BL?^ GTJSKJ:C?>*?AS8V^GV.I >'+=[:SU!L6\DA1MV<D G"KQWP*
M /HG3-5L-9L([[3;R&[M9/NRPN&4^HX[^U0:UXAT?P[;)<:QJ5M91.=J&9PN
MX^@'4_A7 ?"+P]K?AR_\2P:K!8VD5Q/'<165I<!UMV;?D;025!&W&>R^U8OB
M>SL]:_:-TC3=>CCGT]=/W6UO/S'(V'/0\'D'Z[0* /5X/$FB7.B/K4&JVDFF
M("7NEE!1<=<GM^-5[;QEX:O-2M].MM<L9;RX020PI,"SJ1D8^HYQUQ7@EO'#
M8VOQ;TW2B/[&A0&-$.41O,(PO_CP^BCTI+WP]IFB>&?A?JUA;+#J%S>PO/<+
M]Z0LRMR?;H/04 >Z^/-=N_#/@C5-9L5B:YM8U:-9E)4DL!R 0>_K7":1\6K_
M %7X/ZOXE6*S76],<)+%L;RCN==K;=V<%6(Z]5-=1\7O^24Z_P#]<5_]&+7A
M'B*VF\+>#M/O+>,_V?XHT*""X"]%N(BC!OQ4?JQH ^B=&\56[^ ]+\1:[=6M
MDMQ:1332,VR,,R@X&3Z]!R:M6/B[P]J>EW.I66LV<]G;#,\J2C$0]6_N_C7A
MOB!8KS3O@_IVIG&C3Q1>>K'".?W0PQ^AQ]&-:]EHFF6_Q]U;P_H\,<.EWND/
M%?VT Q&FY!GY1P.2O_?1]: /8;CQ)HEII$&K7&JVD6GSE1%<M* CD],'OG!J
M#5O&'AS0;R.SU76K*SN9 "L4TH#8/0D=A[FO ?#4UQK]WX0^'MT"7T75[F2]
M0CC9$=RY]N9%_*D72-=\3^./'\%MH6DZK=-=20-)J$F)+5-SJC19(QP%Y_V1
MZ\@'T5J6N:5H]I%=:EJ%M:V\SA(Y99 JNQ!( /?(!-44\:^&)!?E->T\C3QF
MZ/GK^Z&<<_CQ]>.M>)>.]/O[+X"^%-.U.:*2YAU00F2&82KM G"@,.#A<#VQ
MBKEWX(\/0_M!:9H<6FPKI;:=YTEKSLD95?&X=^54GU(YH ]"\=^-A:_"Z_\
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MX<FTI6ALI6W1H^) (\G[W*1+[C'K5>."VTOQ7\5M+T5531ET69C'$?D24*O
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MAE95EP6]>44GU(K?^!D26=UXSL(!MM;;52L4>>%&6'\E'Y4 >HZQ_P >4?\
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MV;:SFXC43,'#G=DENI^\?T]*[*B@#G]2\%Z+JMKHUM<P/Y6CR1R6:I(5V%
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MTZ]*Z&SOK/48//LKJ"YAR5\R"0.N1VR.*AM=9TJ^NGM;34K.XN$!+113J[J
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MYD@/4%_)?!]QNQ^%=S:_"BU\3^&O!,^K^;9W>DVT:7%NT7,R@@^6V3\O(/\
MWT:KV'AW75^.GBS4XK*Y@MKK37BM;UD(C,A2(##?4'\C0!!J7Q.\:^%[ZUN?
M$=CX>&G27*PSVUG<[KF 'N1O/( /;';C-=+!\1+NUUCQOI^KV]M%)H$)NK7R
MPP\Z':6&[)//*#C'+5XA/X+UV;P6NG1> =136K>]+7>I.C%IE.["H.XZ9(X^
M4<_-7<?'/1+X>*M)N=+;8^O0C29PO\1$B,N?KD#Z+0!M7/Q5\1+X:\,1VNDV
M4_B?Q!N>&#YEABCW85B"V3D8/4 <^G.[X$\>ZQJWB;4_"GBG3K>RURQC$V;8
MGRY8^.1DGGYE/7D'MBL7X@^&-5T77?"7B;P[I<NIQ:'&+62RA&9#$!A=H )/
M!8< XXXI_@#2]=UWXFZQX[U?1[C1[>:V%K;6MR"LAX09((!QA.X'+<=* #Q]
M_P EP\ _]M*Y?XOVUSXW^(CZ!9N2FAZ1->2*.?WFW?C\?W0_&NV\::+J=[\7
MO!>HVUA<365IYGGSHA*19Z;CVKB]&^&_BWQ=XC\0^(YM:U/PK+=7;K&@A=9)
M8CR <.AV@;1WSCVH TM3\<73?LV6NHVD[)?21QZ=)*I^92#L8Y]2JYS_ +5=
M#X3^#GA;3M+T._-M*=7MC#=M=B9LM(,,1MSMVYXQC..^>:XWP_\ #K7I?!GC
M'P+=V\R+'=+<Z7>RQ%(IW4X)!YP&"KW.-Q]*Z+PCXT\>A](\-WW@:\CE@>*W
MNM2EW"+R5(#..-I;:.S$$]!VH K^ _\ DX/QO_UQ/_H4=9?@C4GT;Q9\7=4C
M ,EF]Q.H/<J\S#]15S6K7Q/X ^+>J>*-+\-W6NZ=JT&TI:ABR-\N<[58@[D]
M,$-ZU?\ ACX+U6XL/%^I^);-[&7Q,[J;9AAT1]Y8D'IDR8 //R^] &5\-OA;
MH'B[P0/$'B2.>^U/59)9#<&=U:/#LN1@X))4G)!ZU[-<)<Z?H,J:=$+BZM[4
MBVCD8 2.J_*">,9('I7BOAG6/B!\.--D\)?\(5=:P(97^Q7D&[R=K$GDA2,9
M)/)4C.#BO4O&%GJVJ_#O5+2R4KJL]B5"(V,N1\R@Y[\CKWH X;3_ (E>*]-\
M8Z1I/B>WT"2VU6;[.C:7.7>"0D !OG/<@?G@\8JI<?%'QS>7_BRVT/0=-N(]
M NI1)/(6&(49Q@KO&YR$)XQT/'(KC=&\*:I)J7@6:S\"7^F'3]0A_M&[EC;?
M.PD0LY!&50 $Y/') Z5;TO6M?TC6OB9#H_AZXU=+[49[<M;99K>0O*%8J 25
MP3_WR.F: .TU?XPWT7A;PEK6DZ7!</K,[03VLA)8.K!2J$$<DYP3GJ.*N>'?
MB'XC_P"$JU3PUXKTJRL]1BLVO+0VS$HR@9VD[CGCN,?=->?>(?#VJ>$_!_PU
MT\PJVKKJ;3"!VP!*TB,J$]NJ@_C74:+8^(O%_P 2M3\5ZEX>N]'M[33'LX(+
MA3OD<J1@9 W#YF.0,=* #P[\7/%>IZ0?$5_H%I'X=LXYOMMS$V&>4*2BQAGR
M 244G!Y8]*B@^+GC'38-)\0>(M L(?#&J3"..2!F\V-3G#'+'/ )Z#(':K_A
M7P7JE]^S_=>&KJUDLM1G$Q2*X4H=PDWIG/0$@<^]<C=6/C/QCX5\/?#^?PG?
M:<-/F07.HSH1%L0,@()&#\K$\$Y(XZT >F6OQ"NK?Q)XSTO6(+:-=#MOMMJT
M08&:#:6^;).3R@XQR37/S?%?Q"/"WAHQ:;IQ\1:^SM#&Y9((8E; =LMGD<]>
MF?H:/QC\'Z_>>(K*\\-64\PU&Q.FWIA0L$0.K L>P/ SZ+5CXH^ 9-WA>^LM
M#EUO3-(A%G=:= S+(\0 "E=OS>O3OCMF@#H/"/Q+N;RU\1V_B6VMK?4M C,]
MP;)]T4T04G<F2>>/7N/H/*_'OC/Q9XK^&J7^KZ':VVBWM\ILKB!SN4KO&UP2
M<@X;#8'*].17;^$?"EEJFD^)[?3/ ]YX7CO=/:TBFOYY6>9F#=4<G: =IZ<^
MM<1J=IXYU+X6VG@T^#-0C.E7.9+G83YPR^T(N.?O<L"1P/6@#Z%U[4I=&\'Z
MGJD"(\UE82W$:R9VEDC+ ''.,BO(X_C%XQ@T32/$^H>'K%/#EQ-Y$\L;-YC-
MN(+(-WRCY2!D')4\C(KU#QL"/AMXB!&"-(N<_P#?EJ\$M$\6>*?A?X=\%V?A
MN<VLT_FKJRY:'RM[_>XPI!)SDYPHP#F@#T;Q%\1_%D7Q!OO"GAG1;+491:I-
M;,Y*X)56+.2X7;@D#IR5Y[&E=_$WQMJFK:I9^%="L)TT.(?VB]R22TH!WJ@#
MCNK@#G.WKVK8T/0;^R^.^KZB;*X73#HT=O%=,AV.P\GY0W3/RG\C7*M%XK^'
M'BSQ>MAX7O=9M->D,]I<6J,ZQ,2Y&[:#C'F$$''W?>@#*^)/C2_\:_#_ ,,:
MM96,,=H^HA9U9\M'=J&"H.1E2I8YQZ<BNTUKXB>,=%M-&T:;0]/;Q?JLSK';
MHY,$<8.%8X;DGG^(8P2:Y>\^&_B+3?@CIEC#8M<:M#JRZG/:1D%E&UEVC'4@
M;<X]_2M/Q0GBC4M3\+?$2U\*7BW5@SPW>D9+3*FX@$?*"<@MT'&1UH VO#WQ
M2U""Y\0Z5XRTZ"SU71+5KQQ:$E)HP >,D\G<F.>=W;%.\'^-O&^LB/7M8T73
MK/PK-%+,)8V)FB1%8ACEN0=N/NCUX%<WIOA'Q!X]UWQ?XDU/2IM%74M-:QLK
M:Z!5]V$ + @''[L9X_BXSBM3P5J'B:]\/1^ -7\)7]@B64UE-J<BD0A/+95*
M\8)Y X8^M &:?C!XU;27\71^&['_ (1-+GR2"Y\_;NVYSNQU(&=N,\>]:TM]
M!JG[0OAC4+5BUO=>'?.B)[JQF(_0UQ0M/',/P]E^&/\ PA]ZTSW.T:B ?(\O
MS1)G?C;]X=<]#ZUW-EX4U'2?B[X49+6>73M-\.I927BH?+\Q1(,$]B<@X]Q0
M OA'Q]XS\7:RMU9Z?HIT$WAADB$Q^UPQ@XWD;OZ?058^/O\ R3&3_K\A_F:X
MD:%=ZG\0]%O-&\!:MX>U&+4EGO[MF?[*T8;+E20%Y&>!C/3!S7;?'W_DF,G_
M %^0_P S0!K_ !)O[3P?\+-6_L^"&T5H3;6\4""-5:4[25 X!^9F_"O-_@_;
M7/@GXA#P_>L0NMZ1#>QJ>#Y@7=C\/WH_"ND^+>G:CX\'AK1="5[G2[FZ,MUJ
M%NOFPQ '8"6!P<9D.,]JYS5_AQXL\(^)O#OB.'6M3\526UVJ2*87:2&$<D#+
MN=I!8=L9]Z *?]@V7CFY^*>N:NC37>G&5+!BY'DB,2;> <=$4?GZU6\.7 ^(
M_B?P+H^OE[K3[;297DA9R/-=7E0$D'/2./\ (^M;&M:;XK\(:SXVTK2O#=YJ
MEGXIW-;75NI*P&3<&W8! QYC#DC[H/2I)?!NO?#F^\'^(=,TB;6#86#6FH6E
MIEGWN78D8!)&93R!_",XS0!Q5]J%SI^@>(/ EM<2K81^)EM4RQ)$):0;?IF-
M3]<^M=I=Z39^!?BU=:'H<36^G:KX=F>2WWLPW*DI!Y)Y_=?^/'UJA)\-O$NI
M^!=6\0/I[0>(+S6!JT=BWW]@W_+@_P 69&..ORCN<5OZ-%XJ\3^.K[QW<>&;
MC39--TE[?3[*\!5IY]K8'(4[26;GCJ/? !QWPW'A+2==\/6^O^&=5T_6I) ;
M?4)W=(I9=WRG8<<<J,C(SUJ.Y\0^'K_QYXKU7Q9H.I:XD-T;>(0 ^79VZL4#
M,0PP3@8Z#.><FNIUF?Q9\3_$GANRF\&WVB6^FW8N+JZN@VT8(R%8JN>!P!G)
M(Z8S575]'\1^$]2\<Z/8>%[W5;;Q02UK=VR%DBWE\AR <8\P]<?=ST.: (?'
M3^&++Q7X,U;4(CJ/A Z.(+:TCDW2 *&VL4+!B,%,GU7GIBK_ ( T709?@W>W
MWB>/[3H,6HR:A#;1S%S$@4( VPYSR3MSW!/6HE\.>(OAUXE\,ZT-!N]=@M='
M%G-'9*9'AE)8L  "<9;KC!R:N>#G\5^!?"MYJLG@^[O/[6U22=]+A!\VWB*\
M-M )Z\8(Z =* *_P?FT2+QIXMUO1[B/3O#"11HD-U<!64D@[V!8D+D/@G^]C
MUKTKQ7\0=)T#P9>^(+*YM=36%A#&MM.KJTK8PI9<XZY/M7G_ (/\)WWC'QMX
MEU_7_#<VCZ-J=H+7[#+NB>4[HSGC:?\ EGDG Y;OS6WXS^%5DGPRO]#\)61B
ME-RMZD#3,WFNH"D9<G!*].V0* (_"WQ(\1MXNTW0_%ECID0U:$RV<MA(6\M@
M,[)!N;G Q]2.O::W^*%_;^&O&MSJEK:1ZGX>N6@2.,,(Y-QVQ$@L3RP/0]*Y
MKP)H6FMXIT=H/A9JFD7-NQ>YU"[N+A8X6"'E%=L/EL#\>AIOQ#\":YJ7Q/$>
MFV=P^B:ZUJVI2QH2B&-L'<>WR@-^- '5ZIXH\?KHFBWMC:^';<W=DEQ<2:A,
M8E65LGRT!<'(7&<YZUP_C+QI)XY^$FEZA<VT=O>6_B&*VN(XFRF]8W.5Z\$,
M.Y[\UL?$30;]_BI8:C=>%+OQ'HIL!!;VT&?+BER?O8X49(.3@8/M7*VW@OQ-
M%\+GT]M!O$NQXH2X\A(6XB$)!<#^[GC- 'L$OC*_3XOP>$!!;?89+ W1EPWF
M;N>,YQCCTK,T'QWXC\0Z;XN-EI^GO?Z3?&VM(V)1'4.06D);L 3P1TK)\;V_
MB'P_\8=,\5Z5X>NM:MI+ VK1VX/ROEA\Q .T<J<D8ZUR5MX2\92_#CQQ;R:7
M=0ZC>:DEPT"(0;A Q+B/^\,\\=0* .MTCXD^+O\ A)G\-ZG::#<ZE=V4TVFR
M:=.6B,RHS*DAWG@[3W!_.N1^%^H>)K;P7XF']DZ?<>'@;Z6\>5SO\X6X/EX#
M E#A <#N>:M^$?#=]_PL_P *:M9>";S0=+AMY$F,J,6+^5("[D\KDD 9Y.,]
MZN^$[#Q1H&A>+_!USX7O&BNUOIX=00DH[-#M5  ,'=M&.>^,4 :D/Q%'A?X.
M^';[3M'MA?ZD[06=A#N$2MO;)Y)8CIQGDMVK3\+^/_$L?CF+PAXUTNSM+ZZ@
M,]I+9L=C  G!RS?W6YSU7&.<URFH>"O$4GPB\&W%GILS:OH-PUP]A(NV1E,A
M;IU)X4X[@FM30K;Q#X[^+>G>+-1\.WFAZ=I-J8ECO%*O*Y#] 0">7)Z8POJ:
M ,E/C-XXNO#5]KEKX?TQK+3;OR[NX)8+M)4*JKOSNR>3R/F7CK7M5CK=M>>&
M;?7FS%:S6:WASR40IOY^@KQ71/"NO0? ?Q;I4ND7B:A<ZD9(;9HB))%S!R!U
M(^5OR->J:#H\L_PNTW1;M'MYI-&CM)5=<-&QA"D$>HYH \T/Q@\:R:3+XN@\
M-V)\)Q7/DD,Y\\KN SG=CJ0,[<9..>M9/C^]UGQ)\4O#,MAI&G:E:7%F)]*M
M[S!CN4>+>QE4MC(.>./NCK59;3QS:?#ZX^&8\'WLDTESA=14'R/+\P/G?C;U
M'7/0],UVTGA+4M,^)'P\6&UFN++2=-:VN+M$)C5A&R\GMD_SH W?B@=3MOA)
M?QV-E;!OLHCN8A\J0Q;?GV $=. !S7D^JW/B2;]GP1:O8VD&EQBT&G30OEY5
MW')<;CCMV'6O>O&NEW.M>"-:TVS4-<W-G)'$I.-S;3@9]SQ7C5[;>*M:^",O
MAF;PCJ-K>:8UM'%E2QNAN;<RKM&-N!GD]: .C\-?$7Q-%XPT'0M>T2VLM,U:
MU#6#(Y:4 )E2YW$9..1@$;AZ53U/XO>)9;K6=1T'2]*DT#1YS#*;J8B>XP<,
M4^8<=^AX/?I6IX@T+5;CXD?#Z]AT^X>ULH"MS*L9*PG;T8]JX ^!XO#>N:Q9
M:Y\.M4\2>;<M+87ME+,J&,GA7*'"_CR#GMB@#Z'T35K?7=#L=6M<B"\@29 W
M4!AG!]QTKY6TR\^']MK.OKXQTW4KNY.HRF!K1L!4W'(/SKSFOJ#PI9#3O">E
M6HT\:<8[9-UF)#)Y#$9*;B23@DC.:\/\.7GC'P7J&O11?#V\U2.\U"2=)7C9
M<#)QCY3D'K0!V.DQK%^TEJD:#"IH**![!HJ;\=+N6\TO0O"EJV+G6]01"!_<
M4@<_\"9#^%9&NW7BS0?BW<>)],\(7NIQW.EQ6Y1%8*K$(S?,%/(*XQ6?J'A_
MQC\4?'UE>W5KJ/A2.RL 8[DQ.?+D#9(0Y0[CNZY'W: .@^#-Q)IVD^*?"%RY
M,VC7DH3/>-LCCVRA/_ J\5M;;P>/A5<WDUP4\6K> 6R)(^3'E.J_= QO.>N0
M*]9\,^"_$O@?XJOYUQ?ZY8ZII[I<ZFT+8#G)4.2S<Y11DGH]:'P<^'ME;>%E
MN?$?AJ)-6CO'9&O;?]X% 7:0&]\XH ]+\+R7DWA+1I-0W?;7L8&N-_WO,*#=
MGWSFM:BB@ HHHH H:Q_QY1_]?5O_ .CDHHUC_CRC_P"OJW_]')10!@_"_P#Y
M)CX=_P"O-*ZVN0^&<B1?"WP_)(ZHBV*LS,<  9Y)JCK/CRXM?B#X7T333876
MFZNLAEG!+L-N?N,K;>W<&@#O:*JSZG86UW':SWUM%<R_ZN&255=_H"<FI6NK
M=+E+9IXEG<92(N S#U ZGH: ):*P/%6L7NGZ#J#Z#]@N-9MU1H[:YF55Y90=
MV67 P21DCM5ZSU QZ!:7^KR6UK*UO&]PWF 1(Y4;@&R1C.<<GZF@#1HJLNH6
M3V7VU;RW:T SYXE4QX]=V<4^UO+6^MUGL[F&XA;I)"X=3^(XH FKF](\&V>C
M^+]9\1PW,[W.JA1+&^-B;<8VX&>W>D\0:KKUCXD\/VFEVMC+I]W*ZW\EQ*JR
M1J-NTQ@NI8\MT#=JVIM5TZW$QGO[6+R #+OF5?+STW9/'XT 6Z*;'(DT:R1.
MKQN RLIR"#T(-5)=9TN&\6SEU*SCNF.!"\ZAR?3;G- %VBD9E1"S,%51DDG
M JM'J=A-+%'%?6SR3 M$JRJ2X'4J,\X]J +5%5;;4["]GE@M;ZVGEB_UD<4J
MLR?4 \5)%=VT_F^5<12>4=LFQP=A]#Z4 3455;4[!;(WK7UL+4=9S*NP?\"S
MBI(KRUGM!=Q7,,EL5+><C@I@=3NZ8H FHJF-6TXLJC4+4EHS*H$R\H.K#GH/
M6L_5-<\SPWJ-[X=N+"_O((6:%3.IB+XX#-N  ^I% &Y17FNO^//$&A:9X+>:
MTTX7NLW4=O?(,R)'DJ#Y95R._7+"N].IVLUI=RV5U;W#VRMO$<@?8P&<-@\?
M2@"[17'_  U\67GC#P1#K>IQVT$[R2*P@!5 %.,_,2>GO73V>HV6HHSV-Y;W
M2(=K-!*K@'T.#0!9HJ&YN[:SC$EU<101DX#2N%&?3)J-=2L7>X1;VV+6W^O4
M2KF+_>Y^7\: +5%0VUW;7MNMQ:7$4\#?=DB<,I^A'%16NJ:??2R16=_:W$D?
M^L2&97*?4 \4 6Z*R]:UF#3+&\VW-M]OCM9+B*WD<;GVJ3G;D$CCM6-\/?%=
MSXI\!6?B#51:V\LIE\SRLI&H5V7/S$XX'<T 5/%OPRLO%NJM>SZWK%FDT2PW
M-M:3A8IE7.,K@\\]\UUNEZ9::-I=MIMA"(;6VC$<2#G 'OW/O4EI?6FH0>?9
M74%S#G'F0R!USZ9%<C\+O%^H>-O"3ZKJ4-M%.+J2';;*RKM4+CAF)SSZT =K
M156]U*PTU4:^O;:U5SA3/*J!CZ#)YKGOB!XR3P9X-N=9A6&XG^5;:)WPLA8@
M9XY( .>* .KHKFO NJZYK/AT7NOKIBW4DF473G+((]JD;LLWS9)R,^E<I\3O
MBV_@'6;/3;;38[Z26#SYM\I7RU+;5Z ]<-^E 'J%%<9XZ\=?\(MX&B\2V-M'
M>I,T7EH[E0RN,@Y'M5[QQXHE\)>![WQ!%:I<26XB(A=BH.^15Z_\"S^% '2T
M5Y[X&\:^*_$NJ+'J_A%]+TZ2V,T=V78JYXV@9'<$G\*UO'_BF[\+Z-:-IL4$
MVJ:A>PV5I'."4+N>20""1@'H>I% '645POQ%\<ZMX*M(I[#P[)J<7EM)<7.\
MI%  0/FX/)SP,_G4M_XQUA? 6BZYI&@-J6HZHL.VSCD(6,R1ER2V/NC&.<=>
MHH [6N2N? -E?>/(?%5[?WMQ);8-K9/)F"!]H7<J^O&?KS61X$^(NHZ_XEU#
MPQXBT4:5K-G%YQ1'W*R?+G\?F4C!((/M7>W=[:V$!GO+F&WA!P9)I BC\3Q0
M!/15<WUH+,79NH!;$ B8R#80>GS=*5KVU1H5>YA5I_\ 5 R &3_=]>HZ4 3T
M52DUC2XD+R:E9HHD\HLTZ@!_[O7K[58N+F"T@:>YGCAA3EI)7"JOU)XH EHJ
M"&\M;FU%U!<PRVQ!83(X9,#J<CBL7Q'K\EKX?N9M"GTZZU0Q&2TAGN$"2X;!
M.2R\#GG(Y% '0T5EZ5J;OHNE3:O):6VH74$;21)*NTRE1N5#N.X9.!@GMR:L
M#5]-:VFN1J-H;>%MLLHF7;&?1CG /UH N45$MS ]L+E9HS 5WB4,-NWKG/3'
MO3+._L]1B,MC=P748.TO!(' /ID&@"Q7-^&?!MGX7U77;^UN9Y9-9NS=3++C
M",68X7 Z?.>M:[ZSI<:;Y-2LT3S/*W-.H&_^[UZ^U<]XI\>V?A?Q%H&D30K*
MVK2M&TGGA!;@%1N8$=#N/I]TT 6O%'@VS\57^B7=U<SPOI-V+J(18P[ J<-D
M'CY1TKI*HSZSI5LD+SZG9Q+-_JFDG51)_NY//X5@>(/%5UH?C+PU8,EN^DZP
MTD#38/F), "F#G&&SCI^- '6T45G:]JT6@^']0U:8 QV=N\Q7.-VT$@?B>/Q
MH T:*\Y^%WQ/?X@MJ4-S81V-S:"-U1)"V]&SSR!T('YBLOQ'\7=4L==U>#0O
M#G]I:9H3!=3NC+MVG."%'L01WZ'@ 9H ]:HKS7Q%\4Y8SH5EX3TG^U]4UFV^
MUPPN^P1Q8)RWO\K#J,;34"_&:T'P[F\0RZ:Z:G%=?8&T[?S]HZXSC.W&3T[$
M4 >B:QIL6LZ)?Z7,[I%>VTEN[IC<JNI4D9[\U5\+^'[?PKX;L]$M9I9H+12J
M/+C<<L6YP .]<9X:^*%S+>ZOIGB_2/[&U'3;0WS(K[U>$#)(]P".,G//3%9F
M@_&/4KW6-);6/#9T_0]:F:#3[SSMQ+ [1N'H3@=NN1D"@#UVBO)O%7Q,\8^%
M[R\O9_!:_P#"/6UT8/M37&&D7=M#X_A#=LC'(YJ]X@^)VH?VO8:/X/T/^U]0
MN;%=0<2R",1Q,-P'7[Q!'?N.N: /2Z*\NG^,ML_@/3=;T_3'N-5U"Z^PPZ<9
M,;9QC(+8Z<J1Z[ATYQH^%?B/+>R:[I_BC3ET?5=$B^T742R>8AAV[MZD9Z C
MN>HYYX /0**\Q\,?$+Q=XFU&TO(/!IC\,W<WEI>-<#S%7)&\KU(X[#'O7H][
M,UM8W$Z %HXF< ],@9H GHKRS3?'WBS6OA3:^(]-L-)DU>6Z:)H97\J (&89
M&^0<\#^+\*].6ZMWN7MDGB:>,9>(."RCU(ZCJ* ):S]:T/3/$6GFPU:S2[M2
MP<Q.3C(Z'BK*WUHZ3.EU RPDB5A("(R.N[T_&DL[^SU&$S65W!<Q [=\,@=<
M^F10!%I.D6&A:9#INF6R6UG#N\N),X7)+'K[DFKM5%U73F,86_M297,<8$R_
M.XY*CGD^U<YXF\>V?AKQ1H6B30K(VJ.RM,9P@MP-O+ CH<^W2@#KJ*J'5=.
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MQ#X;MK'^UW4-'8W=RFU!YP0[R63'RY(R1SCKWZ^WOQ%HMO>ZI+;VS&%'G8R
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M#IU]HLCW$!D9PK!7(Y8D]4!Y_O'UKO-6^%6B:SX=T+0[NYO3::.1Y6UU#2C
M&'.WN!VQ1X5^%FD^%]3U#4A?7^H7MW$8!/>2!WCC/8'')X')]!TYR >,37]W
M:?LVZ5;6S.L=[J[03[&V[DR[;<]LE1^5=7X"T#7=(^)UC>V7@RZ\.:+-:M;W
ML3WOVA78*S*^3@YR%'3U]37H%O\ "[08O +>#IGNKC3R[2K+(R^:CDY# @
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M^,_,U341>2>'['[/I2,I&Z(NP,@!] 0OK\P]*]0LOAI:V?AG5M';7=8GDU;
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M8L8V#V( S]!Z5G:!\%] T'Q#;:HM[J%U%9NTEE9W$@:*W8G.1QS@\CW )R:
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M<:I(\%W^\8>8B;-HX/'WCTQUKTWP=X/L?!6F7-A83W$T=Q=/=,TY4D,P4$#
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MIYC#UX&>E<K=^&[/2/@]X6\8VSSC6I-3"B8RMA$#2[55<X&#&#QW)KW?P_\
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M'=@*".!D,.G2H)_B_J5MI\)E\(7D>J:C=^3I=A(Q1IX]JGS&)7C[P&!^?!-
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MS7T310!XS?:)>:K\;O%END,B1WWAR2V2<H0FYTC4?-T__57"C6]0'PJ/PO\
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M$G!.W(''&>,XKTCXU^'[_P 1?#J>'3H7GN+:=+GR8QEG5<@@#N<-G'M7H=%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 4-8_X\H_^OJW_P#1R44:Q_QY1_\
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M@[_H,K_WXE_^)H ZVBN2_P"%G>#O^@RO_?B7_P")H_X6=X._Z#*_]^)?_B:
M.MHKDO\ A9W@[_H,K_WXE_\ B:/^%G>#O^@RO_?B7_XF@#K:*Y+_ (6=X._Z
M#*_]^)?_ (FC_A9W@[_H,K_WXE_^)H ZVBN2_P"%G>#O^@RO_?B7_P")H_X6
M=X._Z#*_]^)?_B: .MHKDO\ A9W@[_H,K_WXE_\ B:/^%G>#O^@RO_?B7_XF
M@#K:*Y+_ (6=X._Z#*_]^)?_ (FC_A9W@[_H,K_WXE_^)H ZVBN2_P"%G>#O
M^@RO_?B7_P")H_X6=X._Z#*_]^)?_B: .MHKDO\ A9W@[_H,K_WXE_\ B:/^
M%G>#O^@RO_?B7_XF@#K:*Y+_ (6=X._Z#*_]^)?_ (FC_A9W@[_H,K_WXE_^
M)H ZVBN2_P"%G>#O^@RO_?B7_P")H_X6=X._Z#*_]^)?_B: .MHKDO\ A9W@
M[_H,K_WXE_\ B:/^%G>#O^@RO_?B7_XF@#K:*Y+_ (6=X._Z#*_]^)?_ (FC
M_A9W@[_H,K_WXE_^)H ZVBN2_P"%G>#O^@RO_?B7_P")H_X6=X._Z#*_]^)?
M_B: .MHKDO\ A9W@[_H,K_WXE_\ B:/^%G>#O^@RO_?B7_XF@#K:*Y+_ (6=
MX._Z#*_]^)?_ (FC_A9W@[_H,K_WXE_^)H ZVBN2_P"%G>#O^@RO_?B7_P")
MH_X6=X._Z#*_]^)?_B: .MHKDO\ A9W@[_H,K_WXE_\ B:/^%G>#O^@RO_?B
M7_XF@#K:*Y+_ (6=X._Z#*_]^)?_ (FC_A9W@[_H,K_WXE_^)H ZVBN2_P"%
MG>#O^@RO_?B7_P")H_X6=X._Z#*_]^)?_B: .MHKDO\ A9W@[_H,K_WXE_\
MB:/^%G>#O^@RO_?B7_XF@#K:*Y+_ (6=X._Z#*_]^)?_ (FC_A9W@[_H,K_W
MXE_^)H ZVBN2_P"%G>#O^@RO_?B7_P")H_X6=X._Z#*_]^)?_B: .MHKDO\
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M@[_H,K_WXE_^)H ZVBN2_P"%G>#O^@RO_?B7_P")H_X6=X._Z#*_]^)?_B:
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M/!<W-Q=$B&"V3<S8QD]?<5Y;;:EXKNO USXB_P"$BN$2QN0BQ#[TF2@)8YY
MW#@@CK6GXBM=1UCQAX8N8]5DMI-1MEDA*)G[,=@+;>><GZ5A+%.4?<6NGXGI
MT<CA3KVKU$XKFO:^\5>VW9WT\UN>L6EQ]KLH+GRWB\Z-9/+D&&7(S@CU%35Y
MI>RZYX@\:R>&;37)["#3K16EN(@0\S[5R3@@\EAQGL:S#XKUL> M;AGO7&I:
M7=I!]J0X9E+XY/?H>?3%:?64KW7?\-SE623GRN$U=\NFNBF[1>W_  3UZBO(
M_$,GBG0?"\&J3Z]-)=:A<P%8TRHA&R0E!ST.5ST^[4C#Q9;^-CX;/B21S?V_
MFO<&/_4]2?+7/'W2.,<&D\39VY7_ ,/L$<DYHN:K1MKW^S;FZ=+_ #Z'K%%>
M7:%KE[+X+UNWU77Y;62QNQ"-0(+R!=PR!W).& [\^U4?#VM7UYXE?0['Q'J%
MS:WUH_EW-W$=\,@!(903D\#U'7VI_6HZ:;^@?V'52J-R7N;Z.UK)WO:VSVW/
M1HO%&F7?A^[UJQE>ZM+97+;$922HR0 P%7-(U*/6-)MM0BC>..X3>J2?>'UK
MR7P5::G:^!M5UFWUF:*"&*X"VBIP) @(?=GKT[=JUM1\2:Q_PB'A6RM+QTU#
M66$;W3<L/F Z_5AS[5$,2[<TET_4WQ&2P55T:$K^_:[OHDFVGIT2O='J-%><
MZ->:SX<\>IX:U#59=3MKNV,T4LWWT(#'N2?X&&,^E<I;ZEXKN? \_B,^(KA$
MLKD(L0ZR9*@ECGD L."".M4\4DMGU_ QIY'*<M*D>5\MGKKS72Z7W5M3VRYF
M%M:RSL"RQ(7('4X&:HZ!K4/B#1H=2@AEACE+ )*!N&&(YQ]*3[;)<>%OMX.R
M62R\X%?X24SQ7G,WB#5_^%9:+>2:C=Q?:+QH[R]C&Z1(][#C\A^0'>KJ5N1W
MZ6O^1SX3+GB(.*TESJ-]>TGM;7;].IZU17,>!IXKC1YGAU^768O..V692LD8
MP/D8'GU.?>N>E;7?&'C'6+*RUR?2K+2BL:B '+N<\G!&>5;]*;K>ZFE=LB&7
M-U:D)3Y8PU;:?=+:U[W?8](HKS6_GUWQ#XWD\-6NM3:?#I]HKS3P [I7VKD\
M$'JXXSV-9G_"5:V/ >OP3WK_ -I:5=1P"Z0X9E,FWKW^ZW/I4/$I-W7?\-SH
MADE2<8VFKOETUT4W:+V_X*/7:YJ7QI9#Q1_8,%G>7-PKJDTL4>8XB?[QS_2N
M0L[WQ'I'BCPS+?ZS)=Q:Q&/,MR,)'D#@#/4;@<\'(-1^#-&U(>/]:SK<Q^QS
MH;G]W_Q]YW8W?-QC\:EUY2:45;7]+F\,IHTH5*E::DE&ZM>U^;E[7T>GG==+
MGH/ASQ!!XDT^6\MX)H4CF:$K*!DD '/';FFZMXCMM(UC2]-FAE>747*1LF,*
M1CKD^]>?VWBW5;7X8:EJ#W<DMZ;]K:*9SDH"%Z?09Q[FHKK3=7TSQ=X.CU35
M7U$22^8C2#YHV)7<N222.F/QI/$/E5M]-?5FD<GA[>;J-**YTE=MOEC?1VZ.
MV]CUZBO%-9\875[JVLS-XDN=,:SD9+"TAC8K+M)^\1QSCOGKZ"MOQ!XIU:Z\
M&>&M2L+AK>[O)PDFPX5V&5(/L2.E4L7!W\O^&,)</XB+IIM+FTZZ.W-O;73J
MKZGJ%8\/B;3+S0KW5[&5KJVM%D+[4922B[BH# <XQ7%Z:?$%GXUU#PU=>()[
MG[78M)'<LG^I<CAE7/&.> 0.E8W@FRU.W\(:UK%OK4T4-M'= 6BIP9!%D2;L
M\'..W:D\1)M)+O\ @5#)Z4:<ISJ)_ U:]FI7\KZVLNW4]7T;5(]:TBVU&&.2
M..==RI)C<.2.<?2EU?4H]'TFZU&9'>.WC,C*F,D#TS7!S:LTGPYT6[U'Q'<Z
M=+,27FB4O+-]X;1CGT.?:L*PU^[O=!\6:7+J-SJ%K#9^;!-=*5D X!!SSW'Y
M>]#Q-DEU:_2^P4\E<YRFOAC*S6NW-RZ2M9_F>MZ7J$>JZ5:ZA$C)'<1+(JOU
M (SS5NL/P;_R)>C?]>D?\JW*Z8.\4V>+B8*G6G".R;7XG.ZYXVT7P]J4=AJ$
MLJ32() 5C)4*21DG\#5W7?$.G>'+!+W4)&6%W$:[%W$D@G@?0&O-?B!I?]M?
M$RQTX'#3V!"'_:'FE?U K%NM0NO%^EP6DZR*FA:9+)<$\;I1\J_CPG_CU<<L
M3.+DK>A]+0R/#U:=&IS.S5Y^CO:WJU8]KT?5[77=+AU&R+FWFW;2Z[3PQ4\?
M4&KU>5:7=Q6OPCT=IM<FTA3<29E@0M)(-\GR*!SUP<^U5-$UO5[^+Q%I-EK-
M]=>39_:K.YG4I,&4J2O.3SG'^&:T6)LHIK5K]#CGDCE*K*G*T8R:U3V4K7O:
MSMNT>P45YK;^)K[7KOP9:6=W)&\\;3WQ1L;Q'P0?8E'_ #%9D=YXD\4VVNZ_
M:Z[/8P:>[_9[6+A6"#=@\^F.3G)/I3>)7V5?_AKF4<DJ?\O9J-M[WT]YQ6RZ
MM/Y'KM%8'A+79-;\(6FJ7( E*,)=HQDJ2"<>^,_C7*>$H_$7BN5?$DNOS6T
MN_EL4!\MHU894\XZ9'0^M6ZR]WE5[G-'+I+VOM9**INSW>NNBMZ/4]*HKQGQ
M/K\EA?W]QIWC#4)[R&X)6VCB/V=!O^X3G!P.^"#BM?4=4UW6?&>DZ?IVJ26$
M5_I:3R;1N";@Q) ]> !6?UI7:MK\CL_L*IRQFYI1:;NU)6LDWHU?9Z6/3Z*\
MFLM?UJ'P+XHAGU&:6\TNY$4=T6^?&\ \]>Q_.FV^H>)=+U+PCJ-YK4MU#JYC
MC>V(PBJ=@!//+$,#G .:/K2TT_J]A?V%4O)<ZNFTM];1YM-.W<];JAJVM:?H
M5M'<ZE<>1%)((E;8S98@D#"@^AKSYYO$'C'Q+K\5AK<VFVVDL8HHX<CS'!8#
M=@CJ4/KU'%<[KNJZCXF\ :5J-U>L'@O_ +)*@3B1]NY9.O4#CIW/2E/%63<5
MZ>=C7#9%S5(1JS5KKF2O=<RNNEM?P/<J*R=(T_4-)T9X+K49-3NE+,LTB;2?
M1<9/\Z\^\#ZQ+J.M6K7WBJ]_M$R2>?IEQ&1&WWAA3T!'!Q[8Q6LJW*XIK5GG
MT<O=:%6I"=U#LGKOY72TW=CO=!\26WB"74([>&6,V,Y@<R8^8C/(P>G%;5>(
M6EOK36WBZ]T[5I+"&RNY)F6($-,P9N"P/  'XYKI=5UT7GA+P_>W_B.ZTJ6>
M(EULXRTEPPP,\=!D$^G-90Q/N^\M?^#8]#%9*E62HR]UM*UFVGR\W1:W\MNI
MZ517C=GXLU9O _B94U.YFET^:#[-=N-LI1Y,<]^BGKZU/JVI^)?#WAN"_N]=
M9Y]8\H+\IQ:)M);;UYP5R0,\'J>:?UN-KVZ7_0C^P*O/[-S5^;E2UUT4NW9W
M^5CUVLC7?$$&@FQ$T$TOVRX6W7RP/E)[G/:N&\$>)9&\7/HT>N3ZS83P&2.>
MX1E=)!R1\W., _I[UO\ CW4KW3GT'['<R0>?J*1R[#C>IZ@^U5[=2IN<3'^R
MY4<;'#U-;J_5:6?E=;=CL:*\VU>;7M4^)-WH6GZS+8VQLP[%1NV# R5&1R3@
M9SW-9,/C+6;3X9WLDET\FH17_P!B2Y8Y8 C=G)ZGAAGZ4GB8INZVO^!<,DJU
M(0<)IN7+IKHI;-Z>1Z-J7B.VTS7M-TF6&5YM0+"-UQM7'KS3M&\00:U>:G;0
MP31MI]P;=S(!AR"1E<=N*\[FTS5M)\?>%+?5-4?422S))(/F4G[RYR<C.,$^
MM7X-0UG4-.\<K#J%P)[&[<VI5N8U1F.U?J%Q4JO+F=U\OE<WJ971]E'DDG=+
MWKNVLW&]K=MSTRLC0?$$&OI>-!!-%]EN&MV\T#YB.XQVKD+?Q)?:]JG@ZTL[
MN2/SK<W5\4.-X7@@^Q9&'XU4M?%>J6?@SQ1?O=237,%^T%NTASY8)4#'TR35
M/$*]UM_P+F,<GJ*#A*W.VDM7I>3CVZV^2.XUOQ';:%>Z7;3PRR-J,X@C*8PI
M) R<GI\U;->,ZA8:S97W@N74]6DU!+J\BF E&6A8LA*AB<D8(_+WKJ](U:_F
M\8^+;66[E:"UB!@C+<1G':E"NW)J2_JUQXC*81HQG2DG9-MZZ^_RZ7]3NZJZ
ME?)IFEW5_*K/';1-*RKU(49P/RKS:PUN:Y^&=K>:IXDN;"1KQE:Y0%Y9 ,_(
MN.?0Y]JS]*\075U9^*](;4[K4;-=+EGAENT*R A0"#GG^+].U#Q2T\T.&1U+
MR<G=0E9Z/5)I.SM;KM>YZKHVJ1:UI%MJ4*.D=PF]5?&0/?%7JYSP%_R(VD?]
M</ZFN6T >(?&=]>:U'K\]C:6]X8H+2,'8RK@D,,CL1SSR35^U:C'2[9RO 1E
M5K>\HP@[7=WU:2TOV/3**\L:?Q#XPUSQ UCK<VFVVE,8X(H<@2,"P&[!'7:>
MN>M4KKQEJFH^#M$N9[^XLHGNI+>_O+5/G^4 J>,8R#SCT_"H>*BM;?\ !UL=
M$<BJR:BIJ^EUK[MTY+IK=+IUT/4M6UFPT*Q-[J4_D6X8+OV,W)Z<*":NJ0RA
MAT(R*\<\6(]W\.H+N#Q++JEK%=E2SH0S[L8#9.05P>O7=5[Q$VL>&[71[*_\
M37_V*YED>>_AB(=/E78G#$XSD]>YXXI/$M-W6EEVZFBR6$X04:GOMR5FI?95
M]%:]_+K=)=3U:BL/PC*LWAV!TU=M60LVVZ92K,,\!@>01TYK@_M/B/Q;=>(-
M1L]<GT^WTQV6VMXL@/MR?FP1U ZG/7T%:RK<J32NV<-#+75J5(N:C&&C;3ZN
MRTM?7S6G4]8HKR2]\7:YJ7AKPO=65T8;^YO&MY2O"RL" -P]#D9'N:] T?3M
M0T?0IX;_ %.34+G+R"=P01D<#DG&*(5E-V2'BLLGAH*522YFVK:WT=F^UC;H
MKR?PJWB+5=!;7=0\426ME;I/& P+9RC#S&YYVL00.?NU2TOQ)<6_BK3+?3_$
MNHZG;7LA@F^UQ,J@G@,F3ZG/&.GO6?UI63:W]#K>13YIPC43<+WLI6NKNU[6
MO9'JVGZUI^JW%Y;V5QYLME*8;A=C+L<$C'(&>AZ9J_7C_@W3]1M-:\17QUN;
MR],NY&NHQ'_Q^%=^2?FXS@GOUK'7QOJ*P+K1\2SMJ7VC)TORF\GR\]/[O]<=
M\U*Q=HIS7<VEP^ZE:4,/.Z7+T>[5[;;=;[)-7U/>**CMYEN+>*9>%D0.,^A&
M:DKL/G&FG9A1110(**** "BBB@ HHHH **** *&L?\>4?_7U;_\ HY**-8_X
M\H_^OJW_ /1R44 8/PO_ .28^'?^O-*Z:\ADN+&XAAE,4LD;(D@ZH2, _A7,
M_"__ ))CX=_Z\TKK:!IM.Z/.X?"?B[4M7TT^(=5M)['3YQ.OE#YY&7IGY1Z=
M_?K4%SX%\1+<:_:V%_8IIVJR-,S2!O,R22%X' R<$\\5Z717/]6AUO\ >>LL
MZQ*=XJ*7;E5M[WMWN<-IO@S4;/6_#5[)-:F/2[-K><*S99BKC*_+R/F'7%9$
MO@#Q(EIK.DVE_8+IE[.9U+AO,8Y!"D@<#@9Z]/<UZA13>&@U;^MK"CG.*C+F
MTZ=.TG)/U3;.+TWPC?V?B;1-2DFMC#8Z5'92JK-N+JI!*_+C;SW(/M6%\3M/
MM]6\0:':6URGV^:3[--$C9<1D@@L.P')Y]:]1J@-%TT:N=6^QQ&_*[?/(RP&
M,<>G'%*=!.'(NK'ALUG3Q*Q%3>,6E;YVOY:EEK:,V9M5&R+R_+ 7L,8XKRU_
MAUXI?PZ^@C4--%C%<>=#]X-(?]HA3CCMSSWXKUBBKJ48U-SGP>8U\)?V=M6G
MJKZK9_BSE=.\,WMIX^O=>DE@-K/9+;JBL=X8>7R1C&/D/?TK A^'%Z? ][HU
MS<VPO'OC>6\D;,4!VA0&R >F[H.XKTFBDZ$'OY_B7#-L3!IQ>W+T_EV_X/<\
M^L?"7B>?Q3I&N:UJ%E.]HI1TCR"%P0,?+@DDY)XK9\>>&[OQ3H,5A92P1R+<
M+*3,Q P%8=@>>:ZBBA48J+CW%+,Z\JT*^B<-K*R6K>WS.$TWPCKLWB^WU;Q!
MJ%O=16$9CM1$N"_4 L,8!YR>O..U4[;P?XIT%[JRT*ZTLZ=-*9(WNHR9(<]N
MA!Z#U'TKT>BE]7AYE_VOB+ZJ+5DK65M+M:>K?WG):MX7O[_6_#-ZEQ;E=+_X
M^"Y*LY^7E0 1V/7%1#P9//XG\17MW+";'5;80*J,?,7Y5&2",=L]379453HP
M;N_ZTL91S+$1BHQ>RM\N;F_,\]TGPUXQTU+;3!>Z3_9T#C]_Y1,S1@YV\C&<
M<>WK6Y)X=NW^(</B 20?9$L_(*;CYF[)YQC&.?6NFHI*C%*PZF9UJDG*R3::
M=E:]]_F<KI?A>YM?$'B.]N983;:J%$8C8EU&"#G(QW[$U#X)\.Z]X:62POKV
MSGTM%;[.L0(<,6SDY4<=>YKL**:HQ3372_XDSS"M.$H2LU+EZ?RJR:[.QS*>
M';M?B')X@,D'V1K/[.$W'S-V1SC&,<>M<]>>"/$*ZEX@33;ZRCL-8W/(TH/F
M G<=O X&6()YX]Z]'HI2H0E^9=+-,13=U;91U5]$[KYIGGESX$UD:+X=%A?6
MD.J:1O\ F?<8VW'/!VYXQZ=ZEU'PIXA75[;7M-N=/?5'M5@OHYU/E2, ,LO'
ML/3I^%=]12^KP_KR+6<8F]W9[]%JI.[3\KZF/X<L]5L]/D&LSVTUW)*7_P!&
M3:B+@ *.!GH>?>J5IX>NX/B#?Z^TD!M+BT6!$#'>&&SDC&,?*>]=+16GLU9+
ML<JQ=12G)67.K/32VFWW'GEGX#U2W^&VH>''GLS>7-P)4<.WE@!D/)VYS\A[
M>E:,GA._;5_"MV)K;R])MQ%.-S98[0/EXY''?%=E14*A!6^7X:G3+-L3)R;:
MU<GMUDN5_@</KOA76XO%3^(O#5W;17,\/E7$5R#AN ,C@_W5_*J/_"N[Y/!-
M_IHO+>75;^X6>>9RPCR&SC(&?7MU->C44GAX-M]_UW'#-\3"$8JWNVUMJ^79
M-]4CD?%_A:^\0>'=.T^TEMTFMIXY':5F"D*C*<8![FI9O#5Y)\1K;Q")8/LD
M5J82A8^9NPW;&,<CO74T53HQ;OZ?@8QS"M&G[-;6DO\ P*U_R/-)OASJ4V@Z
MW9/=6HFN[X7=N59BO&>&^7CANV:T-,\*^(V\9:?X@UB\L9#!;M$\<&Y=G# !
M1C!^]DG(ZGT%=W14K#P331O/.<3.,HRMK=;=TD[>J2/.M+\$^(=*TS5]&34+
M&32KJ&985.X.)&&%+?+P,=<$U8O_  )>W7A+1;.&[AAU?22'AE!)C+9R1G&>
MRG..W2N]HH6'A:PI9QBG-5-+WOLM7:VOJGJ<1H/A766\3/XB\1W5M+>+"88(
M[<':@(QD\#L3Q[FJ=KX#U2#X;7OAQI[,WD]P)5<.WE@;D/)VYS\I[5Z'11]7
MA:WK^(GF^)YN965G%I6T7+>UO+5F;#I\L?AF/32R><MF+<L"=NX)MSTSC/M7
M-6'AWQ+HG@NPTS3;C3C>022&9906BE1F8XY7/<>E=O15NFG^1A3QM2":LFF^
M9IJ^NJ_5G+>"O#EYH,%_-J#VYN[Z?SGCMEQ''Z <#U-9NH>%O$5AXGO=6\,7
MMI&FH ?:(KD'"L/XAP<]S^)ZUW=%+V,>51[&BS*LJTZSL^96::T:TMIY65C@
M]5\)Z_!XA3Q!H%]:K?RVZPW:W .UR !N&!_LCCCI^%5E^'E\G@G4M-^V02ZM
MJ,Z3S3.2(\A@<9 SZ\XZFO1:*EX>#;??]32.<8F,8Q5O=MK97?*[I/R1QVH^
M%+^[U3PM=1RVP320!.&9LMPOW>.?NGKBK>@>';O2O%&OZG/) T.H2(T2HQ+*
M!G.[( '7L373452HQ4N;^MK&,LPK2I.D]K6^7-S?F>?VGP^NO^$$O]!O+BW%
MS-=-<PR1EF53\N,Y /8@\=Z@MO!OBJYUG0M1U?4;*7^SG ,:E@0@Q@@[>6/.
M<XZ"O1Z*GZM#3R-UG.*][;WFWMM=6=NUT>?3>$O$>D:WJ%SX>GTUK34)/->.
M]0DQ.<DXP#QR?\.*NZYX4U75])T*W:[M7NK*X6:XD;**^.NT!?\ "NTHI^PA
M9KHR'FM=RC/3FCUMJ]+:OKH<N?#EX?B*OB'S(/L@M/(V;CYF[Z8QC\:Q-+\%
M>(=*M-9TJ+4+)])O8K@1(P8.)'3:I/R\#IG!->AT4.A%N_\ 6HHYI7C'ET:L
MEM_+M\U?<\\O? VK_P#".^'(K.XM/[3T:0N Y)B?+ ]<9XP.WK3$\#:]+<>(
M;F]O;&6?5;01*REE"O\ +U&WA1C ZG %>C44OJT/Z]+&JSG%)6TZ]-=9<WW7
MU.0?PYK<>C^&[*SU!(&TYX_MFR9U65%QE1@?-T/!Q77T45I&"CL<%;$3K6YK
M:7_%W9R&I>%;Z\^(NF^(8Y;<6EK#Y;HS-YA/S]!C'\0[U=O_  G9?V3K<.E6
M\5O=ZK&PED9VVLYSR>N!ECT%=%12]E#73<V>85WR:_"DODG=7[ZGG$W@'5U\
M(:'9V]S:?VGI5RTZY+&)\N6ZD9].WK6CH/AO5M+\5ZAXBUN^LI%N+3;(T9*A
M"-I/!& H"D9SVS7;5'<0175M+;SH'AE0HZGHRD8(_*H6'@FFNGZ&\LWQ%2,H
M3M:5[Z:VD[NWSU/,OAMH\$?BO7KZVD6:SMG:VM9%.5*LQ8[3[ #I_>]ZFN?
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M$2Y\0F2#[)+:" (&/F;OEYQC&.#WK B^'5X_A'5=)NKFV%Q<7IN[=XRQ53@
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MKHHS=2/-TZ'C9AA8X2JJ/VDES>KU_P @HHHK4X0HHHH **** "BBB@ HHHH
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MF@MUVPH\8(C&,8'H.!^58G_"S/"7_03D_P# *?\ ^(H_X69X2_Z"<G_@%/\
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MS0M*U"\BO+O3[>:YBQLE= 6&#D<^QJ>_T^SU2U-M?6\=Q 2"8Y!D$CI7-_\
M"S/"7_03D_\  *?_ .(H_P"%F>$O^@G)_P" 4_\ \13Y5V)]M4T]YZ;:[>G8
MZF"&.V@C@A0)%&H1$7HJ@8 %58='TZWOKB]ALX4N;@$32A>7!]?6L#_A9GA+
M_H)R?^ 4_P#\11_PLSPE_P!!.3_P"G_^(HLA*I-7L]]_,THO!_AV%2L>CVB@
MR"7[G\0S@_AD_G6-J.B:MKOCRPN;RRAATG2W,D,P<%YV(4CC.1A@.H'0U/\
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M':7 074CM-.$.0&/;\  *Z2N2_X69X2_Z"<G_@%/_P#$4?\ "S/"7_03D_\
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M2_Z"<G_@%/\ _$4 =;17)?\ "S/"7_03D_\  *?_ .(H_P"%F>$O^@G)_P"
M4_\ \10!UM%<E_PLSPE_T$Y/_ *?_P"(H_X69X2_Z"<G_@%/_P#$4 =;17)?
M\+,\)?\ 03D_\ I__B*/^%F>$O\ H)R?^ 4__P 10!O:Q_QY1_\ 7U;_ /HY
M**YJY\?>&M2-K96E_))<37ELJ*;69<GSD[E !^-% #OAM<P6WPQ\,B>:.+S;
M5(TWL%W,<G SU/!XK<M?$>F7-LT[W*6R"66+%PZH28R=Y'/08)^E<?X6TJ?6
MO@YX=L8$LCYEL@=[J,N(UP?F4#^(<8Y%5_"G@W4],%Q=)!9W#N\\.S4X&#@
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MHXDC5QT8 UP_Q:_Y$AO^OF/^M9<4VN^&?&.A+>ZS-?6^KKLE@;A(VX&$&<
MLO(QWHE6<:C36FGXDT<MA7P<:D)6G>>COKRI/3IM<].HKS'2]:U.7PSXTGDO
M[AI;6:40.7.8@,XV^E5;G6=9U/2O"&C6VISVUQJ2%[B[5SYA /J#GU[\\4?6
M5:]OZO8:R6ISN+FK)V;UT]WF;^X[^U\1VUUXJO?#ZPRBXM(EE>0XV$$*<#G/
M\0K9KR33)K[P_P"-_%<UW<_;+JRTHN)F7!DVK&4W#UQMS^-16TWB.QC\*7\_
MB"ZN(M7OHVEA9C\H+#Y0<\J0>1P*F.):W75_+6QT5<EC)KV<TERQ[^\W'F=M
M--KZV/8*S]7UO3]#@AFU"8Q1S2B%"$+9<@D#@'T->1ZYXNN+W6]:>7Q'>:8;
M.1H["UMU;;*5)'SXXY('7/7T%6?%UW>>(?!7AG69+QXS+.(9(E'RF3+#S.O7
MY3Q[TI8M-2Y5JATN'Y1G2]O*T9.ST>C:NDG:S]5LSV.BLG2[2XT+0G2^U&;4
M9(0\C3RC#,.N.IKR^.Y\3ZGX7O?&2^(;F!X9B8[.,D1; 0#QG'?N#TYZUK.M
MR6NM=S@PN6_6'+EJ)1344W?5O;I?[]CV:J>JZC'I.E76H2HSQV\9D94ZD#TK
MSC5-=UK6=9\*QZ=J$E@=3M-TH3E%8YW';WQ@X_"H+.\U./0_'&AZCJ$U^+&(
M^5-,Q+$'<#R23V'&>.:AXE:I+Y_*YTPR62495)+I>.M[<W*_+<].TG48]7TF
MUU"%'2.XC$BJ_4 ^N*N5Y>NH7FBZ!X(U2*YE2P^2WNX@QV,&'!(]AN_2M_PI
M?WNK^*O$=X]S*UA!.+6WBW'8"O#$#\ ?^!54*]VHO?\ X%S#$Y8X1G6B_<5_
MPERV]>OH=C17FVO/KVI_$B30]-UF:PMY+(.[*20@[E1D?,3@9R.IKFM5\27;
M:OJ%E>>*+ZP_LQ!;VP@#_P"D2H,,SD'NRYYS][VJ9XI1O==;&]#(YUE'EFKN
M*E:S;2>VR[_AJ>MZ_KMIX<TB74;W>8D(4+&,LS'H!61%XXMV;25FTR_MGU.=
MH(DF0*5QM^8@GH=PZ5PGBO4+SQ%\+](UB>Z97CF:*>%1\LS9P'/H1M)Z?Q&M
M?6]/N=+UKP/:W>HRZA,+Z0F>488@M'@=3TJ)5YMMQVT_%G32RK#PIQC6UFW4
M3W^Q%[=-[/Y^IZ=17C?B3Q5-=^*-7MY_$-YI,-CF*TBME;$L@Z[BO;([^HK1
MNO&6KWO@#1C;3>5J>HW/V-[@#&,$C</0GY?S.*OZW"[78YGD&(4:<KKWK=]+
MJ^]M=%K;9Z'HVJZK9Z)ITE_?RF*VC(#.%+8R0!P.>IJU#,EQ!'-$<QR*'4XQ
MD$9%>6>,_#6J:3X'O&N?$EY?Q)+$Y2?)+98*026/&2#^%1:PFK^'?#6C+/XA
MU$V%W*K7%S"I$ENFQ=J*<].OITH>(E&3YHZ)#IY11K4H.E53E*36SL[)/16O
M?\]$CUNL^UUNPO=6N],@F+7=H 9DV$;<].2,'\*S/!4T4^@;X-:EU>+S6VW$
MP(=>!\C9YR/ZUP^@:%J,OQ)UF-->N8WM9(Y)G"G-PN0=C?-TQQWJI59+E<5N
M<]#+Z4G7C5G;V:NM'W2U5K_+>[]3T+P_XDMO$)OA;PRQ_8YS _F8^8CN,'I6
MS7AME:ZPVF>*;^PU>:PALKQY3'#E6F;)SE@00 .W?-;'B#QE>RZ3X:MY=2ET
MY+VW$U[=P*=^!Q\N.1D@]/4=JSABK1O-?U>QW8C(>:ORX>2LW:VK:]WF[:Z=
MO0]:HKSWX;^(IM0O=4TM]1FU&WMRLEM=3@B1D/!#9Y].OO4_CZ]MH+NSBF\1
M:CIS,C%;;3U8R2\_>)!' QCWY]*U5=.G[1'GRRNI'&?5)/7>]F]+7VM?_+J=
MW6-?>([:P\2:?HDD,K3WRLR.N-JX!Z\Y[5YC%XUUA/ %W$E[-+=C4!9PW4G$
M@1E+9/O\I&>HS[5?&EZCI'Q,\-6NH:I)J6(G9)I1\XRK94DDDC/()]:S>)YK
M<B[?BSNADGLG/ZQ):*=EKKRQO?\ %:/S/3=4U"/2M*NM0E1GCMHFE94ZD 9X
MK&3QE:R0Z%*MG=%=88K%@#]W@@9;GW[5Y_)-KOB71O$VO#69HK6 R0+8]8VC
M Y&,X!VD<XSFK]GJ-Y9Z9\/8+:YEBBN9629$8@2#<O!]>I_.D\0V[K1?\&Q<
M<GITX6FU*=VGJU;W'*VW3R]#T6'6["XUNYT>*8F^MD$DL>PC:I (.<8/WA4.
MC:]#K5QJ$,5O/";*X,#&4 !R"1E?;BO.K/0M1N?BMK-O%KUS!+$J3O,JG,B'
M81&?FZ $#\*OV?BC4;#1O&E_)<23O97K16PE;<(\N57 ]!D<>U..(=_>5EK^
M!E4RFGRVHRYI-0?56<FO+9W^1Z917CL]UXC\,:1HOBF?7[J]CO70SVDK$H%=
M2P !.!\H/0#!K4OO[?UOXC:YHMCKEQ8VL5NDGR$G;\D?"\C;ECR1[^M5]9_N
MZ_YF;R5IM^U7*DW?7[+2:M:_5>IZ=4%]=)8:?<WDBLR01-*P7J0H)X_*O,]+
M\0RWWPQ6XU77[FP>*[,!NXP6FD &0HQR3SU]!5'0]>NI)_$.D_VG?W]@VE33
M1/?@B56"^Y)QR?TI/%1TMU*CD=1<[D_@=GH[-)J]G:W78]0T+5X=>T6VU."-
MXXIP2JR8W##$<X^E9;^,[0^*3H-O8WMS-&ZI--%'F.(G^\<\ >M1_#C_ )$#
M2O\ <?\ ]&-7(>#-%OQX_P!:SK=P?L4Z&?Y?^/O.[[W/&/QH=6?+"W7_ "%3
MP6&57%<[TIWLM?YK+;^KOM<]8HKRC3-=U67X4Z]?R:A<M=PWA2.8R'<@_=<
M_B?SJ35-3UR>?P5:V.JS6\M_8IYTA.X,Q5<N1_$1DGGO3^LJU[=OQ=B?[$J<
M[@YI6<E?7[,>9O[CU.L;Q'XCMO#5I;7%S#+*L\ZP*(\9!()R<GIQ7":5KVK^
M'D\76-WJ$NH/IL8>WFG)8ACP.I/'*G&>U86M66M)X5T+4M0UF:^BO[N.4PS9
M;RF()7:2>F"<C@=*B>)?+[JU_+6QT8;(X^W2K33C=);^]>/-IIIIW/<:CN)X
M[6VEN)FVQ1(7<XSA0,FO*O$FK3CQOJ%IJ?B34M%AC$?V+R%8Q,"O)8 \\_UY
M&*[OQ3;RWO@N_C@O6B8VQ?SX^=P4;B.O1@"/H:UC6YN:RV//J9;[%T?:2TJ6
MZ/1.W6UGOK:]AUSXKTZ+PH_B. R7-BHR-B[6;Y]G1L=ZT]/O$U'3;6^C5E2Y
MA295;J P! /YUX]9:7=P_!^\U&35)I;6>';'9,/DB(N!D@Y[X/;O5NQFU[0;
M[P9<RZQ+/;:HL4!L^1'''A%48S@G:P.< Y%8QQ,KIR6C2_%GIU<EHN,XT9^\
MIR2O?7EC>VVZUN]NQZ_6?=ZW866JV>FW$Q6[O,^0FPG=CKR!@?C7F/C'5UMM
M5U)[/Q7J_P!M@?*VMLK>1$1_ QSCZFJVI1:CX@\1^%+PZM-;SZC;!E>-?^/=
M@N&*C/\ $03VZU4\5JU%:_\ !,\/D:<8U*T[1:;V:U4;K=:KTWMIT/7-4U"/
M2M*NM0E1GCMHFE94ZD 9XIFC:I%K6CVVI0H\<=PFY5?&1SCG%9/B.WEM/AYJ
M-O-<-<RQ:>R/,XP9"$P6/N>M>;VDVO:#H/AC6EUB4VTTZP"Q7(C"9/7G#$@'
MDC(S[552LX3U6EOU,,'ED,5AVXR2ES65[Z^ZW;Y^9[917EGCC4HH=;OEA\4Z
MM#=QQAH[.R5O+B(4??((')Y/IFG6'B357/@S6;F\E-M>L]E=Q[L(SAF17(Z9
M/7\*/K,5)QMM_G82R6K*C&LI?%T::UY7*VJUO9Z[7/4:*\GN/%FJPZ)XFUZ&
M[E:.2^%G8!CE8@,Y8#IG&/QJOX5\42V_BW3+.'Q#>:O;7R[+E;I6_=28X*;N
MV?3W]J7UJ-TNY?\ 8%?V<ZEU[OD^B3:O:RM>VN[/8**Y_P 9W,-KX<EDGU>7
M2D+J/M$*DOU^ZH'.37 >'O%EUINLZE#'J6H:E8II\MU'_: (<.@R.I)P<'\_
M:KJ5XPFHLYL+E57%4)5H/;I9^77;KL>D>)/$-OX9TDZC<PRRQAU3;%C.3]36
MK&XDC5QP& ->&:S!KMS\.X]=OM:FNHKZX!>UEY6/#,%*G/'(Z  8/M76ZG/J
M^O\ CJ#0+#5I],M[.R6=WASEVP.HR,CYE&#QUK*.);>W:R];G=5R6$::2J*Z
M<^:6MER\NEK7W?3<Z_0O$=MK\^HQ6\,L9L9S YDQ\Q!/(P>G%;->,Z-K5]X>
M\+^+KQ74Z@+\1^8%X#LQ!8#\R/PIWAGQ5-:^*-(@A\0WFK17W[J[BN5;$4AZ
M;-W;)[>A]:(8I62EN_\ .Q6(R";E4G1?NQVW=[14GK;3?2^^QZ_<SK;6LT[
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M\>4?_7U;_P#HY**-8_X\H_\ KZM__1R44 8/PO\ ^28^'?\ KS2NMKDOA?\
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M^O,W>=8I\NVGDM=.77O=:' Z7X*U&WUC6=1UV_@NH]1L6AF:,$,"0N[ QC
M('T%<?;VLHUGPKIT?B&WU>."^5[>&V (AB#!F+]\X'0] #7MI 92K $$8(/>
MLZP\/Z/I=P]Q8Z9:V\S#!>*(*<>GL*F>&3LH_P!=3HH9W*//*JKMJR22MHFN
MVFCZ;K0Y2?PGXCTK7=0O/#=[8+;:A)YLL5XA)C<Y)*X![D_X<5=U_P )ZCKG
MA&STZ74(SJ=M*L_V@IA'<;NP' ^;T[=*["BM/80LUT9Q/-,0Y0GIS1MK97=E
M97?70S='MM271D@UR>&ZO#N$KQ+A6!)QQ@=O:N!;X>^);>RN=!LM8M5T&XF\
MQO,4^:HR#CI[#N,X[9->H44YT8S23Z"P^95L/*4J:7O.]K*R:V:72W0X^3P;
M+%XD\.WEG+$MEI-N82CD[VX(!&!CO5<^"[\W/BR3[1;8UB/;!RWR'G[W'OVS
M7<44O80_KTL"S3$KKT2^Z7-^9P?B33;;3/A2=)U.[MTGAM@L3;\;Y4Y 3."2
M<8_&M/X>::VF^"[(2 B:Y!N9">I+G(S_ ,!VUN:CI&GZLD2:A:17*1-O195R
M ?7%7      !T HC2M4YNRL55S!SPGL-;RDY/M?R_4YM/#MTOQ!D\0&6'[*U
MG]G$>3OW9'/3&./6LF]\*>(-/\1W^I^&KRQ6/4"&GAO%)"OZC /J3^/>N[HI
MNC%_?<BGF5>#OHURJ-FKII;7.,U[PIJ^M^"(-(FOK>741,)99W!1&Y8X  [
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>tmb-20210930.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7908.23199 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/15/2021 8:22:51 PM-->
<!--Modified on: 11/15/2021 8:22:51 PM-->
<xsd:schema targetNamespace="http://miromatrix.com/20210930" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:attributeFormDefault="unqualified" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:miro="http://miromatrix.com/20210930">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://miromatrix.com/role/StatementCondensedBalanceSheets" id="StatementCondensedBalanceSheets">
        <link:definition>00100 - Statement - Condensed Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/StatementCondensedStatementsOfOperations" id="StatementCondensedStatementsOfOperations">
        <link:definition>00200 - Statement - Condensed Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows" id="StatementCondensedStatementsOfCashFlows">
        <link:definition>00400 - Statement - Condensed Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails" id="DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails">
        <link:definition>40301 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureAccruedExpensesDetails" id="DisclosureAccruedExpensesDetails">
        <link:definition>40501 - Disclosure - ACCRUED EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails" id="DisclosureDebtAndCapitalLeaseObligationMaturityDetails">
        <link:definition>40702 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION - Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationDetailsCalc2" id="DisclosureDebtAndCapitalLeaseObligationDetailsCalc2">
        <link:definition>40702 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION (DETAILS) Calc 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails" id="DisclosureCommitmentsAndContingenciesLeasesDetails">
        <link:definition>41102 - Disclosure - COMMITMENTS AND CONTINGENCIES - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical" id="StatementCondensedBalanceSheetsParenthetical">
        <link:definition>00105 - Statement - Condensed Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit" id="StatementCondensedStatementsOfShareholdersEquityDeficit">
        <link:definition>00300 - Statement - Condensed Statements of Shareholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureInitialPublicOffering" id="DisclosureInitialPublicOffering">
        <link:definition>10201 - Disclosure - INITIAL PUBLIC OFFERING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails" id="DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails">
        <link:definition>40101 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Charter (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails" id="DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails">
        <link:definition>40102 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Equity Method Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails" id="DisclosureInitialPublicOfferingDetails">
        <link:definition>40201 - Disclosure - INITIAL PUBLIC OFFERING (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails" id="DisclosureEquityMethodInvestmentRepriseDetails">
        <link:definition>40401 - Disclosure - EQUITY METHOD INVESTMENT - Reprise (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails" id="DisclosureEquityMethodInvestmentBalanceSheetDetails">
        <link:definition>40402 - Disclosure - EQUITY METHOD INVESTMENT - Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails" id="DisclosureEquityMethodInvestmentIncomeStatementDetails">
        <link:definition>40403 - Disclosure - EQUITY METHOD INVESTMENT - Income Statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails" id="DisclosureFairValueMeasurementChangesDetails">
        <link:definition>40601 - Disclosure - FAIR VALUE MEASUREMENT - Changes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails" id="DisclosureDebtAndCapitalLeaseObligationAgreementsDetails">
        <link:definition>40701 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION - Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails" id="DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails">
        <link:definition>40801 - Disclosure - CAPITAL STOCK - Convertible Preferred Stock, Prior to IPO (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails" id="DisclosureCapitalStockCommonStockAndPreferredStockDetails">
        <link:definition>40802 - Disclosure - CAPITAL STOCK - Common Stock and Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails" id="DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails">
        <link:definition>40803 - Disclosure - CAPITAL STOCK - Series C Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails" id="DisclosureCapitalStockStockOptionsDetails">
        <link:definition>40804 - Disclosure - CAPITAL STOCK - Stock options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails" id="DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails">
        <link:definition>40805 - Disclosure - CAPITAL STOCK - Estimate the fair value of stock option grants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails" id="DisclosureCapitalStockRestrictedStockUnitsDetails">
        <link:definition>40806 - Disclosure - CAPITAL STOCK - Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails" id="DisclosureCapitalStockEmployeeStockPurchasePlanDetails">
        <link:definition>40807 - Disclosure - CAPITAL STOCK - Employee Stock Purchase Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails" id="DisclosureCapitalStockWarrantsDetails">
        <link:definition>40808 - Disclosure - CAPITAL STOCK - Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/ScheduleSignificantCustomersDetails" id="ScheduleSignificantCustomersDetails">
        <link:definition>41001 - Schedule - SIGNIFICANT CUSTOMERS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails" id="DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails">
        <link:definition>41101 - Disclosure - COMMITMENTS AND CONTINGENCIES - Patent License Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails" id="DisclosureCommitmentsAndContingenciesLicenseContractDetails">
        <link:definition>41103 - Disclosure - COMMITMENTS AND CONTINGENCIES - License Contract (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails" id="DisclosureRelatedPartyTransactionsDetails">
        <link:definition>41201 - Disclosure - RELATED PARTY TRANSACTIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureNetLossPerShareDetails" id="DisclosureNetLossPerShareDetails">
        <link:definition>41301 - Disclosure - NET LOSS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails" id="Disclosure11401DisclosureSubsequentEventsDetails">
        <link:definition>414001 - Disclosure - 11401 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPolicies" id="DisclosureDescriptionOfBusinessAndSignificantAccountingPolicies">
        <link:definition>10101 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgress" id="DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgress">
        <link:definition>10301 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureEquityMethodInvestment" id="DisclosureEquityMethodInvestment">
        <link:definition>10401 - Disclosure - EQUITY METHOD INVESTMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureAccruedExpenses" id="DisclosureAccruedExpenses">
        <link:definition>10501 - Disclosure - ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureFairValueMeasurement" id="DisclosureFairValueMeasurement">
        <link:definition>10601 - Disclosure - FAIR VALUE MEASUREMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligation" id="DisclosureDebtAndCapitalLeaseObligation">
        <link:definition>10701 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCapitalStock" id="DisclosureCapitalStock">
        <link:definition>10801 - Disclosure - CAPITAL STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureEmployeeBenefitPlans" id="DisclosureEmployeeBenefitPlans">
        <link:definition>10901 - Disclosure - EMPLOYEE BENEFIT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureSignificantCustomers" id="DisclosureSignificantCustomers">
        <link:definition>11001 - Disclosure - SIGNIFICANT CUSTOMERS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingencies" id="DisclosureCommitmentsAndContingencies">
        <link:definition>11101 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureRelatedPartyTransactions" id="DisclosureRelatedPartyTransactions">
        <link:definition>11201 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureNetLossPerShare" id="DisclosureNetLossPerShare">
        <link:definition>11301 - Disclosure - NET LOSS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>11401 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies" id="DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies">
        <link:definition>20102 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressTables" id="DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressTables">
        <link:definition>30303 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureEquityMethodInvestmentTables" id="DisclosureEquityMethodInvestmentTables">
        <link:definition>30403 - Disclosure - EQUITY METHOD INVESTMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureAccruedExpensesTables" id="DisclosureAccruedExpensesTables">
        <link:definition>30503 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureFairValueMeasurementTables" id="DisclosureFairValueMeasurementTables">
        <link:definition>30603 - Disclosure - FAIR VALUE MEASUREMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationTables" id="DisclosureDebtAndCapitalLeaseObligationTables">
        <link:definition>30703 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCapitalStockTables" id="DisclosureCapitalStockTables">
        <link:definition>30803 - Disclosure - CAPITAL STOCK (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesTables" id="DisclosureCommitmentsAndContingenciesTables">
        <link:definition>31103 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureNetLossPerShareTables" id="DisclosureNetLossPerShareTables">
        <link:definition>31303 - Disclosure - NET LOSS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureEmployeeBenefitPlansDetails" id="DisclosureEmployeeBenefitPlansDetails">
        <link:definition>40901 - Disclosure - EMPLOYEE BENEFIT PLANS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="tmb-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="tmb-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="tmb-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="tmb-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://miromatrix.com/role/DisclosureStandardAndCustomAxisDomainDefaults" id="DisclosureStandardAndCustomAxisDomainDefaults">
        <link:definition>99900 - Disclosure - Standard And Custom Axis Domain Defaults</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xsd:element name="SeriesConvertiblePreferredStockMember" id="miro_SeriesConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SeriesBConvertiblePreferredStockMember" id="miro_SeriesBConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SeriesB2ConvertiblePreferredStockMember" id="miro_SeriesB2ConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="AccruedRoyaltiesNoncurrent" id="miro_AccruedRoyaltiesNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="InterestPayableNoncurrent" id="miro_InterestPayableNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="RegulatoryAndClinicalExpense" id="miro_RegulatoryAndClinicalExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="QualityExpense" id="miro_QualityExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ResearchGrants" id="miro_ResearchGrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="AccruedKeyOpinionLeadedCompensationCurrent" id="miro_AccruedKeyOpinionLeadedCompensationCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="IncreaseDecreaseInGrantsReceivable" id="miro_IncreaseDecreaseInGrantsReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="FurnitureFixturesAndComputersMember" id="miro_FurnitureFixturesAndComputersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="RepriseBiomedicalInc.Member" id="miro_RepriseBiomedicalInc.Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ConvertiblePreferredStockWarrantsMember" id="miro_ConvertiblePreferredStockWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CommonStockWarrantsMember" id="miro_CommonStockWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SeriesCConvertiblePreferredStockMember" id="miro_SeriesCConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="EmergingGrowthCompanyStatusPolicyPolicyTextBlock" id="miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PatentLicenseAgreementMember" id="miro_PatentLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="PatentAndKnowHowLicenseAgreementMember" id="miro_PatentAndKnowHowLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="UniversityOfMinnesotaMember" id="miro_UniversityOfMinnesotaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="FirstFacilityEdenPrairieMember" id="miro_FirstFacilityEdenPrairieMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SecondFacilityEdenPrairieMember" id="miro_SecondFacilityEdenPrairieMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="Period1Member" id="miro_Period1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="Period2Member" id="miro_Period2Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="Period3Member" id="miro_Period3Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="MinimumRoyaltyPayable" id="miro_MinimumRoyaltyPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="MinimumRoyaltyReceivable" id="miro_MinimumRoyaltyReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="MonthlyLeaseRentPayments" id="miro_MonthlyLeaseRentPayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="IncreaseInYearlyRentPercentage" id="miro_IncreaseInYearlyRentPercentage" type="xbrli:pureItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="ResearchAndDevelopmentContractMember" id="miro_ResearchAndDevelopmentContractMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CorporationOwnedByDirectorMember" id="miro_CorporationOwnedByDirectorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="NumberOfCustomers" id="miro_NumberOfCustomers" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="StockOptionPlan2010Member" id="miro_StockOptionPlan2010Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="StockOptionPlan2019Member" id="miro_StockOptionPlan2019Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ExercisePriceOf0.10Member" id="miro_ExercisePriceOf0.10Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ExercisePriceOf1.25Member" id="miro_ExercisePriceOf1.25Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="NumberOfVotesForCommonStockHolders" id="miro_NumberOfVotesForCommonStockHolders" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="SeriesPreferredWarrantsMember" id="miro_SeriesPreferredWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CommonWarrantsMember" id="miro_CommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ClassOfWarrantOrRightGranted" id="miro_ClassOfWarrantOrRightGranted" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ClassOfWarrantOrRightExercised" id="miro_ClassOfWarrantOrRightExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ClassOfWarrantOrRightTerminated" id="miro_ClassOfWarrantOrRightTerminated" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="WarrantsOutstandingWeightedAverageExercisePrice" id="miro_WarrantsOutstandingWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="WarrantsOutstandingWeightedAverageRemainingContractualTerm" id="miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PaycheckProtectionProgramMember" id="miro_PaycheckProtectionProgramMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="DebtInstrumentConvertibleMinimumPreferredStockOffering" id="miro_DebtInstrumentConvertibleMinimumPreferredStockOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="DebtInstrumentPrincipalForgiveness" id="miro_DebtInstrumentPrincipalForgiveness" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="DebtInstrumentInterestForgiveness" id="miro_DebtInstrumentInterestForgiveness" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="StockIssuedDuringPeriodValueWarrantsExercised" id="miro_StockIssuedDuringPeriodValueWarrantsExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne" id="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo" id="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree" id="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour" id="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember" id="miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="PromissoryNoteWithUniversityOfMinnesotaMember" id="miro_PromissoryNoteWithUniversityOfMinnesotaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="DebtInstrumentPeriodicMonthlyPaymentNumber" id="miro_DebtInstrumentPeriodicMonthlyPaymentNumber" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DebtInstrumentNumberOfFinalPayment" id="miro_DebtInstrumentNumberOfFinalPayment" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DebtInstrumentAdditionalCompensation" id="miro_DebtInstrumentAdditionalCompensation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="StockIssuedDuringPeriodSharesWarrantsExercised" id="miro_StockIssuedDuringPeriodSharesWarrantsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" id="miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="IncreaseDecreaseInInterestPayableNoncurrent" id="miro_IncreaseDecreaseInInterestPayableNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock" id="miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest" id="miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest" id="miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions" id="miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="EquityMethodInvestmentSharesOwned" id="miro_EquityMethodInvestmentSharesOwned" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="EquityMethodInvestmentSharesSold" id="miro_EquityMethodInvestmentSharesSold" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="AccruedLiabilitiesPublicOfferingExpensesCurrent" id="miro_AccruedLiabilitiesPublicOfferingExpensesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="OneCustomerMember" id="miro_OneCustomerMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="WarrantsAndRightsAdditionalCoverage" id="miro_WarrantsAndRightsAdditionalCoverage" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ClassOfWarrantOrRightNumberOfWarrantsIssued" id="miro_ClassOfWarrantOrRightNumberOfWarrantsIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="StockholdersEquityNoteInitialPublicOfferingAbstract" id="miro_StockholdersEquityNoteInitialPublicOfferingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember" id="miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="NoteCompanyShareholderMember" id="miro_NoteCompanyShareholderMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="WarrantsRegentsOfUniversityOfMinnesotaMember" id="miro_WarrantsRegentsOfUniversityOfMinnesotaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="WarrantsUniversityOfMinnesotaMember" id="miro_WarrantsUniversityOfMinnesotaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="WarrantsCompanyShareholderMember" id="miro_WarrantsCompanyShareholderMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember" id="miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CapitalStockDisclosureAbstract" id="miro_CapitalStockDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" id="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" id="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" id="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour" id="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive" id="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ConsultingServicesMember" id="miro_ConsultingServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="LesseeOperatingLeaseAnnualBaseRateIncreasePercentage" id="miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="LesseeOperatingLeaseRealPropertyTaxesPercentage" id="miro_LesseeOperatingLeaseRealPropertyTaxesPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="LesseeOperatingLeaseManagementFeePercentage" id="miro_LesseeOperatingLeaseManagementFeePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts" id="miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="BuildingResearchAndDevelopmentAndOfficeSpaceMember" id="miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="OperatingLeaseNumberOfOptionsToExtend" id="miro_OperatingLeaseNumberOfOptionsToExtend" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="LesseeOperatingLeaseOptionToExtendTermOfContract" id="miro_LesseeOperatingLeaseOptionToExtendTermOfContract" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NumberOfStockPurchaseAgreements" id="miro_NumberOfStockPurchaseAgreements" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="StockConversionDiscount" id="miro_StockConversionDiscount" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" id="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" id="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="EquityIncentivePlan2021Member" id="miro_EquityIncentivePlan2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear" id="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" id="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee" id="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="NoncashInvestingAndFinancingFinancingExpenses" id="miro_NoncashInvestingAndFinancingFinancingExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="GainOnForgivenessOfDebt" id="miro_GainOnForgivenessOfDebt" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="NumberOfClassesOfStock" id="miro_NumberOfClassesOfStock" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="StockConversionPercentage" id="miro_StockConversionPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock" id="miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="TemporaryEquitySharesConvertedInPeriod" id="miro_TemporaryEquitySharesConvertedInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" id="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="StockIssuedDuringPeriodValueConversionOfPreferredStock" id="miro_StockIssuedDuringPeriodValueConversionOfPreferredStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="StockIssuedDuringPeriodSharesConversionOfPreferredStock" id="miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ProceedsFromIssuanceOfCommonStockNet" id="miro_ProceedsFromIssuanceOfCommonStockNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="DebtAndCapitalLeaseObligationsGross" id="miro_DebtAndCapitalLeaseObligationsGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="DebtAndCapitalLeaseObligationsGrossCurrent" id="miro_DebtAndCapitalLeaseObligationsGrossCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="DebtAndCapitalLeaseObligationsGrossNoncurrent" id="miro_DebtAndCapitalLeaseObligationsGrossNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet" id="miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="AllowanceForDoubtfulAccountsRelatedParties" id="miro_AllowanceForDoubtfulAccountsRelatedParties" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="SubstantialOwnershipChangePercentage" id="miro_SubstantialOwnershipChangePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="NumberOfShareholders" id="miro_NumberOfShareholders" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="AccruedBoardCompensationCurrent" id="miro_AccruedBoardCompensationCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="AccruedSuppliesCurrent" id="miro_AccruedSuppliesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="AdditionalFundingToBeProvided" id="miro_AdditionalFundingToBeProvided" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="CapitalLeaseJuly2021Member" id="miro_CapitalLeaseJuly2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CapitalLeaseSeptember2021Member" id="miro_CapitalLeaseSeptember2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CapitalLeaseOctober2018Member" id="miro_CapitalLeaseOctober2018Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements" id="miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>tmb-20210930_cal.xml
<DESCRIPTION>EX-101.CAL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7908.23199 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/15/2021 8:22:51 PM-->
<!--Modified on: 11/15/2021 8:22:51 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#StatementCondensedBalanceSheets" roleURI="http://miromatrix.com/role/StatementCondensedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#StatementCondensedStatementsOfOperations" roleURI="http://miromatrix.com/role/StatementCondensedStatementsOfOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#StatementCondensedStatementsOfCashFlows" roleURI="http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails" roleURI="http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureAccruedExpensesDetails" roleURI="http://miromatrix.com/role/DisclosureAccruedExpensesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDebtAndCapitalLeaseObligationMaturityDetails" roleURI="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDebtAndCapitalLeaseObligationDetailsCalc2" roleURI="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationDetailsCalc2" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCommitmentsAndContingenciesLeasesDetails" roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <calculationLink xlink:role="http://miromatrix.com/role/StatementCondensedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - Condensed Balance Sheets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_637726045699151620" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent_637726045699151620" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_637726045699151620" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637726045699151620" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_637726045699151620" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_637726045699151620" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637726045699151620" xlink:to="us-gaap_DueFromRelatedPartiesCurrent_637726045699151620" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivableCurrent" xlink:label="us-gaap_GrantsReceivableCurrent_637726045699151620" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637726045699151620" xlink:to="us-gaap_GrantsReceivableCurrent_637726045699151620" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637726045699151620" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637726045699151620" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637726045699151620" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments_637726045699151620" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_EquityMethodInvestments_637726045699151620" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_637726045699161580" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_637726045699161580" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637726045699161580" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity_637726045699161580" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_637726045699161580" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637726045699161580" xlink:to="us-gaap_CommonStockValue_637726045699161580" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_637726045699161580" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637726045699161580" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_637726045699161580" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_637726045699161580" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637726045699161580" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_637726045699161580" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_637726045699161580" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities_637726045699161580" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_637726045699161580" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637726045699161580" xlink:to="us-gaap_LiabilitiesCurrent_637726045699161580" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_637726045699161580" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637726045699161580" xlink:to="us-gaap_AccountsPayableCurrent_637726045699161580" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_637726045699161580" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637726045699161580" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_637726045699161580" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_637726045699171585" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637726045699161580" xlink:to="us-gaap_AccruedLiabilitiesCurrent_637726045699171585" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent_637726045699171585" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637726045699161580" xlink:to="us-gaap_InterestPayableCurrent_637726045699171585" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_637726045699171585" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637726045699161580" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_637726045699171585" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_637726045699171585" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637726045699161580" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_637726045699171585" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedRoyaltiesNoncurrent" xlink:label="miro_AccruedRoyaltiesNoncurrent_637726045699171585" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637726045699161580" xlink:to="miro_AccruedRoyaltiesNoncurrent_637726045699171585" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_InterestPayableNoncurrent" xlink:label="miro_InterestPayableNoncurrent_637726045699171585" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637726045699161580" xlink:to="miro_InterestPayableNoncurrent_637726045699171585" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_637726045699171585" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies_637726045699171585" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637726045699171585" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637726045699171585" order="4" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://miromatrix.com/role/StatementCondensedStatementsOfOperations" xlink:type="extended" xlink:title="00200 - Statement - Condensed Statements of Operations" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_637726045699181589" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_637726045699181589" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_637726045699181589" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_637726045699181589" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_637726045699181589" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_637726045699181589" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_637726045699181589" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_637726045699181589" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit_637726045699181589" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_637726045699181589" xlink:to="us-gaap_GrossProfit_637726045699181589" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637726045699181589" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit_637726045699181589" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637726045699181589" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold_637726045699181589" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit_637726045699181589" xlink:to="us-gaap_CostOfGoodsAndServicesSold_637726045699181589" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses_637726045699181589" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_637726045699181589" xlink:to="us-gaap_OperatingExpenses_637726045699181589" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_637726045699181589" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_637726045699181589" xlink:to="us-gaap_ResearchAndDevelopmentExpense_637726045699181589" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RegulatoryAndClinicalExpense" xlink:label="miro_RegulatoryAndClinicalExpense_637726045699181589" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_637726045699181589" xlink:to="miro_RegulatoryAndClinicalExpense_637726045699181589" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_QualityExpense" xlink:label="miro_QualityExpense_637726045699191560" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_637726045699181589" xlink:to="miro_QualityExpense_637726045699191560" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_637726045699191560" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_637726045699181589" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_637726045699191560" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest_637726045699191560" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_InvestmentIncomeInterest_637726045699191560" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_637726045699191560" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization_637726045699191560" order="6" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts_637726045699191560" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_AmortizationOfFinancingCosts_637726045699191560" order="7" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative" xlink:label="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative_637726045699201897" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative_637726045699201897" order="8" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ResearchGrants" xlink:label="miro_ResearchGrants_637726045699201897" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="miro_ResearchGrants_637726045699201897" order="9" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows" xlink:type="extended" xlink:title="00400 - Statement - Condensed Statements of Cash Flows" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_637726045699201897" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_637726045699201897" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt_637726045699201897" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637726045699201897" xlink:to="us-gaap_RepaymentsOfLongTermDebt_637726045699201897" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_637726045699201897" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637726045699201897" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_637726045699201897" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ProceedsFromIssuanceOfCommonStockNet" xlink:label="miro_ProceedsFromIssuanceOfCommonStockNet_637726045699201897" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637726045699201897" xlink:to="miro_ProceedsFromIssuanceOfCommonStockNet_637726045699201897" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet" xlink:label="miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet_637726045699211552" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637726045699201897" xlink:to="miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet_637726045699211552" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises_637726045699211552" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637726045699201897" xlink:to="us-gaap_ProceedsFromWarrantExercises_637726045699211552" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_637726045699211552" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637726045699201897" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_637726045699211552" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss_637726045699211552" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="us-gaap_ProfitLoss_637726045699211552" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_637726045699211552" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="us-gaap_DepreciationDepletionAndAmortization_637726045699211552" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_637726045699211552" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="us-gaap_ShareBasedCompensation_637726045699211552" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_637726045699211552" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_637726045699211552" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_637726045699211552" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_637726045699211552" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative" xlink:label="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative_637726045699211552" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative_637726045699211552" order="6" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_GainOnForgivenessOfDebt" xlink:label="miro_GainOnForgivenessOfDebt_637726045699221605" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="miro_GainOnForgivenessOfDebt_637726045699221605" order="7" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_637726045699221605" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_637726045699221605" order="8" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_637726045699221605" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_637726045699221605" order="9" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_637726045699221605" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_637726045699221605" order="10" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_637726045699221605" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_637726045699221605" order="11" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_IncreaseDecreaseInGrantsReceivable" xlink:label="miro_IncreaseDecreaseInGrantsReceivable_637726045699221605" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="miro_IncreaseDecreaseInGrantsReceivable_637726045699221605" order="12" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_637726045699221605" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_637726045699221605" order="13" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_637726045699221605" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_637726045699221605" order="14" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_IncreaseDecreaseInInterestPayableNoncurrent" xlink:label="miro_IncreaseDecreaseInInterestPayableNoncurrent_637726045699231627" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045699211552" xlink:to="miro_IncreaseDecreaseInInterestPayableNoncurrent_637726045699231627" order="15" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_637726045699231627" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_637726045699231627" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_637726045699231627" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637726045699231627" xlink:to="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_637726045699231627" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements" xlink:label="miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements_637726045699231627" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637726045699231627" xlink:to="miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements_637726045699231627" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForConstructionInProcess" xlink:label="us-gaap_PaymentsForConstructionInProcess_637726045699231627" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637726045699231627" xlink:to="us-gaap_PaymentsForConstructionInProcess_637726045699231627" order="3" use="optional" weight="-1" />
  </calculationLink>
  <calculationLink xlink:role="http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails" xlink:type="extended" xlink:title="40301 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637726045699231627" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637726045699231627" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_637726045699231627" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_637726045699231627" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://miromatrix.com/role/DisclosureAccruedExpensesDetails" xlink:type="extended" xlink:title="40501 - Disclosure - ACCRUED EXPENSES (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent_637726045699241617" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_637726045699241617" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_637726045699241617" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_637726045699241617" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="us-gaap_AccruedRoyaltiesCurrent_637726045699241617" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedRoyaltiesCurrent_637726045699241617" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedSuppliesCurrent" xlink:label="miro_AccruedSuppliesCurrent_637726045699241617" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="miro_AccruedSuppliesCurrent_637726045699241617" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedLiabilitiesPublicOfferingExpensesCurrent" xlink:label="miro_AccruedLiabilitiesPublicOfferingExpensesCurrent_637726045699241617" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="miro_AccruedLiabilitiesPublicOfferingExpensesCurrent_637726045699241617" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedKeyOpinionLeadedCompensationCurrent" xlink:label="miro_AccruedKeyOpinionLeadedCompensationCurrent_637726045699241617" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="miro_AccruedKeyOpinionLeadedCompensationCurrent_637726045699241617" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedBoardCompensationCurrent" xlink:label="miro_AccruedBoardCompensationCurrent_637726045699241617" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="miro_AccruedBoardCompensationCurrent_637726045699241617" order="7" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_637726045699241617" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_637726045699241617" order="8" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails" xlink:type="extended" xlink:title="40702 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION - Maturity (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtAndCapitalLeaseObligationsGross" xlink:label="miro_DebtAndCapitalLeaseObligationsGross_1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtAndCapitalLeaseObligationsGrossCurrent" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossCurrent_637726045699251739" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="miro_DebtAndCapitalLeaseObligationsGross_1" xlink:to="miro_DebtAndCapitalLeaseObligationsGrossCurrent_637726045699251739" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtAndCapitalLeaseObligationsGrossNoncurrent" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossNoncurrent_637726045699251739" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="miro_DebtAndCapitalLeaseObligationsGross_1" xlink:to="miro_DebtAndCapitalLeaseObligationsGrossNoncurrent_637726045699251739" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="us-gaap_DebtAndCapitalLeaseObligations_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_637726045699251739" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtAndCapitalLeaseObligations_1" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_637726045699251739" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_637726045699251739" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtAndCapitalLeaseObligations_1" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_637726045699251739" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationDetailsCalc2" xlink:type="extended" xlink:title="40702 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION (DETAILS) Calc 2" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtAndCapitalLeaseObligationsGross" xlink:label="miro_DebtAndCapitalLeaseObligationsGross" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths_637726045699251739" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="miro_DebtAndCapitalLeaseObligationsGross" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths_637726045699251739" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo_637726045699262016" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="miro_DebtAndCapitalLeaseObligationsGross" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo_637726045699262016" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree_637726045699262016" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="miro_DebtAndCapitalLeaseObligationsGross" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree_637726045699262016" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour_637726045699262016" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="miro_DebtAndCapitalLeaseObligationsGross" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour_637726045699262016" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive_637726045699262016" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="miro_DebtAndCapitalLeaseObligationsGross" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive_637726045699262016" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="us-gaap_DebtAndCapitalLeaseObligations_2" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths_637726045699262016" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtAndCapitalLeaseObligations_2" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths_637726045699262016" order="1" use="optional" weight="1" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtAndCapitalLeaseObligations_2" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo_637726045699262016" order="2" use="optional" weight="1" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtAndCapitalLeaseObligations_2" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree_637726045699262016" order="3" use="optional" weight="1" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtAndCapitalLeaseObligations_2" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour_637726045699262016" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive_637726045699271559" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtAndCapitalLeaseObligations_2" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive_637726045699271559" order="5" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails" xlink:type="extended" xlink:title="41102 - Disclosure - COMMITMENTS AND CONTINGENCIES - Leases (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_637726045699271559" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_637726045699271559" order="1" use="optional" weight="1" />
  </calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>tmb-20210930_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7908.23199 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/15/2021 8:22:51 PM-->
<!--Modified on: 11/15/2021 8:22:51 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#StatementCondensedBalanceSheets" roleURI="http://miromatrix.com/role/StatementCondensedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#StatementCondensedBalanceSheetsParenthetical" roleURI="http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#StatementCondensedStatementsOfShareholdersEquityDeficit" roleURI="http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails" roleURI="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails" roleURI="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureInitialPublicOfferingDetails" roleURI="http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails" roleURI="http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureEquityMethodInvestmentRepriseDetails" roleURI="http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureEquityMethodInvestmentBalanceSheetDetails" roleURI="http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureEquityMethodInvestmentIncomeStatementDetails" roleURI="http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureFairValueMeasurementChangesDetails" roleURI="http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDebtAndCapitalLeaseObligationAgreementsDetails" roleURI="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDebtAndCapitalLeaseObligationMaturityDetails" roleURI="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockCommonStockAndPreferredStockDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockStockOptionsDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockRestrictedStockUnitsDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockEmployeeStockPurchasePlanDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockWarrantsDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#ScheduleSignificantCustomersDetails" roleURI="http://miromatrix.com/role/ScheduleSignificantCustomersDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails" roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCommitmentsAndContingenciesLeasesDetails" roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCommitmentsAndContingenciesLicenseContractDetails" roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureRelatedPartyTransactionsDetails" roleURI="http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureNetLossPerShareDetails" roleURI="http://miromatrix.com/role/DisclosureNetLossPerShareDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#Disclosure11401DisclosureSubsequentEventsDetails" roleURI="http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:roleRef roleURI="http://miromatrix.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:href="tmb-20210930.xsd#DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" />
  <link:definitionLink xlink:role="http://miromatrix.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="extended" xlink:title="99900 - Disclosure - Standard And Custom Axis Domain Defaults">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_1" xlink:title="us-gaap_StatementClassOfStockAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_1" xlink:title="us-gaap_ClassOfStockDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_StatementClassOfStockAxis_1" xlink:to="us-gaap_ClassOfStockDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_StatementClassOfStockAxis_1 To us-gaap_ClassOfStockDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_1" xlink:title="us-gaap_StatementEquityComponentsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_1" xlink:title="us-gaap_EquityComponentDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_StatementEquityComponentsAxis_1" xlink:to="us-gaap_EquityComponentDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_StatementEquityComponentsAxis_1 To us-gaap_EquityComponentDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_PropertyPlantAndEquipmentByTypeAxis_1 To us-gaap_PropertyPlantAndEquipmentTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_1" xlink:title="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_1" xlink:title="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_1" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_1 To us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_1" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1 To us-gaap_AntidilutiveSecuritiesNameDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis_1" xlink:title="us-gaap_SubsequentEventTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_1" xlink:title="us-gaap_SubsequentEventTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_SubsequentEventTypeAxis_1" xlink:to="us-gaap_SubsequentEventTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_SubsequentEventTypeAxis_1 To us-gaap_SubsequentEventTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_1" xlink:title="srt_CounterpartyNameAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_1" xlink:title="srt_RepurchaseAgreementCounterpartyNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_CounterpartyNameAxis_1" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_CounterpartyNameAxis_1 To srt_RepurchaseAgreementCounterpartyNameDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_1" xlink:title="us-gaap_SubsidiarySaleOfStockAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_1" xlink:title="us-gaap_SaleOfStockNameOfTransactionDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_1" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_SubsidiarySaleOfStockAxis_1 To us-gaap_SaleOfStockNameOfTransactionDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_1" xlink:title="us-gaap_FairValueByFairValueHierarchyLevelAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" xlink:title="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_1" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_FairValueByFairValueHierarchyLevelAxis_1 To us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis_1" xlink:title="us-gaap_MeasurementInputTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_1" xlink:title="us-gaap_MeasurementInputTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_MeasurementInputTypeAxis_1" xlink:to="us-gaap_MeasurementInputTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_MeasurementInputTypeAxis_1 To us-gaap_MeasurementInputTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis_1" xlink:title="us-gaap_IncomeTaxAuthorityAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_1" xlink:title="us-gaap_IncomeTaxAuthorityDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_IncomeTaxAuthorityAxis_1" xlink:to="us-gaap_IncomeTaxAuthorityDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_IncomeTaxAuthorityAxis_1 To us-gaap_IncomeTaxAuthorityDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1" xlink:title="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1" xlink:title="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1 To us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis" xlink:label="us-gaap_DisposalGroupClassificationAxis_1" xlink:title="us-gaap_DisposalGroupClassificationAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain" xlink:label="us-gaap_DisposalGroupClassificationDomain_1" xlink:title="us-gaap_DisposalGroupClassificationDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_DisposalGroupClassificationAxis_1" xlink:to="us-gaap_DisposalGroupClassificationDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_DisposalGroupClassificationAxis_1 To us-gaap_DisposalGroupClassificationDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis_1" xlink:title="us-gaap_CashAndCashEquivalentsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" xlink:title="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_CashAndCashEquivalentsAxis_1" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_CashAndCashEquivalentsAxis_1 To us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_1" xlink:title="srt_RangeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_1" xlink:title="srt_RangeMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_RangeAxis_1" xlink:to="srt_RangeMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_RangeAxis_1 To srt_RangeMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis_1" xlink:title="us-gaap_BalanceSheetLocationAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_1" xlink:title="us-gaap_BalanceSheetLocationDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_BalanceSheetLocationAxis_1" xlink:to="us-gaap_BalanceSheetLocationDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_BalanceSheetLocationAxis_1 To us-gaap_BalanceSheetLocationDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_1" xlink:title="us-gaap_TypeOfArrangementAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" xlink:title="us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_TypeOfArrangementAxis_1" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_TypeOfArrangementAxis_1 To us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xlink:title="us-gaap_LeaseContractualTermAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:title="us-gaap_LeaseContractualTermDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_LeaseContractualTermAxis_1 To us-gaap_LeaseContractualTermDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_1" xlink:title="us-gaap_RelatedPartyDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="us-gaap_RelatedPartyDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1 To us-gaap_RelatedPartyDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1" xlink:title="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_1" xlink:title="srt_EquityMethodInvesteeNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1" xlink:to="srt_EquityMethodInvesteeNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1 To srt_EquityMethodInvesteeNameDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_1" xlink:title="us-gaap_RelatedPartyTransactionAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_1" xlink:title="us-gaap_RelatedPartyTransactionDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_RelatedPartyTransactionAxis_1" xlink:to="us-gaap_RelatedPartyTransactionDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_RelatedPartyTransactionAxis_1 To us-gaap_RelatedPartyTransactionDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_1" xlink:title="us-gaap_ConcentrationRiskByBenchmarkAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_1" xlink:title="us-gaap_ConcentrationRiskBenchmarkDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis_1" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_ConcentrationRiskByBenchmarkAxis_1 To us-gaap_ConcentrationRiskBenchmarkDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_1" xlink:title="us-gaap_ConcentrationRiskByTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_1" xlink:title="us-gaap_ConcentrationRiskTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_ConcentrationRiskByTypeAxis_1" xlink:to="us-gaap_ConcentrationRiskTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_ConcentrationRiskByTypeAxis_1 To us-gaap_ConcentrationRiskTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis_1" xlink:title="srt_MajorCustomersAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain_1" xlink:title="srt_NameOfMajorCustomerDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_MajorCustomersAxis_1" xlink:to="srt_NameOfMajorCustomerDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_MajorCustomersAxis_1 To srt_NameOfMajorCustomerDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis_1" xlink:title="us-gaap_PlanNameAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_1" xlink:title="us-gaap_PlanNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_PlanNameAxis_1" xlink:to="us-gaap_PlanNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_PlanNameAxis_1 To us-gaap_PlanNameDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1 To us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis_1" xlink:title="us-gaap_DebtInstrumentAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_1" xlink:title="us-gaap_DebtInstrumentNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_DebtInstrumentAxis_1" xlink:to="us-gaap_DebtInstrumentNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_DebtInstrumentAxis_1 To us-gaap_DebtInstrumentNameDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_1" xlink:title="srt_StatementScenarioAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_1" xlink:title="srt_ScenarioUnspecifiedDomain_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_1" xlink:title="dei_LegalEntityAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_1" xlink:title="dei_EntityDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="dei_LegalEntityAxis_1" xlink:to="dei_EntityDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:dei_LegalEntityAxis_1 To dei_EntityDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_1" xlink:title="us-gaap_ClassOfWarrantOrRightAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_1" xlink:title="us-gaap_ClassOfWarrantOrRightDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_1" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_ClassOfWarrantOrRightAxis_1 To us-gaap_ClassOfWarrantOrRightDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis_1" xlink:title="srt_OwnershipAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain_1" xlink:title="srt_OwnershipDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_OwnershipAxis_1" xlink:to="srt_OwnershipDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_OwnershipAxis_1 To srt_OwnershipDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis_1" xlink:title="us-gaap_LongtermDebtTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_1" xlink:title="us-gaap_LongtermDebtTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_LongtermDebtTypeAxis_1" xlink:to="us-gaap_LongtermDebtTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_LongtermDebtTypeAxis_1 To us-gaap_LongtermDebtTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis_1" xlink:title="us-gaap_StatementOperatingActivitiesSegmentAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="us-gaap_SegmentOperatingActivitiesDomain_1" xlink:title="us-gaap_SegmentOperatingActivitiesDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_StatementOperatingActivitiesSegmentAxis_1" xlink:to="us-gaap_SegmentOperatingActivitiesDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_StatementOperatingActivitiesSegmentAxis_1 To us-gaap_SegmentOperatingActivitiesDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_1" xlink:title="us-gaap_AwardTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_AwardTypeAxis_1" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_AwardTypeAxis_1 To us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="1" />
  </link:definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/StatementCondensedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - Condensed Balance Sheets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045699271559" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_637726045699271559" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesConvertiblePreferredStockMember" xlink:label="miro_SeriesConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesBConvertiblePreferredStockMember" xlink:label="miro_SeriesBConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesBConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesB2ConvertiblePreferredStockMember" xlink:label="miro_SeriesB2ConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesB2ConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivableCurrent" xlink:label="us-gaap_GrantsReceivableCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_GrantsReceivableCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_EquityMethodInvestments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_InterestPayableCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedRoyaltiesNoncurrent" xlink:label="miro_AccruedRoyaltiesNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="miro_AccruedRoyaltiesNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_InterestPayableNoncurrent" xlink:label="miro_InterestPayableNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="miro_InterestPayableNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical" xlink:type="extended" xlink:title="00105 - Statement - Condensed Balance Sheets (Parenthetical)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045699331522" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_637726045699331522" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesB2ConvertiblePreferredStockMember" xlink:label="miro_SeriesB2ConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesB2ConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesBConvertiblePreferredStockMember" xlink:label="miro_SeriesBConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesBConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesConvertiblePreferredStockMember" xlink:label="miro_SeriesConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit" xlink:type="extended" xlink:title="00300 - Statement - Condensed  Statements of Shareholders' Equity (Deficit)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_637726045699351543" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_637726045699351543" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_SharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="miro_StockIssuedDuringPeriodValueWarrantsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="miro_StockIssuedDuringPeriodValueWarrantsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="miro_StockIssuedDuringPeriodSharesWarrantsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="miro_StockIssuedDuringPeriodSharesWarrantsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodValueConversionOfPreferredStock" xlink:label="miro_StockIssuedDuringPeriodValueConversionOfPreferredStock" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="miro_StockIssuedDuringPeriodValueConversionOfPreferredStock" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock" xlink:label="miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest" xlink:label="miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest" xlink:label="miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails" xlink:type="extended" xlink:title="40101 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Charter (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045699381531" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_637726045699381531" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesCConvertiblePreferredStockMember" xlink:label="miro_SeriesCConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesCConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockConversionPercentage" xlink:label="miro_StockConversionPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="miro_StockConversionPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfClassesOfStock" xlink:label="miro_NumberOfClassesOfStock" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="miro_NumberOfClassesOfStock" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails" xlink:type="extended" xlink:title="40102 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Equity Method Investments (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="srt_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637726045699391496" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_637726045699391496" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_637726045699391496" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_637726045699391496" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="miro_RepriseBiomedicalInc.Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails" xlink:type="extended" xlink:title="40201 - Disclosure - INITIAL PUBLIC OFFERING (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_637726045699401623" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_637726045699401623" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_OverAllotmentOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_637726045699401623" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_637726045699401623" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_637726045699421442" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_637726045699421442" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CommonWarrantsMember" xlink:label="miro_CommonWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="miro_CommonWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightGranted" xlink:label="miro_ClassOfWarrantOrRightGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="miro_ClassOfWarrantOrRightGranted" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails" xlink:type="extended" xlink:title="40301 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045699441543" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045699441543" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_FurnitureFixturesAndComputersMember" xlink:label="miro_FurnitureFixturesAndComputersMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="miro_FurnitureFixturesAndComputersMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForConstructionInProcess" xlink:label="us-gaap_PaymentsForConstructionInProcess" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PaymentsForConstructionInProcess" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails" xlink:type="extended" xlink:title="40401 - Disclosure - EQUITY METHOD INVESTMENT - Reprise (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="dei_LegalEntityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_637726045699451496" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_637726045699451496" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="dei_EntityDomain" xlink:to="miro_RepriseBiomedicalInc.Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_637726045699451496" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_637726045699451496" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="miro_RepriseBiomedicalInc.Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_SharePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EquityMethodInvestmentSharesOwned" xlink:label="miro_EquityMethodInvestmentSharesOwned" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="miro_EquityMethodInvestmentSharesOwned" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EquityMethodInvestmentSharesSold" xlink:label="miro_EquityMethodInvestmentSharesSold" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="miro_EquityMethodInvestmentSharesSold" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="us-gaap_ProceedsFromSaleOfEquityMethodInvestments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ProceedsFromSaleOfEquityMethodInvestments" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails" xlink:type="extended" xlink:title="40402 - Disclosure - EQUITY METHOD INVESTMENT - Balance Sheet (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_637726045699471539" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_637726045699471539" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="miro_RepriseBiomedicalInc.Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_AssetsCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_Assets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_LiabilitiesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_LiabilitiesNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_MinorityInterest" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails" xlink:type="extended" xlink:title="40403 - Disclosure - EQUITY METHOD INVESTMENT - Income Statement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_637726045699481523" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_637726045699481523" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="miro_RepriseBiomedicalInc.Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_GrossProfit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails" xlink:type="extended" xlink:title="40601 - Disclosure - FAIR VALUE MEASUREMENT - Changes (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeTable" xlink:label="us-gaap_EmbeddedDerivativeTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_EmbeddedDerivativeTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637726045699491470" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637726045699491470" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeLineItems" xlink:label="us-gaap_EmbeddedDerivativeLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_EmbeddedDerivativeLineItems" xlink:to="us-gaap_EmbeddedDerivativeTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EmbeddedDerivativeLineItems" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions" xlink:label="miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_EmbeddedDerivativeLineItems" xlink:to="miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_EmbeddedDerivativeLineItems" xlink:to="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="us-gaap_DerivativeFairValueOfDerivativeLiability" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_EmbeddedDerivativeLineItems" xlink:to="us-gaap_DerivativeFairValueOfDerivativeLiability" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails" xlink:type="extended" xlink:title="40701 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION -  Agreements (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_637726045699501247" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_637726045699501247" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember" xlink:label="miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember" xlink:label="miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PromissoryNoteWithUniversityOfMinnesotaMember" xlink:label="miro_PromissoryNoteWithUniversityOfMinnesotaMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="miro_PromissoryNoteWithUniversityOfMinnesotaMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember" xlink:label="miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalLeaseOctober2018Member" xlink:label="miro_CapitalLeaseOctober2018Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="miro_CapitalLeaseOctober2018Member" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NoteCompanyShareholderMember" xlink:label="miro_NoteCompanyShareholderMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="miro_NoteCompanyShareholderMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PaycheckProtectionProgramMember" xlink:label="miro_PaycheckProtectionProgramMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="miro_PaycheckProtectionProgramMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalLeaseJuly2021Member" xlink:label="miro_CapitalLeaseJuly2021Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="miro_CapitalLeaseJuly2021Member" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalLeaseSeptember2021Member" xlink:label="miro_CapitalLeaseSeptember2021Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="miro_CapitalLeaseSeptember2021Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637726045699521503" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_637726045699521503" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_637726045699521503" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_637726045699521503" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsRegentsOfUniversityOfMinnesotaMember" xlink:label="miro_WarrantsRegentsOfUniversityOfMinnesotaMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="miro_WarrantsRegentsOfUniversityOfMinnesotaMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsUniversityOfMinnesotaMember" xlink:label="miro_WarrantsUniversityOfMinnesotaMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="miro_WarrantsUniversityOfMinnesotaMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsCompanyShareholderMember" xlink:label="miro_WarrantsCompanyShareholderMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="miro_WarrantsCompanyShareholderMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045699531469" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_637726045699531469" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesCConvertiblePreferredStockMember" xlink:label="miro_SeriesCConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesCConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfShareholders" xlink:label="miro_NumberOfShareholders" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="miro_NumberOfShareholders" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasedAssetsGross" xlink:label="us-gaap_CapitalLeasedAssetsGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_CapitalLeasedAssetsGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentPeriodicMonthlyPaymentNumber" xlink:label="miro_DebtInstrumentPeriodicMonthlyPaymentNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="miro_DebtInstrumentPeriodicMonthlyPaymentNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentNumberOfFinalPayment" xlink:label="miro_DebtInstrumentNumberOfFinalPayment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="miro_DebtInstrumentNumberOfFinalPayment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPayment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SubstantialOwnershipChangePercentage" xlink:label="miro_SubstantialOwnershipChangePercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="miro_SubstantialOwnershipChangePercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentAdditionalCompensation" xlink:label="miro_DebtInstrumentAdditionalCompensation" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="miro_DebtInstrumentAdditionalCompensation" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligations" xlink:label="us-gaap_CapitalLeaseObligations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_CapitalLeaseObligations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:label="miro_ClassOfWarrantOrRightNumberOfWarrantsIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="miro_ClassOfWarrantOrRightNumberOfWarrantsIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentConvertibleMinimumPreferredStockOffering" xlink:label="miro_DebtInstrumentConvertibleMinimumPreferredStockOffering" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="miro_DebtInstrumentConvertibleMinimumPreferredStockOffering" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsAndRightsAdditionalCoverage" xlink:label="miro_WarrantsAndRightsAdditionalCoverage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="miro_WarrantsAndRightsAdditionalCoverage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentPrincipalForgiveness" xlink:label="miro_DebtInstrumentPrincipalForgiveness" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="miro_DebtInstrumentPrincipalForgiveness" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentInterestForgiveness" xlink:label="miro_DebtInstrumentInterestForgiveness" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="22" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="miro_DebtInstrumentInterestForgiveness" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="23" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="24" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails" xlink:type="extended" xlink:title="40702 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION - Maturity (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_637726045699601197" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_637726045699601197" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember" xlink:label="us-gaap_LongTermDebtMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongTermDebtMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsMember" xlink:label="us-gaap_CapitalLeaseObligationsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_CapitalLeaseObligationsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:label="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtAndCapitalLeaseObligationsGross" xlink:label="miro_DebtAndCapitalLeaseObligationsGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="miro_DebtAndCapitalLeaseObligationsGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtAndCapitalLeaseObligationsGrossCurrent" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="miro_DebtAndCapitalLeaseObligationsGrossCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtAndCapitalLeaseObligationsGrossNoncurrent" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="miro_DebtAndCapitalLeaseObligationsGrossNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="us-gaap_DebtAndCapitalLeaseObligations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="us-gaap_DebtAndCapitalLeaseObligations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails" xlink:type="extended" xlink:title="40801 - Disclosure - CAPITAL STOCK - Convertible Preferred Stock, Prior to IPO (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045699721519" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_637726045699721519" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesConvertiblePreferredStockMember" xlink:label="miro_SeriesConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesBConvertiblePreferredStockMember" xlink:label="miro_SeriesBConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesBConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesCConvertiblePreferredStockMember" xlink:label="miro_SeriesCConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesCConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesB2ConvertiblePreferredStockMember" xlink:label="miro_SeriesB2ConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesB2ConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_637726045699721519" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_637726045699721519" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails" xlink:type="extended" xlink:title="40802 - Disclosure - CAPITAL STOCK - Common Stock and Preferred Stock (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_637726045699741763" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_637726045699741763" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ExercisePriceOf0.10Member" xlink:label="miro_ExercisePriceOf0.10Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="miro_ExercisePriceOf0.10Member" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ExercisePriceOf1.25Member" xlink:label="miro_ExercisePriceOf1.25Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="miro_ExercisePriceOf1.25Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfVotesForCommonStockHolders" xlink:label="miro_NumberOfVotesForCommonStockHolders" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="miro_NumberOfVotesForCommonStockHolders" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="miro_StockIssuedDuringPeriodSharesWarrantsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="miro_StockIssuedDuringPeriodSharesWarrantsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails" xlink:type="extended" xlink:title="40803 - Disclosure - CAPITAL STOCK - Series C Convertible Preferred Stock (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045699761527" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_637726045699761527" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesCConvertiblePreferredStockMember" xlink:label="miro_SeriesCConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesCConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_DebtInstrumentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_637726045699771516" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_637726045699771516" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NoteCompanyShareholderMember" xlink:label="miro_NoteCompanyShareholderMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="miro_NoteCompanyShareholderMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_637726045699771516" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_637726045699771516" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsCompanyShareholderMember" xlink:label="miro_WarrantsCompanyShareholderMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="miro_WarrantsCompanyShareholderMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfStockPurchaseAgreements" xlink:label="miro_NumberOfStockPurchaseAgreements" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="miro_NumberOfStockPurchaseAgreements" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="miro_StockIssuedDuringPeriodSharesWarrantsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="miro_StockIssuedDuringPeriodSharesWarrantsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockConversionDiscount" xlink:label="miro_StockConversionDiscount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="miro_StockConversionDiscount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_TemporaryEquitySharesConvertedInPeriod" xlink:label="miro_TemporaryEquitySharesConvertedInPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="miro_TemporaryEquitySharesConvertedInPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails" xlink:type="extended" xlink:title="40804 - Disclosure - CAPITAL STOCK - Stock options (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_637726045699791517" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_637726045699791517" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockOptionPlan2010Member" xlink:label="miro_StockOptionPlan2010Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PlanNameDomain" xlink:to="miro_StockOptionPlan2010Member" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockOptionPlan2019Member" xlink:label="miro_StockOptionPlan2019Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PlanNameDomain" xlink:to="miro_StockOptionPlan2019Member" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EquityIncentivePlan2021Member" xlink:label="miro_EquityIncentivePlan2021Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PlanNameDomain" xlink:to="miro_EquityIncentivePlan2021Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails" xlink:type="extended" xlink:title="40805 - Disclosure - CAPITAL STOCK - Estimate the fair value of stock option grants (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045699851489" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045699851489" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails" xlink:type="extended" xlink:title="40806 - Disclosure - CAPITAL STOCK - Restricted Stock Units (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_StatementScenarioAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_637726045699861510" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_637726045699861510" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045699861510" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045699861510" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails" xlink:type="extended" xlink:title="40807 - Disclosure - CAPITAL STOCK - Employee Stock Purchase Plan (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637726045699871514" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_637726045699871514" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045699871514" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045699871514" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails" xlink:type="extended" xlink:title="40808 - Disclosure - CAPITAL STOCK - Warrants (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_637726045699891629" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_637726045699891629" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesPreferredWarrantsMember" xlink:label="miro_SeriesPreferredWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="miro_SeriesPreferredWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CommonWarrantsMember" xlink:label="miro_CommonWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="miro_CommonWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightGranted" xlink:label="miro_ClassOfWarrantOrRightGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="miro_ClassOfWarrantOrRightGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightExercised" xlink:label="miro_ClassOfWarrantOrRightExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="miro_ClassOfWarrantOrRightExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightTerminated" xlink:label="miro_ClassOfWarrantOrRightTerminated" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="miro_ClassOfWarrantOrRightTerminated" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsOutstandingWeightedAverageExercisePrice" xlink:label="miro_WarrantsOutstandingWeightedAverageExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="miro_WarrantsOutstandingWeightedAverageExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/ScheduleSignificantCustomersDetails" xlink:type="extended" xlink:title="41001 - Schedule - SIGNIFICANT CUSTOMERS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_637726045699911805" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_637726045699911805" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_637726045699921566" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_637726045699921566" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="srt_MajorCustomersAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain_637726045699921566" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain_637726045699921566" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_OneCustomerMember" xlink:label="miro_OneCustomerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="miro_OneCustomerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfCustomers" xlink:label="miro_NumberOfCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="miro_NumberOfCustomers" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails" xlink:type="extended" xlink:title="41101 - Disclosure - COMMITMENTS AND CONTINGENCIES - Patent License Agreement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045699931583" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045699931583" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncollaborativeArrangementTransactionsMember" xlink:label="us-gaap_NoncollaborativeArrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_NoncollaborativeArrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PatentLicenseAgreementMember" xlink:label="miro_PatentLicenseAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_NoncollaborativeArrangementTransactionsMember" xlink:to="miro_PatentLicenseAgreementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_637726045699941928" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_637726045699941928" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_UniversityOfMinnesotaMember" xlink:label="miro_UniversityOfMinnesotaMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="miro_UniversityOfMinnesotaMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_637726045699941928" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_637726045699941928" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="miro_RepriseBiomedicalInc.Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_637726045699951622" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_637726045699951622" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PatentAndKnowHowLicenseAgreementMember" xlink:label="miro_PatentAndKnowHowLicenseAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="miro_PatentAndKnowHowLicenseAgreementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_MinimumRoyaltyPayable" xlink:label="miro_MinimumRoyaltyPayable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="miro_MinimumRoyaltyPayable" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_MinimumRoyaltyReceivable" xlink:label="miro_MinimumRoyaltyReceivable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="miro_MinimumRoyaltyReceivable" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails" xlink:type="extended" xlink:title="41102 - Disclosure - COMMITMENTS AND CONTINGENCIES - Leases (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045699961565" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045699961565" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_FirstFacilityEdenPrairieMember" xlink:label="miro_FirstFacilityEdenPrairieMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="miro_FirstFacilityEdenPrairieMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SecondFacilityEdenPrairieMember" xlink:label="miro_SecondFacilityEdenPrairieMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="miro_SecondFacilityEdenPrairieMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember" xlink:label="miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="srt_StatementScenarioAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_637726045699971614" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_637726045699971614" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_Period1Member" xlink:label="miro_Period1Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="miro_Period1Member" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_Period2Member" xlink:label="miro_Period2Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="miro_Period2Member" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_Period3Member" xlink:label="miro_Period3Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="miro_Period3Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_MonthlyLeaseRentPayments" xlink:label="miro_MonthlyLeaseRentPayments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="miro_MonthlyLeaseRentPayments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_IncreaseInYearlyRentPercentage" xlink:label="miro_IncreaseInYearlyRentPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="miro_IncreaseInYearlyRentPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage" xlink:label="miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseRealPropertyTaxesPercentage" xlink:label="miro_LesseeOperatingLeaseRealPropertyTaxesPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="miro_LesseeOperatingLeaseRealPropertyTaxesPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseManagementFeePercentage" xlink:label="miro_LesseeOperatingLeaseManagementFeePercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="miro_LesseeOperatingLeaseManagementFeePercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts" xlink:label="miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_OperatingLeaseNumberOfOptionsToExtend" xlink:label="miro_OperatingLeaseNumberOfOptionsToExtend" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="miro_OperatingLeaseNumberOfOptionsToExtend" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseOptionToExtendTermOfContract" xlink:label="miro_LesseeOperatingLeaseOptionToExtendTermOfContract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="miro_LesseeOperatingLeaseOptionToExtendTermOfContract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets" xlink:label="us-gaap_DepositAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_DepositAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails" xlink:type="extended" xlink:title="41103 - Disclosure - COMMITMENTS AND CONTINGENCIES - License Contract (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045700001556" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045700001556" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncollaborativeArrangementTransactionsMember" xlink:label="us-gaap_NoncollaborativeArrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_NoncollaborativeArrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ResearchAndDevelopmentContractMember" xlink:label="miro_ResearchAndDevelopmentContractMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_NoncollaborativeArrangementTransactionsMember" xlink:to="miro_ResearchAndDevelopmentContractMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045700001556" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_637726045700001556" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesBConvertiblePreferredStockMember" xlink:label="miro_SeriesBConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="miro_SeriesBConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SharePrice" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails" xlink:type="extended" xlink:title="41201 - Disclosure - RELATED PARTY TRANSACTIONS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_637726045700011549" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_637726045700011549" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CorporationOwnedByDirectorMember" xlink:label="miro_CorporationOwnedByDirectorMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="miro_CorporationOwnedByDirectorMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="miro_RepriseBiomedicalInc.Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_637726045700021526" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_637726045700021526" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ConsultingServicesMember" xlink:label="miro_ConsultingServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="miro_ConsultingServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PatentAndKnowHowLicenseAgreementMember" xlink:label="miro_PatentAndKnowHowLicenseAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="miro_PatentAndKnowHowLicenseAgreementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="us-gaap_RevenueFromRelatedParties" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RevenueFromRelatedParties" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesNoncurrent" xlink:label="us-gaap_AccountsReceivableRelatedPartiesNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_AccountsReceivableRelatedPartiesNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AllowanceForDoubtfulAccountsRelatedParties" xlink:label="miro_AllowanceForDoubtfulAccountsRelatedParties" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="miro_AllowanceForDoubtfulAccountsRelatedParties" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/DisclosureNetLossPerShareDetails" xlink:type="extended" xlink:title="41301 - Disclosure - NET LOSS PER SHARE (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_637726045700031524" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_637726045700031524" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ConvertiblePreferredStockWarrantsMember" xlink:label="miro_ConvertiblePreferredStockWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="miro_ConvertiblePreferredStockWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CommonStockWarrantsMember" xlink:label="miro_CommonStockWarrantsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="miro_CommonStockWarrantsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails" xlink:type="extended" xlink:title="414001 - Disclosure - 11401 - Disclosure - SUBSEQUENT EVENTS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_637726045700041572" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_637726045700041572" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045700041572" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045700041572" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncollaborativeArrangementTransactionsMember" xlink:label="us-gaap_NoncollaborativeArrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_NoncollaborativeArrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_CounterpartyNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_637726045700041572" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_637726045700041572" use="optional" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_UniversityOfMinnesotaMember" xlink:label="miro_UniversityOfMinnesotaMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="miro_UniversityOfMinnesotaMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AdditionalFundingToBeProvided" xlink:label="miro_AdditionalFundingToBeProvided" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="miro_AdditionalFundingToBeProvided" priority="1" use="optional" />
  </definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>tmb-20210930_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7908.23199 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/15/2021 8:22:51 PM-->
<!--Modified on: 11/15/2021 8:22:51 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Quarterly Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Transition Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address State Or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Current Reporting Status</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Interactive Data Current</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Filer Category</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Small Business</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Ex Transition Period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Shell Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Common Stock, Shares Outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Fiscal Year End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Year Focus</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Period Focus</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condensed Balance Sheets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Stock [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Stock [Domain]</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesB2ConvertiblePreferredStockMember" xlink:label="miro_SeriesB2ConvertiblePreferredStockMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_SeriesB2ConvertiblePreferredStockMember" xlink:to="miro_SeriesB2ConvertiblePreferredStockMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_SeriesB2ConvertiblePreferredStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Series B2 preferred stock that may be exchanged into common shares or other types of securities at the owner's option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_SeriesB2ConvertiblePreferredStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Series B-2 Convertible Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_SeriesB2ConvertiblePreferredStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible preferred stock - Series B-2</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesBConvertiblePreferredStockMember" xlink:label="miro_SeriesBConvertiblePreferredStockMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_SeriesBConvertiblePreferredStockMember" xlink:to="miro_SeriesBConvertiblePreferredStockMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_SeriesBConvertiblePreferredStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Series B preferred stock that may be exchanged into common shares or other types of securities at the owner's option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_SeriesBConvertiblePreferredStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Series B Convertible Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_SeriesBConvertiblePreferredStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible preferred stock - Series B</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesConvertiblePreferredStockMember" xlink:label="miro_SeriesConvertiblePreferredStockMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_SeriesConvertiblePreferredStockMember" xlink:to="miro_SeriesConvertiblePreferredStockMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_SeriesConvertiblePreferredStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Series A preferred stock that may be exchanged into common shares or other types of securities at the owner's option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_SeriesConvertiblePreferredStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Series A Convertible Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_SeriesConvertiblePreferredStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible preferred stock - Series A</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ASSETS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents, at Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedPartiesCurrent" xlink:to="us-gaap_DueFromRelatedPartiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Due from Related Parties, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receivable from Reprise Biomedical, Inc.</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivableCurrent" xlink:label="us-gaap_GrantsReceivableCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivableCurrent" xlink:to="us-gaap_GrantsReceivableCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivableCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grants Receivable, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GrantsReceivableCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grant receivable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid Expense and Other Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and other current assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total current assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lab equipment, furniture, leasehold improvements and construction in progress, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lab equipment, furniture, leasehold improvements and construction in progress, net, net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investment in Reprise Biomedical, Inc</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities and Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt and Lease Obligation, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less current portion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current portion of long-term debt</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts Payable, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts payable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Payable, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued interest expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Embedded Derivative, Fair Value of Embedded Derivative Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative liability ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative liability beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Embedded derivative liability</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total current liabilities</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedRoyaltiesNoncurrent" xlink:label="miro_AccruedRoyaltiesNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_AccruedRoyaltiesNoncurrent" xlink:to="miro_AccruedRoyaltiesNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_AccruedRoyaltiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying value as of the balance sheet date of royalty obligations incurred through that date and due after one year (or beyond the operating cycle if longer).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_AccruedRoyaltiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Royalties, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_AccruedRoyaltiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued royalties</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt and Lease Obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term debt, less current portion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term portion</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_InterestPayableNoncurrent" xlink:label="miro_InterestPayableNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_InterestPayableNoncurrent" xlink:to="miro_InterestPayableNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_InterestPayableNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying value as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_InterestPayableNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Payable, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_InterestPayableNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued interest</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and contingencies</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Mezzanine equity:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Carrying Amount, Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible preferred stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity Attributable to Parent [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shareholders' equity (deficit):</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Value, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, par value $0.00001; 190,000,000 shares authorized; 20,254,645 issued and outstanding as of September 30, 2021 and 30,000,000 shares authorized; 2,185,822 issued and outstanding as of December 31, 2020</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Paid in Capital, Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional paid-in capital</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained Earnings (Accumulated Deficit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated deficit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Miromatrix Medical Inc. share of shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total shareholders' equity (deficit)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Liabilities, Mezzanine Equity and Shareholders' Equity (Deficit)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible preferred stock, par value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible preferred stock, authorized (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible preferred stock, authorized (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible preferred stock, issued (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible preferred stock, outstanding (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Liquidation Preference</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible preferred stock, liquidation preference</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, par value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, authorized (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, issued (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, outstanding (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condensed Statements of Operations</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from Contract with Customer, Excluding Assessed Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Licensing revenue</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:to="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost of Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost of goods sold</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:label="us-gaap_TypeOfCostGoodOrServiceExtensibleList" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:to="us-gaap_TypeOfCostGoodOrServiceExtensibleList_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfCostGoodOrServiceExtensibleList_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost, Product and Service [Extensible Enumeration]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross Profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross margin</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross margin</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Expenses [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating expenses:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development expenses</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RegulatoryAndClinicalExpense" xlink:label="miro_RegulatoryAndClinicalExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_RegulatoryAndClinicalExpense" xlink:to="miro_RegulatoryAndClinicalExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_RegulatoryAndClinicalExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of regulatory and clinical expenses incurred during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_RegulatoryAndClinicalExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Regulatory and Clinical Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_RegulatoryAndClinicalExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Regulatory and clinical</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_QualityExpense" xlink:label="miro_QualityExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_QualityExpense" xlink:to="miro_QualityExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_QualityExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of quality expense incurred during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_QualityExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Quality Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_QualityExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Quality</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Selling, General and Administrative Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General &amp; administration</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total operating expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Income (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating loss</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investment Income, Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization of Debt Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization of discount on note</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative" xlink:label="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative" xlink:to="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Embedded Derivative, Gain on Embedded Derivative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in fair value of derivative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in fair value of derivative</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ResearchGrants" xlink:label="miro_ResearchGrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ResearchGrants" xlink:to="miro_ResearchGrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ResearchGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of income from research grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ResearchGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ResearchGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research grants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income (Loss) from Equity Method Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity loss in affiliate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity loss in affiliate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Securities, FV-NI, Realized Gain (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain on sale of equity investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain on sale of equity investment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain (Loss) on Extinguishment of Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain on debt extinguishment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Income (Loss) Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Miromatrix Medical Inc. share of net loss</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net loss per share, basic (in dollar per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net loss per share, diluted (in dollar per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Number of Shares Outstanding, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average shares used in computing net loss per share, basic (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Number of Shares Outstanding, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average shares used in computing net loss per share, diluted (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condensed Statements of Shareholders' Equity (Deficit)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Components [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Component [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Paid-in Capital</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Deficit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Stockholders' Equity [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Stockholders' Equity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at end of period (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at beginning of period (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-based compensation expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Value, Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise of stock options</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise of stock options (in shares)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="miro_StockIssuedDuringPeriodValueWarrantsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="miro_StockIssuedDuringPeriodValueWarrantsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_StockIssuedDuringPeriodValueWarrantsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of stock issued as a result of the exercise of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_StockIssuedDuringPeriodValueWarrantsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Value, Warrants Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_StockIssuedDuringPeriodValueWarrantsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise of stock warrants</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="miro_StockIssuedDuringPeriodSharesWarrantsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="miro_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of stock issued as a result of the exercise of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Shares, Warrants Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise of stock warrants (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="miro_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock issued upon exercise of warrants (in shares)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodValueConversionOfPreferredStock" xlink:label="miro_StockIssuedDuringPeriodValueConversionOfPreferredStock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_StockIssuedDuringPeriodValueConversionOfPreferredStock" xlink:to="miro_StockIssuedDuringPeriodValueConversionOfPreferredStock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_StockIssuedDuringPeriodValueConversionOfPreferredStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The gross value of stock issued during the period as a result of the conversion of preferred stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_StockIssuedDuringPeriodValueConversionOfPreferredStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Value, Conversion of Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_StockIssuedDuringPeriodValueConversionOfPreferredStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conversion of preferred stock to common stock</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock" xlink:label="miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock" xlink:to="miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued during the period as a result of the conversion of preferred stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Shares, Conversion of Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conversion of preferred stock to common stock (in shares)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest" xlink:label="miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest" xlink:to="miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of stock issued as a result of the conversion of note payable and accrued interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Value, Conversion of Note Payable and Accrued Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Note payable and accrued interest converted to common stock</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest" xlink:label="miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest" xlink:to="miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued during the period as a result of the conversion of note payable and accrued interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Shares, Conversion of Note Payable and Accrued Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Note payable and accrued interest converted to common stock (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Value, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sales of common stock, net of expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Shares, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sales of common stock, net of expenses (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of common stock (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condensed Statements of Cash Flows</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from operating activities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net loss</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to reconcile net loss to net cash from operating activities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation, Depletion and Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation and amortization expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Noncash Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-based compensation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts Receivable, Credit Loss Expense (Reversal)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reserve for bad debt</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization of Debt Discount (Premium)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization of discount on note</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_GainOnForgivenessOfDebt" xlink:label="miro_GainOnForgivenessOfDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_GainOnForgivenessOfDebt" xlink:to="miro_GainOnForgivenessOfDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_GainOnForgivenessOfDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain on amounts of indebtedness forgiven by the holder of the debt instrument.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_GainOnForgivenessOfDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain on Forgiveness of Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="miro_GainOnForgivenessOfDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forgiveness of paycheck protection program loan</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Operating Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in operating assets and liabilities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Accounts Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts receivable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Due from Related Parties, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receivable from Reprise Biomedical, Inc</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_IncreaseDecreaseInGrantsReceivable" xlink:label="miro_IncreaseDecreaseInGrantsReceivable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_IncreaseDecreaseInGrantsReceivable" xlink:to="miro_IncreaseDecreaseInGrantsReceivable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_IncreaseDecreaseInGrantsReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) during the reporting period in amount due within one year (or one business cycle) for grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_IncreaseDecreaseInGrantsReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Grants Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_IncreaseDecreaseInGrantsReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grant receivable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Prepaid Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Accounts Payable and Accrued Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts payable and accrued expenses</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_IncreaseDecreaseInInterestPayableNoncurrent" xlink:label="miro_IncreaseDecreaseInInterestPayableNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_IncreaseDecreaseInInterestPayableNoncurrent" xlink:to="miro_IncreaseDecreaseInInterestPayableNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_IncreaseDecreaseInInterestPayableNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) during the reporting period in the amounts for noncurrent interest payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_IncreaseDecreaseInInterestPayableNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) In Interest Payable, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="miro_IncreaseDecreaseInInterestPayableNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued interest</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash used in operating activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from investing activities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Sale of Equity Method Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of equity method investment shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForConstructionInProcess" xlink:label="us-gaap_PaymentsForConstructionInProcess" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForConstructionInProcess" xlink:to="us-gaap_PaymentsForConstructionInProcess_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForConstructionInProcess_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for Construction in Process</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForConstructionInProcess_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchases of construction in process</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaymentsForConstructionInProcess_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leasehold improvements recorded as construction in progress</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements" xlink:label="miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements" xlink:to="miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash outflow associated with the acquisition of lab equipment, furniture and leasehold improvements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Lab Equipment, Furniture and Leasehold Improvements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchases of lab equipment, furniture and leasehold improvements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash provided by (used in) investing activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from financing activities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayments of Long-term Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments on long-term debt</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of Long-term Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from long-term debt</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ProceedsFromIssuanceOfCommonStockNet" xlink:label="miro_ProceedsFromIssuanceOfCommonStockNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ProceedsFromIssuanceOfCommonStockNet" xlink:to="miro_ProceedsFromIssuanceOfCommonStockNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ProceedsFromIssuanceOfCommonStockNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The net cash inflow from the additional capital contribution to the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ProceedsFromIssuanceOfCommonStockNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of Common Stock, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ProceedsFromIssuanceOfCommonStockNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of common stock, net</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet" xlink:label="miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet" xlink:to="miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The net cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of Redeemable Convertible Preferred Stock, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of preferred stock, net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Warrant Exercises</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from stock warrants exercise</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from stock options exercise</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash provided by financing activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents at beginning of period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supplemental Cash Flow Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supplemental disclosure of cash flow information:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Paid, Excluding Capitalized Interest, Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest paid</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Noncash Investing and Financing Items [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supplemental disclosure of non-cash activities:</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NoncashInvestingAndFinancingFinancingExpenses" xlink:label="miro_NoncashInvestingAndFinancingFinancingExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_NoncashInvestingAndFinancingFinancingExpenses" xlink:to="miro_NoncashInvestingAndFinancingFinancingExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_NoncashInvestingAndFinancingFinancingExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of financing expenses accrued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_NoncashInvestingAndFinancingFinancingExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Noncash Investing and Financing, Financing Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_NoncashInvestingAndFinancingFinancingExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses related to financing</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockholdersEquityNoteInitialPublicOfferingAbstract" xlink:label="miro_StockholdersEquityNoteInitialPublicOfferingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_StockholdersEquityNoteInitialPublicOfferingAbstract" xlink:to="miro_StockholdersEquityNoteInitialPublicOfferingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_StockholdersEquityNoteInitialPublicOfferingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_StockholdersEquityNoteInitialPublicOfferingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">INITIAL PUBLIC OFFERING</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsidiary, Sale of Stock [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPO</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock" xlink:label="miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock" xlink:to="miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure for initial public offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity Note, Initial Public Offering Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">INITIAL PUBLIC OFFERING</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">EQUITY METHOD INVESTMENT</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investments and Joint Ventures Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">EQUITY METHOD INVESTMENT</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ACCRUED EXPENSES</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ACCRUED EXPENSES</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">FAIR VALUE MEASUREMENT</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Disclosures [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">FAIR VALUE MEASUREMENT</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">DEBT AND CAPITAL LEASE OBLIGATION</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:label="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:to="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt and Capital Leases Disclosures [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">DEBT AND CAPITAL LEASE OBLIGATION</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalStockDisclosureAbstract" xlink:label="miro_CapitalStockDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_CapitalStockDisclosureAbstract" xlink:to="miro_CapitalStockDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_CapitalStockDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_CapitalStockDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CAPITAL STOCK</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock" xlink:label="miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock" xlink:to="miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). Also includes disclosure of temporary equity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shareholders' Equity, Share-based Payments and Temporary Equity [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SHAREHOLDERS' DEFICIT AND MEZZANINE EQUITY</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">EMPLOYEE BENEFIT PLANS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanTextBlock" xlink:label="us-gaap_DefinedContributionPlanTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanTextBlock" xlink:to="us-gaap_DefinedContributionPlanTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Contribution Plan [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">EMPLOYEE BENEFIT PLANS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SIGNIFICANT CUSTOMERS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SIGNIFICANT CUSTOMERS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">COMMITMENTS AND CONTINGENCIES</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">COMMITMENTS AND CONTINGENCIES</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RELATED PARTY TRANSACTIONS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transactions Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RELATED PARTY TRANSACTIONS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">NET LOSS PER SHARE</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">NET LOSS PER SHARE</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SUBSEQUENT EVENTS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Events [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SUBSEQUENT EVENTS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of Accounting, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of Preparation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsPolicy" xlink:to="us-gaap_EquityMethodInvestmentsPolicy_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investments [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investments</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development Expense, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development Costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-Based Compensation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration of Credit Risk</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Use of Estimates, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Use of Estimates</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock" xlink:label="miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock" xlink:to="miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of accounting policy for emerging growth company status.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Emerging Growth Company Status, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Emerging Growth Company Status</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Loss Per Share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Recent Accounting Pronouncements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of lab equipment, furniture, leasehold improvements and construction in progress</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investments [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of financial information from the financial statements of Reprise</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Accrued Liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of current accrued expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of changes in value of the Company's embedded derivative liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Maturities of Long-term Debt [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of maturities of debt</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityTableTextBlock" xlink:to="us-gaap_TemporaryEquityTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of convertible preferred stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of stock option activity table text block</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of weighted average assumptions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of warrants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of future minimum non-cancelable lease commitments</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of potentially dilutive securities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Stock by Class [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Stock [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital stock</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockConversionPercentage" xlink:label="miro_StockConversionPercentage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_StockConversionPercentage" xlink:to="miro_StockConversionPercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_StockConversionPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of common stock price at which convertible preferred stock was converted into common stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_StockConversionPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Conversion, Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_StockConversionPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock conversion, percentage common stock price</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred stock , authorized (in shares)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfClassesOfStock" xlink:label="miro_NumberOfClassesOfStock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_NumberOfClassesOfStock" xlink:to="miro_NumberOfClassesOfStock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_NumberOfClassesOfStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of classes of stock entity may authorize to issue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_NumberOfClassesOfStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Classes of Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_NumberOfClassesOfStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of classes of stock</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesCConvertiblePreferredStockMember" xlink:label="miro_SeriesCConvertiblePreferredStockMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_SeriesCConvertiblePreferredStockMember" xlink:to="miro_SeriesCConvertiblePreferredStockMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_SeriesCConvertiblePreferredStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Series C preferred stock that may be exchanged into common shares or other types of securities at the owner's option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_SeriesCConvertiblePreferredStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Series C Convertible Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_SeriesCConvertiblePreferredStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible Preferred Stock - Series C</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting Standards Update and Change in Accounting Principle [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investment, Name [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investment, Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_RepriseBiomedicalInc.Member" xlink:to="miro_RepriseBiomedicalInc.Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_RepriseBiomedicalInc.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reprise Biomedical, Inc., acquirer business from entity in June 2019 and equity method investee of entity until March 2021.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_RepriseBiomedicalInc.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reprise Biomedical, Inc.[Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_RepriseBiomedicalInc.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reprise Biomedical, Inc.</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statistical Measurement [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statistical Measurement [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investment, Ownership Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ownership interest (as a percent)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of Stock [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale of Stock [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Public offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPO</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Over-Allotment Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Over-allotment option</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares Issued, Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share price (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of common stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conversion of preferred stock to common stock (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Value, Conversion of Convertible Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conversion of preferred stock to common stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments of Stock Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Offering costs</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightGranted" xlink:label="miro_ClassOfWarrantOrRightGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ClassOfWarrantOrRightGranted" xlink:to="miro_ClassOfWarrantOrRightGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ClassOfWarrantOrRightGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of warrants or rights granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ClassOfWarrantOrRightGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right, Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ClassOfWarrantOrRightGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="miro_ClassOfWarrantOrRightGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants issued (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right [Domain]</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CommonWarrantsMember" xlink:label="miro_CommonWarrantsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_CommonWarrantsMember" xlink:to="miro_CommonWarrantsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_CommonWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to common warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_CommonWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Warrants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-Lived Tangible Asset [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-Lived Tangible Asset [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lab equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Construction in progress</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leasehold improvements</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_FurnitureFixturesAndComputersMember" xlink:label="miro_FurnitureFixturesAndComputersMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_FurnitureFixturesAndComputersMember" xlink:to="miro_FurnitureFixturesAndComputersMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_FurnitureFixturesAndComputersMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to furniture, fixtures and computers.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_FurnitureFixturesAndComputersMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Furniture, Fixtures And Computers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_FurnitureFixturesAndComputersMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Furniture and fixtures &amp; computers</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lab equipment, furniture, leasehold improvements and construction in progress, gross</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less accumulated depreciation and amortization</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Equity Method Investments [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Legal Entity [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Equity Method Investments [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity method investment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share price (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investment, Realized Gain (Loss) on Disposal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain on sale of equity method investment</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EquityMethodInvestmentSharesOwned" xlink:label="miro_EquityMethodInvestmentSharesOwned" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_EquityMethodInvestmentSharesOwned" xlink:to="miro_EquityMethodInvestmentSharesOwned_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_EquityMethodInvestmentSharesOwned_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of common shares owned of equity method investment by entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_EquityMethodInvestmentSharesOwned_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investment, Shares Owned</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_EquityMethodInvestmentSharesOwned_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of equity method investment shares owned</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EquityMethodInvestmentSharesSold" xlink:label="miro_EquityMethodInvestmentSharesSold" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_EquityMethodInvestmentSharesSold" xlink:to="miro_EquityMethodInvestmentSharesSold_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_EquityMethodInvestmentSharesSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of common shares of equity method investment sold by entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_EquityMethodInvestmentSharesSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investment, Shares Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_EquityMethodInvestmentSharesSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of equity method investment shares sold</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investment, Nonconsolidated Investee [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investment, Nonconsolidated Investee [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shareholders' equity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Income (Loss) Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net loss</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Salaries, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Wages</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Professional Fees, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Legal</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="us-gaap_AccruedRoyaltiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedRoyaltiesCurrent" xlink:to="us-gaap_AccruedRoyaltiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedRoyaltiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Royalties, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedRoyaltiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Royalties</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedSuppliesCurrent" xlink:label="miro_AccruedSuppliesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_AccruedSuppliesCurrent" xlink:to="miro_AccruedSuppliesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_AccruedSuppliesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying value as of the balance sheet date of obligations incurred through that date and payable for supplies. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_AccruedSuppliesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Supplies, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_AccruedSuppliesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supplies</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedLiabilitiesPublicOfferingExpensesCurrent" xlink:label="miro_AccruedLiabilitiesPublicOfferingExpensesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_AccruedLiabilitiesPublicOfferingExpensesCurrent" xlink:to="miro_AccruedLiabilitiesPublicOfferingExpensesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_AccruedLiabilitiesPublicOfferingExpensesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying value as of the balance sheet date of obligations incurred through that date and payable for public offering expenses, due within one year or the normal operating cycle, if longer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_AccruedLiabilitiesPublicOfferingExpensesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Liabilities, Public Offering Expenses, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_AccruedLiabilitiesPublicOfferingExpensesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPO expenses</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedKeyOpinionLeadedCompensationCurrent" xlink:label="miro_AccruedKeyOpinionLeadedCompensationCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_AccruedKeyOpinionLeadedCompensationCurrent" xlink:to="miro_AccruedKeyOpinionLeadedCompensationCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_AccruedKeyOpinionLeadedCompensationCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying value as of the balance sheet date of obligations incurred through that date and payable for key opinion leader compensation. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_AccruedKeyOpinionLeadedCompensationCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Key Opinion Leaded Compensation, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_AccruedKeyOpinionLeadedCompensationCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key opinion leader compensation</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedBoardCompensationCurrent" xlink:label="miro_AccruedBoardCompensationCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_AccruedBoardCompensationCurrent" xlink:to="miro_AccruedBoardCompensationCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_AccruedBoardCompensationCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying value as of the balance sheet date of the obligations incurred through that date and payable for services provided by board of directors. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_AccruedBoardCompensationCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Board Compensation, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_AccruedBoardCompensationCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Board compensation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Accrued Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeTable" xlink:label="us-gaap_EmbeddedDerivativeTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeTable" xlink:to="us-gaap_EmbeddedDerivativeTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Embedded Derivative [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Hierarchy and NAV [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Hierarchy and NAV [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Level 3</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeLineItems" xlink:label="us-gaap_EmbeddedDerivativeLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeLineItems" xlink:to="us-gaap_EmbeddedDerivativeLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Embedded Derivative [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmbeddedDerivativeLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">FAIR VALUE MEASUREMENT</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions" xlink:label="miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions" xlink:to="miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of additions of embedded derivative or group of embedded derivatives classified as a liability during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Embedded Derivative, Fair Value of Embedded Derivative Liability, Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative instrument related to March 2020 Note</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:to="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Embedded Derivative, Gain (Loss) on Embedded Derivative, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain/Loss recognized to revalue derivative instrument at fair value</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="us-gaap_DerivativeFairValueOfDerivativeLiability" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="us-gaap_DerivativeFairValueOfDerivativeLiability_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFairValueOfDerivativeLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Liability, Fair Value, Gross Liability</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Long-term Debt Instruments [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember" xlink:label="miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember" xlink:to="miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan agreement with Minnesota Agricultural and Economic Development Board with maturity date of November 1, 2020.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan, Minnesota Agricultural and Economic Development Board [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan, Minnesota Agricultural and Economic Development Board, Due November 1, 2020</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember" xlink:label="miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember" xlink:to="miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to promissory Note with the Regents of the University of Minnesota, due December 31, 2022.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Promissory Note With Regents of the University of Minnesota [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Promissory Note, Regents of the University of Minnesota, Due December 31, 2022</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember" xlink:label="miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember" xlink:to="miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan agreement with the Minnesota Department of Employment and Economic Development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan, Minnesota Department of Employment and Economic Development [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loan, Minnesota Department of Employment and Economic Development.</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalLeaseOctober2018Member" xlink:label="miro_CapitalLeaseOctober2018Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_CapitalLeaseOctober2018Member" xlink:to="miro_CapitalLeaseOctober2018Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_CapitalLeaseOctober2018Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital lease agreement entered into by entity in October 2018.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_CapitalLeaseOctober2018Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital Lease, October 2018</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PromissoryNoteWithUniversityOfMinnesotaMember" xlink:label="miro_PromissoryNoteWithUniversityOfMinnesotaMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_PromissoryNoteWithUniversityOfMinnesotaMember" xlink:to="miro_PromissoryNoteWithUniversityOfMinnesotaMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_PromissoryNoteWithUniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to Promissory Note with the University of Minnesota, due January 31, 2025.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_PromissoryNoteWithUniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Promissory Note With University of Minnesota [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_PromissoryNoteWithUniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Promissory Note, University of Minnesota, Due January 31, 2025</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NoteCompanyShareholderMember" xlink:label="miro_NoteCompanyShareholderMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_NoteCompanyShareholderMember" xlink:to="miro_NoteCompanyShareholderMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_NoteCompanyShareholderMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Note agreement with one of Company's shareholders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_NoteCompanyShareholderMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Note, Company Shareholder [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_NoteCompanyShareholderMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Note, Company shareholder</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PaycheckProtectionProgramMember" xlink:label="miro_PaycheckProtectionProgramMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_PaycheckProtectionProgramMember" xlink:to="miro_PaycheckProtectionProgramMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_PaycheckProtectionProgramMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to the Paycheck Protection Program Note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_PaycheckProtectionProgramMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Paycheck Protection Program</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_PaycheckProtectionProgramMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Paycheck Protection Program Note</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalLeaseJuly2021Member" xlink:label="miro_CapitalLeaseJuly2021Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_CapitalLeaseJuly2021Member" xlink:to="miro_CapitalLeaseJuly2021Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_CapitalLeaseJuly2021Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital lease agreement entered into by entity in July 2021.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_CapitalLeaseJuly2021Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital Lease, July 2021</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalLeaseSeptember2021Member" xlink:label="miro_CapitalLeaseSeptember2021Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_CapitalLeaseSeptember2021Member" xlink:to="miro_CapitalLeaseSeptember2021Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_CapitalLeaseSeptember2021Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital lease agreement entered into by entity in September 2021.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_CapitalLeaseSeptember2021Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital Lease, September 2021</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsRegentsOfUniversityOfMinnesotaMember" xlink:label="miro_WarrantsRegentsOfUniversityOfMinnesotaMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_WarrantsRegentsOfUniversityOfMinnesotaMember" xlink:to="miro_WarrantsRegentsOfUniversityOfMinnesotaMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_WarrantsRegentsOfUniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Information pertaining to warrants issued to the Regents of the University of Minnesota</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_WarrantsRegentsOfUniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants, Regents of the University of Minnesota [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_WarrantsRegentsOfUniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants, Regents of the University of Minnesota</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsUniversityOfMinnesotaMember" xlink:label="miro_WarrantsUniversityOfMinnesotaMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_WarrantsUniversityOfMinnesotaMember" xlink:to="miro_WarrantsUniversityOfMinnesotaMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_WarrantsUniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Information pertaining to warrants issued to the University of Minnesota.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_WarrantsUniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants, University of Minnesota [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_WarrantsUniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants, University of Minnesota</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsCompanyShareholderMember" xlink:label="miro_WarrantsCompanyShareholderMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_WarrantsCompanyShareholderMember" xlink:to="miro_WarrantsCompanyShareholderMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_WarrantsCompanyShareholderMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Information pertaining to warrants issued to a shareholder of the company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_WarrantsCompanyShareholderMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants, Company Shareholder [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_WarrantsCompanyShareholderMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants, Company shareholder</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">DEBT AND CAPITAL LEASE OBLIGATION</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfShareholders" xlink:label="miro_NumberOfShareholders" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_NumberOfShareholders" xlink:to="miro_NumberOfShareholders_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_NumberOfShareholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shareholders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_NumberOfShareholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_NumberOfShareholders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shareholders</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Face Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Face value of debt</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasedAssetsGross" xlink:label="us-gaap_CapitalLeasedAssetsGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasedAssetsGross" xlink:to="us-gaap_CapitalLeasedAssetsGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasedAssetsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital Leased Assets, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CapitalLeasedAssetsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capitalized lease</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Interest Rate, Stated Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate (as a percent)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentPeriodicMonthlyPaymentNumber" xlink:label="miro_DebtInstrumentPeriodicMonthlyPaymentNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_DebtInstrumentPeriodicMonthlyPaymentNumber" xlink:to="miro_DebtInstrumentPeriodicMonthlyPaymentNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_DebtInstrumentPeriodicMonthlyPaymentNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of monthly payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_DebtInstrumentPeriodicMonthlyPaymentNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Periodic Monthly Payment, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_DebtInstrumentPeriodicMonthlyPaymentNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of monthly payment</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentNumberOfFinalPayment" xlink:label="miro_DebtInstrumentNumberOfFinalPayment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_DebtInstrumentNumberOfFinalPayment" xlink:to="miro_DebtInstrumentNumberOfFinalPayment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_DebtInstrumentNumberOfFinalPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of final payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_DebtInstrumentNumberOfFinalPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Number of Final Payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_DebtInstrumentNumberOfFinalPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of final payment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Periodic Payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of principal and interest payment</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SubstantialOwnershipChangePercentage" xlink:label="miro_SubstantialOwnershipChangePercentage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_SubstantialOwnershipChangePercentage" xlink:to="miro_SubstantialOwnershipChangePercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_SubstantialOwnershipChangePercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Threshold percentage defined as substantial ownership change for one entity under terms of agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_SubstantialOwnershipChangePercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Substantial Ownership Change, Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_SubstantialOwnershipChangePercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Substantial ownership change threshold (as a percent)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentAdditionalCompensation" xlink:label="miro_DebtInstrumentAdditionalCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_DebtInstrumentAdditionalCompensation" xlink:to="miro_DebtInstrumentAdditionalCompensation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_DebtInstrumentAdditionalCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of additional compensation cost to be paid upon specified ownership change.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_DebtInstrumentAdditionalCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Additional Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_DebtInstrumentAdditionalCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential additional compensation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligations" xlink:label="us-gaap_CapitalLeaseObligations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeaseObligations" xlink:to="us-gaap_CapitalLeaseObligations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeaseObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital Lease Obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CapitalLeaseObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants outstanding, ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants outstanding, beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of warrants outstanding</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:label="miro_ClassOfWarrantOrRightNumberOfWarrantsIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:to="miro_ClassOfWarrantOrRightNumberOfWarrantsIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ClassOfWarrantOrRightNumberOfWarrantsIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of warrants issued, in terms of number of securities into which the class of warrant or right may be converted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ClassOfWarrantOrRightNumberOfWarrantsIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right, Number of Warrants Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ClassOfWarrantOrRightNumberOfWarrantsIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of warrants issued</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants and Rights Outstanding, Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Term of warrant</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant exercise price (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentConvertibleMinimumPreferredStockOffering" xlink:label="miro_DebtInstrumentConvertibleMinimumPreferredStockOffering" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_DebtInstrumentConvertibleMinimumPreferredStockOffering" xlink:to="miro_DebtInstrumentConvertibleMinimumPreferredStockOffering_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_DebtInstrumentConvertibleMinimumPreferredStockOffering_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum amount of preferred stock offering for conversion of debt into preferred shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_DebtInstrumentConvertibleMinimumPreferredStockOffering_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument convertible, Minimum Preferred Stock Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_DebtInstrumentConvertibleMinimumPreferredStockOffering_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum amount of preferred stock offering for conversion of debt</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants and Rights Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrant coverage amount</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsAndRightsAdditionalCoverage" xlink:label="miro_WarrantsAndRightsAdditionalCoverage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_WarrantsAndRightsAdditionalCoverage" xlink:to="miro_WarrantsAndRightsAdditionalCoverage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_WarrantsAndRightsAdditionalCoverage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of additional warrants to be issued under specified terms of the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_WarrantsAndRightsAdditionalCoverage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants and Rights, Additional Coverage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_WarrantsAndRightsAdditionalCoverage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional warrant coverage</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:to="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Interest Rate, Increase (Decrease)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in interest rate (as a percent)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Interest Rate During Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate during period (as a percent)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentPrincipalForgiveness" xlink:label="miro_DebtInstrumentPrincipalForgiveness" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_DebtInstrumentPrincipalForgiveness" xlink:to="miro_DebtInstrumentPrincipalForgiveness_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_DebtInstrumentPrincipalForgiveness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amounts of principal forgiven by the holder of the debt instrument.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_DebtInstrumentPrincipalForgiveness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Principal, Forgiveness</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_DebtInstrumentPrincipalForgiveness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of principal forgiven</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentInterestForgiveness" xlink:label="miro_DebtInstrumentInterestForgiveness" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_DebtInstrumentInterestForgiveness" xlink:to="miro_DebtInstrumentInterestForgiveness_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_DebtInstrumentInterestForgiveness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amounts of interest forgiven by the holder of the debt instrument.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_DebtInstrumentInterestForgiveness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Interest, Forgiveness</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="miro_DebtInstrumentInterestForgiveness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of interest forgiven</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" xlink:to="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of temporary equity shares issued during the period as a result of the conversion of note payable and accrued interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Stock Issued During Period, Conversion Of Note Payable and Accrued Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary equity issued upon conversion of note and accrued interest (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term debt outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember" xlink:label="us-gaap_LongTermDebtMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMember" xlink:to="us-gaap_LongTermDebtMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsMember" xlink:label="us-gaap_CapitalLeaseObligationsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeaseObligationsMember" xlink:to="us-gaap_CapitalLeaseObligationsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeaseObligationsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital Lease</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:label="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturities of Long-term Debt and Capital Lease Obligations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt and Lease Total</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Principal amount of long-term debt and capital lease obligation maturing in the next rolling twelve months following the latest balance sheet.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Rolling Twelve Months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Year 1</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Principal amount of long-term debt and capital lease obligation  maturing in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Rolling Year Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Year 2</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Principal amount of long-term debt and capital lease obligation maturing in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Rolling Year Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Year 3</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Principal amount of long-term debt and capital lease obligation maturing in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Rolling Year Four</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Year 4</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Principal amount of long-term debt and capital lease obligation maturing in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Rolling Year Five</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Year 5</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtAndCapitalLeaseObligationsGross" xlink:label="miro_DebtAndCapitalLeaseObligationsGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_DebtAndCapitalLeaseObligationsGross" xlink:to="miro_DebtAndCapitalLeaseObligationsGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_DebtAndCapitalLeaseObligationsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount, before unamortized (discount) premium and debt issuance costs, of short-term and  long-term debt and capital leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_DebtAndCapitalLeaseObligationsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt and Capital Lease Obligations, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="miro_DebtAndCapitalLeaseObligationsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Totals</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtAndCapitalLeaseObligationsGrossCurrent" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_DebtAndCapitalLeaseObligationsGrossCurrent" xlink:to="miro_DebtAndCapitalLeaseObligationsGrossCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount, before unamortized (discount) premium and debt issuance costs, of short-term and  long-term debt and capital leases, classified as current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt and Capital Lease Obligations, Gross, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less current portion</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtAndCapitalLeaseObligationsGrossNoncurrent" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_DebtAndCapitalLeaseObligationsGrossNoncurrent" xlink:to="miro_DebtAndCapitalLeaseObligationsGrossNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount, before unamortized (discount) premium and debt issuance costs, of short-term and  long-term debt and capital leases, classified as noncurrent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt and Capital Lease Obligations, Gross, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term portion</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="us-gaap_DebtAndCapitalLeaseObligations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtAndCapitalLeaseObligations" xlink:to="us-gaap_DebtAndCapitalLeaseObligations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtAndCapitalLeaseObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt and Lease Obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DebtAndCapitalLeaseObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Totals</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfVotesForCommonStockHolders" xlink:label="miro_NumberOfVotesForCommonStockHolders" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_NumberOfVotesForCommonStockHolders" xlink:to="miro_NumberOfVotesForCommonStockHolders_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_NumberOfVotesForCommonStockHolders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of votes each common stock holder is entitled to vote.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_NumberOfVotesForCommonStockHolders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Votes for Common Stock Holders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_NumberOfVotesForCommonStockHolders_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of votes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Option exercise price (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred stock, par value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred stock, issued (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred stock, outstanding (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise Price Range [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise Price Range [Domain]</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ExercisePriceOf0.10Member" xlink:label="miro_ExercisePriceOf0.10Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ExercisePriceOf0.10Member" xlink:to="miro_ExercisePriceOf0.10Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ExercisePriceOf0.10Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to exercise price of $0.10.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ExercisePriceOf0.10Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise price of $0.10</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ExercisePriceOf1.25Member" xlink:label="miro_ExercisePriceOf1.25Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ExercisePriceOf1.25Member" xlink:to="miro_ExercisePriceOf1.25Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ExercisePriceOf1.25Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to exercise price of $1.25.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ExercisePriceOf1.25Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise price of $1.25</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfStockPurchaseAgreements" xlink:label="miro_NumberOfStockPurchaseAgreements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_NumberOfStockPurchaseAgreements" xlink:to="miro_NumberOfStockPurchaseAgreements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_NumberOfStockPurchaseAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of stock purchase agreements entity entered into during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_NumberOfStockPurchaseAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Stock Purchase Agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_NumberOfStockPurchaseAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of stock purchase agreements entered into</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of new stock classified as temporary equity issued during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Stock Issued During Period, Shares, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares issued (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Redemption Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share issue price (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of Redeemable Convertible Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross proceeds</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockConversionDiscount" xlink:label="miro_StockConversionDiscount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_StockConversionDiscount" xlink:to="miro_StockConversionDiscount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_StockConversionDiscount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount in which convertible preferred stock was converted into common stock, as a percent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_StockConversionDiscount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Conversion, Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_StockConversionDiscount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conversion discount (as a percent)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_TemporaryEquitySharesConvertedInPeriod" xlink:label="miro_TemporaryEquitySharesConvertedInPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_TemporaryEquitySharesConvertedInPeriod" xlink:to="miro_TemporaryEquitySharesConvertedInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_TemporaryEquitySharesConvertedInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares classified as temporary equity  converted to common stock during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_TemporaryEquitySharesConvertedInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary Equity, Shares Converted In Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_TemporaryEquitySharesConvertedInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares converted to common stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plan Name [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plan Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockOptionPlan2010Member" xlink:label="miro_StockOptionPlan2010Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_StockOptionPlan2010Member" xlink:to="miro_StockOptionPlan2010Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_StockOptionPlan2010Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to 2010 stock option plan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_StockOptionPlan2010Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2010 Plan</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockOptionPlan2019Member" xlink:label="miro_StockOptionPlan2019Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_StockOptionPlan2019Member" xlink:to="miro_StockOptionPlan2019Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_StockOptionPlan2019Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to 2019 stock option plan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_StockOptionPlan2019Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2019 Plan</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EquityIncentivePlan2021Member" xlink:label="miro_EquityIncentivePlan2021Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_EquityIncentivePlan2021Member" xlink:to="miro_EquityIncentivePlan2021Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_EquityIncentivePlan2021Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2021 Equity Incentive Plan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_EquityIncentivePlan2021Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Incentive Plan 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_EquityIncentivePlan2021Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2021 Equity Incentive Plan</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares authorized</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Awards available for grant (in shares)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum annual increase in shares reserved for issuance under share-based payment arrangement as a percent of total shares of common stock outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Percent of Additional Shares Reserved, Maximum Annual Increase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum annual increase in shares reserved for issuance, as a percent of total shares of common stock outstanding</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum annual increase in number of shares reserved for issuance under share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Reserved, Maximum Annual Increase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum number of additional shares reserved for issuance annually</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of options granted - Shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options outstanding at end of the period (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options outstanding at beginning of the period (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Canceled or expired (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Exercisable (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of options granted - Weighted Average Exercise Price</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options outstanding at end of the period (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options outstanding at beginning of the period (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Canceled or expired (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Exercisable (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average fair value of options granted (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining contractual term, Options outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining contractual term, Options exercisable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intrinsic value, Options outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intrinsic value, Options exercisable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intrinsic value, Options exercised</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock based compensation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized compensation costs</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of cost not yet recognized expected to be recognized for award under share-based payment arrangement in the remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, To Be Recognized In Remainder of Fiscal Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Remainder of fiscal year</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of cost not yet recognized is expected to be recognized for award under share-based payment arrangement in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, To Be Recognized In Year One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost to be recognized year 1</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of cost not yet recognized is expected to be recognized for award under share-based payment arrangement in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, To Be Recognized In Year Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost to be recognized in year 2</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of cost not yet recognized is expected to be recognized for award under share-based payment arrangement in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, To Be Recognized In Year Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost to be recognized in year 3</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of cost not yet recognized is expected to be recognized for award under share-based payment arrangement in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, To Be Recognized In Year Four</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost to be recognized in year 4</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Award Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Award Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock options</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected life in years</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk-free interest rate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected volatility</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forecast</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Award granted (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Awards granted, Weighted average fair value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized compensation costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units (RSUs) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchase price as a percent of market price</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The length of each purchase period under the plan, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Based Compensation Arrangement By Share Based Payment Award, Purchase Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchase period</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The maximum fair value of shares an employee can purchase under the plan per period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Amount of Shares Per Employee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum fair value of shares employee may purchase per purchase period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum number of shares employee may purchase per purchase period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Capital Shares Reserved for Future Issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares reserved for issuance</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Shares, Employee Stock Purchase Plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued, ESPP</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2021 ESPP</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right [Table]</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesPreferredWarrantsMember" xlink:label="miro_SeriesPreferredWarrantsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_SeriesPreferredWarrantsMember" xlink:to="miro_SeriesPreferredWarrantsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_SeriesPreferredWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to Series A Preferred warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_SeriesPreferredWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Series A Preferred Warrants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SHAREHOLDERS' DEFICIT AND MEZZANINE EQUITY</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightExercised" xlink:label="miro_ClassOfWarrantOrRightExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ClassOfWarrantOrRightExercised" xlink:to="miro_ClassOfWarrantOrRightExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ClassOfWarrantOrRightExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of warrants or rights exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ClassOfWarrantOrRightExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right, Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ClassOfWarrantOrRightExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightTerminated" xlink:label="miro_ClassOfWarrantOrRightTerminated" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ClassOfWarrantOrRightTerminated" xlink:to="miro_ClassOfWarrantOrRightTerminated_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ClassOfWarrantOrRightTerminated_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of warrants or rights terminated.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ClassOfWarrantOrRightTerminated_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Class of Warrant or Right, Terminated</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="miro_ClassOfWarrantOrRightTerminated_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Terminated</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsOutstandingWeightedAverageExercisePrice" xlink:label="miro_WarrantsOutstandingWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_WarrantsOutstandingWeightedAverageExercisePrice" xlink:to="miro_WarrantsOutstandingWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_WarrantsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average price at which grantees can acquire the warrants reserved for issuance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_WarrantsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_WarrantsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining contractual term for warrants outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Warrants Outstanding, Weighted Average Remaining Contractual Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining contractual life in years</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Contribution Plan, Employer Discretionary Contribution Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discretionary contributions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk Benchmark [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk Benchmark [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Customer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Customer [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Customer [Domain]</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_OneCustomerMember" xlink:label="miro_OneCustomerMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_OneCustomerMember" xlink:to="miro_OneCustomerMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_OneCustomerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">One customer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_OneCustomerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">One Customer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_OneCustomerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">One customer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SIGNIFICANT CUSTOMERS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk, Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration risk, percentage</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfCustomers" xlink:label="miro_NumberOfCustomers" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_NumberOfCustomers" xlink:to="miro_NumberOfCustomers_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_NumberOfCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to number of customers.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_NumberOfCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_NumberOfCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Customers</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Counterparty Name [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Counterparty Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_UniversityOfMinnesotaMember" xlink:label="miro_UniversityOfMinnesotaMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_UniversityOfMinnesotaMember" xlink:to="miro_UniversityOfMinnesotaMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_UniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to University of Minnesota.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_UniversityOfMinnesotaMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">University</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncollaborativeArrangementTransactionsMember" xlink:label="us-gaap_NoncollaborativeArrangementTransactionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncollaborativeArrangementTransactionsMember" xlink:to="us-gaap_NoncollaborativeArrangementTransactionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncollaborativeArrangementTransactionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">License Agreements</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PatentLicenseAgreementMember" xlink:label="miro_PatentLicenseAgreementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_PatentLicenseAgreementMember" xlink:to="miro_PatentLicenseAgreementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_PatentLicenseAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to Patent License Agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_PatentLicenseAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Patent License Agreement</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transaction [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transaction [Domain]</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PatentAndKnowHowLicenseAgreementMember" xlink:label="miro_PatentAndKnowHowLicenseAgreementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_PatentAndKnowHowLicenseAgreementMember" xlink:to="miro_PatentAndKnowHowLicenseAgreementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_PatentAndKnowHowLicenseAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to Patent and Know-How License agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_PatentAndKnowHowLicenseAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Patent and Know-How License Agreement</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Agreements</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_MinimumRoyaltyPayable" xlink:label="miro_MinimumRoyaltyPayable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_MinimumRoyaltyPayable" xlink:to="miro_MinimumRoyaltyPayable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_MinimumRoyaltyPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum amount of royalty payments to be paid by entity per year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_MinimumRoyaltyPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum Royalty Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_MinimumRoyaltyPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum royalty payments to be paid per year</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_MinimumRoyaltyReceivable" xlink:label="miro_MinimumRoyaltyReceivable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_MinimumRoyaltyReceivable" xlink:to="miro_MinimumRoyaltyReceivable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_MinimumRoyaltyReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum amount of royalty payments to be received by entity per year from related party.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_MinimumRoyaltyReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum Royalty Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_MinimumRoyaltyReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum royalty payments to be received per year</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Operating Leased Assets [Table]</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_FirstFacilityEdenPrairieMember" xlink:label="miro_FirstFacilityEdenPrairieMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_FirstFacilityEdenPrairieMember" xlink:to="miro_FirstFacilityEdenPrairieMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_FirstFacilityEdenPrairieMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to first facility in Eden Prairie, MN.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_FirstFacilityEdenPrairieMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">First facility</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SecondFacilityEdenPrairieMember" xlink:label="miro_SecondFacilityEdenPrairieMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_SecondFacilityEdenPrairieMember" xlink:to="miro_SecondFacilityEdenPrairieMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_SecondFacilityEdenPrairieMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to second facility in Eden Prairie, MN.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_SecondFacilityEdenPrairieMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Second facility</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember" xlink:label="miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember" xlink:to="miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Building to be used for research and development and office space located at 6455 Flying Cloud Drive, Eden Prairie, Minnesota 55344.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Building, Research and Development and Office Space [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Building</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_Period1Member" xlink:label="miro_Period1Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_Period1Member" xlink:to="miro_Period1Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_Period1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to period until March 31, 2020.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_Period1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Up to March 31, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_Period1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Up to March 31, 2020</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_Period2Member" xlink:label="miro_Period2Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_Period2Member" xlink:to="miro_Period2Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_Period2Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to period from April 1, 2020 to December 31, 2020.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_Period2Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">April 1, 2020 to December 31, 2020</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_Period3Member" xlink:label="miro_Period3Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_Period3Member" xlink:to="miro_Period3Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_Period3Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to period from January 1, 2021 to December 31, 2021.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_Period3Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">January 1, 2021 to December 31, 2021</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasedAssetsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasedAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Leased Assets [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasedAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leases</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfRealEstateProperty" xlink:to="us-gaap_AreaOfRealEstateProperty_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Area of Real Estate Property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leased space (in square feet)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_MonthlyLeaseRentPayments" xlink:label="miro_MonthlyLeaseRentPayments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_MonthlyLeaseRentPayments" xlink:to="miro_MonthlyLeaseRentPayments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_MonthlyLeaseRentPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of monthly lease rent payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_MonthlyLeaseRentPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Monthly Lease Rent Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_MonthlyLeaseRentPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Monthly rent</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_IncreaseInYearlyRentPercentage" xlink:label="miro_IncreaseInYearlyRentPercentage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_IncreaseInYearlyRentPercentage" xlink:to="miro_IncreaseInYearlyRentPercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_IncreaseInYearlyRentPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of yearly increase in rent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_IncreaseInYearlyRentPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in Yearly Rent, Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_IncreaseInYearlyRentPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of increase in yearly rent</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Leases, Rent Expense, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating lease rent expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Term of Contract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease term</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage" xlink:label="miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage" xlink:to="miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Annual base rate increase percentage under terms of agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Annual Base Rate Increase Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Annual base rent increase (as a percent)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseRealPropertyTaxesPercentage" xlink:label="miro_LesseeOperatingLeaseRealPropertyTaxesPercentage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_LesseeOperatingLeaseRealPropertyTaxesPercentage" xlink:to="miro_LesseeOperatingLeaseRealPropertyTaxesPercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_LesseeOperatingLeaseRealPropertyTaxesPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of real property taxes on building and land to be paid under the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_LesseeOperatingLeaseRealPropertyTaxesPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Real Property Taxes Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_LesseeOperatingLeaseRealPropertyTaxesPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Real property taxes (as a percent)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseManagementFeePercentage" xlink:label="miro_LesseeOperatingLeaseManagementFeePercentage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_LesseeOperatingLeaseManagementFeePercentage" xlink:to="miro_LesseeOperatingLeaseManagementFeePercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_LesseeOperatingLeaseManagementFeePercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of Landlord's management fee to be paid under the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_LesseeOperatingLeaseManagementFeePercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Management Fee Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_LesseeOperatingLeaseManagementFeePercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Management fee (as a percent)</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts" xlink:label="miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts" xlink:to="miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum management fee as a percent of Landlord's gross receipts to be paid under the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Management Fee As Percentage of Gross Receipts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum management fee to be paid as a percent of Landlord's gross receipts</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_OperatingLeaseNumberOfOptionsToExtend" xlink:label="miro_OperatingLeaseNumberOfOptionsToExtend" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_OperatingLeaseNumberOfOptionsToExtend" xlink:to="miro_OperatingLeaseNumberOfOptionsToExtend_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_OperatingLeaseNumberOfOptionsToExtend_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of options to extend operating lease.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_OperatingLeaseNumberOfOptionsToExtend_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Number of Options To Extend</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_OperatingLeaseNumberOfOptionsToExtend_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of options to extend</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseOptionToExtendTermOfContract" xlink:label="miro_LesseeOperatingLeaseOptionToExtendTermOfContract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_LesseeOperatingLeaseOptionToExtendTermOfContract" xlink:to="miro_LesseeOperatingLeaseOptionToExtendTermOfContract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_LesseeOperatingLeaseOptionToExtendTermOfContract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Option to extend term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_LesseeOperatingLeaseOptionToExtendTermOfContract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Option to Extend, Term of Contract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_LesseeOperatingLeaseOptionToExtendTermOfContract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Option to extend term</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets" xlink:label="us-gaap_DepositAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositAssets" xlink:to="us-gaap_DepositAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deposit Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepositAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security amount</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Future minimum non-cancelable lease commitments</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2021</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, to be Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ResearchAndDevelopmentContractMember" xlink:label="miro_ResearchAndDevelopmentContractMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ResearchAndDevelopmentContractMember" xlink:to="miro_ResearchAndDevelopmentContractMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ResearchAndDevelopmentContractMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to research and development contract.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ResearchAndDevelopmentContractMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development contract</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Shares, Issued for Services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consideration for the developer's services</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CorporationOwnedByDirectorMember" xlink:label="miro_CorporationOwnedByDirectorMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_CorporationOwnedByDirectorMember" xlink:to="miro_CorporationOwnedByDirectorMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_CorporationOwnedByDirectorMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to corporation owned by director of the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_CorporationOwnedByDirectorMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Corporation owned by director</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ConsultingServicesMember" xlink:label="miro_ConsultingServicesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ConsultingServicesMember" xlink:to="miro_ConsultingServicesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ConsultingServicesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consulting services provided by related party.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ConsultingServicesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consulting Services [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_ConsultingServicesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consulting services</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transaction [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RELATED PARTY TRANSACTIONS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party Transaction, Expenses from Transactions with Related Party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consulting services</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="us-gaap_RevenueFromRelatedParties" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromRelatedParties" xlink:to="us-gaap_RevenueFromRelatedParties_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromRelatedParties_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from Related Parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromRelatedParties_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Royalty</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesNoncurrent" xlink:label="us-gaap_AccountsReceivableRelatedPartiesNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableRelatedPartiesNoncurrent" xlink:to="us-gaap_AccountsReceivableRelatedPartiesNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableRelatedPartiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts Receivable, Related Parties, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableRelatedPartiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long term receivables</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AllowanceForDoubtfulAccountsRelatedParties" xlink:label="miro_AllowanceForDoubtfulAccountsRelatedParties" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_AllowanceForDoubtfulAccountsRelatedParties" xlink:to="miro_AllowanceForDoubtfulAccountsRelatedParties_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_AllowanceForDoubtfulAccountsRelatedParties_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value arising from transactions with related parties, which would be presented in parentheses on the face of the balance sheet.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_AllowanceForDoubtfulAccountsRelatedParties_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Allowance for Doubtful Accounts, Related Parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_AllowanceForDoubtfulAccountsRelatedParties_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reserve against receivable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities, Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible preferred stock outstanding</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ConvertiblePreferredStockWarrantsMember" xlink:label="miro_ConvertiblePreferredStockWarrantsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_ConvertiblePreferredStockWarrantsMember" xlink:to="miro_ConvertiblePreferredStockWarrantsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_ConvertiblePreferredStockWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to convertible preferred stock warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_ConvertiblePreferredStockWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible preferred stock warrants</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CommonStockWarrantsMember" xlink:label="miro_CommonStockWarrantsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_CommonStockWarrantsMember" xlink:to="miro_CommonStockWarrantsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_CommonStockWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to common stock warrants .</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_CommonStockWarrantsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock warrants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">NET LOSS PER SHARE</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potentially dilutive securities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Event [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Event Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Event Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Event [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent Event [Line Items]</label>
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AdditionalFundingToBeProvided" xlink:label="miro_AdditionalFundingToBeProvided" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="miro_AdditionalFundingToBeProvided" xlink:to="miro_AdditionalFundingToBeProvided_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="miro_AdditionalFundingToBeProvided_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional amount of funding to be provided by entity under the terms of the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="miro_AdditionalFundingToBeProvided_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Funding to be Provided</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="miro_AdditionalFundingToBeProvided_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional funding to be provided</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>tmb-20210930_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7908.23199 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/15/2021 8:22:51 PM-->
<!--Modified on: 11/15/2021 8:22:51 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DocumentDocumentAndEntityInformation" roleURI="http://miromatrix.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#StatementCondensedBalanceSheets" roleURI="http://miromatrix.com/role/StatementCondensedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#StatementCondensedBalanceSheetsParenthetical" roleURI="http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#StatementCondensedStatementsOfOperations" roleURI="http://miromatrix.com/role/StatementCondensedStatementsOfOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#StatementCondensedStatementsOfShareholdersEquityDeficit" roleURI="http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#StatementCondensedStatementsOfCashFlows" roleURI="http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDescriptionOfBusinessAndSignificantAccountingPolicies" roleURI="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureInitialPublicOffering" roleURI="http://miromatrix.com/role/DisclosureInitialPublicOffering" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgress" roleURI="http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgress" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureEquityMethodInvestment" roleURI="http://miromatrix.com/role/DisclosureEquityMethodInvestment" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureAccruedExpenses" roleURI="http://miromatrix.com/role/DisclosureAccruedExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureFairValueMeasurement" roleURI="http://miromatrix.com/role/DisclosureFairValueMeasurement" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDebtAndCapitalLeaseObligation" roleURI="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStock" roleURI="http://miromatrix.com/role/DisclosureCapitalStock" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureEmployeeBenefitPlans" roleURI="http://miromatrix.com/role/DisclosureEmployeeBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureSignificantCustomers" roleURI="http://miromatrix.com/role/DisclosureSignificantCustomers" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCommitmentsAndContingencies" roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingencies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureRelatedPartyTransactions" roleURI="http://miromatrix.com/role/DisclosureRelatedPartyTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureNetLossPerShare" roleURI="http://miromatrix.com/role/DisclosureNetLossPerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureSubsequentEvents" roleURI="http://miromatrix.com/role/DisclosureSubsequentEvents" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies" roleURI="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressTables" roleURI="http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureEquityMethodInvestmentTables" roleURI="http://miromatrix.com/role/DisclosureEquityMethodInvestmentTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureAccruedExpensesTables" roleURI="http://miromatrix.com/role/DisclosureAccruedExpensesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureFairValueMeasurementTables" roleURI="http://miromatrix.com/role/DisclosureFairValueMeasurementTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDebtAndCapitalLeaseObligationTables" roleURI="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockTables" roleURI="http://miromatrix.com/role/DisclosureCapitalStockTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCommitmentsAndContingenciesTables" roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureNetLossPerShareTables" roleURI="http://miromatrix.com/role/DisclosureNetLossPerShareTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails" roleURI="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails" roleURI="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureInitialPublicOfferingDetails" roleURI="http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails" roleURI="http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureEquityMethodInvestmentRepriseDetails" roleURI="http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureEquityMethodInvestmentBalanceSheetDetails" roleURI="http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureEquityMethodInvestmentIncomeStatementDetails" roleURI="http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureAccruedExpensesDetails" roleURI="http://miromatrix.com/role/DisclosureAccruedExpensesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureFairValueMeasurementChangesDetails" roleURI="http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDebtAndCapitalLeaseObligationAgreementsDetails" roleURI="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureDebtAndCapitalLeaseObligationMaturityDetails" roleURI="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockCommonStockAndPreferredStockDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockStockOptionsDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockRestrictedStockUnitsDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockEmployeeStockPurchasePlanDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCapitalStockWarrantsDetails" roleURI="http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureEmployeeBenefitPlansDetails" roleURI="http://miromatrix.com/role/DisclosureEmployeeBenefitPlansDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#ScheduleSignificantCustomersDetails" roleURI="http://miromatrix.com/role/ScheduleSignificantCustomersDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails" roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCommitmentsAndContingenciesLeasesDetails" roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureCommitmentsAndContingenciesLicenseContractDetails" roleURI="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureRelatedPartyTransactionsDetails" roleURI="http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#DisclosureNetLossPerShareDetails" roleURI="http://miromatrix.com/role/DisclosureNetLossPerShareDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="tmb-20210930.xsd#Disclosure11401DisclosureSubsequentEventsDetails" roleURI="http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://miromatrix.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType_637726045700051501" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_637726045700051501" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport_637726045700051501" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentQuarterlyReport_637726045700051501" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_637726045700061482" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_637726045700061482" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport_637726045700061482" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentTransitionReport_637726045700061482" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_637726045700061482" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_637726045700061482" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_637726045700061482" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_637726045700061482" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_637726045700061482" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_637726045700061482" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_637726045700061482" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_637726045700061482" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_637726045700061482" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_637726045700061482" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_637726045700061482" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_637726045700061482" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_637726045700061482" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_637726045700061482" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_637726045700061482" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_637726045700061482" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_637726045700061482" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_637726045700061482" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_637726045700061482" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_637726045700061482" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_637726045700061482" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_637726045700061482" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_637726045700071512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_637726045700071512" order="16" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_637726045700071512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_637726045700071512" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus_637726045700071512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus_637726045700071512" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent_637726045700071512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent_637726045700071512" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_637726045700071512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFilerCategory_637726045700071512" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness_637726045700071512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntitySmallBusiness_637726045700071512" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_637726045700071512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_637726045700071512" order="22" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod_637726045700071512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityExTransitionPeriod_637726045700071512" order="23" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany_637726045700071512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityShellCompany_637726045700071512" order="24" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding_637726045700071512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding_637726045700071512" order="25" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_637726045700071512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_637726045700071512" order="26" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_637726045700081496" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate_637726045700081496" order="27" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus_637726045700081496" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus_637726045700081496" order="28" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus_637726045700081496" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus_637726045700081496" order="29" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_637726045700081496" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_637726045700081496" order="30" use="optional" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/StatementCondensedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - Condensed Balance Sheets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637726045700081496" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable_637726045700081496" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637726045700091545" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637726045700081496" xlink:to="us-gaap_StatementClassOfStockAxis_637726045700091545" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045700091545" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637726045700091545" xlink:to="us-gaap_ClassOfStockDomain_637726045700091545" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesB2ConvertiblePreferredStockMember" xlink:label="miro_SeriesB2ConvertiblePreferredStockMember_637726045700091545" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700091545" xlink:to="miro_SeriesB2ConvertiblePreferredStockMember_637726045700091545" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesBConvertiblePreferredStockMember" xlink:label="miro_SeriesBConvertiblePreferredStockMember_637726045700091545" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700091545" xlink:to="miro_SeriesBConvertiblePreferredStockMember_637726045700091545" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesConvertiblePreferredStockMember" xlink:label="miro_SeriesConvertiblePreferredStockMember_637726045700091545" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700091545" xlink:to="miro_SeriesConvertiblePreferredStockMember_637726045700091545" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637726045700091545" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637726045700081496" xlink:to="us-gaap_StatementLineItems_637726045700091545" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract_637726045700091545" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637726045700091545" xlink:to="us-gaap_AssetsAbstract_637726045700091545" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_637726045700091545" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637726045700091545" xlink:to="us-gaap_AssetsCurrentAbstract_637726045700091545" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_637726045700091545" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637726045700091545" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_637726045700091545" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_637726045700091545" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637726045700091545" xlink:to="us-gaap_DueFromRelatedPartiesCurrent_637726045700091545" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivableCurrent" xlink:label="us-gaap_GrantsReceivableCurrent_637726045700091545" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637726045700091545" xlink:to="us-gaap_GrantsReceivableCurrent_637726045700091545" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637726045700091545" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637726045700091545" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637726045700091545" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_637726045700091545" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637726045700091545" xlink:to="us-gaap_AssetsCurrent_637726045700091545" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_637726045700101492" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637726045700091545" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_637726045700101492" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments_637726045700101492" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637726045700091545" xlink:to="us-gaap_EquityMethodInvestments_637726045700101492" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_637726045700101492" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637726045700091545" xlink:to="us-gaap_Assets_637726045700101492" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637726045700101492" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637726045700091545" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637726045700101492" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract_637726045700101492" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637726045700101492" xlink:to="us-gaap_LiabilitiesCurrentAbstract_637726045700101492" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_637726045700101492" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637726045700101492" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_637726045700101492" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_637726045700101492" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637726045700101492" xlink:to="us-gaap_AccountsPayableCurrent_637726045700101492" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent_637726045700101492" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637726045700101492" xlink:to="us-gaap_InterestPayableCurrent_637726045700101492" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_637726045700101492" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637726045700101492" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_637726045700101492" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_637726045700111819" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637726045700101492" xlink:to="us-gaap_AccruedLiabilitiesCurrent_637726045700111819" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_637726045700111819" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637726045700101492" xlink:to="us-gaap_LiabilitiesCurrent_637726045700111819" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedRoyaltiesNoncurrent" xlink:label="miro_AccruedRoyaltiesNoncurrent_637726045700111819" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637726045700101492" xlink:to="miro_AccruedRoyaltiesNoncurrent_637726045700111819" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_637726045700111819" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637726045700101492" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_637726045700111819" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_InterestPayableNoncurrent" xlink:label="miro_InterestPayableNoncurrent_637726045700111819" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637726045700101492" xlink:to="miro_InterestPayableNoncurrent_637726045700111819" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_637726045700111819" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637726045700101492" xlink:to="us-gaap_Liabilities_637726045700111819" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_637726045700111819" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637726045700101492" xlink:to="us-gaap_CommitmentsAndContingencies_637726045700111819" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract_637726045700111819" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637726045700101492" xlink:to="us-gaap_TemporaryEquityAbstract_637726045700111819" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637726045700121521" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityAbstract_637726045700111819" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637726045700121521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract_637726045700121521" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637726045700101492" xlink:to="us-gaap_StockholdersEquityAbstract_637726045700121521" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_637726045700121521" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637726045700121521" xlink:to="us-gaap_CommonStockValue_637726045700121521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_637726045700121521" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637726045700121521" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_637726045700121521" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_637726045700171621" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637726045700121521" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_637726045700171621" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637726045700171621" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637726045700121521" xlink:to="us-gaap_StockholdersEquity_637726045700171621" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_637726045700171621" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637726045700101492" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_637726045700171621" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical" xlink:type="extended" xlink:title="00105 - Statement - Condensed Balance Sheets (Parenthetical)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637726045700181503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_2" xlink:to="us-gaap_StatementTable_637726045700181503" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637726045700181503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637726045700181503" xlink:to="us-gaap_StatementClassOfStockAxis_637726045700181503" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045700181503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637726045700181503" xlink:to="us-gaap_ClassOfStockDomain_637726045700181503" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesB2ConvertiblePreferredStockMember" xlink:label="miro_SeriesB2ConvertiblePreferredStockMember_637726045700181503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700181503" xlink:to="miro_SeriesB2ConvertiblePreferredStockMember_637726045700181503" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesBConvertiblePreferredStockMember" xlink:label="miro_SeriesBConvertiblePreferredStockMember_637726045700181503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700181503" xlink:to="miro_SeriesBConvertiblePreferredStockMember_637726045700181503" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesConvertiblePreferredStockMember" xlink:label="miro_SeriesConvertiblePreferredStockMember_637726045700181503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700181503" xlink:to="miro_SeriesConvertiblePreferredStockMember_637726045700181503" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637726045700181503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637726045700181503" xlink:to="us-gaap_StatementLineItems_637726045700181503" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_637726045700181503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637726045700181503" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_637726045700181503" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_637726045700181503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637726045700181503" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_637726045700181503" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued_637726045700181503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637726045700181503" xlink:to="us-gaap_TemporaryEquitySharesIssued_637726045700181503" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_637726045700181503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637726045700181503" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_637726045700181503" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_637726045700181503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637726045700181503" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_637726045700181503" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_637726045700181503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637726045700181503" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_637726045700181503" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_637726045700191540" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637726045700181503" xlink:to="us-gaap_CommonStockSharesAuthorized_637726045700191540" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_637726045700191540" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637726045700181503" xlink:to="us-gaap_CommonStockSharesIssued_637726045700191540" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_637726045700191540" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637726045700181503" xlink:to="us-gaap_CommonStockSharesOutstanding_637726045700191540" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/StatementCondensedStatementsOfOperations" xlink:type="extended" xlink:title="00200 - Statement - Condensed Statements of Operations" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637726045700191540" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637726045700191540" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_637726045700191540" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_637726045700191540" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold_637726045700191540" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold_637726045700191540" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:label="us-gaap_TypeOfCostGoodOrServiceExtensibleList_637726045700191540" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_TypeOfCostGoodOrServiceExtensibleList_637726045700191540" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit_637726045700191540" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit_637726045700191540" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract_637726045700201552" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_637726045700201552" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_637726045700201552" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_637726045700201552" xlink:to="us-gaap_ResearchAndDevelopmentExpense_637726045700201552" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RegulatoryAndClinicalExpense" xlink:label="miro_RegulatoryAndClinicalExpense_637726045700201552" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_637726045700201552" xlink:to="miro_RegulatoryAndClinicalExpense_637726045700201552" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_QualityExpense" xlink:label="miro_QualityExpense_637726045700201552" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_637726045700201552" xlink:to="miro_QualityExpense_637726045700201552" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_637726045700201552" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_637726045700201552" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_637726045700201552" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses_637726045700201552" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_637726045700201552" xlink:to="us-gaap_OperatingExpenses_637726045700201552" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_637726045700201552" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss_637726045700201552" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest_637726045700201552" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InvestmentIncomeInterest_637726045700201552" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_637726045700211497" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization_637726045700211497" order="9" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts_637726045700211497" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts_637726045700211497" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative" xlink:label="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative_637726045700211497" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative_637726045700211497" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ResearchGrants" xlink:label="miro_ResearchGrants_637726045700211497" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="miro_ResearchGrants_637726045700211497" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_637726045700211497" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_637726045700211497" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_637726045700211497" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_637726045700211497" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_637726045700211497" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_637726045700211497" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637726045700211497" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss_637726045700211497" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_637726045700211497" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic_637726045700211497" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_637726045700211497" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted_637726045700211497" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_637726045700221470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_637726045700221470" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_637726045700221470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_637726045700221470" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit" xlink:type="extended" xlink:title="00300 - Statement - Condensed  Statements of Shareholders' Equity (Deficit)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637726045700221470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable_637726045700221470" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_637726045700221470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637726045700221470" xlink:to="us-gaap_StatementEquityComponentsAxis_637726045700221470" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_637726045700221470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637726045700221470" xlink:to="us-gaap_CommonStockMember_637726045700221470" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_637726045700221470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637726045700221470" xlink:to="us-gaap_AdditionalPaidInCapitalMember_637726045700221470" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember_637726045700221470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637726045700221470" xlink:to="us-gaap_RetainedEarningsMember_637726045700221470" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_637726045700221470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637726045700221470" xlink:to="us-gaap_EquityComponentDomain_637726045700221470" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637726045700221470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637726045700221470" xlink:to="us-gaap_StatementLineItems_637726045700221470" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637726045700221470" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637726045700221470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="us-gaap_StockholdersEquity_637726045700221470" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_637726045700231498" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="us-gaap_SharesOutstanding_637726045700231498" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_637726045700231498" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_637726045700231498" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_637726045700231498" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_637726045700231498" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637726045700231498" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637726045700231498" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="miro_StockIssuedDuringPeriodValueWarrantsExercised_637726045700231498" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="miro_StockIssuedDuringPeriodValueWarrantsExercised_637726045700231498" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="miro_StockIssuedDuringPeriodSharesWarrantsExercised_637726045700231498" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="miro_StockIssuedDuringPeriodSharesWarrantsExercised_637726045700231498" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodValueConversionOfPreferredStock" xlink:label="miro_StockIssuedDuringPeriodValueConversionOfPreferredStock_637726045700231498" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="miro_StockIssuedDuringPeriodValueConversionOfPreferredStock_637726045700231498" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock" xlink:label="miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock_637726045700231498" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock_637726045700231498" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest" xlink:label="miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest_637726045700231498" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest_637726045700231498" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest" xlink:label="miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest_637726045700231498" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest_637726045700231498" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_637726045700231498" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_637726045700231498" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637726045700241548" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637726045700241548" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637726045700241548" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="us-gaap_NetIncomeLoss_637726045700241548" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637726045700241548" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="us-gaap_StockholdersEquity_637726045700241548" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_637726045700241548" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637726045700221470" xlink:to="us-gaap_SharesOutstanding_637726045700241548" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows" xlink:type="extended" xlink:title="00400 - Statement - Condensed Statements of Cash Flows" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss_637726045700241548" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" xlink:to="us-gaap_ProfitLoss_637726045700241548" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_637726045700241548" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" xlink:to="us-gaap_DepreciationDepletionAndAmortization_637726045700241548" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_637726045700241548" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" xlink:to="us-gaap_ShareBasedCompensation_637726045700241548" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_637726045700251462" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_637726045700251462" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_637726045700251462" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_637726045700251462" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative" xlink:label="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative_637726045700251462" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" xlink:to="us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative_637726045700251462" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_GainOnForgivenessOfDebt" xlink:label="miro_GainOnForgivenessOfDebt_637726045700251462" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" xlink:to="miro_GainOnForgivenessOfDebt_637726045700251462" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_637726045700251462" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_637726045700251462" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_637726045700251462" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" xlink:to="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_637726045700251462" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_637726045700251462" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_637726045700251462" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_637726045700251462" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_637726045700251462" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_637726045700251462" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_637726045700251462" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_637726045700251462" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_637726045700251462" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_IncreaseDecreaseInGrantsReceivable" xlink:label="miro_IncreaseDecreaseInGrantsReceivable_637726045700251462" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_637726045700251462" xlink:to="miro_IncreaseDecreaseInGrantsReceivable_637726045700251462" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_637726045700251462" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_637726045700251462" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_637726045700251462" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_637726045700251462" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_637726045700251462" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_637726045700251462" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_IncreaseDecreaseInInterestPayableNoncurrent" xlink:label="miro_IncreaseDecreaseInInterestPayableNoncurrent_637726045700261463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_637726045700251462" xlink:to="miro_IncreaseDecreaseInInterestPayableNoncurrent_637726045700261463" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045700261463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637726045700241548" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_637726045700261463" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637726045700261463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637726045700261463" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_637726045700261463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637726045700261463" xlink:to="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_637726045700261463" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForConstructionInProcess" xlink:label="us-gaap_PaymentsForConstructionInProcess_637726045700261463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637726045700261463" xlink:to="us-gaap_PaymentsForConstructionInProcess_637726045700261463" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements" xlink:label="miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements_637726045700261463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637726045700261463" xlink:to="miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements_637726045700261463" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_637726045700261463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637726045700261463" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_637726045700261463" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637726045700261463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637726045700261463" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt_637726045700261463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637726045700261463" xlink:to="us-gaap_RepaymentsOfLongTermDebt_637726045700261463" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_637726045700271458" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637726045700261463" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_637726045700271458" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ProceedsFromIssuanceOfCommonStockNet" xlink:label="miro_ProceedsFromIssuanceOfCommonStockNet_637726045700271458" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637726045700261463" xlink:to="miro_ProceedsFromIssuanceOfCommonStockNet_637726045700271458" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet" xlink:label="miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet_637726045700271458" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637726045700261463" xlink:to="miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet_637726045700271458" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises_637726045700271458" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637726045700261463" xlink:to="us-gaap_ProceedsFromWarrantExercises_637726045700271458" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_637726045700271458" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637726045700261463" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_637726045700271458" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_637726045700271458" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637726045700261463" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_637726045700271458" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_637726045700271458" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_637726045700271458" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637726045700271458" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637726045700271458" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6377260457002714581" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6377260457002714581" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_637726045700281439" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_637726045700281439" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet_637726045700281439" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract_637726045700281439" xlink:to="us-gaap_InterestPaidNet_637726045700281439" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_637726045700281439" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_637726045700281439" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NoncashInvestingAndFinancingFinancingExpenses" xlink:label="miro_NoncashInvestingAndFinancingFinancingExpenses_637726045700281439" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract_637726045700281439" xlink:to="miro_NoncashInvestingAndFinancingFinancingExpenses_637726045700281439" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPolicies" xlink:type="extended" xlink:title="10101 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_637726045700291530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_637726045700291530" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureInitialPublicOffering" xlink:type="extended" xlink:title="10201 - Disclosure - INITIAL PUBLIC OFFERING" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockholdersEquityNoteInitialPublicOfferingAbstract" xlink:label="miro_StockholdersEquityNoteInitialPublicOfferingAbstract_1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock" xlink:label="miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock_637726045700291530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_StockholdersEquityNoteInitialPublicOfferingAbstract_1" xlink:to="miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock_637726045700291530" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgress" xlink:type="extended" xlink:title="10301 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_637726045700291530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_637726045700291530" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureEquityMethodInvestment" xlink:type="extended" xlink:title="10401 - Disclosure - EQUITY METHOD INVESTMENT" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_637726045700291530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_637726045700291530" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureAccruedExpenses" xlink:type="extended" xlink:title="10501 - Disclosure - ACCRUED EXPENSES" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_637726045700291530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_637726045700291530" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureFairValueMeasurement" xlink:type="extended" xlink:title="10601 - Disclosure - FAIR VALUE MEASUREMENT" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock_637726045700301457" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock_637726045700301457" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligation" xlink:type="extended" xlink:title="10701 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:label="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_637726045700301457" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_637726045700301457" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStock" xlink:type="extended" xlink:title="10801 - Disclosure - CAPITAL STOCK" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalStockDisclosureAbstract" xlink:label="miro_CapitalStockDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock" xlink:label="miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock_637726045700301457" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_CapitalStockDisclosureAbstract" xlink:to="miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock_637726045700301457" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureEmployeeBenefitPlans" xlink:type="extended" xlink:title="10901 - Disclosure - EMPLOYEE BENEFIT PLANS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanTextBlock" xlink:label="us-gaap_DefinedContributionPlanTextBlock_637726045700301457" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanTextBlock_637726045700301457" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureSignificantCustomers" xlink:type="extended" xlink:title="11001 - Disclosure - SIGNIFICANT CUSTOMERS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_637726045700311276" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_637726045700311276" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCommitmentsAndContingencies" xlink:type="extended" xlink:title="11101 - Disclosure - COMMITMENTS AND CONTINGENCIES" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_637726045700311276" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_637726045700311276" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureRelatedPartyTransactions" xlink:type="extended" xlink:title="11201 - Disclosure - RELATED PARTY TRANSACTIONS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_637726045700311276" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_637726045700311276" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureNetLossPerShare" xlink:type="extended" xlink:title="11301 - Disclosure - NET LOSS PER SHARE" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock_637726045700311276" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock_637726045700311276" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureSubsequentEvents" xlink:type="extended" xlink:title="11401 - Disclosure - SUBSEQUENT EVENTS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock_637726045700321454" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock_637726045700321454" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies" xlink:type="extended" xlink:title="20102 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_637726045700321454" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_637726045700321454" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_637726045700321454" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_EquityMethodInvestmentsPolicy_637726045700321454" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_637726045700321454" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_637726045700321454" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_637726045700321454" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_637726045700321454" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk_637726045700321454" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk_637726045700321454" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates_637726045700321454" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_UseOfEstimates_637726045700321454" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock" xlink:label="miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock_637726045700321454" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock_637726045700321454" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_637726045700321454" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_637726045700321454" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_637726045700321454" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_637726045700321454" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressTables" xlink:type="extended" xlink:title="30303 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_637726045700331518" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract_1" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_637726045700331518" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureEquityMethodInvestmentTables" xlink:type="extended" xlink:title="30403 - Disclosure - EQUITY METHOD INVESTMENT (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock_637726045700331518" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_1" xlink:to="us-gaap_EquityMethodInvestmentsTextBlock_637726045700331518" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureAccruedExpensesTables" xlink:type="extended" xlink:title="30503 - Disclosure - ACCRUED EXPENSES (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_637726045700331518" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract_1" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_637726045700331518" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureFairValueMeasurementTables" xlink:type="extended" xlink:title="30603 - Disclosure - FAIR VALUE MEASUREMENT (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_637726045700331518" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_1" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_637726045700331518" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationTables" xlink:type="extended" xlink:title="30703 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_637726045700341472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract_1" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_637726045700341472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockTables" xlink:type="extended" xlink:title="30803 - Disclosure - CAPITAL STOCK (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalStockDisclosureAbstract" xlink:label="miro_CapitalStockDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock_637726045700341472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_CapitalStockDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityTableTextBlock_637726045700341472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_637726045700341472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_CapitalStockDisclosureAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_637726045700341472" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_637726045700341472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_CapitalStockDisclosureAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_637726045700341472" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_637726045700341472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_CapitalStockDisclosureAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_637726045700341472" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesTables" xlink:type="extended" xlink:title="31103 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_637726045700341472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_637726045700341472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureNetLossPerShareTables" xlink:type="extended" xlink:title="31303 - Disclosure - NET LOSS PER SHARE (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_637726045700351708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_1" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_637726045700351708" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails" xlink:type="extended" xlink:title="40101 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Charter (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable_637726045700351708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1" xlink:to="us-gaap_ScheduleOfStockByClassTable_637726045700351708" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems_637726045700351708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637726045700351708" xlink:to="us-gaap_ClassOfStockLineItems_637726045700351708" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockConversionPercentage" xlink:label="miro_StockConversionPercentage_637726045700351708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700351708" xlink:to="miro_StockConversionPercentage_637726045700351708" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_637726045700351708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700351708" xlink:to="us-gaap_CommonStockSharesAuthorized_637726045700351708" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_637726045700351708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700351708" xlink:to="us-gaap_PreferredStockSharesAuthorized_637726045700351708" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfClassesOfStock" xlink:label="miro_NumberOfClassesOfStock_637726045700351708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700351708" xlink:to="miro_NumberOfClassesOfStock_637726045700351708" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637726045700351708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637726045700351708" xlink:to="us-gaap_StatementClassOfStockAxis_637726045700351708" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045700351708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637726045700351708" xlink:to="us-gaap_ClassOfStockDomain_637726045700351708" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesCConvertiblePreferredStockMember" xlink:label="miro_SeriesCConvertiblePreferredStockMember_637726045700351708" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700351708" xlink:to="miro_SeriesCConvertiblePreferredStockMember_637726045700351708" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails" xlink:type="extended" xlink:title="40102 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Equity Method Investments (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_637726045700361511" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_637726045700361511" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_637726045700361511" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_637726045700361511" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_637726045700361511" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_637726045700361511" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_637726045700361511" xlink:to="srt_EquityMethodInvesteeNameDomain_637726045700361511" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member_637726045700361511" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain_637726045700361511" xlink:to="miro_RepriseBiomedicalInc.Member_637726045700361511" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637726045700361511" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_637726045700361511" xlink:to="srt_RangeAxis_637726045700361511" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637726045700361511" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637726045700361511" xlink:to="srt_RangeMember_637726045700361511" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_637726045700361511" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637726045700361511" xlink:to="srt_MaximumMember_637726045700361511" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_637726045700361511" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_637726045700361511" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_637726045700361511" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_637726045700361511" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_637726045700361511" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_637726045700361511" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails" xlink:type="extended" xlink:title="40201 - Disclosure - INITIAL PUBLIC OFFERING (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockholdersEquityNoteInitialPublicOfferingAbstract" xlink:label="miro_StockholdersEquityNoteInitialPublicOfferingAbstract_2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_637726045700361511" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_StockholdersEquityNoteInitialPublicOfferingAbstract_2" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_637726045700361511" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_637726045700361511" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_637726045700361511" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_637726045700361511" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_637726045700361511" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_637726045700371461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_637726045700371461" xlink:to="us-gaap_IPOMember_637726045700371461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IPOMember_637726045700371461" xlink:to="us-gaap_OverAllotmentOptionMember_637726045700371461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_637726045700361511" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_637726045700371461" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_637726045700371461" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637726045700371461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_637726045700371461" xlink:to="us-gaap_SharesIssuedPricePerShare_637726045700371461" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_637726045700371461" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_637726045700371461" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_637726045700371461" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_637726045700371461" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_637726045700371461" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_637726045700371461" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_637726045700371461" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_637726045700371461" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightGranted" xlink:label="miro_ClassOfWarrantOrRightGranted_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_637726045700371461" xlink:to="miro_ClassOfWarrantOrRightGranted_637726045700371461" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_637726045700361511" xlink:to="us-gaap_StatementEquityComponentsAxis_637726045700371461" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637726045700371461" xlink:to="us-gaap_EquityComponentDomain_637726045700371461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_637726045700371461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain_637726045700371461" xlink:to="us-gaap_CommonStockMember_637726045700371461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_637726045700381515" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain_637726045700371461" xlink:to="us-gaap_AdditionalPaidInCapitalMember_637726045700381515" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_637726045700381515" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_637726045700361511" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_637726045700381515" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_637726045700381515" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_637726045700381515" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_637726045700381515" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CommonWarrantsMember" xlink:label="miro_CommonWarrantsMember_637726045700381515" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_637726045700381515" xlink:to="miro_CommonWarrantsMember_637726045700381515" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails" xlink:type="extended" xlink:title="40301 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637726045700381515" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract_2" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637726045700381515" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637726045700381515" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637726045700381515" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637726045700381515" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045700381515" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637726045700381515" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045700381515" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember_637726045700381515" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045700381515" xlink:to="us-gaap_EquipmentMember_637726045700381515" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember_637726045700381515" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045700381515" xlink:to="us-gaap_ConstructionInProgressMember_637726045700381515" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember_637726045700381515" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045700381515" xlink:to="us-gaap_LeaseholdImprovementsMember_637726045700381515" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_FurnitureFixturesAndComputersMember" xlink:label="miro_FurnitureFixturesAndComputersMember_637726045700381515" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045700381515" xlink:to="miro_FurnitureFixturesAndComputersMember_637726045700381515" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_637726045700391512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637726045700381515" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_637726045700391512" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_637726045700391512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637726045700391512" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_637726045700391512" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637726045700391512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637726045700391512" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637726045700391512" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_637726045700391512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637726045700391512" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_637726045700391512" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_637726045700391512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637726045700391512" xlink:to="us-gaap_DepreciationDepletionAndAmortization_637726045700391512" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForConstructionInProcess" xlink:label="us-gaap_PaymentsForConstructionInProcess_637726045700391512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637726045700391512" xlink:to="us-gaap_PaymentsForConstructionInProcess_637726045700391512" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails" xlink:type="extended" xlink:title="40401 - Disclosure - EQUITY METHOD INVESTMENT - Reprise (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable_637726045700391512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_3" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable_637726045700391512" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_637726045700391512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable_637726045700391512" xlink:to="dei_LegalEntityAxis_637726045700391512" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_637726045700391512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis_637726045700391512" xlink:to="dei_EntityDomain_637726045700391512" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member_637726045700391512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain_637726045700391512" xlink:to="miro_RepriseBiomedicalInc.Member_637726045700391512" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_637726045700391512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable_637726045700391512" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_637726045700391512" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_637726045700391512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_637726045700391512" xlink:to="srt_EquityMethodInvesteeNameDomain_637726045700391512" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member_6377260457003915121" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain_637726045700391512" xlink:to="miro_RepriseBiomedicalInc.Member_6377260457003915121" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700391512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable_637726045700391512" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700391512" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_637726045700401510" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700391512" xlink:to="us-gaap_SharePrice_637726045700401510" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_637726045700401510" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700391512" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_637726045700401510" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EquityMethodInvestmentSharesOwned" xlink:label="miro_EquityMethodInvestmentSharesOwned_637726045700401510" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700391512" xlink:to="miro_EquityMethodInvestmentSharesOwned_637726045700401510" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_637726045700401510" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700391512" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_637726045700401510" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EquityMethodInvestmentSharesSold" xlink:label="miro_EquityMethodInvestmentSharesSold_637726045700401510" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700391512" xlink:to="miro_EquityMethodInvestmentSharesSold_637726045700401510" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_637726045700401510" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700391512" xlink:to="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_637726045700401510" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails" xlink:type="extended" xlink:title="40402 - Disclosure - EQUITY METHOD INVESTMENT - Balance Sheet (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable_637726045700401510" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable_637726045700401510" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_637726045700401510" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable_637726045700401510" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_637726045700401510" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_637726045700401510" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_637726045700401510" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_637726045700401510" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member_637726045700411718" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_637726045700401510" xlink:to="miro_RepriseBiomedicalInc.Member_637726045700411718" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700411718" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable_637726045700401510" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700411718" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_637726045700411718" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700411718" xlink:to="us-gaap_AssetsCurrent_637726045700411718" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_637726045700411718" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700411718" xlink:to="us-gaap_Assets_637726045700411718" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_637726045700411718" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700411718" xlink:to="us-gaap_LiabilitiesCurrent_637726045700411718" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent_637726045700411718" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700411718" xlink:to="us-gaap_LiabilitiesNoncurrent_637726045700411718" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest_637726045700411718" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700411718" xlink:to="us-gaap_MinorityInterest_637726045700411718" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637726045700411718" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700411718" xlink:to="us-gaap_StockholdersEquity_637726045700411718" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails" xlink:type="extended" xlink:title="40403 - Disclosure - EQUITY METHOD INVESTMENT - Income Statement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable_637726045700411718" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_4" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable_637726045700411718" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_637726045700411718" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable_637726045700411718" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_637726045700411718" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_637726045700421539" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_637726045700411718" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_637726045700421539" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member_637726045700421539" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_637726045700421539" xlink:to="miro_RepriseBiomedicalInc.Member_637726045700421539" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700421539" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable_637726045700411718" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700421539" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637726045700421539" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700421539" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637726045700421539" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit_637726045700421539" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700421539" xlink:to="us-gaap_GrossProfit_637726045700421539" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_637726045700421539" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700421539" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_637726045700421539" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637726045700421539" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_637726045700421539" xlink:to="us-gaap_NetIncomeLoss_637726045700421539" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureAccruedExpensesDetails" xlink:type="extended" xlink:title="40501 - Disclosure - ACCRUED EXPENSES (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract_2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent_637726045700421539" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract_2" xlink:to="us-gaap_AccruedSalariesCurrent_637726045700421539" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_637726045700421539" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract_2" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_637726045700421539" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="us-gaap_AccruedRoyaltiesCurrent_637726045700421539" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract_2" xlink:to="us-gaap_AccruedRoyaltiesCurrent_637726045700421539" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedSuppliesCurrent" xlink:label="miro_AccruedSuppliesCurrent_637726045700421539" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract_2" xlink:to="miro_AccruedSuppliesCurrent_637726045700421539" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedLiabilitiesPublicOfferingExpensesCurrent" xlink:label="miro_AccruedLiabilitiesPublicOfferingExpensesCurrent_637726045700421539" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract_2" xlink:to="miro_AccruedLiabilitiesPublicOfferingExpensesCurrent_637726045700421539" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedKeyOpinionLeadedCompensationCurrent" xlink:label="miro_AccruedKeyOpinionLeadedCompensationCurrent_637726045700421539" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract_2" xlink:to="miro_AccruedKeyOpinionLeadedCompensationCurrent_637726045700421539" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AccruedBoardCompensationCurrent" xlink:label="miro_AccruedBoardCompensationCurrent_637726045700431530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract_2" xlink:to="miro_AccruedBoardCompensationCurrent_637726045700431530" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_637726045700431530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract_2" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_637726045700431530" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_637726045700431530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract_2" xlink:to="us-gaap_AccruedLiabilitiesCurrent_637726045700431530" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails" xlink:type="extended" xlink:title="40601 - Disclosure - FAIR VALUE MEASUREMENT - Changes (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract_2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeTable" xlink:label="us-gaap_EmbeddedDerivativeTable_637726045700431530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_2" xlink:to="us-gaap_EmbeddedDerivativeTable_637726045700431530" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_637726045700431530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmbeddedDerivativeTable_637726045700431530" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_637726045700431530" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637726045700431530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_637726045700431530" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637726045700431530" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member_637726045700431530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637726045700431530" xlink:to="us-gaap_FairValueInputsLevel3Member_637726045700431530" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeLineItems" xlink:label="us-gaap_EmbeddedDerivativeLineItems_637726045700431530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmbeddedDerivativeTable_637726045700431530" xlink:to="us-gaap_EmbeddedDerivativeLineItems_637726045700431530" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_637726045700431530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmbeddedDerivativeLineItems_637726045700431530" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_637726045700431530" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions" xlink:label="miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions_637726045700431530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmbeddedDerivativeLineItems_637726045700431530" xlink:to="miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions_637726045700431530" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_637726045700431530" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmbeddedDerivativeLineItems_637726045700431530" xlink:to="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_637726045700431530" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_637726045700441507" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmbeddedDerivativeLineItems_637726045700431530" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_637726045700441507" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="us-gaap_DerivativeFairValueOfDerivativeLiability_637726045700441507" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmbeddedDerivativeLineItems_637726045700431530" xlink:to="us-gaap_DerivativeFairValueOfDerivativeLiability_637726045700441507" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails" xlink:type="extended" xlink:title="40701 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION -  Agreements (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract_3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable_637726045700441507" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract_3" xlink:to="us-gaap_DebtInstrumentTable_637726045700441507" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis_637726045700441507" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637726045700441507" xlink:to="us-gaap_DebtInstrumentAxis_637726045700441507" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_637726045700441507" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis_637726045700441507" xlink:to="us-gaap_DebtInstrumentNameDomain_637726045700441507" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember" xlink:label="miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_637726045700441507" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637726045700441507" xlink:to="miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_637726045700441507" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember" xlink:label="miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_637726045700441507" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637726045700441507" xlink:to="miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_637726045700441507" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember" xlink:label="miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_637726045700441507" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637726045700441507" xlink:to="miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_637726045700441507" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalLeaseOctober2018Member" xlink:label="miro_CapitalLeaseOctober2018Member_637726045700441507" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637726045700441507" xlink:to="miro_CapitalLeaseOctober2018Member_637726045700441507" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PromissoryNoteWithUniversityOfMinnesotaMember" xlink:label="miro_PromissoryNoteWithUniversityOfMinnesotaMember_637726045700441507" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637726045700441507" xlink:to="miro_PromissoryNoteWithUniversityOfMinnesotaMember_637726045700441507" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NoteCompanyShareholderMember" xlink:label="miro_NoteCompanyShareholderMember_637726045700441507" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637726045700441507" xlink:to="miro_NoteCompanyShareholderMember_637726045700441507" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PaycheckProtectionProgramMember" xlink:label="miro_PaycheckProtectionProgramMember_637726045700451463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637726045700441507" xlink:to="miro_PaycheckProtectionProgramMember_637726045700451463" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalLeaseJuly2021Member" xlink:label="miro_CapitalLeaseJuly2021Member_637726045700451463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637726045700441507" xlink:to="miro_CapitalLeaseJuly2021Member_637726045700451463" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalLeaseSeptember2021Member" xlink:label="miro_CapitalLeaseSeptember2021Member_637726045700451463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637726045700441507" xlink:to="miro_CapitalLeaseSeptember2021Member_637726045700451463" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637726045700451463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637726045700441507" xlink:to="srt_RangeAxis_637726045700451463" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637726045700451463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637726045700451463" xlink:to="srt_RangeMember_637726045700451463" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_637726045700451463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637726045700451463" xlink:to="srt_MaximumMember_637726045700451463" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_637726045700451463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637726045700441507" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_637726045700451463" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_637726045700451463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_637726045700451463" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_637726045700451463" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsRegentsOfUniversityOfMinnesotaMember" xlink:label="miro_WarrantsRegentsOfUniversityOfMinnesotaMember_637726045700451463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_637726045700451463" xlink:to="miro_WarrantsRegentsOfUniversityOfMinnesotaMember_637726045700451463" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsUniversityOfMinnesotaMember" xlink:label="miro_WarrantsUniversityOfMinnesotaMember_637726045700451463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_637726045700451463" xlink:to="miro_WarrantsUniversityOfMinnesotaMember_637726045700451463" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsCompanyShareholderMember" xlink:label="miro_WarrantsCompanyShareholderMember_637726045700451463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_637726045700451463" xlink:to="miro_WarrantsCompanyShareholderMember_637726045700451463" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637726045700451463" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637726045700441507" xlink:to="us-gaap_StatementClassOfStockAxis_637726045700451463" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045700461477" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637726045700451463" xlink:to="us-gaap_ClassOfStockDomain_637726045700461477" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesCConvertiblePreferredStockMember" xlink:label="miro_SeriesCConvertiblePreferredStockMember_637726045700461477" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700461477" xlink:to="miro_SeriesCConvertiblePreferredStockMember_637726045700461477" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems_637726045700461477" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637726045700441507" xlink:to="us-gaap_DebtInstrumentLineItems_637726045700461477" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfShareholders" xlink:label="miro_NumberOfShareholders_637726045700461477" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="miro_NumberOfShareholders_637726045700461477" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount_637726045700461477" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="us-gaap_DebtInstrumentFaceAmount_637726045700461477" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasedAssetsGross" xlink:label="us-gaap_CapitalLeasedAssetsGross_637726045700461477" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="us-gaap_CapitalLeasedAssetsGross_637726045700461477" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_637726045700461477" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_637726045700461477" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentPeriodicMonthlyPaymentNumber" xlink:label="miro_DebtInstrumentPeriodicMonthlyPaymentNumber_637726045700461477" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="miro_DebtInstrumentPeriodicMonthlyPaymentNumber_637726045700461477" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentNumberOfFinalPayment" xlink:label="miro_DebtInstrumentNumberOfFinalPayment_637726045700461477" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="miro_DebtInstrumentNumberOfFinalPayment_637726045700461477" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_637726045700461477" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_637726045700461477" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SubstantialOwnershipChangePercentage" xlink:label="miro_SubstantialOwnershipChangePercentage_637726045700471505" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="miro_SubstantialOwnershipChangePercentage_637726045700471505" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentAdditionalCompensation" xlink:label="miro_DebtInstrumentAdditionalCompensation_637726045700471505" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="miro_DebtInstrumentAdditionalCompensation_637726045700471505" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligations" xlink:label="us-gaap_CapitalLeaseObligations_637726045700471505" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="us-gaap_CapitalLeaseObligations_637726045700471505" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_637726045700471505" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_637726045700471505" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:label="miro_ClassOfWarrantOrRightNumberOfWarrantsIssued_637726045700471505" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="miro_ClassOfWarrantOrRightNumberOfWarrantsIssued_637726045700471505" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_637726045700471505" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_637726045700471505" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_637726045700471505" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_637726045700471505" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentConvertibleMinimumPreferredStockOffering" xlink:label="miro_DebtInstrumentConvertibleMinimumPreferredStockOffering_637726045700481493" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="miro_DebtInstrumentConvertibleMinimumPreferredStockOffering_637726045700481493" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding_637726045700481493" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="us-gaap_WarrantsAndRightsOutstanding_637726045700481493" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsAndRightsAdditionalCoverage" xlink:label="miro_WarrantsAndRightsAdditionalCoverage_637726045700481493" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="miro_WarrantsAndRightsAdditionalCoverage_637726045700481493" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_637726045700481493" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_637726045700481493" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_637726045700481493" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_637726045700481493" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentPrincipalForgiveness" xlink:label="miro_DebtInstrumentPrincipalForgiveness_637726045700481493" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="miro_DebtInstrumentPrincipalForgiveness_637726045700481493" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtInstrumentInterestForgiveness" xlink:label="miro_DebtInstrumentInterestForgiveness_637726045700481493" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="miro_DebtInstrumentInterestForgiveness_637726045700481493" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest_637726045700491526" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest_637726045700491526" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt_637726045700491526" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700461477" xlink:to="us-gaap_LongTermDebt_637726045700491526" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails" xlink:type="extended" xlink:title="40702 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION - Maturity (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract_2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable_637726045700491526" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract_2" xlink:to="us-gaap_DebtInstrumentTable_637726045700491526" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis_637726045700491526" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637726045700491526" xlink:to="us-gaap_LongtermDebtTypeAxis_637726045700491526" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_637726045700491526" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis_637726045700491526" xlink:to="us-gaap_LongtermDebtTypeDomain_637726045700491526" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember" xlink:label="us-gaap_LongTermDebtMember_637726045700491526" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain_637726045700491526" xlink:to="us-gaap_LongTermDebtMember_637726045700491526" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsMember" xlink:label="us-gaap_CapitalLeaseObligationsMember_637726045700491526" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain_637726045700491526" xlink:to="us-gaap_CapitalLeaseObligationsMember_637726045700491526" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems_637726045700491526" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_637726045700491526" xlink:to="us-gaap_DebtInstrumentLineItems_637726045700491526" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:label="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_637726045700501491" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_637726045700491526" xlink:to="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_637726045700501491" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths_637726045700501491" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_637726045700501491" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths_637726045700501491" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo_637726045700501491" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_637726045700501491" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo_637726045700501491" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree_637726045700501491" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_637726045700501491" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree_637726045700501491" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour_637726045700501491" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_637726045700501491" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour_637726045700501491" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive" xlink:label="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive_637726045700501491" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_637726045700501491" xlink:to="miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive_637726045700501491" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtAndCapitalLeaseObligationsGross" xlink:label="miro_DebtAndCapitalLeaseObligationsGross_637726045700501491" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_637726045700501491" xlink:to="miro_DebtAndCapitalLeaseObligationsGross_637726045700501491" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtAndCapitalLeaseObligationsGrossCurrent" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossCurrent_637726045700501491" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_637726045700501491" xlink:to="miro_DebtAndCapitalLeaseObligationsGrossCurrent_637726045700501491" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_DebtAndCapitalLeaseObligationsGrossNoncurrent" xlink:label="miro_DebtAndCapitalLeaseObligationsGrossNoncurrent_637726045700501491" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_637726045700501491" xlink:to="miro_DebtAndCapitalLeaseObligationsGrossNoncurrent_637726045700501491" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="us-gaap_DebtAndCapitalLeaseObligations_637726045700501491" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_637726045700501491" xlink:to="us-gaap_DebtAndCapitalLeaseObligations_637726045700501491" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_637726045700511428" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_637726045700501491" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_637726045700511428" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_637726045700511428" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_637726045700501491" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_637726045700511428" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails" xlink:type="extended" xlink:title="40801 - Disclosure - CAPITAL STOCK - Convertible Preferred Stock, Prior to IPO (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalStockDisclosureAbstract" xlink:label="miro_CapitalStockDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable_637726045700511428" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_CapitalStockDisclosureAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable_637726045700511428" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637726045700511428" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637726045700511428" xlink:to="us-gaap_StatementClassOfStockAxis_637726045700511428" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045700511428" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637726045700511428" xlink:to="us-gaap_ClassOfStockDomain_637726045700511428" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesCConvertiblePreferredStockMember" xlink:label="miro_SeriesCConvertiblePreferredStockMember_637726045700511428" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700511428" xlink:to="miro_SeriesCConvertiblePreferredStockMember_637726045700511428" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesB2ConvertiblePreferredStockMember" xlink:label="miro_SeriesB2ConvertiblePreferredStockMember_637726045700521701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700511428" xlink:to="miro_SeriesB2ConvertiblePreferredStockMember_637726045700521701" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesBConvertiblePreferredStockMember" xlink:label="miro_SeriesBConvertiblePreferredStockMember_637726045700521701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700511428" xlink:to="miro_SeriesBConvertiblePreferredStockMember_637726045700521701" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesConvertiblePreferredStockMember" xlink:label="miro_SeriesConvertiblePreferredStockMember_637726045700521701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700511428" xlink:to="miro_SeriesConvertiblePreferredStockMember_637726045700521701" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems_637726045700521701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637726045700511428" xlink:to="us-gaap_ClassOfStockLineItems_637726045700521701" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_637726045700521701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700521701" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_637726045700521701" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_637726045700521701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700521701" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_637726045700521701" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_637726045700521701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700521701" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_637726045700521701" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_637726045700521701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700521701" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_637726045700521701" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_637726045700521701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700521701" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_637726045700521701" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_637726045700521701" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637726045700511428" xlink:to="us-gaap_StatementEquityComponentsAxis_637726045700521701" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_637726045700531854" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637726045700521701" xlink:to="us-gaap_EquityComponentDomain_637726045700531854" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_637726045700531854" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain_637726045700531854" xlink:to="us-gaap_CommonStockMember_637726045700531854" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_637726045700531854" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain_637726045700531854" xlink:to="us-gaap_AdditionalPaidInCapitalMember_637726045700531854" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails" xlink:type="extended" xlink:title="40802 - Disclosure - CAPITAL STOCK - Common Stock and Preferred Stock (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalStockDisclosureAbstract" xlink:label="miro_CapitalStockDisclosureAbstract_3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable_637726045700531854" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_CapitalStockDisclosureAbstract_3" xlink:to="us-gaap_ScheduleOfStockByClassTable_637726045700531854" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems_637726045700531854" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637726045700531854" xlink:to="us-gaap_ClassOfStockLineItems_637726045700531854" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_637726045700531854" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700531854" xlink:to="us-gaap_CommonStockSharesAuthorized_637726045700531854" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_637726045700531854" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700531854" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_637726045700531854" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfVotesForCommonStockHolders" xlink:label="miro_NumberOfVotesForCommonStockHolders_637726045700531854" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700531854" xlink:to="miro_NumberOfVotesForCommonStockHolders_637726045700531854" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637726045700541773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700531854" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637726045700541773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_637726045700541773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700531854" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_637726045700541773" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="miro_StockIssuedDuringPeriodSharesWarrantsExercised_637726045700541773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700531854" xlink:to="miro_StockIssuedDuringPeriodSharesWarrantsExercised_637726045700541773" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_637726045700541773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700531854" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_637726045700541773" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_637726045700541773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700531854" xlink:to="us-gaap_CommonStockSharesIssued_637726045700541773" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_637726045700541773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700531854" xlink:to="us-gaap_CommonStockSharesOutstanding_637726045700541773" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_637726045700541773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700531854" xlink:to="us-gaap_PreferredStockSharesAuthorized_637726045700541773" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_637726045700541773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700531854" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_637726045700541773" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_637726045700541773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700531854" xlink:to="us-gaap_PreferredStockSharesIssued_637726045700541773" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_637726045700551181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700531854" xlink:to="us-gaap_PreferredStockSharesOutstanding_637726045700551181" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_637726045700551181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637726045700531854" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_637726045700551181" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_637726045700551181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_637726045700551181" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_637726045700551181" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ExercisePriceOf0.10Member" xlink:label="miro_ExercisePriceOf0.10Member_637726045700551181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_637726045700551181" xlink:to="miro_ExercisePriceOf0.10Member_637726045700551181" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ExercisePriceOf1.25Member" xlink:label="miro_ExercisePriceOf1.25Member_637726045700551181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_637726045700551181" xlink:to="miro_ExercisePriceOf1.25Member_637726045700551181" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails" xlink:type="extended" xlink:title="40803 - Disclosure - CAPITAL STOCK - Series C Convertible Preferred Stock (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalStockDisclosureAbstract" xlink:label="miro_CapitalStockDisclosureAbstract_2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_CapitalStockDisclosureAbstract_2" xlink:to="us-gaap_ScheduleOfStockByClassTable_637726045700561263" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637726045700561263" xlink:to="us-gaap_StatementClassOfStockAxis_637726045700561263" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637726045700561263" xlink:to="us-gaap_ClassOfStockDomain_637726045700561263" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesCConvertiblePreferredStockMember" xlink:label="miro_SeriesCConvertiblePreferredStockMember_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700561263" xlink:to="miro_SeriesCConvertiblePreferredStockMember_637726045700561263" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637726045700561263" xlink:to="us-gaap_DebtInstrumentAxis_637726045700561263" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis_637726045700561263" xlink:to="us-gaap_DebtInstrumentNameDomain_637726045700561263" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NoteCompanyShareholderMember" xlink:label="miro_NoteCompanyShareholderMember_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_637726045700561263" xlink:to="miro_NoteCompanyShareholderMember_637726045700561263" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637726045700561263" xlink:to="us-gaap_ClassOfStockLineItems_637726045700561263" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfStockPurchaseAgreements" xlink:label="miro_NumberOfStockPurchaseAgreements_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700561263" xlink:to="miro_NumberOfStockPurchaseAgreements_637726045700561263" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700561263" xlink:to="miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_637726045700561263" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700561263" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_637726045700561263" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700561263" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_637726045700561263" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700561263" xlink:to="us-gaap_DebtInstrumentFaceAmount_637726045700561263" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest" xlink:label="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700561263" xlink:to="miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest_637726045700561263" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="miro_StockIssuedDuringPeriodSharesWarrantsExercised_637726045700561263" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700561263" xlink:to="miro_StockIssuedDuringPeriodSharesWarrantsExercised_637726045700561263" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockConversionDiscount" xlink:label="miro_StockConversionDiscount_637726045700571602" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700561263" xlink:to="miro_StockConversionDiscount_637726045700571602" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_TemporaryEquitySharesConvertedInPeriod" xlink:label="miro_TemporaryEquitySharesConvertedInPeriod_637726045700571602" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700561263" xlink:to="miro_TemporaryEquitySharesConvertedInPeriod_637726045700571602" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_637726045700571602" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700561263" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_637726045700571602" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_637726045700571602" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700561263" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_637726045700571602" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_637726045700571602" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637726045700561263" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_637726045700571602" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_637726045700571602" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637726045700561263" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_637726045700571602" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_637726045700571602" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_637726045700571602" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_637726045700571602" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsCompanyShareholderMember" xlink:label="miro_WarrantsCompanyShareholderMember_637726045700571602" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_637726045700571602" xlink:to="miro_WarrantsCompanyShareholderMember_637726045700571602" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails" xlink:type="extended" xlink:title="40804 - Disclosure - CAPITAL STOCK - Stock options (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalStockDisclosureAbstract" xlink:label="miro_CapitalStockDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700581536" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_CapitalStockDisclosureAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700581536" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis_637726045700581536" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700581536" xlink:to="us-gaap_PlanNameAxis_637726045700581536" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_637726045700581536" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis_637726045700581536" xlink:to="us-gaap_PlanNameDomain_637726045700581536" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockOptionPlan2010Member" xlink:label="miro_StockOptionPlan2010Member_637726045700581536" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_637726045700581536" xlink:to="miro_StockOptionPlan2010Member_637726045700581536" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_StockOptionPlan2019Member" xlink:label="miro_StockOptionPlan2019Member_637726045700581536" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_637726045700581536" xlink:to="miro_StockOptionPlan2019Member_637726045700581536" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_EquityIncentivePlan2021Member" xlink:label="miro_EquityIncentivePlan2021Member_637726045700581536" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_637726045700581536" xlink:to="miro_EquityIncentivePlan2021Member_637726045700581536" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700581536" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_637726045700581536" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_637726045700581536" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_637726045700581536" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_637726045700581536" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease_637726045700581536" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease_637726045700581536" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease_637726045700581536" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease_637726045700581536" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637726045700581536" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637726045700581536" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_637726045700581536" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637726045700581536" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_637726045700581536" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_637726045700591633" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637726045700581536" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_637726045700591633" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637726045700591633" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637726045700581536" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637726045700591633" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_637726045700591633" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637726045700581536" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_637726045700591633" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_637726045700591633" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637726045700581536" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_637726045700591633" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_637726045700591633" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637726045700581536" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_637726045700591633" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637726045700591633" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637726045700591633" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637726045700591633" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637726045700591633" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637726045700591633" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_637726045700591633" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637726045700591633" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_637726045700591633" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_637726045700591633" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637726045700591633" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_637726045700591633" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_637726045700591633" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637726045700591633" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_637726045700591633" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637726045700601609" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637726045700591633" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637726045700601609" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_637726045700601609" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637726045700591633" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_637726045700601609" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_637726045700601609" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_637726045700601609" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_637726045700601609" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_637726045700601609" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_637726045700601609" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_637726045700601609" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_637726045700601609" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_637726045700601609" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_637726045700601609" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_637726045700601609" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_637726045700601609" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_637726045700601609" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_637726045700631457" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_637726045700631457" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_637726045700631457" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_637726045700631457" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear_637726045700631457" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear_637726045700631457" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne_637726045700631457" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne_637726045700631457" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo_637726045700631457" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo_637726045700631457" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree_637726045700641442" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree_637726045700641442" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour" xlink:label="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour_637726045700641442" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700581536" xlink:to="miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour_637726045700641442" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails" xlink:type="extended" xlink:title="40805 - Disclosure - CAPITAL STOCK - Estimate the fair value of stock option grants (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalStockDisclosureAbstract" xlink:label="miro_CapitalStockDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700691470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_CapitalStockDisclosureAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700691470" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_637726045700691470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700691470" xlink:to="us-gaap_AwardTypeAxis_637726045700691470" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045700691470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_637726045700691470" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045700691470" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_637726045700691470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045700691470" xlink:to="us-gaap_EmployeeStockOptionMember_637726045700691470" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700691470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700691470" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700691470" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_637726045700691470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700691470" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_637726045700691470" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_637726045700691470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700691470" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_637726045700691470" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_637726045700691470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700691470" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_637726045700691470" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails" xlink:type="extended" xlink:title="40806 - Disclosure - CAPITAL STOCK - Restricted Stock Units (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalStockDisclosureAbstract" xlink:label="miro_CapitalStockDisclosureAbstract_4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700691470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_CapitalStockDisclosureAbstract_4" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700691470" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_637726045700691470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700691470" xlink:to="srt_StatementScenarioAxis_637726045700691470" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_637726045700691470" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_637726045700691470" xlink:to="srt_ScenarioUnspecifiedDomain_637726045700691470" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember_637726045700701441" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_637726045700691470" xlink:to="srt_ScenarioForecastMember_637726045700701441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700701441" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700691470" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700701441" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_637726045700701441" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700701441" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_637726045700701441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_637726045700701441" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700701441" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_637726045700701441" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_637726045700701441" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700701441" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_637726045700701441" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_637726045700701441" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700701441" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_637726045700701441" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_637726045700701441" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700691470" xlink:to="us-gaap_AwardTypeAxis_637726045700701441" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045700701441" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_637726045700701441" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045700701441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_637726045700701441" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045700701441" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_637726045700701441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails" xlink:type="extended" xlink:title="40807 - Disclosure - CAPITAL STOCK - Employee Stock Purchase Plan (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalStockDisclosureAbstract" xlink:label="miro_CapitalStockDisclosureAbstract_5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700701441" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_CapitalStockDisclosureAbstract_5" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700701441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637726045700701441" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700701441" xlink:to="srt_RangeAxis_637726045700701441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637726045700711472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637726045700701441" xlink:to="srt_RangeMember_637726045700711472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_637726045700711472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637726045700711472" xlink:to="srt_MinimumMember_637726045700711472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700711472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700701441" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700711472" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_637726045700711472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700711472" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_637726045700711472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_637726045700711472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700711472" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_637726045700711472" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee_637726045700711472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700711472" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee_637726045700711472" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_637726045700711472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700711472" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_637726045700711472" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_637726045700711472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700711472" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_637726045700711472" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease_637726045700711472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700711472" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease_637726045700711472" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease" xlink:label="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease_637726045700711472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700711472" xlink:to="miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease_637726045700711472" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_637726045700711472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637726045700711472" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_637726045700711472" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_637726045700711472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637726045700701441" xlink:to="us-gaap_AwardTypeAxis_637726045700711472" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045700721616" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_637726045700711472" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045700721616" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember_637726045700721616" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637726045700721616" xlink:to="us-gaap_EmployeeStockMember_637726045700721616" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails" xlink:type="extended" xlink:title="40808 - Disclosure - CAPITAL STOCK - Warrants (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CapitalStockDisclosureAbstract" xlink:label="miro_CapitalStockDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable_637726045700721616" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="miro_CapitalStockDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable_637726045700721616" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_637726045700721616" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable_637726045700721616" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_637726045700721616" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_637726045700721616" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_637726045700721616" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_637726045700721616" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesPreferredWarrantsMember" xlink:label="miro_SeriesPreferredWarrantsMember_637726045700721616" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_637726045700721616" xlink:to="miro_SeriesPreferredWarrantsMember_637726045700721616" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CommonWarrantsMember" xlink:label="miro_CommonWarrantsMember_637726045700721616" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_637726045700721616" xlink:to="miro_CommonWarrantsMember_637726045700721616" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_637726045700721616" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable_637726045700721616" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_637726045700721616" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_637726045700721616" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_637726045700721616" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_637726045700721616" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightGranted" xlink:label="miro_ClassOfWarrantOrRightGranted_637726045700721616" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_637726045700721616" xlink:to="miro_ClassOfWarrantOrRightGranted_637726045700721616" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightExercised" xlink:label="miro_ClassOfWarrantOrRightExercised_637726045700721616" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_637726045700721616" xlink:to="miro_ClassOfWarrantOrRightExercised_637726045700721616" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ClassOfWarrantOrRightTerminated" xlink:label="miro_ClassOfWarrantOrRightTerminated_637726045700731524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_637726045700721616" xlink:to="miro_ClassOfWarrantOrRightTerminated_637726045700731524" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_637726045700731524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_637726045700721616" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_637726045700731524" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsOutstandingWeightedAverageExercisePrice" xlink:label="miro_WarrantsOutstandingWeightedAverageExercisePrice_637726045700731524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_637726045700721616" xlink:to="miro_WarrantsOutstandingWeightedAverageExercisePrice_637726045700731524" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm_637726045700731524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_637726045700721616" xlink:to="miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm_637726045700731524" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureEmployeeBenefitPlansDetails" xlink:type="extended" xlink:title="40901 - Disclosure - EMPLOYEE BENEFIT PLANS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_637726045700731524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract_1" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_637726045700731524" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/ScheduleSignificantCustomersDetails" xlink:type="extended" xlink:title="41001 - Schedule - SIGNIFICANT CUSTOMERS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable_637726045700731524" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RisksAndUncertaintiesAbstract_2" xlink:to="us-gaap_ConcentrationRiskTable_637726045700731524" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_637726045700741485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable_637726045700731524" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_637726045700741485" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_637726045700741485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis_637726045700741485" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_637726045700741485" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember_637726045700741485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain_637726045700741485" xlink:to="us-gaap_SalesRevenueNetMember_637726045700741485" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_637726045700741485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable_637726045700731524" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_637726045700741485" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_637726045700741485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis_637726045700741485" xlink:to="us-gaap_ConcentrationRiskTypeDomain_637726045700741485" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember_637726045700741485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain_637726045700741485" xlink:to="us-gaap_CustomerConcentrationRiskMember_637726045700741485" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis_637726045700741485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable_637726045700731524" xlink:to="srt_MajorCustomersAxis_637726045700741485" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain_637726045700741485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis_637726045700741485" xlink:to="srt_NameOfMajorCustomerDomain_637726045700741485" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_OneCustomerMember" xlink:label="miro_OneCustomerMember_637726045700741485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain_637726045700741485" xlink:to="miro_OneCustomerMember_637726045700741485" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems_637726045700741485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable_637726045700731524" xlink:to="us-gaap_ConcentrationRiskLineItems_637726045700741485" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1_637726045700741485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems_637726045700741485" xlink:to="us-gaap_ConcentrationRiskPercentage1_637726045700741485" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_NumberOfCustomers" xlink:label="miro_NumberOfCustomers_637726045700741485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems_637726045700741485" xlink:to="miro_NumberOfCustomers_637726045700741485" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails" xlink:type="extended" xlink:title="41101 - Disclosure - COMMITMENTS AND CONTINGENCIES - Patent License Agreement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637726045700741485" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637726045700741485" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637726045700741485" xlink:to="srt_CounterpartyNameAxis_637726045700751490" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis_637726045700751490" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_637726045700751490" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_UniversityOfMinnesotaMember" xlink:label="miro_UniversityOfMinnesotaMember_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_637726045700751490" xlink:to="miro_UniversityOfMinnesotaMember_637726045700751490" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637726045700741485" xlink:to="us-gaap_TypeOfArrangementAxis_637726045700751490" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_637726045700751490" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045700751490" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncollaborativeArrangementTransactionsMember" xlink:label="us-gaap_NoncollaborativeArrangementTransactionsMember_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045700751490" xlink:to="us-gaap_NoncollaborativeArrangementTransactionsMember_637726045700751490" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PatentLicenseAgreementMember" xlink:label="miro_PatentLicenseAgreementMember_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncollaborativeArrangementTransactionsMember_637726045700751490" xlink:to="miro_PatentLicenseAgreementMember_637726045700751490" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637726045700741485" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_637726045700751490" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_637726045700751490" xlink:to="us-gaap_RelatedPartyDomain_637726045700751490" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_637726045700751490" xlink:to="miro_RepriseBiomedicalInc.Member_637726045700751490" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637726045700741485" xlink:to="us-gaap_RelatedPartyTransactionAxis_637726045700751490" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_637726045700751490" xlink:to="us-gaap_RelatedPartyTransactionDomain_637726045700751490" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PatentAndKnowHowLicenseAgreementMember" xlink:label="miro_PatentAndKnowHowLicenseAgreementMember_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_637726045700751490" xlink:to="miro_PatentAndKnowHowLicenseAgreementMember_637726045700751490" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637726045700741485" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637726045700751490" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_MinimumRoyaltyPayable" xlink:label="miro_MinimumRoyaltyPayable_637726045700751490" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637726045700751490" xlink:to="miro_MinimumRoyaltyPayable_637726045700751490" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_MinimumRoyaltyReceivable" xlink:label="miro_MinimumRoyaltyReceivable_637726045700761461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637726045700751490" xlink:to="miro_MinimumRoyaltyReceivable_637726045700761461" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails" xlink:type="extended" xlink:title="41102 - Disclosure - COMMITMENTS AND CONTINGENCIES - Leases (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable_637726045700761461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable_637726045700761461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637726045700761461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable_637726045700761461" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637726045700761461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045700761461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637726045700761461" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045700761461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_FirstFacilityEdenPrairieMember" xlink:label="miro_FirstFacilityEdenPrairieMember_637726045700761461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045700761461" xlink:to="miro_FirstFacilityEdenPrairieMember_637726045700761461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SecondFacilityEdenPrairieMember" xlink:label="miro_SecondFacilityEdenPrairieMember_637726045700761461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045700761461" xlink:to="miro_SecondFacilityEdenPrairieMember_637726045700761461" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember" xlink:label="miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_637726045700761461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637726045700761461" xlink:to="miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_637726045700761461" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_637726045700761461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable_637726045700761461" xlink:to="srt_StatementScenarioAxis_637726045700761461" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_637726045700761461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_637726045700761461" xlink:to="srt_ScenarioUnspecifiedDomain_637726045700761461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_Period1Member" xlink:label="miro_Period1Member_637726045700761461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_637726045700761461" xlink:to="miro_Period1Member_637726045700761461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_Period2Member" xlink:label="miro_Period2Member_637726045700761461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_637726045700761461" xlink:to="miro_Period2Member_637726045700761461" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_Period3Member" xlink:label="miro_Period3Member_637726045700761461" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_637726045700761461" xlink:to="miro_Period3Member_637726045700761461" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable_637726045700761461" xlink:to="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty_637726045700771151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" xlink:to="us-gaap_AreaOfRealEstateProperty_637726045700771151" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_MonthlyLeaseRentPayments" xlink:label="miro_MonthlyLeaseRentPayments_637726045700771151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" xlink:to="miro_MonthlyLeaseRentPayments_637726045700771151" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_IncreaseInYearlyRentPercentage" xlink:label="miro_IncreaseInYearlyRentPercentage_637726045700771151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" xlink:to="miro_IncreaseInYearlyRentPercentage_637726045700771151" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_637726045700771151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_637726045700771151" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_637726045700771151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_637726045700771151" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage" xlink:label="miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage_637726045700771151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" xlink:to="miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage_637726045700771151" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseRealPropertyTaxesPercentage" xlink:label="miro_LesseeOperatingLeaseRealPropertyTaxesPercentage_637726045700771151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" xlink:to="miro_LesseeOperatingLeaseRealPropertyTaxesPercentage_637726045700771151" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseManagementFeePercentage" xlink:label="miro_LesseeOperatingLeaseManagementFeePercentage_637726045700771151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" xlink:to="miro_LesseeOperatingLeaseManagementFeePercentage_637726045700771151" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts" xlink:label="miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts_637726045700771151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" xlink:to="miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts_637726045700771151" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_OperatingLeaseNumberOfOptionsToExtend" xlink:label="miro_OperatingLeaseNumberOfOptionsToExtend_637726045700771151" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" xlink:to="miro_OperatingLeaseNumberOfOptionsToExtend_637726045700771151" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_LesseeOperatingLeaseOptionToExtendTermOfContract" xlink:label="miro_LesseeOperatingLeaseOptionToExtendTermOfContract_637726045700781128" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" xlink:to="miro_LesseeOperatingLeaseOptionToExtendTermOfContract_637726045700781128" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets" xlink:label="us-gaap_DepositAssets_637726045700781128" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" xlink:to="us-gaap_DepositAssets_637726045700781128" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637726045700781128" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_637726045700771151" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637726045700781128" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_637726045700781128" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637726045700781128" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_637726045700781128" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_637726045700781128" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637726045700781128" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_637726045700781128" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails" xlink:type="extended" xlink:title="41103 - Disclosure - COMMITMENTS AND CONTINGENCIES - License Contract (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637726045700781128" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637726045700781128" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_637726045700781128" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637726045700781128" xlink:to="us-gaap_TypeOfArrangementAxis_637726045700781128" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045700781128" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_637726045700781128" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045700781128" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncollaborativeArrangementTransactionsMember" xlink:label="us-gaap_NoncollaborativeArrangementTransactionsMember_637726045700781128" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045700781128" xlink:to="us-gaap_NoncollaborativeArrangementTransactionsMember_637726045700781128" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ResearchAndDevelopmentContractMember" xlink:label="miro_ResearchAndDevelopmentContractMember_637726045700781128" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncollaborativeArrangementTransactionsMember_637726045700781128" xlink:to="miro_ResearchAndDevelopmentContractMember_637726045700781128" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637726045700781128" xlink:to="us-gaap_StatementClassOfStockAxis_637726045700791472" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637726045700791472" xlink:to="us-gaap_ClassOfStockDomain_637726045700791472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_SeriesBConvertiblePreferredStockMember" xlink:label="miro_SeriesBConvertiblePreferredStockMember_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637726045700791472" xlink:to="miro_SeriesBConvertiblePreferredStockMember_637726045700791472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637726045700781128" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637726045700791472" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637726045700791472" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_637726045700791472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637726045700791472" xlink:to="us-gaap_SharePrice_637726045700791472" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails" xlink:type="extended" xlink:title="41201 - Disclosure - RELATED PARTY TRANSACTIONS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract_1" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637726045700791472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637726045700791472" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_637726045700791472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_637726045700791472" xlink:to="us-gaap_RelatedPartyDomain_637726045700791472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CorporationOwnedByDirectorMember" xlink:label="miro_CorporationOwnedByDirectorMember_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_637726045700791472" xlink:to="miro_CorporationOwnedByDirectorMember_637726045700791472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_RepriseBiomedicalInc.Member" xlink:label="miro_RepriseBiomedicalInc.Member_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_637726045700791472" xlink:to="miro_RepriseBiomedicalInc.Member_637726045700791472" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637726045700791472" xlink:to="us-gaap_RelatedPartyTransactionAxis_637726045700791472" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_637726045700791472" xlink:to="us-gaap_RelatedPartyTransactionDomain_637726045700791472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ConsultingServicesMember" xlink:label="miro_ConsultingServicesMember_637726045700791472" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_637726045700791472" xlink:to="miro_ConsultingServicesMember_637726045700791472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_PatentAndKnowHowLicenseAgreementMember" xlink:label="miro_PatentAndKnowHowLicenseAgreementMember_637726045700801476" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_637726045700791472" xlink:to="miro_PatentAndKnowHowLicenseAgreementMember_637726045700801476" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems_637726045700801476" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637726045700791472" xlink:to="us-gaap_RelatedPartyTransactionLineItems_637726045700801476" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_637726045700801476" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637726045700801476" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_637726045700801476" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="us-gaap_RevenueFromRelatedParties_637726045700801476" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637726045700801476" xlink:to="us-gaap_RevenueFromRelatedParties_637726045700801476" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesNoncurrent" xlink:label="us-gaap_AccountsReceivableRelatedPartiesNoncurrent_637726045700801476" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637726045700801476" xlink:to="us-gaap_AccountsReceivableRelatedPartiesNoncurrent_637726045700801476" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AllowanceForDoubtfulAccountsRelatedParties" xlink:label="miro_AllowanceForDoubtfulAccountsRelatedParties_637726045700801476" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637726045700801476" xlink:to="miro_AllowanceForDoubtfulAccountsRelatedParties_637726045700801476" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/DisclosureNetLossPerShareDetails" xlink:type="extended" xlink:title="41301 - Disclosure - NET LOSS PER SHARE (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract_2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_637726045700801476" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_2" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_637726045700801476" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_637726045700801476" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_637726045700801476" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_637726045700801476" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_637726045700801476" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_637726045700801476" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_637726045700801476" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember_637726045700801476" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_637726045700801476" xlink:to="us-gaap_ConvertiblePreferredStockMember_637726045700801476" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_ConvertiblePreferredStockWarrantsMember" xlink:label="miro_ConvertiblePreferredStockWarrantsMember_637726045700801476" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_637726045700801476" xlink:to="miro_ConvertiblePreferredStockWarrantsMember_637726045700801476" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_637726045700801476" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_637726045700801476" xlink:to="us-gaap_EmployeeStockOptionMember_637726045700801476" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_CommonStockWarrantsMember" xlink:label="miro_CommonStockWarrantsMember_637726045700801476" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_637726045700801476" xlink:to="miro_CommonStockWarrantsMember_637726045700801476" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_637726045700811504" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_637726045700801476" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_637726045700811504" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_637726045700811504" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_637726045700811504" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_637726045700811504" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails" xlink:type="extended" xlink:title="414001 - Disclosure - 11401 - Disclosure - SUBSEQUENT EVENTS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract_2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable_637726045700811504" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract_2" xlink:to="us-gaap_SubsequentEventTable_637726045700811504" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis_637726045700811504" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_637726045700811504" xlink:to="us-gaap_SubsequentEventTypeAxis_637726045700811504" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_637726045700811504" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis_637726045700811504" xlink:to="us-gaap_SubsequentEventTypeDomain_637726045700811504" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember_637726045700811504" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain_637726045700811504" xlink:to="us-gaap_SubsequentEventMember_637726045700811504" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems_637726045700811504" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_637726045700811504" xlink:to="us-gaap_SubsequentEventLineItems_637726045700811504" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_AdditionalFundingToBeProvided" xlink:label="miro_AdditionalFundingToBeProvided_637726045700811504" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637726045700811504" xlink:to="miro_AdditionalFundingToBeProvided_637726045700811504" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_637726045700811504" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_637726045700811504" xlink:to="us-gaap_TypeOfArrangementAxis_637726045700811504" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045700821651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_637726045700811504" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045700821651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncollaborativeArrangementTransactionsMember" xlink:label="us-gaap_NoncollaborativeArrangementTransactionsMember_637726045700821651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637726045700821651" xlink:to="us-gaap_NoncollaborativeArrangementTransactionsMember_637726045700821651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_637726045700821651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_637726045700811504" xlink:to="srt_CounterpartyNameAxis_637726045700821651" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_637726045700821651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis_637726045700821651" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_637726045700821651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="tmb-20210930.xsd#miro_UniversityOfMinnesotaMember" xlink:label="miro_UniversityOfMinnesotaMember_637726045700821651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_637726045700821651" xlink:to="miro_UniversityOfMinnesotaMember_637726045700821651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>tmb-20210930x10q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:miro="http://miromatrix.com/20210930"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="tmb-20210930.xsd" xlink:type="simple"/>
    <context id="As_Of_3_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_fmQDXKgxeEiyIStEpmlASQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsCompanyShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_ze4CSI6Mzk-ZR5OI8HnD8w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_b56DfHPV7k2k1IdW58ycBg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_giB21kpH7UCySM-3NM5GMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_XRcRC9vzqUmNSRJaT8OgEQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesB2ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_Ho_LSq9GrEC0Bq3haRfarQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_iKt7zxYygUezKqnAXBiqsQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_P0FovK3_vEmt4Nbg26vc9g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_hOJYsLwUhE-2VMUraYrYJA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesB2ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2021_J4lgZ-q5v02aj1SQxigv9w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesB2ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_jgndyTBo4kmjINCHYzZc9Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_g67rL0VSYUuJLtgWVN02og">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_JwkSx9yECEqsu5y6ZmvOwA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="Duration_6_1_2021_To_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_s5dfWC6rwUCezVcVwV3Tlg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2015_To_1_1_2015_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_us-gaap_TypeOfArrangementAxis_miro_ResearchAndDevelopmentContractMember_6E_wdZQoSUqyfCptlYZBkg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">miro:ResearchAndDevelopmentContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-01-01</endDate>
        </period>
    </context>
    <context id="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Q9R7jNA_kk6E26TVZk6K5Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_BAFNsPfZ306w0rPJrdHROA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_hJm_H_CmaUKQYQsG7Q0bOA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_8YSV2HeTl0O8xWN1mRaSSw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_ReKi1zH93kOF4ZIWEaTZLQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2021_SPtw5tHT3k6JDysLGb0wNw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_UkafvMeDh02ELaaw-wUr5A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_QPA5yoiM3U6iLWS98GAGHw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2021_svAh3vgTQEO6ofy12nzIaw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_skQC9Tm4L068d2CO6DNYuA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_CSxBNgaEF0Os5-o-5D0nNg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_7YsfFYJ7r02IKnkspoVFDQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_IeptdhXZvES-2yRyQFy8qw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_X24d21muVUiqauo73XMZ6Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_USH1GwFq-EuR2zkUYP0bfw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2020_NdUbxN7H60abPZxL_rdgcg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_YGScN6RDoUitB_OqPuCA3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_bCstooZB5EijeOk-sHr8Sw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2020_UOLsCPKKbEmhyF78HT5_XQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_Fqh6xEaMFkaS8jG4_GyGRQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_jD--vlyzLkiWS0X8coG22g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_qsMCAn9EN0mSGkuoU6XYuQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_D8qKF6W_5EqZAfHpIf6RUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_MJo6GylBG0KwIG9o-vIDAA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Ej34jWijlUGaHWWuYVa4Yg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Ujd_JULeH0eOzL9jR9r4VQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Zp8WC33yq0ebMiPW4NZNIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ttLecL7oRkWwB-XxzLao0g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_wKqlw5fr5EWLskUxmEQ3gw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_yAsbjp9bDUazwowV3IQPOg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2019_dei_LegalEntityAxis_miro_RepriseBiomedicalInc.Member_R2d8cn9CGUK8VjOUJnYEwQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="As_Of_1_1_2015_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_us-gaap_TypeOfArrangementAxis_miro_ResearchAndDevelopmentContractMember_Y_meruMSPEO7A3bUcsxnaA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">miro:ResearchAndDevelopmentContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-01-01</instant>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_miro_ExercisePriceOf1.25Member_oooEOJ4y2kee2kSZatqRNg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">miro:ExercisePriceOf1.25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_miro_ExercisePriceOf0.10Member_xehDfIZz-EWtTdFbk8j1fQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">miro:ExercisePriceOf0.10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_tNkW5JyZSEem2SQQAsVb6w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_5_20_2021_To_5_20_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_t8AKALY0zUWWcDB5cdE9FQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-20</startDate>
            <endDate>2021-05-20</endDate>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_9z94lpGqiUK-UGTQzRUXmg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_lHsE8nx05E6MJohdoQuOHw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_2DJ3l3afI0CleWh6XWHWoQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:EquityIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_o6eAWaymy0yRcfbd6hpu6g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_McJXXc_Kf0uPYR-o6Dcyzw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_7_31_2019_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_C6HVYrURKkyIQjOgOtfdLA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="As_Of_12_13_2017_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_6aqbm-JWHUKb0XhszArtdQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-13</instant>
        </period>
    </context>
    <context id="As_Of_8_12_2016_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_bHSdVDHwNkir9pwGVxJShw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-08-12</instant>
        </period>
    </context>
    <context id="As_Of_7_31_2015_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_IOV5CcCN1kafEI0aNGuk7A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-31</instant>
        </period>
    </context>
    <context id="As_Of_3_1_2014_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_B1MdDsK4eU6ABBhy1iHGqQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-03-01</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2013_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_jitbOwlHxEatY3c8sdyT8Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-09-30</instant>
        </period>
    </context>
    <context id="As_Of_6_20_2011_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_p8iI4CpuukSW-_z9m6tgFw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2011-06-20</instant>
        </period>
    </context>
    <context id="As_Of_2_28_2010_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_KR1v8aGoW06UTHLbKbrWzg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:StockOptionPlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-02-28</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_gR2zVN5q-0a1swvGNHwoWw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_9_30_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_2DY7Kr23UEejqlQcdXp2IQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_YBwL7RLuskyd3vBZWh7WQw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_BOZzIx3NHUyi4rOJ8vvwWg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_GGnger605kSAQV-cbnUI1Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_vmM7oFOzwUe43nHIwqu2bA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_cVjMYLi1J0iHUg_2B18WtQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_qnWtgiTGikOSXP25mjvZYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:CorporationOwnedByDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_9WxjyLUpOUiRks_Oq_p5vw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:CorporationOwnedByDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_XueQO35tzkidWpI2arMRfw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:CorporationOwnedByDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_6W4hac0WQU-mcQ8HdTtbAQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:CorporationOwnedByDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_fRxvAQCNO0uRd-IxLvwfDg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_meG4-bg4kUO8x0E1C04Kqw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember_lwr3FLyMikqQkZtq70jcoQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FurnitureFixturesAndComputersMember_S_oUYLkJy06xhe5H4RKyJw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:FurnitureFixturesAndComputersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_eOuiFcUJCEOgeU3oV-a2mw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_jFveJ8RoEEKFIHidVPDl4w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FurnitureFixturesAndComputersMember__gu0MdxH50m20YVzxIH-Pg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:FurnitureFixturesAndComputersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_3_1_2021_To_3_31_2021_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_5uz6xTTzoUS7vZbEYgcwoA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="Duration_6_1_2021_To_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_5Odx1hNFgE-EjIs5X0GrZQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="Duration_6_1_2021_To_6_30_2021_v1CMQoC_MEO53dW7J_nzAA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_YIeLLI8Zuka4IuRCQnSL5A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_oBuuB5uPg0C8wAZV2nRBKg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_ogBGhyb8QkWldjubXwC2ug">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_QSVhaJp0c0qau5mbNttKZw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2020_To_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_pw-r84ndYkSP68XRrV0yTw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_nMl7KbsZzkqXzxdBQILxoA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_EZhNVV5fvEixIfenKVx60Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_lP4_QEOZzE2bhzXyZUrCrQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_qjeQidbY9E2QpOxvv_Bvsg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_on7-uRHX1EqyH81rkRruuw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_7Seab1iWakasudo2xAp8XA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_La1M4nHdNUqTqG0rxpNa8w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_m4hqd27BVkSFna6qz43sIQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_hmQR2sxXt0-QPIS6GgjMrQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_-vxPZ28Xykq2zceJbECjfg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_CthJKcprL0eLenTLOw8F7g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_DTVpyL5NAkWKW7wh4gUxRg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_2TuG7gXboUazxii0VRpqgg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_8sleYqexjESt21JPVmSmbw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_6_30_2019_To_6_30_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_W19jgtfrJ0q1_pcaKF15Lg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="As_Of_11_30_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_2ePGV84R7kOqVJlCe8VRFw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="As_Of_11_15_2020_srt_RangeAxis_srt_MaximumMember_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_GHS7IyK-b0atc14LN7N6WA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-15</instant>
        </period>
    </context>
    <context id="As_Of_11_14_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_Aj4TjkpEqk2FBavVoeElPg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-14</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_1WHSkAXpykyT6aLBtPKDLQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_XGJvV0_cDkeQhRzARKjL8g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_xQEMjYvAV02ThX-j5BQaAQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_27cslPMf0kKYRf5e8pUZUg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2016_To_1_1_2016_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_U8JeOxzzD0Gx5vKq-ysy3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-01-01</endDate>
        </period>
    </context>
    <context id="As_Of_5_1_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_MVZBEzT7O0S0Q0T1zli4Gw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-01</instant>
        </period>
    </context>
    <context id="As_Of_1_1_2016_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_tqLAJsmEVECzNI54zhIGFA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-01-01</instant>
        </period>
    </context>
    <context id="As_Of_12_1_2014_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_6QJUbguDpkyAkL3RR7QOTA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-01</instant>
        </period>
    </context>
    <context id="Duration_6_1_2020_To_6_1_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_0lnUqVT07kOlXfiqqRCW9Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-01</endDate>
        </period>
    </context>
    <context id="Duration_6_1_2020_To_6_1_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_NAJB56TxHEmziVpHGC_jWw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-01</endDate>
        </period>
    </context>
    <context id="As_Of_4_16_2020_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_K_b8S5kNXUi8BLFNMA8rKw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-16</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_ez_THl-rSUu9GNrnq2nCuA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="As_Of_1_31_2019_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithUniversityOfMinnesotaMember_cdcye0WMqEqRbPNdnP1VxQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PromissoryNoteWithUniversityOfMinnesotaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-31</instant>
        </period>
    </context>
    <context id="As_Of_1_31_2012_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_QQnUDFDrzk2Vm5Fpppjj3g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-01-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2010_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_pkNNDT8Wak6IONNfMjjxqg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-12-31</instant>
        </period>
    </context>
    <context id="As_Of_6_23_2021_1kBpKsAjAkafdUqrpHlz-w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <instant>2021-06-23</instant>
        </period>
    </context>
    <context id="As_Of_6_22_2021_jAIYqLNp8kqUDCDCdGqUMQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <instant>2021-06-22</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2018_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_HGDc3Os7mEWTu-CAaq3ruA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:SeriesPreferredWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2018_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_qZGOmr_ea0Ows1t9YaOzcw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="As_Of_1_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsUniversityOfMinnesotaMember_2n5C9faFyUubXOXkidk78w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsUniversityOfMinnesotaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-31</instant>
        </period>
    </context>
    <context id="As_Of_1_31_2012_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsRegentsOfUniversityOfMinnesotaMember_ZXk4sItmP06Wo1dejovXIg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-01-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2020_LW-AR2B-IUCYjTsTG_L0Gg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_gbPT0CGmrE-mrppNChpn0g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_bva1e1NEu0CDDbO2hz_bYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseOctober2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_We8kS0mQrU-z2lQGO0T3dw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseJuly2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_Atsn9P5ITkm9fny6aynNaw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseOctober2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_QDAsoSke6UmzGRrYBpT5Ug">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseSeptember2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_7_31_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_ny50Pi8_jEyfyuCfKjRFVA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseJuly2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="As_Of_10_31_2018_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_gG5hkjufDEyK2-0RVsaTHg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseOctober2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_7_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_1Bh3g4CG70OKdz3TgSxqQg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_hUvKTTEpGkeeRuM5ul5Jjg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">miro:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_nC9T8Rfgokqilo8qcuIGWw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_YiQ5qq1-cUeG-3Hyz5MNuw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">miro:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_GmTrWD189EWwo_du3vbdCQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertiblePreferredStockMember_G2AenK_gbk-ZZfv0d9YO_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_ByAiKa5lkUuPyzg8VR9VHQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">miro:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_idwa40aKQUC_0HjRs6iVKQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertiblePreferredStockMember_Gh_jQ_Q0W02MUqDL5oQyCw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_ConvertiblePreferredStockWarrantsMember_nZXuGpmc3kOiTFiqFvQENQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">miro:ConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_Jdt9LOisJEWDjroNeaE7OA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">miro:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_vdIpyWd9LEaTHDagY0ShUQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_XIKPHQwclUmF18L2ad03-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_A4MlM41kpUeFYHhM3kDtsg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_SBOFqQEpQEyPvYOkIlK1HA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_JGIso0rEp0yd4KJDkgW6xQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_3_31_2021_foKQtmn6f0it35GNZ-xuwQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gkWjeTErEEKrQ1vY2z-omg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2020_To_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_Qm42BmYK-UOKhFqGE3GLXA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2020_To_6_30_2020_NDTiF3J6pE6DAJHe0861mA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_iRO3LslO3kas_t0T5hUdPQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:SeriesPreferredWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_qaXZChAjbUKzlsfIAO2k2w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_ECMqdRae7ESrv1pIfHDKnQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_NJLzPJiJr0KqVC9ODnYXMg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:SeriesPreferredWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_PzoHbCzBmE6ej-n_Qpwy4w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_2H40H7i-ukaCvdguWaUOFw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsCompanyShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="Duration_6_1_2021_To_6_30_2021_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_VeZ4VJDJtkmpGyjtYu7oNw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_1_QI08EAgkeFGMJvDi62nw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DZF78Qgsdk-UpOA4nYZypg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DhADGZrh1EmAAzxwiQhJGw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_3_31_2020_5jHwYW7aQkqXNV2KSw6vaQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6V1pKA0LTEOpb09NqY9M3g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_6_1_2021_To_6_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_eJwJJs9VSkeObpA8PJb8LQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsCompanyShareholderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_B2zSRfZBIkue8c0XT4p-dw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="As_Of_5_20_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_GpP9eDFV_U6tUH14QDYSzA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-20</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_gq9MkhmKcki_IgIkqiLqdA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_w0E9NO5A40-QYiUe_4grhw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_5_20_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_tlUM_j86VUem4H1Fs0WXtA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:EquityIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-20</instant>
        </period>
    </context>
    <context id="Duration_5_20_2021_To_5_20_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_bH9uVGXInE2mfvC2nlVwVA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">miro:EquityIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-20</startDate>
            <endDate>2021-05-20</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_EyrEwEwwC0iERsWsXg8aaw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_5_20_2021_To_5_20_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_iDuQ8yFyEEqVI8V78JY8tg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-20</startDate>
            <endDate>2021-05-20</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_5_1_2021_To_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_2kXm4JqYrUGIQ5XQlQ4tBQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">miro:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="Duration_3_1_2020_To_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_Bn7cHTalvk6YlTP7ftzPRg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_q7UZpcFoxEOYivXSsLQKIA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">miro:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_tRMEi9tWY0-0d3TnCQQhlg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">miro:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_9_30_2020_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_1uLdZHYzVEqRW879bg0kPQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">miro:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_9_30_2020_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_vwuQIzABmEWaeqLv7nnUlg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">miro:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_6_23_2021_To_6_23_2021_nAJYhIVR5k6XfLRbSV0y5A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <startDate>2021-06-23</startDate>
            <endDate>2021-06-23</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_srt_StatementScenarioAxis_miro_Period3Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_SecondFacilityEdenPrairieMember_xF6oO6QCv0CweJW-fgnyeA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">miro:Period3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:SecondFacilityEdenPrairieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_srt_StatementScenarioAxis_miro_Period3Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_rhWhUWLpAkCFncruQK6Agg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">miro:Period3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:FirstFacilityEdenPrairieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_5_1_2020_To_5_31_2020_srt_StatementScenarioAxis_miro_Period2Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_SecondFacilityEdenPrairieMember_XQsUNAY8E0CKMy7vg7p45g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">miro:Period2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:SecondFacilityEdenPrairieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="Duration_11_1_2019_To_11_30_2019_srt_StatementScenarioAxis_miro_Period2Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_A300O00RHU28LyFbFXEpQw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">miro:Period2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:FirstFacilityEdenPrairieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="Duration_2_1_2015_To_2_28_2015_srt_StatementScenarioAxis_miro_Period1Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_P0y2up9X2E6mBHwqP3Cl8A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">miro:Period1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:FirstFacilityEdenPrairieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-02-01</startDate>
            <endDate>2015-02-28</endDate>
        </period>
    </context>
    <context id="As_Of_9_30_2021_srt_CounterpartyNameAxis_miro_UniversityOfMinnesotaMember_us-gaap_TypeOfArrangementAxis_miro_PatentLicenseAgreementMember_jedF-oqTMEuu3qGVMv8CqQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">miro:UniversityOfMinnesotaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">miro:PatentLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="Duration_8_2_2021_To_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_FAYf9bRq1UeMVt01TiNLBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:BuildingResearchAndDevelopmentAndOfficeSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-02</startDate>
            <endDate>2021-08-02</endDate>
        </period>
    </context>
    <context id="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:BuildingResearchAndDevelopmentAndOfficeSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-02</instant>
        </period>
    </context>
    <context id="As_Of_2_28_2015_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_Cl7f8VTFAUeR61K3rR-tWg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">miro:FirstFacilityEdenPrairieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-02-28</instant>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_11_30_2020_To_11_30_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_npnVQruhDkGjzL1UROIouw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-30</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="As_Of_11_15_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_2Sa5NjL2Kk-ibyq3uXUDjQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-15</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_CSoklVBQa02SoJByMzWnzQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_m7wWrzDt8kKqdsrFFqI6Aw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_9_1_2021_To_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_XoFDCEt86EOimiVOhB2Tgw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseSeptember2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2021_To_7_31_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_Jz0WwUyS-E6Z18dHVsppFw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseJuly2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="Duration_10_1_2018_To_10_31_2018_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_OZdwLy5NM0Go4Ki1KftRlw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:CapitalLeaseOctober2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-31</endDate>
        </period>
    </context>
    <context id="Duration_12_1_2015_To_12_1_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_jA_SRrDvgkqJaPnK7QABEg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-12-01</startDate>
            <endDate>2015-12-01</endDate>
        </period>
    </context>
    <context id="Duration_8_6_2021_To_8_6_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_FHW-5iosOkaC1XBwtIzjrw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="Duration_3_4_2021_To_3_4_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_YFZmZWhoU0m7w2SwZnEVSQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-04</startDate>
            <endDate>2021-03-04</endDate>
        </period>
    </context>
    <context id="As_Of_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_KFeJzTMvrEGq3LDu1xCU5Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:NoteCompanyShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_A9qxS9oZnkya-NmJw5L2zg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">miro:LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-05-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_1dorSEZUh0ybHPBVgUSX4A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:SeriesPreferredWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_1_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsUniversityOfMinnesotaMember_MJIM8ECHsEqx2RTxL_0tQg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsUniversityOfMinnesotaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-01-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2012_To_1_31_2012_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsRegentsOfUniversityOfMinnesotaMember_sZ5sdIuCHkukaGha2I_3MQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:WarrantsRegentsOfUniversityOfMinnesotaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-01-31</endDate>
        </period>
    </context>
    <context id="Duration_6_1_2021_To_6_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_Umm_MfnOZUaOKyWI9XnCRg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_3gjNoRIV2UGDPT9hi71nlw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_YDeFWSbjDkOyTwmafCkiqQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_N-QYK6IT_0K6cQJR8rQQUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">miro:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_gQqNjbZf3kitvnDKHNvcqQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_cRCCz2S2j0Sk68z8xyXCTg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_saJtd_zSdkCdwSY-MhYn9A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">miro:PatentAndKnowHowLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">miro:RepriseBiomedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="As_Of_10_31_2021_srt_CounterpartyNameAxis_miro_UniversityOfMinnesotaMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_us-gaap_NoncollaborativeArrangementTransactionsMember_3MpIEZ7k8UW2x-fwsNXB8Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">miro:UniversityOfMinnesotaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:NoncollaborativeArrangementTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_11_11_2021_bEdaa5RP50iWhTuUho5FFw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <instant>2021-11-11</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527096</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <unit id="Unit_Standard_item_dMkQsh8WpkaQAEVQgwXZFA">
        <measure>miro:item</measure>
    </unit>
    <unit id="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_sqft_TVbtuT9o3UCYFiZW5wDD2w">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">
        <measure>shares</measure>
    </unit>
    <unit id="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_Standard_payment_r6kmSj8FdkWHfPCK9l_Ahg">
        <measure>miro:payment</measure>
    </unit>
    <unit id="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_Standard_class_iV0uheBxPk-h-k5jyvqyzg">
        <measure>miro:class</measure>
    </unit>
    <unit id="Unit_Standard_customer_oBpQWOLWXkK3Il-nSeGoKQ">
        <measure>miro:customer</measure>
    </unit>
    <unit id="Unit_Standard_shareholder_EnWQEbPDAka0m--RoRqebg">
        <measure>miro:shareholder</measure>
    </unit>
    <unit id="Unit_Standard_agreement_od-gDHq4Z0WVrTpltuYtzw">
        <measure>miro:agreement</measure>
    </unit>
    <unit id="Unit_Standard_Vote_5PNXDYCebUiYVCiCDg0ocw">
        <measure>miro:Vote</measure>
    </unit>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      id="Hidden_a3dZYnuF80uCmmcOGnAHdg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      id="Hidden_8IARyE5qLU6M9kDYiwZ6Nw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Hidden_Aa8SLdhSCEmHjN0NIXjQTg">http://fasb.org/us-gaap/2021-01-31#LicenseMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      id="Hidden_Jg-kJ7EoyEe8QiseRbAy9g">http://fasb.org/us-gaap/2021-01-31#LicenseMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      id="Hidden_NtwjgHBUbE6ggkKaDV2M7w">http://fasb.org/us-gaap/2021-01-31#LicenseMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      id="Hidden_FVobFD_ldkmQEKAnaRHG_w">http://fasb.org/us-gaap/2021-01-31#LicenseMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Hidden_3Z1TCFvbYESFeSplnZ2XZQ">http://fasb.org/us-gaap/2021-01-31#LicenseMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      id="Hidden_m9qCGqblck2nOBvfto9KFA">http://fasb.org/us-gaap/2021-01-31#LicenseMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      id="Hidden_rWrUtBmjtk-Ptlvu5g_p0Q">http://fasb.org/us-gaap/2021-01-31#LicenseMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      id="Hidden_yd-2sSkQ2E62uxjYMXKFvA">http://fasb.org/us-gaap/2021-01-31#LicenseMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="2"
      id="Hidden_I4VPS8bWE0WnUenLiYZkQw"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">-0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="2"
      id="Hidden_8yC7k7zXREiHVz3catFFWA"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">-1.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="2"
      id="Hidden_qMPm0a8gzUeNb9ssrLV5OA"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">-1.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="2"
      id="Hidden_66drd2pNjES43DZ-at97TQ"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">-4.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Hidden_fvJrsBFr1E2lunLbPO2EXw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">20145321</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Hidden_iP19vIz9-USU7gCXl-FY3Q"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2183322</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Hidden_nzRDPD1O80mQadrXfO_6qA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">8503743</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Hidden_CcWn9M-hb0yP9KhyA0Paww"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2158632</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_XRcRC9vzqUmNSRJaT8OgEQ"
      decimals="INF"
      id="Hidden_A19XiktScUSoIq3tNHnEPg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_XRcRC9vzqUmNSRJaT8OgEQ"
      decimals="INF"
      id="Hidden_U4StnGehukefsbxQPJkgtA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_giB21kpH7UCySM-3NM5GMA"
      decimals="INF"
      id="Hidden_e9vz8cVU5kOiNrHdxSP9lA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_giB21kpH7UCySM-3NM5GMA"
      decimals="INF"
      id="Hidden_ITvLAd6LUU6dorEH8hxqzQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_b56DfHPV7k2k1IdW58ycBg"
      decimals="INF"
      id="Hidden_qLigljAiDEeLWxvU7929eQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Hidden_95DdDuScoU63qH12JU9kvw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">20254645</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="INF"
      id="Hidden_okO5EGoGLke5FxP0c_-aoA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2185822</us-gaap:CommonStockSharesOutstanding>
    <dei:EntityCentralIndexKey
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tc_4apVpxyyf0KAUm-lEdwxlA_2_1">0001527096</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tc_y1WOUxeSPEKd7O_fZQYHGQ_3_1">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tc_6rF0RqVjrESmovi7QBmGcg_4_1">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tc_Z7LPQf0gFE25EeYZ6HlVPQ_5_1">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tc_V6jF4MnDBECTb5NrYH-Uaw_6_1">false</dei:AmendmentFlag>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ"
      decimals="INF"
      id="Hidden_vz2qWyZfgEqnJs_vv-BXMg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2095874</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w"
      decimals="INF"
      id="Hidden_AXJ02AwWXEOrPkGjAArO4A"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3218282</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_b56DfHPV7k2k1IdW58ycBg"
      decimals="INF"
      id="Hidden_9PlECnxOG0GNJW38iWPKbQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg"
      decimals="INF"
      id="Hidden_9o88EG-w5E-Zb117OIqlQA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3000380</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA"
      id="Hidden_Hm1nq61nbUCGgQMTKFG8ew">P12M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="INF"
      id="Hidden_GdaMreGh4UWpAbI1JPGEhQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2185822</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Hidden_WX4Ga6iaZ02G6yjt970rOA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">20254645</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Hidden_DNi9Vf20okCb087fMwdOZw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:PreferredStockSharesOutstanding>
    <miro:AllowanceForDoubtfulAccountsRelatedParties
      contextRef="As_Of_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_gQqNjbZf3kitvnDKHNvcqQ"
      decimals="0"
      id="Hidden_2po9q6YWxEaI543p-8A5uQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">803404</miro:AllowanceForDoubtfulAccountsRelatedParties>
    <miro:AllowanceForDoubtfulAccountsRelatedParties
      contextRef="As_Of_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_saJtd_zSdkCdwSY-MhYn9A"
      decimals="0"
      id="Hidden_Q7GTX4o5nEWWyrC9lnCvQw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">343672</miro:AllowanceForDoubtfulAccountsRelatedParties>
    <miro:AllowanceForDoubtfulAccountsRelatedParties
      contextRef="As_Of_12_31_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_cRCCz2S2j0Sk68z8xyXCTg"
      decimals="0"
      id="Hidden_V19YDa0XdUuAk6nk7v2a7g"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">453470</miro:AllowanceForDoubtfulAccountsRelatedParties>
    <dei:DocumentType
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_E2ZN_yMlAkCjwB3d6nlYBQ">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_9rOUUdR-wEy2tyo3fLyRiA">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_DE5tMjd1IEil80jzy7tZvw">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_2JE5kTFxrEyeLDnXOCEEDA">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_jDLr5yNPska5SvVhKp2T-w">001-40518</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_HjwAbCbGY02IpW3tMcS5xA">Miromatrix Medical&#160;Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tc_N1wjOkKIME21zeOwiKsXYg_1_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tc_WDLn0VdO7EqPUQPNMODBrg_1_1">27-1285782</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_27gtKxmlIUqVuRnLeyf_bg">10399 West 70th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_KU2zp-F8IE-4YdOh_PzSlw">Eden Prairie</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_a9DEEijDmEWYXlez-N2GdA">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_fTpLC27JLU6iV4oBHGOuKg">55344</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_BNuuacAn902ljKP8qDEaKQ">952</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_0u7q7v1F3ESE-gNZCnKLgQ">942-6000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_IKJtwMvbvEyaHIHgPAC0ZQ">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tc_ToIVqIlsD0iuSZc0vIsY3Q_2_1">MIRO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tc_oYjbL10xj0GCfxcY-xd9MA_2_2">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_dCzXX4frC06BOiVxCX82xQ">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_2CQN6J004kywi3KxV-WB8w">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tc_Q2br1jl2Pku895aEoTuu1A_3_0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tc_mR_ar6dFqk6dR-f6TqCbAg_3_3">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tc_fpau0F9jqUabB1Kx0C_l8Q_3_5">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_5BVUbaHTGkatfT5JF3dAEw">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_LghKAs_pwUeMoMbsvSwhpw">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="As_Of_11_11_2021_bEdaa5RP50iWhTuUho5FFw"
      decimals="INF"
      id="Narr_J5ejU1HJ4U-XVYMgRtt16g"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">20254645</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_JdC2Bm4cOkSOZtcMQ9sJsA_7_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">62087678</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_ThZFrjbGr0Gk4wXoz5MVSA_7_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">4444395</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_lCGY4R5q7Uu7qNHZ8iVpNA_8_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">9819</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_n-7gAxOM9kmK-_f4Ttkazw_8_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">15202</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:GrantsReceivableCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_z6xmWFSCJUGB8dHqCRjFkg_9_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">115530</us-gaap:GrantsReceivableCurrent>
    <us-gaap:GrantsReceivableCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_8fvYpwGMR0eVbw3JdVTpRQ_9_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">100000</us-gaap:GrantsReceivableCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_DuWbATjm_Eu16fPjOOM2VA_10_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">334310</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_sOxWj4fxeEinIDjqMZe3IQ_10_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">130576</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_6tvybIUy0EO2bpn59cTQzw_11_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">62547337</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_exicNHfsP0atF_LXeiB9TQ_11_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">4690173</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_pwAxuehDeEi-lJ42aREgog_12_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1678648</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_wvzftnQB30SkyJ4pdq8qeg_12_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">324534</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:EquityMethodInvestments
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_PL4KoK9zckygIxzVYGxdoQ_13_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">239721</us-gaap:EquityMethodInvestments>
    <us-gaap:Assets
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_CAjukAOZTE6KbMOopnBv-A_14_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">64225985</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_ntwOiMhMzkmFTmEr4LDlNw_14_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">5254428</us-gaap:Assets>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_XF2YLgX2gUCN3I4M8qxK4Q_17_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">386161</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_hqZMq2QJzkmnX5eQvV_lXQ_17_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6413733</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_7_ci4tnWYU-BnaU4VqRQuA_18_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1249259</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_-BhswkUqlU6r-Fataf_ktw_18_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">130160</us-gaap:AccountsPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_F4dteZ9PfE6MVcSkQabOPA_19_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">612705</us-gaap:InterestPayableCurrent>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_mBaeS1lCfE6RiTwZTwjC1g_20_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">246962</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_5Hyqed0Q_UW_hhjXXwB6qw_21_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1922617</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_M2RpYVz1uEylMunl8SzjLw_21_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">760889</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_as-qnpGpME-foHV_2mLmAw_22_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">3558037</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_vMKj-KQ5EEadO7KUGjwGLQ_22_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">8164449</us-gaap:LiabilitiesCurrent>
    <miro:AccruedRoyaltiesNoncurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_DkqvHKwae02QY45mYsHSzw_23_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">857101</miro:AccruedRoyaltiesNoncurrent>
    <miro:AccruedRoyaltiesNoncurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_y50ajNj5VEGhcaa_txCkXw_23_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">488368</miro:AccruedRoyaltiesNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_O8lt4WPYfUSa_qkgkHnqGw_24_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">478766</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_EKKTShjh2Ui5un6myfn4vQ_24_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">928623</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <miro:InterestPayableNoncurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_w5k9wEtU-0yplgiInM6k8g_25_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">65032</miro:InterestPayableNoncurrent>
    <miro:InterestPayableNoncurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_HYC59kvd1EiFN8aVdEDo5w_25_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">45691</miro:InterestPayableNoncurrent>
    <us-gaap:Liabilities
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_SELLcu1znUGeztI0MSLeew_26_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">4958936</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_9eco0mj2dEajPJIW3XsGng_26_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">9627131</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ"
      decimals="INF"
      id="Narr_0SKrW4469k69jRFZY_JRrA"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">0.00001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_XRcRC9vzqUmNSRJaT8OgEQ"
      decimals="INF"
      id="Narr_EFeAtuIil0-xQoHBuvtyzw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ"
      decimals="INF"
      id="Narr_MR5rhiy1oUOUsgBJQlu4Hg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2500000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ"
      decimals="INF"
      id="Narr_N5BKvma4I0ilxH8Dcr1wsg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2095874</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_XRcRC9vzqUmNSRJaT8OgEQ"
      decimals="0"
      id="Narr_fdtzR9odi0Kz_rB2uSBldA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ"
      decimals="0"
      id="Narr_XIMAlcxBg0CwW3LK6ckacw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">15719055</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ"
      decimals="0"
      id="Tc_V327DxGIck2E55tDucNfIw_29_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">15670097</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w"
      decimals="INF"
      id="Narr_I_YIztCeWEuSzS3DXImn8g"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">0.00001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_giB21kpH7UCySM-3NM5GMA"
      decimals="INF"
      id="Narr_m6aXntvrT0u4PiE9rZR7Ug"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w"
      decimals="INF"
      id="Narr_Y61d4q46KEWVKGqCVHlfwQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">4000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w"
      decimals="INF"
      id="Narr_m6UFXLO0E0G8Y6e8w_9EpA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3218282</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_giB21kpH7UCySM-3NM5GMA"
      decimals="0"
      id="Narr_ZIQsIJTwskurg_VFqwePbg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w"
      decimals="0"
      id="Narr_3pCBc4242UufuZD0ee4Abw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">24137115</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_k4zR9HiJakmMXHPsxbPO5w"
      decimals="0"
      id="Tc_qwjBlbmhAkieuCM6JxTh6A_30_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">23865732</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg"
      decimals="INF"
      id="Narr_dtxJ23urp0eOlbSqu0xgnQ"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">0.00001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_b56DfHPV7k2k1IdW58ycBg"
      decimals="INF"
      id="Narr_O8Fgnl6ZdUKanj3rnsrY_Q"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg"
      decimals="INF"
      id="Narr_QuU1Tx5_iUmSEZK4eXbi7w"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3300000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg"
      decimals="INF"
      id="Narr_86LTHXJM60OhcMGGQI-H0A"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3000380</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_b56DfHPV7k2k1IdW58ycBg"
      decimals="0"
      id="Narr_GvC7vWtGx0qX3SF0jlFQKg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg"
      decimals="0"
      id="Narr_cRJHB6212kWlpQt_up5duw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">7500950</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_nM1XOYiEKkm6AJis69VxVg"
      decimals="0"
      id="Tc_1gSgEppYRki3DUfQYBSWmA_31_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">7125661</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Narr_S7NuntstEESB_pv6Z74wfQ"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="INF"
      id="Narr_lzprEsdEB0yMRw5Wg6dOhg"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Narr_Xo1bmdb-2E-wQg83LSzbWw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">190000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Narr_pBXkRR0fUUiefjIWDk4YFw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">20254645</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="INF"
      id="Narr_WD_uqxXlsU-zAL0z1OwVAQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">30000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="INF"
      id="Narr_iCeaex4B9ECjimXj4GFPfA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2185822</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_6csO5B6Xj0Sl7ZVvLGVoBQ_33_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">202</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_CrTn3k02CkO0VxZDwgvh3g_33_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">22</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_wqPpn_8XjE2uUmaeFCvGHQ_34_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">127842762</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_zdBcJS5oV06zaFKXHDpJOQ_34_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">8346943</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_vp8Ox2iS9kSb5AuC_sMNkQ_35_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-68575915</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_2kgYWSEAd0albqcxuDaJbg_35_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-59381158</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_j4awgVUuuEOH4zOiFLDg1Q_36_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">59267049</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_qF-xZ7ECJ06ctpwdCqy4qQ_36_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-51034193</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_CoPRdbbXvkmB28JMrNc3wQ_37_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">64225985</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_CavV-gY9pkuERrKq9tbiuA_37_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">5254428</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_9y3u4CTlS0iWutnfWAq6Aw_5_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">9819</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_DDZPfiAjXkOSQDbzBSBRnw_5_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">10846</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_VvGZXhHxY0ytbunZ_6jR3g_5_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">25066</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_uGxJIzqZDEmMIB-HXUOHGQ_5_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">31328</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_R6diytMZt0Ocl1m5OTaNiw_6_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">125000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_sAVq3PMy9U-8nW-b5D2M2g_6_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">125000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_xwa6-nr1GU-p0I1cp-6Uyg_6_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">375000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_tBQiydMvBUqDsp6nvPgq4w_6_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">375000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_ttqZaR_6gkquy8EP1pbDEw_7_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-115181</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_NuTJXjoyCkaTN05YLtrAeQ_7_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-114154</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_AchSD9KF6UqGwAAPKrAICg_7_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-349934</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_1UWncQ5xnUO8OwZsmzlY9g_7_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-343672</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_TDxKBQi41k-Dfs_QKLrjPA_9_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">3349898</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_GDYDLKHoOUq9JmkF7891UA_9_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1870039</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_nm7O5RzqQUOA91tfu1jUqg_9_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">7698786</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_XXpEbrXCLE6kIqmbbf3QQQ_9_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">5750320</us-gaap:ResearchAndDevelopmentExpense>
    <miro:RegulatoryAndClinicalExpense
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_X_9gJ2q5N0u1Hon2yneOBg_10_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">105208</miro:RegulatoryAndClinicalExpense>
    <miro:RegulatoryAndClinicalExpense
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_mNglrMfkSkqVpoXuJiVClg_10_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">64083</miro:RegulatoryAndClinicalExpense>
    <miro:RegulatoryAndClinicalExpense
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_eKyvPvnnb0mz77OA7pL07Q_10_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">292169</miro:RegulatoryAndClinicalExpense>
    <miro:RegulatoryAndClinicalExpense
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_tbRjxgMJP0uDybQnXsGq8w_10_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">208276</miro:RegulatoryAndClinicalExpense>
    <miro:QualityExpense
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_zcPwh5DErE6WwMVrgQs72A_11_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">150675</miro:QualityExpense>
    <miro:QualityExpense
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_StHsCqPuAkapX6M1eZGctg_11_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">75850</miro:QualityExpense>
    <miro:QualityExpense
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_LPDcP5EzAEO6xPms7OhaAQ_11_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">322719</miro:QualityExpense>
    <miro:QualityExpense
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_BTQImFOZt06yXETPvOZ0RQ_11_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">75850</miro:QualityExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_QM_-YeKc8Ee10U9cq4-FCA_12_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1487654</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_9oFvbCK0xEanA2K8oQxCfg_12_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">460105</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_TlMuAmYovkW7obMKmuT3Aw_12_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">2836850</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_4Z99Tkoj3EasGglZzOz_aA_12_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1530915</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_yKpKTWHVGk2_RZjjOPjOrA_13_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">5093435</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_zGI174JTmE6IQfCi5A2gwg_13_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">2470077</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_xWuDJxYCpk-TScV9hMk_AA_13_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">11150524</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_0W0_PFaXiUeOF80KQ-l2Hw_13_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">7565361</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_cfsaa4mLgUy5lHuuYwi2nQ_14_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-5208616</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_g7Egj-pQj0qGcBFT8cG2eg_14_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-2584231</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_DOugF10Ll060zP3oE5CJcg_14_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-11500458</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_wWQFanZC7EGiDtxbUgy9qw_14_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-7909033</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_zdsjsFQd30ScgSvAiqA3kA_15_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">766</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc__u6FZoTPHkmEaKtZgDzJWg_15_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">94</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_8MXObQh4QEi5XlIPaUZ4ng_15_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">851</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_MInOyD9QxU6AvlYSsMw9gw_15_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">8683</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_I8r0hSOoNk-aUJ5r0Hhexg_16_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">15255</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_IIbH9ZMNDUKTdajFfk-KvQ_16_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">208926</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_R99D81Q4wUSbtoVLWbmRrg_16_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">601292</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_nCp1x_qcCEuav1NVJly9JQ_16_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">363444</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_CfTd-G6qY0OrmXE1LqdayA_17_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">32586</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_cfMxTJ4_rESEtNnQT85Z8g_17_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">62638</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_7ItGDp_x902ZPQuAZ8BUjA_17_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">76034</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:EmbeddedDerivativeGainOnEmbeddedDerivative
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_kYQDwGoNR0-WJoiFt_EUjg_18_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">246962</us-gaap:EmbeddedDerivativeGainOnEmbeddedDerivative>
    <miro:ResearchGrants
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_svuz1j8Y9ESZOh8gLKayGA_19_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">115069</miro:ResearchGrants>
    <miro:ResearchGrants
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_rS_8_2K-tE-zHRGVSCjXQg_19_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">328424</miro:ResearchGrants>
    <miro:ResearchGrants
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_A2LvEOCqDE-_0Xyl0qycdg_19_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">393034</miro:ResearchGrants>
    <miro:ResearchGrants
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_A155qoRaaEyrX3r-KuymRg_19_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">794291</miro:ResearchGrants>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_jN0vIg6BNkejw6ZOMHQ_kA_20_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-495000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_TmKyrm5rgUSIZx_oZ6nInA_20_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-223633</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_5sL98mJzc0W9mwC3k4iO1A_20_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-1676000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_Rpt_qyp7hEC4jkCazlxNcw_21_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1983912</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_sBI0VIS78kqMe4EsvDknbw_22_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">50455</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_1m2ssYZmMkWa_BO-eZ0BcQ_22_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">568505</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_khnr9XOkEEKJEcV1M_NCVw_23_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-5057581</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_F2SuwBuUakiqLBDqDjBjVQ_23_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-2992225</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_NPzIdUuK-0OTyZoqMfG3jA_23_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-9194757</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_8sQX3vM6ek68TxLYxFqD6g_23_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-9221537</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="2"
      id="Tc_GXVLYXXyX0m59KGcGJL6Bw_24_3"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">-0.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="2"
      id="Tc_Os4-omp0wEqe5X99GSWM_Q_24_6"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">-1.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="2"
      id="Tc_ZIFKNJIsNkqCankCYipKug_24_9"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">-1.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="2"
      id="Tc_1gB946Tds02abPO1hzlLbA_24_12"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">-4.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_NUv_r9LsTECKFtQWfagf4A_25_3"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">20145321</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_NRczvRsB1E6frI8WteySOA_25_6"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2183322</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_yEQ01RfS6EuyhP5pGXiHbA_25_9"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">8503743</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_fkwLLyaxT0W7a1t-4YPulA_25_12"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2158632</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Ej34jWijlUGaHWWuYVa4Yg"
      decimals="INF"
      id="Tc_1dJ9YEtwq0GKUHPBhvKvrA_4_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2185822</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Ej34jWijlUGaHWWuYVa4Yg"
      decimals="0"
      id="Tc_e5J9wQEbwk2CwRyqDRF3-A_4_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">22</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_CSxBNgaEF0Os5-o-5D0nNg"
      decimals="0"
      id="Tc_8At6nacWREqHFoxRclerBw_4_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">8346943</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_skQC9Tm4L068d2CO6DNYuA"
      decimals="0"
      id="Tc_GMMOAPugFkG5tjVAyWj9zw_4_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-59381158</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_xu-kmwc11U6rBG2uQyoAFg_4_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-51034193</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_JGIso0rEp0yd4KJDkgW6xQ"
      decimals="0"
      id="Tc_pAc7JCu2eki_KaDj4CQYvw_5_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">133451</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_1_1_2021_To_3_31_2021_foKQtmn6f0it35GNZ-xuwQ"
      decimals="0"
      id="Tc_4mekugnTTU23N0G5rFwIzQ_5_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">133451</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_g67rL0VSYUuJLtgWVN02og"
      decimals="INF"
      id="Tc_CqpYDSjQFk6sx7Ej_WC2-w_6_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">105000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_g67rL0VSYUuJLtgWVN02og"
      decimals="0"
      id="Tc_8F0gTUeNSkG-z1RwtDPUvw_6_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_JGIso0rEp0yd4KJDkgW6xQ"
      decimals="0"
      id="Tc_y9pgV0HGJECele8ufSMWvA_6_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">28749</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2021_To_3_31_2021_foKQtmn6f0it35GNZ-xuwQ"
      decimals="0"
      id="Tc_rlWBBwLcxk-PHhoDkoZfPw_6_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">28750</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_ogBGhyb8QkWldjubXwC2ug"
      decimals="0"
      id="Tc_mhbn-3XD00Snfafjvy0Xyg_7_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-434342</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_3_31_2021_foKQtmn6f0it35GNZ-xuwQ"
      decimals="0"
      id="Tc_LTLW3leDxk-kMysQ3Gm2Fw_7_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-434342</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_MJo6GylBG0KwIG9o-vIDAA"
      decimals="INF"
      id="Tc_lskt-gZVGE--Yg-hdngqXA_8_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2290822</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_MJo6GylBG0KwIG9o-vIDAA"
      decimals="0"
      id="Tc_o-zyS9eHkESjg3oXiEY7jA_8_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">23</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_QPA5yoiM3U6iLWS98GAGHw"
      decimals="0"
      id="Tc_1r8kfDbMCk20zDOUqfq_CQ_8_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">8509143</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_UkafvMeDh02ELaaw-wUr5A"
      decimals="0"
      id="Tc_NdOl53KgxEuakaACLDWtaw_8_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-59815500</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2021_svAh3vgTQEO6ofy12nzIaw"
      decimals="0"
      id="Tc_WX7RhkXZ20y4CnhkLRLRcw_8_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-51306334</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w"
      decimals="0"
      id="Tc_7iO8l67XP02l74Sx_B1_Kw_9_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">105879</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg"
      decimals="0"
      id="Tc_XOTEoURsIU66iYHV00Tm2A_9_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">105879</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q"
      decimals="INF"
      id="Tc_OZl602-k9EOtgzye9p2fKQ_10_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">58750</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q"
      decimals="0"
      id="Tc_1U3bxAwJg0izfOHap695gA_10_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w"
      decimals="0"
      id="Tc_ZQ-ogcnPuEe4AvYCUVK5gg_10_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">5874</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg"
      decimals="0"
      id="Tc_TeMFj0h9H0qCqBzWQUhHsQ_10_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">5875</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <miro:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q"
      decimals="INF"
      id="Tc_kZBfqtT_60uS2PEA8L0QBQ_11_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">65909</miro:StockIssuedDuringPeriodSharesWarrantsExercised>
    <miro:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w"
      decimals="0"
      id="Tc_Z_WlMx3MukG2odLaI4DT-w_11_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6250</miro:StockIssuedDuringPeriodValueWarrantsExercised>
    <miro:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg"
      decimals="0"
      id="Tc_L7k7sv-WcUmPcnvtOzPxNQ_11_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6250</miro:StockIssuedDuringPeriodValueWarrantsExercised>
    <miro:StockIssuedDuringPeriodSharesConversionOfPreferredStock
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q"
      decimals="INF"
      id="Tc_n_bBQB2v702QYhpc0QQ0jg_12_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">11092314</miro:StockIssuedDuringPeriodSharesConversionOfPreferredStock>
    <miro:StockIssuedDuringPeriodValueConversionOfPreferredStock
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q"
      decimals="0"
      id="Tc_lvbtvemcyEeR5y4LVrMaHQ_12_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">111</miro:StockIssuedDuringPeriodValueConversionOfPreferredStock>
    <miro:StockIssuedDuringPeriodValueConversionOfPreferredStock
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w"
      decimals="0"
      id="Tc_xreZnSIFiUmK1jf4s4KbCg_12_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">66553049</miro:StockIssuedDuringPeriodValueConversionOfPreferredStock>
    <miro:StockIssuedDuringPeriodValueConversionOfPreferredStock
      contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg"
      decimals="0"
      id="Tc_W4elq_10q0my0JWvBfucvQ_12_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">66553160</miro:StockIssuedDuringPeriodValueConversionOfPreferredStock>
    <miro:StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q"
      decimals="INF"
      id="Tc_xN0asDbjq0O5aOysijZbXA_13_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">996757</miro:StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest>
    <miro:StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q"
      decimals="0"
      id="Tc_NKzskZ_PdEumn5DNfRd5mA_13_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">10</miro:StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest>
    <miro:StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w"
      decimals="0"
      id="Tc_yYauVxQY6kWnqP8kMWFuOw_13_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">7152389</miro:StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest>
    <miro:StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest
      contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg"
      decimals="0"
      id="Tc_g6hSF_eXFkW78Sa91j_Zgw_13_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">7152399</miro:StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q"
      decimals="INF"
      id="Tc_byLA0Ng5tEOMdAaXM31bIw_14_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">5520000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6y5Oic4zjkmsn2dDtQd0_Q"
      decimals="0"
      id="Tc_NYn-v-JCLkWJAYowBOdd0Q_14_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">55</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_h6ZN-uRh0E2Xzwe93Dj-3w"
      decimals="0"
      id="Tc_PTIoWte65kWaSqgln2FoDA_14_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">44593631</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg"
      decimals="0"
      id="Tc_GJFktKcSCkaJ7UR4XkHC-g_14_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">44593686</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_4_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_oBuuB5uPg0C8wAZV2nRBKg"
      decimals="0"
      id="Tc_z0GMWus_j0msrQ9LZr-Wsg_15_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-3702834</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_4_1_2021_To_6_30_2021_tOw951eVwEC-1JdaLd01Vg"
      decimals="0"
      id="Tc_i5Mc8dZyZUWe4QI1um9IpA_15_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-3702834</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_D8qKF6W_5EqZAfHpIf6RUw"
      decimals="INF"
      id="Tc_NKl9OLLqa0uNntBXmrPZzg_16_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">20024552</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_D8qKF6W_5EqZAfHpIf6RUw"
      decimals="0"
      id="Tc_fERF5PMqeUq2qV_iuri5wg_16_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">200</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_ReKi1zH93kOF4ZIWEaTZLQ"
      decimals="0"
      id="Tc_Suoj_JbTC0GzWF0yRbIBww_16_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">126926215</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_8YSV2HeTl0O8xWN1mRaSSw"
      decimals="0"
      id="Tc_W-PkikEA-kydJH3LKdk4cw_16_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-63518334</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2021_SPtw5tHT3k6JDysLGb0wNw"
      decimals="0"
      id="Tc_Kg59qmWuVUW9X67bB_ULdQ_16_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">63408081</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DZF78Qgsdk-UpOA4nYZypg"
      decimals="0"
      id="Tc_NfI23UTiUkWLMfCeBknD0A_17_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">144969</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_STKRDcEyCUyborZvQ-x-qA_17_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">144969</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <miro:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6V1pKA0LTEOpb09NqY9M3g"
      decimals="INF"
      id="Tc_FNrc_1uwyU6IHftAN4peMA_18_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">11977</miro:StockIssuedDuringPeriodSharesWarrantsExercised>
    <miro:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DZF78Qgsdk-UpOA4nYZypg"
      decimals="0"
      id="Tc_TisWagc6vE6bC8KDJL_NHQ_18_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">2725</miro:StockIssuedDuringPeriodValueWarrantsExercised>
    <miro:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_g3EWDwojhkuxwNMZ5HTGyg_18_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">2725</miro:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6V1pKA0LTEOpb09NqY9M3g"
      decimals="INF"
      id="Tc_UUUQZf4GFUWB7WGCZ5QrcA_19_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">218116</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_6V1pKA0LTEOpb09NqY9M3g"
      decimals="0"
      id="Tc_kNDjjYjixEWtxMpUgeb3gw_19_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">2</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DZF78Qgsdk-UpOA4nYZypg"
      decimals="0"
      id="Tc_uPSFI8iyhk6iA8X9TOzaow_19_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">768853</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_8cjIwKIrk0eMykN5VWAPlg_19_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">768855</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_YIeLLI8Zuka4IuRCQnSL5A"
      decimals="0"
      id="Tc_whMPaAOI90uaSsFXLUGgng_20_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-5057581</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Tc_1KIcqhuP8k2rApK1-DGAZA_20_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-5057581</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_qsMCAn9EN0mSGkuoU6XYuQ"
      decimals="INF"
      id="Tc_Slfjg2D_AUCwi1pS4QUv_A_21_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">20254645</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_qsMCAn9EN0mSGkuoU6XYuQ"
      decimals="0"
      id="Tc_my52tBAf7Uyuxq2gFt4VIA_21_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">202</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_hJm_H_CmaUKQYQsG7Q0bOA"
      decimals="0"
      id="Tc__4v5tkUC80W9P8Kq2qUf6A_21_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">127842762</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_9_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_BAFNsPfZ306w0rPJrdHROA"
      decimals="0"
      id="Tc_WAK7RNn7iE-ETWfifPm2tw_21_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-68575915</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_H2H46lZltEeGO0jkbFTJfg_21_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">59267049</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_wKqlw5fr5EWLskUxmEQ3gw"
      decimals="INF"
      id="Tc_IHUKu1p3yEafeVOJ6PfjVA_4_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2075822</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_wKqlw5fr5EWLskUxmEQ3gw"
      decimals="0"
      id="Tc_6attWkLkMEmWm7gTW-XsXA_4_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">21</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_jD--vlyzLkiWS0X8coG22g"
      decimals="0"
      id="Tc_8jqglSJCukOQBuNeVlgaSA_4_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">7638190</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_Fqh6xEaMFkaS8jG4_GyGRQ"
      decimals="0"
      id="Tc_pnkY7obhWEa9TDeaX7PZ7w_4_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-49071590</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_gbPT0CGmrE-mrppNChpn0g"
      decimals="0"
      id="Tc_cIDyA4OpH0ilTLFich6GaQ_4_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-41433379</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DhADGZrh1EmAAzxwiQhJGw"
      decimals="0"
      id="Tc_CY3EaMnD40W3NkG1s7Pcrw_5_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">157398</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_1_1_2020_To_3_31_2020_5jHwYW7aQkqXNV2KSw6vaQ"
      decimals="0"
      id="Tc_v34nimvZb0KAw6cr7b8QZA_5_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">157398</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <miro:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DhADGZrh1EmAAzxwiQhJGw"
      decimals="0"
      id="Tc_jDk_UCaRLEy2OmWh3mzXnQ_6_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">56250</miro:StockIssuedDuringPeriodValueWarrantsExercised>
    <miro:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="Duration_1_1_2020_To_3_31_2020_5jHwYW7aQkqXNV2KSw6vaQ"
      decimals="0"
      id="Tc_m_4ef5m7xEu2jT0vXRMhdw_6_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">56250</miro:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_JwkSx9yECEqsu5y6ZmvOwA"
      decimals="INF"
      id="Tc_AyZ5PNMD8U2TBmp1ZsauHw_7_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">62500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_JwkSx9yECEqsu5y6ZmvOwA"
      decimals="0"
      id="Tc_lKMgCrQXAUaZjk9zOPBc1w_7_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DhADGZrh1EmAAzxwiQhJGw"
      decimals="0"
      id="Tc_XcCkDlo5LkyLtEBioV9OWA_7_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6249</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2020_To_3_31_2020_5jHwYW7aQkqXNV2KSw6vaQ"
      decimals="0"
      id="Tc_C_J9eFYV_kGCtR-BFahDaA_7_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6250</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_nMl7KbsZzkqXzxdBQILxoA"
      decimals="0"
      id="Tc_nY5qQNQ0DEapmrn7PU0J_Q_8_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-2956233</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_3_31_2020_5jHwYW7aQkqXNV2KSw6vaQ"
      decimals="0"
      id="Tc_dsKzSIZ1MUWmsndskl_ClQ_8_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-2956233</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ttLecL7oRkWwB-XxzLao0g"
      decimals="INF"
      id="Tc_0IKNz0NOYUG5sXxg_vKbVw_9_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2138322</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ttLecL7oRkWwB-XxzLao0g"
      decimals="0"
      id="Tc_CDHPdWLB_E2GFmsJo-by2g_9_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">22</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_bCstooZB5EijeOk-sHr8Sw"
      decimals="0"
      id="Tc_rCbzJw3_0U63JyrwYZTrBw_9_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">7858087</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_YGScN6RDoUitB_OqPuCA3A"
      decimals="0"
      id="Tc_YhVIjZHyd06-Nb_b9pt7gA_9_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-52027823</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2020_UOLsCPKKbEmhyF78HT5_XQ"
      decimals="0"
      id="Tc_ANLsIy6yRU2Hy_unNT_b6A_9_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-44169714</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_4_1_2020_To_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_Qm42BmYK-UOKhFqGE3GLXA"
      decimals="0"
      id="Tc_CB4GVJV9Rki3sFt8CjjPMg_10_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">157398</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_4_1_2020_To_6_30_2020_NDTiF3J6pE6DAJHe0861mA"
      decimals="0"
      id="Tc_BAYwFmKr802RS1zQjfx52A_10_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">157398</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_4_1_2020_To_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_pw-r84ndYkSP68XRrV0yTw"
      decimals="0"
      id="Tc_wEAfMA32KUGQISOt9-k7lg_11_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-3273079</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_4_1_2020_To_6_30_2020_NDTiF3J6pE6DAJHe0861mA"
      decimals="0"
      id="Tc_2x6ws_S1aUeHl1QXGp0sVg_11_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-3273079</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Zp8WC33yq0ebMiPW4NZNIw"
      decimals="INF"
      id="Tc_H-zVW8zQUE23qdjCe5Vanw_12_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2138322</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Zp8WC33yq0ebMiPW4NZNIw"
      decimals="0"
      id="Tc_9Sr_uBHtEU2Pq5LqozgmqA_12_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">22</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_USH1GwFq-EuR2zkUYP0bfw"
      decimals="0"
      id="Tc_Ly2DfZNatky8BVeoaTKYSg_12_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">8015485</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_X24d21muVUiqauo73XMZ6Q"
      decimals="0"
      id="Tc_mPlvfO2bx0G7YkeaGbR59Q_12_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-55300902</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2020_NdUbxN7H60abPZxL_rdgcg"
      decimals="0"
      id="Tc_Wbmq0RXEKk66LaUNi30adw_12_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-47285395</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_gkWjeTErEEKrQ1vY2z-omg"
      decimals="0"
      id="Tc_JjbGlhPPKUG0JEVC9_fD3A_13_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">157398</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_Hl0TqnxSnUmsIkNjuCYLWg_13_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">157398</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_QSVhaJp0c0qau5mbNttKZw"
      decimals="0"
      id="Tc_fgUhi93J20a_U1w7woxOVw_14_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-2992225</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Tc_IZoFBfKoF0GOzVWbuFZmaw_14_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-2992225</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Ujd_JULeH0eOzL9jR9r4VQ"
      decimals="INF"
      id="Tc_CARebtryOU-HYzYwW6ft3w_15_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2138322</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Ujd_JULeH0eOzL9jR9r4VQ"
      decimals="0"
      id="Tc_ejS1h8yZW0yWTZOHPLhKQA_15_5"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">22</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_IeptdhXZvES-2yRyQFy8qw"
      decimals="0"
      id="Tc_D5CL3rIkb0K1qDnNo0bwhg_15_8"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">8172883</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_9_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_7YsfFYJ7r02IKnkspoVFDQ"
      decimals="0"
      id="Tc_3xIi6eISNkikg9UdhZyNIQ_15_11"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-58293127</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_9_30_2020_LW-AR2B-IUCYjTsTG_L0Gg"
      decimals="0"
      id="Tc_I5r0fXAc9EawtxKvGqLWPw_15_14"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-50120222</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_ZuGI_UfDFkWpfHv0wAnVvQ_6_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-9194757</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_EMGRRXlyTUKIVThAdcRtzg_6_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-9221537</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_jQJNE3Qdc0OwYSJLujF7FQ_8_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">93575</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_mHdT6-CJmUyIqSWwUmvQEw_8_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">139921</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_c2SSxnCEC0e8CjMqK8bkzw_9_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">384299</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_BZUEMuXEGUWnFpsJaHRcDA_9_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">472194</us-gaap:ShareBasedCompensation>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_5n5sxi3UjEG9wLuXQfAAaw_10_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-7501</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_kDGc00davEm7eYIyaEocFQ_11_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">62638</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_AqWxVWK5uk2GZhBOzEIBCw_11_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">76034</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:EmbeddedDerivativeGainOnEmbeddedDerivative
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_jV7ysQ_Jx0uJL2A2FjyW-A_12_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">246962</us-gaap:EmbeddedDerivativeGainOnEmbeddedDerivative>
    <miro:GainOnForgivenessOfDebt
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_N-f9F-nLBEy-uk-yIXNLbw_13_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">568505</miro:GainOnForgivenessOfDebt>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_XyXwzIPVWUSL6oDXvsaMTg_14_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-223633</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_1tKvUXX_vkKN7cEwvGDxhw_14_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-1676000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_L7XJ68zq40C7-pqwWTKG4g_15_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1983912</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_o5KF4HYjqEuuDp8SznBJ-w_17_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-49676</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_bi3Ub0RFTE277Bsc414DTQ_18_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-5383</us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_RPpk06hHUkeKpUJIL7VQbQ_18_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-217405</us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent>
    <miro:IncreaseDecreaseInGrantsReceivable
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_Y5rXrNQjs0y8FVC991cqCw_19_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-15530</miro:IncreaseDecreaseInGrantsReceivable>
    <miro:IncreaseDecreaseInGrantsReceivable
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_aJleuRMf80qOg8PLXidogA_19_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">257380</miro:IncreaseDecreaseInGrantsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_5haYDEXIgUqDFhlSqDv9ng_20_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">203734</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_g_vZO0EPr0iUzfBQlWtd-A_20_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">17535</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_hlvhOq1I30mHI9empLIpJA_21_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">2649560</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_GLQi1mKiQk6jzcfDVh7L6Q_21_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-83702</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <miro:IncreaseDecreaseInInterestPayableNoncurrent
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_KALY6XgJME6QfQZpL8O4AQ_22_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">583293</miro:IncreaseDecreaseInInterestPayableNoncurrent>
    <miro:IncreaseDecreaseInInterestPayableNoncurrent
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_tb5r-eh0l0S3OAyWmD_B-A_22_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">347349</miro:IncreaseDecreaseInInterestPayableNoncurrent>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_TAzJcJ0UskO8sESGRSAsKQ_23_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-8211019</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_3DqyROC2G0Ohuh3X7mz8EQ_23_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-6094316</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_T1zoHvDflkyOPS7RDOp1_g_25_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">2000000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:PaymentsForConstructionInProcess
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_879WbaWoAkORumoUJ_rt3g_26_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1166129</us-gaap:PaymentsForConstructionInProcess>
    <miro:PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_aSKPakiot0Ce6o6PHDYEAA_27_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">281560</miro:PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements>
    <miro:PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_CdBlOh_600qRPpxwFx60Ug_27_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">123167</miro:PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_PUrKlkp94kC22LOQjogCFA_28_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">552311</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_lXRQYoolNUGLKr0HocJpjg_28_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-123167</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_HVG0XgIQwE-GoKE-GmTZyQ_30_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">83387</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_vpDsLwqqIEWb_HM10QREWg_30_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">97311</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_DxsQx8hEAkSMCWSLDHLedA_31_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">87567</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_PxXtyRKwwESB_wj5ZqmB3A_31_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6563397</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <miro:ProceedsFromIssuanceOfCommonStockNet
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_xqySPdDjJkqDT9QAbrHZ0g_32_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">44593686</miro:ProceedsFromIssuanceOfCommonStockNet>
    <miro:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_IL2UxXSsLU6NleeV8vNP6g_33_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">19891670</miro:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_p3Mypcd1LEq5w0f_Q7qahQ_34_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">8975</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_Zk9puF8U4EesK9lpDZ0P9w_34_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6250</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_C-iEW0BIW0m0rcfeYE0gwg_35_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">803480</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_B9hS54Y1skqyVtKA1Q-LSQ_35_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">56250</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_cx9kZ6xx4U6pC_kiuYaefQ_36_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">65301991</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_Hqw-ktFQrE-IT5t9NuQuTQ_36_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6528586</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_8DRgJduQyE2rDaRKALqsWQ_37_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">57643283</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_ldoh1O5-w0uEfgNcWGpZQQ_37_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">311103</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_HjvzSw96mEananLUpF98Tg_38_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">4444395</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2019_gbPT0CGmrE-mrppNChpn0g"
      decimals="0"
      id="Tc_fMkzQ5AuSEeMPhdhEaltYA_38_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">3250014</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_EUYOqkU_nEuWMpC_HlMt3w_39_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">62087678</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_9_30_2020_LW-AR2B-IUCYjTsTG_L0Gg"
      decimals="0"
      id="Tc_8TDm1mSVc0K1yyTOVxIu5A_39_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">3561117</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_7sY0HnbbQk-aQNbydxnBcw_42_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">17999</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Tc_4uzhqneCO0uI2TVGMd2CfQ_42_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">16095</us-gaap:InterestPaidNet>
    <miro:NoncashInvestingAndFinancingFinancingExpenses
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Tc_9BP8mj4ik0i4gHJMEPTj5Q_45_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">936652</miro:NoncashInvestingAndFinancingFinancingExpenses>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_VHlajgWLfEG7fOZ-XmoQyw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;NOTE&#160;1&#160;&#x2014; DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Description of Business&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Miromatrix Medical&#160;Inc. (the &#x201c;Company&#x201d;) is a life science company that has a proprietary technology to remove cells from, or decellularize, and also to recellularize organs and tissues from animal and human sources, facilitating the creation of numerous products.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Basis of Preparation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.3pt;margin:0pt 0pt 12pt 0pt;"&gt;The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and the rules of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) applicable to interim reports of companies filing as a smaller reporting company.&#160; These financial statements should be read in conjunction with the audited financial statements and notes thereto contained in the Company&#x2019;s Registration Statement on Form S-1 (File No. 333-256649), as amended, (the &#x201c;Form S-1&#x201d;) for the fiscal year ended December 31, 2020 filed with the SEC on June 22, 2021.&#160; In the opinion of management, the accompanying condensed interim financial statements include all adjustments necessary in order to make the financial statements not misleading.&#160; The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year or any other future period.&#160; Certain notes to the financial statements that would substantially duplicate disclosures contained in the audited financial statements for the most recent fiscal year as reported in the Company&#x2019;s Form S-1 have been omitted.&#160; The accompanying condensed balance sheet at December 31, 2020 has been derived from the audited balance sheet at December 31, 2020 contained in the Form S-1.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;"&gt;In the opinion of management, the accompanying condensed financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, stockholders' equity and cash flows for the interim periods but are not necessarily indicative of the results of operations or cash flows to be anticipated for the full year 2021 or any future period. The Company has evaluated subsequent events occurring after the date of the condensed financial statements for events requiring recording or disclosure in the condensed financial statements.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Amended and Restated Charter&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;On May 20, 2021, the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) and stockholders approved an amendment and restatement of the Company&#x2019;s then-existing certificate of incorporation (the &#x201c;Pre-IPO Certificate&#x201d;) to create, among other changes, a Series C Convertible Preferred Stock (&#x201c;Series C Stock&#x201d;). The Series C Stock would convert into shares of the Company&#x2019;s common stock upon the Company&#x2019;s initial public offering at 80% of the price at which the common stock is being sold in the initial public offering (see Note 8).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;June 2021 Amended and Restated Charter&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Prior to the completion of the initial public offering of the Company&#x2019;s common stock (the &#x201c;IPO&#x201d;), the Company's Board and stockholders approved an amendment (the &#x201c;Charter Amendment&#x201d;) to the Pre-IPO Certificate and an amended and restated certificate of incorporation (&#x201c;Post-IPO Certificate&#x201d;) that became effective on June 23, 2021. The Charter Amendment increased the number of authorized shares of the Company&#x2019;s common stock from 30,000,000 to 190,000,000 and authorized 10,000,000 shares of undesignated preferred stock. Under the Post-IPO Certificate, the Company is authorized to issue two classes of stock, Common Stock and Preferred Stock.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Equity Method Investments&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"&gt;Investments in 20% to 50%-owned companies are accounted for under the equity method as the Company can exercise significant influence, but not control, over such investments. The equity method requires that gains (losses) are &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;recognized in other income (expense), net in the statements of operations. The gain on equity investment in Reprise Biomedical,&#160;Inc. (&#x201c;Reprise&#x201d;) resulted from recording the fair value of the Company&#x2019;s investment in Reprise upon losing a controlling interest in the Company on June&#160;30, 2019. The Company recorded its equity method share of losses in Reprise from July&#160;1, 2019 through December&#160;31, 2019, from January&#160;1, 2020 to December&#160;31, 2020 and from January&#160;1, 2021 to March&#160;15, 2021 in the statements of operations. Even though the Company&#x2019;s ownership dropped below 20% on November&#160;15, 2020, the Company still had significant influence over the activities of Reprise due to common board members (See Note&#160;4).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Research and Development Costs&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Research and development expenses consist primarily of engineering, product development, consulting services, materials, depreciation and other costs associated with products and technologies in development. These expenses include employee and non-employee compensation, including stock-based compensation, supplies, materials, consulting expenses, related travel expenses, and facility costs. Expenditures for research and development activities are charged to operations as incurred.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Stock-Based Compensation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company is required to determine the fair value of equity incentive awards and recognize compensation expense for all equity incentive awards made to employees and directors, including employee stock options. The Company also determines the fair value of non-statutory stock options issued to consultants based on the fair value of the consultant&#x2019;s commitment at the date of grant. Such expense is recognized over the requisite service period. In addition, stock-based compensation expense recognized in the statements of operations is based on awards expected to vest and therefore the amount of expense has been reduced for estimated forfeitures. The Company uses the straight-line method for expense attribution, except for awards issued with performance-based conditions which require an accelerated attribution method over the requisite performance and service periods.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Under the applicable accounting guidance for equity incentive awards issued to non-employees, the date at which the fair value of such awards is measured is equal to the earlier of: 1) the date at which a commitment for performance by the counterparty to earn the equity instrument is reached; or &lt;span style="color:#231f20;"&gt;2) the date at which the counterparty&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial','Helvetica','sans-serif';"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#231f20;"&gt;s performance is complete. The Company recognizes stock-based compensation expense for the fair value of the vested portion of the non-employee awards in the statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The valuation model used for calculating the fair value of awards for stock-based compensation expense is the Black-Scholes option-pricing model (the &#x201c;Black-Scholes model&#x201d;). The Black-Scholes model requires the Company to make assumptions and judgments about the variables used in the calculation, including the expected term (weighted average period of time that the options granted are expected to be outstanding), the volatility of common stock, and an assumed risk-free interest rate. The Company uses the &#x201c;simplified method&#x201d; to determine the expected term of the stock option. Volatility is based on an average of the historical volatilities of the common stock of publicly-traded companies with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected term of the option. The expected dividend assumption is based on the Company&#x2019;s history of not paying dividends and its expectation that it will not declare dividends for the foreseeable future. Potential forfeitures of awards are estimated based on the Company&#x2019;s historical forfeiture experience. The estimate of forfeitures will be adjusted over the service period to the extent that actual forfeitures differ, or are expected to differ, from prior estimates.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, accounts receivable, and accounts payable. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Emerging Growth Company Status&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (&#x201c;JOBS Act&#x201d;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as to those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i)&#160;is no longer an emerging growth company or (ii)&#160;affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Net Loss Per Share&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Basic net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock and dilutive potential shares of common stock outstanding during the period. Because we have reported a net loss for all periods presented, diluted net loss per share is the same as basic net loss per share for those periods as all potentially dilutive shares consisting of stock options and warrants were antidilutive in those periods (See Note 13).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"&gt;During February&#160;2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No.&#160;2016-02, &#x201c;Leases (Topic 842).&#x201d; ASU No. 2016-02 requires lessees to recognize the assets and liabilities that arise from leases on the balance sheet. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. During 2018, the FASB also issued ASU No.&#160;2018-10, &#x201c;Codification Improvements to Topic 842, Leases&#x201d;, which addresses narrow aspects of the guidance originally issued in ASU No.&#160;2016-02; ASU 2018-11, &#x201c;Targeted Improvements&#x201d;, which provides entities with an additional (and optional) transition method whereby an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption and also provides lessors with a practical expedient, by class of underlying asset, to not separate non-lease components from the associated lease component and, instead, to account for those components as a single component. During 2019, the FASB also issued ASU No.&#160;2019-01, which clarified Topic 842&#x2019;s interim disclosure requirements and amend certain industry-specific guidance related to determining the fair value of leased assets and the cash flow presentation of principal payments received under sales-type and direct finance leases. Topic 842 (as amended) is effective for annual periods beginning after December&#160;15, 2021, and interim periods within fiscal&#160;years beginning after December&#160;15, 2022. Early adoption is permitted. The Company is currently assessing the effect that Topic 842 (as amended) will have on its results of operations, financial position and cash flows.&lt;/p&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_CFka2W-5ckC4FvFklKU7Ug">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Basis of Preparation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.3pt;margin:0pt 0pt 12pt 0pt;"&gt;The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and the rules of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) applicable to interim reports of companies filing as a smaller reporting company.&#160; These financial statements should be read in conjunction with the audited financial statements and notes thereto contained in the Company&#x2019;s Registration Statement on Form S-1 (File No. 333-256649), as amended, (the &#x201c;Form S-1&#x201d;) for the fiscal year ended December 31, 2020 filed with the SEC on June 22, 2021.&#160; In the opinion of management, the accompanying condensed interim financial statements include all adjustments necessary in order to make the financial statements not misleading.&#160; The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year or any other future period.&#160; Certain notes to the financial statements that would substantially duplicate disclosures contained in the audited financial statements for the most recent fiscal year as reported in the Company&#x2019;s Form S-1 have been omitted.&#160; The accompanying condensed balance sheet at December 31, 2020 has been derived from the audited balance sheet at December 31, 2020 contained in the Form S-1.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;"&gt;In the opinion of management, the accompanying condensed financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, stockholders' equity and cash flows for the interim periods but are not necessarily indicative of the results of operations or cash flows to be anticipated for the full year 2021 or any future period. The Company has evaluated subsequent events occurring after the date of the condensed financial statements for events requiring recording or disclosure in the condensed financial statements.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <miro:StockConversionPercentage
      contextRef="As_Of_5_20_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_GpP9eDFV_U6tUH14QDYSzA"
      decimals="INF"
      id="Narr_aDGcF9l3VkiDJCQWpPOeyA"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.80</miro:StockConversionPercentage>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_6_22_2021_jAIYqLNp8kqUDCDCdGqUMQ"
      decimals="INF"
      id="Narr_A7qSELFEf0i2rq-vBj41NA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">30000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_6_23_2021_1kBpKsAjAkafdUqrpHlz-w"
      decimals="INF"
      id="Narr_EfHuuS05ckmpEWdvK72WZA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">190000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_6_23_2021_1kBpKsAjAkafdUqrpHlz-w"
      decimals="INF"
      id="Narr_Kc0sclJ1n0eXOgxwxmAtIw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">10000000</us-gaap:PreferredStockSharesAuthorized>
    <miro:NumberOfClassesOfStock
      contextRef="Duration_6_23_2021_To_6_23_2021_nAJYhIVR5k6XfLRbSV0y5A"
      decimals="INF"
      id="Narr_UM6hSoIC9EWoCU2cpC4GhQ"
      unitRef="Unit_Standard_class_iV0uheBxPk-h-k5jyvqyzg">2</miro:NumberOfClassesOfStock>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_flYd0p0Y0kKFyrP_CyBYpg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Equity Method Investments&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"&gt;Investments in 20% to 50%-owned companies are accounted for under the equity method as the Company can exercise significant influence, but not control, over such investments. The equity method requires that gains (losses) are &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"&gt;recognized in other income (expense), net in the statements of operations. The gain on equity investment in Reprise Biomedical,&#160;Inc. (&#x201c;Reprise&#x201d;) resulted from recording the fair value of the Company&#x2019;s investment in Reprise upon losing a controlling interest in the Company on June&#160;30, 2019. The Company recorded its equity method share of losses in Reprise from July&#160;1, 2019 through December&#160;31, 2019, from January&#160;1, 2020 to December&#160;31, 2020 and from January&#160;1, 2021 to March&#160;15, 2021 in the statements of operations. Even though the Company&#x2019;s ownership dropped below 20% on November&#160;15, 2020, the Company still had significant influence over the activities of Reprise due to common board members (See Note&#160;4).&lt;/p&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="As_Of_11_15_2020_srt_RangeAxis_srt_MaximumMember_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_GHS7IyK-b0atc14LN7N6WA"
      decimals="INF"
      id="Narr_gh-GeyDNpUeZUf74gooBBQ"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_iujWOVpViEmUwfcG-7Z_Xg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Research and Development Costs&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Research and development expenses consist primarily of engineering, product development, consulting services, materials, depreciation and other costs associated with products and technologies in development. These expenses include employee and non-employee compensation, including stock-based compensation, supplies, materials, consulting expenses, related travel expenses, and facility costs. Expenditures for research and development activities are charged to operations as incurred.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_ZwZNNXFe3UmeHN7j3WPcQA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Stock-Based Compensation&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company is required to determine the fair value of equity incentive awards and recognize compensation expense for all equity incentive awards made to employees and directors, including employee stock options. The Company also determines the fair value of non-statutory stock options issued to consultants based on the fair value of the consultant&#x2019;s commitment at the date of grant. Such expense is recognized over the requisite service period. In addition, stock-based compensation expense recognized in the statements of operations is based on awards expected to vest and therefore the amount of expense has been reduced for estimated forfeitures. The Company uses the straight-line method for expense attribution, except for awards issued with performance-based conditions which require an accelerated attribution method over the requisite performance and service periods.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Under the applicable accounting guidance for equity incentive awards issued to non-employees, the date at which the fair value of such awards is measured is equal to the earlier of: 1) the date at which a commitment for performance by the counterparty to earn the equity instrument is reached; or &lt;span style="color:#231f20;"&gt;2) the date at which the counterparty&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial','Helvetica','sans-serif';"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#231f20;"&gt;s performance is complete. The Company recognizes stock-based compensation expense for the fair value of the vested portion of the non-employee awards in the statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The valuation model used for calculating the fair value of awards for stock-based compensation expense is the Black-Scholes option-pricing model (the &#x201c;Black-Scholes model&#x201d;). The Black-Scholes model requires the Company to make assumptions and judgments about the variables used in the calculation, including the expected term (weighted average period of time that the options granted are expected to be outstanding), the volatility of common stock, and an assumed risk-free interest rate. The Company uses the &#x201c;simplified method&#x201d; to determine the expected term of the stock option. Volatility is based on an average of the historical volatilities of the common stock of publicly-traded companies with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected term of the option. The expected dividend assumption is based on the Company&#x2019;s history of not paying dividends and its expectation that it will not declare dividends for the foreseeable future. Potential forfeitures of awards are estimated based on the Company&#x2019;s historical forfeiture experience. The estimate of forfeitures will be adjusted over the service period to the extent that actual forfeitures differ, or are expected to differ, from prior estimates.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_RtFOfRz_6Uup6G6oK9KaTw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, accounts receivable, and accounts payable. &lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:UseOfEstimates
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_5IP9-_ggAEmrXpmSmVwdMQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <miro:EmergingGrowthCompanyStatusPolicyPolicyTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_ARHOnVaBrUiBLo_W3IFMKQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Emerging Growth Company Status&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (&#x201c;JOBS Act&#x201d;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as to those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i)&#160;is no longer an emerging growth company or (ii)&#160;affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.&lt;/p&gt;</miro:EmergingGrowthCompanyStatusPolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_MgDqvZarjU6BqH7sMRKQtA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Net Loss Per Share&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Basic net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock and dilutive potential shares of common stock outstanding during the period. Because we have reported a net loss for all periods presented, diluted net loss per share is the same as basic net loss per share for those periods as all potentially dilutive shares consisting of stock options and warrants were antidilutive in those periods (See Note 13).&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_Nb8XS8ZFxU2IT72vR9tWMA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"&gt;During February&#160;2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No.&#160;2016-02, &#x201c;Leases (Topic 842).&#x201d; ASU No. 2016-02 requires lessees to recognize the assets and liabilities that arise from leases on the balance sheet. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. During 2018, the FASB also issued ASU No.&#160;2018-10, &#x201c;Codification Improvements to Topic 842, Leases&#x201d;, which addresses narrow aspects of the guidance originally issued in ASU No.&#160;2016-02; ASU 2018-11, &#x201c;Targeted Improvements&#x201d;, which provides entities with an additional (and optional) transition method whereby an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption and also provides lessors with a practical expedient, by class of underlying asset, to not separate non-lease components from the associated lease component and, instead, to account for those components as a single component. During 2019, the FASB also issued ASU No.&#160;2019-01, which clarified Topic 842&#x2019;s interim disclosure requirements and amend certain industry-specific guidance related to determining the fair value of leased assets and the cash flow presentation of principal payments received under sales-type and direct finance leases. Topic 842 (as amended) is effective for annual periods beginning after December&#160;15, 2021, and interim periods within fiscal&#160;years beginning after December&#160;15, 2022. Early adoption is permitted. The Company is currently assessing the effect that Topic 842 (as amended) will have on its results of operations, financial position and cash flows.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <miro:StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_xg9Rit5yeUSRrDOFj8-nbw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;NOTE 2 &#x2014; INITIAL PUBLIC OFFERING&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 10pt 0pt;"&gt;In June 2021, the Company completed the IPO in which the Company sold 5,520,000 shares of its common stock at a price to the public of $9.00 per share, which included the sale of 720,000 shares of common stock as a result of the full exercise of the underwriter&#x2019;s overallotment option. The Company received proceeds of $49.7 million, excluding underwriting discounts and commissions, which was recorded to additional paid-in capital. The Company&#x2019;s common stock commenced trading on the Nasdaq Capital Market on June 24, 2021 under the trading symbol &#x201c;MIRO.&#x201d;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-weight:normal;"&gt;Upon the closing of the IPO, all shares of the then-outstanding convertible preferred stock were converted on their respective terms into a total of &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;12,139,071&lt;/span&gt;&lt;span style="font-weight:normal;"&gt; shares of common stock. This resulted in a reclassification of &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;$73.7&lt;/span&gt;&lt;span style="font-weight:normal;"&gt; million to additional paid-in capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Offering costs incurred by the Company were approximately $1.6 million, excluding underwriting commissions and discounts, which were recorded to additional paid-in capital. The Company issued the underwriter in the IPO a warrant to purchase up to 276,000 shares of its common stock.&lt;/p&gt;</miro:StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_5Odx1hNFgE-EjIs5X0GrZQ"
      decimals="INF"
      id="Narr_3BeVnzqb1kuxcnhaQs2Vgg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">5520000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="As_Of_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_yAsbjp9bDUazwowV3IQPOg"
      decimals="INF"
      id="Narr_A3YUCY33KEKMJ3pu9yikCg"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">9.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember_s5dfWC6rwUCezVcVwV3Tlg"
      decimals="INF"
      id="Narr_BKlr8jDWOEOV7zONFt8_0A"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">720000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_5Odx1hNFgE-EjIs5X0GrZQ"
      decimals="-5"
      id="Narr_qXUvYuyQMEGE8Lm2UwIT5A"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">49700000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Q9R7jNA_kk6E26TVZk6K5Q"
      decimals="INF"
      id="Narr_K7v8_D2hk0We9eMF5nYLNA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">12139071</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_jgndyTBo4kmjINCHYzZc9Q"
      decimals="-5"
      id="Narr_q0F-wSsYM0u47k82GhyNkg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">73700000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="Duration_6_1_2021_To_6_30_2021_v1CMQoC_MEO53dW7J_nzAA"
      decimals="-5"
      id="Narr_kq6pFgvNmkynVzEjnXTDEQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1600000</us-gaap:PaymentsOfStockIssuanceCosts>
    <miro:ClassOfWarrantOrRightGranted
      contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_Umm_MfnOZUaOKyWI9XnCRg"
      decimals="INF"
      id="Narr_EL9TeyvEFEOh2TeKDjY0mg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">276000</miro:ClassOfWarrantOrRightGranted>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_0RzrDhjoIUiSj4JF1sSSvQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:49.5pt;text-indent:-49.5pt;margin:0pt 0pt 12pt 0pt;"&gt;NOTE&#160;3&#160;&#x2014; LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Lab equipment, furniture, leasehold improvements and construction in progress consisted of the following as of:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;September&#160;30,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Lab equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,762,512&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,480,952&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Construction in progress&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,166,129&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 310,225&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 310,225&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Furniture and fixtures &amp;amp; computers&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 112,302&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 112,302&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,351,168&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,903,479&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less accumulated depreciation and amortization&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,672,520)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,578,945)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,678,648&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 324,534&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"&gt;Depreciation and amortization expense was $34,401 and $34,901 for the three&#160;months ended September 30, 2021 and 2020, respectively, and $93,575 and $139,921 for the nine&#160;months ended September 30, 2021 and 2020, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"&gt;The Company is moving into a new facility in December 2021 and has paid $1,166,129 toward leasehold improvements and other costs and recorded these as construction in progress.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_76NnM7h-8UyXRWcfhx8wig">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;September&#160;30,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Lab equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,762,512&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,480,952&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Construction in progress&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,166,129&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 310,225&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 310,225&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Furniture and fixtures &amp;amp; computers&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 112,302&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 112,302&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,351,168&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,903,479&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less accumulated depreciation and amortization&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,672,520)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,578,945)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,678,648&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 324,534&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_meG4-bg4kUO8x0E1C04Kqw"
      decimals="0"
      id="Tc_Mx66UWRG6UqSBL0MBuGv-w_3_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1762512</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_jFveJ8RoEEKFIHidVPDl4w"
      decimals="0"
      id="Tc_v5DUugQss0uVDhUY9Gaxhg_3_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1480952</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember_lwr3FLyMikqQkZtq70jcoQ"
      decimals="0"
      id="Tc_HL9SImqmvkinEkcF8sM5Ag_4_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1166129</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_fRxvAQCNO0uRd-IxLvwfDg"
      decimals="0"
      id="Tc_Sl8RrCxmSUCNVlUSTlxXEg_5_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">310225</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_eOuiFcUJCEOgeU3oV-a2mw"
      decimals="0"
      id="Tc_sMYbBUqr-U6WdHEKvHn9Aw_5_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">310225</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_9_30_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FurnitureFixturesAndComputersMember_S_oUYLkJy06xhe5H4RKyJw"
      decimals="0"
      id="Tc_SVu1ZQmKvUO4j3FV3ziPgw_6_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">112302</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2020_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FurnitureFixturesAndComputersMember__gu0MdxH50m20YVzxIH-Pg"
      decimals="0"
      id="Tc_01KrcCosJUGli7xvq9LU6A_6_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">112302</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_kDFnka3nzU2TZMG_RDexig_7_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">3351168</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_960Nvup9p0ucD8XC1kFcRQ_7_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1903479</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_n6JL4JC2fk6jwgQywUmCbA_8_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1672520</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_psQioS1PlEKUaYek9oP2Tw_8_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1578945</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_gJ121esKrU-rJJG2YqOC4g_9_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1678648</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_oX1watLw_kCh-hmaHMu2Gg_9_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">324534</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Narr_6DXHuxTFRkSN5KoBgMekHg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">34401</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Narr_XIYRopEof02dxu1BrGFwUg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">34901</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Narr_QLJROIeJd0OzLJAmVLholw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">93575</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Narr_k2dF54pcpkGIcuBS7mYR0w"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">139921</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsForConstructionInProcess
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Narr_Hg1px2gUGEyd5cWidY9TgA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1166129</us-gaap:PaymentsForConstructionInProcess>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_pMfdQHkAoki_Pe9EEJpF1g">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;NOTE 4 &#x2014; EQUITY METHOD INVESTMENT&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company previously manufactured and sold acellular medical devices in the hernia mesh and wound care markets through a separately identifiable business unit (the &#x201c;Acellular Business&#x201d;). On June&#160;30, 2019, the Acellular Business was spun-out to Reprise. At the time of the spin-out the common stock of Reprise was valued at $1.00 per share and therefore the Company recognized a gain of $4,495,500 on its Reprise common stock holdings. At the time of the spin-out and until November&#160;15, 2020, the Company owned 4,500,000 shares of common stock of Reprise, which represented 45% ownership in Reprise. In November&#160;2020, the Company sold 2,700,000 shares of common stock of Reprise and retained an 18% ownership interest in Reprise. The Company sold its remaining shares of Reprise in March&#160;2021 for $2,000,000.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December&#160;31, 2020, the Company had an investment in Reprise that it accounts for under the equity method (See Note&#160;1). The Company considers its investment in Reprise to be significant to its income as of December&#160;31, 2020. Financial information from the financial statements of Reprise are summarized as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;September&#160;30,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 4,309,045&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 5,312,350&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 2,534,673&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Non-current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 489,785&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Shareholders&#x2019; equity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 2,287,892&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Miromatrix Medical Inc. share of shareholders&#x2019; equity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 411,821&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;width:22.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;For the Three Months Ended September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;width:24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;For the Nine Months Ended September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net sales&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 169,277&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 93,985&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 484,067&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Gross margin&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 109,497&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 47,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 307,573&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,188,678)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,376,522)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,723,533)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Miromatrix Medical Inc. share of net loss&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (495,000)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (223,633)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,676,000)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:SharePrice
      contextRef="As_Of_6_30_2019_dei_LegalEntityAxis_miro_RepriseBiomedicalInc.Member_R2d8cn9CGUK8VjOUJnYEwQ"
      decimals="0"
      id="Narr_oHH5QS-ReEi3Ciw1wUMK6A"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">1.00</us-gaap:SharePrice>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="Duration_6_30_2019_To_6_30_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_W19jgtfrJ0q1_pcaKF15Lg"
      decimals="-2"
      id="Narr_iyveAqEhakODMHNw4QjHfw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">4495500</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <miro:EquityMethodInvestmentSharesOwned
      contextRef="As_Of_6_30_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_CSoklVBQa02SoJByMzWnzQ"
      decimals="-5"
      id="Narr_fBVzGqIkykSDt0jTK17JJw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">4500000</miro:EquityMethodInvestmentSharesOwned>
    <miro:EquityMethodInvestmentSharesOwned
      contextRef="As_Of_11_15_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_2Sa5NjL2Kk-ibyq3uXUDjQ"
      decimals="-5"
      id="Narr_IdmOLkjBYk-0j5r_RY79aA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">4500000</miro:EquityMethodInvestmentSharesOwned>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="As_Of_6_30_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_CSoklVBQa02SoJByMzWnzQ"
      decimals="2"
      id="Narr_pKWljZ6kJEK5Uc03QUgTmw"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.45</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="As_Of_11_14_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_Aj4TjkpEqk2FBavVoeElPg"
      decimals="2"
      id="Narr_M8mu1S-cqU2UbH3lNPP22A"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.45</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <miro:EquityMethodInvestmentSharesSold
      contextRef="Duration_11_30_2020_To_11_30_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_npnVQruhDkGjzL1UROIouw"
      decimals="-5"
      id="Narr_UZH8p4QKdkmyqH44NbVMCg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2700000</miro:EquityMethodInvestmentSharesSold>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="As_Of_11_30_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_2ePGV84R7kOqVJlCe8VRFw"
      decimals="2"
      id="Narr_YmbirHa6-E6oiZt8NJmf3w"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.18</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="Duration_3_1_2021_To_3_31_2021_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_5uz6xTTzoUS7vZbEYgcwoA"
      decimals="-6"
      id="Narr_utyhq5ik4E2OuMx_8aHDDQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">2000000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_30AJEDGYmEqSMlW8yIm9aQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;September&#160;30,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 4,309,045&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 5,312,350&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 2,534,673&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Non-current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 489,785&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Shareholders&#x2019; equity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 2,287,892&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Miromatrix Medical Inc. share of shareholders&#x2019; equity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 411,821&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;width:22.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;For the Three Months Ended September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;width:24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;For the Nine Months Ended September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net sales&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 169,277&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 93,985&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 484,067&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Gross margin&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 109,497&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 47,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 307,573&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,188,678)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,376,522)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,723,533)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Miromatrix Medical Inc. share of net loss&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (495,000)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (223,633)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,676,000)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw"
      decimals="0"
      id="Tc_pd80biH1mU25f3Ph9aNEcQ_3_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">4309045</us-gaap:AssetsCurrent>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw"
      decimals="0"
      id="Tc_aVgLnrBD_kSeJk__JzNUmw_4_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">5312350</us-gaap:Assets>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw"
      decimals="0"
      id="Tc_YbJ1f3mEEU27UtyuJCy-rw_5_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">2534673</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw"
      decimals="0"
      id="Tc_jjmf_RoK0kC2_TjFksuX4Q_6_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">489785</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:MinorityInterest
      contextRef="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw"
      decimals="0"
      id="Tc_3lOYjtjLvkOWMngg3yz0SQ_7_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">2287892</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw"
      decimals="0"
      id="Tc_NcDC5vdndUixIC3VVe8zfg_8_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">411821</us-gaap:StockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_2TuG7gXboUazxii0VRpqgg"
      decimals="0"
      id="Tc_7A76f1qqRk60X7ib9WvtcQ_5_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">169277</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_DTVpyL5NAkWKW7wh4gUxRg"
      decimals="0"
      id="Tc_6sT3yBwwOkm6JgKCKGHv1w_5_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">93985</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_8sleYqexjESt21JPVmSmbw"
      decimals="0"
      id="Tc_IrUTzRJIk0ilzoGjdPfwUQ_5_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">484067</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_2TuG7gXboUazxii0VRpqgg"
      decimals="0"
      id="Tc_QR3hCU6xA06FOeUTBgzYVA_6_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">109497</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_DTVpyL5NAkWKW7wh4gUxRg"
      decimals="0"
      id="Tc_oPFBzwHOJU-cj8ZYamk5GQ_6_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">47708</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_8sleYqexjESt21JPVmSmbw"
      decimals="0"
      id="Tc_zCNe2_OydU2FM1sOvfW4Lw_6_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">307573</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_2TuG7gXboUazxii0VRpqgg"
      decimals="0"
      id="Tc_g-ABKIYxjEa6QRAhJmGITg_7_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-1188678</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_DTVpyL5NAkWKW7wh4gUxRg"
      decimals="0"
      id="Tc_QOVmfQlUAESJza1vlpL3NA_7_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-1376522</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_8sleYqexjESt21JPVmSmbw"
      decimals="0"
      id="Tc_vs3Chqcq_kmy8MwBTCDdVw_7_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-3723533</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_2TuG7gXboUazxii0VRpqgg"
      decimals="0"
      id="Tc_MMa3VYBQWUOmUrGdmmgwzQ_8_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-495000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_DTVpyL5NAkWKW7wh4gUxRg"
      decimals="0"
      id="Tc_1OBfCT6BikWZBQrSxgz-lg_8_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-223633</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_8sleYqexjESt21JPVmSmbw"
      decimals="0"
      id="Tc_HgBGjUt6502hPrvCu9r43g_8_12"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-1676000</us-gaap:NetIncomeLoss>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_n7SwvtQjS0-375fioqlYVQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;NOTE 5 &#x2014; ACCRUED EXPENSES&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Accrued expenses consisted of the following as of:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Wages&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 549,685&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 217,825&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Legal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 120,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 452,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Royalties&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 2,455&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 3,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Supplies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 80,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;IPO expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 936,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Key opinion leader compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 100,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 34,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Board compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 58,125&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 75,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 52,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 1,922,617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 760,889&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_6EDWKe6sn0ignSqyDkxAtA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Wages&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 549,685&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 217,825&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Legal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 120,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 452,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Royalties&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 2,455&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 3,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Supplies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 80,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;IPO expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 936,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Key opinion leader compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 100,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 34,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Board compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 58,125&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 75,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 52,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="color:#231f20;"&gt;Accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 1,922,617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 760,889&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_5xEWFV8P_UO_YHxNfDXD3Q_4_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">549685</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_bIR-s4PYJUaIEDvSi4Pe8A_4_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">217825</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_pyD65p5QTEmXiv5HrCc5FA_5_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">120000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_QeDG8LXxwEaT4YE_j7L-og_5_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">452778</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_N2x3fa8_R0ee2y1TCJbzjQ_6_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">2455</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_qcirMwROwUyWxuoimbW9FA_6_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">3800</us-gaap:AccruedRoyaltiesCurrent>
    <miro:AccruedSuppliesCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_I3fuQgv_0UqTJ6_GZxdNbA_7_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">80700</miro:AccruedSuppliesCurrent>
    <miro:AccruedLiabilitiesPublicOfferingExpensesCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc__0J1cxDcYE2jPSFI-mYXZg_8_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">936652</miro:AccruedLiabilitiesPublicOfferingExpensesCurrent>
    <miro:AccruedKeyOpinionLeadedCompensationCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_SPw6XLk3m0C4YQ2eQsQ3ww_9_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">100000</miro:AccruedKeyOpinionLeadedCompensationCurrent>
    <miro:AccruedKeyOpinionLeadedCompensationCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_kXwhrb7ygUWgDrQ4ZACMNg_9_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">34000</miro:AccruedKeyOpinionLeadedCompensationCurrent>
    <miro:AccruedBoardCompensationCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_XDg6UllOik2L_vUD3jTe8A_10_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">58125</miro:AccruedBoardCompensationCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_gUH37bBDbE2YP43TTzsBpA_11_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">75000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_26_0amDqDEW-SY83UKFAug_11_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">52486</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_nCPNsrPQCEmkzlaDKqBwtg_12_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1922617</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_HzxH_-yla0Ca-Y10_orbEg_12_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">760889</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_EewxaU0xTEOhLejtb1Y5VQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;NOTE 6 &#x2014; FAIR VALUE MEASUREMENT&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;"&gt;The fair value of the Company&#x2019;s financial instruments reflect the amount that the Company estimates that it would receive in connection with the sale of an asset or paid in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;"&gt;ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes a fair value hierarchy that distinguishes between (1)&#160;market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2)&#160;an entity&#x2019;s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC 820 are described below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"&gt;Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"&gt;Level 2: Directly or indirectly observable inputs as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data from actively quoted markets for substantially the full term of the financial instrument.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"&gt;Level 3: Unobservable inputs that are supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management&#x2019;s estimates of market participant assumptions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company classified its equity method investments as Level 3 securities.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company determined that a promissory note issued in March&#160;2020 (&#x201c;March&#160;2020 Note&#x201d;) contained a change in control provision which is a level 3 embedded derivative and is required to be bifurcated. In accordance with ASC 815, &lt;i style="font-style:italic;"&gt;Derivatives and Hedging&lt;/i&gt;, the Company determined the fair value of the derivative liability and recorded it on the balance sheet. At inception, the fair value of the derivative liability was $195,516.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The table below discloses changes in value of the Company&#x2019;s embedded derivative liabilities discussed above.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Derivative liability balance at December&#160;31,&#160;2019&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Derivative instrument related to March 2020 Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 195,516&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Gain/Loss recognized to revalue derivative instrument at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 51,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Derivative liability balance at December&#160;31,&#160;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 246,962&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Gain/Loss recognized to revalue derivative instrument at fair value (unaudited)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt; (246,962)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Derivative liability balance at September&#160;30,&#160;2021 (unaudited)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="As_Of_3_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_27cslPMf0kKYRf5e8pUZUg"
      decimals="0"
      id="Narr_uCzOPTmDiUST31BsBEmEiQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">195516</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_D_QZrd4KBkWCHRK1TQakPA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Derivative liability balance at December&#160;31,&#160;2019&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Derivative instrument related to March 2020 Note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 195,516&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Gain/Loss recognized to revalue derivative instrument at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 51,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Derivative liability balance at December&#160;31,&#160;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 246,962&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Gain/Loss recognized to revalue derivative instrument at fair value (unaudited)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt; (246,962)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;Derivative liability balance at September&#160;30,&#160;2021 (unaudited)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <miro:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_m7wWrzDt8kKqdsrFFqI6Aw"
      decimals="0"
      id="Tc__qVgnYHqDUqA2Ye3u77AFQ_2_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">195516</miro:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_m7wWrzDt8kKqdsrFFqI6Aw"
      decimals="0"
      id="Tc_oKIUBq8BL0qjhd9O8DySlQ_3_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">-51446</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="As_Of_12_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_xQEMjYvAV02ThX-j5BQaAQ"
      decimals="0"
      id="Tc_ajtcm4d9EU-ArWZINwn_mw_4_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">246962</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_XGJvV0_cDkeQhRzARKjL8g"
      decimals="0"
      id="Tc_ms315N9G_ESp24S5pYUhAw_5_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">246962</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_pqeIgJrR_USXjgxkNFZc8w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;NOTE&#160;7&#160;&#x2014; DEBT AND CAPITAL LEASE OBLIGATION&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;"&gt;In December&#160;2010, the Company entered into a loan and security agreement with the Minnesota Agricultural and Economic Development Board under which the Company borrowed $250,000. The loan had a maturity date of November&#160;1, 2020. Commencing on December&#160;1, 2014, the loan started to bear interest at a rate of 6% per annum. Per the loan agreement, the Company began making&#160;monthly principal and interest payments on December&#160;1, 2015 in the amount of $3,000. The Company made 59&#160;monthly payments, plus one final payment equal to the then unpaid principal and interest. The loan was secured by the Company&#x2019;s accounts receivable. As of September 30, 2021 and December&#160;31, 2020, the principal outstanding on this loan was $0 and $168,193, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In January&#160;2012, the Company signed a promissory note with the Regents of the University of Minnesota (the &#x201c;University&#x201d;) for $405,559. Commencing on January&#160;1, 2016 the promissory note bears interest at 3% per annum, compounded&#160;monthly. On or before January&#160;31, 2018, the Company is required to make&#160;monthly principal and interest payments of $7,737 until the note is paid in full. The note has a maturity date of December&#160;31, 2022 and is unsecured. In association with the promissory note, the Company issued the University warrants to purchase 80,000 shares of the Company&#x2019;s common stock at an exercise price of $1.69. As of September 30, 2021 and December&#160;31, 2020, the principal outstanding on this loan was $106,320 and $172,731, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In May&#160;2015, the Company entered into a loan agreement with the Minnesota Department of Employment&#160;&amp;amp; Economic Development under which the Company borrowed $250,000. The loan does not bear interest, is due in a lump sum payment on April&#160;1, 2022 and is uncollateralized. If there is a substantial ownership change in the Company (greater than 50% to one entity), the Company will pay the Minnesota Department of Employment&#160;&amp;amp; Economic Development additional compensation of $75,000. As of both September 30, 2021 and December&#160;31, 2020, the balance outstanding on this loan was $250,000.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In October&#160;2018, the Company signed a lease agreement for a piece of equipment that is being accounted for as a capitalized lease. The total cost of the equipment was $102,026. The lease bears interest at 7.2% and the Company will make 60 monthly payments of $2,003 until the lease is paid in full. As of September 30, 2021 and December&#160;31, 2020, the amount outstanding on the lease was $43,113 and $57,127, respectively. The lease is secured by the piece of equipment.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In January&#160;2019, Company issued the University a promissory note in the amount of $385,997 in satisfaction of the Company&#x2019;s minimum royalty obligation for the&#160;year ended December&#160;31, 2018. The note bears interest at 6% per annum and is due on January&#160;31, 2025. In addition, the Company issued the University a 10-year warrant to purchase 20,587 shares of the Company&#x2019;s common stock at an exercise price of $3.75 per share.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In March&#160;2020, the Company entered into a note and warrant purchase agreement (the &#x201c;Purchase Agreement&#x201d;) with one of the Company&#x2019;s shareholders under which the Company borrowed $6,000,000. As part of the Purchase Agreement, the Company signed a convertible promissory note (the &#x201c;Note&#x201d;) and issued the shareholder a warrant (the &#x201c;Warrant&#x201d;). The Note&#160;was unsecured and had a maturity date of September&#160;6, 2021. If the Company completed a preferred stock offering of at least $34,000,000 prior to the maturity date, the Note&#160;and all accrued interest would have automatically converted into preferred shares of such offering at the offering price. The Note&#160;initially bore interest at 5% per annum. If the Note&#160;was not converted prior to May&#160;1, 2020, the interest rate increased to 7% on May&#160;1, 2020 and by an additional 2% on the first day of each subsequent&#160;month prior to the maturity date starting on June&#160;1, 2020, provided that the interest rate shall not exceed 20%. The 5-year Warrant has a warrant coverage amount of $750,000 with an exercise price equal to the conversion price of the Note. If the Note&#160;had not been converted or repaid in accordance with its terms prior to May&#160;1, 2020, the Company will issue an additional warrant on May&#160;1, 2020, and the first day of each additional&#160;month the Note&#160;remains outstanding, for $75,000 of warrant coverage. In June 2021, the Note and all accrued interest was converted into 956,887 shares of the Company&#x2019;s Series C Convertible Preferred Stock. As of September 30, 2021 and December&#160;31, 2020, the balance outstanding on the Note was $0 and $6,000,000, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;"&gt;On April&#160;16, 2020, the Company issued a promissory note for $563,397 under the Paycheck Protection Program (&#x201c;PPP&#x201d;) through the U.S. Small Business Administration (SBA). The PPP was authorized in the Coronavirus Aid, Relief and Economic Security (CARES) Act. The promissory note is uncollateralized and is fully guaranteed by the Federal government. The outstanding balance of the promissory note bears interest at 1% per annum and is due on April&#160;16, 2022. Per the PPP&#x2019;s terms, some or all of the debt may be forgiven based upon the Company&#x2019;s use of the funds. On March&#160;4, 2021, $513,520 of the principal balance under the promissory note and associated interest of $4,530 were forgiven by the SBA. On August 6, 2021, the remaining principal balance of $49,877 along with associated interest of $440 were forgiven by the SBA. As of September 30, 2021 and December&#160;31, 2020, the balance outstanding on the promissory note was $0 and $563,397 respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In July&#160;2021, the Company signed a lease agreement for a piece of equipment that is being accounted for as a capitalized lease. The total cost of the equipment was $44,251. The lease bears interest at 5.0% and the Company will make 24 monthly payments of $1,941 until the lease is paid in full. As of September 30, 2021, the amount outstanding on the lease was $37,178. The lease is secured by the piece of equipment.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In September&#160;2021, the Company signed a lease agreement for a piece of equipment that is being accounted for as a capitalized lease. The total cost of the equipment was $43,317. The lease bears interest at 6.8% and the Company will make 36 monthly payments of $1,448 until the lease is paid in full. As of September 30, 2021, the amount outstanding on the lease was $42,319. The lease is secured by the piece of equipment.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Principal maturities were as follows as of the periods indicated:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Debt&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Capital Lease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,481,774&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,855&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,500,629&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 504,354&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 20,261&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 524,615&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,011&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,011&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 385,997&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 385,997&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Totals&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,372,125&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 57,127&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,429,252&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less current portion &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,481,774)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (18,855)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,500,629)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term portion &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 890,351&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 38,272&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 928,623&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Debt&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Capital Lease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 333,223&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 52,938&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 386,161&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 23,097&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 51,008&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 74,105&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,664&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,664&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 385,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 385,997&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Totals &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 742,317&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 122,610&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 864,927&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less current portion &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (333,223)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (52,938)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (386,161)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term portion &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 409,094&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 69,672&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 478,766&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_12_31_2010_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_pkNNDT8Wak6IONNfMjjxqg"
      decimals="0"
      id="Narr_2ZE8UmtsAUabYzGnadB0bw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_12_1_2014_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_6QJUbguDpkyAkL3RR7QOTA"
      decimals="INF"
      id="Narr_yzEm_rscCU6aw3VKnn6QOg"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="Duration_12_1_2015_To_12_1_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_jA_SRrDvgkqJaPnK7QABEg"
      decimals="0"
      id="Narr_UT0b3GGpTUm9UP5Y5LC-7w"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">3000</us-gaap:DebtInstrumentPeriodicPayment>
    <miro:DebtInstrumentPeriodicMonthlyPaymentNumber
      contextRef="Duration_12_1_2015_To_12_1_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_jA_SRrDvgkqJaPnK7QABEg"
      decimals="INF"
      id="Narr_gmOWOsdw00a0Zf8KJZrg0Q"
      unitRef="Unit_Standard_payment_r6kmSj8FdkWHfPCK9l_Ahg">59</miro:DebtInstrumentPeriodicMonthlyPaymentNumber>
    <miro:DebtInstrumentNumberOfFinalPayment
      contextRef="Duration_12_1_2015_To_12_1_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_jA_SRrDvgkqJaPnK7QABEg"
      decimals="INF"
      id="Narr_dt84fjJUmEy0S5KpMY725Q"
      unitRef="Unit_Standard_payment_r6kmSj8FdkWHfPCK9l_Ahg">1</miro:DebtInstrumentNumberOfFinalPayment>
    <us-gaap:LongTermDebt
      contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_7Seab1iWakasudo2xAp8XA"
      decimals="0"
      id="Narr_tybDeAs7RUmeec_jcqab-Q"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember_CthJKcprL0eLenTLOw8F7g"
      decimals="0"
      id="Narr__V6BSnL5KECL0VA-6_apQg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">168193</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_1_31_2012_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_QQnUDFDrzk2Vm5Fpppjj3g"
      decimals="0"
      id="Narr_0_KRXiUZlk62kJ3gSYM0Wg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">405559</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_1_1_2016_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_tqLAJsmEVECzNI54zhIGFA"
      decimals="INF"
      id="Narr_y_k4dgbsEES67eJiCi8qNQ"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="Duration_1_1_2016_To_1_1_2016_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_U8JeOxzzD0Gx5vKq-ysy3A"
      decimals="0"
      id="Narr_vSy3NRyt40OOtEocy-Pk9w"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">7737</us-gaap:DebtInstrumentPeriodicPayment>
    <miro:ClassOfWarrantOrRightNumberOfWarrantsIssued
      contextRef="Duration_1_1_2012_To_1_31_2012_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsRegentsOfUniversityOfMinnesotaMember_sZ5sdIuCHkukaGha2I_3MQ"
      decimals="INF"
      id="Narr_Q_hA2LK5sk--YzxMgw4sWA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">80000</miro:ClassOfWarrantOrRightNumberOfWarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="As_Of_1_31_2012_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsRegentsOfUniversityOfMinnesotaMember_ZXk4sItmP06Wo1dejovXIg"
      decimals="2"
      id="Narr_IBM9SqRg_0GBisAwAlDfQA"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">1.69</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:LongTermDebt
      contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_EZhNVV5fvEixIfenKVx60Q"
      decimals="0"
      id="Narr_atB1rl_UTUeU3TfKdzqArw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">106320</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember_La1M4nHdNUqTqG0rxpNa8w"
      decimals="0"
      id="Narr_Z9FZg809kE-pIIEuaGmA2Q"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">172731</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_5_31_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_A9qxS9oZnkya-NmJw5L2zg"
      decimals="0"
      id="Narr_QZFDqaa1AUi_KTp_eo647w"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">250000</us-gaap:DebtInstrumentFaceAmount>
    <miro:SubstantialOwnershipChangePercentage
      contextRef="As_Of_5_31_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_A9qxS9oZnkya-NmJw5L2zg"
      decimals="INF"
      id="Narr_mOOeUJwaFU6-keecoIncWg"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.50</miro:SubstantialOwnershipChangePercentage>
    <miro:DebtInstrumentAdditionalCompensation
      contextRef="As_Of_5_31_2015_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_A9qxS9oZnkya-NmJw5L2zg"
      decimals="0"
      id="Narr_qKwPnkk_UEeGhCm597IHTg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">75000</miro:DebtInstrumentAdditionalCompensation>
    <us-gaap:LongTermDebt
      contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_on7-uRHX1EqyH81rkRruuw"
      decimals="0"
      id="Narr_q_xH_W21c0K44U85HV3rMA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">250000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember_-vxPZ28Xykq2zceJbECjfg"
      decimals="0"
      id="Narr_OwYFbFDP_kujcU0LBE0vCw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">250000</us-gaap:LongTermDebt>
    <us-gaap:CapitalLeasedAssetsGross
      contextRef="As_Of_10_31_2018_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_gG5hkjufDEyK2-0RVsaTHg"
      decimals="0"
      id="Narr_gUGBBTIr80qbUj678P-fQQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">102026</us-gaap:CapitalLeasedAssetsGross>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_10_31_2018_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_gG5hkjufDEyK2-0RVsaTHg"
      decimals="INF"
      id="Narr_lGmM1RtIG0-NKd_0jtUxbg"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.072</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <miro:DebtInstrumentPeriodicMonthlyPaymentNumber
      contextRef="Duration_10_1_2018_To_10_31_2018_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_OZdwLy5NM0Go4Ki1KftRlw"
      decimals="INF"
      id="Narr_RY5Py3pnq0S3zc_M7kk9lw"
      unitRef="Unit_Standard_payment_r6kmSj8FdkWHfPCK9l_Ahg">60</miro:DebtInstrumentPeriodicMonthlyPaymentNumber>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="Duration_10_1_2018_To_10_31_2018_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_OZdwLy5NM0Go4Ki1KftRlw"
      decimals="0"
      id="Narr_x8LT8AXlnkmI8lR2RjFMrg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">2003</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:CapitalLeaseObligations
      contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_bva1e1NEu0CDDbO2hz_bYA"
      decimals="0"
      id="Narr_UKpMb7rOPUmfHfds9yQBwg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">43113</us-gaap:CapitalLeaseObligations>
    <us-gaap:CapitalLeaseObligations
      contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseOctober2018Member_Atsn9P5ITkm9fny6aynNaw"
      decimals="0"
      id="Narr_QNm-TMwZKEa2bN3iZFVg3g"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">57127</us-gaap:CapitalLeaseObligations>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_1_31_2019_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithUniversityOfMinnesotaMember_cdcye0WMqEqRbPNdnP1VxQ"
      decimals="0"
      id="Narr_ArF7cy8d2EWgSt8se8cfbg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">385997</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_1_31_2019_us-gaap_DebtInstrumentAxis_miro_PromissoryNoteWithUniversityOfMinnesotaMember_cdcye0WMqEqRbPNdnP1VxQ"
      decimals="INF"
      id="Narr_SvkOJsIQUkORQH4JcM-7PQ"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="As_Of_1_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsUniversityOfMinnesotaMember_2n5C9faFyUubXOXkidk78w"
      id="Narr_CxHDOO8GDEm4IA40J_6GEQ">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <miro:ClassOfWarrantOrRightNumberOfWarrantsIssued
      contextRef="Duration_1_1_2019_To_1_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsUniversityOfMinnesotaMember_MJIM8ECHsEqx2RTxL_0tQg"
      decimals="INF"
      id="Narr_serHxm36rkquLiF2MIe-bQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">20587</miro:ClassOfWarrantOrRightNumberOfWarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="As_Of_1_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsUniversityOfMinnesotaMember_2n5C9faFyUubXOXkidk78w"
      decimals="2"
      id="Narr_qQxrOqAJ5EmanHqWzB4ODQ"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">3.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <miro:NumberOfShareholders
      contextRef="Duration_3_1_2020_To_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_Bn7cHTalvk6YlTP7ftzPRg"
      decimals="INF"
      id="Narr_ZwYMQgFA8k-tHLSxoEB0-g"
      unitRef="Unit_Standard_shareholder_EnWQEbPDAka0m--RoRqebg">1</miro:NumberOfShareholders>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_KFeJzTMvrEGq3LDu1xCU5Q"
      decimals="0"
      id="Narr_5aCgZsPr9UuxgadS-gYTjA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6000000</us-gaap:DebtInstrumentFaceAmount>
    <miro:DebtInstrumentConvertibleMinimumPreferredStockOffering
      contextRef="As_Of_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_KFeJzTMvrEGq3LDu1xCU5Q"
      decimals="0"
      id="Narr_JfS0zyLTbU2AcezNa4k2jw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">34000000</miro:DebtInstrumentConvertibleMinimumPreferredStockOffering>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_KFeJzTMvrEGq3LDu1xCU5Q"
      decimals="INF"
      id="Narr_UwDmMrGD00G43AYbE-5LRw"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_5_1_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_MVZBEzT7O0S0Q0T1zli4Gw"
      decimals="INF"
      id="Narr_urUm-oNNP0SYfERg4PCXvw"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.07</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease
      contextRef="Duration_6_1_2020_To_6_1_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_0lnUqVT07kOlXfiqqRCW9Q"
      decimals="INF"
      id="Narr_0FJZoJGgYEqyLIVvvG1wkQ"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.02</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="Duration_6_1_2020_To_6_1_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_NAJB56TxHEmziVpHGC_jWw"
      decimals="INF"
      id="Narr_BYc4x6SXaEWm-KYLUF1qQQ"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.20</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="As_Of_3_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_fmQDXKgxeEiyIStEpmlASQ"
      id="Narr_EoWnt-np1E6XckgZVME4kA">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="As_Of_3_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_fmQDXKgxeEiyIStEpmlASQ"
      decimals="0"
      id="Narr_bZ_V9uz2y0aO4vXRGAwvwQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">750000</us-gaap:WarrantsAndRightsOutstanding>
    <miro:WarrantsAndRightsAdditionalCoverage
      contextRef="As_Of_5_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_2H40H7i-ukaCvdguWaUOFw"
      decimals="0"
      id="Narr_4kDHvGaEKE6XmVERFFkZeg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">75000</miro:WarrantsAndRightsAdditionalCoverage>
    <miro:TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest
      contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_VeZ4VJDJtkmpGyjtYu7oNw"
      decimals="INF"
      id="Narr_0pF6KWEyQEWPGEmpD0-S1g"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">956887</miro:TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest>
    <us-gaap:LongTermDebt
      contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_qjeQidbY9E2QpOxvv_Bvsg"
      decimals="0"
      id="Narr_8GY6AcqA_k2d0pKyv4PDNg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_hmQR2sxXt0-QPIS6GgjMrQ"
      decimals="0"
      id="Narr_MrfqItHmakOiLuk-f7h10w"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_4_16_2020_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_K_b8S5kNXUi8BLFNMA8rKw"
      decimals="0"
      id="Narr_jZIVhtrJVE6sao3ECCpARg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">563397</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_4_16_2020_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_K_b8S5kNXUi8BLFNMA8rKw"
      decimals="INF"
      id="Narr_fdeNmSQWZU6kdMR12-AK3w"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <miro:DebtInstrumentPrincipalForgiveness
      contextRef="Duration_3_4_2021_To_3_4_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_YFZmZWhoU0m7w2SwZnEVSQ"
      decimals="0"
      id="Narr_xVpTvMviyEubWe-TZH655w"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">513520</miro:DebtInstrumentPrincipalForgiveness>
    <miro:DebtInstrumentInterestForgiveness
      contextRef="Duration_3_4_2021_To_3_4_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_YFZmZWhoU0m7w2SwZnEVSQ"
      decimals="0"
      id="Narr_6bqe08ccw0iBeVvzIM_wSA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">4530</miro:DebtInstrumentInterestForgiveness>
    <miro:DebtInstrumentPrincipalForgiveness
      contextRef="Duration_8_6_2021_To_8_6_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_FHW-5iosOkaC1XBwtIzjrw"
      decimals="0"
      id="Narr_0pkCWnG_wEuQONSTtMPN-g"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">49877</miro:DebtInstrumentPrincipalForgiveness>
    <miro:DebtInstrumentInterestForgiveness
      contextRef="Duration_8_6_2021_To_8_6_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_FHW-5iosOkaC1XBwtIzjrw"
      decimals="0"
      id="Narr_aBfz9T5JlEm2CC5xlh7j5A"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">440</miro:DebtInstrumentInterestForgiveness>
    <us-gaap:LongTermDebt
      contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_lP4_QEOZzE2bhzXyZUrCrQ"
      decimals="0"
      id="Narr_xS1HIU5XhESrKmHwwOZtvw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_miro_PaycheckProtectionProgramMember_m4hqd27BVkSFna6qz43sIQ"
      decimals="0"
      id="Narr_Dj0tSd86GEOncsHOAQutmw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">563397</us-gaap:LongTermDebt>
    <us-gaap:CapitalLeasedAssetsGross
      contextRef="As_Of_7_31_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_ny50Pi8_jEyfyuCfKjRFVA"
      decimals="0"
      id="Narr_9TbRz4YM60ihHsbYpSBEbw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">44251</us-gaap:CapitalLeasedAssetsGross>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_7_31_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_ny50Pi8_jEyfyuCfKjRFVA"
      decimals="3"
      id="Narr_x6uTwDtz6kmT8A3BF2t-Iw"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <miro:DebtInstrumentPeriodicMonthlyPaymentNumber
      contextRef="Duration_7_1_2021_To_7_31_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_Jz0WwUyS-E6Z18dHVsppFw"
      decimals="INF"
      id="Narr_KyTDPa-Hu0ir6iiLa49mlg"
      unitRef="Unit_Standard_payment_r6kmSj8FdkWHfPCK9l_Ahg">24</miro:DebtInstrumentPeriodicMonthlyPaymentNumber>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="Duration_7_1_2021_To_7_31_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_Jz0WwUyS-E6Z18dHVsppFw"
      decimals="0"
      id="Narr_62VDSXz-mUastop9Vky-XQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1941</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:CapitalLeaseObligations
      contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseJuly2021Member_We8kS0mQrU-z2lQGO0T3dw"
      decimals="0"
      id="Narr_JRHoflfd7kipvLJHuAB6JA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">37178</us-gaap:CapitalLeaseObligations>
    <us-gaap:CapitalLeasedAssetsGross
      contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_QDAsoSke6UmzGRrYBpT5Ug"
      decimals="0"
      id="Narr_YyCUVBFqm0KFHBkgP-CWPA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">43317</us-gaap:CapitalLeasedAssetsGross>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_QDAsoSke6UmzGRrYBpT5Ug"
      decimals="3"
      id="Narr_2Mmxoq1ppUW_CZUdg4Ambg"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.068</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <miro:DebtInstrumentPeriodicMonthlyPaymentNumber
      contextRef="Duration_9_1_2021_To_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_XoFDCEt86EOimiVOhB2Tgw"
      decimals="INF"
      id="Narr_5E6i5b23006GRojeUTNq_w"
      unitRef="Unit_Standard_payment_r6kmSj8FdkWHfPCK9l_Ahg">36</miro:DebtInstrumentPeriodicMonthlyPaymentNumber>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="Duration_9_1_2021_To_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_XoFDCEt86EOimiVOhB2Tgw"
      decimals="0"
      id="Narr_micB3tCqBkakpqIN_AiIvQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1448</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:CapitalLeaseObligations
      contextRef="As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_miro_CapitalLeaseSeptember2021Member_QDAsoSke6UmzGRrYBpT5Ug"
      decimals="0"
      id="Narr_lw93ITQ_WUCO83hU257lOA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">42319</us-gaap:CapitalLeaseObligations>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_lH1KONhxIUmykJDX1GhD1Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Debt&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Capital Lease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,481,774&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,855&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,500,629&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 504,354&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 20,261&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 524,615&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,011&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,011&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 385,997&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 385,997&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Totals&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,372,125&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 57,127&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,429,252&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less current portion &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,481,774)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (18,855)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,500,629)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term portion &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 890,351&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 38,272&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 928,623&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Debt&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Capital Lease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 333,223&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 52,938&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 386,161&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 23,097&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 51,008&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 74,105&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,664&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,664&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 385,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 385,997&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Totals &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 742,317&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 122,610&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 864,927&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less current portion &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (333,223)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (52,938)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (386,161)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term portion &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 409,094&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 69,672&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 478,766&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths
      contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA"
      decimals="0"
      id="Tc_kLPigzBzeUSVqi2axgt8xw_2_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6481774</miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths>
    <miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths
      contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w"
      decimals="0"
      id="Tc_RorQ5tXcmUCjyE5uDQdLzg_2_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">18855</miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths>
    <miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_iIMpnh-8EUOui5nPob0D7Q_2_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6500629</miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo
      contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA"
      decimals="0"
      id="Tc_WuGrn22vx0GO-_5ICsABQg_3_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">504354</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo
      contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w"
      decimals="0"
      id="Tc_8Fm-moaemEGv7tv_8V7IKA_3_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">20261</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_aUrwQKAotkWteLCOkPSN2g_3_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">524615</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree
      contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w"
      decimals="0"
      id="Tc_-OhDZR4pckmf8s2XNCsltg_4_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">18011</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_1wadrcFH5EuXpsNRHo3Xmw_4_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">18011</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive
      contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA"
      decimals="0"
      id="Tc_xeqhKwBnmEC4A-Bgr41bGQ_6_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">385997</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_K55nA1A7vEKE3dkIyQLURw_6_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">385997</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive>
    <miro:DebtAndCapitalLeaseObligationsGross
      contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA"
      decimals="0"
      id="Tc_bp4QypgLPUS3L2P8g_ckVw_7_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">7372125</miro:DebtAndCapitalLeaseObligationsGross>
    <miro:DebtAndCapitalLeaseObligationsGross
      contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w"
      decimals="0"
      id="Tc_fScKERAMIUSTSYNHTSTYxQ_7_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">57127</miro:DebtAndCapitalLeaseObligationsGross>
    <miro:DebtAndCapitalLeaseObligationsGross
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_b-w35YVIREqXdpGvJ6EwOA_7_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">7429252</miro:DebtAndCapitalLeaseObligationsGross>
    <miro:DebtAndCapitalLeaseObligationsGrossCurrent
      contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA"
      decimals="0"
      id="Tc_SrIOE4vVE0SHVMd8JWCb4g_8_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6481774</miro:DebtAndCapitalLeaseObligationsGrossCurrent>
    <miro:DebtAndCapitalLeaseObligationsGrossCurrent
      contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w"
      decimals="0"
      id="Tc_O9QEC9TZi0G1_wGZQ46wcA_8_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">18855</miro:DebtAndCapitalLeaseObligationsGrossCurrent>
    <miro:DebtAndCapitalLeaseObligationsGrossCurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_P-QN6-Nik0urEudb7WEjPA_8_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6500629</miro:DebtAndCapitalLeaseObligationsGrossCurrent>
    <miro:DebtAndCapitalLeaseObligationsGrossNoncurrent
      contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember__pQ9JeES00GpblJ84aA_OA"
      decimals="0"
      id="Tc_Cg5ezGm6G0K0fpcUSxSe7g_9_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">890351</miro:DebtAndCapitalLeaseObligationsGrossNoncurrent>
    <miro:DebtAndCapitalLeaseObligationsGrossNoncurrent
      contextRef="As_Of_12_31_2020_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_cIbKbE96EUKkWUJXANad1w"
      decimals="0"
      id="Tc_ZEi_nNIV3UWMiYQSw8fhKA_9_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">38272</miro:DebtAndCapitalLeaseObligationsGrossNoncurrent>
    <miro:DebtAndCapitalLeaseObligationsGrossNoncurrent
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Tc_RkYbCXV3_UWujvtPDSEYUg_9_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">928623</miro:DebtAndCapitalLeaseObligationsGrossNoncurrent>
    <miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths
      contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ"
      decimals="0"
      id="Tc_vKXthKnSuESY5UySPNpKcQ_3_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">333223</miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths>
    <miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths
      contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw"
      decimals="0"
      id="Tc_GbHDbMw-e0Sx8PWnWI3Gzg_3_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">52938</miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths>
    <miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_xOlUP5YGnkaWTHiMZZ0awg_3_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">386161</miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo
      contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ"
      decimals="0"
      id="Tc_4wiUMLaHg0ulPu4A3Xd_Aw_4_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">23097</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo
      contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw"
      decimals="0"
      id="Tc_VI4TkBdxukGsNi1b_WsRKg_4_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">51008</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_ErPd5p41pUOkVp4Mnh4R2g_4_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">74105</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree
      contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw"
      decimals="0"
      id="Tc_APEimxsyJkCFcxLBD24QwQ_5_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">18664</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_lfsVii5HrkiNeKQKq29rbQ_5_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">18664</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour
      contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ"
      decimals="0"
      id="Tc_AGNFevvUrkqzWqBUeyowjA_6_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">385997</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour>
    <miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_KGo_EoHel0SvtKLJvHiYRg_6_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">385997</miro:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ"
      decimals="0"
      id="Tc_LiO2ABPxAEOFEqEk7a8nag_7_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">742317</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw"
      decimals="0"
      id="Tc_OmtkIvdvqUOPcWm8a804zA_7_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">122610</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_gt3GmokWhUWRHkXjIyL_UQ_7_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">864927</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ"
      decimals="0"
      id="Tc_w6Z1M1TDP02ahuMaChijvg_8_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">333223</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw"
      decimals="0"
      id="Tc_fqyp4siVNk-9uJ-ghqPguA_8_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">52938</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_dt1QAkp5I0CC79oNRvSxMg_8_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">386161</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LongTermDebtMember_SlCUidPxO0a6FaczqAz-QQ"
      decimals="0"
      id="Tc_jwHT6pFp10a80jeFJ5Tuqw_9_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">409094</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="As_Of_9_30_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember_mLT-R8xQ5ke0f4mOKfIUhw"
      decimals="0"
      id="Tc_leIYNuWtmUWkYqNKKCtLhQ_9_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">69672</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_Z2lPURKNMEmjthtLrRz41Q_9_9"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">478766</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <miro:ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_ISwHjizDiE2PmA_hIt3kkw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;NOTE&#160;8&#160;&#x2014; CAPITAL STOCK&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Convertible Preferred Stock&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Immediately prior to the IPO, the Company had the following outstanding convertible preferred stock:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Aggregate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Liquidation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Authorized&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Outstanding&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Preference&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible Preferred Stock - Series C&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,100,000&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,671,554&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;$ 27,536,655&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible Preferred Stock - Series B-2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,500,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,095,874&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,719,055&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible Preferred Stock - Series B&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,000,000&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,218,282&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,137,115&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible Preferred Stock - Series A&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,300,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,000,380&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,500,950&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,900,000&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,986,090&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;$ 74,893,775&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Upon the closing of the IPO, all shares of convertible preferred stock then outstanding were automatically converted into an aggregate of 12,139,071 shares of common stock, resulting in the reclassification of the related convertible preferred stock into $121 of common stock and $73.7 million into additional paid-in capital.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;As of September 30, 2021, there were no shares of convertible preferred stock outstanding.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Common Stock&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;All of the shares sold by the Company in the IPO were common stock. The Company is authorized to issue 190,000,000 shares of common stock, with a par value of $0.00001. Holders of common stock are entitled to one vote for each share held on all matters submitted to a vote of common shareholders, as provided in the Post-IPO Certificate. Subject to preferences that may be applicable to any outstanding preferred shares, each share of common stock is entitled to share pro rata in any distributions. In any distribution of capital assets, holders of common stock are entitled to receive pro rata the assets remaining after payment of liabilities and liquidation preferences on any outstanding preferred stock.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In 2020, the Company issued 64,000 and 1,000 shares of common stock in connection with the exercise of stock option agreements at exercise prices of $0.10 and $1.25 per share, respectively. The Company also issued 45,000 shares of common stock in connection with the exercise of stock warrant agreements at an exercise price of $1.25 per share.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In 2019, the Company issued 50,000 shares of common stock in connection with the exercise of stock option agreements at exercise price of $1.25 per share.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;At December 31, 2020, there were 2,185,822 shares of common stock issued and &lt;span style="-sec-ix-hidden:Hidden_GdaMreGh4UWpAbI1JPGEhQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"&gt;outstanding&lt;/span&gt;&lt;/span&gt;. At September 30, 2021, there were 20,254,645 shares of common stock issued and &lt;span style="-sec-ix-hidden:Hidden_WX4Ga6iaZ02G6yjt970rOA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"&gt;outstanding&lt;/span&gt;&lt;/span&gt;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Preferred Stock&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company is authorized to issue 10,000,000 shares of preferred stock, with a par value of $0.00001, as provided in the Post-IPO Certificate. As of September 30, 2021, there were no shares of preferred stock issued and &lt;span style="-sec-ix-hidden:Hidden_DNi9Vf20okCb087fMwdOZw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"&gt;outstanding&lt;/span&gt;&lt;/span&gt;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company previously classified its Series&#160;A Convertible Preferred Stock, Series&#160;B Convertible Preferred Stock, Series&#160;B-2 Convertible Preferred Stock, and Series C Convertible Preferred Stock as mezzanine equity due to their liquidation provisions under a change in control.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Series&#160;C Convertible Preferred Stock&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In May 2021, the Company entered into two stock purchase agreements under which it sold an aggregate of 2,666,667 shares of Series C Preferred Stock at $7.50 per share for gross proceeds of $20,000,003. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In June 2021, the $6,000,000 Note issue by the Company in March 2020 (See Note 7) and all accrued interest was converted into 956,887 shares of Series C Preferred Stock. On the same date, the Warrant issued in connection with the Note was converted into 48,000 shares of Series C Preferred Stock via a cashless exercise.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The Series C Preferred Stock converted into common stock at a 20% discount to the price to the public in the IPO.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;As of September 30, 2021, all 3,671,554 shares of the Series C Preferred Stock had been converted into common stock and none remained outstanding.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Stock Options&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In February 2010, the Company adopted a stock option plan (the &#x201c;2010 Plan&#x201d;) which authorized options to acquire 375,000 shares of the Company&#x2019;s common stock. On June&#160;20, 2011, the number of shares authorized to be issued as options under the 2010 Plan was increased to 600,000. On September&#160;30, 2013, the number of shares authorized to be issued as options under the 2010 Plan was increased to 1,300,000. On March&#160;1, 2014, the number of shares authorized to be issued as options under the 2010 Plan was increased to 1,700,000. On July&#160;31, 2015, the number of shares authorized to be issued as options under the 2010 Plan was increased to 2,500,000 shares. On August&#160;12, 2016, the number of shares authorized to be issued as options under the 2010 Plan was increased to 3,250,000 shares. On December&#160;13, 2017, the number of shares authorized to be issued as options under the 2010 Plan was increased to 3,850,000 shares. At September 30, 2021, there were 2,876,305 options outstanding under the 2010 Plan and 0 options available for grant. At December&#160;31, 2020, there were 3,287,230 options outstanding under the 2010 Plan and 0 options available for grant. The Company ceased making awards under the 2010 Plan upon approval of the 2019 Plan.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In July 2019, the Company adopted a stock option plan (the &#x201c;2019 Plan&#x201d;) which authorized options to acquire 1,000,000 shares of the Company&#x2019;s common stock. At September 30, 2021, there were 377,000 options outstanding under the 2019 Plan and 0 options available for grant. At December&#160;31, 2020, there were 481,500 options outstanding under the 2019 Plan and 518,500 options available for grant. The Company ceased making awards under the 2019 Plan upon stockholder approval of the 2021 Plan.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;On May 20, 2021, the Company&#x2019;s stockholders approved the 2021 Equity Incentive Plan (the &#x201c;2021 Plan&#x201d;). The 2021 Plan provides for the issuance of stock options, restricted stock units and other awards to employees, directors and consultants of the Company. The number of shares of common stock that may be the subject of awards issued under the 2021 plan is 1,000,000. In addition, shares of common stock that would have otherwise been available under our 2019 Plan will increase the number of shares of common stock available for issuance under our 2021 plan. Shares of common stock subject to outstanding awards under the 2019 Plan that would otherwise return to the share reserve of the 2019 plan upon expiration, forfeiture, retention by the Company to satisfy any exercise price or any tax withholding, repurchase by the Company at their original purchase price, or settlement in cash of awards outstanding under the 2019 Plan may be added to the number of shares of common stock available for issuance under the 2021 Plan. The number of shares of common stock reserved for issuance under our 2021 Plan will automatically increase on the first day of each year, beginning on January 1, 2022, in amount equal to the lesser of (a) 4.5% of the total number of shares of common stock outstanding on December 31 of the immediately preceding calendar year, (b) 600,000 shares of common stock, or (c) such lesser number of shares as determined by the Board. At September 30, 2021, there were 244,831 awards outstanding and 1,323,169 awards available for grant under our 2021 Plan.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The following is a summary of options to purchase common stock during the nine&#160;months ended September 30 (unaudited):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:25.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Nine months ended &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:25.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;September&#160;30,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Weighted &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Average &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Exercise&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Options outstanding at beginning of the period &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,768,730&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.15&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Granted &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 215,500&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 9.99&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Exercised &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (381,866)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2.10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Canceled or expired &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (137,559)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.01&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Options outstanding at end of the period &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,464,805&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.70&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Options Exercisable &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,075,006&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.29&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The weighted average fair value of options granted for the nine months ended September 30, 2021 and 2020 was $4.33 and $0.94 per share, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;As of September 30, 2021, there were 3,464,805 common stock options outstanding with a weighted average remaining contractual life of &lt;span style="color:#231f20;"&gt;4.73&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial','Helvetica','sans-serif';"&gt;&#160;&lt;/span&gt;&lt;span style="color:#231f20;"&gt;years.&lt;/span&gt; As of December&#160;31, 2020, there were 3,768,730 common stock options outstanding with a weighted average remaining contractual life of 5.08&#160;years&lt;span style="color:#231f20;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;As of September 30, 2021, there were 3,075,006 common stock options exercisable with a weighted average remaining contractual life of &lt;span style="color:#231f20;"&gt;4.19&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial','Helvetica','sans-serif';"&gt;&#160;&lt;/span&gt;&lt;span style="color:#231f20;"&gt;years. &lt;/span&gt;As of December&#160;31, 2020, there were 3,426,440 common stock options exercisable with a weighted average remaining contractual life of 4.74&#160;years.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The intrinsic value of the outstanding options as of September 30, 2021 and December&#160;31, 2020 was $11,962,604 and $1,906,200, respectively. The intrinsic value of the exercisable options as of September 30, 2021 and December 31, 2020 was $11,342,114 and $1,906,200, respectively. The intrinsic value of options exercised was $1,418,173 and $1,915,060 for the three and nine months ended September 30, 2021, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company recognized $167,469 and $157,398 of stock-based compensation related to option grants during the three&#160;months ended September 30, 2021 and 2020, respectively, and $450,300 and $472,194 of stock-based compensation related to option grants during the nine&#160;months ended September 30, 2021 and 2020, respectively. As of December&#160;31, 2020, there was $562,456 of unrecognized compensation costs related to stock option grants of which $280,269, $182,465, $61,890 and $37,832 is expected to be recognized during the years ending December 31, 2021, 2022, 2023 and 2024, respectively. As of September 30, 2021, there was $1,106,705 of unrecognized compensation costs related to stock option grants of which $98,154, $391,038, $274,705, $255,880 and $86,929 is expected to be recognized during the years ending December 31, 2021, 2022, 2023, 2024, and 2025 respectively. The Company issues new common shares for options exercised.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Black-Scholes Assumptions&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option grants with the following weighted average assumptions:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100.14%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Nine months ended &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:10.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:10.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;Expected life in years &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 5.99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 5.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;Risk-free interest rate &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 1.16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 0.67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;Expected dividend yield &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;Expected volatility &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 44.30&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 35.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Restricted Stock Units&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"&gt;During the nine months ended September 30, 2021, the Company granted directors restricted stock unit (&#x201c;RSU&#x201d;) awards totaling 33,331 shares of common stock under the 2021 Plan in accordance with the Company&#x2019;s non-employee director compensation policy. Each RSU is eligible to vest over time and settle into one newly issued share of Company common stock. The weighted average fair value of $9.00 per unit was calculated based upon the IPO stock price.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"&gt;As of September 30, 2021, there was $250,000 of unrecognized compensation costs related to restricted stock units of which $50,000, $125,000, $50,000 and $25,000 is expected to be recognized during the years ending December 31, 2021, 2022, 2023 and 2024 respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;2021 Employee Stock Purchase Plan&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"&gt;On May 20, 2021, the Company&#x2019;s stockholders adopted the 2021 Employee Stock Purchase Plan (&#x201c;2021 ESPP&#x201d;), which became effective in connection with the Company&#x2019;s IPO. The 2021 ESPP allows eligible employees to purchase shares of the Company&#x2019;s common stock in an offering on each purchase date no less than 85% of the lower of (i) the closing market price per share of common stock on the first day of the applicable purchase period or (ii) the closing market price per share of common stock on the purchase date at the end of the applicable six-month purchase period. No participant will have the right to purchase shares in an amount that has a fair value of more than $25,000 determined as of the first day of the applicable purchase period, for each calendar year, nor purchase more than 5,000 shares of common stock on any one purchase date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"&gt;There were 300,000 shares of common stock initially reserved for issuance under the 2021 ESPP. In addition the 2021 ESPP contains a provision which provides for an automatic annual share increase on January 1 of each year, in an amount equal to the lesser of (i) 1% of the total number of shares outstanding as of December 31 of the immediately preceding calendar year, (ii) 200,000 shares or (iii) such number of shares as determined by the Board.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"&gt;The Company accounts for employee stock purchases made under its 2021 ESPP using the estimated grant date fair value of accounting in accordance with ASC 718, &lt;i style="font-style:italic;"&gt;Stock Compensation&lt;/i&gt;. The Company values ESPP shares using the Black-Scholes model.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"&gt;There were no shares issued under the 2021 ESPP during the three and nine months ended September 30, 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Stock Warrants&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Information with respect to warrants is summarized as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;white-space:nowrap;width:13.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Series A Preferred&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Common warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Warrants outstanding December&#160;31,&#160;2018&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 732,082&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 20,587&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Terminated&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Warrants outstanding December&#160;31,&#160;2019&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 752,669&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; (45,000)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Terminated&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; (40,000)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Warrants outstanding December&#160;31,&#160;2020&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 707,669&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 276,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; (32,790)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Terminated&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Warrants outstanding September&#160;30,&#160;2021 (unaudited)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 950,879&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average exercise price:&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;September&#160;30,&#160;2021 (unaudited)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;4.53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2020&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;2.34&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2019&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;2.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;2.27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average remaining contractual life in years:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;September&#160;30,&#160;2021 (unaudited)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;2.56&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;2.32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2019&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;0.83&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;3.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</miro:ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_Y0GXwhtmaki1bZn1FFX0_w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Aggregate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Liquidation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Authorized&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Outstanding&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Preference&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible Preferred Stock - Series C&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,100,000&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,671,554&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;$ 27,536,655&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible Preferred Stock - Series B-2&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,500,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,095,874&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,719,055&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible Preferred Stock - Series B&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,000,000&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,218,282&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,137,115&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible Preferred Stock - Series A&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,300,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,000,380&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,500,950&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,900,000&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,986,090&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;$ 74,893,775&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_iKt7zxYygUezKqnAXBiqsQ"
      decimals="INF"
      id="Tc_jTXc0hhc9EyxAgn3Ie3mog_5_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">6100000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_iKt7zxYygUezKqnAXBiqsQ"
      decimals="INF"
      id="Tc_NCDVIJ0YKEeCAoC-Am4qEw_5_4"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3671554</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_iKt7zxYygUezKqnAXBiqsQ"
      decimals="0"
      id="Tc_1ikDtRPKPEqbAHjJS1RpWA_5_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">27536655</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_hOJYsLwUhE-2VMUraYrYJA"
      decimals="INF"
      id="Tc_gEna43-BOkaveouMtFay2A_6_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2500000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_hOJYsLwUhE-2VMUraYrYJA"
      decimals="INF"
      id="Tc_lS7s_X93_EC7yDttOASMbg_6_4"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2095874</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_hOJYsLwUhE-2VMUraYrYJA"
      decimals="0"
      id="Tc_-ZkEh4EZ40qNg78q-5hv6Q_6_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">15719055</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_P0FovK3_vEmt4Nbg26vc9g"
      decimals="INF"
      id="Tc_ZNJGHi2F0UekpqhQDAjJnA_7_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">4000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_P0FovK3_vEmt4Nbg26vc9g"
      decimals="INF"
      id="Tc_sJz_NaIKTkeIcp_UAf1RiQ_7_4"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3218282</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_P0FovK3_vEmt4Nbg26vc9g"
      decimals="0"
      id="Tc_R2ZZsoyVMkqIfJ5kf8Q1yQ_7_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">24137115</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_Ho_LSq9GrEC0Bq3haRfarQ"
      decimals="INF"
      id="Tc_lYsT4qBEl0evNpotk0xPFg_8_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3300000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_Ho_LSq9GrEC0Bq3haRfarQ"
      decimals="INF"
      id="Tc_Zw9KhN4d2k-shPvbJH9Rkg_8_4"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3000380</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesConvertiblePreferredStockMember_Ho_LSq9GrEC0Bq3haRfarQ"
      decimals="0"
      id="Tc_G3HLBtaDhEmUlzmsjOwD_Q_8_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">7500950</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="As_Of_5_31_2021_J4lgZ-q5v02aj1SQxigv9w"
      decimals="INF"
      id="Tc_IYZEIY-KH02gjym4yB5Chg_9_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">15900000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_5_31_2021_J4lgZ-q5v02aj1SQxigv9w"
      decimals="INF"
      id="Tc_P9wfWMewuEim2iABFTgbHQ_9_4"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">11986090</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="As_Of_5_31_2021_J4lgZ-q5v02aj1SQxigv9w"
      decimals="0"
      id="Tc_m01bZvx5o02RYNwhdMj_vQ_9_6"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">74893775</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Q9R7jNA_kk6E26TVZk6K5Q"
      decimals="INF"
      id="Narr_P94CvedodEGuJ-kAVXzXGA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">12139071</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_Q9R7jNA_kk6E26TVZk6K5Q"
      decimals="0"
      id="Narr_syfrGjwmJEWG9YDSBKyN7Q"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">121</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_jgndyTBo4kmjINCHYzZc9Q"
      decimals="-5"
      id="Narr_VyPdbj7ZSESwutEd0At3kA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">73700000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Narr_Zktvjk_gy0ClXB0E2ZYcYA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Narr_MhAz_dLoG0u29RtLT7-_tA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">190000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Narr_3i_mb0NP70SjMb23DH3KPg"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <miro:NumberOfVotesForCommonStockHolders
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Narr_Riyw1bxpg0e7yckFpNqumA"
      unitRef="Unit_Standard_Vote_5PNXDYCebUiYVCiCDg0ocw">1</miro:NumberOfVotesForCommonStockHolders>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_miro_ExercisePriceOf0.10Member_xehDfIZz-EWtTdFbk8j1fQ"
      decimals="INF"
      id="Narr_qjkcCU-3SkWOe1LGSY0NJA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">64000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_miro_ExercisePriceOf1.25Member_oooEOJ4y2kee2kSZatqRNg"
      decimals="INF"
      id="Narr_HRRPw21RQkWZxzudufQh7A"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">1000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_miro_ExercisePriceOf0.10Member_xehDfIZz-EWtTdFbk8j1fQ"
      decimals="INF"
      id="Narr_7FkLTCFidU-9rPHhlwoeyA"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">0.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_miro_ExercisePriceOf1.25Member_oooEOJ4y2kee2kSZatqRNg"
      decimals="INF"
      id="Narr_lp5s4mibAEyYOKEoxw3fow"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">1.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <miro:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_B2zSRfZBIkue8c0XT4p-dw"
      decimals="INF"
      id="Narr_BOqQEA-OS0CGpRrwf2NNUA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">45000</miro:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="INF"
      id="Narr_uxovBIRCNEe5xRDOn3W1NA"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">1.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2019_To_12_31_2019_tNkW5JyZSEem2SQQAsVb6w"
      decimals="INF"
      id="Narr_btpZyAPHOEinrfyalOh23A"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">50000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2019_To_12_31_2019_tNkW5JyZSEem2SQQAsVb6w"
      decimals="INF"
      id="Narr_vtq2CzupH0yl8JWkLxh0Fg"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">1.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="INF"
      id="Narr_cnTwmCHxFUGCWKfjdv4hTw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2185822</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Narr_N5f3ajCHH0y1L8Q4bZDkdA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">20254645</us-gaap:CommonStockSharesIssued>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Narr_l5-YomqlgEupX6d7wfrS3g"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Narr_5pAeh-tTO0i0d-qgBkuUNw"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Narr_8iMpC9C3m0y18z7Bhi4U5g"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:PreferredStockSharesIssued>
    <miro:NumberOfStockPurchaseAgreements
      contextRef="Duration_5_1_2021_To_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_2kXm4JqYrUGIQ5XQlQ4tBQ"
      decimals="INF"
      id="Narr_xGR2Fm9tRESWhnalkooNAQ"
      unitRef="Unit_Standard_agreement_od-gDHq4Z0WVrTpltuYtzw">2</miro:NumberOfStockPurchaseAgreements>
    <miro:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="Duration_5_1_2021_To_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_2kXm4JqYrUGIQ5XQlQ4tBQ"
      decimals="INF"
      id="Narr_gaeo2lIye0ugEtIWkWOh3g"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2666667</miro:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="As_Of_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_iKt7zxYygUezKqnAXBiqsQ"
      decimals="INF"
      id="Narr_DGioDeDkFEaFJNC0OUQaMQ"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">7.50</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="Duration_5_1_2021_To_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_2kXm4JqYrUGIQ5XQlQ4tBQ"
      decimals="0"
      id="Narr_Eh9LVK3pi0mtrcTEODYDvg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">20000003</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_3_31_2020_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_ez_THl-rSUu9GNrnq2nCuA"
      decimals="0"
      id="Narr_Dl97VncYQEaODS0dSy5SMg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">6000000</us-gaap:DebtInstrumentFaceAmount>
    <miro:TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest
      contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_DebtInstrumentAxis_miro_NoteCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_VeZ4VJDJtkmpGyjtYu7oNw"
      decimals="INF"
      id="Narr_w_Hr0JtnvEaaweafmICzeg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">956887</miro:TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest>
    <miro:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="Duration_6_1_2021_To_6_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsCompanyShareholderMember_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_eJwJJs9VSkeObpA8PJb8LQ"
      decimals="INF"
      id="Narr_OTIYwFrfGEyxbownLoP_dg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">48000</miro:StockIssuedDuringPeriodSharesWarrantsExercised>
    <miro:StockConversionDiscount
      contextRef="As_Of_6_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_gq9MkhmKcki_IgIkqiLqdA"
      decimals="INF"
      id="Narr_1JPArNbRp0q7lRXOe7gU7g"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.20</miro:StockConversionDiscount>
    <miro:TemporaryEquitySharesConvertedInPeriod
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_1_QI08EAgkeFGMJvDi62nw"
      decimals="INF"
      id="Narr_JfSRQc6cUEOTGUXDOwtJXg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3671554</miro:TemporaryEquitySharesConvertedInPeriod>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="As_Of_9_30_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_ze4CSI6Mzk-ZR5OI8HnD8w"
      decimals="INF"
      id="Narr_4Ulp8_ctjUOMRY5o6JYIbA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="As_Of_2_28_2010_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_KR1v8aGoW06UTHLbKbrWzg"
      decimals="INF"
      id="Narr_rI_y9AFj0UacEufpuZ5BIw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">375000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="As_Of_6_20_2011_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_p8iI4CpuukSW-_z9m6tgFw"
      decimals="INF"
      id="Narr_UTgNczwVrEe_u7my7--zmA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="As_Of_9_30_2013_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_jitbOwlHxEatY3c8sdyT8Q"
      decimals="INF"
      id="Narr_KPIG5oX4NES7WFyhi3oFtg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="As_Of_3_1_2014_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_B1MdDsK4eU6ABBhy1iHGqQ"
      decimals="INF"
      id="Narr_Bhp67QDycE23asbAmwLsLQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="As_Of_7_31_2015_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_IOV5CcCN1kafEI0aNGuk7A"
      decimals="INF"
      id="Narr_qnCgBGj6Q0SKBI-eXLvhuQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="As_Of_8_12_2016_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_bHSdVDHwNkir9pwGVxJShw"
      decimals="INF"
      id="Narr_DR5mawXaB0qheKMJdAsGyg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="As_Of_12_13_2017_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_6aqbm-JWHUKb0XhszArtdQ"
      decimals="INF"
      id="Narr_DFPSH3o4DEaj-TlAH7VVZg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3850000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_lHsE8nx05E6MJohdoQuOHw"
      decimals="INF"
      id="Narr_QanRAKDEo0-6WzvAipaVJw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">2876305</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_lHsE8nx05E6MJohdoQuOHw"
      decimals="INF"
      id="Narr_PCx4J6va4UOGB1HRqCpknQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2020_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_McJXXc_Kf0uPYR-o6Dcyzw"
      decimals="INF"
      id="Narr_yVYs5NLTCEuRBoDJocQqzA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3287230</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="As_Of_12_31_2020_us-gaap_PlanNameAxis_miro_StockOptionPlan2010Member_McJXXc_Kf0uPYR-o6Dcyzw"
      decimals="INF"
      id="Narr_rVdH3aUphEumpbj-ScmzxA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="As_Of_7_31_2019_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_C6HVYrURKkyIQjOgOtfdLA"
      decimals="INF"
      id="Narr_C2zFa5mWGUSFLZxXpNkEkg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_9z94lpGqiUK-UGTQzRUXmg"
      decimals="INF"
      id="Narr_Bc_ftQrQt0CBZ0yIUyeA1A"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">377000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_9z94lpGqiUK-UGTQzRUXmg"
      decimals="INF"
      id="Narr_bXdepU4-ZkmobTEF2XMXfQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2020_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_o6eAWaymy0yRcfbd6hpu6g"
      decimals="INF"
      id="Narr_hD6qa_a3rEymOxpCstsovg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">481500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="As_Of_12_31_2020_us-gaap_PlanNameAxis_miro_StockOptionPlan2019Member_o6eAWaymy0yRcfbd6hpu6g"
      decimals="INF"
      id="Narr_se0imehZFUyzbQar-vyC0Q"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">518500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="As_Of_5_20_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_tlUM_j86VUem4H1Fs0WXtA"
      decimals="INF"
      id="Narr_T77-C5-BMka3eLlEof8WQg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease
      contextRef="As_Of_5_20_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_tlUM_j86VUem4H1Fs0WXtA"
      decimals="INF"
      id="Narr_Z07uYBmAUkaJhqtK4xZuXw"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.045</miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease>
    <miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease
      contextRef="Duration_5_20_2021_To_5_20_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_bH9uVGXInE2mfvC2nlVwVA"
      decimals="INF"
      id="Narr_7phMnGVZFEiSIKEXJghsnQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">600000</miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_2DJ3l3afI0CleWh6XWHWoQ"
      decimals="INF"
      id="Narr_dmYruulgDUG5Zr9D8bDRaw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">244831</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="As_Of_9_30_2021_us-gaap_PlanNameAxis_miro_EquityIncentivePlan2021Member_2DJ3l3afI0CleWh6XWHWoQ"
      decimals="INF"
      id="Narr_Yq_fszHw_E2HPAj4MY7PZw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">1323169</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_TK-jJtqhc0KRauu5KLgmFg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:25.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Nine months ended &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:25.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;September&#160;30,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Weighted &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Average &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Exercise&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Options outstanding at beginning of the period &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,768,730&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.15&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Granted &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 215,500&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 9.99&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Exercised &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (381,866)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 2.10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Canceled or expired &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (137,559)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.01&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Options outstanding at end of the period &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,464,805&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.70&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Options Exercisable &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3,075,006&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 3.29&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="INF"
      id="Tc_D-1_62cQSkek4jzhLvBAAA_7_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3768730</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="2"
      id="Tc_xsXoM9mqJE-_cZlmBhJV9g_7_5"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">3.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="INF"
      id="Tc_KV8QlzSUPE-Hx6AlTZtjsQ_8_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">215500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="2"
      id="Tc_5bG6QxTxh0Oi2EXPkl0HOA_8_5"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">9.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="INF"
      id="Tc_Vfffim2CpUisQlb-hqqT4g_9_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">381866</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="2"
      id="Tc_gwK4JZSADkiMblSpXn_KEA_9_5"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">2.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="INF"
      id="Tc_FaV3HMcmYEirWqSF4y9z1w_10_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">137559</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="2"
      id="Tc_sUXSFytCGUaMl8LU93IQdA_10_5"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">3.01</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Tc_sgftyc4_DkK53FUDL0QiuA_11_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3464805</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="2"
      id="Tc_LLcggoI70UewZEhlaxSdVQ_11_5"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">3.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Tc_aRV6OSBbAUeeS9shy4yrYQ_12_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3075006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="2"
      id="Tc_vKLUJqVW1U6uJMUNZnI70A_12_5"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">3.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="2"
      id="Narr_4cbX7nrs1ketw1ECYPRBOw"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">4.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2020_To_12_31_2020_B2zSRfZBIkue8c0XT4p-dw"
      decimals="2"
      id="Narr_RNBc7AG8OEC6c0mLZXf7rQ"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">0.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Narr_Q5M87DNOp0iOy2S0yYrJ7w"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3464805</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_2_cW6N2MWU-STnfpkgEgAw">P4Y8M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="INF"
      id="Narr_yJuYmD_3YE-meOMUSDTUjw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3768730</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="Duration_1_1_2020_To_12_31_2020_B2zSRfZBIkue8c0XT4p-dw"
      id="Narr__UTWE05RDE-rMzTDie-iBg">P5Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="INF"
      id="Narr_4oweQCCC_0Cb0xMI_iJJlQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3075006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Narr_yT8hmaO4s06F-CLDBwKehw">P4Y2M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="INF"
      id="Narr__X2Q0AzBp0SCZEMLF8Uqpw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3426440</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="Duration_1_1_2020_To_12_31_2020_B2zSRfZBIkue8c0XT4p-dw"
      id="Narr_omOsMkTc0ECfTKl-IYuz2A">P4Y8M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Narr_7A0VTXhjB06xe7npummalw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">11962604</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Narr_b2jqn5kw8kS6YM3ivtnMAQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1906200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Narr_9zA6PL0BpUeMXiiZtQi8_A"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">11342114</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Narr_rQpRkNHES0i5jA8tdr_2jg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1906200</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Narr_DtQuYfxX4kSj8_qCkcg22w"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1418173</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Narr_AKk8EzNV406IXo6DexeZeg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1915060</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Narr_4cgjA9_wjkir2NkVvZ-1tg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">167469</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Narr_apEVF0XleUWzbxK2Qc6HYQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">157398</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Narr_JXMv-YrWqUyJVtiLZmGRCg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">450300</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Narr_wL0HH5RE4kO8SYZu30xUGQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">472194</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Narr_SayZ2mAvJEGXiAfuA4QyPg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">562456</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Narr_UQ_XwJTsb06x8yW2XwGcWQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">280269</miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne>
    <miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Narr_aAUMuNDgfkahdP_nz7Mv3A"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">182465</miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo>
    <miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Narr_DlQT7TEGJ0iTzUaJXab38g"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">61890</miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree>
    <miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour
      contextRef="As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw"
      decimals="0"
      id="Narr_UA9hSV9J1E2k5jWwkeFO8w"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">37832</miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Narr_DpjLdiR5BUqToFBKMFBFzQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1106705</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Narr_exqgou1kqkmHUbk716HGSg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">98154</miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear>
    <miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Narr_tUvLDbH8WkCXNhw9seACxg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">391038</miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne>
    <miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Narr_mhi0k4WIKkSarNXSAgfC0w"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">274705</miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo>
    <miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Narr_AtaTOIa-10SDIpW_4-XsGQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">255880</miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree>
    <miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Narr_JCUfJC37k0-xCDKXMjrz9g"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">86929</miro:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_nDvFMzDqa0K_wllxGh4WBw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100.14%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Nine months ended &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:10.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:10.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;Expected life in years &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 5.99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 5.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;Risk-free interest rate &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 1.16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 0.67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;Expected dividend yield &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;Expected volatility &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 44.30&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 35.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_gR2zVN5q-0a1swvGNHwoWw"
      id="Tc_miN_DSAdcE2J8ZafNYPSFQ_5_2">P5Y11M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_2DY7Kr23UEejqlQcdXp2IQ"
      id="Tc_ib3BvCOnckewr4gQpPKEaQ_5_4">P5Y11M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_gR2zVN5q-0a1swvGNHwoWw"
      decimals="4"
      id="Tc_VP1Vuozbz0OQiJvcXQ62Nw_6_2"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.0116</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_2DY7Kr23UEejqlQcdXp2IQ"
      decimals="4"
      id="Tc_AJD4OVtKMUqI1np_7VqHGA_6_4"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.0067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_gR2zVN5q-0a1swvGNHwoWw"
      decimals="4"
      id="Tc_HAk6rdyQU06RxmyDzwmjmg_8_2"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.4430</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_2DY7Kr23UEejqlQcdXp2IQ"
      decimals="4"
      id="Tc_FH6L4lufLUeGJV6dctkDjA_8_4"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.3500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_YBwL7RLuskyd3vBZWh7WQw"
      decimals="INF"
      id="Narr_CgrrQSpZBEu_G74rZqXe7w"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">33331</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_YBwL7RLuskyd3vBZWh7WQw"
      decimals="2"
      id="Narr_ZaETHvSs4EmEHk4KFhGARA"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">9.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="As_Of_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_1WHSkAXpykyT6aLBtPKDLQ"
      decimals="-3"
      id="Narr_7zqAUzg6N0umU8eIdQG2Zw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">250000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_SBOFqQEpQEyPvYOkIlK1HA"
      decimals="-3"
      id="Narr_JDXdgimkIUeaDPKT8h6lpw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">50000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_A4MlM41kpUeFYHhM3kDtsg"
      decimals="-3"
      id="Narr_JEyX-V3wp0ml1TGdsfxweQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">125000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_XIKPHQwclUmF18L2ad03-g"
      decimals="-3"
      id="Narr_p54O2hfBA02xpcZjnLOHyA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">50000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2024_To_12_31_2024_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_vdIpyWd9LEaTHDagY0ShUQ"
      decimals="-3"
      id="Narr_Z99Xdg0LbUyyQHyukzG-Lg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">25000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="Duration_5_20_2021_To_5_20_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_t8AKALY0zUWWcDB5cdE9FQ"
      decimals="INF"
      id="Narr_52wQSxbOx0GoMJLve5oz0A"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod
      contextRef="Duration_5_20_2021_To_5_20_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_iDuQ8yFyEEqVI8V78JY8tg"
      id="Narr_o-h_MwGFDEqVqN-i5IwHmw">P6M</miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod>
    <miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee
      contextRef="Duration_5_20_2021_To_5_20_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_iDuQ8yFyEEqVI8V78JY8tg"
      decimals="0"
      id="Narr_WT4GoDyL0UqvWwojcLspUg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">25000</miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="Duration_5_20_2021_To_5_20_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_iDuQ8yFyEEqVI8V78JY8tg"
      decimals="INF"
      id="Narr_rs37CJwkDUumby_WtGVOzA"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">5000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="As_Of_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_w0E9NO5A40-QYiUe_4grhw"
      decimals="INF"
      id="Narr_9BrEn7s3sUm9zOEYimd8dQ"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">300000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease
      contextRef="As_Of_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_w0E9NO5A40-QYiUe_4grhw"
      decimals="INF"
      id="Narr_EA40RaUCqkO-gkN5seK2fg"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.01</miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease>
    <miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_EyrEwEwwC0iERsWsXg8aaw"
      decimals="INF"
      id="Narr_CJ4Ao22YS0-hoknEZiVozw"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">200000</miro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="INF"
      id="Narr_TcWfUk8NQ0CbVkslRAQXOg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">0</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_GdrFGXZwU0yhdX5QgOMfkA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;white-space:nowrap;width:13.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Series A Preferred&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Common warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Warrants outstanding December&#160;31,&#160;2018&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 732,082&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 20,587&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Terminated&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Warrants outstanding December&#160;31,&#160;2019&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 752,669&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; (45,000)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Terminated&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; (40,000)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Warrants outstanding December&#160;31,&#160;2020&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 707,669&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 276,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; (32,790)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Terminated&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Warrants outstanding September&#160;30,&#160;2021 (unaudited)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 950,879&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average exercise price:&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;September&#160;30,&#160;2021 (unaudited)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;4.53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2020&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;2.34&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2019&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;2.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;2.27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average remaining contractual life in years:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;September&#160;30,&#160;2021 (unaudited)&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;2.56&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;2.32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2019&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;0.83&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;3.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="As_Of_12_31_2018_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_HGDc3Os7mEWTu-CAaq3ruA"
      decimals="INF"
      id="Tc_gH0uXh-Mp0OA3O7opZtGyQ_3_3"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">40000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="As_Of_12_31_2018_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_qZGOmr_ea0Ows1t9YaOzcw"
      decimals="INF"
      id="Tc_qUg6DZf1LUivsQt_GKXiLA_3_6"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">732082</us-gaap:ClassOfWarrantOrRightOutstanding>
    <miro:ClassOfWarrantOrRightGranted
      contextRef="Duration_1_1_2019_To_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_3gjNoRIV2UGDPT9hi71nlw"
      decimals="INF"
      id="Tc_k1_leAtMnkulV8Q6ACdKpQ_4_6"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">20587</miro:ClassOfWarrantOrRightGranted>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="As_Of_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_NJLzPJiJr0KqVC9ODnYXMg"
      decimals="INF"
      id="Tc_meJ51i-7XkOcMzKM4qF7Ag_7_3"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">40000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="As_Of_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_PzoHbCzBmE6ej-n_Qpwy4w"
      decimals="INF"
      id="Tc_ShKcJnv9Z0eSF7NOGTHpvA_7_6"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">752669</us-gaap:ClassOfWarrantOrRightOutstanding>
    <miro:ClassOfWarrantOrRightExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_N-QYK6IT_0K6cQJR8rQQUw"
      decimals="INF"
      id="Tc_9OiZmiJZLUu_I_VhEUPk3A_9_6"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">-45000</miro:ClassOfWarrantOrRightExercised>
    <miro:ClassOfWarrantOrRightTerminated
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_1dorSEZUh0ybHPBVgUSX4A"
      decimals="INF"
      id="Tc_YWzfV3GywUSqLponMoCBoQ_10_3"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">40000</miro:ClassOfWarrantOrRightTerminated>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_ECMqdRae7ESrv1pIfHDKnQ"
      decimals="INF"
      id="Tc_3P9zRV5KKUWS4vt-PPRXyw_11_6"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">707669</us-gaap:ClassOfWarrantOrRightOutstanding>
    <miro:ClassOfWarrantOrRightGranted
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_YDeFWSbjDkOyTwmafCkiqQ"
      decimals="INF"
      id="Tc_YE8UGeupZ0yRBNelqJ_pWw_12_6"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">276000</miro:ClassOfWarrantOrRightGranted>
    <miro:ClassOfWarrantOrRightExercised
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_YDeFWSbjDkOyTwmafCkiqQ"
      decimals="INF"
      id="Tc_XQQONUgvMkOpZkBs2HdiIw_13_6"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">-32790</miro:ClassOfWarrantOrRightExercised>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="As_Of_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_qaXZChAjbUKzlsfIAO2k2w"
      decimals="INF"
      id="Tc_S_9kYMLnkUqyf6t9tdSHrg_15_6"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">950879</us-gaap:ClassOfWarrantOrRightOutstanding>
    <miro:WarrantsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_qaXZChAjbUKzlsfIAO2k2w"
      decimals="2"
      id="Tc_VaTkcsCLCkqlQZimcUktuw_18_6"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">4.53</miro:WarrantsOutstandingWeightedAverageExercisePrice>
    <miro:WarrantsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_ECMqdRae7ESrv1pIfHDKnQ"
      decimals="2"
      id="Tc_UzqZqw-m6UWkFRH3BKsquA_19_6"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">2.34</miro:WarrantsOutstandingWeightedAverageExercisePrice>
    <miro:WarrantsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_NJLzPJiJr0KqVC9ODnYXMg"
      decimals="2"
      id="Tc_1jTpWF-UgUCZCeKGGPIerg_20_3"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">2.88</miro:WarrantsOutstandingWeightedAverageExercisePrice>
    <miro:WarrantsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_PzoHbCzBmE6ej-n_Qpwy4w"
      decimals="2"
      id="Tc_w_imGlDyd0mQrMZkpXNdZQ_20_6"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">2.27</miro:WarrantsOutstandingWeightedAverageExercisePrice>
    <miro:WarrantsOutstandingWeightedAverageRemainingContractualTerm
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_YDeFWSbjDkOyTwmafCkiqQ"
      id="Tc_1wJY7NbgIEiAm-jRA241FA_23_6">P2Y6M21D</miro:WarrantsOutstandingWeightedAverageRemainingContractualTerm>
    <miro:WarrantsOutstandingWeightedAverageRemainingContractualTerm
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_N-QYK6IT_0K6cQJR8rQQUw"
      id="Tc_FvDz9JO5JUS2iD1u0YKR0A_24_6">P2Y3M25D</miro:WarrantsOutstandingWeightedAverageRemainingContractualTerm>
    <miro:WarrantsOutstandingWeightedAverageRemainingContractualTerm
      contextRef="Duration_1_1_2019_To_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_iRO3LslO3kas_t0T5hUdPQ"
      id="Tc_zEKezr2cC0mC_IO2lX1-YQ_25_3">P0Y9M29D</miro:WarrantsOutstandingWeightedAverageRemainingContractualTerm>
    <miro:WarrantsOutstandingWeightedAverageRemainingContractualTerm
      contextRef="Duration_1_1_2019_To_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_CommonWarrantsMember_3gjNoRIV2UGDPT9hi71nlw"
      id="Tc_LvRweFN230Wn7DPk84pNsw_25_6">P3Y2M23D</miro:WarrantsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:DefinedContributionPlanTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_FogMotxGKkORufscx2Q6Fg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;NOTE&#160;9&#160;&#x2014; EMPLOYEE BENEFIT PLANS&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;The Company&#x2019;s employees are eligible to participate in a defined contribution benefit plan. Employees may contribute a&#160;percentage of their wages, subject to limits established by the Internal Revenue Code. The Company may elect to make discretionary contributions to the plan. There were no discretionary contributions during the three and nine months ended September 30, 2021 and 2020.&lt;/p&gt;</us-gaap:DefinedContributionPlanTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="-3"
      id="Narr_D8ZjpAtQqkyKp8u1igS81g"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="-3"
      id="Narr_0cMbPXEGUUSzcIy2Z37pPg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="-3"
      id="Narr_7glaYRfAb0KCr-gbIPH_6A"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="-3"
      id="Narr_e7ptxEIq7kOUNIrWmbdYRQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_F0UYwIC3tEiLd5oeewylTw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;NOTE&#160;10&#160;&#x2014; SIGNIFICANT CUSTOMERS&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt;"&gt;The Company had one customer that accounted for 100% of total revenue for the three&#160;and nine months ended September 30, 2021 and 2020. The current receivable for this customer is included in Receivable From Reprise Biomedical,&#160;Inc. The long-term receivable related to minimum royalties from this customer has been completely reserved against due to uncertainty regarding collectability.&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <miro:NumberOfCustomers
      contextRef="Duration_1_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_tRMEi9tWY0-0d3TnCQQhlg"
      decimals="INF"
      id="Narr_9YqXaowic0Sh8M8Mhxjbaw"
      unitRef="Unit_Standard_customer_oBpQWOLWXkK3Il-nSeGoKQ">1</miro:NumberOfCustomers>
    <miro:NumberOfCustomers
      contextRef="Duration_7_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_q7UZpcFoxEOYivXSsLQKIA"
      decimals="INF"
      id="Narr_V0a4cmuh_06Cjs9CgTlK8g"
      unitRef="Unit_Standard_customer_oBpQWOLWXkK3Il-nSeGoKQ">1</miro:NumberOfCustomers>
    <miro:NumberOfCustomers
      contextRef="Duration_1_1_2020_To_9_30_2020_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_vwuQIzABmEWaeqLv7nnUlg"
      decimals="INF"
      id="Narr_evJubFEka021ug_LuzSspA"
      unitRef="Unit_Standard_customer_oBpQWOLWXkK3Il-nSeGoKQ">1</miro:NumberOfCustomers>
    <miro:NumberOfCustomers
      contextRef="Duration_7_1_2020_To_9_30_2020_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_1uLdZHYzVEqRW879bg0kPQ"
      decimals="INF"
      id="Narr_u7I2JPprQUShQPmbkhUMlw"
      unitRef="Unit_Standard_customer_oBpQWOLWXkK3Il-nSeGoKQ">1</miro:NumberOfCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_tRMEi9tWY0-0d3TnCQQhlg"
      decimals="2"
      id="Narr_X71UYQcUDUO9URcMMbcnlw"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_7_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_q7UZpcFoxEOYivXSsLQKIA"
      decimals="2"
      id="Narr_jZF9SRzBpUy1CNiosk6soQ"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2020_To_9_30_2020_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_vwuQIzABmEWaeqLv7nnUlg"
      decimals="2"
      id="Narr_cZWKQBX150q3RBJMiiOSRg"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_7_1_2020_To_9_30_2020_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_1uLdZHYzVEqRW879bg0kPQ"
      decimals="2"
      id="Narr_D0FoBHViV0W2TbVtj92FpA"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_nquln7adJkWfiddWnUp8jA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;NOTE&#160;11&#160;&#x2014; COMMITMENTS AND CONTINGENCIES&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Patent License Agreement&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Under an Exclusive Patent License Agreement between the Company and the University (the &#x201c;Agreement&#x201d;) the Company is required to make minimum royalty payments to the University of $500,000 per&#160;year. Under the Patent and Know-How License Agreement with Reprise, Reprise has minimum royalty obligations to the Company of $500,000 per&#160;year. (See Note&#160;12.)&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;Leases&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In February&#160;2015, the Company executed a lease for a facility in Eden Prairie, Minnesota. The Company had leased this facility through March&#160;31, 2020 at a rate of $13,100 per&#160;month with&#160;yearly rent increases of approximately 3% per&#160;year. In November&#160;2019, the lease for the facility was extended to December&#160;31, 2020 at a rate of $15,100 per&#160;month starting April&#160;1, 2020. In August&#160;2020, the lease for this facility was extended to December&#160;31, 2021 at a rate of $16,600 per&#160;month starting in January&#160;2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;In May&#160;2020, the Company executed a lease for a second facility in the same Eden Prairie, Minnesota office park as its other facility. The Company leased this space through December&#160;31, 2020 at a rate of $2,500 per&#160;month starting in May&#160;2020. In August&#160;2020, the lease for this facility was extended to December&#160;31, 2021 at a rate of $3,400 per&#160;month starting in January&#160;2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Total rent expense under operating leases was $60,096 and $52,865 for the three&#160;months ended September 30, 2021 and 2020, respectively, and $183,389 and $148,425 for the nine&#160;months ended September 30, 2021 and 2020, respectively. The Company has future minimum non-cancelable lease commitments as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;At September&#160;30,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 60,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 60,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On August 2, 2021, the Company entered into a Multi-Tenant Industrial Triple Net Lease (the &#x201c;Lease&#x201d;) with B9 Polar Prairie Oaks Corporate LLC, a Delaware limited liability company (the &#x201c;Landlord&#x201d;), for research and development and office space located at 6455 Flying Cloud Drive, Eden Prairie, Minnesota 55344 (the &#x201c;Building&#x201d;). Under the terms of the Lease, starting on December 31, 2021 (the &#x201c;Commencement Date&#x201d;) the Company will lease approximately 42,278 square feet of the Building (the &#x201c;Premises&#x201d;) as the sole tenant at the Premises, which will replace the Company&#x2019;s current leased premises at 10399 West 70&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;th&lt;/sup&gt; Street, Eden Prairie, Minnesota 55344. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The base rent under the Lease is $41,397 per month for the &lt;span style="-sec-ix-hidden:Hidden_Hm1nq61nbUCGgQMTKFG8ew;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;white-space:pre-wrap;"&gt;12-month&lt;/span&gt;&lt;/span&gt;&lt;span style="white-space:pre-wrap;"&gt; period beginning on the Commencement Date and ending on December 31, 2022, and thereafter is subject to scheduled annual increases of approximately 3% during the term of the Lease. However, under the terms of the Lease, the Company&#x2019;s monthly base rent will be abated for the period beginning on the Commencement Date and ending on May 31, 2022, provided the Lease is not terminated due to default. In addition to base rent, the Company is obligated under the Lease to pay to the Landlord certain costs, operating expenses and taxes, including approximately 61.08% of the real property taxes of the Building and the land on which it is located and approximately 61.08% of the Landlord&#x2019;s management fee, which equals an amount of up to 5% of the Landlord&#x2019;s gross receipts from leases at the Building. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The term of the Lease begins on the Commencement Date and ends on May 31, 2029. The Company has one option to extend the term for a period of &lt;span style="white-space:pre-wrap;"&gt;five years&lt;/span&gt;&lt;span style="white-space:pre-wrap;"&gt; beginning on June 1, 2029.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;The Company plans to deliver a security deposit to the Landlord through an irrevocable, standby letter of credit (&#x201c;LOC&#x201d;) issued by Park State Bank in the amount of $800,000 (&#x201c;Security Amount&#x201d;), which will be retained by the Landlord as security for the Company&#x2019;s performance and observance of its obligations under the Lease. To secure the LOC, the Company will be required to place the Security Amount in a restricted cash account at Park State Bank, which may be drawn from in limited circumstances.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration:underline;"&gt;License Contract&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"&gt;On December&#160;1, 2014, the Company entered into a research and development contract with an outside developer. The term of the contract was set to expire on December&#160;31, 2016, but in September&#160;2016 the expiration date was extended to December&#160;31, 2017; in January&#160;2018 the expiration date was extended to June&#160;30, 2019; in May&#160;2019 the expiration date was extended to March&#160;30, 2020; in February&#160;2020 the expiration date was extended to February&#160;28, 2021. In February&#160;2021 the contract was extended to December&#160;31, 2021. As partial consideration for the developer&#x2019;s &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;services, on January&#160;1, 2015, the Company issued 26,667 shares of Series&#160;B preferred stock at a fair value of $7.50 per share. The value of these shares was charged to research&#160;&amp;amp; development expenses in the statements of operations.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <miro:MinimumRoyaltyPayable
      contextRef="As_Of_9_30_2021_srt_CounterpartyNameAxis_miro_UniversityOfMinnesotaMember_us-gaap_TypeOfArrangementAxis_miro_PatentLicenseAgreementMember_jedF-oqTMEuu3qGVMv8CqQ"
      decimals="0"
      id="Narr_GYMPJXaydkeWftGjZVaMPw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">500000</miro:MinimumRoyaltyPayable>
    <miro:MinimumRoyaltyReceivable
      contextRef="As_Of_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_gQqNjbZf3kitvnDKHNvcqQ"
      decimals="0"
      id="Narr_Y97ji8VVrUW9IL-kSc0F1g"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">500000</miro:MinimumRoyaltyReceivable>
    <miro:MonthlyLeaseRentPayments
      contextRef="Duration_2_1_2015_To_2_28_2015_srt_StatementScenarioAxis_miro_Period1Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_P0y2up9X2E6mBHwqP3Cl8A"
      decimals="0"
      id="Narr_7JrU9Qn24keTeItG83AQ6Q"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">13100</miro:MonthlyLeaseRentPayments>
    <miro:IncreaseInYearlyRentPercentage
      contextRef="As_Of_2_28_2015_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_Cl7f8VTFAUeR61K3rR-tWg"
      decimals="INF"
      id="Narr_VE9cNAlboU-22XFs2rOEZw"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">3</miro:IncreaseInYearlyRentPercentage>
    <miro:MonthlyLeaseRentPayments
      contextRef="Duration_11_1_2019_To_11_30_2019_srt_StatementScenarioAxis_miro_Period2Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_A300O00RHU28LyFbFXEpQw"
      decimals="0"
      id="Narr_hNH2ywTzJ0ukYGQrn8n98A"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">15100</miro:MonthlyLeaseRentPayments>
    <miro:MonthlyLeaseRentPayments
      contextRef="Duration_1_1_2021_To_9_30_2021_srt_StatementScenarioAxis_miro_Period3Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_FirstFacilityEdenPrairieMember_rhWhUWLpAkCFncruQK6Agg"
      decimals="0"
      id="Narr_cf3kNIDM3UKXoDwU6BVyow"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">16600</miro:MonthlyLeaseRentPayments>
    <miro:MonthlyLeaseRentPayments
      contextRef="Duration_5_1_2020_To_5_31_2020_srt_StatementScenarioAxis_miro_Period2Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_SecondFacilityEdenPrairieMember_XQsUNAY8E0CKMy7vg7p45g"
      decimals="0"
      id="Narr_HH2QcrpNB0ylSUj7IKupfQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">2500</miro:MonthlyLeaseRentPayments>
    <miro:MonthlyLeaseRentPayments
      contextRef="Duration_1_1_2021_To_9_30_2021_srt_StatementScenarioAxis_miro_Period3Member_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_SecondFacilityEdenPrairieMember_xF6oO6QCv0CweJW-fgnyeA"
      decimals="0"
      id="Narr_Vvs_txhNiEmD389SRsFSJw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">3400</miro:MonthlyLeaseRentPayments>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="0"
      id="Narr_1F2iUc26D0CIG-I6daJLHg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">60096</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="0"
      id="Narr_EOsBjQSEcEyHw6svBNy8mw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">52865</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="0"
      id="Narr_w_pSl8GLpUSklT6SWem88w"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">183389</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="0"
      id="Narr_99yU7LsliU2_4v8b30L89g"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">148425</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_bKEj-TTqEUKBK7qba8PvwA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;At September&#160;30,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 60,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;"&gt; 60,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_sEYATzzLKUOcdxnxBvEJtQ_2_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">60096</us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ"
      decimals="0"
      id="Tc_rFpZ8lU67U2hfLpW0SEFEQ_3_3"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">60096</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA"
      decimals="0"
      id="Narr_zaFE1ywOCku17EQNMWdsgA"
      unitRef="Unit_Standard_sqft_TVbtuT9o3UCYFiZW5wDD2w">42278</us-gaap:AreaOfRealEstateProperty>
    <miro:MonthlyLeaseRentPayments
      contextRef="Duration_8_2_2021_To_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_FAYf9bRq1UeMVt01TiNLBA"
      decimals="0"
      id="Narr_epTmZ87lukim7muN3U6h9Q"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">41397</miro:MonthlyLeaseRentPayments>
    <miro:LesseeOperatingLeaseAnnualBaseRateIncreasePercentage
      contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA"
      decimals="2"
      id="Narr_m1CXY_y3IU6FWfJzY5ftig"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.03</miro:LesseeOperatingLeaseAnnualBaseRateIncreasePercentage>
    <miro:LesseeOperatingLeaseRealPropertyTaxesPercentage
      contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA"
      decimals="4"
      id="Narr_vt_kFjgW0Eu7cwbwdMKS5A"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.6108</miro:LesseeOperatingLeaseRealPropertyTaxesPercentage>
    <miro:LesseeOperatingLeaseManagementFeePercentage
      contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA"
      decimals="4"
      id="Narr_BdqTjzjHFUeNxf84ybHIpg"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.6108</miro:LesseeOperatingLeaseManagementFeePercentage>
    <miro:LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts
      contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA"
      decimals="2"
      id="Narr_e1zdEnLhsUm2eo152TyHlQ"
      unitRef="Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q">0.05</miro:LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts>
    <miro:OperatingLeaseNumberOfOptionsToExtend
      contextRef="Duration_8_2_2021_To_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_FAYf9bRq1UeMVt01TiNLBA"
      decimals="INF"
      id="Narr_HU6FpcO_X0KVZB67NnT1wQ"
      unitRef="Unit_Standard_item_dMkQsh8WpkaQAEVQgwXZFA">1</miro:OperatingLeaseNumberOfOptionsToExtend>
    <miro:LesseeOperatingLeaseOptionToExtendTermOfContract
      contextRef="Duration_8_2_2021_To_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_FAYf9bRq1UeMVt01TiNLBA"
      id="Narr_4VuSYZcQTE6GTv9CW_6QrQ">P5Y</miro:LesseeOperatingLeaseOptionToExtendTermOfContract>
    <us-gaap:DepositAssets
      contextRef="As_Of_8_2_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember_U__t5Qbl5EGqiPsLntDkyA"
      decimals="0"
      id="Narr_aczIJgSnFkui3taEZL1xTA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">800000</us-gaap:DepositAssets>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="Duration_1_1_2015_To_1_1_2015_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_us-gaap_TypeOfArrangementAxis_miro_ResearchAndDevelopmentContractMember_6E_wdZQoSUqyfCptlYZBkg"
      decimals="INF"
      id="Narr_cyZPcs0pJkipKyJ6Iv-Nvg"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">26667</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:SharePrice
      contextRef="As_Of_1_1_2015_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_us-gaap_TypeOfArrangementAxis_miro_ResearchAndDevelopmentContractMember_Y_meruMSPEO7A3bUcsxnaA"
      decimals="2"
      id="Narr_TthDp-mQWkuw3qouehlLnQ"
      unitRef="Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug">7.50</us-gaap:SharePrice>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_jKKVP3FFsEWVoTejXMBIEQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;NOTE&#160;12&#160;&#x2014; RELATED PARTY TRANSACTIONS&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;A corporation owned by a former director of the Company that resigned as a director in June 2021 received payments for providing a consultant to the Company of $1,141 and $1,579 for the three&#160;months ended September 30, 2021 and 2020, respectively, and $4,992 and $4,626 for the nine&#160;months ended September 30, 2021 and 2020, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company received $9,819 and $10,846 for the three&#160;months ended September 30, 2021 and 2020, respectively, and $25,066 and $31,328 for the nine&#160;months ended September 30, 2021 and 2020, respectively, as royalty related to the spin-out of the Acellular Business to Reprise. As of September 30, 2021 and 2020 the Company had long term receivables of $803,404 and $343,672, respectively, but due to the uncertainty regarding collectability the Company fully &lt;span style="-sec-ix-hidden:Hidden_2po9q6YWxEaI543p-8A5uQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"&gt;reserved&lt;/span&gt;&lt;/span&gt; against the &lt;span style="-sec-ix-hidden:Hidden_Q7GTX4o5nEWWyrC9lnCvQw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"&gt;receivables&lt;/span&gt;&lt;/span&gt;. The Company recorded a long-term receivable of $453,470 related to the minimum royalty due from Reprise for the&#160;year ended December&#160;31, 2020, but due to the uncertainty regarding collectability the Company fully &lt;span style="-sec-ix-hidden:Hidden_V19YDa0XdUuAk6nk7v2a7g;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"&gt;reserved&lt;/span&gt;&lt;/span&gt; against the receivable. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_qnWtgiTGikOSXP25mjvZYA"
      decimals="0"
      id="Narr_bsNstKCsskuzmjQJj2GA1g"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1141</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_XueQO35tzkidWpI2arMRfw"
      decimals="0"
      id="Narr_bA-ka9-V_Eu72mQCWHBtVA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">1579</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_9WxjyLUpOUiRks_Oq_p5vw"
      decimals="0"
      id="Narr_hp6rhxD3kUyUTAkKM7hlmA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">4992</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_6W4hac0WQU-mcQ8HdTtbAQ"
      decimals="0"
      id="Narr_S5_MyzqM5E-gxVeL_OgzRQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">4626</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RevenueFromRelatedParties
      contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_BOZzIx3NHUyi4rOJ8vvwWg"
      decimals="0"
      id="Narr_7kd8JyFGzE6PwFPC6SLgtQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">9819</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_vmM7oFOzwUe43nHIwqu2bA"
      decimals="0"
      id="Narr_akzDJn_KoUmPVOq3PJ9w9w"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">10846</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_GGnger605kSAQV-cbnUI1Q"
      decimals="0"
      id="Narr_JCMOnNUXVECmgwPt5eYKJA"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">25066</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_cVjMYLi1J0iHUg_2B18WtQ"
      decimals="0"
      id="Narr_ww-pIQ4lQ0SzjJ6EB1VXBQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">31328</us-gaap:RevenueFromRelatedParties>
    <us-gaap:AccountsReceivableRelatedPartiesNoncurrent
      contextRef="As_Of_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_gQqNjbZf3kitvnDKHNvcqQ"
      decimals="0"
      id="Narr_nWM9G7QADEi6-EmnSK8Keg"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">803404</us-gaap:AccountsReceivableRelatedPartiesNoncurrent>
    <us-gaap:AccountsReceivableRelatedPartiesNoncurrent
      contextRef="As_Of_9_30_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_saJtd_zSdkCdwSY-MhYn9A"
      decimals="0"
      id="Narr_vrbt-25dF02RPrqGWePw9g"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">343672</us-gaap:AccountsReceivableRelatedPartiesNoncurrent>
    <us-gaap:AccountsReceivableRelatedPartiesNoncurrent
      contextRef="As_Of_12_31_2020_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_cRCCz2S2j0Sk68z8xyXCTg"
      decimals="0"
      id="Narr_tHmdAWXBwkiB7ubHiKRymQ"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">453470</us-gaap:AccountsReceivableRelatedPartiesNoncurrent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_bz2ELx46a0yaZTkrTnBJGg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;NOTE&#160;13&#160;&#x2014; NET LOSS PER SHARE&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;Under the two-class method, for periods with net income, basic net income per common share is computed by dividing the net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Net income attributable to common stockholders is computed by subtracting from net income the portion of current&#160;year earnings that participating securities would have been entitled to receive pursuant to their dividend rights had all of the&#160;year&#x2019;s earnings been distributed. No such adjustment to earnings is made during periods with a net loss as the holders of the participating securities have no obligation to fund losses. Diluted net loss per common share is computed under the two-class method by using the weighted average number of shares of common stock outstanding plus, for periods with net income attributable to common stockholders, the potential dilutive effects of stock options and warrants. In addition, the Company analyzes the potential dilutive effect of the outstanding participating securities under the if-converted method when calculating diluted earnings per share in which it is assumed that the outstanding participating securities convert into common stock at the beginning of the period. The Company reports the more dilutive of the approaches (two-class or if-converted) as its diluted net income per share during the period. Due to the existence of net losses for the three and nine&#160;months ended September 30, 2021 and 2020, basic and diluted loss per share were the same, as the effect of potentially dilutive securities would have been anti-dilutive.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"&gt;The following potentially dilutive securities outstanding have been excluded from the computations of diluted weighted average shares outstanding because such securities have an antidilutive impact due to losses reported:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;white-space:nowrap;width:25.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Three Months Ended September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;white-space:nowrap;width:25.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Nine Months Ended September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible preferred stock outstanding &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,314,536&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,314,536&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible preferred stock warrants &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 40,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Common stock options outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,464,805&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,907,163&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,464,805&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,907,163&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Common stock warrants &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 950,879&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 707,669&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 950,879&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 707,669&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,415,684&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 12,929,368&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,415,684&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 12,969,368&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_H96j84GCiUumc-W9uAXBEQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;white-space:nowrap;width:25.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Three Months Ended September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;white-space:nowrap;width:25.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#231f20;font-weight:bold;"&gt;Nine Months Ended September&#160;30,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(unaudited)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible preferred stock outstanding &lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,314,536&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,314,536&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible preferred stock warrants &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 40,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Common stock options outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,464,805&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,907,163&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,464,805&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,907,163&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Common stock warrants &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 950,879&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 707,669&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 950,879&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 707,669&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,415,684&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 12,929,368&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,415,684&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 12,969,368&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertiblePreferredStockMember_G2AenK_gbk-ZZfv0d9YO_A"
      decimals="INF"
      id="Tc_QJVMrchetEemth1IumZ9Pg_4_4"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">8314536</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_ConvertiblePreferredStockMember_Gh_jQ_Q0W02MUqDL5oQyCw"
      decimals="INF"
      id="Tc_F3w0OqsNwUOJah6DrlKzjQ_4_8"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">8314536</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_ConvertiblePreferredStockWarrantsMember_nZXuGpmc3kOiTFiqFvQENQ"
      decimals="INF"
      id="Tc_c5SKp0P-yE2LP72aMw415Q_5_8"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">40000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_1Bh3g4CG70OKdz3TgSxqQg"
      decimals="INF"
      id="Tc_SUGeQOvQh0aOBV0nIAB1KQ_6_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3464805</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_GmTrWD189EWwo_du3vbdCQ"
      decimals="INF"
      id="Tc_WPCCo_LkjUy-6YRXDCgA6A_6_4"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3907163</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_nC9T8Rfgokqilo8qcuIGWw"
      decimals="INF"
      id="Tc_9phku3lbkEijL3Q4lPF7wg_6_6"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3464805</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember_idwa40aKQUC_0HjRs6iVKQ"
      decimals="INF"
      id="Tc_IWKrvlK_ck-AEX3Yh56Axg_6_8"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">3907163</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_7_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_hUvKTTEpGkeeRuM5ul5Jjg"
      decimals="INF"
      id="Tc_k8EKwwf8zUGYx_e6kCw7gQ_7_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">950879</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_7_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_ByAiKa5lkUuPyzg8VR9VHQ"
      decimals="INF"
      id="Tc_E4dD1Fn0CEOynD5mjwVYTw_7_4"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">707669</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2021_To_9_30_2021_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_YiQ5qq1-cUeG-3Hyz5MNuw"
      decimals="INF"
      id="Tc_6-XvrEn9WE62FiJolSkl5g_7_6"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">950879</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2020_To_9_30_2020_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_miro_CommonStockWarrantsMember_Jdt9LOisJEWDjroNeaE7OA"
      decimals="INF"
      id="Tc_Vydo2rnz_0Si6GBL7FpKSQ_7_8"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">707669</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw"
      decimals="INF"
      id="Tc_sbB3iGZsNkGiQf1zR-4JQA_8_2"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">4415684</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_7_1_2020_To_9_30_2020_J0mfnhy5b0W07F_UTK_nAw"
      decimals="INF"
      id="Tc_ANVeV8b_3ka9-QzzyL0_zA_8_4"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">12929368</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      decimals="INF"
      id="Tc_Jxls6xCYN0iwtysjQQbPXQ_8_6"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">4415684</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2020_To_9_30_2020_9WqOhXK1gUyqyT4NbYeGUg"
      decimals="INF"
      id="Tc_YwYAsLog0EyeZKCApOSymA_8_8"
      unitRef="Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg">12969368</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw"
      id="Tb_VRepn3R-MUmIL0GBm7wV5Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 9pt 0pt;"&gt;NOTE&#160;14&#160;&#x2014; SUBSEQUENT EVENTS&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 9pt 0pt;"&gt;&lt;span style="font-weight:normal;text-decoration:none;"&gt;In October 2021, the Company and Mayo Foundation for Medical Education and Research executed a ninth amendment to their agreement whereby the term was extended to March 31, 2022 and the Company agreed to provide &lt;/span&gt;&lt;span style="font-weight:normal;text-decoration:none;"&gt;$279,500&lt;/span&gt;&lt;span style="font-weight:normal;text-decoration:none;"&gt; of additional funding.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <miro:AdditionalFundingToBeProvided
      contextRef="As_Of_10_31_2021_srt_CounterpartyNameAxis_miro_UniversityOfMinnesotaMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_us-gaap_NoncollaborativeArrangementTransactionsMember_3MpIEZ7k8UW2x-fwsNXB8Q"
      decimals="0"
      id="Narr_IdefF9yXnkWd2v0D8hEEMw"
      unitRef="Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA">279500</miro:AdditionalFundingToBeProvided>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153941288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Nov. 11, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Miromatrix Medical&#160;Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-1285782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10399 West 70th Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Eden Prairie<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">MN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">942-6000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MIRO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,254,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001527096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784154092840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 62,087,678<span></span>
</td>
<td class="nump">$ 4,444,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Receivable from Reprise Biomedical, Inc.</a></td>
<td class="nump">9,819<span></span>
</td>
<td class="nump">15,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivableCurrent', window );">Grant receivable</a></td>
<td class="nump">115,530<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">334,310<span></span>
</td>
<td class="nump">130,576<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">62,547,337<span></span>
</td>
<td class="nump">4,690,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Lab equipment, furniture, leasehold improvements and construction in progress, net</a></td>
<td class="nump">1,678,648<span></span>
</td>
<td class="nump">324,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment in Reprise Biomedical, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,721<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">64,225,985<span></span>
</td>
<td class="nump">5,254,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">386,161<span></span>
</td>
<td class="nump">6,413,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,249,259<span></span>
</td>
<td class="nump">130,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">612,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Embedded derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,922,617<span></span>
</td>
<td class="nump">760,889<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,558,037<span></span>
</td>
<td class="nump">8,164,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_AccruedRoyaltiesNoncurrent', window );">Accrued royalties</a></td>
<td class="nump">857,101<span></span>
</td>
<td class="nump">488,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt, less current portion</a></td>
<td class="nump">478,766<span></span>
</td>
<td class="nump">928,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_InterestPayableNoncurrent', window );">Accrued interest</a></td>
<td class="nump">65,032<span></span>
</td>
<td class="nump">45,691<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">4,958,936<span></span>
</td>
<td class="nump">9,627,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.00001; 190,000,000 shares authorized; 20,254,645 issued and outstanding as of September 30, 2021 and 30,000,000 shares authorized; 2,185,822 issued and outstanding as of December 31, 2020</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">127,842,762<span></span>
</td>
<td class="nump">8,346,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(68,575,915)<span></span>
</td>
<td class="num">(59,381,158)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity (deficit)</a></td>
<td class="nump">59,267,049<span></span>
</td>
<td class="num">(51,034,193)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities, Mezzanine Equity and Shareholders' Equity (Deficit)</a></td>
<td class="nump">$ 64,225,985<span></span>
</td>
<td class="nump">5,254,428<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesB2ConvertiblePreferredStockMember', window );">Convertible preferred stock - Series B-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Mezzanine equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,670,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesBConvertiblePreferredStockMember', window );">Convertible preferred stock - Series B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Mezzanine equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,865,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesConvertiblePreferredStockMember', window );">Convertible preferred stock - Series A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Mezzanine equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,125,661<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_AccruedRoyaltiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of royalty obligations incurred through that date and due after one year (or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_AccruedRoyaltiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_InterestPayableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_InterestPayableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesB2ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesB2ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784254874056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">190,000,000<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">20,254,645<span></span>
</td>
<td class="nump">2,185,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">20,254,645<span></span>
</td>
<td class="nump">2,185,822<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesB2ConvertiblePreferredStockMember', window );">Series B-2 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, authorized (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,095,874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,095,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 15,719,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, authorized (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,218,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,218,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 24,137,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, authorized (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,000,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,000,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7,500,950<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesB2ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesB2ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784154144920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Condensed Statements of Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Licensing revenue</a></td>
<td class="nump">$ 9,819<span></span>
</td>
<td class="nump">$ 10,846<span></span>
</td>
<td class="nump">$ 25,066<span></span>
</td>
<td class="nump">$ 31,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList', window );">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</a></td>
<td class="text">us-gaap:LicenseMember<span></span>
</td>
<td class="text">us-gaap:LicenseMember<span></span>
</td>
<td class="text">us-gaap:LicenseMember<span></span>
</td>
<td class="text">us-gaap:LicenseMember<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="nump">$ 375,000<span></span>
</td>
<td class="nump">$ 375,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Cost, Product and Service [Extensible Enumeration]</a></td>
<td class="text">us-gaap:LicenseMember<span></span>
</td>
<td class="text">us-gaap:LicenseMember<span></span>
</td>
<td class="text">us-gaap:LicenseMember<span></span>
</td>
<td class="text">us-gaap:LicenseMember<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="num">$ (115,181)<span></span>
</td>
<td class="num">$ (114,154)<span></span>
</td>
<td class="num">$ (349,934)<span></span>
</td>
<td class="num">$ (343,672)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">3,349,898<span></span>
</td>
<td class="nump">1,870,039<span></span>
</td>
<td class="nump">7,698,786<span></span>
</td>
<td class="nump">5,750,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_RegulatoryAndClinicalExpense', window );">Regulatory and clinical</a></td>
<td class="nump">105,208<span></span>
</td>
<td class="nump">64,083<span></span>
</td>
<td class="nump">292,169<span></span>
</td>
<td class="nump">208,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_QualityExpense', window );">Quality</a></td>
<td class="nump">150,675<span></span>
</td>
<td class="nump">75,850<span></span>
</td>
<td class="nump">322,719<span></span>
</td>
<td class="nump">75,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">General &amp; administration</a></td>
<td class="nump">1,487,654<span></span>
</td>
<td class="nump">460,105<span></span>
</td>
<td class="nump">2,836,850<span></span>
</td>
<td class="nump">1,530,915<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">5,093,435<span></span>
</td>
<td class="nump">2,470,077<span></span>
</td>
<td class="nump">11,150,524<span></span>
</td>
<td class="nump">7,565,361<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(5,208,616)<span></span>
</td>
<td class="num">(2,584,231)<span></span>
</td>
<td class="num">(11,500,458)<span></span>
</td>
<td class="num">(7,909,033)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">766<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">851<span></span>
</td>
<td class="nump">8,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Interest expense</a></td>
<td class="num">(15,255)<span></span>
</td>
<td class="num">(208,926)<span></span>
</td>
<td class="num">(601,292)<span></span>
</td>
<td class="num">(363,444)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of discount on note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,586)<span></span>
</td>
<td class="num">(62,638)<span></span>
</td>
<td class="num">(76,034)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative', window );">Change in fair value of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ResearchGrants', window );">Research grants</a></td>
<td class="nump">115,069<span></span>
</td>
<td class="nump">328,424<span></span>
</td>
<td class="nump">393,034<span></span>
</td>
<td class="nump">794,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss in affiliate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(495,000)<span></span>
</td>
<td class="num">(223,633)<span></span>
</td>
<td class="num">(1,676,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Gain on sale of equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,983,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on debt extinguishment</a></td>
<td class="nump">50,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">568,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (5,057,581)<span></span>
</td>
<td class="num">$ (2,992,225)<span></span>
</td>
<td class="num">$ (9,194,757)<span></span>
</td>
<td class="num">$ (9,221,537)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollar per share)</a></td>
<td class="num">$ (0.25)<span></span>
</td>
<td class="num">$ (1.37)<span></span>
</td>
<td class="num">$ (1.08)<span></span>
</td>
<td class="num">$ (4.27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollar per share)</a></td>
<td class="num">$ (0.25)<span></span>
</td>
<td class="num">$ (1.37)<span></span>
</td>
<td class="num">$ (1.08)<span></span>
</td>
<td class="num">$ (4.27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares used in computing net loss per share, basic (in shares)</a></td>
<td class="nump">20,145,321<span></span>
</td>
<td class="nump">2,183,322<span></span>
</td>
<td class="nump">8,503,743<span></span>
</td>
<td class="nump">2,158,632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares used in computing net loss per share, diluted (in shares)</a></td>
<td class="nump">20,145,321<span></span>
</td>
<td class="nump">2,183,322<span></span>
</td>
<td class="nump">8,503,743<span></span>
</td>
<td class="nump">2,158,632<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_QualityExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of quality expense incurred during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_QualityExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_RegulatoryAndClinicalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of regulatory and clinical expenses incurred during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_RegulatoryAndClinicalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ResearchGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income from research grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ResearchGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -URI http://asc.fasb.org/subtopic&amp;trid=2229187<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123410239&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123410239&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784150451240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Statements of Shareholders' Equity (Deficit) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 7,638,190<span></span>
</td>
<td class="num">$ (49,071,590)<span></span>
</td>
<td class="num">$ (41,433,379)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="nump">2,075,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">6,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">62,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,956,233)<span></span>
</td>
<td class="num">(2,956,233)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2020</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">7,858,087<span></span>
</td>
<td class="num">(52,027,823)<span></span>
</td>
<td class="num">(44,169,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Mar. 31, 2020</a></td>
<td class="nump">2,138,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">7,638,190<span></span>
</td>
<td class="num">(49,071,590)<span></span>
</td>
<td class="num">(41,433,379)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="nump">2,075,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,221,537)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2020</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">8,172,883<span></span>
</td>
<td class="num">(58,293,127)<span></span>
</td>
<td class="num">(50,120,222)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2020</a></td>
<td class="nump">2,138,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">7,638,190<span></span>
</td>
<td class="num">(49,071,590)<span></span>
</td>
<td class="num">$ (41,433,379)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="nump">2,075,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of stock warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2020</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">8,346,943<span></span>
</td>
<td class="num">(59,381,158)<span></span>
</td>
<td class="num">$ (51,034,193)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2020</a></td>
<td class="nump">2,185,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2020</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">7,858,087<span></span>
</td>
<td class="num">(52,027,823)<span></span>
</td>
<td class="num">(44,169,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period (in shares) at Mar. 31, 2020</a></td>
<td class="nump">2,138,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,273,079)<span></span>
</td>
<td class="num">(3,273,079)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2020</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">8,015,485<span></span>
</td>
<td class="num">(55,300,902)<span></span>
</td>
<td class="num">(47,285,395)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Jun. 30, 2020</a></td>
<td class="nump">2,138,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,992,225)<span></span>
</td>
<td class="num">(2,992,225)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2020</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">8,172,883<span></span>
</td>
<td class="num">(58,293,127)<span></span>
</td>
<td class="num">(50,120,222)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2020</a></td>
<td class="nump">2,138,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">8,346,943<span></span>
</td>
<td class="num">(59,381,158)<span></span>
</td>
<td class="num">(51,034,193)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="nump">2,185,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">28,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(434,342)<span></span>
</td>
<td class="num">(434,342)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2021</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">8,509,143<span></span>
</td>
<td class="num">(59,815,500)<span></span>
</td>
<td class="num">(51,306,334)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Mar. 31, 2021</a></td>
<td class="nump">2,290,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">8,346,943<span></span>
</td>
<td class="num">(59,381,158)<span></span>
</td>
<td class="num">$ (51,034,193)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="nump">2,185,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">381,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,194,757)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2021</a></td>
<td class="nump">$ 202<span></span>
</td>
<td class="nump">127,842,762<span></span>
</td>
<td class="num">(68,575,915)<span></span>
</td>
<td class="nump">59,267,049<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2021</a></td>
<td class="nump">20,254,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2021</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">8,509,143<span></span>
</td>
<td class="num">(59,815,500)<span></span>
</td>
<td class="num">(51,306,334)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period (in shares) at Mar. 31, 2021</a></td>
<td class="nump">2,290,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">5,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">58,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of stock warrants (in shares)</a></td>
<td class="nump">65,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockIssuedDuringPeriodValueConversionOfPreferredStock', window );">Conversion of preferred stock to common stock</a></td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">66,553,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,553,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock', window );">Conversion of preferred stock to common stock (in shares)</a></td>
<td class="nump">11,092,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest', window );">Note payable and accrued interest converted to common stock</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">7,152,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,152,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest', window );">Note payable and accrued interest converted to common stock (in shares)</a></td>
<td class="nump">996,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Sales of common stock, net of expenses</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">44,593,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,593,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sales of common stock, net of expenses (in shares)</a></td>
<td class="nump">5,520,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,702,834)<span></span>
</td>
<td class="num">(3,702,834)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">126,926,215<span></span>
</td>
<td class="num">(63,518,334)<span></span>
</td>
<td class="nump">63,408,081<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Jun. 30, 2021</a></td>
<td class="nump">20,024,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">768,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">768,855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">218,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of stock warrants (in shares)</a></td>
<td class="nump">11,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,057,581)<span></span>
</td>
<td class="num">(5,057,581)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2021</a></td>
<td class="nump">$ 202<span></span>
</td>
<td class="nump">$ 127,842,762<span></span>
</td>
<td class="num">$ (68,575,915)<span></span>
</td>
<td class="nump">$ 59,267,049<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2021</a></td>
<td class="nump">20,254,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of note payable and accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock issued as a result of the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the conversion of note payable and accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_StockIssuedDuringPeriodValueConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period as a result of the conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_StockIssuedDuringPeriodValueConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784237019464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (9,194,757)<span></span>
</td>
<td class="num">$ (9,221,537)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">93,575<span></span>
</td>
<td class="nump">139,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">384,299<span></span>
</td>
<td class="nump">472,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Reserve for bad debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,501)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of discount on note</a></td>
<td class="nump">62,638<span></span>
</td>
<td class="nump">76,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative', window );">Change in fair value of derivative</a></td>
<td class="num">(246,962)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_GainOnForgivenessOfDebt', window );">Forgiveness of paycheck protection program loan</a></td>
<td class="num">(568,505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss in affiliate</a></td>
<td class="nump">223,633<span></span>
</td>
<td class="nump">1,676,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Gain on sale of equity investment</a></td>
<td class="num">(1,983,912)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent', window );">Receivable from Reprise Biomedical, Inc</a></td>
<td class="nump">5,383<span></span>
</td>
<td class="nump">217,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_IncreaseDecreaseInGrantsReceivable', window );">Grant receivable</a></td>
<td class="num">(15,530)<span></span>
</td>
<td class="nump">257,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="num">(203,734)<span></span>
</td>
<td class="num">(17,535)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">2,649,560<span></span>
</td>
<td class="num">(83,702)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_IncreaseDecreaseInInterestPayableNoncurrent', window );">Accrued interest</a></td>
<td class="num">(583,293)<span></span>
</td>
<td class="num">(347,349)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(8,211,019)<span></span>
</td>
<td class="num">(6,094,316)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of equity method investment shares</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForConstructionInProcess', window );">Purchases of construction in process</a></td>
<td class="num">(1,166,129)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements', window );">Purchases of lab equipment, furniture and leasehold improvements</a></td>
<td class="num">(281,560)<span></span>
</td>
<td class="num">(123,167)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">552,311<span></span>
</td>
<td class="num">(123,167)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on long-term debt</a></td>
<td class="num">(83,387)<span></span>
</td>
<td class="num">(97,311)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt</a></td>
<td class="nump">87,567<span></span>
</td>
<td class="nump">6,563,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ProceedsFromIssuanceOfCommonStockNet', window );">Proceeds from sale of common stock, net</a></td>
<td class="nump">44,593,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet', window );">Proceeds from sale of preferred stock, net</a></td>
<td class="nump">19,891,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from stock warrants exercise</a></td>
<td class="nump">8,975<span></span>
</td>
<td class="nump">6,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercise</a></td>
<td class="nump">803,480<span></span>
</td>
<td class="nump">56,250<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">65,301,991<span></span>
</td>
<td class="nump">6,528,586<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">57,643,283<span></span>
</td>
<td class="nump">311,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">4,444,395<span></span>
</td>
<td class="nump">3,250,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">62,087,678<span></span>
</td>
<td class="nump">3,561,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">17,999<span></span>
</td>
<td class="nump">$ 16,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_NoncashInvestingAndFinancingFinancingExpenses', window );">Accrued expenses related to financing</a></td>
<td class="nump">$ 936,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_GainOnForgivenessOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on amounts of indebtedness forgiven by the holder of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_GainOnForgivenessOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_IncreaseDecreaseInGrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) for grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_IncreaseDecreaseInGrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_IncreaseDecreaseInInterestPayableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts for noncurrent interest payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_IncreaseDecreaseInInterestPayableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_NoncashInvestingAndFinancingFinancingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of financing expenses accrued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_NoncashInvestingAndFinancingFinancingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of lab equipment, furniture and leasehold improvements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ProceedsFromIssuanceOfCommonStockNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ProceedsFromIssuanceOfCommonStockNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -URI http://asc.fasb.org/subtopic&amp;trid=2229187<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForConstructionInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from construction costs to date on capital projects that have not been completed and assets being constructed that are not ready to be placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForConstructionInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784147770120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;1&#160;&#8212; DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Description of Business</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Miromatrix Medical&#160;Inc. (the &#8220;Company&#8221;) is a life science company that has a proprietary technology to remove cells from, or decellularize, and also to recellularize organs and tissues from animal and human sources, facilitating the creation of numerous products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Basis of Preparation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.3pt;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and the rules of the Securities and Exchange Commission (&#8220;SEC&#8221;) applicable to interim reports of companies filing as a smaller reporting company.&#160; These financial statements should be read in conjunction with the audited financial statements and notes thereto contained in the Company&#8217;s Registration Statement on Form S-1 (File No. 333-256649), as amended, (the &#8220;Form S-1&#8221;) for the fiscal year ended December 31, 2020 filed with the SEC on June 22, 2021.&#160; In the opinion of management, the accompanying condensed interim financial statements include all adjustments necessary in order to make the financial statements not misleading.&#160; The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year or any other future period.&#160; Certain notes to the financial statements that would substantially duplicate disclosures contained in the audited financial statements for the most recent fiscal year as reported in the Company&#8217;s Form S-1 have been omitted.&#160; The accompanying condensed balance sheet at December 31, 2020 has been derived from the audited balance sheet at December 31, 2020 contained in the Form S-1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">In the opinion of management, the accompanying condensed financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, stockholders' equity and cash flows for the interim periods but are not necessarily indicative of the results of operations or cash flows to be anticipated for the full year 2021 or any future period. The Company has evaluated subsequent events occurring after the date of the condensed financial statements for events requiring recording or disclosure in the condensed financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Amended and Restated Charter</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">On May 20, 2021, the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) and stockholders approved an amendment and restatement of the Company&#8217;s then-existing certificate of incorporation (the &#8220;Pre-IPO Certificate&#8221;) to create, among other changes, a Series C Convertible Preferred Stock (&#8220;Series C Stock&#8221;). The Series C Stock would convert into shares of the Company&#8217;s common stock upon the Company&#8217;s initial public offering at 80% of the price at which the common stock is being sold in the initial public offering (see Note 8).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">June 2021 Amended and Restated Charter</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Prior to the completion of the initial public offering of the Company&#8217;s common stock (the &#8220;IPO&#8221;), the Company's Board and stockholders approved an amendment (the &#8220;Charter Amendment&#8221;) to the Pre-IPO Certificate and an amended and restated certificate of incorporation (&#8220;Post-IPO Certificate&#8221;) that became effective on June 23, 2021. The Charter Amendment increased the number of authorized shares of the Company&#8217;s common stock from 30,000,000 to 190,000,000 and authorized 10,000,000 shares of undesignated preferred stock. Under the Post-IPO Certificate, the Company is authorized to issue two classes of stock, Common Stock and Preferred Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Equity Method Investments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;">Investments in 20% to 50%-owned companies are accounted for under the equity method as the Company can exercise significant influence, but not control, over such investments. The equity method requires that gains (losses) are </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">recognized in other income (expense), net in the statements of operations. The gain on equity investment in Reprise Biomedical,&#160;Inc. (&#8220;Reprise&#8221;) resulted from recording the fair value of the Company&#8217;s investment in Reprise upon losing a controlling interest in the Company on June&#160;30, 2019. The Company recorded its equity method share of losses in Reprise from July&#160;1, 2019 through December&#160;31, 2019, from January&#160;1, 2020 to December&#160;31, 2020 and from January&#160;1, 2021 to March&#160;15, 2021 in the statements of operations. Even though the Company&#8217;s ownership dropped below 20% on November&#160;15, 2020, the Company still had significant influence over the activities of Reprise due to common board members (See Note&#160;4).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Research and Development Costs</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Research and development expenses consist primarily of engineering, product development, consulting services, materials, depreciation and other costs associated with products and technologies in development. These expenses include employee and non-employee compensation, including stock-based compensation, supplies, materials, consulting expenses, related travel expenses, and facility costs. Expenditures for research and development activities are charged to operations as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Stock-Based Compensation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company is required to determine the fair value of equity incentive awards and recognize compensation expense for all equity incentive awards made to employees and directors, including employee stock options. The Company also determines the fair value of non-statutory stock options issued to consultants based on the fair value of the consultant&#8217;s commitment at the date of grant. Such expense is recognized over the requisite service period. In addition, stock-based compensation expense recognized in the statements of operations is based on awards expected to vest and therefore the amount of expense has been reduced for estimated forfeitures. The Company uses the straight-line method for expense attribution, except for awards issued with performance-based conditions which require an accelerated attribution method over the requisite performance and service periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Under the applicable accounting guidance for equity incentive awards issued to non-employees, the date at which the fair value of such awards is measured is equal to the earlier of: 1) the date at which a commitment for performance by the counterparty to earn the equity instrument is reached; or <span style="color:#231f20;">2) the date at which the counterparty</span><span style="color:#231f20;font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="color:#231f20;">s performance is complete. The Company recognizes stock-based compensation expense for the fair value of the vested portion of the non-employee awards in the statements of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The valuation model used for calculating the fair value of awards for stock-based compensation expense is the Black-Scholes option-pricing model (the &#8220;Black-Scholes model&#8221;). The Black-Scholes model requires the Company to make assumptions and judgments about the variables used in the calculation, including the expected term (weighted average period of time that the options granted are expected to be outstanding), the volatility of common stock, and an assumed risk-free interest rate. The Company uses the &#8220;simplified method&#8221; to determine the expected term of the stock option. Volatility is based on an average of the historical volatilities of the common stock of publicly-traded companies with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected term of the option. The expected dividend assumption is based on the Company&#8217;s history of not paying dividends and its expectation that it will not declare dividends for the foreseeable future. Potential forfeitures of awards are estimated based on the Company&#8217;s historical forfeiture experience. The estimate of forfeitures will be adjusted over the service period to the extent that actual forfeitures differ, or are expected to differ, from prior estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, accounts receivable, and accounts payable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Use of Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Emerging Growth Company Status</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (&#8220;JOBS Act&#8221;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as to those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i)&#160;is no longer an emerging growth company or (ii)&#160;affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Net Loss Per Share</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Basic net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock and dilutive potential shares of common stock outstanding during the period. Because we have reported a net loss for all periods presented, diluted net loss per share is the same as basic net loss per share for those periods as all potentially dilutive shares consisting of stock options and warrants were antidilutive in those periods (See Note 13).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Recent Accounting Pronouncements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;">During February&#160;2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No.&#160;2016-02, &#8220;Leases (Topic 842).&#8221; ASU No. 2016-02 requires lessees to recognize the assets and liabilities that arise from leases on the balance sheet. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. During 2018, the FASB also issued ASU No.&#160;2018-10, &#8220;Codification Improvements to Topic 842, Leases&#8221;, which addresses narrow aspects of the guidance originally issued in ASU No.&#160;2016-02; ASU 2018-11, &#8220;Targeted Improvements&#8221;, which provides entities with an additional (and optional) transition method whereby an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption and also provides lessors with a practical expedient, by class of underlying asset, to not separate non-lease components from the associated lease component and, instead, to account for those components as a single component. During 2019, the FASB also issued ASU No.&#160;2019-01, which clarified Topic 842&#8217;s interim disclosure requirements and amend certain industry-specific guidance related to determining the fair value of leased assets and the cash flow presentation of principal payments received under sales-type and direct finance leases. Topic 842 (as amended) is effective for annual periods beginning after December&#160;15, 2021, and interim periods within fiscal&#160;years beginning after December&#160;15, 2022. Early adoption is permitted. The Company is currently assessing the effect that Topic 842 (as amended) will have on its results of operations, financial position and cash flows.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784147649736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockholdersEquityNoteInitialPublicOfferingAbstract', window );"><strong>INITIAL PUBLIC OFFERING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock', window );">INITIAL PUBLIC OFFERING</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 2 &#8212; INITIAL PUBLIC OFFERING</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 10pt 0pt;">In June 2021, the Company completed the IPO in which the Company sold 5,520,000 shares of its common stock at a price to the public of $9.00 per share, which included the sale of 720,000 shares of common stock as a result of the full exercise of the underwriter&#8217;s overallotment option. The Company received proceeds of $49.7 million, excluding underwriting discounts and commissions, which was recorded to additional paid-in capital. The Company&#8217;s common stock commenced trading on the Nasdaq Capital Market on June 24, 2021 under the trading symbol &#8220;MIRO.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">Upon the closing of the IPO, all shares of the then-outstanding convertible preferred stock were converted on their respective terms into a total of </span><span style="font-weight:normal;">12,139,071</span><span style="font-weight:normal;"> shares of common stock. This resulted in a reclassification of </span><span style="font-weight:normal;">$73.7</span><span style="font-weight:normal;"> million to additional paid-in capital.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Offering costs incurred by the Company were approximately $1.6 million, excluding underwriting commissions and discounts, which were recorded to additional paid-in capital. The Company issued the underwriter in the IPO a warrant to purchase up to 276,000 shares of its common stock.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_StockholdersEquityNoteInitialPublicOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_StockholdersEquityNoteInitialPublicOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure for initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153773048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:49.5pt;text-indent:-49.5pt;margin:0pt 0pt 12pt 0pt;">NOTE&#160;3&#160;&#8212; LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Lab equipment, furniture, leasehold improvements and construction in progress consisted of the following as of:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&#160;30,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lab equipment</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,762,512</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,480,952</p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Construction in progress</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,166,129</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Leasehold improvements</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 310,225</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 310,225</p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Furniture and fixtures &amp; computers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 112,302</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 112,302</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,351,168</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,903,479</p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less accumulated depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,672,520)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,578,945)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,678,648</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 324,534</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;">Depreciation and amortization expense was $34,401 and $34,901 for the three&#160;months ended September 30, 2021 and 2020, respectively, and $93,575 and $139,921 for the nine&#160;months ended September 30, 2021 and 2020, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;">The Company is moving into a new facility in December 2021 and has paid $1,166,129 toward leasehold improvements and other costs and recorded these as construction in progress.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784243870136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY METHOD INVESTMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>EQUITY METHOD INVESTMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">EQUITY METHOD INVESTMENT</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 4 &#8212; EQUITY METHOD INVESTMENT</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company previously manufactured and sold acellular medical devices in the hernia mesh and wound care markets through a separately identifiable business unit (the &#8220;Acellular Business&#8221;). On June&#160;30, 2019, the Acellular Business was spun-out to Reprise. At the time of the spin-out the common stock of Reprise was valued at $1.00 per share and therefore the Company recognized a gain of $4,495,500 on its Reprise common stock holdings. At the time of the spin-out and until November&#160;15, 2020, the Company owned 4,500,000 shares of common stock of Reprise, which represented 45% ownership in Reprise. In November&#160;2020, the Company sold 2,700,000 shares of common stock of Reprise and retained an 18% ownership interest in Reprise. The Company sold its remaining shares of Reprise in March&#160;2021 for $2,000,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2020, the Company had an investment in Reprise that it accounts for under the equity method (See Note&#160;1). The Company considers its investment in Reprise to be significant to its income as of December&#160;31, 2020. Financial information from the financial statements of Reprise are summarized as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Current assets</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 4,309,045</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Total assets</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 5,312,350</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Current liabilities</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 2,534,673</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Non-current liabilities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 489,785</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Shareholders&#8217; equity</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 2,287,892</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Miromatrix Medical Inc. share of shareholders&#8217; equity</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 411,821</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;width:22.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">For the Three Months Ended September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;width:24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">For the Nine Months Ended September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net sales</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 169,277</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 93,985</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 484,067</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross margin</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 109,497</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 47,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 307,573</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,188,678)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,376,522)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,723,533)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Miromatrix Medical Inc. share of net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (495,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (223,633)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,676,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153689224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>ACCRUED EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">ACCRUED EXPENSES</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 5 &#8212; ACCRUED EXPENSES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Accrued expenses consisted of the following as of:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Wages</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 549,685</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 217,825</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Legal</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 120,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 452,778</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Royalties</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 2,455</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 3,800</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Supplies</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 80,700</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">IPO expenses</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 936,652</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Key opinion leader compensation</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 100,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 34,000</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Board compensation</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 58,125</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Other</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 75,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 52,486</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Accrued expenses</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 1,922,617</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 760,889</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153453496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE MEASUREMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENT</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 6 &#8212; FAIR VALUE MEASUREMENT</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">The fair value of the Company&#8217;s financial instruments reflect the amount that the Company estimates that it would receive in connection with the sale of an asset or paid in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes a fair value hierarchy that distinguishes between (1)&#160;market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2)&#160;an entity&#8217;s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC 820 are described below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Level 2: Directly or indirectly observable inputs as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data from actively quoted markets for substantially the full term of the financial instrument.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Level 3: Unobservable inputs that are supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management&#8217;s estimates of market participant assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company classified its equity method investments as Level 3 securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company determined that a promissory note issued in March&#160;2020 (&#8220;March&#160;2020 Note&#8221;) contained a change in control provision which is a level 3 embedded derivative and is required to be bifurcated. In accordance with ASC 815, <i style="font-style:italic;">Derivatives and Hedging</i>, the Company determined the fair value of the derivative liability and recorded it on the balance sheet. At inception, the fair value of the derivative liability was $195,516.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The table below discloses changes in value of the Company&#8217;s embedded derivative liabilities discussed above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative liability balance at December&#160;31,&#160;2019</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative instrument related to March 2020 Note</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 195,516</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Gain/Loss recognized to revalue derivative instrument at fair value</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 51,446</span></p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative liability balance at December&#160;31,&#160;2020</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 246,962</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Gain/Loss recognized to revalue derivative instrument at fair value (unaudited)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (246,962)</span></p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative liability balance at September&#160;30,&#160;2021 (unaudited)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153524248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT AND CAPITAL LEASE OBLIGATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock', window );">DEBT AND CAPITAL LEASE OBLIGATION</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;7&#160;&#8212; DEBT AND CAPITAL LEASE OBLIGATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2010, the Company entered into a loan and security agreement with the Minnesota Agricultural and Economic Development Board under which the Company borrowed $250,000. The loan had a maturity date of November&#160;1, 2020. Commencing on December&#160;1, 2014, the loan started to bear interest at a rate of 6% per annum. Per the loan agreement, the Company began making&#160;monthly principal and interest payments on December&#160;1, 2015 in the amount of $3,000. The Company made 59&#160;monthly payments, plus one final payment equal to the then unpaid principal and interest. The loan was secured by the Company&#8217;s accounts receivable. As of September 30, 2021 and December&#160;31, 2020, the principal outstanding on this loan was $0 and $168,193, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In January&#160;2012, the Company signed a promissory note with the Regents of the University of Minnesota (the &#8220;University&#8221;) for $405,559. Commencing on January&#160;1, 2016 the promissory note bears interest at 3% per annum, compounded&#160;monthly. On or before January&#160;31, 2018, the Company is required to make&#160;monthly principal and interest payments of $7,737 until the note is paid in full. The note has a maturity date of December&#160;31, 2022 and is unsecured. In association with the promissory note, the Company issued the University warrants to purchase 80,000 shares of the Company&#8217;s common stock at an exercise price of $1.69. As of September 30, 2021 and December&#160;31, 2020, the principal outstanding on this loan was $106,320 and $172,731, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2015, the Company entered into a loan agreement with the Minnesota Department of Employment&#160;&amp; Economic Development under which the Company borrowed $250,000. The loan does not bear interest, is due in a lump sum payment on April&#160;1, 2022 and is uncollateralized. If there is a substantial ownership change in the Company (greater than 50% to one entity), the Company will pay the Minnesota Department of Employment&#160;&amp; Economic Development additional compensation of $75,000. As of both September 30, 2021 and December&#160;31, 2020, the balance outstanding on this loan was $250,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In October&#160;2018, the Company signed a lease agreement for a piece of equipment that is being accounted for as a capitalized lease. The total cost of the equipment was $102,026. The lease bears interest at 7.2% and the Company will make 60 monthly payments of $2,003 until the lease is paid in full. As of September 30, 2021 and December&#160;31, 2020, the amount outstanding on the lease was $43,113 and $57,127, respectively. The lease is secured by the piece of equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In January&#160;2019, Company issued the University a promissory note in the amount of $385,997 in satisfaction of the Company&#8217;s minimum royalty obligation for the&#160;year ended December&#160;31, 2018. The note bears interest at 6% per annum and is due on January&#160;31, 2025. In addition, the Company issued the University a 10-year warrant to purchase 20,587 shares of the Company&#8217;s common stock at an exercise price of $3.75 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In March&#160;2020, the Company entered into a note and warrant purchase agreement (the &#8220;Purchase Agreement&#8221;) with one of the Company&#8217;s shareholders under which the Company borrowed $6,000,000. As part of the Purchase Agreement, the Company signed a convertible promissory note (the &#8220;Note&#8221;) and issued the shareholder a warrant (the &#8220;Warrant&#8221;). The Note&#160;was unsecured and had a maturity date of September&#160;6, 2021. If the Company completed a preferred stock offering of at least $34,000,000 prior to the maturity date, the Note&#160;and all accrued interest would have automatically converted into preferred shares of such offering at the offering price. The Note&#160;initially bore interest at 5% per annum. If the Note&#160;was not converted prior to May&#160;1, 2020, the interest rate increased to 7% on May&#160;1, 2020 and by an additional 2% on the first day of each subsequent&#160;month prior to the maturity date starting on June&#160;1, 2020, provided that the interest rate shall not exceed 20%. The 5-year Warrant has a warrant coverage amount of $750,000 with an exercise price equal to the conversion price of the Note. If the Note&#160;had not been converted or repaid in accordance with its terms prior to May&#160;1, 2020, the Company will issue an additional warrant on May&#160;1, 2020, and the first day of each additional&#160;month the Note&#160;remains outstanding, for $75,000 of warrant coverage. In June 2021, the Note and all accrued interest was converted into 956,887 shares of the Company&#8217;s Series C Convertible Preferred Stock. As of September 30, 2021 and December&#160;31, 2020, the balance outstanding on the Note was $0 and $6,000,000, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">On April&#160;16, 2020, the Company issued a promissory note for $563,397 under the Paycheck Protection Program (&#8220;PPP&#8221;) through the U.S. Small Business Administration (SBA). The PPP was authorized in the Coronavirus Aid, Relief and Economic Security (CARES) Act. The promissory note is uncollateralized and is fully guaranteed by the Federal government. The outstanding balance of the promissory note bears interest at 1% per annum and is due on April&#160;16, 2022. Per the PPP&#8217;s terms, some or all of the debt may be forgiven based upon the Company&#8217;s use of the funds. On March&#160;4, 2021, $513,520 of the principal balance under the promissory note and associated interest of $4,530 were forgiven by the SBA. On August 6, 2021, the remaining principal balance of $49,877 along with associated interest of $440 were forgiven by the SBA. As of September 30, 2021 and December&#160;31, 2020, the balance outstanding on the promissory note was $0 and $563,397 respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In July&#160;2021, the Company signed a lease agreement for a piece of equipment that is being accounted for as a capitalized lease. The total cost of the equipment was $44,251. The lease bears interest at 5.0% and the Company will make 24 monthly payments of $1,941 until the lease is paid in full. As of September 30, 2021, the amount outstanding on the lease was $37,178. The lease is secured by the piece of equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In September&#160;2021, the Company signed a lease agreement for a piece of equipment that is being accounted for as a capitalized lease. The total cost of the equipment was $43,317. The lease bears interest at 6.8% and the Company will make 36 monthly payments of $1,448 until the lease is paid in full. As of September 30, 2021, the amount outstanding on the lease was $42,319. The lease is secured by the piece of equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Principal maturities were as follows as of the periods indicated:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Debt</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Capital Lease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Total</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,481,774</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,855</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,500,629</p></td></tr><tr><td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 504,354</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20,261</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 524,615</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,011</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,011</p></td></tr><tr><td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 385,997</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 385,997</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Totals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,372,125</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 57,127</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,429,252</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less current portion </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,481,774)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (18,855)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,500,629)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term portion </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 890,351</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 38,272</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 928,623</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Debt</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Capital Lease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 333,223</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52,938</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 386,161</p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 23,097</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 51,008</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74,105</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,664</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,664</p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 385,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 385,997</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Totals </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 742,317</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 122,610</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 864,927</p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less current portion </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (333,223)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (52,938)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (386,161)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term portion </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 409,094</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 69,672</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 478,766</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -URI http://asc.fasb.org/topic&amp;trid=2208923<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784150229336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_CapitalStockDisclosureAbstract', window );"><strong>CAPITAL STOCK</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock', window );">SHAREHOLDERS' DEFICIT AND MEZZANINE EQUITY</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;8&#160;&#8212; CAPITAL STOCK</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Convertible Preferred Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Immediately prior to the IPO, the Company had the following outstanding convertible preferred stock:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Liquidation</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Authorized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Preference</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible Preferred Stock - Series C</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,100,000</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,671,554</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">$ 27,536,655</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible Preferred Stock - Series B-2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,500,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,095,874</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,719,055</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible Preferred Stock - Series B</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,000,000</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,218,282</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,137,115</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible Preferred Stock - Series A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,000,380</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,500,950</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,900,000</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,986,090</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">$ 74,893,775</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Upon the closing of the IPO, all shares of convertible preferred stock then outstanding were automatically converted into an aggregate of 12,139,071 shares of common stock, resulting in the reclassification of the related convertible preferred stock into $121 of common stock and $73.7 million into additional paid-in capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2021, there were no shares of convertible preferred stock outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Common Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">All of the shares sold by the Company in the IPO were common stock. The Company is authorized to issue 190,000,000 shares of common stock, with a par value of $0.00001. Holders of common stock are entitled to one vote for each share held on all matters submitted to a vote of common shareholders, as provided in the Post-IPO Certificate. Subject to preferences that may be applicable to any outstanding preferred shares, each share of common stock is entitled to share pro rata in any distributions. In any distribution of capital assets, holders of common stock are entitled to receive pro rata the assets remaining after payment of liabilities and liquidation preferences on any outstanding preferred stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In 2020, the Company issued 64,000 and 1,000 shares of common stock in connection with the exercise of stock option agreements at exercise prices of $0.10 and $1.25 per share, respectively. The Company also issued 45,000 shares of common stock in connection with the exercise of stock warrant agreements at an exercise price of $1.25 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In 2019, the Company issued 50,000 shares of common stock in connection with the exercise of stock option agreements at exercise price of $1.25 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">At December 31, 2020, there were 2,185,822 shares of common stock issued and <span style="-sec-ix-hidden:Hidden_GdaMreGh4UWpAbI1JPGEhQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span>. At September 30, 2021, there were 20,254,645 shares of common stock issued and <span style="-sec-ix-hidden:Hidden_WX4Ga6iaZ02G6yjt970rOA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Preferred Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company is authorized to issue 10,000,000 shares of preferred stock, with a par value of $0.00001, as provided in the Post-IPO Certificate. As of September 30, 2021, there were no shares of preferred stock issued and <span style="-sec-ix-hidden:Hidden_DNi9Vf20okCb087fMwdOZw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">outstanding</span></span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">The Company previously classified its Series&#160;A Convertible Preferred Stock, Series&#160;B Convertible Preferred Stock, Series&#160;B-2 Convertible Preferred Stock, and Series C Convertible Preferred Stock as mezzanine equity due to their liquidation provisions under a change in control.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Series&#160;C Convertible Preferred Stock</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In May 2021, the Company entered into two stock purchase agreements under which it sold an aggregate of 2,666,667 shares of Series C Preferred Stock at $7.50 per share for gross proceeds of $20,000,003. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In June 2021, the $6,000,000 Note issue by the Company in March 2020 (See Note 7) and all accrued interest was converted into 956,887 shares of Series C Preferred Stock. On the same date, the Warrant issued in connection with the Note was converted into 48,000 shares of Series C Preferred Stock via a cashless exercise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Series C Preferred Stock converted into common stock at a 20% discount to the price to the public in the IPO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2021, all 3,671,554 shares of the Series C Preferred Stock had been converted into common stock and none remained outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Stock Options</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In February 2010, the Company adopted a stock option plan (the &#8220;2010 Plan&#8221;) which authorized options to acquire 375,000 shares of the Company&#8217;s common stock. On June&#160;20, 2011, the number of shares authorized to be issued as options under the 2010 Plan was increased to 600,000. On September&#160;30, 2013, the number of shares authorized to be issued as options under the 2010 Plan was increased to 1,300,000. On March&#160;1, 2014, the number of shares authorized to be issued as options under the 2010 Plan was increased to 1,700,000. On July&#160;31, 2015, the number of shares authorized to be issued as options under the 2010 Plan was increased to 2,500,000 shares. On August&#160;12, 2016, the number of shares authorized to be issued as options under the 2010 Plan was increased to 3,250,000 shares. On December&#160;13, 2017, the number of shares authorized to be issued as options under the 2010 Plan was increased to 3,850,000 shares. At September 30, 2021, there were 2,876,305 options outstanding under the 2010 Plan and 0 options available for grant. At December&#160;31, 2020, there were 3,287,230 options outstanding under the 2010 Plan and 0 options available for grant. The Company ceased making awards under the 2010 Plan upon approval of the 2019 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In July 2019, the Company adopted a stock option plan (the &#8220;2019 Plan&#8221;) which authorized options to acquire 1,000,000 shares of the Company&#8217;s common stock. At September 30, 2021, there were 377,000 options outstanding under the 2019 Plan and 0 options available for grant. At December&#160;31, 2020, there were 481,500 options outstanding under the 2019 Plan and 518,500 options available for grant. The Company ceased making awards under the 2019 Plan upon stockholder approval of the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">On May 20, 2021, the Company&#8217;s stockholders approved the 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;). The 2021 Plan provides for the issuance of stock options, restricted stock units and other awards to employees, directors and consultants of the Company. The number of shares of common stock that may be the subject of awards issued under the 2021 plan is 1,000,000. In addition, shares of common stock that would have otherwise been available under our 2019 Plan will increase the number of shares of common stock available for issuance under our 2021 plan. Shares of common stock subject to outstanding awards under the 2019 Plan that would otherwise return to the share reserve of the 2019 plan upon expiration, forfeiture, retention by the Company to satisfy any exercise price or any tax withholding, repurchase by the Company at their original purchase price, or settlement in cash of awards outstanding under the 2019 Plan may be added to the number of shares of common stock available for issuance under the 2021 Plan. The number of shares of common stock reserved for issuance under our 2021 Plan will automatically increase on the first day of each year, beginning on January 1, 2022, in amount equal to the lesser of (a) 4.5% of the total number of shares of common stock outstanding on December 31 of the immediately preceding calendar year, (b) 600,000 shares of common stock, or (c) such lesser number of shares as determined by the Board. At September 30, 2021, there were 244,831 awards outstanding and 1,323,169 awards available for grant under our 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following is a summary of options to purchase common stock during the nine&#160;months ended September 30 (unaudited):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:25.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine months ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:25.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Weighted </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Average </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Exercise</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Price</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options outstanding at beginning of the period </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,768,730</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.15</p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 215,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9.99</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (381,866)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.10</p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled or expired </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (137,559)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.01</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options outstanding at end of the period </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,464,805</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.70</p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options Exercisable </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,075,006</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.29</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The weighted average fair value of options granted for the nine months ended September 30, 2021 and 2020 was $4.33 and $0.94 per share, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2021, there were 3,464,805 common stock options outstanding with a weighted average remaining contractual life of <span style="color:#231f20;">4.73</span><span style="color:#231f20;font-family:'Arial','Helvetica','sans-serif';">&#160;</span><span style="color:#231f20;">years.</span> As of December&#160;31, 2020, there were 3,768,730 common stock options outstanding with a weighted average remaining contractual life of 5.08&#160;years<span style="color:#231f20;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2021, there were 3,075,006 common stock options exercisable with a weighted average remaining contractual life of <span style="color:#231f20;">4.19</span><span style="color:#231f20;font-family:'Arial','Helvetica','sans-serif';">&#160;</span><span style="color:#231f20;">years. </span>As of December&#160;31, 2020, there were 3,426,440 common stock options exercisable with a weighted average remaining contractual life of 4.74&#160;years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The intrinsic value of the outstanding options as of September 30, 2021 and December&#160;31, 2020 was $11,962,604 and $1,906,200, respectively. The intrinsic value of the exercisable options as of September 30, 2021 and December 31, 2020 was $11,342,114 and $1,906,200, respectively. The intrinsic value of options exercised was $1,418,173 and $1,915,060 for the three and nine months ended September 30, 2021, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company recognized $167,469 and $157,398 of stock-based compensation related to option grants during the three&#160;months ended September 30, 2021 and 2020, respectively, and $450,300 and $472,194 of stock-based compensation related to option grants during the nine&#160;months ended September 30, 2021 and 2020, respectively. As of December&#160;31, 2020, there was $562,456 of unrecognized compensation costs related to stock option grants of which $280,269, $182,465, $61,890 and $37,832 is expected to be recognized during the years ending December 31, 2021, 2022, 2023 and 2024, respectively. As of September 30, 2021, there was $1,106,705 of unrecognized compensation costs related to stock option grants of which $98,154, $391,038, $274,705, $255,880 and $86,929 is expected to be recognized during the years ending December 31, 2021, 2022, 2023, 2024, and 2025 respectively. The Company issues new common shares for options exercised.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Black-Scholes Assumptions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option grants with the following weighted average assumptions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100.14%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Nine months ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Expected life in years </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 5.99</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 5.95</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Risk-free interest rate </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 1.16</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">%</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 0.67</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">%</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Expected dividend yield </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Expected volatility </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 44.30</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">%</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 35.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">%</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Restricted Stock Units</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">During the nine months ended September 30, 2021, the Company granted directors restricted stock unit (&#8220;RSU&#8221;) awards totaling 33,331 shares of common stock under the 2021 Plan in accordance with the Company&#8217;s non-employee director compensation policy. Each RSU is eligible to vest over time and settle into one newly issued share of Company common stock. The weighted average fair value of $9.00 per unit was calculated based upon the IPO stock price.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">As of September 30, 2021, there was $250,000 of unrecognized compensation costs related to restricted stock units of which $50,000, $125,000, $50,000 and $25,000 is expected to be recognized during the years ending December 31, 2021, 2022, 2023 and 2024 respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">2021 Employee Stock Purchase Plan</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">On May 20, 2021, the Company&#8217;s stockholders adopted the 2021 Employee Stock Purchase Plan (&#8220;2021 ESPP&#8221;), which became effective in connection with the Company&#8217;s IPO. The 2021 ESPP allows eligible employees to purchase shares of the Company&#8217;s common stock in an offering on each purchase date no less than 85% of the lower of (i) the closing market price per share of common stock on the first day of the applicable purchase period or (ii) the closing market price per share of common stock on the purchase date at the end of the applicable six-month purchase period. No participant will have the right to purchase shares in an amount that has a fair value of more than $25,000 determined as of the first day of the applicable purchase period, for each calendar year, nor purchase more than 5,000 shares of common stock on any one purchase date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">There were 300,000 shares of common stock initially reserved for issuance under the 2021 ESPP. In addition the 2021 ESPP contains a provision which provides for an automatic annual share increase on January 1 of each year, in an amount equal to the lesser of (i) 1% of the total number of shares outstanding as of December 31 of the immediately preceding calendar year, (ii) 200,000 shares or (iii) such number of shares as determined by the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">The Company accounts for employee stock purchases made under its 2021 ESPP using the estimated grant date fair value of accounting in accordance with ASC 718, <i style="font-style:italic;">Stock Compensation</i>. The Company values ESPP shares using the Black-Scholes model.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;">There were no shares issued under the 2021 ESPP during the three and nine months ended September 30, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Stock Warrants</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Information with respect to warrants is summarized as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:middle;white-space:nowrap;width:13.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Series A Preferred</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:middle;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Common warrants</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding December&#160;31,&#160;2018</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 40,000</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 732,082</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted</p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 20,587</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Terminated</p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding December&#160;31,&#160;2019</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 40,000</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 752,669</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted</p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (45,000)</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Terminated</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (40,000)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding December&#160;31,&#160;2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 707,669</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted</p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 276,000</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (32,790)</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Terminated</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding September&#160;30,&#160;2021 (unaudited)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 950,879</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average exercise price:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">September&#160;30,&#160;2021 (unaudited)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">4.53</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">2.34</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">2.88</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">2.27</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average remaining contractual life in years:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">September&#160;30,&#160;2021 (unaudited)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">2.56</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">2.32</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2019</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">0.83</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">3.23</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_CapitalStockDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_CapitalStockDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). Also includes disclosure of temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153459496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>EMPLOYEE BENEFIT PLANS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanTextBlock', window );">EMPLOYEE BENEFIT PLANS</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;9&#160;&#8212; EMPLOYEE BENEFIT PLANS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The Company&#8217;s employees are eligible to participate in a defined contribution benefit plan. Employees may contribute a&#160;percentage of their wages, subject to limits established by the Internal Revenue Code. The Company may elect to make discretionary contributions to the plan. There were no discretionary contributions during the three and nine months ended September 30, 2021 and 2020.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -URI http://asc.fasb.org/subtopic&amp;trid=2235116<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153462472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT CUSTOMERS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>SIGNIFICANT CUSTOMERS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">SIGNIFICANT CUSTOMERS</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;10&#160;&#8212; SIGNIFICANT CUSTOMERS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt;">The Company had one customer that accounted for 100% of total revenue for the three&#160;and nine months ended September 30, 2021 and 2020. The current receivable for this customer is included in Receivable From Reprise Biomedical,&#160;Inc. The long-term receivable related to minimum royalties from this customer has been completely reserved against due to uncertainty regarding collectability.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784149116648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;11&#160;&#8212; COMMITMENTS AND CONTINGENCIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Patent License Agreement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Under an Exclusive Patent License Agreement between the Company and the University (the &#8220;Agreement&#8221;) the Company is required to make minimum royalty payments to the University of $500,000 per&#160;year. Under the Patent and Know-How License Agreement with Reprise, Reprise has minimum royalty obligations to the Company of $500,000 per&#160;year. (See Note&#160;12.)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Leases</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In February&#160;2015, the Company executed a lease for a facility in Eden Prairie, Minnesota. The Company had leased this facility through March&#160;31, 2020 at a rate of $13,100 per&#160;month with&#160;yearly rent increases of approximately 3% per&#160;year. In November&#160;2019, the lease for the facility was extended to December&#160;31, 2020 at a rate of $15,100 per&#160;month starting April&#160;1, 2020. In August&#160;2020, the lease for this facility was extended to December&#160;31, 2021 at a rate of $16,600 per&#160;month starting in January&#160;2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2020, the Company executed a lease for a second facility in the same Eden Prairie, Minnesota office park as its other facility. The Company leased this space through December&#160;31, 2020 at a rate of $2,500 per&#160;month starting in May&#160;2020. In August&#160;2020, the lease for this facility was extended to December&#160;31, 2021 at a rate of $3,400 per&#160;month starting in January&#160;2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Total rent expense under operating leases was $60,096 and $52,865 for the three&#160;months ended September 30, 2021 and 2020, respectively, and $183,389 and $148,425 for the nine&#160;months ended September 30, 2021 and 2020, respectively. The Company has future minimum non-cancelable lease commitments as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">At September&#160;30,&#160;2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">2021</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 60,096</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Total</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 60,096</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On August 2, 2021, the Company entered into a Multi-Tenant Industrial Triple Net Lease (the &#8220;Lease&#8221;) with B9 Polar Prairie Oaks Corporate LLC, a Delaware limited liability company (the &#8220;Landlord&#8221;), for research and development and office space located at 6455 Flying Cloud Drive, Eden Prairie, Minnesota 55344 (the &#8220;Building&#8221;). Under the terms of the Lease, starting on December 31, 2021 (the &#8220;Commencement Date&#8221;) the Company will lease approximately 42,278 square feet of the Building (the &#8220;Premises&#8221;) as the sole tenant at the Premises, which will replace the Company&#8217;s current leased premises at 10399 West 70<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street, Eden Prairie, Minnesota 55344. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The base rent under the Lease is $41,397 per month for the <span style="-sec-ix-hidden:Hidden_Hm1nq61nbUCGgQMTKFG8ew;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;white-space:pre-wrap;">12-month</span></span><span style="white-space:pre-wrap;"> period beginning on the Commencement Date and ending on December 31, 2022, and thereafter is subject to scheduled annual increases of approximately 3% during the term of the Lease. However, under the terms of the Lease, the Company&#8217;s monthly base rent will be abated for the period beginning on the Commencement Date and ending on May 31, 2022, provided the Lease is not terminated due to default. In addition to base rent, the Company is obligated under the Lease to pay to the Landlord certain costs, operating expenses and taxes, including approximately 61.08% of the real property taxes of the Building and the land on which it is located and approximately 61.08% of the Landlord&#8217;s management fee, which equals an amount of up to 5% of the Landlord&#8217;s gross receipts from leases at the Building. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The term of the Lease begins on the Commencement Date and ends on May 31, 2029. The Company has one option to extend the term for a period of <span style="white-space:pre-wrap;">five years</span><span style="white-space:pre-wrap;"> beginning on June 1, 2029.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">The Company plans to deliver a security deposit to the Landlord through an irrevocable, standby letter of credit (&#8220;LOC&#8221;) issued by Park State Bank in the amount of $800,000 (&#8220;Security Amount&#8221;), which will be retained by the Landlord as security for the Company&#8217;s performance and observance of its obligations under the Lease. To secure the LOC, the Company will be required to place the Security Amount in a restricted cash account at Park State Bank, which may be drawn from in limited circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">License Contract</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;">On December&#160;1, 2014, the Company entered into a research and development contract with an outside developer. The term of the contract was set to expire on December&#160;31, 2016, but in September&#160;2016 the expiration date was extended to December&#160;31, 2017; in January&#160;2018 the expiration date was extended to June&#160;30, 2019; in May&#160;2019 the expiration date was extended to March&#160;30, 2020; in February&#160;2020 the expiration date was extended to February&#160;28, 2021. In February&#160;2021 the contract was extended to December&#160;31, 2021. As partial consideration for the developer&#8217;s </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">services, on January&#160;1, 2015, the Company issued 26,667 shares of Series&#160;B preferred stock at a fair value of $7.50 per share. The value of these shares was charged to research&#160;&amp; development expenses in the statements of operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153462472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;12&#160;&#8212; RELATED PARTY TRANSACTIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">A corporation owned by a former director of the Company that resigned as a director in June 2021 received payments for providing a consultant to the Company of $1,141 and $1,579 for the three&#160;months ended September 30, 2021 and 2020, respectively, and $4,992 and $4,626 for the nine&#160;months ended September 30, 2021 and 2020, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company received $9,819 and $10,846 for the three&#160;months ended September 30, 2021 and 2020, respectively, and $25,066 and $31,328 for the nine&#160;months ended September 30, 2021 and 2020, respectively, as royalty related to the spin-out of the Acellular Business to Reprise. As of September 30, 2021 and 2020 the Company had long term receivables of $803,404 and $343,672, respectively, but due to the uncertainty regarding collectability the Company fully <span style="-sec-ix-hidden:Hidden_2po9q6YWxEaI543p-8A5uQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">reserved</span></span> against the <span style="-sec-ix-hidden:Hidden_Q7GTX4o5nEWWyrC9lnCvQw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">receivables</span></span>. The Company recorded a long-term receivable of $453,470 related to the minimum royalty due from Reprise for the&#160;year ended December&#160;31, 2020, but due to the uncertainty regarding collectability the Company fully <span style="-sec-ix-hidden:Hidden_V19YDa0XdUuAk6nk7v2a7g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">reserved</span></span> against the receivable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784149101816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>NET LOSS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET LOSS PER SHARE</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE&#160;13&#160;&#8212; NET LOSS PER SHARE</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Under the two-class method, for periods with net income, basic net income per common share is computed by dividing the net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Net income attributable to common stockholders is computed by subtracting from net income the portion of current&#160;year earnings that participating securities would have been entitled to receive pursuant to their dividend rights had all of the&#160;year&#8217;s earnings been distributed. No such adjustment to earnings is made during periods with a net loss as the holders of the participating securities have no obligation to fund losses. Diluted net loss per common share is computed under the two-class method by using the weighted average number of shares of common stock outstanding plus, for periods with net income attributable to common stockholders, the potential dilutive effects of stock options and warrants. In addition, the Company analyzes the potential dilutive effect of the outstanding participating securities under the if-converted method when calculating diluted earnings per share in which it is assumed that the outstanding participating securities convert into common stock at the beginning of the period. The Company reports the more dilutive of the approaches (two-class or if-converted) as its diluted net income per share during the period. Due to the existence of net losses for the three and nine&#160;months ended September 30, 2021 and 2020, basic and diluted loss per share were the same, as the effect of potentially dilutive securities would have been anti-dilutive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The following potentially dilutive securities outstanding have been excluded from the computations of diluted weighted average shares outstanding because such securities have an antidilutive impact due to losses reported:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:middle;white-space:nowrap;width:25.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Three Months Ended September&#160;30,&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:middle;white-space:nowrap;width:25.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Nine Months Ended September&#160;30,&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible preferred stock outstanding </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,314,536</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,314,536</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible preferred stock warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 40,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Common stock options outstanding</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,464,805</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,907,163</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,464,805</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,907,163</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Common stock warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 950,879</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 707,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 950,879</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 707,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,415,684</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,929,368</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,415,684</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,969,368</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153462472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 9pt 0pt;">NOTE&#160;14&#160;&#8212; SUBSEQUENT EVENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 9pt 0pt;"><span style="font-weight:normal;text-decoration:none;">In October 2021, the Company and Mayo Foundation for Medical Education and Research executed a ninth amendment to their agreement whereby the term was extended to March 31, 2022 and the Company agreed to provide </span><span style="font-weight:normal;text-decoration:none;">$279,500</span><span style="font-weight:normal;text-decoration:none;"> of additional funding.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784237039160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Preparation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Basis of Preparation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.3pt;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and the rules of the Securities and Exchange Commission (&#8220;SEC&#8221;) applicable to interim reports of companies filing as a smaller reporting company.&#160; These financial statements should be read in conjunction with the audited financial statements and notes thereto contained in the Company&#8217;s Registration Statement on Form S-1 (File No. 333-256649), as amended, (the &#8220;Form S-1&#8221;) for the fiscal year ended December 31, 2020 filed with the SEC on June 22, 2021.&#160; In the opinion of management, the accompanying condensed interim financial statements include all adjustments necessary in order to make the financial statements not misleading.&#160; The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year or any other future period.&#160; Certain notes to the financial statements that would substantially duplicate disclosures contained in the audited financial statements for the most recent fiscal year as reported in the Company&#8217;s Form S-1 have been omitted.&#160; The accompanying condensed balance sheet at December 31, 2020 has been derived from the audited balance sheet at December 31, 2020 contained in the Form S-1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt 0pt 12pt 0pt;">In the opinion of management, the accompanying condensed financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, stockholders' equity and cash flows for the interim periods but are not necessarily indicative of the results of operations or cash flows to be anticipated for the full year 2021 or any future period. The Company has evaluated subsequent events occurring after the date of the condensed financial statements for events requiring recording or disclosure in the condensed financial statements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Equity Method Investments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;">Investments in 20% to 50%-owned companies are accounted for under the equity method as the Company can exercise significant influence, but not control, over such investments. The equity method requires that gains (losses) are </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">recognized in other income (expense), net in the statements of operations. The gain on equity investment in Reprise Biomedical,&#160;Inc. (&#8220;Reprise&#8221;) resulted from recording the fair value of the Company&#8217;s investment in Reprise upon losing a controlling interest in the Company on June&#160;30, 2019. The Company recorded its equity method share of losses in Reprise from July&#160;1, 2019 through December&#160;31, 2019, from January&#160;1, 2020 to December&#160;31, 2020 and from January&#160;1, 2021 to March&#160;15, 2021 in the statements of operations. Even though the Company&#8217;s ownership dropped below 20% on November&#160;15, 2020, the Company still had significant influence over the activities of Reprise due to common board members (See Note&#160;4).</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Research and Development Costs</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Research and development expenses consist primarily of engineering, product development, consulting services, materials, depreciation and other costs associated with products and technologies in development. These expenses include employee and non-employee compensation, including stock-based compensation, supplies, materials, consulting expenses, related travel expenses, and facility costs. Expenditures for research and development activities are charged to operations as incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Stock-Based Compensation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company is required to determine the fair value of equity incentive awards and recognize compensation expense for all equity incentive awards made to employees and directors, including employee stock options. The Company also determines the fair value of non-statutory stock options issued to consultants based on the fair value of the consultant&#8217;s commitment at the date of grant. Such expense is recognized over the requisite service period. In addition, stock-based compensation expense recognized in the statements of operations is based on awards expected to vest and therefore the amount of expense has been reduced for estimated forfeitures. The Company uses the straight-line method for expense attribution, except for awards issued with performance-based conditions which require an accelerated attribution method over the requisite performance and service periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Under the applicable accounting guidance for equity incentive awards issued to non-employees, the date at which the fair value of such awards is measured is equal to the earlier of: 1) the date at which a commitment for performance by the counterparty to earn the equity instrument is reached; or <span style="color:#231f20;">2) the date at which the counterparty</span><span style="color:#231f20;font-family:'Arial','Helvetica','sans-serif';">&#8217;</span><span style="color:#231f20;">s performance is complete. The Company recognizes stock-based compensation expense for the fair value of the vested portion of the non-employee awards in the statements of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The valuation model used for calculating the fair value of awards for stock-based compensation expense is the Black-Scholes option-pricing model (the &#8220;Black-Scholes model&#8221;). The Black-Scholes model requires the Company to make assumptions and judgments about the variables used in the calculation, including the expected term (weighted average period of time that the options granted are expected to be outstanding), the volatility of common stock, and an assumed risk-free interest rate. The Company uses the &#8220;simplified method&#8221; to determine the expected term of the stock option. Volatility is based on an average of the historical volatilities of the common stock of publicly-traded companies with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected term of the option. The expected dividend assumption is based on the Company&#8217;s history of not paying dividends and its expectation that it will not declare dividends for the foreseeable future. Potential forfeitures of awards are estimated based on the Company&#8217;s historical forfeiture experience. The estimate of forfeitures will be adjusted over the service period to the extent that actual forfeitures differ, or are expected to differ, from prior estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, accounts receivable, and accounts payable. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Use of Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock', window );">Emerging Growth Company Status</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Emerging Growth Company Status</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (&#8220;JOBS Act&#8221;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as to those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i)&#160;is no longer an emerging growth company or (ii)&#160;affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Net Loss Per Share</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt 0pt 12pt 0pt;">Basic net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock and dilutive potential shares of common stock outstanding during the period. Because we have reported a net loss for all periods presented, diluted net loss per share is the same as basic net loss per share for those periods as all potentially dilutive shares consisting of stock options and warrants were antidilutive in those periods (See Note 13).</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration:underline;">Recent Accounting Pronouncements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:19.95pt;margin:0pt;">During February&#160;2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No.&#160;2016-02, &#8220;Leases (Topic 842).&#8221; ASU No. 2016-02 requires lessees to recognize the assets and liabilities that arise from leases on the balance sheet. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. During 2018, the FASB also issued ASU No.&#160;2018-10, &#8220;Codification Improvements to Topic 842, Leases&#8221;, which addresses narrow aspects of the guidance originally issued in ASU No.&#160;2016-02; ASU 2018-11, &#8220;Targeted Improvements&#8221;, which provides entities with an additional (and optional) transition method whereby an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption and also provides lessors with a practical expedient, by class of underlying asset, to not separate non-lease components from the associated lease component and, instead, to account for those components as a single component. During 2019, the FASB also issued ASU No.&#160;2019-01, which clarified Topic 842&#8217;s interim disclosure requirements and amend certain industry-specific guidance related to determining the fair value of leased assets and the cash flow presentation of principal payments received under sales-type and direct finance leases. Topic 842 (as amended) is effective for annual periods beginning after December&#160;15, 2021, and interim periods within fiscal&#160;years beginning after December&#160;15, 2022. Early adoption is permitted. The Company is currently assessing the effect that Topic 842 (as amended) will have on its results of operations, financial position and cash flows.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for emerging growth company status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784243624152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of lab equipment, furniture, leasehold improvements and construction in progress</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&#160;30,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lab equipment</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,762,512</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,480,952</p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Construction in progress</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,166,129</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Leasehold improvements</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 310,225</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 310,225</p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Furniture and fixtures &amp; computers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 112,302</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 112,302</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,351,168</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,903,479</p></td></tr><tr><td style="vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less accumulated depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,672,520)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,578,945)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,678,648</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 324,534</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784149750168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY METHOD INVESTMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>EQUITY METHOD INVESTMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of financial information from the financial statements of Reprise</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Current assets</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 4,309,045</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Total assets</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 5,312,350</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Current liabilities</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 2,534,673</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Non-current liabilities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 489,785</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Shareholders&#8217; equity</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 2,287,892</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Miromatrix Medical Inc. share of shareholders&#8217; equity</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 411,821</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;width:22.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">For the Three Months Ended September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;width:24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">For the Nine Months Ended September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net sales</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 169,277</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 93,985</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 484,067</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross margin</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 109,497</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 47,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 307,573</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,188,678)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,376,522)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,723,533)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Miromatrix Medical Inc. share of net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (495,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (223,633)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,676,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784149032040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>ACCRUED EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of current accrued expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Wages</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 549,685</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 217,825</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Legal</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 120,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 452,778</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Royalties</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 2,455</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 3,800</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Supplies</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 80,700</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">IPO expenses</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 936,652</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Key opinion leader compensation</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 100,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 34,000</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Board compensation</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 58,125</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Other</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 75,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 52,486</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="color:#231f20;">Accrued expenses</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 1,922,617</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 760,889</span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153459496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE MEASUREMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Schedule of changes in value of the Company's embedded derivative liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative liability balance at December&#160;31,&#160;2019</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;&#160;&#160;&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative instrument related to March 2020 Note</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 195,516</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Gain/Loss recognized to revalue derivative instrument at fair value</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 51,446</span></p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative liability balance at December&#160;31,&#160;2020</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 246,962</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Gain/Loss recognized to revalue derivative instrument at fair value (unaudited)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (246,962)</span></p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative liability balance at September&#160;30,&#160;2021 (unaudited)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784147666344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT AND CAPITAL LEASE OBLIGATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of maturities of debt</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Debt</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Capital Lease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Total</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,481,774</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,855</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,500,629</p></td></tr><tr><td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 504,354</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20,261</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 524,615</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,011</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,011</p></td></tr><tr><td style="vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 30pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 385,997</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 385,997</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Totals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,372,125</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 57,127</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,429,252</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less current portion </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,481,774)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (18,855)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,500,629)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term portion </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 890,351</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 38,272</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 928,623</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Debt</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Capital Lease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 333,223</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52,938</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 386,161</p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 23,097</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 51,008</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74,105</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,664</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,664</p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 385,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 385,997</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Totals </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 742,317</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 122,610</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 864,927</p></td></tr><tr><td style="vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less current portion </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (333,223)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (52,938)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (386,161)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:62.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term portion </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 409,094</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 69,672</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 478,766</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784149183768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_CapitalStockDisclosureAbstract', window );"><strong>CAPITAL STOCK</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of convertible preferred stock</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Liquidation</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Authorized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Preference</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible Preferred Stock - Series C</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,100,000</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,671,554</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">$ 27,536,655</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible Preferred Stock - Series B-2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,500,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,095,874</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,719,055</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible Preferred Stock - Series B</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,000,000</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,218,282</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,137,115</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible Preferred Stock - Series A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,000,380</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,500,950</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:60.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,900,000</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,986,090</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">$ 74,893,775</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity table text block</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:25.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine months ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:25.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Weighted </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Average </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Exercise</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Price</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options outstanding at beginning of the period </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,768,730</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.15</p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 215,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9.99</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (381,866)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.10</p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled or expired </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (137,559)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.01</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options outstanding at end of the period </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,464,805</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.70</p></td></tr><tr><td style="vertical-align:bottom;width:72.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Options Exercisable </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,075,006</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.29</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of weighted average assumptions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100.14%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Nine months ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Expected life in years </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 5.99</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 5.95</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Risk-free interest rate </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 1.16</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">%</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 0.67</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">%</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Expected dividend yield </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Expected volatility </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 44.30</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">%</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 35.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">%</span></p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of warrants</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:middle;white-space:nowrap;width:13.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Series A Preferred</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:middle;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Common warrants</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding December&#160;31,&#160;2018</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 40,000</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 732,082</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted</p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 20,587</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Terminated</p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding December&#160;31,&#160;2019</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 40,000</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 752,669</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted</p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (45,000)</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Terminated</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (40,000)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding December&#160;31,&#160;2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 707,669</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted</p></td><td style="vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 276,000</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercised</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> (32,790)</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Terminated</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding September&#160;30,&#160;2021 (unaudited)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 950,879</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average exercise price:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">September&#160;30,&#160;2021 (unaudited)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">4.53</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">2.34</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">2.88</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">2.27</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average remaining contractual life in years:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">September&#160;30,&#160;2021 (unaudited)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">2.56</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">2.32</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2019</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">0.83</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;">3.23</span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_CapitalStockDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_CapitalStockDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153448888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>COMMITMENTS AND CONTINGENCIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of future minimum non-cancelable lease commitments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">At September&#160;30,&#160;2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">2021</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 60,096</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Total</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 60,096</span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784147701464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>NET LOSS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of potentially dilutive securities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:middle;white-space:nowrap;width:25.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Three Months Ended September&#160;30,&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:middle;white-space:nowrap;width:25.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Nine Months Ended September&#160;30,&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible preferred stock outstanding </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,314,536</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,314,536</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible preferred stock warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 40,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Common stock options outstanding</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,464,805</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,907,163</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,464,805</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,907,163</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Common stock warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 950,879</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 707,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 950,879</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 707,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,415,684</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,929,368</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,415,684</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,969,368</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153213256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Charter (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 23, 2021 </div>
<div>class </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 22, 2021 </div>
<div>shares</div>
</th>
<th class="th"><div>May 20, 2021</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">190,000,000<span></span>
</td>
<td class="nump">190,000,000<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock , authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_NumberOfClassesOfStock', window );">Number of classes of stock | class</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesCConvertiblePreferredStockMember', window );">Series C Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockConversionPercentage', window );">Stock conversion, percentage common stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_NumberOfClassesOfStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of classes of stock entity may authorize to issue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_NumberOfClassesOfStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_StockConversionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of common stock price at which convertible preferred stock was converted into common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_StockConversionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesCConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesCConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784147556104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Equity Method Investments (Details) - Reprise Biomedical, Inc.<br></strong></div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Nov. 15, 2020</div></th>
<th class="th"><div>Nov. 14, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (as a percent)</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=miro_RepriseBiomedicalInc.Member', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=miro_RepriseBiomedicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=miro_RepriseBiomedicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784150998200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INITIAL PUBLIC OFFERING (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>IPO</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=miro_CommonWarrantsMember', window );">Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>IPO</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ClassOfWarrantOrRightGranted', window );">Warrants issued (in shares)</a></td>
<td class="nump">276,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">276,000<span></span>
</td>
<td class="nump">20,587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>IPO</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,520,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock (in shares)</a></td>
<td class="nump">12,139,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>IPO</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock</a></td>
<td class="nump">$ 73,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>IPO</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock (in shares)</a></td>
<td class="nump">5,520,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock</a></td>
<td class="nump">$ 49,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>IPO</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock (in shares)</a></td>
<td class="nump">720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ClassOfWarrantOrRightGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ClassOfWarrantOrRightGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=miro_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=miro_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784154081528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Lab equipment, furniture, leasehold improvements and construction in progress, gross</a></td>
<td class="nump">$ 3,351,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,351,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,903,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(1,672,520)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,672,520)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,578,945)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Lab equipment, furniture, leasehold improvements and construction in progress, net, net</a></td>
<td class="nump">1,678,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,678,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">34,401<span></span>
</td>
<td class="nump">$ 34,901<span></span>
</td>
<td class="nump">93,575<span></span>
</td>
<td class="nump">$ 139,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForConstructionInProcess', window );">Leasehold improvements recorded as construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,166,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Lab equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Lab equipment, furniture, leasehold improvements and construction in progress, gross</a></td>
<td class="nump">1,762,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,762,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,480,952<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Lab equipment, furniture, leasehold improvements and construction in progress, gross</a></td>
<td class="nump">1,166,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,166,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Lab equipment, furniture, leasehold improvements and construction in progress, gross</a></td>
<td class="nump">310,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310,225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_FurnitureFixturesAndComputersMember', window );">Furniture and fixtures &amp; computers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Lab equipment, furniture, leasehold improvements and construction in progress, gross</a></td>
<td class="nump">$ 112,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,302<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForConstructionInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from construction costs to date on capital projects that have not been completed and assets being constructed that are not ready to be placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForConstructionInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_FurnitureFixturesAndComputersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_FurnitureFixturesAndComputersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784237130248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY METHOD INVESTMENT - Reprise (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Nov. 15, 2020</div></th>
<th class="th"><div>Nov. 14, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of equity method investment shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=miro_RepriseBiomedicalInc.Member', window );">Reprise Biomedical, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on sale of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,495,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_EquityMethodInvestmentSharesOwned', window );">Number of equity method investment shares owned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (as a percent)</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_EquityMethodInvestmentSharesSold', window );">Number of equity method investment shares sold</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of equity method investment shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=miro_RepriseBiomedicalInc.Member', window );">Reprise Biomedical, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_EquityMethodInvestmentSharesOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares owned of equity method investment by entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_EquityMethodInvestmentSharesOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_EquityMethodInvestmentSharesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares of equity method investment sold by entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_EquityMethodInvestmentSharesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=miro_RepriseBiomedicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=miro_RepriseBiomedicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=miro_RepriseBiomedicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=miro_RepriseBiomedicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784236862936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>EQUITY METHOD INVESTMENT - Balance Sheet (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Equity method investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 62,547,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,690,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">64,225,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,254,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">3,558,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,164,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Miromatrix Medical Inc. share of shareholders' equity</a></td>
<td class="nump">$ 59,267,049<span></span>
</td>
<td class="nump">$ 63,408,081<span></span>
</td>
<td class="num">$ (51,306,334)<span></span>
</td>
<td class="num">(51,034,193)<span></span>
</td>
<td class="num">$ (50,120,222)<span></span>
</td>
<td class="num">$ (47,285,395)<span></span>
</td>
<td class="num">$ (44,169,714)<span></span>
</td>
<td class="num">$ (41,433,379)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=miro_RepriseBiomedicalInc.Member', window );">Reprise Biomedical, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Equity method investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,309,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,312,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,534,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">489,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Shareholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,287,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Miromatrix Medical Inc. share of shareholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 411,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=miro_RepriseBiomedicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=miro_RepriseBiomedicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784237132904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY METHOD INVESTMENT - Income Statement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Equity method investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 9,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,066<span></span>
</td>
<td class="nump">$ 31,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="num">(115,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114,154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(349,934)<span></span>
</td>
<td class="num">(343,672)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Miromatrix Medical Inc. share of net loss</a></td>
<td class="num">$ (5,057,581)<span></span>
</td>
<td class="num">$ (3,702,834)<span></span>
</td>
<td class="num">$ (434,342)<span></span>
</td>
<td class="num">(2,992,225)<span></span>
</td>
<td class="num">$ (3,273,079)<span></span>
</td>
<td class="num">$ (2,956,233)<span></span>
</td>
<td class="num">(9,194,757)<span></span>
</td>
<td class="num">(9,221,537)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=miro_RepriseBiomedicalInc.Member', window );">Reprise Biomedical, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Equity method investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,985<span></span>
</td>
<td class="nump">484,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,708<span></span>
</td>
<td class="nump">307,573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,188,678)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,376,522)<span></span>
</td>
<td class="num">(3,723,533)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Miromatrix Medical Inc. share of net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (495,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (223,633)<span></span>
</td>
<td class="num">$ (1,676,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=miro_RepriseBiomedicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=miro_RepriseBiomedicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784152992360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>ACCRUED EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Wages</a></td>
<td class="nump">$ 549,685<span></span>
</td>
<td class="nump">$ 217,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal</a></td>
<td class="nump">120,000<span></span>
</td>
<td class="nump">452,778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties</a></td>
<td class="nump">2,455<span></span>
</td>
<td class="nump">3,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_AccruedSuppliesCurrent', window );">Supplies</a></td>
<td class="nump">80,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_AccruedLiabilitiesPublicOfferingExpensesCurrent', window );">IPO expenses</a></td>
<td class="nump">936,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_AccruedKeyOpinionLeadedCompensationCurrent', window );">Key opinion leader compensation</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">34,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_AccruedBoardCompensationCurrent', window );">Board compensation</a></td>
<td class="nump">58,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">52,486<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 1,922,617<span></span>
</td>
<td class="nump">$ 760,889<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_AccruedBoardCompensationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for services provided by board of directors. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_AccruedBoardCompensationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_AccruedKeyOpinionLeadedCompensationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for key opinion leader compensation. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_AccruedKeyOpinionLeadedCompensationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_AccruedLiabilitiesPublicOfferingExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for public offering expenses, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_AccruedLiabilitiesPublicOfferingExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_AccruedSuppliesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for supplies. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_AccruedSuppliesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784236871832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENT - Changes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeLineItems', window );"><strong>FAIR VALUE MEASUREMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Derivative liability beginning balance</a></td>
<td class="nump">$ 246,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Derivative liability ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 246,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeLineItems', window );"><strong>FAIR VALUE MEASUREMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Derivative liability beginning balance</a></td>
<td class="nump">246,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions', window );">Derivative instrument related to March 2020 Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet', window );">Gain/Loss recognized to revalue derivative instrument at fair value</a></td>
<td class="num">$ (246,962)<span></span>
</td>
<td class="nump">51,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Derivative liability ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 246,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liability, Fair Value, Gross Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195,516<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additions of embedded derivative or group of embedded derivatives classified as a liability during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -URI http://asc.fasb.org/subtopic&amp;trid=2229187<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784137698072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT AND CAPITAL LEASE OBLIGATION - Agreements (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="7">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 06, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jun. 01, 2020</div></th>
<th class="th">
<div>Jan. 01, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 01, 2015 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($) </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Jan. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2018 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Jan. 31, 2012 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>May 01, 2020</div></th>
<th class="th">
<div>Apr. 16, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 01, 2014</div></th>
<th class="th">
<div>Dec. 31, 2010 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=miro_WarrantsRegentsOfUniversityOfMinnesotaMember', window );">Warrants, Regents of the University of Minnesota</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ClassOfWarrantOrRightNumberOfWarrantsIssued', window );">Number of warrants issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=miro_WarrantsUniversityOfMinnesotaMember', window );">Warrants, University of Minnesota</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ClassOfWarrantOrRightNumberOfWarrantsIssued', window );">Number of warrants issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Term of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=miro_WarrantsCompanyShareholderMember', window );">Warrants, Company shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Term of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant coverage amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_WarrantsAndRightsAdditionalCoverage', window );">Additional warrant coverage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember', window );">Loan, Minnesota Agricultural and Economic Development Board, Due November 1, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtInstrumentPeriodicMonthlyPaymentNumber', window );">Number of monthly payment | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtInstrumentNumberOfFinalPayment', window );">Number of final payment | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Amount of principal and interest payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember', window );">Promissory Note, Regents of the University of Minnesota, Due December 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 405,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Amount of principal and interest payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember', window );">Loan, Minnesota Department of Employment and Economic Development.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_SubstantialOwnershipChangePercentage', window );">Substantial ownership change threshold (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtInstrumentAdditionalCompensation', window );">Potential additional compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=miro_CapitalLeaseOctober2018Member', window );">Capital Lease, October 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasedAssetsGross', window );">Capitalized lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtInstrumentPeriodicMonthlyPaymentNumber', window );">Number of monthly payment | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Amount of principal and interest payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligations', window );">Lease outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=miro_PromissoryNoteWithUniversityOfMinnesotaMember', window );">Promissory Note, University of Minnesota, Due January 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 385,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=miro_NoteCompanyShareholderMember', window );">Note, Company shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_NumberOfShareholders', window );">Number of shareholders | shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtInstrumentConvertibleMinimumPreferredStockOffering', window );">Minimum amount of preferred stock offering for conversion of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease', window );">Increase in interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=miro_NoteCompanyShareholderMember', window );">Note, Company shareholder | Series C Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest', window );">Temporary equity issued upon conversion of note and accrued interest (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">956,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=miro_NoteCompanyShareholderMember', window );">Note, Company shareholder | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate during period (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=miro_PaycheckProtectionProgramMember', window );">Paycheck Protection Program Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 563,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtInstrumentPrincipalForgiveness', window );">Amount of principal forgiven</a></td>
<td class="nump">$ 49,877<span></span>
</td>
<td class="nump">$ 513,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtInstrumentInterestForgiveness', window );">Amount of interest forgiven</a></td>
<td class="nump">$ 440<span></span>
</td>
<td class="nump">$ 4,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 563,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=miro_CapitalLeaseJuly2021Member', window );">Capital Lease, July 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasedAssetsGross', window );">Capitalized lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtInstrumentPeriodicMonthlyPaymentNumber', window );">Number of monthly payment | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Amount of principal and interest payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligations', window );">Lease outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=miro_CapitalLeaseSeptember2021Member', window );">Capital Lease, September 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND CAPITAL LEASE OBLIGATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasedAssetsGross', window );">Capitalized lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtInstrumentPeriodicMonthlyPaymentNumber', window );">Number of monthly payment | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Amount of principal and interest payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligations', window );">Lease outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ClassOfWarrantOrRightNumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants issued, in terms of number of securities into which the class of warrant or right may be converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ClassOfWarrantOrRightNumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_DebtInstrumentAdditionalCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additional compensation cost to be paid upon specified ownership change.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_DebtInstrumentAdditionalCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_DebtInstrumentConvertibleMinimumPreferredStockOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of preferred stock offering for conversion of debt into preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_DebtInstrumentConvertibleMinimumPreferredStockOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_DebtInstrumentInterestForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of interest forgiven by the holder of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_DebtInstrumentInterestForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_DebtInstrumentNumberOfFinalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of final payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_DebtInstrumentNumberOfFinalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_DebtInstrumentPeriodicMonthlyPaymentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of monthly payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_DebtInstrumentPeriodicMonthlyPaymentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_DebtInstrumentPrincipalForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of principal forgiven by the holder of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_DebtInstrumentPrincipalForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_NumberOfShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_NumberOfShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_SubstantialOwnershipChangePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold percentage defined as substantial ownership change for one entity under terms of agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_SubstantialOwnershipChangePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of temporary equity shares issued during the period as a result of the conversion of note payable and accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_WarrantsAndRightsAdditionalCoverage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of additional warrants to be issued under specified terms of the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_WarrantsAndRightsAdditionalCoverage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123386454&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasedAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of leased physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123406127&amp;loc=d3e45014-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasedAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental percentage increase (decrease) in the stated rate on a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=miro_WarrantsRegentsOfUniversityOfMinnesotaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=miro_WarrantsRegentsOfUniversityOfMinnesotaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=miro_WarrantsUniversityOfMinnesotaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=miro_WarrantsUniversityOfMinnesotaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=miro_WarrantsCompanyShareholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=miro_WarrantsCompanyShareholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=miro_CapitalLeaseOctober2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=miro_CapitalLeaseOctober2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=miro_PromissoryNoteWithUniversityOfMinnesotaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=miro_PromissoryNoteWithUniversityOfMinnesotaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=miro_NoteCompanyShareholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=miro_NoteCompanyShareholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesCConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesCConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=miro_PaycheckProtectionProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=miro_PaycheckProtectionProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=miro_CapitalLeaseJuly2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=miro_CapitalLeaseJuly2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=miro_CapitalLeaseSeptember2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=miro_CapitalLeaseSeptember2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784239931560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT AND CAPITAL LEASE OBLIGATION - Maturity (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Debt and Lease Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths', window );">Year 1</a></td>
<td class="nump">$ 386,161<span></span>
</td>
<td class="nump">$ 6,500,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo', window );">Year 2</a></td>
<td class="nump">74,105<span></span>
</td>
<td class="nump">524,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree', window );">Year 3</a></td>
<td class="nump">18,664<span></span>
</td>
<td class="nump">18,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour', window );">Year 4</a></td>
<td class="nump">385,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive', window );">Year 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385,997<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtAndCapitalLeaseObligationsGross', window );">Totals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,429,252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtAndCapitalLeaseObligationsGrossCurrent', window );">Less current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,500,629)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtAndCapitalLeaseObligationsGrossNoncurrent', window );">Long-term portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">928,623<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Totals</a></td>
<td class="nump">864,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less current portion</a></td>
<td class="num">(386,161)<span></span>
</td>
<td class="num">(6,413,733)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term portion</a></td>
<td class="nump">478,766<span></span>
</td>
<td class="nump">928,623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember', window );">Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Debt and Lease Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths', window );">Year 1</a></td>
<td class="nump">333,223<span></span>
</td>
<td class="nump">6,481,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo', window );">Year 2</a></td>
<td class="nump">23,097<span></span>
</td>
<td class="nump">504,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour', window );">Year 4</a></td>
<td class="nump">385,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive', window );">Year 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385,997<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtAndCapitalLeaseObligationsGross', window );">Totals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,372,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtAndCapitalLeaseObligationsGrossCurrent', window );">Less current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,481,774)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtAndCapitalLeaseObligationsGrossNoncurrent', window );">Long-term portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">890,351<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Totals</a></td>
<td class="nump">742,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less current portion</a></td>
<td class="num">(333,223)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term portion</a></td>
<td class="nump">409,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember', window );">Capital Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Debt and Lease Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths', window );">Year 1</a></td>
<td class="nump">52,938<span></span>
</td>
<td class="nump">18,855<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo', window );">Year 2</a></td>
<td class="nump">51,008<span></span>
</td>
<td class="nump">20,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree', window );">Year 3</a></td>
<td class="nump">18,664<span></span>
</td>
<td class="nump">18,011<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtAndCapitalLeaseObligationsGross', window );">Totals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtAndCapitalLeaseObligationsGrossCurrent', window );">Less current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,855)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_DebtAndCapitalLeaseObligationsGrossNoncurrent', window );">Long-term portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,272<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Totals</a></td>
<td class="nump">122,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less current portion</a></td>
<td class="num">(52,938)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term portion</a></td>
<td class="nump">$ 69,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_DebtAndCapitalLeaseObligationsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of short-term and  long-term debt and capital leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_DebtAndCapitalLeaseObligationsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_DebtAndCapitalLeaseObligationsGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of short-term and  long-term debt and capital leases, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_DebtAndCapitalLeaseObligationsGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_DebtAndCapitalLeaseObligationsGrossNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of short-term and  long-term debt and capital leases, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_DebtAndCapitalLeaseObligationsGrossNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation  maturing in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the next rolling twelve months following the latest balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784236993032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK - Convertible Preferred Stock, Prior to IPO (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,986,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,893,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock (in shares)</a></td>
<td class="nump">12,139,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock</a></td>
<td class="nump">$ 73,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesCConvertiblePreferredStockMember', window );">Convertible Preferred Stock - Series C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,671,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,536,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesB2ConvertiblePreferredStockMember', window );">Convertible preferred stock - Series B-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,095,874<span></span>
</td>
<td class="nump">2,095,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 15,719,055<span></span>
</td>
<td class="nump">$ 15,719,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesBConvertiblePreferredStockMember', window );">Convertible preferred stock - Series B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,218,282<span></span>
</td>
<td class="nump">3,218,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 24,137,115<span></span>
</td>
<td class="nump">$ 24,137,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesConvertiblePreferredStockMember', window );">Convertible preferred stock - Series A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,000,380<span></span>
</td>
<td class="nump">3,000,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7,500,950<span></span>
</td>
<td class="nump">$ 7,500,950<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesCConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesCConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesB2ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesB2ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153903192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK - Common Stock and Preferred Stock (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>Vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 23, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 22, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">190,000,000<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,000,000<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_NumberOfVotesForCommonStockHolders', window );">Number of votes | Vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">381,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Option exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 2.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Stock issued upon exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">20,254,645<span></span>
</td>
<td class="nump">2,185,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">20,254,645<span></span>
</td>
<td class="nump">2,185,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock , authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=miro_ExercisePriceOf0.10Member', window );">Exercise price of $0.10</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Option exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=miro_ExercisePriceOf1.25Member', window );">Exercise price of $1.25</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Option exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_NumberOfVotesForCommonStockHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of votes each common stock holder is entitled to vote.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_NumberOfVotesForCommonStockHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock issued as a result of the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=miro_ExercisePriceOf0.10Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=miro_ExercisePriceOf0.10Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=miro_ExercisePriceOf1.25Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=miro_ExercisePriceOf1.25Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784236957992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK - Series C Convertible Preferred Stock (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($) </div>
<div>agreement </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of stock warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,986,090<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=miro_NoteCompanyShareholderMember', window );">Note, Company shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value of debt | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesCConvertiblePreferredStockMember', window );">Series C Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_NumberOfStockPurchaseAgreements', window );">Number of stock purchase agreements entered into | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Share issue price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Gross proceeds | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockConversionDiscount', window );">Conversion discount (as a percent)</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_TemporaryEquitySharesConvertedInPeriod', window );">Number of shares converted to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,671,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,671,554<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesCConvertiblePreferredStockMember', window );">Series C Convertible Preferred Stock | Warrants, Company shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of stock warrants (in shares)</a></td>
<td class="nump">48,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=miro_SeriesCConvertiblePreferredStockMember', window );">Series C Convertible Preferred Stock | Note, Company shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value of debt | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest', window );">Temporary equity issued upon conversion of note and accrued interest (in shares)</a></td>
<td class="nump">956,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_NumberOfStockPurchaseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock purchase agreements entity entered into during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_NumberOfStockPurchaseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_StockConversionDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount in which convertible preferred stock was converted into common stock, as a percent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_StockConversionDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock issued as a result of the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_TemporaryEquitySharesConvertedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares classified as temporary equity  converted to common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_TemporaryEquitySharesConvertedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of temporary equity shares issued during the period as a result of the conversion of note payable and accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=miro_NoteCompanyShareholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=miro_NoteCompanyShareholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesCConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesCConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=miro_WarrantsCompanyShareholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=miro_WarrantsCompanyShareholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784141820360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK - Stock options (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 20, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Dec. 13, 2017</div></th>
<th class="th"><div>Aug. 12, 2016</div></th>
<th class="th"><div>Jul. 31, 2015</div></th>
<th class="th"><div>Mar. 01, 2014</div></th>
<th class="th"><div>Sep. 30, 2013</div></th>
<th class="th"><div>Jun. 20, 2011</div></th>
<th class="th"><div>Feb. 28, 2010</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Summary of options granted - Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at beginning of the period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,768,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(381,866)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled or expired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(137,559)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at end of the period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,464,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,464,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,768,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options Exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,075,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,075,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,426,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Summary of options granted - Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at beginning of the period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Canceled or expired (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at end of the period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options Exercisable (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual term, Options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 8 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term, Options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 2 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 8 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Intrinsic value, Options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,962,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,962,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,906,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Intrinsic value, Options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,342,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,342,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,906,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value, Options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,418,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,915,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,469<span></span>
</td>
<td class="nump">$ 157,398<span></span>
</td>
<td class="nump">450,300<span></span>
</td>
<td class="nump">$ 472,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,106,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,106,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear', window );">Remainder of fiscal year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne', window );">Cost to be recognized year 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">391,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">391,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo', window );">Cost to be recognized in year 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree', window );">Cost to be recognized in year 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour', window );">Cost to be recognized in year 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=miro_StockOptionPlan2010Member', window );">2010 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,850,000<span></span>
</td>
<td class="nump">3,250,000<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Awards available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Summary of options granted - Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at beginning of the period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,287,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at end of the period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,876,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,876,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,287,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=miro_StockOptionPlan2019Member', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Awards available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">518,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Summary of options granted - Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at beginning of the period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">481,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at end of the period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">481,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=miro_EquityIncentivePlan2021Member', window );">2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Awards available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,323,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,323,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease', window );">Maximum annual increase in shares reserved for issuance, as a percent of total shares of common stock outstanding</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease', window );">Maximum number of additional shares reserved for issuance annually</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Summary of options granted - Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at end of the period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum annual increase in number of shares reserved for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum annual increase in shares reserved for issuance under share-based payment arrangement as a percent of total shares of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized expected to be recognized for award under share-based payment arrangement in the remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized is expected to be recognized for award under share-based payment arrangement in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized is expected to be recognized for award under share-based payment arrangement in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized is expected to be recognized for award under share-based payment arrangement in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized is expected to be recognized for award under share-based payment arrangement in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=miro_StockOptionPlan2010Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=miro_StockOptionPlan2010Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=miro_StockOptionPlan2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=miro_StockOptionPlan2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=miro_EquityIncentivePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=miro_EquityIncentivePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784149061864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK - Estimate the fair value of stock option grants (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life in years</a></td>
<td class="text">5 years 11 months 26 days<span></span>
</td>
<td class="text">5 years 11 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.16%<span></span>
</td>
<td class="nump">0.67%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">44.30%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784236716088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK - Restricted Stock Units (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation</a></td>
<td class="nump">$ 167,469<span></span>
</td>
<td class="nump">$ 157,398<span></span>
</td>
<td class="nump">$ 450,300<span></span>
</td>
<td class="nump">$ 472,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Award granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Awards granted, Weighted average fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784154131912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK - Employee Stock Purchase Plan (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 20, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Number of shares issued, ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">2021 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod', window );">Purchase period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee', window );">Maximum fair value of shares employee may purchase per purchase period</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares employee may purchase per purchase period</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease', window );">Maximum annual increase in shares reserved for issuance, as a percent of total shares of common stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease', window );">Maximum number of additional shares reserved for issuance annually</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | 2021 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price as a percent of market price</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum fair value of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum annual increase in number of shares reserved for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum annual increase in shares reserved for issuance under share-based payment arrangement as a percent of total shares of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The length of each purchase period under the plan, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784154063608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK - Warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=miro_SeriesPreferredWarrantsMember', window );">Series A Preferred Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>SHAREHOLDERS' DEFICIT AND MEZZANINE EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ClassOfWarrantOrRightTerminated', window );">Terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding, ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_WarrantsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted average remaining contractual life in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months 29 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=miro_CommonWarrantsMember', window );">Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>SHAREHOLDERS' DEFICIT AND MEZZANINE EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">707,669<span></span>
</td>
<td class="nump">752,669<span></span>
</td>
<td class="nump">732,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ClassOfWarrantOrRightGranted', window );">Granted (in shares)</a></td>
<td class="nump">276,000<span></span>
</td>
<td class="nump">276,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_ClassOfWarrantOrRightExercised', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,790)<span></span>
</td>
<td class="num">(45,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding, ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950,879<span></span>
</td>
<td class="nump">707,669<span></span>
</td>
<td class="nump">752,669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_WarrantsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.53<span></span>
</td>
<td class="nump">$ 2.34<span></span>
</td>
<td class="nump">$ 2.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted average remaining contractual life in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months 21 days<span></span>
</td>
<td class="text">2 years 3 months 25 days<span></span>
</td>
<td class="text">3 years 2 months 23 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ClassOfWarrantOrRightGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ClassOfWarrantOrRightGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_ClassOfWarrantOrRightTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_ClassOfWarrantOrRightTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_WarrantsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the warrants reserved for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_WarrantsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for warrants outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=miro_SeriesPreferredWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=miro_SeriesPreferredWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=miro_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=miro_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784244080056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>EMPLOYEE BENEFIT PLANS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Discretionary contributions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784147695256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT CUSTOMERS (Details) - Revenue - Customer - One customer - customer<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>SIGNIFICANT CUSTOMERS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_NumberOfCustomers', window );">Number of Customers</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_NumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to number of customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_NumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=miro_OneCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=miro_OneCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784149078744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Patent License Agreement (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=miro_RepriseBiomedicalInc.Member', window );">Reprise Biomedical, Inc. | Patent and Know-How License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_MinimumRoyaltyReceivable', window );">Minimum royalty payments to be received per year</a></td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=miro_UniversityOfMinnesotaMember', window );">University | Patent License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_MinimumRoyaltyPayable', window );">Minimum royalty payments to be paid per year</a></td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_MinimumRoyaltyPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of royalty payments to be paid by entity per year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_MinimumRoyaltyPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_MinimumRoyaltyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of royalty payments to be received by entity per year from related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_MinimumRoyaltyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=miro_RepriseBiomedicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=miro_RepriseBiomedicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=miro_PatentAndKnowHowLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=miro_PatentAndKnowHowLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=miro_UniversityOfMinnesotaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=miro_UniversityOfMinnesotaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=miro_PatentLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=miro_PatentLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784240015736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Leases (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 02, 2021 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>item</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating lease rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,096<span></span>
</td>
<td class="nump">$ 52,865<span></span>
</td>
<td class="nump">$ 183,389<span></span>
</td>
<td class="nump">$ 148,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract', window );"><strong>Future minimum non-cancelable lease commitments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_FirstFacilityEdenPrairieMember', window );">First facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_IncreaseInYearlyRentPercentage', window );">Percentage of increase in yearly rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_FirstFacilityEdenPrairieMember', window );">First facility | Up to March 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_MonthlyLeaseRentPayments', window );">Monthly rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_FirstFacilityEdenPrairieMember', window );">First facility | April 1, 2020 to December 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_MonthlyLeaseRentPayments', window );">Monthly rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_FirstFacilityEdenPrairieMember', window );">First facility | January 1, 2021 to December 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_MonthlyLeaseRentPayments', window );">Monthly rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_SecondFacilityEdenPrairieMember', window );">Second facility | April 1, 2020 to December 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_MonthlyLeaseRentPayments', window );">Monthly rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_SecondFacilityEdenPrairieMember', window );">Second facility | January 1, 2021 to December 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_MonthlyLeaseRentPayments', window );">Monthly rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Leased space (in square feet) | ft&#178;</a></td>
<td class="nump">42,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_MonthlyLeaseRentPayments', window );">Monthly rent</a></td>
<td class="nump">$ 41,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage', window );">Annual base rent increase (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LesseeOperatingLeaseRealPropertyTaxesPercentage', window );">Real property taxes (as a percent)</a></td>
<td class="nump">61.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LesseeOperatingLeaseManagementFeePercentage', window );">Management fee (as a percent)</a></td>
<td class="nump">61.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts', window );">Maximum management fee to be paid as a percent of Landlord's gross receipts</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_OperatingLeaseNumberOfOptionsToExtend', window );">Number of options to extend | item</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_LesseeOperatingLeaseOptionToExtendTermOfContract', window );">Option to extend term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Security amount</a></td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_IncreaseInYearlyRentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of yearly increase in rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_IncreaseInYearlyRentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual base rate increase percentage under terms of agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum management fee as a percent of Landlord's gross receipts to be paid under the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_LesseeOperatingLeaseManagementFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Landlord's management fee to be paid under the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_LesseeOperatingLeaseManagementFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_LesseeOperatingLeaseOptionToExtendTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Option to extend term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_LesseeOperatingLeaseOptionToExtendTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_LesseeOperatingLeaseRealPropertyTaxesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of real property taxes on building and land to be paid under the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_LesseeOperatingLeaseRealPropertyTaxesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_MonthlyLeaseRentPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of monthly lease rent payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_MonthlyLeaseRentPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_OperatingLeaseNumberOfOptionsToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options to extend operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_OperatingLeaseNumberOfOptionsToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_FirstFacilityEdenPrairieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_FirstFacilityEdenPrairieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=miro_Period1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=miro_Period1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=miro_Period2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=miro_Period2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=miro_Period3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=miro_Period3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_SecondFacilityEdenPrairieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_SecondFacilityEdenPrairieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784149622040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - License Contract (Details) - Research and development contract - Series B Convertible Preferred Stock<br></strong></div></th>
<th class="th">
<div>Jan. 01, 2015 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Consideration for the developer's services | shares</a></td>
<td class="nump">26,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 7.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=miro_ResearchAndDevelopmentContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=miro_ResearchAndDevelopmentContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=miro_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=miro_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784149321960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=miro_CorporationOwnedByDirectorMember', window );">Corporation owned by director | Consulting services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Consulting services</a></td>
<td class="nump">$ 1,141<span></span>
</td>
<td class="nump">$ 1,579<span></span>
</td>
<td class="nump">$ 4,992<span></span>
</td>
<td class="nump">$ 4,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=miro_RepriseBiomedicalInc.Member', window );">Reprise Biomedical, Inc. | Patent and Know-How License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>RELATED PARTY TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Royalty</a></td>
<td class="nump">9,819<span></span>
</td>
<td class="nump">10,846<span></span>
</td>
<td class="nump">25,066<span></span>
</td>
<td class="nump">31,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesNoncurrent', window );">Long term receivables</a></td>
<td class="nump">803,404<span></span>
</td>
<td class="nump">343,672<span></span>
</td>
<td class="nump">803,404<span></span>
</td>
<td class="nump">343,672<span></span>
</td>
<td class="nump">$ 453,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_AllowanceForDoubtfulAccountsRelatedParties', window );">Reserve against receivable</a></td>
<td class="nump">$ 803,404<span></span>
</td>
<td class="nump">$ 343,672<span></span>
</td>
<td class="nump">$ 803,404<span></span>
</td>
<td class="nump">$ 343,672<span></span>
</td>
<td class="nump">$ 453,470<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_AllowanceForDoubtfulAccountsRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value arising from transactions with related parties, which would be presented in parentheses on the face of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_AllowanceForDoubtfulAccountsRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivables arising from transactions with related parties, due after 1 year (or 1 business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=miro_CorporationOwnedByDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=miro_CorporationOwnedByDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=miro_ConsultingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=miro_ConsultingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=miro_RepriseBiomedicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=miro_RepriseBiomedicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=miro_PatentAndKnowHowLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=miro_PatentAndKnowHowLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153594200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>NET LOSS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="nump">4,415,684<span></span>
</td>
<td class="nump">12,929,368<span></span>
</td>
<td class="nump">4,415,684<span></span>
</td>
<td class="nump">12,969,368<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible preferred stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>NET LOSS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,314,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,314,536<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=miro_ConvertiblePreferredStockWarrantsMember', window );">Convertible preferred stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>NET LOSS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>NET LOSS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="nump">3,464,805<span></span>
</td>
<td class="nump">3,907,163<span></span>
</td>
<td class="nump">3,464,805<span></span>
</td>
<td class="nump">3,907,163<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=miro_CommonStockWarrantsMember', window );">Common stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>NET LOSS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="nump">950,879<span></span>
</td>
<td class="nump">707,669<span></span>
</td>
<td class="nump">950,879<span></span>
</td>
<td class="nump">707,669<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=miro_ConvertiblePreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=miro_ConvertiblePreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=miro_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=miro_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139784153450520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>11401 - Disclosure - SUBSEQUENT EVENTS (Details)<br></strong></div></th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | License Agreements | University</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_miro_AdditionalFundingToBeProvided', window );">Additional funding to be provided</a></td>
<td class="nump">$ 279,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_miro_AdditionalFundingToBeProvided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional amount of funding to be provided by entity under the terms of the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">miro_AdditionalFundingToBeProvided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>miro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_NoncollaborativeArrangementTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_NoncollaborativeArrangementTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=miro_UniversityOfMinnesotaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=miro_UniversityOfMinnesotaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>72
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M 'U_P[EZ/3$[)\U.V?P_4$L#!!0    ( &>!;U,JOJ*^TP8  - =   8
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M&0 \7RAPG.V%Z6!_B'O]'U!+ P04    " !G@6]3]4TAF&,)  !!.P  &
M 'AL+W=O<FMS:&5E=',O<VAE970U+GAM;+V;?6_;.!*'OXI@'+ ML*[Y3FJ1
M!-C&.=P>L(=B<[OWMV(SB5!;\DI*TW[[HVS5E,@A)3MI4*#QRX_4<$C.PR'I
MB^>R^EP_:MTD7[>;HKZ</3;-[I?%HEX]ZFU6?RAWNC#?W)?5-FO,V^IA4>\J
MG:WWA;:;!4%(++997LRN+O:??:JN+LJG9I,7^E.5U$_;;59]^Z@WY?/E#,^^
M?_!'_O#8M!\LKBYVV8.^U<V?NT^5>;<XUK+.M[JH\[)(*GU_.?L5_W(C95M@
MK_@KU\]U[W72-N6N+#^W;WY;7\Y0:Y'>Z%735I&9/U_TM=YLVIJ,'7]WE<Z.
MSVP+]E]_K_V?^\:;QMQEM;XN-__+U\WCY4S-DK6^SYXVS1_E\[]TUR#>UK<J
M-_7^_^3YH)5DEJR>ZJ;<=H6-!=N\./S-OG:.Z!7 -%" = 6(4X#(0 ':%:!N
M 10HP+H";*I)O"NP;_KBT/:]XY99DUU=5.5S4K5J4UO[8N_]?6GCK[QH!\IM
M4YEO<U.NN;HNB[7I=KU.;INLT68(-'52WB>WCUFE'\O-6E?U3\G-WT]Y\RUY
MM]3W^2IOWB?SY,_;9?+N'^\O%HVQHJUKL>J>^/'P1!)\XG9K1LAM4ZX^ Z6O
MXZ5_7:_S=H1EF^13EJ_G>9%<9[N\R39 7<N1NE:KI^W3QC1[G70M RJYB5?R
MW])[]L+TP;$CR+$CR+X>%JCG8[;)BI5.LB:YTP]Y4>3%0]L1.UWEY;K]>*E7
M'Q**?TX(PBGD]\,#Q/X!;8#X<D7PQ>)+W[F^1 JJ<(J&NJ6OF[,42<Q=Y0VD
MQ(Q2*M.C<N 0>G0(?8E#WIF>K]M!6K^?Y)S#PWC?.4AR10AL)3M:R?8%:<#*
MWXJ5B<^U;N?&X=7[).]&MS-](H.$'Y_&HS[95SMO ^,Z695;0XLZV\=;_;5]
MK:'YQ+V&8RYIJIQ^')4-#!9'@T74X)NONEKEQCVFX^K6^*3<M0;74!<);RBY
MPU=X1@K"4J<ED(@CN!WRV YY7COZXQ!JDP2-"5BCCM:H$ZUYSJHJ,Z$;&@#*
M,X$/''+PVIAJ8&AZ-#2-&OH?L]+9E#5DUC+U'C@GJ7DFI8YE$X0#XS"R[$-3
M0XPNUL-H^WM6?0\H!(&40WZX)<YX[31]VZ7B"BGIQ%M ..?FR5(1UQV0E#$L
M4HE9P"&]Q0 ^SR%.M!UW#O;#+::*AL(MMIC$/YR3> (H.PT?)24@#*$2E$99
MB2TL\9O2$I^(2VQYB=\"F-@2$\>1&0E!-]B'WCPE!',J \VTW,-Q\,5"RZW>
M&>^CR.SQ2>B'%A]S"DNB%'4'J"^<FXY,*2;2':"0%&%C9K#?+4!QG*!30\NX
M<WRDQD.+I2J.8_4U0HN:$%I\U 9"BR\,AA;_N6.AQ3(<QR'^VJ'%YWDTM!"+
M<X+>(+002TL2IV5X&3:R*KPA/AZ9614&5ENDET-.AJ,7=7H= T\L F#1C3K$
M1YBB3*3,C3J <,Y3,\HQ=S,/X+ESCA%E. VL\(C%(IF,Q6C4&7<. $2L(J/6
M I&P%T:=T=56]X1XS[&)2U% &%J*0M+X4I18;I,XMT^+.N,N\E$?I0:QI"?B
M+:*.!2F)@_2</0#B,Q/<!!C7#8VV:"5QM,8200)@CA))D70S^RG*H8$6<F0R
MY+S(^>^G(KXDZ>J.SS\?>PIASA1WYQ^0[W).$4H1<?T!2)E9 W*:<M@AU,*4
MGID;.S-OU#G4SU>C,X]:_E+\!C./6KK2.%W/F7G4YR X\\9U0Z-[NZAQ L9F
M'O6A-B>IR8 (=\V;H!P::/E')_/O]$R)3B ?]2D%9TJ ,)0I@=)HID0M^>AD
M\KTL4Z(G,H]:YM')V>UXIA0P;D*.2X$<%UQM L+0:A.41E>;U**93LYQ3\N4
M BZ",MW(FI-:'%/U%I'3TI7&Z7I6Y/3AABEE'+L=.JH;'NQ8 K(X 4\ZNV#^
M;K";]S, A$IZQQ>P++03SRPMV:G9ZL0C#.8GJQB%LU5F><KB/(VAB4%[I=3\
M<]= $X1#\RPYV9FYHY-O8-!IU ]OU!T0/E051RGVPAL@-.%-8=X_2>K< 4DQ
M1<),B8!#>D>=9Y(ZDHS!SO'I24B*PH>QEIWL15GCE*C;/2$*)N:3%083( R!
M"7CN")B8Y35[$:]/!1/S&1H%$[,$9?(-P,0L"-FI)ZG3@N(-\U-1TZM*B( '
M+"K9V4>F-\S/,^<I3IGD@?,*;F''SS\*[2\TP?G,@:-0-UF]YC[7S+I:,2*%
M(UT"TKE07/(4NXD)(.4I$1*QP)8 M\#DKW,8.NX>X# 4$<X$"R1/W"*4O_0T
M=#08<V#;UR45![9]05(!PA"I0&F45-RBF[_F:>BXBX#-WQBON$4J?Y/K0[W[
M0S_@ A%P-0AQY>W.C>N&1EMZ\5>\1,3';Q%Q'U_&3.8V!U2%9JPE'/]!-XFX
MGPWR<%[ +0+Y:UXFXC[W@,M$8ZJAJ9:-/,[&LP_</G(_210\18&A*2PV11R;
MUV7QQ<S1=@:UX:72][JJS-PZ6->4[21K;[O6@=NN'P60-V+OVIL/.2':/6'_
M[EM B47 ^<+B4,1Q>%)3Q_I# #DE1BFAH8,C89$H1K+*LM')+ON6W6T,  RX
ML]6J>C*&YD6CC3V-,;1M27OK=TH'^7C$R.T?X+(0YH0JKWL"PC0T$"WQQ,@V
M[_FM'NTKGWYI*H)K3F'A)^+YY&VVT?O+YGUK?DX*LP(V'W9$@F^*^MN^G+N=
MXB>9C)G<2U!W!RFH5('5O+"\%2.\G=3$T1[PR<HY0<$M&-&[GAM':VP+1@ [
MI50BHJB+RBG*H8$6E^+,:T/.T1.X;NOJ'N8EWN0%SCR),#D$<9.-)2"="\JQ
MHKY+@(N_E"&%5&!?4EA@B\G7E":?S,'N\2EMW$.8&5L!&RVI1?H&ZUII.2SC
M'#YG72N!A)2Q5+A!>UPW--H259ZY(PM>),?^6'9&LO2A*H52W+VV$=(%UK;2
MHE?&T7O^+7F?BP0KC /Q5UHLRC@63UO<2B#/D]Y9Z)AJ:*JEH8S3\/S%K?3Y
MA7$J WR6%E[R[*NS2PEM;"(NN7+I.D4Y--#22[[.)5LP^DG@ -+;M )$H4TK
M0!K:M *D\4TKV?N=RNM?LX7= QP^PIM6B]ZO#]L?E_Z>50^YF?,;?6^*H@_M
M *@.O]<\O&G*W?X'B7=ETY3;_<M'G1DFM +S_7UI%K/=F_8WCL=?S5[]'U!+
M P04    " !G@6]3SGZ,*E$'  !L'   &    'AL+W=O<FMS:&5E=',O<VAE
M970V+GAM;)U977/;MA+]*QC-?4AGHH@ ^)FQ/6,K;6\>VO'8T]MGB(0D-"2A
M@I <]]??!4B+,@'"3O,0D]0".%CLGH,%KIZD^M;M.=?H>U.WW?5BK_7A\VK5
ME7O>L.Z3// 6?ME*U3 -KVJWZ@Z*L\HV:NH5B:)TU3#1+FZN[+=[=7,EC[H6
M+;]7J#LV#5//=[R63]<+O'CY\"!V>VT^K&ZN#FS''[G^XW"OX&UU[J42#6\[
M(5ND^/9Z<8L_KV/;P%K\3_"G[N(9F:ELI/QF7KY6UXO((.(U+[7I@L&?$U_S
MNC8] 8Z_ATX7YS%-P\OGE]Y_L9.'R6Q8Q]>R_E-4>G^]R!>HXEMVK/6#?/HO
M'R:4F/Y*67?V?_34VV9T@<ICIV4S- 8$C6C[O^S[X(B+!M"/OP$9&I!I@WBF
M 1T:4#O1'IF=UA>FV<V5DD](&6OHS3Q8W]C6,!O1FF5\U I^%=!.WZQE6\&B
M\ H]:J8Y+)#ND-RB->OVZ!=8Y XMT1^/7]"'__QTM=(PHFFW*H?>[_K>R4SO
M!?I-MGK?H9]AE.IU^Q4@/<,E+W#O2+##1W[XA&CT$9&(8 ^>]?N;1P$X].P]
M:ONC<]XS7MI:+VV5;!!DEV):M+L^/(46O/L<&"<^CQ/;<>*9<7Z'?*YEU_E6
MH&^9VI8F:4\WRP(7<99D5ZO3I6M\AH3@A(Z&K\ E9W!)T FWU5\0IWWD: FY
M7<JV%#5'[8#:?#7/I?76O_%3>H:2!OWTA0.7E8+U#-%6B#52:?%/_X%_/YA0
M]SFQ[S:Y\$U!DRR9>-"UPK0H3"#Z_)>=06=!T(]:EM^6AHLJ5,K&8+1X?3@S
M!P'-8U(4$Z"N69P1" H_T/P,- \"?> =5R>.0#R .BM@RXWVY6#NC+[,DFC&
M2\5Y\"(X^.WE2@)!5:(KY;'5"%Y;J;VK6CA 4I+2?.(LURI+(SKC*QR-Q!H%
M :_WK-UQ)%JT94*A$ZN/W +G2IR8$2\OGT:N\TB<%BF9P7-!]#B(!U1O!X.V
MO+,$?V#/L"4HOZ&# N_UF@J/.\4:2%KFC;YAA%?@DC1/HF0&'!G!D2"XG_\^
M"OW<LP5XC&VWHH8T]KN(."@(H2FEDW7UV.$4EC:*9M".K(]I$.VOL#TR<=>Q
MVBXI[]&+]L1[(O3"IJ[S<)'3 L\M[:@.. [+D TUZ[D+9NTZ#HQL6!!<N0%_
MOL6R>&1\G(23L;2YUQFRYQ#-F]JW4NNAEU<\5, 2S,QW9'D<IOF'\ZB]G#P
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MZZP.V;JVOQ,Y?SU?F=W:BZ+)]SO\>=U??(W=]/=POS$%J=O!'GH+74:?,EA
MU5]M]2]:'NSMT$9J+1O[N.>LXLH8P.];*?7+BQG@?,%X\W]02P,$%     @
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MXFMLW,8ZT8 HCL@NL!>0BHW$8\=J[<) >AP4/"9]>[U?H7YEN[J"#A6E.-(
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M$ED'/M;H-L:+82W8)V19G58@"PU<]-S1]"\:$0I2GAN0Y_)\%.KSX UA0'(
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MM6O^N(*C:4<#\'YA@2S"%UH@_3SI_?\"4$L#!!0    ( &>!;U-Q*3>FTP,
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M"0  &    'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;,56VV[C-A#]E8&[*+H
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ME,"*UKF<L\TWV.83:+Z8Y<)\T::Q=4,+Q;60K-B"501%5C8K?=K6H0.(\ D
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M6RDH/@L#"_%F]#:"9)49=TLFU? TV]146ANH\Q5C<B=H!^W_;_0/4$L#!!0
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MJ 734^9PYU*7%5=++_OFV+*I5%REDA=,*NM,C2IREFJ(BL%+\%+7BGYRU]7
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M-_B 1*;=5Z-O? MR1@1G9!L- %5GZC8Z]T;]W=W]?\H'R!H%R>Y^_W _^4]
MT?Z!">O7CT;_5C2P_4.,>"%U$61\*]VH<!6(>&?3*^:@\\)>"C/S?TO$_A#>
MW=N[[3\?Y^&%?W4\_&V":"*;+>IG"M'ASIN]'GJ*_RLB7#A=^=?_B79.E_YG
MCC$G#!W \ZE&$L0+,M#^'W3V-U!+ P04    " !G@6]3H9/Y,_$*   B(P
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M\*2'_BD.H@M<^[R?HQXXYV\(%$IR[-N!%033;7@:[73(P];TL3H(3CE"IS?
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MPHKGG;W3+".5M!%XO<>F<4O><X -6 .A#01=L*L$ #VV^V$/S\&K*"02;9@
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M5IH0Z=2X6U,OS([G2<D@ (B=@?0N@7>H1<?[SLB=MCL4Z*4/B]3J3+\[YM#
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M*M$'(YWZ 2YL<D/,/4J3HA)GGIK>7F^OJ 8(LH4_=2/;<H/8 O5$ #WPX5,
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MF DWN&'A=.EO3>?:.9W[QY7@<!)MP/>%UJY9T 'M-?KQOP%02P,$%     @
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M1$;?*GSAL%.].3&1K(3X:A;W^=CQC4-00J8- \/A'[B%LC1$Z,:W/:?3F33
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M3>MMM7K<2-1+>"/TMU2L\U+JJ:TT%)_'D8-$(YZ-H7AE!6O)E98_N]W8"9L
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MN0D\"\GFOFX,+<KZCEP)#3=N/=S!+PZ79@',;X30!\,$Z'Z:IK\ 4$L#!!0
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MKHP ?)](J=<#LX"]Z+KZ!U!+ P04    " !G@6]3&RVDK3 "  #I!   &0
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MVQ!=^(TZI9=.^[IM:(%0KV:Z_BY-%A[\:X ?HLT6;AQIWK.1!=%)F;4%>G5
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M&V+-5>5UM&P8F1>WH0=I\&Y5/"9XA0=E!^#[M91FW[ 7K/I/P?1?4$L#!!0
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MWV%"YP;N^4HI^SK(S[#UE]WH?U!+ P04    " !G@6]3V"_]0/P#  #<#@
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M275KF>'>;#@=H-YO&9.O$WUU-9\JLW]02P,$%     @ 9X%O4W2]\84. P
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M,"HV$_(&\?E+(FK;ZD+^/J3^F=WA_P%02P,$%     @ 9X%O4[N,')-[!
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M?F&-0[88+\CBHOH+'AI9:P*"?5%F20/F%B116O^GC\U$' $@'@"@!H"Z #(
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MEN8?A=(N,/.%$/K8L1_H_GJSOU!+ P04    " !G@6]3_ZS\VWH#  #Y#
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M*;]-,%,&\OF<4K$;* ?-U\[P'U!+ P04    " !G@6]3%C3W+#(#  !A"@
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MX/GH73^SFUA5^I;@6EEL,/RPP!X0M%N WU=*V?N)ZS*:KG+V!U!+ P04
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M/M.9_I\J')Y10RHD:C?E&&O*<1V/RZC<ALH_116=H7)K*M)0N2>;A+TW,F3
MEN6LQF60-KFH?@HWI\T\."RGH(/SD9H3RU%D1U,-F3>4R?++40H+2>FT IG$
MK)K;JHTHUN5@<E\(.>:4RY6<=8$I ?E^413B>:,4--/SX#]02P,$%     @
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MA*L&\O<58^+M15W6E5?8PQ]02P,$%     @ 9X%O4T*Q$F9: @  T00  !D
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M>BI87@S%Q4*RW$Q]2R;5#&DNM^I% G-MH.ZOF:I'N= .JE>3T3]02P,$%
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MGWKG<MJE?.WY7N/U_Y/J<CXW72]_67[O'-WC%YP#_&_Q^ 502P,$%     @
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MK779'/)9][G$Y!-02P$"% ,4    " !G@6]3!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( &>!;U,1
M>?7&[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( &>!;U.97)PC$ 8  )PG   3              "  <P!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 9X%O4^\NBZ1!!0
M#A8  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( &>!;U.%/(;6A 8  '\9   8              " @80-
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " !G@6]3(L.1
M^=T#   U$P  &               @($^%   >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ 9X%O4RJ^HK[3!@  T!T  !@
M ("!41@  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( &>!
M;U/U32&88PD  $$[   8              " @5H?  !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6Q02P$"% ,4    " !G@6]3SGZ,*E$'  !L'   &
M        @('S*   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%
M  @ 9X%O4]53/EMA$@  JC0  !@              ("!>C   'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( &>!;U-Q*3>FTP,  -D(   8
M              " @1%#  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"
M% ,4    " !G@6]345IK'[T#  "H"0  &               @($:1P  >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ 9X%O4\JZW+HL!0
M$PX  !D              ("!#4L  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6Q02P$"% ,4    " !G@6]3ZG9#%=("   +!P  &0              @(%P
M4   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( &>!;U-&
M],58Z@8  !L2   9              " @7E3  !X;"]W;W)K<VAE971S+W-H
M965T,3(N>&UL4$L! A0#%     @ 9X%O4Z&3^3/Q"@  (B,  !D
M     ("!FEH  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &>!;U-QGD-=, ,  +P'   9              "
M@0>%  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ 9X%O
M4XC3N$<Q!0  :@X  !D              ("!;H@  'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6Q02P$"% ,4    " !G@6]3.GY5!W("  !1!0  &0
M        @('6C0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0
M   ( &>!;U/&9E)KW!   &,R   9              " @7^0  !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ 9X%O4WN)O$<4 P  30<
M !D              ("!DJ$  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q0
M2P$"% ,4    " !G@6]3T@57NUX#  "H"0  &0              @('=I
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( &>!;U-Y#:CX
MQP(  ,T&   9              " @7*H  !X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L! A0#%     @ 9X%O4RB?M6RL @  ;P8  !D
M ("!<*L  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " !G
M@6]3FK':(%0#  ! "0  &0              @(%3K@  >&PO=V]R:W-H965T
M<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( &>!;U,+?B9V)04  /02   9
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M970S,2YX;6Q02P$"% ,4    " !G@6]3\0<1+<<#  #K#@  &0
M    @(%JP@  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    (
M &>!;U,7\H+@2 0   H2   9              " @6C&  !X;"]W;W)K<VAE
M971S+W-H965T,S,N>&UL4$L! A0#%     @ 9X%O4]#=V%-G P  ( P  !D
M             ("!Y\H  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"
M% ,4    " !G@6]3YTZE?L #  #E#0  &0              @(&%S@  >&PO
M=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( &>!;U/8+_U _ ,
M -P.   9              " @7S2  !X;"]W;W)K<VAE971S+W-H965T,S8N
M>&UL4$L! A0#%     @ 9X%O4QZ.#=// @  M@@  !D              ("!
MK]8  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " !G@6]3
M=+WQA0X#  #H"0  &0              @(&UV0  >&PO=V]R:W-H965T<R]S
M:&5E=#,X+GAM;%!+ 0(4 Q0    ( &>!;U/TLX\#X D  '(W   9
M      " @?K<  !X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%
M  @ 9X%O4[N,')-[!   F10  !D              ("!$><  'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " !G@6]3ZA"'T9,$  "X%P
M&0              @('#ZP  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+
M 0(4 Q0    ( &>!;U-/,7J[3P0  /@2   9              " @8WP  !X
M;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ 9X%O4P*?6,7.
M!   7A,  !D              ("!$_4  'AL+W=O<FMS:&5E=',O<VAE970T
M,RYX;6Q02P$"% ,4    " !G@6]3M'82,V$(  !2+   &0
M@($8^@  >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( &>!
M;U-L8-(GCP(   $'   9              " @; " 0!X;"]W;W)K<VAE971S
M+W-H965T-#4N>&UL4$L! A0#%     @ 9X%O4_^L_-MZ P  ^0P  !D
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M=#4P+GAM;%!+ 0(4 Q0    ( &>!;U..>?4160(  +L%   9
M  " @0@6 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @
M9X%O4]LSZ I!!0  SA8  !D              ("!F!@! 'AL+W=O<FMS:&5E
M=',O<VAE970U,BYX;6Q02P$"% ,4    " !G@6]30K$29EH"  #1!   &0
M            @($0'@$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4
M Q0    ( &>!;U.2[DQU8 ,  &@+   9              " @:$@ 0!X;"]W
M;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ 9X%O4X'4F@HT P
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M96QS+RYR96QS4$L! A0#%     @ 9X%O4\QP^%X%!0  ?24   \
M     ( !-"X! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( &>!;U,,/Y#\
MY0$  '\A   :              "  68S 0!X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( &>!;U./X;=ITP$  #8A   3
M  "  8,U 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !  $  =Q$  (<W
$ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>235</ContextCount>
  <ElementCount>368</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>66</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00100 - Statement - Condensed Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/StatementCondensedBalanceSheets</Role>
      <ShortName>Condensed Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00105 - Statement - Condensed Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00200 - Statement - Condensed Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/StatementCondensedStatementsOfOperations</Role>
      <ShortName>Condensed Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00300 - Statement - Condensed Statements of Shareholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit</Role>
      <ShortName>Condensed Statements of Shareholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00400 - Statement - Condensed Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows</Role>
      <ShortName>Condensed Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>10101 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPolicies</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>10201 - Disclosure - INITIAL PUBLIC OFFERING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureInitialPublicOffering</Role>
      <ShortName>INITIAL PUBLIC OFFERING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>10301 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgress</Role>
      <ShortName>LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>10401 - Disclosure - EQUITY METHOD INVESTMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureEquityMethodInvestment</Role>
      <ShortName>EQUITY METHOD INVESTMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>10501 - Disclosure - ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureAccruedExpenses</Role>
      <ShortName>ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>10601 - Disclosure - FAIR VALUE MEASUREMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureFairValueMeasurement</Role>
      <ShortName>FAIR VALUE MEASUREMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>10701 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligation</Role>
      <ShortName>DEBT AND CAPITAL LEASE OBLIGATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>10801 - Disclosure - CAPITAL STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCapitalStock</Role>
      <ShortName>CAPITAL STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>10901 - Disclosure - EMPLOYEE BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureEmployeeBenefitPlans</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>11001 - Disclosure - SIGNIFICANT CUSTOMERS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureSignificantCustomers</Role>
      <ShortName>SIGNIFICANT CUSTOMERS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>11101 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>11201 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureRelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>11301 - Disclosure - NET LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureNetLossPerShare</Role>
      <ShortName>NET LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>11401 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureSubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>20102 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>30303 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressTables</Role>
      <ShortName>LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgress</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>30403 - Disclosure - EQUITY METHOD INVESTMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureEquityMethodInvestmentTables</Role>
      <ShortName>EQUITY METHOD INVESTMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureEquityMethodInvestment</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>30503 - Disclosure - ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureAccruedExpensesTables</Role>
      <ShortName>ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureAccruedExpenses</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>30603 - Disclosure - FAIR VALUE MEASUREMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureFairValueMeasurementTables</Role>
      <ShortName>FAIR VALUE MEASUREMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureFairValueMeasurement</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>30703 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationTables</Role>
      <ShortName>DEBT AND CAPITAL LEASE OBLIGATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligation</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>30803 - Disclosure - CAPITAL STOCK (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCapitalStockTables</Role>
      <ShortName>CAPITAL STOCK (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureCapitalStock</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>31103 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>31303 - Disclosure - NET LOSS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureNetLossPerShareTables</Role>
      <ShortName>NET LOSS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureNetLossPerShare</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>40101 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Charter (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Charter (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>40102 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Equity Method Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Equity Method Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>40201 - Disclosure - INITIAL PUBLIC OFFERING (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails</Role>
      <ShortName>INITIAL PUBLIC OFFERING (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureInitialPublicOffering</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>40301 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails</Role>
      <ShortName>LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>40401 - Disclosure - EQUITY METHOD INVESTMENT - Reprise (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails</Role>
      <ShortName>EQUITY METHOD INVESTMENT - Reprise (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>40402 - Disclosure - EQUITY METHOD INVESTMENT - Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails</Role>
      <ShortName>EQUITY METHOD INVESTMENT - Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>40403 - Disclosure - EQUITY METHOD INVESTMENT - Income Statement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails</Role>
      <ShortName>EQUITY METHOD INVESTMENT - Income Statement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>40501 - Disclosure - ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureAccruedExpensesDetails</Role>
      <ShortName>ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureAccruedExpensesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>40601 - Disclosure - FAIR VALUE MEASUREMENT - Changes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENT - Changes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>40701 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION - Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails</Role>
      <ShortName>DEBT AND CAPITAL LEASE OBLIGATION - Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>40702 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION - Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails</Role>
      <ShortName>DEBT AND CAPITAL LEASE OBLIGATION - Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>40801 - Disclosure - CAPITAL STOCK - Convertible Preferred Stock, Prior to IPO (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails</Role>
      <ShortName>CAPITAL STOCK - Convertible Preferred Stock, Prior to IPO (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>40802 - Disclosure - CAPITAL STOCK - Common Stock and Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails</Role>
      <ShortName>CAPITAL STOCK - Common Stock and Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>40803 - Disclosure - CAPITAL STOCK - Series C Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails</Role>
      <ShortName>CAPITAL STOCK - Series C Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>40804 - Disclosure - CAPITAL STOCK - Stock options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails</Role>
      <ShortName>CAPITAL STOCK - Stock options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>40805 - Disclosure - CAPITAL STOCK - Estimate the fair value of stock option grants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails</Role>
      <ShortName>CAPITAL STOCK - Estimate the fair value of stock option grants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>40806 - Disclosure - CAPITAL STOCK - Restricted Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails</Role>
      <ShortName>CAPITAL STOCK - Restricted Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>40807 - Disclosure - CAPITAL STOCK - Employee Stock Purchase Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails</Role>
      <ShortName>CAPITAL STOCK - Employee Stock Purchase Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>40808 - Disclosure - CAPITAL STOCK - Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails</Role>
      <ShortName>CAPITAL STOCK - Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>40901 - Disclosure - EMPLOYEE BENEFIT PLANS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureEmployeeBenefitPlansDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureEmployeeBenefitPlans</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>41001 - Schedule - SIGNIFICANT CUSTOMERS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/ScheduleSignificantCustomersDetails</Role>
      <ShortName>SIGNIFICANT CUSTOMERS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureSignificantCustomers</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>41101 - Disclosure - COMMITMENTS AND CONTINGENCIES - Patent License Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Patent License Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>41102 - Disclosure - COMMITMENTS AND CONTINGENCIES - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>41103 - Disclosure - COMMITMENTS AND CONTINGENCIES - License Contract (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - License Contract (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>41201 - Disclosure - RELATED PARTY TRANSACTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureRelatedPartyTransactions</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>41301 - Disclosure - NET LOSS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/DisclosureNetLossPerShareDetails</Role>
      <ShortName>NET LOSS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://miromatrix.com/role/DisclosureNetLossPerShareTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="tmb-20210930x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>414001 - Disclosure - 11401 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails</Role>
      <ShortName>11401 - Disclosure - SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="tmb-20210930x10q.htm">tmb-20210930x10q.htm</File>
    <File>tmb-20210930.xsd</File>
    <File>tmb-20210930_cal.xml</File>
    <File>tmb-20210930_def.xml</File>
    <File>tmb-20210930_lab.xml</File>
    <File>tmb-20210930_pre.xml</File>
    <File>tmb-20210930xex10d4.htm</File>
    <File>tmb-20210930xex10d5.htm</File>
    <File>tmb-20210930xex31d1.htm</File>
    <File>tmb-20210930xex31d2.htm</File>
    <File>tmb-20210930xex32d1.htm</File>
    <File>tmb-20210930xex32d2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>78
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tmb-20210930x10q.htm": {
   "axisCustom": 0,
   "axisStandard": 25,
   "contextCount": 235,
   "dts": {
    "calculationLink": {
     "local": [
      "tmb-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "tmb-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "tmb-20210930x10q.htm"
     ]
    },
    "labelLink": {
     "local": [
      "tmb-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tmb-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "tmb-20210930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 484,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 33,
    "http://miromatrix.com/20210930": 3,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 41
   },
   "keyCustom": 81,
   "keyStandard": 287,
   "memberCustom": 40,
   "memberStandard": 22,
   "nsprefix": "miro",
   "nsuri": "http://miromatrix.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document and Entity Information",
     "role": "http://miromatrix.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10401 - Disclosure - EQUITY METHOD INVESTMENT",
     "role": "http://miromatrix.com/role/DisclosureEquityMethodInvestment",
     "shortName": "EQUITY METHOD INVESTMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10501 - Disclosure - ACCRUED EXPENSES",
     "role": "http://miromatrix.com/role/DisclosureAccruedExpenses",
     "shortName": "ACCRUED EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10601 - Disclosure - FAIR VALUE MEASUREMENT",
     "role": "http://miromatrix.com/role/DisclosureFairValueMeasurement",
     "shortName": "FAIR VALUE MEASUREMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10701 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION",
     "role": "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligation",
     "shortName": "DEBT AND CAPITAL LEASE OBLIGATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "miro:ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10801 - Disclosure - CAPITAL STOCK",
     "role": "http://miromatrix.com/role/DisclosureCapitalStock",
     "shortName": "CAPITAL STOCK",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "miro:ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10901 - Disclosure - EMPLOYEE BENEFIT PLANS",
     "role": "http://miromatrix.com/role/DisclosureEmployeeBenefitPlans",
     "shortName": "EMPLOYEE BENEFIT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11001 - Disclosure - SIGNIFICANT CUSTOMERS",
     "role": "http://miromatrix.com/role/DisclosureSignificantCustomers",
     "shortName": "SIGNIFICANT CUSTOMERS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11101 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://miromatrix.com/role/DisclosureCommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11201 - Disclosure - RELATED PARTY TRANSACTIONS",
     "role": "http://miromatrix.com/role/DisclosureRelatedPartyTransactions",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11301 - Disclosure - NET LOSS PER SHARE",
     "role": "http://miromatrix.com/role/DisclosureNetLossPerShare",
     "shortName": "NET LOSS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00100 - Statement - Condensed Balance Sheets",
     "role": "http://miromatrix.com/role/StatementCondensedBalanceSheets",
     "shortName": "Condensed Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11401 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://miromatrix.com/role/DisclosureSubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "20102 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30303 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Tables)",
     "role": "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressTables",
     "shortName": "LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30403 - Disclosure - EQUITY METHOD INVESTMENT (Tables)",
     "role": "http://miromatrix.com/role/DisclosureEquityMethodInvestmentTables",
     "shortName": "EQUITY METHOD INVESTMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30503 - Disclosure - ACCRUED EXPENSES (Tables)",
     "role": "http://miromatrix.com/role/DisclosureAccruedExpensesTables",
     "shortName": "ACCRUED EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30603 - Disclosure - FAIR VALUE MEASUREMENT (Tables)",
     "role": "http://miromatrix.com/role/DisclosureFairValueMeasurementTables",
     "shortName": "FAIR VALUE MEASUREMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30703 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION (Tables)",
     "role": "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationTables",
     "shortName": "DEBT AND CAPITAL LEASE OBLIGATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "miro:ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30803 - Disclosure - CAPITAL STOCK (Tables)",
     "role": "http://miromatrix.com/role/DisclosureCapitalStockTables",
     "shortName": "CAPITAL STOCK (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "miro:ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31103 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
     "role": "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesTables",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31303 - Disclosure - NET LOSS PER SHARE (Tables)",
     "role": "http://miromatrix.com/role/DisclosureNetLossPerShareTables",
     "shortName": "NET LOSS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "miro:ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00105 - Statement - Condensed Balance Sheets (Parenthetical)",
     "role": "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical",
     "shortName": "Condensed Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_miro_SeriesB2ConvertiblePreferredStockMember_4Jbe-Gu5xEeD3T6PGRefNQ",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_6_23_2021_1kBpKsAjAkafdUqrpHlz-w",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40101 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Charter (Details)",
     "role": "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Charter (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_6_23_2021_To_6_23_2021_nAJYhIVR5k6XfLRbSV0y5A",
      "decimals": "INF",
      "lang": null,
      "name": "miro:NumberOfClassesOfStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_class_iV0uheBxPk-h-k5jyvqyzg",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_11_30_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_2ePGV84R7kOqVJlCe8VRFw",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40102 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Equity Method Investments (Details)",
     "role": "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Equity Method Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_11_15_2020_srt_RangeAxis_srt_MaximumMember_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_GHS7IyK-b0atc14LN7N6WA",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_6_1_2021_To_6_30_2021_v1CMQoC_MEO53dW7J_nzAA",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40201 - Disclosure - INITIAL PUBLIC OFFERING (Details)",
     "role": "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails",
     "shortName": "INITIAL PUBLIC OFFERING (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_6_1_2021_To_6_30_2021_v1CMQoC_MEO53dW7J_nzAA",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40301 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Details)",
     "role": "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails",
     "shortName": "LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromSaleOfEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40401 - Disclosure - EQUITY METHOD INVESTMENT - Reprise (Details)",
     "role": "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails",
     "shortName": "EQUITY METHOD INVESTMENT - Reprise (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_6_30_2019_To_6_30_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_miro_RepriseBiomedicalInc.Member_W19jgtfrJ0q1_pcaKF15Lg",
      "decimals": "-2",
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40402 - Disclosure - EQUITY METHOD INVESTMENT - Balance Sheet (Details)",
     "role": "http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails",
     "shortName": "EQUITY METHOD INVESTMENT - Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_12_31_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_4teufcmxn0CFTbHAWVVhcw",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40403 - Disclosure - EQUITY METHOD INVESTMENT - Income Statement (Details)",
     "role": "http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails",
     "shortName": "EQUITY METHOD INVESTMENT - Income Statement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2020_To_9_30_2020_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_miro_RepriseBiomedicalInc.Member_2TuG7gXboUazxii0VRpqgg",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40501 - Disclosure - ACCRUED EXPENSES (Details)",
     "role": "http://miromatrix.com/role/DisclosureAccruedExpensesDetails",
     "shortName": "ACCRUED EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40601 - Disclosure - FAIR VALUE MEASUREMENT - Changes (Details)",
     "role": "http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails",
     "shortName": "FAIR VALUE MEASUREMENT - Changes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2020_To_12_31_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_m7wWrzDt8kKqdsrFFqI6Aw",
      "decimals": "0",
      "lang": null,
      "name": "miro:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "miro:ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unitRef": "Unit_Divide_USD_shares_frunxwYeHkK-32VSVJBCug",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40701 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION - Agreements (Details)",
     "role": "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails",
     "shortName": "DEBT AND CAPITAL LEASE OBLIGATION - Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2012_To_1_31_2012_us-gaap_ClassOfWarrantOrRightAxis_miro_WarrantsRegentsOfUniversityOfMinnesotaMember_sZ5sdIuCHkukaGha2I_3MQ",
      "decimals": "INF",
      "lang": null,
      "name": "miro:ClassOfWarrantOrRightNumberOfWarrantsIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00200 - Statement - Condensed Statements of Operations",
     "role": "http://miromatrix.com/role/StatementCondensedStatementsOfOperations",
     "shortName": "Condensed Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40702 - Disclosure - DEBT AND CAPITAL LEASE OBLIGATION - Maturity (Details)",
     "role": "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails",
     "shortName": "DEBT AND CAPITAL LEASE OBLIGATION - Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "miro:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:TemporaryEquityTableTextBlock",
       "miro:ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_5_31_2021_J4lgZ-q5v02aj1SQxigv9w",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40801 - Disclosure - CAPITAL STOCK - Convertible Preferred Stock, Prior to IPO (Details)",
     "role": "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
     "shortName": "CAPITAL STOCK - Convertible Preferred Stock, Prior to IPO (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:TemporaryEquityTableTextBlock",
       "miro:ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_5_31_2021_J4lgZ-q5v02aj1SQxigv9w",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:TemporaryEquityLiquidationPreference",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40802 - Disclosure - CAPITAL STOCK - Common Stock and Preferred Stock (Details)",
     "role": "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails",
     "shortName": "CAPITAL STOCK - Common Stock and Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "miro:ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_9_30_2021_bkpD3G4cREeP9mz2FR5ZuQ",
      "decimals": "INF",
      "lang": null,
      "name": "miro:NumberOfVotesForCommonStockHolders",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_Vote_5PNXDYCebUiYVCiCDg0ocw",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "miro:ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2020_To_12_31_2020_B2zSRfZBIkue8c0XT4p-dw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "miro:StockIssuedDuringPeriodSharesWarrantsExercised",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40803 - Disclosure - CAPITAL STOCK - Series C Convertible Preferred Stock (Details)",
     "role": "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
     "shortName": "CAPITAL STOCK - Series C Convertible Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_5_1_2021_To_5_31_2021_us-gaap_StatementClassOfStockAxis_miro_SeriesCConvertiblePreferredStockMember_2kXm4JqYrUGIQ5XQlQ4tBQ",
      "decimals": "INF",
      "lang": null,
      "name": "miro:NumberOfStockPurchaseAgreements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_agreement_od-gDHq4Z0WVrTpltuYtzw",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_12_31_2020_nsDpd9_kFE6OKE96-HoAYw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40804 - Disclosure - CAPITAL STOCK - Stock options (Details)",
     "role": "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails",
     "shortName": "CAPITAL STOCK - Stock options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_gR2zVN5q-0a1swvGNHwoWw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40805 - Disclosure - CAPITAL STOCK - Estimate the fair value of stock option grants (Details)",
     "role": "http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails",
     "shortName": "CAPITAL STOCK - Estimate the fair value of stock option grants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_gR2zVN5q-0a1swvGNHwoWw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40806 - Disclosure - CAPITAL STOCK - Restricted Stock Units (Details)",
     "role": "http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails",
     "shortName": "CAPITAL STOCK - Restricted Stock Units (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_YBwL7RLuskyd3vBZWh7WQw",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40807 - Disclosure - CAPITAL STOCK - Employee Stock Purchase Plan (Details)",
     "role": "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails",
     "shortName": "CAPITAL STOCK - Employee Stock Purchase Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_12_31_2019_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_NJLzPJiJr0KqVC9ODnYXMg",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40808 - Disclosure - CAPITAL STOCK - Warrants (Details)",
     "role": "http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails",
     "shortName": "CAPITAL STOCK - Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_12_31_2018_us-gaap_ClassOfWarrantOrRightAxis_miro_SeriesPreferredWarrantsMember_HGDc3Os7mEWTu-CAaq3ruA",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
       "p",
       "us-gaap:DefinedContributionPlanTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40901 - Disclosure - EMPLOYEE BENEFIT PLANS (Details)",
     "role": "http://miromatrix.com/role/DisclosureEmployeeBenefitPlansDetails",
     "shortName": "EMPLOYEE BENEFIT PLANS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
       "p",
       "us-gaap:DefinedContributionPlanTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_wKqlw5fr5EWLskUxmEQ3gw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00300 - Statement - Condensed Statements of Shareholders' Equity (Deficit)",
     "role": "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit",
     "shortName": "Condensed Statements of Shareholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember_DhADGZrh1EmAAzxwiQhJGw",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ConcentrationRiskPercentage1",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_q7UZpcFoxEOYivXSsLQKIA",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "41001 - Schedule - SIGNIFICANT CUSTOMERS (Details)",
     "role": "http://miromatrix.com/role/ScheduleSignificantCustomersDetails",
     "shortName": "SIGNIFICANT CUSTOMERS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ConcentrationRiskPercentage1",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_srt_MajorCustomersAxis_miro_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_q7UZpcFoxEOYivXSsLQKIA",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_Lpm5_0_ACk-B7qLJAP4Q0Q",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_gQqNjbZf3kitvnDKHNvcqQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "miro:MinimumRoyaltyReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41101 - Disclosure - COMMITMENTS AND CONTINGENCIES - Patent License Agreement (Details)",
     "role": "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Patent License Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_PatentAndKnowHowLicenseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_RepriseBiomedicalInc.Member_gQqNjbZf3kitvnDKHNvcqQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "miro:MinimumRoyaltyReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41102 - Disclosure - COMMITMENTS AND CONTINGENCIES - Leases (Details)",
     "role": "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2015_To_1_1_2015_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_us-gaap_TypeOfArrangementAxis_miro_ResearchAndDevelopmentContractMember_6E_wdZQoSUqyfCptlYZBkg",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41103 - Disclosure - COMMITMENTS AND CONTINGENCIES - License Contract (Details)",
     "role": "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - License Contract (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2015_To_1_1_2015_us-gaap_StatementClassOfStockAxis_miro_SeriesBConvertiblePreferredStockMember_us-gaap_TypeOfArrangementAxis_miro_ResearchAndDevelopmentContractMember_6E_wdZQoSUqyfCptlYZBkg",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_qnWtgiTGikOSXP25mjvZYA",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41201 - Disclosure - RELATED PARTY TRANSACTIONS (Details)",
     "role": "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails",
     "shortName": "RELATED PARTY TRANSACTIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_miro_ConsultingServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_miro_CorporationOwnedByDirectorMember_qnWtgiTGikOSXP25mjvZYA",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41301 - Disclosure - NET LOSS PER SHARE (Details)",
     "role": "http://miromatrix.com/role/DisclosureNetLossPerShareDetails",
     "shortName": "NET LOSS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_Nk0NJxNmR0-Re7r0r7IYJw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_15b5rVpMiUeNLg7tBpU3Eg",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_10_31_2021_srt_CounterpartyNameAxis_miro_UniversityOfMinnesotaMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_us-gaap_NoncollaborativeArrangementTransactionsMember_3MpIEZ7k8UW2x-fwsNXB8Q",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "miro:AdditionalFundingToBeProvided",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "414001 - Disclosure - 11401 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "role": "http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails",
     "shortName": "11401 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "As_Of_10_31_2021_srt_CounterpartyNameAxis_miro_UniversityOfMinnesotaMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_TypeOfArrangementAxis_us-gaap_NoncollaborativeArrangementTransactionsMember_3MpIEZ7k8UW2x-fwsNXB8Q",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "miro:AdditionalFundingToBeProvided",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00400 - Statement - Condensed Statements of Cash Flows",
     "role": "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows",
     "shortName": "Condensed Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_97g2l-tLbk-oRM-gd_7jXA",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10101 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPolicies",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "miro:StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10201 - Disclosure - INITIAL PUBLIC OFFERING",
     "role": "http://miromatrix.com/role/DisclosureInitialPublicOffering",
     "shortName": "INITIAL PUBLIC OFFERING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "miro:StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10301 - Disclosure - LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS",
     "role": "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgress",
     "shortName": "LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmb-20210930x10q.htm",
      "contextRef": "Duration_1_1_2021_To_9_30_2021_VkmaAX3NNUGvRlmM0yx-fw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 66,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Document and Entity Information"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://miromatrix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "miro_AccruedBoardCompensationCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for services provided by board of directors. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Board Compensation, Current",
        "terseLabel": "Board compensation"
       }
      }
     },
     "localname": "AccruedBoardCompensationCurrent",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_AccruedKeyOpinionLeadedCompensationCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for key opinion leader compensation. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Key Opinion Leaded Compensation, Current",
        "terseLabel": "Key opinion leader compensation"
       }
      }
     },
     "localname": "AccruedKeyOpinionLeadedCompensationCurrent",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_AccruedLiabilitiesPublicOfferingExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for public offering expenses, due within one year or the normal operating cycle, if longer.",
        "label": "Accrued Liabilities, Public Offering Expenses, Current",
        "terseLabel": "IPO expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesPublicOfferingExpensesCurrent",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_AccruedRoyaltiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of royalty obligations incurred through that date and due after one year (or beyond the operating cycle if longer).",
        "label": "Accrued Royalties, Noncurrent",
        "terseLabel": "Accrued royalties"
       }
      }
     },
     "localname": "AccruedRoyaltiesNoncurrent",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_AccruedSuppliesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for supplies. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Supplies, Current",
        "terseLabel": "Supplies"
       }
      }
     },
     "localname": "AccruedSuppliesCurrent",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_AdditionalFundingToBeProvided": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional amount of funding to be provided by entity under the terms of the agreement.",
        "label": "Additional Funding to be Provided",
        "terseLabel": "Additional funding to be provided"
       }
      }
     },
     "localname": "AdditionalFundingToBeProvided",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_AllowanceForDoubtfulAccountsRelatedParties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value arising from transactions with related parties, which would be presented in parentheses on the face of the balance sheet.",
        "label": "Allowance for Doubtful Accounts, Related Parties",
        "terseLabel": "Reserve against receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsRelatedParties",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_BuildingResearchAndDevelopmentAndOfficeSpaceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Building to be used for research and development and office space located at 6455 Flying Cloud Drive, Eden Prairie, Minnesota 55344.",
        "label": "Building, Research and Development and Office Space [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingResearchAndDevelopmentAndOfficeSpaceMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_CapitalLeaseJuly2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital lease agreement entered into by entity in July 2021.",
        "label": "Capital Lease, July 2021"
       }
      }
     },
     "localname": "CapitalLeaseJuly2021Member",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_CapitalLeaseOctober2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital lease agreement entered into by entity in October 2018.",
        "label": "Capital Lease, October 2018"
       }
      }
     },
     "localname": "CapitalLeaseOctober2018Member",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_CapitalLeaseSeptember2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital lease agreement entered into by entity in September 2021.",
        "label": "Capital Lease, September 2021"
       }
      }
     },
     "localname": "CapitalLeaseSeptember2021Member",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_CapitalStockDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "CAPITAL STOCK"
       }
      }
     },
     "localname": "CapitalStockDisclosureAbstract",
     "nsuri": "http://miromatrix.com/20210930",
     "xbrltype": "stringItemType"
    },
    "miro_ClassOfWarrantOrRightExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights exercised.",
        "label": "Class of Warrant or Right, Exercised",
        "terseLabel": "Exercised"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercised",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "miro_ClassOfWarrantOrRightGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights granted.",
        "label": "Class of Warrant or Right, Granted",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Warrants issued (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightGranted",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails",
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "miro_ClassOfWarrantOrRightNumberOfWarrantsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants issued, in terms of number of securities into which the class of warrant or right may be converted.",
        "label": "Class of Warrant or Right, Number of Warrants Issued",
        "terseLabel": "Number of warrants issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsIssued",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "miro_ClassOfWarrantOrRightTerminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights terminated.",
        "label": "Class of Warrant or Right, Terminated",
        "negatedLabel": "Terminated"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTerminated",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "miro_CommonStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to common stock warrants .",
        "label": "Common stock warrants"
       }
      }
     },
     "localname": "CommonStockWarrantsMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_CommonWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to common warrants.",
        "label": "Common Warrants"
       }
      }
     },
     "localname": "CommonWarrantsMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails",
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_ConsultingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consulting services provided by related party.",
        "label": "Consulting Services [Member]",
        "terseLabel": "Consulting services"
       }
      }
     },
     "localname": "ConsultingServicesMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_ConvertiblePreferredStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to convertible preferred stock warrants.",
        "label": "Convertible preferred stock warrants"
       }
      }
     },
     "localname": "ConvertiblePreferredStockWarrantsMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_CorporationOwnedByDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to corporation owned by director of the entity.",
        "label": "Corporation owned by director"
       }
      }
     },
     "localname": "CorporationOwnedByDirectorMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_DebtAndCapitalLeaseObligationsGross": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of short-term and  long-term debt and capital leases.",
        "label": "Debt and Capital Lease Obligations, Gross",
        "totalLabel": "Totals"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligationsGross",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_DebtAndCapitalLeaseObligationsGrossCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails": {
       "order": 1.0,
       "parentTag": "miro_DebtAndCapitalLeaseObligationsGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of short-term and  long-term debt and capital leases, classified as current.",
        "label": "Debt and Capital Lease Obligations, Gross, Current",
        "negatedLabel": "Less current portion"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligationsGrossCurrent",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_DebtAndCapitalLeaseObligationsGrossNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails": {
       "order": 2.0,
       "parentTag": "miro_DebtAndCapitalLeaseObligationsGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of short-term and  long-term debt and capital leases, classified as noncurrent.",
        "label": "Debt and Capital Lease Obligations, Gross, Noncurrent",
        "terseLabel": "Long-term portion"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligationsGrossNoncurrent",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_DebtInstrumentAdditionalCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additional compensation cost to be paid upon specified ownership change.",
        "label": "Debt Instrument, Additional Compensation",
        "terseLabel": "Potential additional compensation"
       }
      }
     },
     "localname": "DebtInstrumentAdditionalCompensation",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_DebtInstrumentConvertibleMinimumPreferredStockOffering": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of preferred stock offering for conversion of debt into preferred shares.",
        "label": "Debt Instrument convertible, Minimum Preferred Stock Offering",
        "terseLabel": "Minimum amount of preferred stock offering for conversion of debt"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleMinimumPreferredStockOffering",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_DebtInstrumentInterestForgiveness": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amounts of interest forgiven by the holder of the debt instrument.",
        "label": "Debt Instrument, Interest, Forgiveness",
        "verboseLabel": "Amount of interest forgiven"
       }
      }
     },
     "localname": "DebtInstrumentInterestForgiveness",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_DebtInstrumentNumberOfFinalPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of final payment.",
        "label": "Debt Instrument, Number of Final Payment",
        "terseLabel": "Number of final payment"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfFinalPayment",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "miro_DebtInstrumentPeriodicMonthlyPaymentNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of monthly payments",
        "label": "Debt Instrument, Periodic Monthly Payment, Number",
        "terseLabel": "Number of monthly payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicMonthlyPaymentNumber",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "miro_DebtInstrumentPrincipalForgiveness": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amounts of principal forgiven by the holder of the debt instrument.",
        "label": "Debt Instrument, Principal, Forgiveness",
        "terseLabel": "Amount of principal forgiven"
       }
      }
     },
     "localname": "DebtInstrumentPrincipalForgiveness",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additions of embedded derivative or group of embedded derivatives classified as a liability during the period.",
        "label": "Embedded Derivative, Fair Value of Embedded Derivative Liability, Additions",
        "terseLabel": "Derivative instrument related to March 2020 Note"
       }
      }
     },
     "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityAdditions",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_EmergingGrowthCompanyStatusPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for emerging growth company status.",
        "label": "Emerging Growth Company Status, Policy [Policy Text Block]",
        "terseLabel": "Emerging Growth Company Status"
       }
      }
     },
     "localname": "EmergingGrowthCompanyStatusPolicyPolicyTextBlock",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "miro_EquityIncentivePlan2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Equity Incentive Plan.",
        "label": "Equity Incentive Plan 2021 [Member]",
        "terseLabel": "2021 Equity Incentive Plan"
       }
      }
     },
     "localname": "EquityIncentivePlan2021Member",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_EquityMethodInvestmentSharesOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares owned of equity method investment by entity.",
        "label": "Equity Method Investment, Shares Owned",
        "terseLabel": "Number of equity method investment shares owned"
       }
      }
     },
     "localname": "EquityMethodInvestmentSharesOwned",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "miro_EquityMethodInvestmentSharesSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares of equity method investment sold by entity.",
        "label": "Equity Method Investment, Shares Sold",
        "terseLabel": "Number of equity method investment shares sold"
       }
      }
     },
     "localname": "EquityMethodInvestmentSharesSold",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "miro_ExercisePriceOf0.10Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to exercise price of $0.10.",
        "label": "Exercise price of $0.10"
       }
      }
     },
     "localname": "ExercisePriceOf0.10Member",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_ExercisePriceOf1.25Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to exercise price of $1.25.",
        "label": "Exercise price of $1.25"
       }
      }
     },
     "localname": "ExercisePriceOf1.25Member",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_FirstFacilityEdenPrairieMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to first facility in Eden Prairie, MN.",
        "label": "First facility"
       }
      }
     },
     "localname": "FirstFacilityEdenPrairieMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_FurnitureFixturesAndComputersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to furniture, fixtures and computers.",
        "label": "Furniture, Fixtures And Computers [Member]",
        "terseLabel": "Furniture and fixtures &amp; computers"
       }
      }
     },
     "localname": "FurnitureFixturesAndComputersMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_GainOnForgivenessOfDebt": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain on amounts of indebtedness forgiven by the holder of the debt instrument.",
        "label": "Gain on Forgiveness of Debt",
        "negatedLabel": "Forgiveness of paycheck protection program loan"
       }
      }
     },
     "localname": "GainOnForgivenessOfDebt",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_IncreaseDecreaseInGrantsReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) for grants.",
        "label": "Increase (Decrease) in Grants Receivable",
        "terseLabel": "Grant receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInGrantsReceivable",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_IncreaseDecreaseInInterestPayableNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts for noncurrent interest payable.",
        "label": "Increase (Decrease) In Interest Payable, Noncurrent",
        "negatedLabel": "Accrued interest"
       }
      }
     },
     "localname": "IncreaseDecreaseInInterestPayableNoncurrent",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_IncreaseInYearlyRentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of yearly increase in rent.",
        "label": "Increase in Yearly Rent, Percentage",
        "terseLabel": "Percentage of increase in yearly rent"
       }
      }
     },
     "localname": "IncreaseInYearlyRentPercentage",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "miro_InterestPayableNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer).",
        "label": "Interest Payable, Noncurrent",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableNoncurrent",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_LesseeOperatingLeaseAnnualBaseRateIncreasePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual base rate increase percentage under terms of agreement.",
        "label": "Lessee, Operating Lease, Annual Base Rate Increase Percentage",
        "terseLabel": "Annual base rent increase (as a percent)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseAnnualBaseRateIncreasePercentage",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "miro_LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum management fee as a percent of Landlord's gross receipts to be paid under the agreement.",
        "label": "Lessee, Operating Lease, Management Fee As Percentage of Gross Receipts",
        "terseLabel": "Maximum management fee to be paid as a percent of Landlord's gross receipts"
       }
      }
     },
     "localname": "LesseeOperatingLeaseManagementFeeAsPercentageOfGrossReceipts",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "miro_LesseeOperatingLeaseManagementFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Landlord's management fee to be paid under the agreement.",
        "label": "Lessee, Operating Lease, Management Fee Percentage",
        "terseLabel": "Management fee (as a percent)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseManagementFeePercentage",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "miro_LesseeOperatingLeaseOptionToExtendTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option to extend term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Option to Extend, Term of Contract",
        "terseLabel": "Option to extend term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToExtendTermOfContract",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "miro_LesseeOperatingLeaseRealPropertyTaxesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of real property taxes on building and land to be paid under the agreement.",
        "label": "Lessee, Operating Lease, Real Property Taxes Percentage",
        "terseLabel": "Real property taxes (as a percent)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRealPropertyTaxesPercentage",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "miro_LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan agreement with Minnesota Agricultural and Economic Development Board with maturity date of November 1, 2020.",
        "label": "Loan, Minnesota Agricultural and Economic Development Board [Member]",
        "terseLabel": "Loan, Minnesota Agricultural and Economic Development Board, Due November 1, 2020"
       }
      }
     },
     "localname": "LoanMinnesotaAgriculturalAndEconomicDevelopmentBoardMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan agreement with the Minnesota Department of Employment and Economic Development.",
        "label": "Loan, Minnesota Department of Employment and Economic Development [Member]",
        "terseLabel": "Loan, Minnesota Department of Employment and Economic Development."
       }
      }
     },
     "localname": "LoanMinnesotaDepartmentOfEmploymentAndEconomicDevelopmentMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationDetailsCalc2": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Rolling Year Five",
        "terseLabel": "Year 5"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFive",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationDetailsCalc2": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Rolling Year Four",
        "terseLabel": "Year 4"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearFour",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationDetailsCalc2": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Rolling Year Three",
        "terseLabel": "Year 3"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearThree",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationDetailsCalc2": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation  maturing in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Rolling Year Two",
        "terseLabel": "Year 2"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInRollingYearTwo",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationDetailsCalc2": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the next rolling twelve months following the latest balance sheet.",
        "label": "Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Rolling Twelve Months",
        "terseLabel": "Year 1"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextRollingTwelveMonths",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_MinimumRoyaltyPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of royalty payments to be paid by entity per year.",
        "label": "Minimum Royalty Payable",
        "terseLabel": "Minimum royalty payments to be paid per year"
       }
      }
     },
     "localname": "MinimumRoyaltyPayable",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_MinimumRoyaltyReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of royalty payments to be received by entity per year from related party.",
        "label": "Minimum Royalty Receivable",
        "terseLabel": "Minimum royalty payments to be received per year"
       }
      }
     },
     "localname": "MinimumRoyaltyReceivable",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_MonthlyLeaseRentPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of monthly lease rent payments.",
        "label": "Monthly Lease Rent Payments",
        "terseLabel": "Monthly rent"
       }
      }
     },
     "localname": "MonthlyLeaseRentPayments",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_NoncashInvestingAndFinancingFinancingExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of financing expenses accrued.",
        "label": "Noncash Investing and Financing, Financing Expenses",
        "terseLabel": "Accrued expenses related to financing"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingFinancingExpenses",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_NoteCompanyShareholderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note agreement with one of Company's shareholders.",
        "label": "Note, Company Shareholder [Member]",
        "terseLabel": "Note, Company shareholder"
       }
      }
     },
     "localname": "NoteCompanyShareholderMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_NumberOfClassesOfStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of classes of stock entity may authorize to issue.",
        "label": "Number of Classes of Stock",
        "terseLabel": "Number of classes of stock"
       }
      }
     },
     "localname": "NumberOfClassesOfStock",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "miro_NumberOfCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to number of customers.",
        "label": "Number of Customers",
        "terseLabel": "Number of Customers"
       }
      }
     },
     "localname": "NumberOfCustomers",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/ScheduleSignificantCustomersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "miro_NumberOfShareholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shareholders.",
        "label": "Number of Shareholders",
        "terseLabel": "Number of shareholders"
       }
      }
     },
     "localname": "NumberOfShareholders",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "miro_NumberOfStockPurchaseAgreements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock purchase agreements entity entered into during the period.",
        "label": "Number of Stock Purchase Agreements",
        "terseLabel": "Number of stock purchase agreements entered into"
       }
      }
     },
     "localname": "NumberOfStockPurchaseAgreements",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "miro_NumberOfVotesForCommonStockHolders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of votes each common stock holder is entitled to vote.",
        "label": "Number of Votes for Common Stock Holders",
        "terseLabel": "Number of votes"
       }
      }
     },
     "localname": "NumberOfVotesForCommonStockHolders",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "miro_OneCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One customer.",
        "label": "One Customer [Member]",
        "terseLabel": "One customer"
       }
      }
     },
     "localname": "OneCustomerMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/ScheduleSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_OperatingLeaseNumberOfOptionsToExtend": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options to extend operating lease.",
        "label": "Operating Lease, Number of Options To Extend",
        "terseLabel": "Number of options to extend"
       }
      }
     },
     "localname": "OperatingLeaseNumberOfOptionsToExtend",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "miro_PatentAndKnowHowLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Patent and Know-How License agreement.",
        "label": "Patent and Know-How License Agreement"
       }
      }
     },
     "localname": "PatentAndKnowHowLicenseAgreementMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails",
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_PatentLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Patent License Agreement.",
        "label": "Patent License Agreement"
       }
      }
     },
     "localname": "PatentLicenseAgreementMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_PaycheckProtectionProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to the Paycheck Protection Program Note.",
        "label": "Paycheck Protection Program",
        "terseLabel": "Paycheck Protection Program Note"
       }
      }
     },
     "localname": "PaycheckProtectionProgramMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of lab equipment, furniture and leasehold improvements.",
        "label": "Payments to Acquire Lab Equipment, Furniture and Leasehold Improvements",
        "negatedLabel": "Purchases of lab equipment, furniture and leasehold improvements"
       }
      }
     },
     "localname": "PaymentsToAcquireLabEquipmentFurnitureAndLeaseholdImprovements",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_Period1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to period until March 31, 2020.",
        "label": "Up to March 31, 2020 [Member]",
        "terseLabel": "Up to March 31, 2020"
       }
      }
     },
     "localname": "Period1Member",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_Period2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to period from April 1, 2020 to December 31, 2020.",
        "label": "April 1, 2020 to December 31, 2020"
       }
      }
     },
     "localname": "Period2Member",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_Period3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to period from January 1, 2021 to December 31, 2021.",
        "label": "January 1, 2021 to December 31, 2021"
       }
      }
     },
     "localname": "Period3Member",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_ProceedsFromIssuanceOfCommonStockNet": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock, Net",
        "terseLabel": "Proceeds from sale of common stock, net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStockNet",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.",
        "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock, Net",
        "terseLabel": "Proceeds from sale of preferred stock, net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to promissory Note with the Regents of the University of Minnesota, due December 31, 2022.",
        "label": "Promissory Note With Regents of the University of Minnesota [Member]",
        "terseLabel": "Promissory Note, Regents of the University of Minnesota, Due December 31, 2022"
       }
      }
     },
     "localname": "PromissoryNoteWithRegentsOfUniversityOfMinnesotaMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_PromissoryNoteWithUniversityOfMinnesotaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Promissory Note with the University of Minnesota, due January 31, 2025.",
        "label": "Promissory Note With University of Minnesota [Member]",
        "terseLabel": "Promissory Note, University of Minnesota, Due January 31, 2025"
       }
      }
     },
     "localname": "PromissoryNoteWithUniversityOfMinnesotaMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_QualityExpense": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of quality expense incurred during the period.",
        "label": "Quality Expense",
        "terseLabel": "Quality"
       }
      }
     },
     "localname": "QualityExpense",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_RegulatoryAndClinicalExpense": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of regulatory and clinical expenses incurred during the period.",
        "label": "Regulatory and Clinical Expense",
        "terseLabel": "Regulatory and clinical"
       }
      }
     },
     "localname": "RegulatoryAndClinicalExpense",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_RepriseBiomedicalInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reprise Biomedical, Inc., acquirer business from entity in June 2019 and equity method investee of entity until March 2021.",
        "label": "Reprise Biomedical, Inc.[Member]",
        "terseLabel": "Reprise Biomedical, Inc."
       }
      }
     },
     "localname": "RepriseBiomedicalInc.Member",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails",
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails",
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails",
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails",
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails",
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_ResearchAndDevelopmentContractMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to research and development contract.",
        "label": "Research and development contract"
       }
      }
     },
     "localname": "ResearchAndDevelopmentContractMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_ResearchGrants": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 9.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income from research grants.",
        "label": "Research Grants",
        "terseLabel": "Research grants"
       }
      }
     },
     "localname": "ResearchGrants",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_SecondFacilityEdenPrairieMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to second facility in Eden Prairie, MN.",
        "label": "Second facility"
       }
      }
     },
     "localname": "SecondFacilityEdenPrairieMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_SeriesB2ConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B2 preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Series B-2 Convertible Preferred Stock",
        "terseLabel": "Convertible preferred stock - Series B-2"
       }
      }
     },
     "localname": "SeriesB2ConvertiblePreferredStockMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_SeriesBConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Series B Convertible Preferred Stock",
        "terseLabel": "Convertible preferred stock - Series B"
       }
      }
     },
     "localname": "SeriesBConvertiblePreferredStockMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_SeriesCConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Series C Convertible Preferred Stock",
        "terseLabel": "Convertible Preferred Stock - Series C"
       }
      }
     },
     "localname": "SeriesCConvertiblePreferredStockMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails",
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_SeriesConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Series A Convertible Preferred Stock",
        "terseLabel": "Convertible preferred stock - Series A"
       }
      }
     },
     "localname": "SeriesConvertiblePreferredStockMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_SeriesPreferredWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Series A Preferred warrants.",
        "label": "Series A Preferred Warrants"
       }
      }
     },
     "localname": "SeriesPreferredWarrantsMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum fair value of shares an employee can purchase under the plan per period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Amount of Shares Per Employee",
        "terseLabel": "Maximum fair value of shares employee may purchase per purchase period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountOfSharesPerEmployee",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum annual increase in number of shares reserved for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Reserved, Maximum Annual Increase",
        "terseLabel": "Maximum number of additional shares reserved for issuance annually"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReservedMaximumAnnualIncrease",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum annual increase in shares reserved for issuance under share-based payment arrangement as a percent of total shares of common stock outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Percent of Additional Shares Reserved, Maximum Annual Increase",
        "terseLabel": "Maximum annual increase in shares reserved for issuance, as a percent of total shares of common stock outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentOfAdditionalSharesReservedMaximumAnnualIncrease",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "miro_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The length of each purchase period under the plan, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Purchase Period",
        "terseLabel": "Purchase period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized expected to be recognized for award under share-based payment arrangement in the remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, To Be Recognized In Remainder of Fiscal Year",
        "terseLabel": "Remainder of fiscal year"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInRemainderOfFiscalYear",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized is expected to be recognized for award under share-based payment arrangement in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, To Be Recognized In Year Four",
        "terseLabel": "Cost to be recognized in year 4"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearFour",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized is expected to be recognized for award under share-based payment arrangement in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, To Be Recognized In Year One",
        "terseLabel": "Cost to be recognized year 1"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearOne",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized is expected to be recognized for award under share-based payment arrangement in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, To Be Recognized In Year Three",
        "terseLabel": "Cost to be recognized in year 3"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearThree",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized is expected to be recognized for award under share-based payment arrangement in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, To Be Recognized In Year Two",
        "terseLabel": "Cost to be recognized in year 2"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedToBeRecognizedInYearTwo",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). Also includes disclosure of temporary equity.",
        "label": "Shareholders' Equity, Share-based Payments and Temporary Equity [Text Block]",
        "terseLabel": "SHAREHOLDERS' DEFICIT AND MEZZANINE EQUITY"
       }
      }
     },
     "localname": "ShareholdersEquityShareBasedPaymentsAndTemporaryEquityTextBlock",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "miro_StockConversionDiscount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount in which convertible preferred stock was converted into common stock, as a percent.",
        "label": "Stock Conversion, Discount",
        "terseLabel": "Conversion discount (as a percent)"
       }
      }
     },
     "localname": "StockConversionDiscount",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "miro_StockConversionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of common stock price at which convertible preferred stock was converted into common stock.",
        "label": "Stock Conversion, Percentage",
        "terseLabel": "Stock conversion, percentage common stock price"
       }
      }
     },
     "localname": "StockConversionPercentage",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "miro_StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of note payable and accrued interest.",
        "label": "Stock Issued During Period, Shares, Conversion of Note Payable and Accrued Interest",
        "terseLabel": "Note payable and accrued interest converted to common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfNotePayableAndAccruedInterest",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "miro_StockIssuedDuringPeriodSharesConversionOfPreferredStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of preferred stock.",
        "label": "Stock Issued During Period, Shares, Conversion of Preferred Stock",
        "terseLabel": "Conversion of preferred stock to common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfPreferredStock",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "miro_StockIssuedDuringPeriodSharesWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock issued as a result of the exercise of warrants.",
        "label": "Stock Issued During Period, Shares, Warrants Exercised",
        "terseLabel": "Exercise of stock warrants (in shares)",
        "verboseLabel": "Stock issued upon exercise of warrants (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesWarrantsExercised",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "miro_StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the conversion of note payable and accrued interest.",
        "label": "Stock Issued During Period, Value, Conversion of Note Payable and Accrued Interest",
        "terseLabel": "Note payable and accrued interest converted to common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_StockIssuedDuringPeriodValueConversionOfPreferredStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period as a result of the conversion of preferred stock.",
        "label": "Stock Issued During Period, Value, Conversion of Preferred Stock",
        "terseLabel": "Conversion of preferred stock to common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfPreferredStock",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_StockIssuedDuringPeriodValueWarrantsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of warrants.",
        "label": "Stock Issued During Period, Value, Warrants Exercised",
        "terseLabel": "Exercise of stock warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueWarrantsExercised",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_StockOptionPlan2010Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to 2010 stock option plan.",
        "label": "2010 Plan"
       }
      }
     },
     "localname": "StockOptionPlan2010Member",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_StockOptionPlan2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to 2019 stock option plan.",
        "label": "2019 Plan"
       }
      }
     },
     "localname": "StockOptionPlan2019Member",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_StockholdersEquityNoteInitialPublicOfferingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "INITIAL PUBLIC OFFERING"
       }
      }
     },
     "localname": "StockholdersEquityNoteInitialPublicOfferingAbstract",
     "nsuri": "http://miromatrix.com/20210930",
     "xbrltype": "stringItemType"
    },
    "miro_StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure for initial public offering.",
        "label": "Stockholders' Equity Note, Initial Public Offering Disclosure [Text Block]",
        "terseLabel": "INITIAL PUBLIC OFFERING"
       }
      }
     },
     "localname": "StockholdersEquityNoteInitialPublicOfferingDisclosureTextBlock",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureInitialPublicOffering"
     ],
     "xbrltype": "textBlockItemType"
    },
    "miro_SubstantialOwnershipChangePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold percentage defined as substantial ownership change for one entity under terms of agreement.",
        "label": "Substantial Ownership Change, Percentage",
        "terseLabel": "Substantial ownership change threshold (as a percent)"
       }
      }
     },
     "localname": "SubstantialOwnershipChangePercentage",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "miro_TemporaryEquitySharesConvertedInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares classified as temporary equity  converted to common stock during the period.",
        "label": "Temporary Equity, Shares Converted In Period",
        "terseLabel": "Number of shares converted to common stock"
       }
      }
     },
     "localname": "TemporaryEquitySharesConvertedInPeriod",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "miro_TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of temporary equity shares issued during the period as a result of the conversion of note payable and accrued interest.",
        "label": "Temporary Equity, Stock Issued During Period, Conversion Of Note Payable and Accrued Interest",
        "terseLabel": "Temporary equity issued upon conversion of note and accrued interest (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodConversionOfNotePayableAndAccruedInterest",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "miro_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "miro_UniversityOfMinnesotaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to University of Minnesota.",
        "label": "University"
       }
      }
     },
     "localname": "UniversityOfMinnesotaMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_WarrantsAndRightsAdditionalCoverage": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of additional warrants to be issued under specified terms of the agreement.",
        "label": "Warrants and Rights, Additional Coverage",
        "terseLabel": "Additional warrant coverage"
       }
      }
     },
     "localname": "WarrantsAndRightsAdditionalCoverage",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "miro_WarrantsCompanyShareholderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to warrants issued to a shareholder of the company.",
        "label": "Warrants, Company Shareholder [Member]",
        "terseLabel": "Warrants, Company shareholder"
       }
      }
     },
     "localname": "WarrantsCompanyShareholderMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_WarrantsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the warrants reserved for issuance.",
        "label": "Warrants Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price"
       }
      }
     },
     "localname": "WarrantsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "miro_WarrantsOutstandingWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for warrants outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Warrants Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life in years"
       }
      }
     },
     "localname": "WarrantsOutstandingWeightedAverageRemainingContractualTerm",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "miro_WarrantsRegentsOfUniversityOfMinnesotaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to warrants issued to the Regents of the University of Minnesota",
        "label": "Warrants, Regents of the University of Minnesota [Member]",
        "terseLabel": "Warrants, Regents of the University of Minnesota"
       }
      }
     },
     "localname": "WarrantsRegentsOfUniversityOfMinnesotaMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "miro_WarrantsUniversityOfMinnesotaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to warrants issued to the University of Minnesota.",
        "label": "Warrants, University of Minnesota [Member]",
        "terseLabel": "Warrants, University of Minnesota"
       }
      }
     },
     "localname": "WarrantsUniversityOfMinnesotaMember",
     "nsuri": "http://miromatrix.com/20210930",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r56",
      "r58",
      "r101",
      "r102",
      "r225",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails",
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r176",
      "r268",
      "r270",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/ScheduleSignificantCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r224",
      "r253",
      "r283",
      "r285",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r463",
      "r465",
      "r485",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails",
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r224",
      "r253",
      "r283",
      "r285",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r463",
      "r465",
      "r485",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r176",
      "r268",
      "r270",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/ScheduleSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r224",
      "r253",
      "r271",
      "r283",
      "r285",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r463",
      "r465",
      "r485",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails",
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r224",
      "r253",
      "r271",
      "r283",
      "r285",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r463",
      "r465",
      "r485",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails",
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r57",
      "r58",
      "r101",
      "r102",
      "r225",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r117",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r117",
      "r122",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails",
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r117",
      "r122",
      "r203",
      "r284",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "ACCRUED EXPENSES"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureAccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r40",
      "r402"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r17",
      "r100",
      "r395",
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of receivables arising from transactions with related parties, due after 1 year (or 1 business cycle).",
        "label": "Accounts Receivable, Related Parties, Noncurrent",
        "terseLabel": "Long term receivables"
       }
      }
     },
     "localname": "AccountsReceivableRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCRUED EXPENSES"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r42"
     ],
     "calculation": {
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Legal"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r42"
     ],
     "calculation": {
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Royalties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r42"
     ],
     "calculation": {
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "terseLabel": "Wages"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r39",
      "r196"
     ],
     "calculation": {
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r318",
      "r319",
      "r320",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails",
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash from operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r287",
      "r310",
      "r323"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r77",
      "r92",
      "r237",
      "r378"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of discount on note"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r69",
      "r92",
      "r237",
      "r380"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 7.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "negatedLabel": "Amortization of discount on note"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "NET LOSS PER SHARE"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of a real estate property.",
        "label": "Area of Real Estate Property",
        "terseLabel": "Leased space (in square feet)"
       }
      }
     },
     "localname": "AreaOfRealEstateProperty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r99",
      "r162",
      "r166",
      "r172",
      "r185",
      "r208",
      "r209",
      "r210",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r331",
      "r336",
      "r361",
      "r400",
      "r402",
      "r435",
      "r451"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r54",
      "r99",
      "r185",
      "r208",
      "r209",
      "r210",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r331",
      "r336",
      "r361",
      "r400",
      "r402"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r288",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Preparation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalLeaseObligations": {
     "auth_ref": [
      "r22",
      "r388",
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.",
        "label": "Capital Lease Obligations",
        "terseLabel": "Lease outstanding"
       }
      }
     },
     "localname": "CapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeaseObligationsMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A borrowing recorded for a lease meeting the criteria for capitalization. A lease is defined as an agreement conveying the right to use property, plant, or equipment (land or depreciable assets) usually for a stated period of time.",
        "label": "Capital Lease"
       }
      }
     },
     "localname": "CapitalLeaseObligationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalLeasedAssetsGross": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of leased physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Capital Leased Assets, Gross",
        "terseLabel": "Capitalized lease"
       }
      }
     },
     "localname": "CapitalLeasedAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r36",
      "r94"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r88",
      "r94",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r88",
      "r370"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r97",
      "r99",
      "r126",
      "r127",
      "r128",
      "r130",
      "r132",
      "r140",
      "r141",
      "r142",
      "r185",
      "r208",
      "r213",
      "r214",
      "r215",
      "r219",
      "r220",
      "r251",
      "r252",
      "r255",
      "r256",
      "r361",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails",
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Capital stock"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r266",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails",
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails",
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "SHAREHOLDERS' DEFICIT AND MEZZANINE EQUITY"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "periodEndLabel": "Warrants outstanding, ending balance",
        "periodStartLabel": "Warrants outstanding, beginning balance",
        "terseLabel": "Number of warrants outstanding"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r266",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Agreements"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r46",
      "r202",
      "r441",
      "r457"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r204",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Number of shares reserved for issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r105",
      "r106",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails",
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails",
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r27",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r27",
      "r402"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.00001; 190,000,000 shares authorized; 20,254,645 issued and outstanding as of September 30, 2021 and 30,000,000 shares authorized; 2,185,822 issued and outstanding as of December 31, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EMPLOYEE BENEFIT PLANS"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r150",
      "r151",
      "r176",
      "r358",
      "r359",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/ScheduleSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r150",
      "r151",
      "r176",
      "r358",
      "r359",
      "r478",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/ScheduleSignificantCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r150",
      "r151",
      "r176",
      "r358",
      "r359",
      "r478",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/ScheduleSignificantCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r145",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "SIGNIFICANT CUSTOMERS"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureSignificantCustomers"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "SIGNIFICANT CUSTOMERS"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/ScheduleSignificantCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r150",
      "r151",
      "r176",
      "r358",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/ScheduleSignificantCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r148",
      "r150",
      "r151",
      "r152",
      "r358",
      "r360",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/ScheduleSignificantCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r150",
      "r151",
      "r176",
      "r358",
      "r359",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/ScheduleSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r251",
      "r252",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible preferred stock outstanding"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r74",
      "r419"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r149",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/ScheduleSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r440",
      "r458"
     ],
     "calculation": {
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "totalLabel": "Totals"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock": {
     "auth_ref": [
      "r246",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.",
        "label": "Debt and Capital Leases Disclosures [Text Block]",
        "terseLabel": "DEBT AND CAPITAL LEASE OBLIGATION"
       }
      }
     },
     "localname": "DebtAndCapitalLeasesDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DEBT AND CAPITAL LEASE OBLIGATION"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r98",
      "r103",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r240",
      "r241",
      "r242",
      "r243",
      "r381",
      "r436",
      "r437",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r221",
      "r240",
      "r241",
      "r379",
      "r381",
      "r382"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face value of debt"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r44",
      "r234",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Interest rate during period (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental percentage increase (decrease) in the stated rate on a debt instrument.",
        "label": "Debt Instrument, Interest Rate, Increase (Decrease)",
        "terseLabel": "Increase in interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r44",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "DEBT AND CAPITAL LEASE OBLIGATION"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r45",
      "r98",
      "r103",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r240",
      "r241",
      "r242",
      "r243",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r45",
      "r447"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Debt Instrument, Periodic Payment",
        "terseLabel": "Amount of principal and interest payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r45",
      "r98",
      "r103",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r240",
      "r241",
      "r242",
      "r243",
      "r259",
      "r262",
      "r263",
      "r264",
      "r378",
      "r379",
      "r381",
      "r382",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Discretionary contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanTextBlock": {
     "auth_ref": [
      "r281",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for defined contribution plan.",
        "label": "Defined Contribution Plan [Text Block]",
        "terseLabel": "EMPLOYEE BENEFIT PLANS"
       }
      }
     },
     "localname": "DefinedContributionPlanTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEmployeeBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DepositAssets": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.",
        "label": "Deposit Assets",
        "terseLabel": "Security amount"
       }
      }
     },
     "localname": "DepositAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r92",
      "r160"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails",
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r55",
      "r58",
      "r59",
      "r341",
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r7",
      "r17",
      "r28",
      "r100",
      "r211",
      "r213",
      "r214",
      "r218",
      "r219",
      "r220",
      "r395"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due from Related Parties, Current",
        "terseLabel": "Receivable from Reprise Biomedical, Inc."
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NET LOSS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r67",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r124",
      "r126",
      "r130",
      "r131",
      "r132",
      "r136",
      "r137",
      "r353",
      "r354",
      "r444",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share, basic (in dollar per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r67",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r126",
      "r130",
      "r131",
      "r132",
      "r136",
      "r137",
      "r353",
      "r354",
      "r444",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share, diluted (in dollar per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r133",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET LOSS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureNetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": {
     "auth_ref": [
      "r342"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.",
        "label": "Embedded Derivative, Fair Value of Embedded Derivative Liability",
        "periodEndLabel": "Derivative liability ending balance",
        "periodStartLabel": "Derivative liability beginning balance",
        "terseLabel": "Embedded derivative liability"
       }
      }
     },
     "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.",
        "label": "Embedded Derivative, Gain (Loss) on Embedded Derivative, Net",
        "negatedLabel": "Gain/Loss recognized to revalue derivative instrument at fair value"
       }
      }
     },
     "localname": "EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmbeddedDerivativeGainOnEmbeddedDerivative": {
     "auth_ref": [
      "r343"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 8.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.",
        "label": "Embedded Derivative, Gain on Embedded Derivative",
        "negatedLabel": "Change in fair value of derivative",
        "terseLabel": "Change in fair value of derivative"
       }
      }
     },
     "localname": "EmbeddedDerivativeGainOnEmbeddedDerivative",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows",
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmbeddedDerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Embedded Derivative [Line Items]",
        "terseLabel": "FAIR VALUE MEASUREMENT"
       }
      }
     },
     "localname": "EmbeddedDerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmbeddedDerivativeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about embedded derivatives.",
        "label": "Embedded Derivative [Table]"
       }
      }
     },
     "localname": "EmbeddedDerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "2021 ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails",
      "http://miromatrix.com/role/DisclosureNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Lab equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r62",
      "r63",
      "r64",
      "r105",
      "r106",
      "r107",
      "r110",
      "r119",
      "r121",
      "r139",
      "r191",
      "r258",
      "r265",
      "r318",
      "r319",
      "r320",
      "r327",
      "r328",
      "r352",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r468",
      "r469",
      "r470",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails",
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r5",
      "r99",
      "r185",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails",
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r5",
      "r99",
      "r185",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails",
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "verboseLabel": "Ownership interest (as a percent)"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails",
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r70",
      "r71",
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "terseLabel": "Gain on sale of equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r37",
      "r163",
      "r181"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investment in Reprise Biomedical, Inc"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EQUITY METHOD INVESTMENT"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "EQUITY METHOD INVESTMENT"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r37",
      "r87",
      "r183",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of financial information from the financial statements of Reprise"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r180",
      "r462"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "negatedLabel": "Gain on sale of equity investment",
        "terseLabel": "Gain on sale of equity investment"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows",
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r230",
      "r240",
      "r241",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r355",
      "r407",
      "r408",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FAIR VALUE MEASUREMENT"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENT"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureFairValueMeasurement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r230",
      "r240",
      "r241",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r355",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r230",
      "r240",
      "r241",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r407",
      "r408",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureFairValueMeasurementChangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r92",
      "r244",
      "r245"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Gain on debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrantsReceivableCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Grants Receivable, Current",
        "terseLabel": "Grant receivable"
       }
      }
     },
     "localname": "GrantsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r73",
      "r99",
      "r162",
      "r165",
      "r168",
      "r171",
      "r173",
      "r185",
      "r208",
      "r209",
      "r210",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r361"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross margin",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails",
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "Public offering",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r65",
      "r92",
      "r161",
      "r181",
      "r442",
      "r459"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity loss in affiliate",
        "terseLabel": "Equity loss in affiliate"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows",
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Statements of Operations"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
        "label": "Increase (Decrease) in Due from Related Parties, Current",
        "negatedLabel": "Receivable from Reprise Biomedical, Inc"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Assets [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r78",
      "r236",
      "r242",
      "r243"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r85",
      "r89",
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r42"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest expense"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r76",
      "r159"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r41",
      "r99",
      "r167",
      "r185",
      "r208",
      "r209",
      "r210",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r332",
      "r336",
      "r337",
      "r361",
      "r400",
      "r401"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r33",
      "r99",
      "r185",
      "r361",
      "r402",
      "r439",
      "r455"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities, Mezzanine Equity and Shareholders' Equity (Deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r43",
      "r99",
      "r185",
      "r208",
      "r209",
      "r210",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r332",
      "r336",
      "r337",
      "r361",
      "r400",
      "r401",
      "r402"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "terseLabel": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r22",
      "r23",
      "r99",
      "r185",
      "r208",
      "r209",
      "r210",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r332",
      "r336",
      "r337",
      "r361",
      "r400",
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r22",
      "r229",
      "r239",
      "r240",
      "r241",
      "r437",
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt outstanding"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      },
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt, less current portion",
        "verboseLabel": "Long-term portion"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      },
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "negatedLabel": "Less current portion",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r45",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Long-term Debt and Capital Lease Obligations [Abstract]",
        "terseLabel": "Debt and Lease Total"
       }
      }
     },
     "localname": "MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r51",
      "r99",
      "r185",
      "r208",
      "r213",
      "r214",
      "r215",
      "r219",
      "r220",
      "r361",
      "r438",
      "r454"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Shareholders' equity"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r88",
      "r90",
      "r93"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r60",
      "r61",
      "r64",
      "r66",
      "r93",
      "r99",
      "r109",
      "r114",
      "r115",
      "r116",
      "r117",
      "r120",
      "r121",
      "r129",
      "r162",
      "r165",
      "r168",
      "r171",
      "r173",
      "r185",
      "r208",
      "r209",
      "r210",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r354",
      "r361",
      "r443",
      "r460"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Miromatrix Medical Inc. share of net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails",
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations",
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r61",
      "r64",
      "r120",
      "r121",
      "r334",
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r108",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r116",
      "r122",
      "r136",
      "r178",
      "r179",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r207",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r325",
      "r326",
      "r327",
      "r328",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r391",
      "r420",
      "r421",
      "r422",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncollaborativeArrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "License Agreements"
       }
      }
     },
     "localname": "NoncollaborativeArrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r162",
      "r165",
      "r168",
      "r171",
      "r173"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r383",
      "r385"
     ],
     "calculation": {
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Future minimum non-cancelable lease commitments"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases, Rent Expense, Net",
        "terseLabel": "Operating lease rent expense"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r104",
      "r123",
      "r156",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r42"
     ],
     "calculation": {
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Over-allotment option"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForConstructionInProcess": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from construction costs to date on capital projects that have not been completed and assets being constructed that are not ready to be placed into service.",
        "label": "Payments for Construction in Process",
        "negatedLabel": "Purchases of construction in process",
        "verboseLabel": "Leasehold improvements recorded as construction in progress"
       }
      }
     },
     "localname": "PaymentsForConstructionInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails",
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r288",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock , authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails",
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r26",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r8",
      "r34",
      "r35"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from sale of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.",
        "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock",
        "terseLabel": "Gross proceeds"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from sale of equity method investment shares"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails",
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r81",
      "r313"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from stock options exercise"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Proceeds from stock warrants exercise"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r5",
      "r60",
      "r61",
      "r64",
      "r86",
      "r99",
      "r109",
      "r120",
      "r121",
      "r162",
      "r165",
      "r168",
      "r171",
      "r173",
      "r185",
      "r208",
      "r209",
      "r210",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r219",
      "r220",
      "r330",
      "r333",
      "r335",
      "r338",
      "r339",
      "r354",
      "r361",
      "r445"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r39",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails",
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r198",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "LAB EQUIPMENT, FURNITURE, LEASEHOLD IMPROVEMENTS AND CONSTRUCTION IN PROGRESS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgress"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r38",
      "r195"
     ],
     "calculation": {
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Lab equipment, furniture, leasehold improvements and construction in progress, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r18",
      "r19",
      "r197",
      "r402",
      "r446",
      "r456"
     ],
     "calculation": {
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Lab equipment, furniture, leasehold improvements and construction in progress, net",
        "totalLabel": "Lab equipment, furniture, leasehold improvements and construction in progress, net, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r18",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of lab equipment, furniture, leasehold improvements and construction in progress"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r18",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails",
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r68",
      "r194"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Reserve for bad debt"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r279",
      "r394",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails",
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r279",
      "r394",
      "r395",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails",
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails",
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r394"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Consulting services"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r279",
      "r394",
      "r397",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails",
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r392",
      "r393",
      "r395",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r324",
      "r418",
      "r487"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r30",
      "r265",
      "r321",
      "r402",
      "r453",
      "r472",
      "r477"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r105",
      "r106",
      "r107",
      "r110",
      "r119",
      "r121",
      "r191",
      "r318",
      "r319",
      "r320",
      "r327",
      "r328",
      "r352",
      "r468",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r157",
      "r158",
      "r164",
      "r169",
      "r170",
      "r174",
      "r175",
      "r176",
      "r267",
      "r268",
      "r419"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales",
        "verboseLabel": "Licensing revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails",
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.",
        "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r72",
      "r211",
      "r213",
      "r214",
      "r218",
      "r219",
      "r220",
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "terseLabel": "Royalty"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT CUSTOMERS"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r150",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/ScheduleSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of current accrued expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureAccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of potentially dilutive securities"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureNetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative liabilities at fair value.",
        "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of changes in value of the Company's embedded derivative liabilities"
       }
      }
     },
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureFairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Equity method investment"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails",
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails",
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r5",
      "r99",
      "r184",
      "r185",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails",
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentIncomeStatementDetails",
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of future minimum non-cancelable lease commitments"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of maturities of debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r39",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureLabEquipmentFurnitureLeaseholdImprovementsAndConstructionInProgressDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r396",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r288",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r292",
      "r299",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of stock option activity table text block"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of weighted average assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r47",
      "r97",
      "r140",
      "r141",
      "r247",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r266",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Schedule of warrants"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "General &amp; administration"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Award granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Awards granted, Weighted average fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares employee may purchase per purchase period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Awards available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Options Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value, Options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Canceled or expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted average fair value of options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Intrinsic value, Options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r294",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding at end of the period (in shares)",
        "periodStartLabel": "Options outstanding at beginning of the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Summary of options granted - Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding at end of the period (in dollars per share)",
        "periodStartLabel": "Options outstanding at beginning of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Summary of options granted - Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r286",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Option exercise price (in dollars per share)",
        "verboseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "verboseLabel": "Canceled or expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r288",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "verboseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails",
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentRepriseDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r306",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEstimateFairValueOfStockOptionGrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Intrinsic value, Options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term, Options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term, Options outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price as a percent of market price"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r97",
      "r99",
      "r126",
      "r127",
      "r128",
      "r130",
      "r132",
      "r140",
      "r141",
      "r142",
      "r185",
      "r208",
      "r213",
      "r214",
      "r215",
      "r219",
      "r220",
      "r251",
      "r252",
      "r255",
      "r256",
      "r258",
      "r361",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails",
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails",
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesCharterDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r50",
      "r62",
      "r63",
      "r64",
      "r105",
      "r106",
      "r107",
      "r110",
      "r119",
      "r121",
      "r139",
      "r191",
      "r258",
      "r265",
      "r318",
      "r319",
      "r320",
      "r327",
      "r328",
      "r352",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r468",
      "r469",
      "r470",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails",
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical",
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Statements of Cash Flows"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Balance Sheets"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Statements of Shareholders' Equity (Deficit)"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r139",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical",
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r49",
      "r232",
      "r258",
      "r259",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of preferred stock to common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r26",
      "r27",
      "r258",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Number of shares issued, ESPP"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "terseLabel": "Consideration for the developer's services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r26",
      "r27",
      "r258",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Sales of common stock, net of expenses (in shares)",
        "verboseLabel": "Sale of common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails",
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r26",
      "r27",
      "r258",
      "r265",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "verboseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockCommonStockAndPreferredStockDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockStockOptionsDetails",
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r50",
      "r258",
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of preferred stock to common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r26",
      "r27",
      "r258",
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Sales of common stock, net of expenses"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r50",
      "r258",
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r27",
      "r31",
      "r32",
      "r99",
      "r177",
      "r185",
      "r361",
      "r402"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Miromatrix Medical Inc. share of shareholders' equity",
        "totalLabel": "Total shareholders' equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureEquityMethodInvestmentBalanceSheetDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheets",
      "http://miromatrix.com/role/StatementCondensedStatementsOfShareholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity (deficit):"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r377",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r377",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r377",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r377",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r403",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureSubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureInitialPublicOfferingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Abstract]",
        "terseLabel": "Mezzanine equity:"
       }
      }
     },
     "localname": "TemporaryEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r208",
      "r213",
      "r214",
      "r215",
      "r219",
      "r220"
     ],
     "calculation": {
      "http://miromatrix.com/role/StatementCondensedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "terseLabel": "Convertible preferred stock"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Liquidation Preference",
        "terseLabel": "Convertible preferred stock, liquidation preference"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r13",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Convertible preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquityRedemptionPricePerShare": {
     "auth_ref": [
      "r13",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Redemption Price Per Share",
        "terseLabel": "Share issue price (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityRedemptionPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Convertible preferred stock, authorized (in shares)",
        "verboseLabel": "Convertible preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Convertible preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "terseLabel": "Convertible preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockConvertiblePreferredStockPriorToIpoDetails",
      "http://miromatrix.com/role/DisclosureCapitalStockSeriesCConvertiblePreferredStockDetails",
      "http://miromatrix.com/role/StatementCondensedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r13",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity [Table Text Block]",
        "terseLabel": "Schedule of convertible preferred stock"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureCapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/Disclosure11401DisclosureSubsequentEventsDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesLicenseContractDetails",
      "http://miromatrix.com/role/DisclosureCommitmentsAndContingenciesPatentLicenseAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates type of cost from product sold and service rendered.",
        "label": "Cost, Product and Service [Extensible Enumeration]"
       }
      }
     },
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r143",
      "r144",
      "r146",
      "r147",
      "r153",
      "r154",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDescriptionOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Warrant coverage amount"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Term of warrant"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/DisclosureDebtAndCapitalLeaseObligationAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r125",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average shares used in computing net loss per share, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r124",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average shares used in computing net loss per share, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://miromatrix.com/role/StatementCondensedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/subtopic&trid=2235116"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "15",
   "Topic": "815",
   "URI": "http://asc.fasb.org/subtopic&trid=2229187"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406127&loc=d3e45014-112735"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123386454&loc=d3e45280-112737"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "840",
   "URI": "http://asc.fasb.org/topic&trid=2208923"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r488": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r489": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r491": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r492": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r493": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r494": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r495": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>79
<FILENAME>0001558370-21-015974-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-21-015974-xbrl.zip
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ML""M7V0!&OPKXL__,85++'?S4D&NPO6-$E<!G!=R;0"L!J#N,P*4^[FUN4B
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M@U.K#3FW5%LI/&2UQ>L5H+;VH:R*+CVNM5%!&.(I6@<N.;=*SF^\XES%%%6
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M15=K+!!#]#W%;.RYY$]S>WL7WR\-=X$&;KJ$[9KVVD$B&T7!-LN8DGT<I'A
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M]\,O#\?"5H7H,VY>/A,@;"Q21-']T6@^PX;K&R8E2ABOHE(12B"13&\S\E+
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M?X3UI&UUDF7"AB#L':U"-_51*0B&?PT]/8SIR&"!( ;VEDD2Q2&J L'$FU-
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MA;O*I'K^<M/]^.463M;J1M2*R1$(FK8SM^ZW+LR\PPKE6W&1K\# 85JIC]D
M0:KE;>7/N8OE_M5S[N+\P1"[TU//]\-5XG!>(Y,<#"N)!E3HL-77,ZN)65'@
M&C@_<&X6LL!.;/^O1XQ0\F#GA!S"RYXCU?MM]1W*:H)5U)EWVHJ:C,K?/(<T
MX]!GPFM255[/K;[L6)^R\M@'P=8Y(8,'VY2ZZ.,WTJZV;?.3S+:Y[V3[,ES4
MS=F&"=.&Z>,@Q1ORZ9 OY*L_IP%18=K[U$2N01298;\4E#MQ&Z8 >07+DIK
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MT9_W5AC3T#O<TUT05D&5O.4(7$NBWK&7'35#[G R:<_VO8PP$90'],,E#=W
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MO*7E.G,_.84L?'&2KU:I(W(\45>^E$3>V LQYK007ONL)F-!@ <4\$NXL+5
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MNT.E/^\MSXT/-3ATT@(S\E2KDV%-^6/LZ"*1MAL\^9L@GN(''OCH6.N$G$&
MZ$<AD_5-J<>(/GVB/EOX> SUILZ6X1(LIV+WF=:O-90[(X49/2.4:J,J]42\
M#&FI@'8-5<%F0A)&? 0LLS*[-!G(#JGZ_]/:[OZ%6 4>>B^(][43J+KQ@C^V
MI:K5[O@ACEBYK-WM\)G98N]>,U$A,CC9U,,0:B(K^":(&H.MU'(LX7:J7F7
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M7V:A1/X>9ZF,F6@P\-.6 QO"\BBO:U:$@0FO  @O)(G+#F@SDS7!X+3S.-%
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M6V$.-^.75.XS"1KBKF5T'827 <\+YWG$L-7.%)&7)&KNAATB%!4O(4-#'\R
MH"JZMN,G#/C&39&%.%#B3$P=)/6O/!-Z8T5IN=*R\KL^E%<O3MJ[\C>P^0/7
M3(B[9;H^)X4<H3A)Z(@';"I,\A16V$1_MSO5\B&8V@QL0S )8/P._GJ]#WTW
MWH>PL9]).R\(6[6]=39%I #8H;FR;?+SR&'?.>](NW,VT_D.1["/8?D!^?L!
M5/A@L05I26+;'"2+W/1>(A.?3SIVHGC".A52)/U7!NS .^J&C9H-5W% $@$(
MDX#,<J-=EXR6HUQ1#B,;[Z9-5QSL-!QM%)MQ9V\[X!T ](VAM^F&>%:LH<2
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M)-6 @ I$Z& &UD?V/<TK2N6XOA@MX+OA/]!<PK&.$'U\6V\<OSN'X[>*KEC
MLA? $R6R9GYM I9Y\U6"%9R34/9WV-'F:O1HH55LA?%(;?1(GUS?AW%4:JDA
MGVG>[W8>OZ]C>2#VM1>\S/UU$&[YR6!#AKMZ;^38W=(,I9>=U;HBQN.V&NB&
M19&/P%/@1 JLC">I&S$%/"[I!1'<IN/'VDG2.AQ\IXS-/MJ45OMSG=.$$7DK
MY"$O4:M</;C4!'$(RR357ZED12A=I[CVNQ1);>[?J9-5JIP,6)&NN>9O3X:
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M-IT"V4YF4D9BOV#-&S9KXMOOC5^,I--HXK-.Z>J(J^HQBABJ%?S\J#CV_2_
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M0YV]Q]>6C#LOXKD3Y4'7>S9OB?DK41Y4"(<RD<3=[L+@F>;WMID+1W&XYY?
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M4>F$% K:*9WE4S7VP)Y-I:[ ^15+TII7HNAR -3KG)D\'I)GJ0=.I.K?)G+
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MYLD07H\,=G0_4ROM*CMTQ]3A2TG77\.M''ZK9T?#F,V$^*E8 />$$MGXX84
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MW YYJ$G%[2;D)@0(DR] ^N09+8,N>A5L+?=X.MG8>&1N6E:RSE%%RQ&YZI'
MW3JK(&[:7=,QH_(IUMJ&(W#3:N5DTQ44+ZVJ3EHZ>D.S:L)BOJA1K3,V]4'N
METHJ*Y0Y0N^M:G)W4O+(H ??6G%R4W^Q+@X?;%DL,<#T,8I#RY8M!\\BB-SW
MSS=6,3#TJ2&.F@Z4TKYTDK&&G97RI(7OL4C+C+&9=R*$H4=L#5HMLXZPRD/
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M5T/(=#0X9-U3#VI/+F'[HXA#%X?B)S7KGE8$D,:ZOC&*(Y5Z;\3#E(82^K#
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M %R%;/#V[L*B.ZZ.<XZDG8+I$O*<LR>F_./.&(\K(JE=2_]N@VU(75-7QN6
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M2.8:#3N9B+8UP908YGA=,17'S:H@<_SG'S?JF&/[P3XL/RH _O4_4$L#!!0
M   ( &>!;U.U)7*<'$\  )X#!@ 4    =&UB+3(P,C$P.3,P7W!R92YX;6SM
M?5MSXSB2[ON)./]!I_?AS$9,=5N^5;EC9C=D6:[6CBUI)+EZ^[Q4T!1D<X<B
M-;RX[/GU!R!%F12)&PF22<BQEW;9 (C,_)!(9"82?_G/UXW=>T&>;[G.7W_J
M_WSR4P\YIKNRG*>__A3ZGPS?M*R?_O,__O?_^LO_^?3IOZ_G=[V5:X8;Y 0]
MTT-&@%:]'U;PW%NZVZWA].Z1YUFVW;OVK-43ZO6N?K[\^?/5R9>?3\_Z5U>]
M3Y]V(UT;/N[I.KUHR-.?^_N_#'>CNLZOO7[_E_[%+Z<GI_W>EU]/3W^]Z/=F
M]_N6]WB::XO?U+:<?_Q*_M\C_F@/$^SXO[[ZUE]_>@Z"[:^__/+CQX^??YS]
M['I/N/])_Y?_OK];F,]H8WRR'#\P'!/]U,/M?_6C7]ZYIA%$W$IU?WWT[&2
MLU_VWZ*V(/_ZE#3[1'[UJ7_ZZ:S_\ZN_^FDW1?)G@8\DS5]S[7<T8;Y?_1+]
M==\4#V0QAMZ3C;G7Z_W%<VTT1^M>-,:OP=L6_?4GW]IL;?+MZ'?/'EK_]:=@
M\_B)".#DZNR$$/)O-SND)/\=.*N1$UC!V]A9N]XF8N-//3+\PWR\G\_&\ES\
M-\]Z_=ET-[^0/_\B-E)$G1#+?JE(V2+ &"43&;K."CD8R]>&35BV>$8H\,6(
MX@X"AIZ9X>&_/:/ ,@U;"7$'([9)Z?XW_G0]W2(O E-I$=)&@T+AXAES_MFU
M5UCGC_X9XB5T@]:6:04J"&8,#H7^H>$_W]KN#R4"3@W6''TWEF_:KA]ZZ ;Y
MIF=M"<*FZ^O0MQSD^U@U+JPG!^^,IH$5I6FZ(=:4SM/,M;$DD"#=E3_2!C_&
MCA58ACT+'_$LINLU\O"49.FE#-(&/7?&(UE%6X*VV]##$R._1/@K9(V--UO/
M?8FAB.6! >H'7F@208V=F><^>5A0LM0K^60;O(K5S3T*GMW5V'E!?D!F*4L^
M;90V*,*KR@O1:O2Z)7I'6I*Y[FW0<&M8WC?##M$]AA#^=QF9%(_1CKY]));G
MT-A:@6%'JV**M<23C"$K.E@;].WFL@A<\Q^RY&3[MJ(!<&OW#:%KY&"C(YAA
M:U-ZT12/T08UJ>UU&/J!N\$FE2PUQ6.T@BQWL[&"U+Y!C 7DE+%'F$.U0=L<
MV<1A@4\TP=O2PX Q3(D3A,@X;5 U0<&=Z_LSY$5&O2PQN>ZMK*'PT4?_##%4
M1B\$+]+K)]>_,U9^H]9^NU:_ I-U:3S:\KQ2^&$X%G,Y5K#' F ]ER.+,@@4
M2[H<4:R1P%G5Y4@4&K)M"[L<:44C +/H2A+&'Q" '52.-LH@G;$FAGC6 ?)N
M4&!8=C,VQ>$G.\.KXJW0;Y)WO"F \<V69 I[K([:H"5YH?++<*S0.=IZEH]*
M\D1L3#C4IB.C2DDN'!@.W6,'4X+V 36EI-/&!G 6*4DG;10HIQ&\8V.#K2QU
M(B.".YT,L/Y$U;9WN='!<>#>P/M-%.=73W]N[+9/;'C[?$%>8&'K?8;[(<\C
MZ0#X#S//<KVE.]ZZ)?E0]BOM<V2S<9WH1RS&['25L$)@^+9YL,#F)SZO4,6F
M@ _"GVB=%^3_3:/C2EF5R!VN;1I'?F#AZ;_O6--U:IY?/:/\=E#Z,VWS9(ZM
M+L\R@QT>'_ Q1 4/F,.V37,2*XYU<^B9S_AC)&*L0OC<L=NF_G?#4X7TW%!0
ML@?*'DA80S68!VD^HU5H%V8!2%$F-! P'_0,:TXGN+-,<E;:&])EP5KZ.\"X
M$AG8I9>L\+C0J(ZE0W[G&68-(*!] %(V2DFJN<,!B,F4)(TV2AL4]?OG)WUZ
MXDE)"D5'E:9XZR$?CQ"=TN_P'W=DDL^KN,:3XB-ZQ?IUA5;[WUH!^<;)R<G5
M2>]3+QDH_:/AK'KQJ+URMX,B&C&5MFMFYF*3FU^NEQ4J&<['XT5C^<C\^<E]
M^66%K.@J&ODA$GDD;OR/[T,7G^ &CWZD*)*1;.,1V7_]Z>!OO]0YCX1;2SSB
MP30.__S]\NSSY]/+D_.+SYCM%_V+DWYJ<FDH#+SL1 W/3,;&/V;0D6?_KL4O
MV^AFT"?SV;+W4E]C*.7XL_N2*SACUULA[Z\_X9]"'\_#C8Y1Y.Y1(WS^>QB%
M,^VW.=JZWJ'D&2V[Q7V1R>\$<9H3Q#;Q:=S%7*%.-IIIQ#K2R7*)DS"2;".B
MQ!N&Y6*]M;K!.R-#D)EV64Y<]L^_G (6(W_J.R&>M;.:(DO$(I_D+J?#IMT2
MA-#L=[(X;U86\19[:]EH$FX>D5<@@\,FW>"]T*QW/+]H@^=S]&21J3O!Q-@4
M::"B9EWBO<#,=_R_;(/_)+3LX=48<2N*, ]) H[W-G17='$P>W5).O*$[(3U
MN0UA+8W7\0H3&SFNR'<YVHK2ODL"DB%A)YHO;8AFL%J1]*/=?_ Y$O6I8BEH
MVR61B$Y_)XZK%L4QQ#].O:7[P^$)X[UE!T7!F7QR6CQI41*1;IUZ,\]]L>(B
M-$QQ'#3OH$Q$*$@$T_ Y/C//F>L'AOW_K"USPR]JW$&A\.>?B"1_HJ]5)&0%
M#SQD4(20_G,WV,Z=<<+HAD_=I.*5/7MV'?I)[[!)-Q@N-.N$Z0T?KQ?(C)+?
M^J>/2^+S+F#Z89-N,%UHU@G3&SY?+SV#5+Y;O&T>7;N XYF_9R?^N7_1A\AN
M_I037C=\EDYP,'HUHS1?BB^CJ%DW."\\\T0 K9R/AZ'GQ9<C7(]$M(D-%OI4
MHZ:X>3<$(DU!(IA63L=C)T"$"NL%W1B!L9LVP[U4U+Q+@I&@(!%,*^=DXAGV
MAOBD\N1Z;TRO][Y5E\3 GW@2P&OE;+S8&+:=7(2D<C_3JDO<YT\\X7XK!^#1
M!GE/6&E^]=P?P?/0W6P-A[X&"EMW21KB!"12:?@,O)OFZWN<, [=TD62:]HI
M>8C-/A%&P^?DW0I^1K;-6QGI1ET2 '?>">M;"4:GK@M%*7W^- Q()>M57,&3
M8M$R.G5)--)T)*)J)88]1"17UAX[*_3Z-T1?* ?M.B40@:DG,FCX[+VSK6\M
MWS3L/Y#AT;.9:$VSY'SIGU]= I2$U.P3831\#D]R?=XG>8M_4V3;4EIV0Q0R
MDT\DT?#!.SO%V, 0DT6J;1>EP9M^(H^&S]L#/,-5-$O;*-K ,W_O!M_Y4TXR
M*VFGZ[_\<IA]7RTGG_\*18I5U'3\_@E)Q]^/A7_>#]?;C=>3?M:B/+;6AO\8
M#1CZGYX,8QL##-F!G_PF0MJGD_[NT95_V_WZ^YZ$Z?K6<O"\2:$A-SYR4/+V
MY;I66#$*J(I*C_'F'S4"LY[*2(8L-PFRJ'<#2J6DMROAH6WX_NZN^.#5.MR[
MN.VS#+KJ7YQ? )$[77X,H0N1IX'\TW3>8"5O':9OT1O"E;B0\/+"%R2Q3:GG
M[@*2K?E[7.?C^I1:Z.,>%21@R'0%)VM!6;T+N3*UBL0>(,]'=\IE7U[T1R7Y
M"H*O>O&L'L&7EOLQB;V"U/.Q@*:DKMK PX<[-,8_<BV[?4-P&*AFTK'I4GN]
MM!51#WP?'Y0YI\UL([@B9DLK+V8!NFK8P55=(ZXJ])W#6DCV!VW!04! DC3Q
MBY"F)0K(BY)104S_F=2U?3%L1 K.!$/#\]XLYRFJ!$<[V8GT!8H2$8$7'/1*
M4ZPE>&Y"=(MYFZK90VRFPL1!D2Y:046:T!I."^TC)"X;.4<FPHL%FUYL<%!:
M:X4+&1IK.$JT#PE\D-H:5E)6'&O3:?",O Q+*? 0Z*D55,K22ZW/T678B !$
M7R@("SV?7"4I=)?418<B])GG;I$7O)&2IE'QMN3ED0FB*PEZEPSC^B?XX-]2
M-E>E$XLTA5I:%I0WARBHH+36 Q RQ&EI4L1<8VX*>DB:08NJ31^4_K^SC$?+
MMLC1B;Q!1CSOY)4I#+X8\QRWE6AW<. H[<RL1+&6^T2*(V*^3GH'<#"I)&TF
M>$0HU]*E=><Z3TOD;9@/!7&.(5)C0 :5" H*8%29?"V1M7LVTY\9;WQ/6'%C
M_; B0:>6NU-T!QT;[$*@*&ZL'R@DZ-3R.#/:/*+5"JUND&>]&*0^0>I-IOP?
M$WX?7FJK.IQ^P%+*"3V]K/&;GWE.T_>IXO99EO7[7TCMC$Z#1XY45>Y84.@0
MAL4QX$$."/D+MZWX98HS0G?0GKMOADWHF;B.62A?3FO(0JYR0"Y#MI;FJMC1
MKM*Q6%<,*> "+&.W6)4<V.YL34)MK"L(2E"MI9F98B??@M 5#**D:AG99[QN
M2,LVI??0'2&RI*NR.4'IC"7:D$= O#>AT!^EM>Y(D2&;^DJ*1BA)$K,'&^)F
M'@2!9SV& =EVE^[,8)Q@I<?)LOBT?W':TKMY9:# !5))^K4,Y$BG(8BN:@"@
M4:R.)"FG/@[49;BDZN0Q+],<- ,'#4E9%ELQ7 JUU!B#U<J*Z9@9UFKL[ []
M*8;0W.O<COK!I"3-6OK;YN3%; >M1H;GX-W7'YAFN FC&T4W:&V9%FW+X7?,
M,O%S_[+SP"E),RRO6FTVBK!MHA\P!&D\R@S:DIFSX$!2GT].G'[J8XI* =1P
M/<;X=/>, LLT]D\4<8LS7@@69^S]*3/^O_]TU,4:OY^VMEU4*]?8_]*_.#EK
M>YL08W#1_L E3(."??44; 0E>;K\&$(7(D\#^:LJV A*XD+"*W!%B)%X] 4;
M(<A:4%8'0?8JU((5>S.U&CLO] HR;Z6*6^ME&KLN\0H"K^KV 6'1W56KT A!
M_-5L.#9=&E1H/ C'XD/SU(NH7T6AE!GRHC>8Q(+9M-YP0<&6+S=Z+46PEA&H
M X;$#W8-PN 9S^M?[QX<-FX.>VF+%R%"M0PX%3)B[/NA'$;B'IKC@T&DEC&E
M0B;07SP4[:8Y2GB4:IG??<").PO_9Q7),+;/D6,*VBJ%7;6%C#BU6MXO3.5X
M2%JX CWU 4U98K5,"\\]0\NU:AD]LFPC599.NH\1(2*U3 ;/,8%IR5)::XP)
M!H&ZI^**6J_"KUSKA0P>E:I27=CPJ#_59?\;?[J>;I&7O<#,27,Y9;Q!^CYP
MSUWW,D-#3G 9.YA9:#]Y3DX+M75+R;(OR(FK[I,K<F0FOUO!\S#T SQ+;_1J
MVB$!-"FBB?]WM31>J=FSTB.!TP4<26839]60J\AS^H*\1Q?0KL%AS\QS5Z%)
M[O(OD/=BF6A$](5/@E%WED]/T*XRJ,9H*T.YV@!/^X@;NGXP77]UW97_S@=_
MX=ITTY76H<M(D:1*3Z<K_L)T33A!^(#/^A(Z1JAOEP%2GD!%7E<P&N.KY_H^
M5IUKZHV@5(LNBYQ'AI;%,G;'!^=I]Q0,[ZE&:OL,RTY/^A<7+9=TE)"\'%%:
M^CKG6#Z8M^0)NAML1=EN].S'CA]40Y/1!QP>Y(1<9%S*4@LKW:,X%7".GL@]
M1M=[(^5?<'-R5Z98[-SVVHB\'*6PLC:*Q?WWT"!59QD"SK;02Z0"M&EIZ2^0
MC0=]^HH<S#P;PWFPVF \$\:18L1L+2_661N@*"!;R[R+'#]%#43MD"%&H=ZG
MA=BXOL,')AX,WEN" T*9$P*''%6Q;E!2?W_X+:8^J3)*#=T4-^^R_*5HTC+
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M!X.AQJ3/ IP(<W1 SSN9Q,<T7:>>C&9F-? [9EGVN7]^"09/(L(M $<YDC5
MR7@V+3R\Y_X.3^;E9)87/IM$#60\Q5;TP+;=V("/"&#*G-H>' ;8HLN+6HXR
MH,YS-78$SVG#[@0."5 L"C:':DB>;RE=%I,Z]OT0K6Y"8NS/L,GOKN+$\ GZ
M$?V)GCLKTADPPH3%78"9\K0WY5%IXU5,/V;)S+-,E-R4IJ&'UEY3P$B1J^GE
M'-=$:.63N_6$$89C8FZF[BU1[^=P^NF)F')DP[JNT\0V]7XADG!GG_[\7M.A
MS/;%'51/S-7 $TVO&17R*2HZKAB/8F,>%1PKL$3+!WV3HE@[+B>;Q=#U QK8
M6%WTQ)(TQ5UXYG=W5VA7GW%7GO$K^3EWVYG;7B^QER-7T;.\X,YFR<V)V$E"
M"ENY3G210N!F;%$?P%AISFTDS2!%MGF;+N@#6IGQI\*V\) C+49:BHT(I1I$
M(5(G4&;T(=<.G.C%Q987N1AU&HA[L%I9\:QGAH7UZ:ZZ-%/TS#Y91GW!ZO6B
MNS"0IQ1>9G_9N@I9LXIA2E#;@X-""V:$'',4>5/ H4>D/$=1#W (DA.G(!P8
MM,*[\Q?OC,F3 ?3+?D7MNB%.AC@.#Z"B-':K!@>>R_X!]]O0<RQ2ISTJPTY2
M2L>;K>>^H%01>#_PPBB?9^S,//<)?U^R],99/@'[;G =/80^(Z\I_+EW^S"?
MC)</\]&?XT<*?YO>W?3&][/Y]-LH\]["8CE_&$8%.\:3'O[SUSDIV-&5@AN8
M?5OD!6\SF]0Y<59[,7"*:7#[M9?&O;]&39VC6,E?=G=PFD5((@5>ARKT:G <
MH5)]_;;$'V=8H0(]P8&DDK0+0\JE6* S;@CA3.M3H"<XW)05M 1D.-1K )D]
MJ4Q?QT&K[D"!(\!B+R>/4@W$7FRO<ER=]"X: T*:; U\7X6G'"8X&#TTQH8L
MU6W&QHK]&/N#[:WU2OX3GV7)DT#(8[@U!+II*/9*I->0(@;+QKSCW-'@=\SR
M[0KSK>6'_IHZF; YH,L]#"KY7SW7ET9-U D<8DJ*6 (K=+JU?#!^8)KA)K2-
M *UN$";$M")QXI]MM*ND.MBX7K"KLDIE&RV(JVAX?8%8*X>JJK:K&+(.>B+S
M P-:*A,F2-IWC;OH"RYIJE7=_' #PP8#%Y%U18&-2%=]X5.:>BWO:Z2>C<XY
M+4Q$M[ XW?2%3RG*%5VN:+%66'&MM%VQ7KF0]7D^9$W"U<L_>O>CY6_3F]YX
M\FVT6)+8-/[3[A.=B4-3'M3 D/LOUW*";_@?D0. \S"WW"C?SUJ/45-F+!:A
M9G4&ITI*R(85K9:F'4PDP4?FST_NRR\K9,6(P3]$0(D@@O_Q_0[;V/;(P4O_
MK2#^7- "G+ KR.E=Z**$=DBR,26%X>'#/X.1J:@8LH+CD@(OT;"NQP5:EAU7
M$@=>=UFZ@%9#ZO:;-KKH\%JX B_LV_[C-2T"IA899R%4@A-'MK]TY/4:%5N.
M3A7X>#J6%^D5'P",NE"ZORCB@P8WJ:.:.E$E,!I4]@TR+#@_P2PX 0X%67<C
MAU9-2^;1O(V&;?T+K;YB97SG^O[4N;'\K>L3>B6\:/1A](>3$H[ JL%7;*(4
M$QJ7ZR(O?!06@>%VTA<@%>C7LK!>.Z_O: 4I-:Q0%'55ML/)JYN%:TMK&])'
M7V24)U_/*G6I>J9Q'04*?^EI0&+]]464&E8T4]BNZ2#]M6&3>GZ+9X0"V4C]
MJ42D?O>=7O2ACW@],R;<_IWR9N+U$)1,"=DHB=<K/J.W?>$S3_/$=4S7\5W;
M6I%,VL1CRKAI+CT..#!5P(&H92S+CF/#ET!I1:F1P&%,#2PJPHW!FZ,)2)WW
M^Y_[7SH$!H;02@:J$A9\Q*FJ'5D@0$GIWE61#[K<3QSX/@K\8>@1YM/NBZ7;
M= \5;$'FD<$G5\]+AQ'93 @<B^R;6O'M"_W.,AXM.WI5@ZT#\@WU!X,@S5K&
MCU*T$UM-%!OO;8\*'ARRM;QY=V\YT0S&#IX7YB$%'(?-],>%$,5:!H*B\MFD
M-!">5<Q,VB$DUU!_6 C2K&<,!Y_.\4%]_R*';!CG3"*,$W^JM__61R2'&2TX
MA^K(4!W) :!32LA&321'[;FU,Y[V^B(Y ,!4 0?*(SE'BJ]Z(SFG_8NS*X@*
M2Q86-41R=KPYGDA.U\# $%K92(Y:F;?N>6\MD@, 2DKWKHI\T"62,T<OR D1
MR1P<NDYD0/YN!<_#T _PRO)&KZ8=KBSGB;BX\?^NEL8K!5@E1NH>PMB@R*-,
M%5.TC!U%]3EGGKNV:,?25 O]L<(C5LM0T@3MO#SD!M8@"#SK,0R(&E^ZL8T0
MX$GCSSYQ',;2X^B/)S4LT3).E6&-"**.#"TL)-1^)ZD^+_/ -+T0K4:O6^3@
M_5;.GWR1+^ W& [G#Z.;WNB_9Z/)8M2=9^-VC,B'JCEN8FZ_UE+\=S-;&+;A
M<=,2BAN#6^-"W"[(1A&G3DNS<D<_L:2P31T1=(L$(4'II!DT9*C4TNK<\6'N
MOADV/XN)TEHS4 B1!\L:+':F)OHOW&YMJFP9+;LN5UG28.49,66:8L$L?+0M
M<[K&,\1'F,2DXPM;= B=4%")9E@Y1TQX_ V]3;>60\X'R, V/'EL"M,728F/
M#('>.H&B++G-I!HIP<.U:WB2(*!UR;+B#+.BY>MR%20O1>-.W)]AB%N1_3<-
MGI%'Y2#%#&1WZCI *E"Y@\@7K2 BBP[M@5$*$U?UOCY4GZOPUK"\;X8=HGMD
MD'\3G^KPV7">9-V&EWFWX>U@/.]]&]P]C'KWH\'B83[:):'N/M 9-^*>2>_D
M\1)-65U:<QZ.-H]HM2*OMGG6"P;-"V*ED5):@UOG/%87)%A)4*9!UMZ>0==O
M^Q]_LY"'6?S\=H=>D,U(!17K# X4,B+. Z0"T3KA);4G^'D^,/,[I<8 AYX*
M\F> J30K=,+4V-F&@1_Q\(SY?CRC!UR\E!8Q S:"]&L DKS2ON-D>3)Z@ -)
MM2U)EE)=$C?S=.\7QG1=Q)3XV$:[6UEVN Z@B8T'$4158(4B[;/%GW-7B\#P
M@MJ*^98D>[!:682H0U6D9E"-\%4C0[0,TN>Y\5ZI/_\W^GOATN-HA#FU/*@:
M_0?Z!CW(K?2\?W'R63_856"%HCR%>"L=.7G\M>5^+.2..-Y$NVN(KTJD*TIL
ML%N(3MR@1_*<^]#86B0^@@_7:/IH6T^Q])X\%)^TY2(5G_.1BIO1];(WF-ST
MAH/9>#FXZ]V-!HM1;WI]-_XZ6(ZG$]RF]_Z]S@0N"/]2:>'LD$5QX]8>'R?3
M&3MX$B'A.2M04= 2G Z@,[=HM8O1HX'')TLJ(PR1;PA2Q")BXPF<2IQV\J:^
M*LMK#ESV5 GR1,^A$%Y!ASO7<.XMQT&^&QAX@[3,T Y"S[#QKCTR7<?=6.8-
M\5R[V^BQ$I*11:_W4'XTX(#@R/7 =Z*8#:V7A"B&S@SSR_)]UWN;N $BM\7G
MZ(E85]/U@X.-6L_'5N9TO6<$'3;E1M(*,@I9 ,O')J!V;A#F;?SJ'#YK;VWW
M+=+!A6M%4/?(#ZD5FNK@10TW:E0@*7.T- ,73__TI/^%CA-F!ZU0($^I(L^5
M0OLDKQ<K[RW'NZ64W$E WZ@AM)$K H;S%CU.&9>@I>.!U5XK\4L36L-]&24:
MP'@SGY'Y#PSG )ED3OBG)\_8,-8\NTN6^HO^^>59=\5<AM8:KLJHWLK_*[3?
M2 NQ?3S;6BOY2I*IZ(J+PAT\3< ";8-H[N*B+>BBK7Q%:55T9T6A']'W@I0/
M$?_KT'^(?_5]3BZ-%+B(,W\#+EP1KS"?'D5']%8$6+AL#_X*1HA\412(C;_R
M 'GPA01W;[Q:F[#88LK]'9[P&//*BH]/!SP!2H=@AK;A^]/U[X;G&4XP]>;6
MTS,K\D9M#T;0U0-P<C0J<F6! P$S%,?H 0X(<N(4A .#5GAQN=W4_;(A%9G^
MW1 _0WP')G5EVH$&W!*Z2D+A"!%04O#MW;EA"U[&S\GKHZO(I>AM/::EZK&%
MY#6P'1.CQ]@8)B&U/3A4E#<)Y6AL,_*EUB2,Z!2Q!%,-LRRY[)]_;CGP(2<\
MJ@'((Q&>W;= 42G<H>O@C2NP,-QGR50B8N@*7ZPG.$D+2NI VU<@5@,/0%8I
MWG&N6%-:@T."JO1;-H4UQ+25A+%# EB\#M[MEL)[JD7M@$N2+8_#J+4H?5I6
M!,\R[M8PT6#CAM12;K3FF@"B%)FPLA]5F7:I(.&*/,$4^-$C/#0#C])<,UQ(
MD0FK('@M^B)Y'F>.;>?(@%[-D&<2D3Z)W;QB#: 9=BH2WH52Y%D29]%M8LN\
M=YW@V7Z;&5$6<+S=%AD:XKTU088*JKN0,'F0K+*SMVXM/,\=@7PX%/72%P;"
MU,*J.%[+'I,LB6*H"/71!"CE:855J9SBAPH?_<!P LNPIS\<_*5G:QM7_:7:
M%,+]LDSYC$_U%UT$0#5Z8=4B%]DJDLI.AITNR<_?+(K[Z02"TO2J*CX.:L,H
M+O8A<E9-M=8$'F6H3#Q;)WJAHBB\.PT#HCW)P](R64NI;KKAI RY"6" ^$(I
MUP"**$LLZR1X/_;]\+W@3^9*@'AW32"AA.P$&GJY0Q/"!\XJ8HB?6B%+Y&TH
MNH3731/@5"(W 8Q>?M+"931ZQ1:ZY:.99YGH?37M_NKW978DWEB:04L=#Q*\
M=<B3FDHZN+<<<M\@FWN0O%G(/QF)CI3EW)?^^16HK*P*9Z5*'$BP \3=VL#F
M5F)CTP0[I4E-0 +$*<M.\-U3E?8AX 5"<;8)=--$_)7(32  Q.%:>^QW[)@>
M<33<H/B_TK'?PP$T 9$BPA,X 7'=U@ZGFY#LP'%@0QI*Z<Y' R,NT0F$@#A^
MA?(',$FFM37L6SP%ZP4Y*)=^)-A+$QA4H39)4@/BXA61?X)O*?$7=-)7^J+$
M)L*OZJ[%%L^C6Y_XEVBS=3W#>QO],\3C1L>QV-.85F_Q <['!$S7I.+4S'@C
MB=O81-L]PYMPI0@LBC^1Y?95_^+TLK/0:H(U"1#U<@[?N;%[DS"?8JZDFV@"
M&F'2$J'7[.!MZ4F)>R,(R4QD'Y0X+?.@1/*QHWI-HKVW9Y2])@%DD1<SEW?.
MH-.CP<4VHKV"G?9:XJ\QKC 7-04I9A'1%>MQ(?(TE#KS\G)Q8W"2%Y8?7_0,
M"C41?F*P,)^3SC<$+W2&Y-B6&X,^#41.289C2I_91R\@R),*KYPDA"OM '!0
M?O^7H;#UJD6*,+ [3UG(GZ[3*XAZVO,Y1YCR V;X?''2QZR&A"0V'O)H4LP(
M6'?O:2_,O&^G=#+G:!M?U,&,V7OOQ\X$O09SU[9)IMP/9+^@Z 9@H<.[CN^
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MW]0HP$Z%@?#0$E^@_5Y5[L4,!D:'!N/Y[RN5=0AL$=26JU4&S2VI>6F&!&Y
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MNL?PL^&<=Q#T=08^BMFMK+R#VDLR[/5JQ%_7DI9M:PCQ/ EK'%Z')]?GR\M
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MFX>^RK;K4D^1M[H-7JYGDH:$3A"D:3=G0'X#WIWGOO!V:;L1%&T5&6;R,W*
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MK 2":1;$[;AQ</-EVXK8MKW5[; 2!N..WVDW)R"F.Z#)!&.)"8CEP9@! GM
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M&/>S&?17H=Q_WT64S[X!'>(LFV3^;6WB4H,%3]'B,F69T+&"3ER+30)?R-T
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M@FP,"_: 8;L*A\WDL9D,I[$0^C2><K <Z,^S7X !_3A[]J7TB60<(XA_^'0
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MMGQT/1\>)W[)_$#>EYN3#TRLR;.K:H$>R)2X&O.3TK(\H3M2]!<)@<FK-,/
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MJSA^7+;.RJ\+O,.)#731+=JA*]'#4=C^W ,]NO/)S,3S,B\)D84MNV1;6LL
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ME*Y,1+&UJB902_),G@BAU\CVE%B<J'3-TK;.Z5D[NQ;8\X%.TT2I94GR0JV
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M;KFONU ?SBS"(5W4(X4S/<B-,7=*@?=G^8?S/H8L_[T2#4.4?V_G5\ZUL+Z
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ML'9D&'1S1YOO^X:LW9JK[E_Z/#?<K>D42M^7DS[Z]EQU_](7[GVA](72=^/
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MSLAEHC1!1%/$N4X45D$,T2A$H_M"H[K,CS?U1)$EQ'%SM*D*ECR5WK>&T+-
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M0M/64C:1&I"1GN_CG2[]C/P%]3.L 4-=..OI=/@O\C]_1Q2HU44T90*@':L
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MJN:"$0@AG55CF<2R6DXWXRVB=:GF$@.M-<]@\TTR8:_O9371AK89GF\:+IN
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MHB.1\6H]46?[;W#XO:R2-@("_\X'.)W%"F";JYL\&/&31'QJ&)D,U,JIBSY
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MP,?VXSGVWMBCG,S ?-.AT7:<+'<8!.I$\URQV#X7[8,[X- S<A'[2;%0_W7
M8:P7DD.UO?'GVL@E@ORYR'Z4O6-/W=O6 PL3.]203W*[M_VOF:M?\V0%?#3
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MW,B''+!#PLFI8_3@+#Y6-@(5(Z=H^,6?/BY/#8,O1[*Q]V"\<189((D(;M?
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M .6R0,"&RV=M8XCWD2P=V/[H#IC@;/URK(7FE0(X0CHO)L$O?!1H.'O?WO[
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M-2;#OJS49]V60 O$TY:S0J\GS7(LJ5*#[F22)JEL0YC"EF=]#NI\7E!W<X(
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MQ41J\7D^$[LV'&?XI17CV;Y<Y"JKHIY*KR&&L-=@R.-Y3/)!>H!W7S<D*+X
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MW\JE8,F &;9H*4/(#!EVR_Q"'S9,K[T &!:]]=;]*]8\H.+?+_3])X2DGI+
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M,7Z0"0B6:7M_\S'$D<6)H<S=K5*!, '@Q$;>YTD(3 'FP7<=CPRS=M!= R/
M>B C0=P10+\=6WKNG>W;=F#:X$\N5#Q(7V#R+5D"L;ZEV"I44\7QH<2V/8D
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M,<-1PA+OE@V#:M;'?_T^W?GZ5VP&"T888#I/,?#8%Z;ME/T0)(;R6( 7GE7
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M*?W W,[T]O,0!GBIIB\-OX")D2U-,2 6 (CQ(@>(. T @K)ER5*L[0#F[;H
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MMBQ3P:_!BR7Q1RIU(5R=7#@D]ICY+Q<#(@J(@O_7:^:B!EN]]Y'^KW CP'Q
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MPY"[#><VHFCZ:W+/;DV^W?X\P?1]GJ!XGR>H7=,\0;9"CZQB$3.QIC;(97K
MO$JID?,$E9ZQVO#&9"@[I)=4%_U)G];F4?,$LRM9:\S66(FIYC.4+.?+ZMB
MDP?/)N41PQ[9&F^60VP5GS&DP"4R5<^=),YGU578K%AK")3 5GLCPA06/5RR
MVY/D^<IFNF_,:JLI+GMR>CHD^OWBD(<KSZ;:F3DQLRD--CG&R=FF.:LU"'T;
M.4^0\PCP/V?*L]4"6T_,2"*/+URP\FS/?J8P+M2';AX;Y!5OFL"806L*5Y*G
M*PO<6,BY=L=@2)Q:5ZJN5Z1=-VI&X<)B^AVIT>0P4=LX&6+94%EI'C6CL"-0
MP%_"<P9;[$^V<;PWVNAHY=G3;6HV-:9R?LQ(6JEJM1,R760C9Q2J\UY]MJC1
M14PMLXK83(M$LN5&S1.TTU:%2!2':;8Y*]E.(9/LT+7(>8(XW]5GR3679[RQ
ML/)HC^HU<+CR[)RSJ<J3]&0\9$1VVJZW;".SR=! TY\]/3^J"^2HF>.8*K?(
M;Q/.,(UEX<JSI]N]Y2R=&HTIV9$*TL!2*HT9UY[@V/FFT_:BVRQCQ:$LK6?-
M7$;,&Y4J6GIV4A-;BFREWQK)76*(S2DRWS%+8"E^OJM9$Q?SNK"-LZ*;R^*R
MO)CT 9& I6=GS3-JK688E35;)36OP&VJDPZ@9IPXWS4]CF\+16LM8![)K!ME
MAQTJ EIZ/LLR-Z?!:W,5F8MW364FC!N;#CA !.-M[.PX,:?RFASGE=9TW,@E
MN4P;+CW;M=?3=2?=5 >LB(\+%,5GTK7F?()',*E3SV2)93-ER=V2D5&*;BN3
M<-IPZ=FNE;YJ"AW2(C N,9\W!"*1G[5HN/0,!>1,:W38U6;$$/URG:WH7GK8
M TLC.'J\+%861M7H85P^@?<+6-$<B'.X].P &CLC*$P;I-CX:%J16JI1BWO@
MK!&\PHLIDM#<K<=VBVV52>&6D*L#N$8P2RU3QRPF;;B,*&0*ILE+9(- 2\_D
MZ22^2G,+?CO#1*J97;GCS*JAS^'2\[,VJH+*)@89UN-)-:/J \"/:.F9[*6)
MFI06BL,L)MG]R=RK5Y)8#[Q6!&O9Z_&PD"=S$UDMU-<4/<<'H]P<+CT[P*;C
M>/G&2G3EE4R"#>.C855S8<C_;-?M-).D&OVX+I.,07,TG<DW:+ T@K0[M$ND
M=*F\Q:JD2H^Y6KG=* +=$T&OV&10%->;T9(5.^T,N]YNZZR!EIZ=5<)XJE#G
M;)9=J6[3(@9T.1<'2R/HU5O(A>G4+"XPLIP7&$LNU=DT6GJV*[;I#Y+\.M]F
MXN1\3FPT;]M-MB?$G@C?/BSUEL:?^C[V@#-1WOD%DTGPB $1!\<O:[YWM\OA
M")*+8#37#4X'DYDL1P6;H.PES@IFEG[Y4-*#]!8_H;^AVV((PZ;9@:"WSN>/
M%@6S4!R.71;S%L(PU9XWZS.9OM#\T0,K'7M\WLG;?Q-[O7_W6:-' _\"^2GP
M'B#\P'=2T"=OF4[Z":-)R<QCFKJBTL6#[[W!_7Y#B_''=.)WO.[3M:I)\I=#
M +CVR5\.@L?TKX= \IK:)GP/&Z13/P($;VS<<[TZ[T)C-:Y5YWUDJB+QU%3%
M%V=>)1XOV[7IPD,330D<A(ZU3'$FFJ8H?-JHD0MKA.^<F7<=RN#3)N^< >BW
MZXN[PO@"@_&R.N1KQ,/+ZN-%0"#U\5,G)KJGL;$K5RH?X9N/2M%/,442R9]+
M3'[&;RR:ICZKG_,5R.8P&'J4R1GF< ;#K?%@N#6!A:D6'VO&>HV&_3>WW_V2
MN-9';;B/6VV?!J^OB8)]?3?%-U=)A,7V>'J7M9Q3.,MJS@+.#FXY4%XSS#F>
M^%[8S@4+!4"0WEPJYOE$TZ)49M!SXCF:6R5,A_Y Y43489I[67.:R=?C)_,2
MY@P7\;J!->E$D]*-L5WTVA-TTYB,3DK^$A:]/G/@BACR)IS0*X+7U_BC/U*
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M?I9!]H/LKA]O7OWT"_Z?>9]_Q5&%'T#[/RBR<+]GOH<,?EW(X-?>#7\[,_Q
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M .LKPDL'#Y9JD,25#YS^W?'1OJQR]##1:+#%=4=1ZYBWB<_<T_Z7>7$F::*
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MT+3!1S9<,P?LXA=$*_#&@//#05\6LLH\9L[B%;<2M5)5R5;!6UBTAH*= (R
MRP&&GHM?:2M'T2A.J,B#&3C\0&.-]#*(UTJ ?@7:?F;=!"[#KRK:A1]'NW+-
M>KW<JS.-7C=&-_+@]T:OW"@RC5R9^<RHUQL.^]]IU!4P^A*B12#L=)\@_G$
M69H*$!7@:RW @8#[:Q*0<("#Z3F0)Q#=__W?Z6?>8#_/#J?OPL(# CD58S9
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M>/I5&T)%N$LBA)ME_G-2#(YG7K718:LCO]X,0SN=]F(BL%=M=_*UM']3AL)
M9SOBY_AXN1#],49;_@A$3H'?A>@.#A0*SAWR=Z+SB2FE-]8-D,#NW0#%>S?
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M^;G2FHAF80*KX0'69 -T[S]!63AP3@2PFU#*#2ROA;U]T#2S*="]4I 3@((
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M,F_G.Z&BU0)E.H3%LUWFV]A\Q:9 -@*O 7);8&?<$$^*B3WV R\8T161!FY
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M**]IE.V-^Y;)]MLQ808."P8ZJ:$#XAV,7I18+', -O8DF4BCQ,)-_X2ZHQ'
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M< 'P_05X6S,;!'#1N_X!"2JUM=$JW;USB5Y\NDG(Z";):%65345MD) 65HA
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MMVX\EB[(-'0CPAXU<7UWDDRD,)A97NP"%1UXW# ,)NEU=(+9L'$0TMBZ(=*
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MTL9:^!<_#-":3'^2CE.Q7NC0STMKL^ 6>)MA<$NPI(\50?/SSG  1>0RZR@
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M5V-,_0P ZE=Z\C7]ZX,;V6#^)2&_:><-.G%\?&-]2RJ.DW)48:12-E08RN$
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MVMTHNW>%L]NJ@6AP&-V22R+*6"/WA248Z0Y\3!8DWY8*&!2,)L"(R CK>1Y
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MP35"!L(Z4Z-,4Q X0,3&,*^0.6E&%^W71HX1L<'$91F90'ZUVILK*_S\.TH
MQ?IS&XLIN3HCGP']<@)J/<G2\!;*M_7X4[YKA*+)4C?N"MP8,_?,U^T:R?%-
MM<E)V^K^)>8\@B[-<CI.XNK='44_,$6WYL0\($5_5$69D7RZ! S, *.W2K.?
M4BJY((6[4;I3XD^^.\\EG"^2J(R)VIA"[-?=IF+CNPEYF0O6+^UKY U*L)\^
MRQ[_E++944KZ&G:QJI-C>Y*-5Q]3#6ME."63YU_R*LY+$K]$"Y96@.)]S5;S
M:ZXR(\=!"=SGQX%C)5&_E37**$>G)$$$IS@W.V^2@"GM0=.@J./#L&#LA1QK
MW@PL<S<\'+/R8QV8+EUX8P)%?@>P=8[/;?G[CCK'IW5\KI5B=2[/;4K#HZV[
M/,]KQFI;+=X6?0IUI@W"9IZB1>NKL.L<M4R1I^:F#L<9_"@HB]R4#I%N2Y*O
MN3X6 +5$.#02JWHN[(9 U8HH$GHF[8?\0BDJR#97R95;F@Q]4YW*)<-8H0,*
MYC@IBYZI,"6WGG%2@+0W\*?)N'J>GBTZ\NZW&@$9MFO+<76AD@QR?&#3C<Y/
M!Q *8+H\\_D<G;,T;_33DAGMDIT:JZ8H>\(U<)AJ:+I^U/5NQUHM&OU8;?JG
MY!G;MHE/<Z0IXX;R:.E$?):8Q8=73=#[DFK%/E)UEHEW;U7;/FTG>MO_S*_#
MV3'.+\#F/Q(=(^-AA0ZQ.=]EVD2%SRR-BS3)HX0>KIG.;$,:L2,-7T%E'OU.
MKF)_9>U=5.<BN=RE$9-E7'/@6Z(9):9S#UG*/ '/;O<6A*.@_>]&\B/[Z-).
M36,8XY?S[ ;;_R7G&LN&K4!9;3U!#=1ZIHP;6PV!\8(.N#CD\KHV'I.W+\,O
M'W3S3M'JL9QGK,QL^*NWC-:9ZRQ3BR2@6H4E(B#6_]1>68UNQ_!*"XV+%RZ@
M,U'LM&8KV1+/1F[2KL!:7O55Y]8UBG/B0!R A_LIF<P&@!GQ9.._L".N@\VW
MEVPHC:)OM(%50E9M_NM3/K/UPNA\;S0,X 5XD0AW+T&G>G^7O-HEKW;)J_>J
MG?RXOF'KQ>,]SOAB1N)BGL"Y!B_J(3H;J#MX3HP+/D]=VN:N/P@Z>@M6?U':
M6($QS72QJO,@(T9KXJ!J>6!%J>.M)FIC>T/T;%>(VIC O9S0F35:HE4E6=+I
M+ST6&&PZ( O%GXS+&GUT.K.%7B#$K[D@7QSUC^C^ZOO3'@IY4N4)UEPH%^<F
MM"QU/8X,0FBALZ(DE=_ZKVQI327P^H]$9_[I;>YM>Z!/@>=ROUMQZO!M2VKQ
M*;( [/1@9Q D>5'E=YIT(B0J4F)NRB8EK69#@-W9[J;5D6F_%.D6=[0W&1WG
M1<8.8C*JK;>8>QMQ*3UK3T%1JU$U#O6U-!BF9Z%)6U4+BK*S43M&CR_]:3.D
MZ$M(V0LVI8I[3M@<!*NS<E<:6;."Y+HBM^:*;M%7V3U1J9AIBJ9'7L$'^2>Z
M,4I,A:F2?4Q_ //4U'2?RM?WBR-Z=)>)_V.?E8DTBBA\V XF28O#?:QF,IH8
M+@[@E:$?9R,UV]]@#,P+SK4/JEUL1OBX]JK2IH%I3TK,N:C4=-I>V+%)F>$M
M-H3HY22@*YWFCI7(XV2A')M.92:GF4QGM:9GZXJT:7()2&7X..YBM:=6(F )
MIFV<RFU2,?3/\S$]='IML4RO8<\MC62\5C2WWNFB)087.7LD-BL@BMQ@C/'D
MO49$W+\&'3VV<"&7<S!*U10(T;9:"8T-@[BE)U7C,L]POH>2A$Y W2R@6DN=
M'U! ?<C4GE.\ZGW9MIKNBC[*2.?<==ZA6?G G;M#%21,<,>D="+B-']IV(E/
MWEP',P5,6HG!Z_UR"S"BWF5UXF[I&F9"D;X;I:UC3\T%;GUCKBIJ@\BWXNUB
MTNV,OS,@@I"IB'$DXR^^7B0S$&2%\0S&QFN6^J3F;2A=<QH$IYU)ST9#WDT-
M[W+79+O*4_7C('6]#-/NT&_7\.S=Z-B['<W:@^ZM\9M*L5G5N^11P*8FGMA/
M9J"D_=0@NKD-W0FT$VJA5^5^AZYK<&N(2^R0=F3<GZ[!(,M&;\9^TE]E^AWN
M.CK@MU'.L:<B&8V:L^]M8C)WB"JCPG:9W:Q7EZ:G*H67\D9=O$&'_(8LA19-
MP"D1#$).28V!@%*D(5/=;E1K9P>[7DPF5V$].>-N>[3NOYTR6528 ;9^YHKE
M>B)+5C(J5GN3#.$)"ENJBA(S7RM%6I$.%><3T!7)LP[*<<P(-Y=?5(_3X3FP
M!VOHF>:JU)DQR0J_HRSK;::%([4PH\1P3@HA[Y!MO&CL$7H8=8RJ+H!:']HY
MN.P9VC'U%1:OBYH+^,Y4]HC[W-])SWI<>M73_I;5JD^U3F9B:/N2;46K:N?1
MZ [TB-J+&E46OYTFY7++ %VO6);=K+CQJE=:K!)K:^%TC/7D<J'@'F-H-CK5
MF.H7-V4ZSV"AFI5$UBXV;KY&AY NCVI;Z4//NCPJFV)JJJ<6B(7 UZ57AM2=
M7+!5+O]LZRE5:P?Y(,]W69VUR3PTTS_?T,>KJ6WN.)70ML:SC'NWYHIT)4YE
ME4V W]=Z&[057!F8=#4R#XWPV\X'6C^ZRM=R#!YLRWOTF%#^YMIF%:-!2)W*
M,M=]S*_',84X:">BW;F<)606-'H))W&M;\W:POV" K"'(B47FYI^]#!^R;-W
M:[$3\TJ0U[+9;>,?#K;<4'J#AXO@.&[I5J_,/>SQ>K)5=A,Y)\"\\WH/UKKO
MW  W]"+6'%<_F@']E$QGVT'4QAEZ6\U3OHBYW)/S89," R2;/3!<;+9,2BPV
MIGXYZ+C ,!7:(C.9S7TWDYXX-P*E'M0J:IO-'6!H&,+@/45E=FK^(=?H-KQW
MSD;Q5)6M*/77/NIZB%4!-XZAM31^\(3$';IZM>Z#:48)7(@.II.MW?D? @%,
M9U6_/7O%<'I5]W9F^-BA%5X&["YS;=S=$1%^&]<_"X?:GMMS/G8WEX0O 2O!
M; ^ ,U+V^E3&\()M <]ON?ZM*Z5&H.R2DW1$3%ZH-'>H;)9BT=F3).-2T\E1
M%&_OF5.+,*,U(.]F#^4B 8,2997=,+L[\+$M\/2X%<EWX()!18)*.SO8VE8C
M%_@.ZI:[=^I4W_YNY'-_]MWK;6I[U)N@UO3<]G*H )QK )]TO00WA]P0+X/-
MB[OW:.%W@**QW%@M=,&YUAQ0(E2SH1:OFBBK3F[84"I?3V][:"#X:8'&)6,+
M/[TD/RQ9=WY+6%^7 -TE0'<)T#]+ C2G!!=9B3EFJ##FRK:8S5FG\+@#<.F8
M:WN4Q ,RZ.ANJIQ@_3FW#7"1NTY50DEG.L":%FD9HE.(JVR)'L?75^*/,J06
M/K6>-;:=3*8FI3F*HG'P%1G0Z[,ES9_B,=X9:KN4Y&:,[C(V(YGCHOE!>HZ-
M>WAPE[D> $I%FIN=AS:B4NNV5"^PB14V&L/^!&@141J?,='GG%BY:<+45,@=
MI@83-O4_9J9AWQF5G<_P0<WW;:>8G:F,,E%.JV/'.>VCD5FXU7PS[PQT5G?8
MP*Q;O]P=0J =0=DK,#D\@UWY@<=-C?]0@ZJ.X> <&4S@J)4':,^[H#@'P_V&
M]<1I 93Y;]464EUS_H4EQ6HK_T*OWO.*)I$$09FNL .QD0-DSF=E7MA3&FU[
M,M^-9HS,M5=.R@BLC,@F1I-9-HZH61B57JZI7!53P3P++_,$7U[G+,;7<B.0
M;>(N;PI^<^<RUL/+]C3,UM9P8&-B[K#E?E.8,BS,]R+KB5T7W(1/-0](JC4?
MK[* 3)MG<P(RP\'3.M&3YB4O.0&"\LJ5:G/*LZW 6>P:XG6H1;ZFL>]H6IEC
M#\/:@49+=*@R8 D-_?8DK2TJUQU2JFK*EZ^[J'ZXK_6G9]RM)\4\9,,(SUMH
M8]O;=;YZ^,NXJ'+3I,QH-.LLQN;K/>NM>3Q)]7&/YHD=,W2:D"S!DI&4]D$%
M+:#QA"8&4VO:#HO!9!E@1[93J?N-7N((9_M$\5/G<3W?=A[7-9[ 1>P-*[@L
MJ^.\O0\4R%+Y5KL<?/:+6UJCG[X$K@IG;!)Q70)2Z\U53=97P42T)FS+Y-2L
M59B3YT%?QV9]MQQ8W-OX7/T@^G;QOML1S[T2SXOM$P^H&(LM-]V[D1YL X6:
M*DJ4D--<U;<>L^%33DN['W/ AHU9^ -3YJ\IQ6S^M@0%<%,?0)L$X,?B*BNJ
MKAS",DF9B[@LQ.]:?@<P7=M3R0][@LN@G[6V99J4A?$"ITEAR-CVZNQ(^%Y)
M^.6V2?BCPA:-6Y9Q0_3!60IRA;CH8:*Y $Z7<PK=V=H81'3<_E01#CA;%(FK
M5_5Q'Z/5LS#-YCT'&=]"BEO;Z^RSZ,LS]<NFGP(;@W ]TJJ$M_:\A)BVD=8:
MW%?9SR%7QY+]]:\2[*_66A/C@41/.8.(WN<HMY6_^3U>?"*'IQMG1&!.4+SG
MY^?PE:#*O>#B[EHC.>UULZDY//)R,L'F.+9/*5<>-?,A:$"R5ZN-0JCRJ08(
M<E2T"\507.&1&%[K!VJQZFJ'+%P0!%3:1AV2Z&*OL7VUJ@PNA+7;U%@&N2@K
M)LK5Y##:'V7,:;_UAD$RY8[)/&5 C F[%5SS\(EU': 7A-/9V=KV\DS,;F=\
M.(/4=UMC\ZQY[VM5NL/I#'G/E9+#?O#1MA0.P$/65;9@I[A->>#&L/NVX9Q9
M+WL,\@VY!UC8;4]'KA_\A.KK6.%OKN]&D9C\CEFRM$7_:%T9Q,"!&WAC7%)4
M1$8$ K*3,"5P[57KN^HE"*2)25T;)UBP8Y,#L?8[\RAOY)N3<[FR_J)Z7"$6
M*O*JRDD-($2EO@&P[4O7*,TU%J@S@CH36#_J %?7Z-7D."-5[BGUQ4 J9UQS
M2,"&:YU=W'"P0B>M[U5:O]JVM!X"GP*F[._G]J3VJ"%U$$==0:XL"HE_"U-L
M6=7#>?:UK-O7SG9L*\=\CK9M;HQ;$I"\=C>&JY6URK*U0JF+:*Y"XTIRW(P2
MU[PI$/>M6"/)-YO71MDV6)=H_:)F_&;W-],9_P_\.L<#B;,6HKM!T*. !B!4
MBZ%>)]AI</U0%%J(]W.EBE0P,0>(K"W#&B M;EWK**"6VSU;IX6UC:@E1"N.
MC8:U_%UW(@"V:L&IK:W5<^R9[G\8FJ2RW)9Y[^2[-8\!M>,&'F8K:C<>7L[W
M;BRXK;NSN6&4_TX*XI@CD9Q<<WM"8\D;#ZKQPPR2NFM@E2L70YLU6VPTK1SK
M-(0N%5!T^3C&ZB0B[J'BAWAE$(#Z8, #]^N,][/CZ/=[ANC!MEGZI5<XO]7B
MT3H[%P$H.DD<X7$ %?YB+U&?SEV59L5P6KK(,*?:U.?(RQ7^T<C[,R#L8-L(
M^QOP'A:TW#LXWRK67J MCGJQ$<QEK $UC:D"*H8?]1R[F'H#/U%'(66\5U4]
M9P7S:Q3B\Y0:5WE-P3+7DZ!N@VTZN:S-J]BE'W;IAUWZX4^2?H@V '8D'=L6
M"JAJ>\XWQV*<CVF1Z)".Y&QVIJO\!XTNT&OY-%Z3%'IRK+F]85N[OYECTZ8=
M3K\J2XK)?8(]TLG5!P:;]8#PO2T)@B8;D9165 ATJ"66!KDR!-9UZ9#2Q)?Q
MSB.TL7#(!3<Z5?9>-8/F&> /KAG\2D=:(D*^DTM"O?]5<:FVK-52MAB@)[J[
MG06E(Y/Q2YZ]H-;/.$NQDU9[61Z1'1_56?7BI][R1O^XMHG#ESJ.59X4LM7<
ME]18B'IK@EU+\7$,);*K;]VM4KD;R(4RIAQ<]C;\4<( H0[\K"U[GFF5R4RN
MZ#M,TFDR8.\#2\M=VWT3>/C#>&,D*53U=V=B@=OKW &%#0'8Z9A)X'FG!2?P
M_*;@_2D=M8NIUSUO0AWQWROQ-\_!>OA<  J\,:%ME>*OC?O-\QT^ZQ_1B;'L
M85L+RM30.%1!)#.#\#>Y>G1,?(5/JZL%%ZOL^+#-_W>S9^>6\T%X^GAH$6:P
MYM4/-TXU)VV#2!0^JUGR:&8^U(#9M.0S8Y%/#$_7<^=0U'ZJK1I=5^0PJ)</
MR#'H%24=6EC+][W#F*9U<6124P%!ZMY7>UZKX554 $K-[+Q,;$KWI<QBCN;A
MXU,*H^6%FV(4)4MW@ A[&,MX(G4F&I'0?1.=F>N\?@2K.V-K<^+ROM?7H78(
M6\?G[I'/;;WQVVFQ][EJJK'UEF^CWRZNQ>FO'X?#R^'52,"7J_<C<2I^_73Z
M\?1J-!R*]Q_%AX_O+R^NX<^W8GCYX=W[W^G>M_#+J3@?OKVXNA@-Q8?AQXOW
MYWC/Z.)RV!.G5^?F[N'04-JU__CGB]%OXNS]Y8?3J]_QO>;,A]/1WN>+=^_L
M&0\XRN7I[^*7H1@-/UY>7)V.AN?BE]_%$!X?PM1./XY^%Z<P91B%7TP#P]SP
M\_VGD3@[_01SQX&:O\!2+\Z&WT="K6W'?B0);2%JZ/=@#B26HT749U^&MBB$
MCM90-E"VN0: #<IF:0UG1]B,.-,OK2T]E=1I8K2<-E,K#VD< 6#R!KRF'/7T
M5=OBUCO7\G[<)=_G9_#WHN[ HL'OZ''YP2NYAVJ*N]3Z/WES<87$?36\OA:?
M@3T,W[^M&T"4)$2-5L(6IP1F[GCQ!PZ+-<,.:^DO)K]R2.$ZS.\Y)\,%JW"^
MB;5L&YO6*/M'HM>&7HP/CEXO#A^'XF%YJJ]UW+K$6RGD<3XUOCM*NF21^L?E
M!6@DIZ./%_\G+H?G%V>G[\3%U5G%N-&U3!#^QQ/<^R>VN:N-*;!G/DBB2*:Y
M.K9_^-N)4S:1 W1)8SX#8(Y9T*M7_9>OR*-^<PO8Q+9Z?7;0/SAT(0%+8>E7
M:FX6"ANZ,+]S%&#3KR8>L.EG=/VO_^CY[+U&JV#9#IX9VN(_[R]*\'.(O>_B
M2RT"ZIJ.] %S[]B@\C_AO_8S$OP'__P1!]6@K02*KL@)F*\6C.OQEFKU>Y',
MB[I"NWE*'J=M4 7O8Z,M,K%*II7#_K-7!"NSH<)N[*W<QD;ZUN)>%B5*_M?!
MV>/*'90[*'=0[J#\"*#\.$7VATQC&QLY=S*[D]<^5@Q>]@^>=>3WUR>_#LH=
ME#LH=U#^JPML]+]VHKH-'T!2#SJZ^^O370?E#LH=E#LH=U!^7%!^C&'>/Q\]
M:1S0MS&X]?15_]6++KC5!;=^61UO.._[/Y7A#%[V#SO&_M=G[!V4.RAW4.Z@
MW$'Y<4'Y<>I!'#&\ZB*&F[2B9_T7G5KT$Y!?!^4.RAV4.RC_U07V"+NU=K*Z
M"QG^O(370;F#<@?E#LH=E!\7E!^G0M2E4'7ZT,]-=QV4.RAW4.Z@W$'Y<4'9
M)1[M8VG]/M7MOS$=8^^[4?$W*45;S<KYTXK;[1NQO@[3H=C?5]>J(7,;]+W
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MYI@56(@.*H*BO38?$[T.LK^667A\+S$'4;7287!DT[,3Q*]R9XH[64$7DKG
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M.,CJAL)TN6;'<4NW>VC_OD*:#MI(-AIB6Z[MJHVUH [RX<J4;04.T,)&9G;
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M9M^T'?\+4$L! A0#%     @ 9X%O4PLZ#E-[%0  5O$  !
M ( !     '1M8BTR,#(Q,#DS,"YX<V102P$"% ,4    " !G@6]33N04]58.
M  !FS   %               @ &I%0  =&UB+3(P,C$P.3,P7V-A;"YX;6Q0
M2P$"% ,4    " !G@6]3IL7'(;8^  "+6@0 %               @ $Q)
M=&UB+3(P,C$P.3,P7V1E9BYX;6Q02P$"% ,4    " !G@6]3% YA;5AZ  #O
MR@< %               @ $98P  =&UB+3(P,C$P.3,P7VQA8BYX;6Q02P$"
M% ,4    " !G@6]3M25RG!Q/  "> P8 %               @ &CW0  =&UB
M+3(P,C$P.3,P7W!R92YX;6Q02P$"% ,4    " !G@6]320^BWM;O 0".3Q<
M%               @ 'Q+ $ =&UB+3(P,C$P.3,P>#$P<2YH=&U02P$"% ,4
M    " !G@6]3^K/HP&H(  #P8@  %P              @ 'Y' , =&UB+3(P
M,C$P.3,P>&5X,3!D-"YH=&U02P$"% ,4    " !G@6]3Z(+R'K@D  !M" $
M%P              @ &8)0, =&UB+3(P,C$P.3,P>&5X,3!D-2YH=&U02P$"
M% ,4    " !G@6]39RR&+:L(  " ,0  %P              @ &%2@, =&UB
M+3(P,C$P.3,P>&5X,S%D,2YH=&U02P$"% ,4    " !G@6]3SE^<0)T(  !<
M,0  %P              @ %E4P, =&UB+3(P,C$P.3,P>&5X,S%D,BYH=&U0
M2P$"% ,4    " !G@6]3&2GO4U\%   X'   %P              @ $W7 ,
M=&UB+3(P,C$P.3,P>&5X,S)D,2YH=&U02P$"% ,4    " !G@6]3WI[A]U\%
M   ^'   %P              @ '+80, =&UB+3(P,C$P.3,P>&5X,S)D,BYH
8=&U02P4&      P #  F P  7V<#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
